@prefix ns1: <https://1145.am/db/> .
@prefix org: <http://www.w3.org/ns/org#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://1145.am/db/2175059/Tv_Everywhere> a org:Organization ;
    ns1:basedInLowRaw "PACIFIC" ;
    ns1:buyer <https://1145.am/db/2175059/Tv_Everywhere_Completed> ;
    ns1:documentDate "2013-10-14T15:14:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aereo set to launch Android app; Vodafone closes Kabel Deutschland deal" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/aereo-set-to-launch-android-app-vodafone-closes-kabel-deutschland-deal> ;
    ns1:foundName "DOCOMO PACIFIC" ;
    ns1:name "TV Everywhere" ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2175059/Vodafone> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:buyer <https://1145.am/db/2175059/Kabel_Deutschland_Acquisition> ;
    ns1:documentDate "2013-10-14T15:14:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aereo set to launch Android app; Vodafone closes Kabel Deutschland deal" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/aereo-set-to-launch-android-app-vodafone-closes-kabel-deutschland-deal> ;
    ns1:foundName "Vodafone" ;
    ns1:name "Vodafone" ;
    ns1:sameAsMedium <https://1145.am/db/102640/Vodafone>,
        <https://1145.am/db/1048791/Vodafone>,
        <https://1145.am/db/1058951/Vodafone>,
        <https://1145.am/db/1071658/Vodafone>,
        <https://1145.am/db/1293352/Vodafone>,
        <https://1145.am/db/1299724/Vodafone>,
        <https://1145.am/db/1358299/Vodafone>,
        <https://1145.am/db/1389347/Vodafone>,
        <https://1145.am/db/1389651/Vodafone>,
        <https://1145.am/db/1420625/Vodafone>,
        <https://1145.am/db/1421912/Vodafone>,
        <https://1145.am/db/1552870/Vodafone>,
        <https://1145.am/db/1627625/Vodafone>,
        <https://1145.am/db/1628420/Vodafone>,
        <https://1145.am/db/1687890/Vodafone>,
        <https://1145.am/db/1729077/Vodafone>,
        <https://1145.am/db/1805873/Vodafone>,
        <https://1145.am/db/181882/Vodafone>,
        <https://1145.am/db/1872318/Vodafone>,
        <https://1145.am/db/1896956/Vodafone>,
        <https://1145.am/db/1919221/Vodafone>,
        <https://1145.am/db/1969437/Vodafone>,
        <https://1145.am/db/1993312/Vodafone>,
        <https://1145.am/db/2005677/Vodafone>,
        <https://1145.am/db/2009302/Vodafone>,
        <https://1145.am/db/2029449/Vodafone>,
        <https://1145.am/db/2036731/Vodafone>,
        <https://1145.am/db/2037305/Vodafone_Uk>,
        <https://1145.am/db/2037901/Vodafone>,
        <https://1145.am/db/2044056/Vodafone>,
        <https://1145.am/db/2066713/Vodafone>,
        <https://1145.am/db/2140764/Vodafone>,
        <https://1145.am/db/2149846/Vodafone>,
        <https://1145.am/db/2162588/Vodafone>,
        <https://1145.am/db/2167342/Vodafone>,
        <https://1145.am/db/2172635/Vodafone>,
        <https://1145.am/db/2174251/Vodafone>,
        <https://1145.am/db/2174257/Vodafone>,
        <https://1145.am/db/2175880/Vodafone>,
        <https://1145.am/db/2176686/Vodafone>,
        <https://1145.am/db/2177533/Vodafone>,
        <https://1145.am/db/219260/Vodafone>,
        <https://1145.am/db/219415/Vodafone>,
        <https://1145.am/db/243358/Vodafone>,
        <https://1145.am/db/245901/Vodafone>,
        <https://1145.am/db/2549313/Vodafone>,
        <https://1145.am/db/2601966/Vodafone>,
        <https://1145.am/db/2602132/Vodafone>,
        <https://1145.am/db/2602659/Vodafone>,
        <https://1145.am/db/2603641/Vodafone>,
        <https://1145.am/db/2604430/Vodafone>,
        <https://1145.am/db/2604744/Vodafone>,
        <https://1145.am/db/2607321/Vodafone>,
        <https://1145.am/db/2610786/Vodafone>,
        <https://1145.am/db/2611210/Vodafone>,
        <https://1145.am/db/2616043/Vodafone>,
        <https://1145.am/db/2618856/Vodafone>,
        <https://1145.am/db/2619168/Vodafone>,
        <https://1145.am/db/2619431/Vodafone>,
        <https://1145.am/db/2619973/Vodafone>,
        <https://1145.am/db/2619998/Vodafone>,
        <https://1145.am/db/2620945/Vodafone>,
        <https://1145.am/db/2621829/Vodafone>,
        <https://1145.am/db/2623767/Vodafone>,
        <https://1145.am/db/2625228/Vodafone>,
        <https://1145.am/db/2627269/Vodafone>,
        <https://1145.am/db/2627411/Vodafone>,
        <https://1145.am/db/2628118/Vodafone>,
        <https://1145.am/db/2629279/Vodafone>,
        <https://1145.am/db/2637785/Vodafone>,
        <https://1145.am/db/2638371/Vodafone>,
        <https://1145.am/db/2639390/Vodafone>,
        <https://1145.am/db/2640422/Vodafone>,
        <https://1145.am/db/2642043/Vodafone>,
        <https://1145.am/db/2642380/Vodafone>,
        <https://1145.am/db/2642427/Vodafone>,
        <https://1145.am/db/2643398/Vodafone>,
        <https://1145.am/db/2643528/Vodafone>,
        <https://1145.am/db/2646466/Vodafone>,
        <https://1145.am/db/2647254/Vodafone>,
        <https://1145.am/db/2648461/Vodafone>,
        <https://1145.am/db/2648535/Vodafone>,
        <https://1145.am/db/2650576/Vodafone>,
        <https://1145.am/db/2650894/Vodafone>,
        <https://1145.am/db/2651116/Vodafone>,
        <https://1145.am/db/2651393/Vodafone>,
        <https://1145.am/db/2651401/Vodafone>,
        <https://1145.am/db/2651472/Vodafone>,
        <https://1145.am/db/2651481/Vodafone>,
        <https://1145.am/db/2651531/Vodafone>,
        <https://1145.am/db/2651536/Vodafone>,
        <https://1145.am/db/2651657/Vodafone>,
        <https://1145.am/db/2651735/Vodafone_Uk>,
        <https://1145.am/db/2651863/Vodafone>,
        <https://1145.am/db/2652007/Vodafone>,
        <https://1145.am/db/2652011/Vodafone>,
        <https://1145.am/db/2652523/Vodafone>,
        <https://1145.am/db/2652568/Vodafone>,
        <https://1145.am/db/2652681/Vodafone>,
        <https://1145.am/db/2652980/Vodafone>,
        <https://1145.am/db/2653074/Vodafone>,
        <https://1145.am/db/2653078/Vodafone>,
        <https://1145.am/db/2653299/Vodafone>,
        <https://1145.am/db/2653355/Vodafone>,
        <https://1145.am/db/2653489/Vodafone>,
        <https://1145.am/db/2653502/Vodafone>,
        <https://1145.am/db/2654160/Vodafone>,
        <https://1145.am/db/2654684/Vodafone>,
        <https://1145.am/db/2654827/Vodafone>,
        <https://1145.am/db/2654966/Vodafone>,
        <https://1145.am/db/2655003/Vodafone>,
        <https://1145.am/db/2655513/Vodafone>,
        <https://1145.am/db/2655523/Vodafone>,
        <https://1145.am/db/2655569/Vodafone>,
        <https://1145.am/db/2655783/Vodafone>,
        <https://1145.am/db/2655927/Vodafone>,
        <https://1145.am/db/2656108/Vodafone>,
        <https://1145.am/db/2656193/Vodafone>,
        <https://1145.am/db/2656296/Vodafone>,
        <https://1145.am/db/2656675/Vodafone>,
        <https://1145.am/db/2656843/Vodafone>,
        <https://1145.am/db/2656915/Vodafone>,
        <https://1145.am/db/2657119/Vodafone>,
        <https://1145.am/db/2657380/Vodafone>,
        <https://1145.am/db/2658006/Vodafone>,
        <https://1145.am/db/2658765/Vodafone>,
        <https://1145.am/db/2658879/Vodafone>,
        <https://1145.am/db/2659254/Vodafone_Uk>,
        <https://1145.am/db/2659542/Vodafone>,
        <https://1145.am/db/2659966/Vodafone>,
        <https://1145.am/db/2660422/Vodafone>,
        <https://1145.am/db/2660581/Vodafone>,
        <https://1145.am/db/2660622/Vodafone>,
        <https://1145.am/db/2660995/Vodafone>,
        <https://1145.am/db/2661169/Vodafone>,
        <https://1145.am/db/2662074/Vodafone>,
        <https://1145.am/db/2662248/Vodafone>,
        <https://1145.am/db/2662640/Vodafone>,
        <https://1145.am/db/2662671/Vodafone>,
        <https://1145.am/db/2662741/Vodafone>,
        <https://1145.am/db/2662747/Vodafone>,
        <https://1145.am/db/2663184/Vodafone>,
        <https://1145.am/db/2663787/Vodafone>,
        <https://1145.am/db/2664232/Vodafone>,
        <https://1145.am/db/2664269/Vodafone>,
        <https://1145.am/db/2664436/Vodafone>,
        <https://1145.am/db/2664734/Vodafone>,
        <https://1145.am/db/2664887/Vodafone>,
        <https://1145.am/db/2665348/Vodafone>,
        <https://1145.am/db/2665363/Vodafone>,
        <https://1145.am/db/2665805/Vodafone>,
        <https://1145.am/db/2665849/Vodafone>,
        <https://1145.am/db/2666006/Vodafone>,
        <https://1145.am/db/2666397/Vodafone>,
        <https://1145.am/db/2666418/Vodafone>,
        <https://1145.am/db/2666740/Vodafone>,
        <https://1145.am/db/2666771/Vodafone>,
        <https://1145.am/db/2667394/Vodafone>,
        <https://1145.am/db/2667413/Vodafone>,
        <https://1145.am/db/2667420/Vodafone>,
        <https://1145.am/db/2667435/Vodafone>,
        <https://1145.am/db/2667439/Vodafone>,
        <https://1145.am/db/2667470/Vodafone>,
        <https://1145.am/db/2667525/Vodafone>,
        <https://1145.am/db/2667804/Vodafone>,
        <https://1145.am/db/2667843/Vodafone>,
        <https://1145.am/db/2668097/Vodafone>,
        <https://1145.am/db/2668504/Vodafone>,
        <https://1145.am/db/2668524/Vodafone>,
        <https://1145.am/db/2668781/Vodafone>,
        <https://1145.am/db/2668926/Vodafone>,
        <https://1145.am/db/2669324/Vodafone>,
        <https://1145.am/db/2669483/Vodafone>,
        <https://1145.am/db/2669642/Vodafone>,
        <https://1145.am/db/2669661/Vodafone>,
        <https://1145.am/db/2670097/Vodafone>,
        <https://1145.am/db/2670157/Vodafone>,
        <https://1145.am/db/2670202/Vodafone>,
        <https://1145.am/db/2670747/Vodafone>,
        <https://1145.am/db/2671282/Vodafone>,
        <https://1145.am/db/2671912/Vodafone>,
        <https://1145.am/db/2671937/Vodafone>,
        <https://1145.am/db/2671975/Vodafone>,
        <https://1145.am/db/2672455/Vodafone>,
        <https://1145.am/db/2672595/Vodafone>,
        <https://1145.am/db/2673101/Vodafone>,
        <https://1145.am/db/2673796/Vodafone>,
        <https://1145.am/db/2673809/Vodafone>,
        <https://1145.am/db/2673830/Vodafone>,
        <https://1145.am/db/2673945/Vodafone>,
        <https://1145.am/db/2673958/Vodafone>,
        <https://1145.am/db/2674304/Vodafone>,
        <https://1145.am/db/2674316/Vodafone>,
        <https://1145.am/db/2674986/Vodafone>,
        <https://1145.am/db/2676263/Vodafone>,
        <https://1145.am/db/2676293/Vodafone>,
        <https://1145.am/db/2676572/Vodafone_Nl>,
        <https://1145.am/db/2676653/Vodafone>,
        <https://1145.am/db/2676679/Vodafone_Uk>,
        <https://1145.am/db/2677037/Vodafone>,
        <https://1145.am/db/2677134/Vodafone>,
        <https://1145.am/db/2677181/Vodafone>,
        <https://1145.am/db/2677247/Vodafone>,
        <https://1145.am/db/2677846/Vodafone>,
        <https://1145.am/db/2678352/Vodafone>,
        <https://1145.am/db/2678973/Vodafone>,
        <https://1145.am/db/2679009/Vodafone>,
        <https://1145.am/db/2679024/Vodafone>,
        <https://1145.am/db/2679037/Vodafone>,
        <https://1145.am/db/2679067/Vodafone>,
        <https://1145.am/db/2679163/Vodafone>,
        <https://1145.am/db/2679561/Vodafone>,
        <https://1145.am/db/2679756/Vodafone>,
        <https://1145.am/db/2679758/Vodafone>,
        <https://1145.am/db/2679807/Vodafone>,
        <https://1145.am/db/2679815/Vodafone>,
        <https://1145.am/db/2680056/Vodafone>,
        <https://1145.am/db/2680662/Vodafone>,
        <https://1145.am/db/2680795/Vodafone>,
        <https://1145.am/db/2681222/Vodafone>,
        <https://1145.am/db/2681332/Vodafone>,
        <https://1145.am/db/2681502/Vodafone>,
        <https://1145.am/db/2682215/Vodafone>,
        <https://1145.am/db/2682262/Vodafone>,
        <https://1145.am/db/2682269/Vodafone>,
        <https://1145.am/db/2682308/Vodafone>,
        <https://1145.am/db/2682869/Vodafone>,
        <https://1145.am/db/2683077/Vodafone>,
        <https://1145.am/db/2683432/Vodafone>,
        <https://1145.am/db/2683443/Vodafone>,
        <https://1145.am/db/2683648/Vodafone>,
        <https://1145.am/db/2683951/Vodafone>,
        <https://1145.am/db/2684208/Vodafone>,
        <https://1145.am/db/276165/Vodafone>,
        <https://1145.am/db/2787061/Vodafone>,
        <https://1145.am/db/2790448/Vodafone>,
        <https://1145.am/db/2792664/Vodafone>,
        <https://1145.am/db/76144/Vodafone>,
        <https://1145.am/db/77455/Vodafone>,
        <https://1145.am/db/776787/Vodafone>,
        <https://1145.am/db/782490/Vodafone>,
        <https://1145.am/db/799527/Vodafone>,
        <https://1145.am/db/821887/Vodafone>,
        <https://1145.am/db/849181/Vodafone>,
        <https://1145.am/db/849502/Vodafone> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2229117/Chv_Capital> a org:Organization ;
    ns1:basedInLowRaw "Indiana" ;
    ns1:description "healthcare" ;
    ns1:documentDate "2014-01-29T18:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Health Catalyst raises $41 million for product development; Austin City Council raises concerns over athenahealth deal;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/health-catalyst-raises-41-million-for-product-development-austin-city-council-raises-concerns> ;
    ns1:foundName "CHV Capital" ;
    ns1:investor <https://1145.am/db/2229117/Investment_Chv_Capital_Health_Catalyst_Kaiser_Permanente_Ventures_Norwest_Venture_Partners_Partners_Healthcare_Sequoia_Capital_Sorenson_Capital_Completed> ;
    ns1:name "CHV Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1223283/Hildred_Capital_Management>,
        <https://1145.am/db/2193635/Firstmark_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1828383/Chv_Capital> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2229117/Kaiser_Permanente_Ventures> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2014-01-29T18:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Health Catalyst raises $41 million for product development; Austin City Council raises concerns over athenahealth deal;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/health-catalyst-raises-41-million-for-product-development-austin-city-council-raises-concerns> ;
    ns1:foundName "Kaiser Permanente Ventures" ;
    ns1:investor <https://1145.am/db/2229117/Investment_Chv_Capital_Health_Catalyst_Kaiser_Permanente_Ventures_Norwest_Venture_Partners_Partners_Healthcare_Sequoia_Capital_Sorenson_Capital_Completed> ;
    ns1:name "Kaiser Permanente Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1352973/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/1715197/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/1842350/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2194210/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2297905/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2300288/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2300340/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2300455/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2300697/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2308556/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2310099/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2326261/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2331820/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2331852/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2331858/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2347876/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2348484/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/2364422/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/325080/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/489208/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/492233/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/770705/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/958767/Kaiser_Permanente_Ventures>,
        <https://1145.am/db/959519/Kaiser_Permanente_Ventures> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2229117/Norwest_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Salt Lake City" ;
    ns1:documentDate "2014-01-29T18:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Health Catalyst raises $41 million for product development; Austin City Council raises concerns over athenahealth deal;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/health-catalyst-raises-41-million-for-product-development-austin-city-council-raises-concerns> ;
    ns1:foundName "Norwest Venture Partners" ;
    ns1:investor <https://1145.am/db/2229117/Investment_Chv_Capital_Health_Catalyst_Kaiser_Permanente_Ventures_Norwest_Venture_Partners_Partners_Healthcare_Sequoia_Capital_Sorenson_Capital_Completed> ;
    ns1:name "Norwest Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1003926/Norwest_Venture_Partners>,
        <https://1145.am/db/1007995/Norwest_Venture_Partners>,
        <https://1145.am/db/1072020/Norwest_Venture_Partners>,
        <https://1145.am/db/1079459/Norwest_Venture_Partners>,
        <https://1145.am/db/1083644/Norwest_Equity_Partners>,
        <https://1145.am/db/1085651/Norwest_Equity_Partners>,
        <https://1145.am/db/11103/Norwest_Venture_Partners>,
        <https://1145.am/db/1180957/Norwest_Equity_Partners>,
        <https://1145.am/db/1181574/Norwest_Equity_Partners>,
        <https://1145.am/db/1203939/Norwest_Venture_Partners>,
        <https://1145.am/db/1268392/Norwest_Venture_Partners>,
        <https://1145.am/db/1275253/Norwest_Venture_Partners>,
        <https://1145.am/db/1300067/Norwest_Venture_Partners>,
        <https://1145.am/db/1300712/Norwest_Venture_Partners>,
        <https://1145.am/db/1335509/Norwest_Venture_Partners>,
        <https://1145.am/db/1335601/Norwest_Venture_Partners>,
        <https://1145.am/db/1355348/Norwest_Venture_Partners>,
        <https://1145.am/db/1359749/Norwest_Venture_Partners>,
        <https://1145.am/db/1386496/Norwest_Venture_Partners>,
        <https://1145.am/db/1413193/Norwest_Venture_Partners>,
        <https://1145.am/db/1425749/Norwest_Venture_Partners>,
        <https://1145.am/db/1455674/Norwest_Venture_Partners>,
        <https://1145.am/db/1475136/Norwest_Venture_Partners>,
        <https://1145.am/db/1528105/Norwest_Venture_Partners>,
        <https://1145.am/db/1574647/Norwest_Venture_Partners>,
        <https://1145.am/db/1629773/Norwest_Venture_Partners>,
        <https://1145.am/db/1648953/Norwest_Venture_Partners>,
        <https://1145.am/db/1653506/Norwest_Venture_Partners>,
        <https://1145.am/db/1693973/Norwest_Venture_Partners>,
        <https://1145.am/db/1694241/Norwest_Venture_Partners>,
        <https://1145.am/db/1695894/Norwest_Venture_Partners>,
        <https://1145.am/db/1698487/Norwest_Venture_Partners>,
        <https://1145.am/db/1700205/Norwest_Venture_Partners>,
        <https://1145.am/db/1702857/Norwest_Venture_Partners>,
        <https://1145.am/db/1708761/Norwest_Ventures>,
        <https://1145.am/db/1713870/Norwest_Venture_Partners>,
        <https://1145.am/db/1716850/Norwest_Venture_Partners>,
        <https://1145.am/db/1717363/Norwest_Venture_Partners>,
        <https://1145.am/db/1718081/Norwest_Venture_Partners>,
        <https://1145.am/db/1723456/Norwest_Venture_Partners>,
        <https://1145.am/db/1724566/Norwest_Venture_Partners>,
        <https://1145.am/db/1728569/Norwest_Venture_Partners>,
        <https://1145.am/db/1730063/Norwest_Venture_Partners>,
        <https://1145.am/db/1735168/Norwest_Venture_Partners>,
        <https://1145.am/db/1735722/Norwest_Venture_Partners>,
        <https://1145.am/db/1737801/Norwest_Venture_Partners>,
        <https://1145.am/db/1738343/Norwest_Venture_Partners>,
        <https://1145.am/db/1738405/Norwest_Venture_Partners>,
        <https://1145.am/db/1742276/Norwest_Venture_Partners>,
        <https://1145.am/db/1744154/Norwest_Venture_Partners>,
        <https://1145.am/db/1744650/Norwest_Venture_Partners>,
        <https://1145.am/db/1748025/Norwest_Venture_Partners>,
        <https://1145.am/db/1748417/Norwest_Venture_Partners>,
        <https://1145.am/db/1750104/Norwest_Venture_Partners>,
        <https://1145.am/db/1750685/Norwest_Venture_Partners>,
        <https://1145.am/db/1753949/Norwest_Venture_Partners>,
        <https://1145.am/db/1754794/Norwest_Venture_Partners>,
        <https://1145.am/db/1756472/Norwest_Venture_Partners>,
        <https://1145.am/db/1758223/Norwest_Venture_Partners>,
        <https://1145.am/db/1760367/Norwest_Venture_Partners>,
        <https://1145.am/db/1761512/Norwest_Venture_Partners>,
        <https://1145.am/db/1762031/Norwest_Venture_Partners>,
        <https://1145.am/db/1762151/Norwest_Venture_Partners>,
        <https://1145.am/db/1765377/Norwest_Venture_Partners>,
        <https://1145.am/db/1768719/Norwest_Venture_Partners>,
        <https://1145.am/db/1769188/Norwest_Venture_Partners>,
        <https://1145.am/db/1770552/Norwest_Venture_Partners>,
        <https://1145.am/db/1772778/Norwest_Venture_Partners>,
        <https://1145.am/db/1775939/Norwest_Venture_Partners>,
        <https://1145.am/db/1776024/Norwest_Venture_Partners>,
        <https://1145.am/db/1779083/Norwest_Venture_Partners>,
        <https://1145.am/db/1780738/Norwest_Venture_Partners>,
        <https://1145.am/db/1780998/Norwest_Venture_Partners>,
        <https://1145.am/db/1781413/Norwest_Venture_Partners>,
        <https://1145.am/db/1783189/Norwest_Venture_Partners>,
        <https://1145.am/db/1785361/Norwest_Venture_Partners>,
        <https://1145.am/db/1789742/Norwest_Venture_Partners>,
        <https://1145.am/db/1790917/Norwest_Venture_Partners>,
        <https://1145.am/db/1793230/Norwest_Venture_Partners>,
        <https://1145.am/db/1794652/Norwest_Venture_Partners>,
        <https://1145.am/db/1796380/Norwest_Venture_Partners>,
        <https://1145.am/db/1797910/Norwest_Venture_Partners>,
        <https://1145.am/db/1799888/Norwest_Venture_Partners>,
        <https://1145.am/db/1803251/Norwest_Venture_Partners>,
        <https://1145.am/db/1812233/Norwest_Venture_Partners>,
        <https://1145.am/db/1815778/Norwest_Venture_Partners>,
        <https://1145.am/db/1816222/Norwest_Venture_Partners>,
        <https://1145.am/db/1817233/Norwest_Venture_Partners>,
        <https://1145.am/db/1817376/Norwest_Venture_Partners>,
        <https://1145.am/db/1818730/Norwest_Venture_Partners>,
        <https://1145.am/db/1819543/Norwest_Venture_Partners>,
        <https://1145.am/db/1822175/Norwest_Venture_Partners>,
        <https://1145.am/db/1823415/Norwest_Venture_Partners>,
        <https://1145.am/db/1823618/Norwest_Venture_Partners>,
        <https://1145.am/db/1824253/Norwest_Venturepartners>,
        <https://1145.am/db/1828979/Norwest_Ventures_Partners>,
        <https://1145.am/db/1829302/Norwest_Venture_Partners>,
        <https://1145.am/db/1831222/Norwest_Venture_Partners>,
        <https://1145.am/db/1832611/Norwest_Venture_Partners>,
        <https://1145.am/db/1833588/Norwest_Venture_Partners>,
        <https://1145.am/db/1835825/Norwest_Venture_Partners>,
        <https://1145.am/db/1837741/Norwest_Venture_Partners>,
        <https://1145.am/db/1839996/Norwest_Venture_Partners>,
        <https://1145.am/db/1840957/Norwest_Venture_Partners>,
        <https://1145.am/db/1840962/Norwest_Venture_Partners>,
        <https://1145.am/db/1843659/Norwest_Venture_Partners>,
        <https://1145.am/db/1844398/Norwest_Venture_Partners>,
        <https://1145.am/db/1847160/Norwest_Venture_Partners>,
        <https://1145.am/db/1850786/Norwest_Venture_Partners>,
        <https://1145.am/db/1851757/Norwest_Venture_Partners>,
        <https://1145.am/db/1852302/Norwest_Venture_Partners>,
        <https://1145.am/db/1853766/Norwest_Venture_Partners>,
        <https://1145.am/db/1854385/Norwest_Venture_Partners>,
        <https://1145.am/db/1857563/Norwest_Venture_Partners>,
        <https://1145.am/db/1857669/Norwest_Venture_Partners>,
        <https://1145.am/db/1859652/Norwest_Venture_Partners>,
        <https://1145.am/db/1861256/Norwest_Venture_Partners>,
        <https://1145.am/db/1868107/Norwest_Venture_Partners>,
        <https://1145.am/db/1872836/Norwest_Venture_Partners>,
        <https://1145.am/db/1873252/Norwest_Venture_Partners>,
        <https://1145.am/db/1875747/Norwest_Venture_Partners>,
        <https://1145.am/db/1876447/Norwest_Venture_Partners>,
        <https://1145.am/db/1879131/Norwest_Venture_Partners>,
        <https://1145.am/db/1884014/Norwest_Venture_Partners>,
        <https://1145.am/db/1887816/Norwest_Venture_Partners>,
        <https://1145.am/db/1889935/Norwest_Venture_Partners>,
        <https://1145.am/db/1891654/Norwest_Venture_Partners>,
        <https://1145.am/db/1895089/Norwest_Venture_Partners>,
        <https://1145.am/db/1915640/Norwest_Venture_Partners>,
        <https://1145.am/db/198163/Norwest_Venture_Partners>,
        <https://1145.am/db/1990586/Norwest_Ventures>,
        <https://1145.am/db/2010246/Norwest_Venture_Partners>,
        <https://1145.am/db/214438/Norwest_Venture_Partners>,
        <https://1145.am/db/2164916/Norwest_Venture_Partners>,
        <https://1145.am/db/2180318/Norwest_Venture_Partners>,
        <https://1145.am/db/2191533/Norwest_Venture_Partners>,
        <https://1145.am/db/2195351/Norwest_Venture_Partners>,
        <https://1145.am/db/2196851/Norwest_Venture_Partners>,
        <https://1145.am/db/2246460/Norwest_Equity_Partners>,
        <https://1145.am/db/2253057/Norwest_Venture_Partners>,
        <https://1145.am/db/2279124/Norwest_Venture_Partners>,
        <https://1145.am/db/2287053/Norwest_Venture_Partners>,
        <https://1145.am/db/2296562/Norwest_Venture_Partners>,
        <https://1145.am/db/2324872/Norwest_Venture_Partners>,
        <https://1145.am/db/2630274/Norwest_Venture_Partners>,
        <https://1145.am/db/266035/Norwest_Venture_Partners>,
        <https://1145.am/db/2797562/Norwest_Venture_Partners>,
        <https://1145.am/db/303058/Norwest_Equity_Partners>,
        <https://1145.am/db/310758/Norwest_Venture_Partners>,
        <https://1145.am/db/312519/Norwest_Venture_Partners>,
        <https://1145.am/db/323838/Norwest_Venture_Partners>,
        <https://1145.am/db/417248/Norwest_Venture_Partners>,
        <https://1145.am/db/425935/Norwest_Venture_Partners>,
        <https://1145.am/db/464808/Norwest_Venture_Partners>,
        <https://1145.am/db/475266/Norwest_Venture_Partners>,
        <https://1145.am/db/475791/Norwest_Venture_Partners>,
        <https://1145.am/db/488743/Norwest_Venture_Partners>,
        <https://1145.am/db/495996/Norwest_Venture_Partners>,
        <https://1145.am/db/496377/Norwest_Venture_Partners>,
        <https://1145.am/db/502832/Norwest_Venture_Partners>,
        <https://1145.am/db/505321/Norwest_Venture_Partners>,
        <https://1145.am/db/505834/Norwest_Venture_Partners>,
        <https://1145.am/db/506460/Norwest_Venture_Partners>,
        <https://1145.am/db/507490/Norwest_Venture_Partners>,
        <https://1145.am/db/559220/Norwest_Venture_Partners>,
        <https://1145.am/db/562996/Norwest_Venture_Partners>,
        <https://1145.am/db/566763/Norwest_Venture_Partners>,
        <https://1145.am/db/567043/Norwest_Venture_Partners>,
        <https://1145.am/db/567895/Norwest_Venture_Partners>,
        <https://1145.am/db/571100/Norwest_Equity_Partners>,
        <https://1145.am/db/572608/Norwest_Equity_Partners>,
        <https://1145.am/db/572644/Norwest_Equity_Partners>,
        <https://1145.am/db/572660/Norwest_Equity_Partners>,
        <https://1145.am/db/572767/Norwest_Equity_Partners>,
        <https://1145.am/db/588551/Norwest_Venture_Partners>,
        <https://1145.am/db/594033/Norwest_Venture_Partners>,
        <https://1145.am/db/604489/Norwest_Venture_Partners>,
        <https://1145.am/db/612996/Norwest_Venture_Partners>,
        <https://1145.am/db/697885/Norwest_Venture_Partners>,
        <https://1145.am/db/700387/Norwest_Venture_Partners>,
        <https://1145.am/db/730742/Norwest_Venture_Partners>,
        <https://1145.am/db/862760/Norwest_Venture_Partners>,
        <https://1145.am/db/862851/Norwest_Venture_Partners>,
        <https://1145.am/db/867197/Norwest_Equity_Partners>,
        <https://1145.am/db/869958/Norwest_Equity_Partners>,
        <https://1145.am/db/913484/Norwest_Venture_Partners>,
        <https://1145.am/db/936906/Norwest_Venture_Partners>,
        <https://1145.am/db/944432/Norwest_Venture_Partners>,
        <https://1145.am/db/945565/Norwest_Venture_Partners>,
        <https://1145.am/db/979607/Norwest_Equity_Partners>,
        <https://1145.am/db/979753/Norwest_Venture_Partners>,
        <https://1145.am/db/979867/Norwest_Equity_Partners>,
        <https://1145.am/db/980678/Norwest_Venture_Partners>,
        <https://1145.am/db/987756/Norwest_Equity_Partners>,
        <https://1145.am/db/987980/Norwest_Equity_Partners>,
        <https://1145.am/db/996080/Norwest_Venture_Partners> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2229117/Partners_Healthcare> a org:Organization ;
    ns1:basedInHighGeoName "Salt Lake City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5780993/about.rdf> ;
    ns1:basedInHighRaw "Salt Lake City" ;
    ns1:documentDate "2014-01-29T18:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Health Catalyst raises $41 million for product development; Austin City Council raises concerns over athenahealth deal;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/health-catalyst-raises-41-million-for-product-development-austin-city-council-raises-concerns> ;
    ns1:foundName "Partners HealthCare" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2229117/Investment_Chv_Capital_Health_Catalyst_Kaiser_Permanente_Ventures_Norwest_Venture_Partners_Partners_Healthcare_Sequoia_Capital_Sorenson_Capital_Completed> ;
    ns1:name "Partners HealthCare" ;
    ns1:sameAsHigh <https://1145.am/db/1082508/Enhanced_Healthcare_Partners>,
        <https://1145.am/db/1169324/Physician_Partners>,
        <https://1145.am/db/1619676/Health_Enterprise_Partners>,
        <https://1145.am/db/1996720/Healthpartners>,
        <https://1145.am/db/2045394/Healthpartners>,
        <https://1145.am/db/2183365/Enhanced_Healthcare_Partners>,
        <https://1145.am/db/2185711/Physician_Partners>,
        <https://1145.am/db/2188322/Partners_Healthcare>,
        <https://1145.am/db/2189675/Health_Partners_Plans>,
        <https://1145.am/db/2192313/Partners>,
        <https://1145.am/db/2192445/Partners>,
        <https://1145.am/db/2193812/Partners>,
        <https://1145.am/db/2198292/Partners_Healthcare>,
        <https://1145.am/db/2200271/Partners_Healthcare>,
        <https://1145.am/db/2204679/Partners_Healthcare>,
        <https://1145.am/db/2214077/Preferred_Care_Partners>,
        <https://1145.am/db/2218369/Healthpartners>,
        <https://1145.am/db/2238943/Healthcare_Partners>,
        <https://1145.am/db/2248326/Preferred_Care_Partners>,
        <https://1145.am/db/2248974/Healthpartners>,
        <https://1145.am/db/2253856/Healthpartners>,
        <https://1145.am/db/2253884/Partners_Healthcare_System>,
        <https://1145.am/db/2257208/Healthpartners>,
        <https://1145.am/db/2258086/Partners_Healthcare_System_Inc>,
        <https://1145.am/db/2266402/Partners_Healthcare_System>,
        <https://1145.am/db/2269431/Partners_Healthcare>,
        <https://1145.am/db/2272588/Partners_Healthcare>,
        <https://1145.am/db/2272871/Partners_Healthcare>,
        <https://1145.am/db/2272935/Preferred_Care_Partners>,
        <https://1145.am/db/2273499/Partners_Healthcare>,
        <https://1145.am/db/2291301/Partners_Healthcare_System>,
        <https://1145.am/db/459223/Physician_Partners>,
        <https://1145.am/db/559940/Population_Health_Partners>,
        <https://1145.am/db/973424/Enhanced_Healthcare_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/2308148/Partners_Healthcare> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2229117/Sequoia_Capital> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2014-01-29T18:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Health Catalyst raises $41 million for product development; Austin City Council raises concerns over athenahealth deal;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/health-catalyst-raises-41-million-for-product-development-austin-city-council-raises-concerns> ;
    ns1:foundName "Sequoia Capital" ;
    ns1:investor <https://1145.am/db/2229117/Investment_Chv_Capital_Health_Catalyst_Kaiser_Permanente_Ventures_Norwest_Venture_Partners_Partners_Healthcare_Sequoia_Capital_Sorenson_Capital_Completed> ;
    ns1:name "Sequoia Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043275/Sequoia_Capital>,
        <https://1145.am/db/1045208/Sequoia_Capital>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1046480/Sequoia_Capital>,
        <https://1145.am/db/1079492/Sequoia_Capital>,
        <https://1145.am/db/1080353/Sequoia_Capital>,
        <https://1145.am/db/10865/Sequoia_Capital>,
        <https://1145.am/db/1100325/Sequoia_Capital>,
        <https://1145.am/db/1100813/Sequoia_Capital>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1156925/Sequoia_Capital>,
        <https://1145.am/db/1157294/Sequoia_Capital>,
        <https://1145.am/db/1177298/Sequoia_Capital>,
        <https://1145.am/db/1238490/Sequoia_Capital>,
        <https://1145.am/db/1268357/Sequoia_Capital>,
        <https://1145.am/db/127229/Sequoia_Capital>,
        <https://1145.am/db/1319807/Sequoia_Capital>,
        <https://1145.am/db/1343813/Sequoia_Capital>,
        <https://1145.am/db/1374986/Sequoia_Capital>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1695423/Sequoia_Capital>,
        <https://1145.am/db/1697031/Sequoia_Capital>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697327/Sequoia_Capital>,
        <https://1145.am/db/1698270/Sequoia_Capital>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702319/Sequoia_Capital>,
        <https://1145.am/db/1704248/Sequoia_Capital>,
        <https://1145.am/db/1707286/Sequoia_Capital>,
        <https://1145.am/db/1709808/Sequoia_Capital>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1722924/Sequoia_Capital>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725546/Sequoia_Capital>,
        <https://1145.am/db/1728375/Sequoia_Capital>,
        <https://1145.am/db/1734791/Sequoia_Capital>,
        <https://1145.am/db/1736130/Sequoia_Capital>,
        <https://1145.am/db/1736614/Sequoia_Capital>,
        <https://1145.am/db/1737036/Sequoia_Capital>,
        <https://1145.am/db/1737079/Sequoia_Capital>,
        <https://1145.am/db/1738378/Sequoia_Capital>,
        <https://1145.am/db/1738401/Sequoia_Capital>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1741183/Sequoia_Capital>,
        <https://1145.am/db/1742891/Sequoia_Capital>,
        <https://1145.am/db/1743290/Sequoia_Capital>,
        <https://1145.am/db/1743541/Sequoia_Capital>,
        <https://1145.am/db/1743766/Sequoia_Capital>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1745768/Sequoia_Capital>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1746537/Sequoia_Capital>,
        <https://1145.am/db/1747112/Sequoia_Capital>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747701/Sequoia_Capital>,
        <https://1145.am/db/1753537/Sequoia_Capital>,
        <https://1145.am/db/1755748/Sequoia_Capital>,
        <https://1145.am/db/1757479/Sequoia_Capital>,
        <https://1145.am/db/1757844/Sequoia_Capital>,
        <https://1145.am/db/1760517/Sequoia_Capital>,
        <https://1145.am/db/1760696/Sequoia_Capital>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1762558/Sequoia_Capital>,
        <https://1145.am/db/1763433/Sequoia_Capital>,
        <https://1145.am/db/1763809/Sequoia_Capital>,
        <https://1145.am/db/1763953/Sequoia_Capital>,
        <https://1145.am/db/1764479/Sequoia_Capital>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1768327/Sequoia_Capital>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1768978/Sequoia_Capital>,
        <https://1145.am/db/1769352/Sequoia_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1772123/Sequoia_Capital>,
        <https://1145.am/db/1772826/Sequoia_Capital>,
        <https://1145.am/db/1774753/Sequoia_Capital>,
        <https://1145.am/db/1774992/Sequoia_Capital>,
        <https://1145.am/db/1776480/Sequoia_Capital>,
        <https://1145.am/db/1778394/Sequoia_Capital>,
        <https://1145.am/db/1779452/Sequoia_Capital>,
        <https://1145.am/db/1782707/Sequoia_Capital>,
        <https://1145.am/db/1783956/Sequoia_Capital>,
        <https://1145.am/db/1785147/Sequoia_Capital>,
        <https://1145.am/db/1785263/Sequoia_Capital>,
        <https://1145.am/db/1785432/Sequoia_Capital>,
        <https://1145.am/db/1785875/Sequoia_Capital>,
        <https://1145.am/db/1786813/Sequoia_Capital>,
        <https://1145.am/db/1788160/Sequoia_Capital>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1790664/Sequoia_Capital>,
        <https://1145.am/db/1790671/Sequoia_Capital>,
        <https://1145.am/db/1791222/Sequoia_Capital>,
        <https://1145.am/db/1792007/Sequoia_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792421/Sequoia_Capital>,
        <https://1145.am/db/1792732/Sequoia_Capital>,
        <https://1145.am/db/1793029/Sequoia_Capital>,
        <https://1145.am/db/1793530/Sequoia_Capital>,
        <https://1145.am/db/1794871/Sequoia_Capital>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795761/Sequoia_Capital>,
        <https://1145.am/db/1796604/Sequoia_Capital>,
        <https://1145.am/db/1796828/Sequoia_Capital>,
        <https://1145.am/db/1797477/Sequoia_Capital>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797691/Sequoia_Capital>,
        <https://1145.am/db/1798000/Sequoia_Capital>,
        <https://1145.am/db/1801332/Sequoia_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802825/Sequoia_Capital>,
        <https://1145.am/db/1802882/Sequoia_Capital>,
        <https://1145.am/db/1806430/Sequoia_Capital>,
        <https://1145.am/db/1806610/Sequoia_Capital>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809610/Sequoia_Capital>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811030/Sequoia_Capital>,
        <https://1145.am/db/1811178/Sequoia_Capital>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1814972/Sequoia_Capital>,
        <https://1145.am/db/1815537/Sequoia_Capital>,
        <https://1145.am/db/1816382/Sequoia_Capital>,
        <https://1145.am/db/1818570/Sequoia_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1824878/Sequoia_Capital>,
        <https://1145.am/db/1826922/Sequoia_Capital>,
        <https://1145.am/db/1828157/Sequoia_Capital>,
        <https://1145.am/db/1829111/Sequoia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832015/Sequoia_Capital>,
        <https://1145.am/db/1832607/Sequoia_Capital>,
        <https://1145.am/db/1832611/Sequoia_Capital>,
        <https://1145.am/db/1833935/Sequoia_Capital>,
        <https://1145.am/db/1834382/Sequoia_Capital>,
        <https://1145.am/db/1835098/Sequoia_Capital>,
        <https://1145.am/db/1835200/Sequoia_Capital>,
        <https://1145.am/db/1836193/Sequoia_Capital>,
        <https://1145.am/db/1836620/Sequoia_Capital>,
        <https://1145.am/db/1838305/Sequoia_Capital>,
        <https://1145.am/db/1839533/Sequoia_Capital>,
        <https://1145.am/db/1839816/Sequoia_Capital>,
        <https://1145.am/db/1842500/Sequoia_Capital>,
        <https://1145.am/db/1842707/Sequoia_Capital>,
        <https://1145.am/db/1843209/Sequoia_Capital>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844405/Sequoia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1845216/Sequoia_Capital>,
        <https://1145.am/db/1847160/Sequoia_Capital>,
        <https://1145.am/db/1847214/Sequoia_Capital>,
        <https://1145.am/db/1847903/Sequoia_Capital>,
        <https://1145.am/db/1848058/Sequoia_Capital>,
        <https://1145.am/db/1848120/Sequoia_Capital>,
        <https://1145.am/db/1848444/Sequoia_Capital>,
        <https://1145.am/db/1848585/Sequoia_Capital>,
        <https://1145.am/db/1849108/Sequoia_Capital>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850973/Sequoia_Capital>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851703/Sequoia_Capital>,
        <https://1145.am/db/1852048/Sequoia_Capital>,
        <https://1145.am/db/1852761/Sequoia_Capital>,
        <https://1145.am/db/1852911/Sequoia_Capital>,
        <https://1145.am/db/1854098/Sequoia_Capital>,
        <https://1145.am/db/1854488/Sequoia_Capital>,
        <https://1145.am/db/1854820/Sequoia_Capital>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1858346/Sequoia_Capital>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858650/Sequoia_Capital>,
        <https://1145.am/db/1859428/Sequoia_Capital>,
        <https://1145.am/db/1859578/Sequoia_Capital>,
        <https://1145.am/db/1859944/Sequoia_Capital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1862233/Sequoia_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1866257/Sequoia_Capital>,
        <https://1145.am/db/1867912/Sequoia_Capital>,
        <https://1145.am/db/1870374/Sequoia_Capital>,
        <https://1145.am/db/1871205/Sequoia_Capital>,
        <https://1145.am/db/1871557/Sequoia_Capital>,
        <https://1145.am/db/1875358/Sequoia_Capital>,
        <https://1145.am/db/1876841/Sequoia_Capital>,
        <https://1145.am/db/1884076/Sequoia_Capital>,
        <https://1145.am/db/1885336/Sequoia_Capital>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1887194/Sequoia_Capital>,
        <https://1145.am/db/1887526/Sequoia_Capital>,
        <https://1145.am/db/1888482/Sequoia_Capital>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1891998/Sequoia_Capital>,
        <https://1145.am/db/1892913/Sequoia_Capital>,
        <https://1145.am/db/1893811/Sequoia_Capital>,
        <https://1145.am/db/1895268/Sequoia_Capital>,
        <https://1145.am/db/1896149/Sequoia_Capital>,
        <https://1145.am/db/1899684/Sequoia_Capital>,
        <https://1145.am/db/1905153/Sequoia_Capital>,
        <https://1145.am/db/1916750/Sequoia_Capital>,
        <https://1145.am/db/1917378/Sequoia_Capital>,
        <https://1145.am/db/1917393/Sequoia_Capital>,
        <https://1145.am/db/1921318/Sequoia_Capital>,
        <https://1145.am/db/1921869/Sequoia_Capital>,
        <https://1145.am/db/1922138/Sequoia_Capital>,
        <https://1145.am/db/1922580/Sequoia_Capital>,
        <https://1145.am/db/1958229/Sequoia_Capital>,
        <https://1145.am/db/1967182/Sequoia_Capital>,
        <https://1145.am/db/2023555/Sequoia_Capital>,
        <https://1145.am/db/2026695/Sequoia_Capital>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2237473/Sequoia_Capital>,
        <https://1145.am/db/2290257/Sequoia_Capital>,
        <https://1145.am/db/2295700/Sequoia_Capital>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2297413/Sequoia_Capital>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2300264/Sequoia_Capital>,
        <https://1145.am/db/2304511/Sequoia_Capital>,
        <https://1145.am/db/2306134/Sequoia_Capital>,
        <https://1145.am/db/2320622/Sequoia_Capital>,
        <https://1145.am/db/2333966/Sequoia_Capital>,
        <https://1145.am/db/2360088/Sequoia_Capital>,
        <https://1145.am/db/2369135/Sequoia_Capital>,
        <https://1145.am/db/2422223/Sequoia_Capital>,
        <https://1145.am/db/2538444/Sequoia_Capital>,
        <https://1145.am/db/2545370/Sequoia_Capital>,
        <https://1145.am/db/2625778/Sequoia_Capital>,
        <https://1145.am/db/2662560/Sequoia_Capital>,
        <https://1145.am/db/2677219/Sequoia_Capital>,
        <https://1145.am/db/271327/Sequoia_Capital>,
        <https://1145.am/db/2758809/Sequoia_Capital>,
        <https://1145.am/db/2765057/Sequoia_Capital>,
        <https://1145.am/db/289656/Sequoia_Capital>,
        <https://1145.am/db/294983/Sequoia_Capital>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/347571/Sequoia_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/405004/Sequoia_Capital>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/522301/Sequoia_Capital>,
        <https://1145.am/db/574921/Sequoia_Capital>,
        <https://1145.am/db/642593/Sequoia_Capital>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/707126/Sequoia_Capital>,
        <https://1145.am/db/709798/Sequoia_Capital>,
        <https://1145.am/db/749014/Sequoia_Capital>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/767209/Sequoia_Capital>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/873571/Sequoia_Capital>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/939164/Sequoia_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/993347/Sequoia_Capital>,
        <https://1145.am/db/995137/Sequoia_Capital> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2229117/Sorenson_Capital> a org:Organization ;
    ns1:basedInHighGeoName "Salt Lake City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5780993/about.rdf> ;
    ns1:basedInHighRaw "Salt Lake City" ;
    ns1:documentDate "2014-01-29T18:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Health Catalyst raises $41 million for product development; Austin City Council raises concerns over athenahealth deal;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/health-catalyst-raises-41-million-for-product-development-austin-city-council-raises-concerns> ;
    ns1:foundName "Sorenson Capital" ;
    ns1:investor <https://1145.am/db/2229117/Investment_Chv_Capital_Health_Catalyst_Kaiser_Permanente_Ventures_Norwest_Venture_Partners_Partners_Healthcare_Sequoia_Capital_Sorenson_Capital_Completed> ;
    ns1:name "Sorenson Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1134554/Sorenson_Capital>,
        <https://1145.am/db/1712857/Sorenson_Capital>,
        <https://1145.am/db/1755127/Sorenson_Capital>,
        <https://1145.am/db/1756326/Sorenson_Capital>,
        <https://1145.am/db/1765997/Sorenson_Capital>,
        <https://1145.am/db/1780470/Sorenson_Capital>,
        <https://1145.am/db/1830667/Sorenson_Capital>,
        <https://1145.am/db/1832611/Sorenson_Capital>,
        <https://1145.am/db/1882242/Sorenson_Capital>,
        <https://1145.am/db/2679901/Sorenson_Capital>,
        <https://1145.am/db/803726/Sorenson_Capital>,
        <https://1145.am/db/804620/Sorenson_Capital>,
        <https://1145.am/db/823733/Sorenson_Capital> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2242437/Glenwood_Regional_Medical_Center_Property_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-08-14T13:00:12+00:00"^^xsd:dateTime ;
    ns1:documentExtract "IASIS Healthcare LLC (\"IASIS\") , a leading provider of high quality, affordable healthcare services, today announced the execution of a sale-leaseback agreement with Medical Properties Trust, Inc., (\"MPT\") , the healthcare real estate investment trust (\"REIT\") that currently owns property associated with another IASIS facility." ;
    ns1:documentTitle "IASIS Healthcare Executes Real Estate Transaction as Part of Long-Term Strategic Growth Plan" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/iasis-healthcare-executes-real-estate-transaction-as-part-long-term-strategic-growth> ;
    ns1:foundName "leaseback",
        "sale" ;
    ns1:name "leaseback",
        "sale" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2242437/Glenwood_Regional_Medical_Center>,
        <https://1145.am/db/2242437/Iasis_Healthcare_Llc> ;
    ns1:targetDetails "property" ;
    ns1:targetName "Glenwood Regional Medical Center" ;
    ns1:valueRaw "$ 281.3 million" ;
    ns1:vendor <https://1145.am/db/2242437/Iasis_Healthcare_Llc> ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2257142/Investment_Cleveland_Clinic_Florida_Cleveland_Clinic_Florida_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-11-18T15:00:14+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cleveland Clinic Florida Receives Transformational $ 30 Million Gift to Establish Neurological Center." ;
    ns1:documentTitle "Cleveland Clinic Florida Receives Transformational $30 Million Gift to Establish Neurological Center" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/cleveland-clinic-florida-receives-transformational-30-million-gift-to-establish> ;
    ns1:foundName "Gift",
        "construction" ;
    ns1:name "Gift",
        "construction" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2257142/Cleveland_Clinic_Florida>,
        <https://1145.am/db/2257142/Establish_Neurological_Center> ;
    ns1:valueRaw "$ 30 Million" ;
    ns1:whereGeoName "Florida" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4155751/about.rdf> ;
    ns1:whereRaw "Florida" .

<https://1145.am/db/2263251/Investment_St_Marys_Health_Wagon_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-02-12T00:00:11+00:00"^^xsd:dateTime ;
    ns1:documentExtract "AstraZeneca HealthCare Foundation Awards $ 200,000 Grant to St. Mary's Health Wagon.",
        "The AstraZeneca HealthCare Foundation's program today announced a grant of $ 200,000 to St. Mary's Health Wagon to support its Heart Health 1, 2, 3 Comprehensive Cardiovascular Disease Initiative." ;
    ns1:documentTitle "AstraZeneca HealthCare Foundation Awards $200,000 Grant to St. Mary's Health Wagon" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/astrazeneca-healthcare-foundation-awards-200-000-grant-to-st-mary-s-health-wagon> ;
    ns1:foundName "grant" ;
    ns1:name "grant" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2263251/St_Marys_Health_Wagon> ;
    ns1:valueRaw "$ 200,000" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2288454/Biovest> a org:Organization ;
    ns1:basedInLowRaw "Belgium" ;
    ns1:documentDate "2013-06-28T15:11:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MDxHealth hauls in $23.5M for cancer test" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/mdxhealth-hauls-23-5m-for-cancer-test> ;
    ns1:foundName "Biovest" ;
    ns1:investor <https://1145.am/db/2288454/Shares_Investment_Biovest_Mdxhealth_Valiance_Asset_Management_Completed> ;
    ns1:name "Biovest" ;
    ns1:sameAsMedium <https://1145.am/db/2322622/Biovest>,
        <https://1145.am/db/2327838/Biovest>,
        <https://1145.am/db/2339419/Biovest>,
        <https://1145.am/db/2339425/Biovest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2288454/Valiance_Asset_Management> a org:Organization ;
    ns1:basedInLowRaw "Belgium" ;
    ns1:documentDate "2013-06-28T15:11:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MDxHealth hauls in $23.5M for cancer test" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/mdxhealth-hauls-23-5m-for-cancer-test> ;
    ns1:foundName "Valiance Asset Management" ;
    ns1:investor <https://1145.am/db/2288454/Shares_Investment_Biovest_Mdxhealth_Valiance_Asset_Management_Completed> ;
    ns1:name "Valiance Asset Management" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2288758/Valeant> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:buyer <https://1145.am/db/2288758/Bausch_+_Lomb_Acquisition>,
        <https://1145.am/db/2288758/Biomet_Acquisition> ;
    ns1:description "eye care" ;
    ns1:documentDate "2013-07-02T19:19:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biomet could be next on the billion-dollar block" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/biomet-could-be-next-billion-dollar-block> ;
    ns1:foundName "Valeant" ;
    ns1:name "Valeant" ;
    ns1:sameAsMedium <https://1145.am/db/2288428/Valeant>,
        <https://1145.am/db/2312221/Valeant>,
        <https://1145.am/db/2315100/Valeant>,
        <https://1145.am/db/2318405/Valeant>,
        <https://1145.am/db/2322159/Valeant>,
        <https://1145.am/db/2323106/Valeant>,
        <https://1145.am/db/2325895/Valeant>,
        <https://1145.am/db/2328143/Valeant>,
        <https://1145.am/db/2336083/Valeant>,
        <https://1145.am/db/2337634/Valeant>,
        <https://1145.am/db/2353646/Valeant>,
        <https://1145.am/db/2354801/Valeant>,
        <https://1145.am/db/2361190/Valeant>,
        <https://1145.am/db/2365199/Valeant>,
        <https://1145.am/db/2367825/Valeant>,
        <https://1145.am/db/2369037/Valeant>,
        <https://1145.am/db/2539802/Valeant>,
        <https://1145.am/db/2540219/Valeant>,
        <https://1145.am/db/2540467/Valeant>,
        <https://1145.am/db/2543904/Valeant>,
        <https://1145.am/db/2544888/Valeant>,
        <https://1145.am/db/2547983/Valeant>,
        <https://1145.am/db/2550867/Valeant>,
        <https://1145.am/db/2556458/Valeant>,
        <https://1145.am/db/2557472/Valeant>,
        <https://1145.am/db/2560716/Valeant>,
        <https://1145.am/db/2566037/Valeant>,
        <https://1145.am/db/2569148/Valeant>,
        <https://1145.am/db/2569149/Valeant>,
        <https://1145.am/db/2571740/Valeant>,
        <https://1145.am/db/2572450/Valeant>,
        <https://1145.am/db/2572930/Valeant>,
        <https://1145.am/db/2573485/Valeant>,
        <https://1145.am/db/2574433/Valeant>,
        <https://1145.am/db/2575133/Valeant>,
        <https://1145.am/db/2576212/Valeant>,
        <https://1145.am/db/2577770/Valeant>,
        <https://1145.am/db/2577775/Valeant>,
        <https://1145.am/db/2577846/Valeant>,
        <https://1145.am/db/2579823/Valeant>,
        <https://1145.am/db/2580775/Valeant>,
        <https://1145.am/db/2580831/Valeant>,
        <https://1145.am/db/2582257/Valeant>,
        <https://1145.am/db/2582894/Valeant>,
        <https://1145.am/db/2583732/Valeant>,
        <https://1145.am/db/2583845/Valeant>,
        <https://1145.am/db/2584676/Valeant>,
        <https://1145.am/db/2589971/Valeant>,
        <https://1145.am/db/2590366/Valeant>,
        <https://1145.am/db/2593483/Valeant>,
        <https://1145.am/db/2594252/Valeant>,
        <https://1145.am/db/2595150/Valeant>,
        <https://1145.am/db/2595706/Valeant>,
        <https://1145.am/db/2597158/Valeant>,
        <https://1145.am/db/2597769/Valeant>,
        <https://1145.am/db/2598205/Valeant> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2288800/Big-Namers_New_Enterprise_Associates> a org:Organization ;
    ns1:basedInLowRaw "Minnesota" ;
    ns1:documentDate "2013-07-11T12:30:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CVRx raises $29.6M for hypertension device" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cvrx-raises-29-6m-for-hypertension-device> ;
    ns1:foundName "Big-namers New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2288800/Investment_Big-Namers_New_Enterprise_Associates_Cvrx_Cvrx_Johnson___Johnson_Completed> ;
    ns1:name "Big-namers New Enterprise Associates" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2288800/Johnson___Johnson> a org:Organization ;
    ns1:basedInLowRaw "Minnesota" ;
    ns1:documentDate "2013-07-11T12:30:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CVRx raises $29.6M for hypertension device" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cvrx-raises-29-6m-for-hypertension-device> ;
    ns1:foundName "Johnson & Johnson" ;
    ns1:investor <https://1145.am/db/2288800/Investment_Big-Namers_New_Enterprise_Associates_Cvrx_Cvrx_Johnson___Johnson_Completed> ;
    ns1:name "Johnson & Johnson" ;
    ns1:sameAsMedium <https://1145.am/db/1048908/Johnson___Johnson>,
        <https://1145.am/db/1148074/Johnson___Johnson>,
        <https://1145.am/db/1214189/Johnson___Johnson>,
        <https://1145.am/db/1217341/Johnson___Johnson>,
        <https://1145.am/db/1262552/Johnson___Johnson>,
        <https://1145.am/db/1270868/Johnson___Johnson>,
        <https://1145.am/db/1463456/Johnson___Johnson>,
        <https://1145.am/db/1464682/Johnson___Johnson>,
        <https://1145.am/db/1465999/Johnson___Johnson>,
        <https://1145.am/db/1466112/Johnson___Johnson>,
        <https://1145.am/db/1466861/Johnson___Johnson>,
        <https://1145.am/db/1506241/Johnson___Johnson>,
        <https://1145.am/db/1543996/Johnson___Johnson>,
        <https://1145.am/db/1544359/Johnson___Johnson>,
        <https://1145.am/db/1544540/Johnson___Johnson>,
        <https://1145.am/db/1551329/Johnson___Johnson>,
        <https://1145.am/db/1578164/Johnson___Johnson>,
        <https://1145.am/db/1591324/Johnson___Johnson>,
        <https://1145.am/db/1597750/Johnson___Johnson>,
        <https://1145.am/db/1598566/Johnson___Johnson>,
        <https://1145.am/db/1673527/Johnson___Johnson>,
        <https://1145.am/db/1673809/Johnson___Johnson>,
        <https://1145.am/db/1822601/Johnson___Johnson>,
        <https://1145.am/db/1979575/Johnson___Johnson>,
        <https://1145.am/db/1988558/Johnson___Johnson_Inc>,
        <https://1145.am/db/1990327/Johnson___Johnson_Inc>,
        <https://1145.am/db/1996518/Johnson___Johnson_Inc>,
        <https://1145.am/db/2057335/Johnson___Johnson>,
        <https://1145.am/db/2089281/Johnson___Johnson>,
        <https://1145.am/db/2095043/Johnson___Johnson>,
        <https://1145.am/db/2096209/Johnson___Johnson>,
        <https://1145.am/db/2103283/Johnson___Johnson>,
        <https://1145.am/db/2152816/Johnson___Johnson>,
        <https://1145.am/db/2153410/Johnson___Johnson>,
        <https://1145.am/db/2153916/Johnson___Johnson>,
        <https://1145.am/db/2154194/Johnson___Johnson>,
        <https://1145.am/db/2154521/Johnson___Johnson>,
        <https://1145.am/db/2154524/Johnson___Johnson>,
        <https://1145.am/db/2188348/Johnson___Johnson>,
        <https://1145.am/db/2193661/Johnson___Johnson>,
        <https://1145.am/db/2211680/Johnson___Johnson>,
        <https://1145.am/db/2226737/Johnson___Johnson>,
        <https://1145.am/db/2278910/Johnson___Johnson>,
        <https://1145.am/db/2279434/Johnson___Johnson>,
        <https://1145.am/db/2280422/Johnson___Johnson>,
        <https://1145.am/db/2281285/Johnson___Johnson>,
        <https://1145.am/db/2282888/Johnson___Johnson>,
        <https://1145.am/db/2284930/Johnson___Johnson>,
        <https://1145.am/db/2285587/Johnson___Johnson>,
        <https://1145.am/db/2286603/Johnson___Johnson>,
        <https://1145.am/db/2287377/Johnson___Johnson>,
        <https://1145.am/db/2287841/Johnson___Johnson>,
        <https://1145.am/db/2288373/Johnson___Johnson>,
        <https://1145.am/db/2289267/Johnson___Johnson>,
        <https://1145.am/db/2289275/Johnson___Johnson>,
        <https://1145.am/db/2289414/Johnson___Johnson>,
        <https://1145.am/db/2290342/Johnson___Johnson>,
        <https://1145.am/db/2290858/Johnson___Johnson>,
        <https://1145.am/db/2290886/Johnson___Johnson>,
        <https://1145.am/db/2290894/Johnson___Johnson>,
        <https://1145.am/db/2291600/Johnson___Johnson>,
        <https://1145.am/db/2291671/Johnson___Johnson>,
        <https://1145.am/db/2291777/Johnson___Johnson>,
        <https://1145.am/db/2292262/Johnson___Johnson>,
        <https://1145.am/db/2293507/Johnson___Johnson>,
        <https://1145.am/db/2293778/Johnson___Johnson>,
        <https://1145.am/db/2294098/Johnson___Johnson>,
        <https://1145.am/db/2294498/Johnson___Johnson>,
        <https://1145.am/db/2294715/Johnson___Johnson>,
        <https://1145.am/db/2294862/Johnson___Johnson>,
        <https://1145.am/db/2294972/Johnson___Johnson>,
        <https://1145.am/db/2295229/Johnson___Johnson>,
        <https://1145.am/db/2295273/Johnson___Johnson>,
        <https://1145.am/db/2295364/Johnson___Johnson>,
        <https://1145.am/db/2295495/Johnson___Johnson>,
        <https://1145.am/db/2296402/Johnson___Johnson>,
        <https://1145.am/db/2296413/Johnson___Johnson>,
        <https://1145.am/db/2296598/Johnson___Johnson>,
        <https://1145.am/db/2297186/Johnson___Johnson>,
        <https://1145.am/db/2297280/Johnson___Johnson>,
        <https://1145.am/db/2297962/Johnson___Johnson>,
        <https://1145.am/db/2298037/Johnson___Johnson>,
        <https://1145.am/db/2298405/Johnson___Johnson>,
        <https://1145.am/db/2298501/Johnson___Johnson>,
        <https://1145.am/db/2298532/Johnson___Johnson>,
        <https://1145.am/db/2298782/Johnson___Johnson>,
        <https://1145.am/db/2299019/Johnson___Johnson>,
        <https://1145.am/db/2299243/Johnson___Johnson>,
        <https://1145.am/db/2299307/Johnson___Johnson>,
        <https://1145.am/db/2299311/Johnson___Johnson>,
        <https://1145.am/db/2299849/Johnson___Johnson>,
        <https://1145.am/db/2300238/Johnson___Johnson>,
        <https://1145.am/db/2300404/Johnson___Johnson>,
        <https://1145.am/db/2300475/Johnson___Johnson>,
        <https://1145.am/db/2300479/Johnson___Johnson>,
        <https://1145.am/db/2300726/Johnson___Johnson>,
        <https://1145.am/db/2300789/Johnson___Johnson>,
        <https://1145.am/db/2300886/Johnson___Johnson>,
        <https://1145.am/db/2301032/Johnson___Johnson>,
        <https://1145.am/db/2301300/Johnson___Johnson>,
        <https://1145.am/db/2301488/Johnson___Johnson>,
        <https://1145.am/db/2301497/Johnson___Johnson>,
        <https://1145.am/db/2301819/Johnson___Johnson>,
        <https://1145.am/db/2302021/Johnson___Johnson>,
        <https://1145.am/db/2303215/Johnson___Johnson>,
        <https://1145.am/db/2309930/Johnson___Johnson>,
        <https://1145.am/db/2309931/Johnson___Johnson>,
        <https://1145.am/db/2310118/Johnson___Johnson>,
        <https://1145.am/db/2311031/Johnson___Johnson>,
        <https://1145.am/db/2311832/Johnson___Johnson>,
        <https://1145.am/db/2311842/Johnson___Johnson>,
        <https://1145.am/db/2314031/Johnson___Johnson>,
        <https://1145.am/db/2314331/Johnson___Johnson>,
        <https://1145.am/db/2315481/Johnson___Johnson>,
        <https://1145.am/db/2316541/Johnson___Johnson>,
        <https://1145.am/db/2317181/Johnson___Johnson>,
        <https://1145.am/db/2317639/Johnson___Johnson>,
        <https://1145.am/db/2318685/Johnson___Johnson>,
        <https://1145.am/db/2319481/Johnson___Johnson>,
        <https://1145.am/db/2319656/Johnson___Johnson>,
        <https://1145.am/db/2322024/Johnson___Johnson>,
        <https://1145.am/db/2322035/Johnson___Johnson>,
        <https://1145.am/db/2322998/Johnson___Johnson>,
        <https://1145.am/db/2323000/Johnson___Johnson>,
        <https://1145.am/db/2324143/Johnson___Johnson>,
        <https://1145.am/db/2327024/Johnson___Johnson>,
        <https://1145.am/db/2329487/Johnson___Johnson>,
        <https://1145.am/db/2330734/Johnson___Johnson>,
        <https://1145.am/db/2331745/Johnson___Johnson>,
        <https://1145.am/db/2331746/Johnson___Johnson>,
        <https://1145.am/db/2336790/Johnson___Johnson>,
        <https://1145.am/db/2336797/Johnson___Johnson>,
        <https://1145.am/db/2339375/Johnson___Johnson>,
        <https://1145.am/db/2339892/Johnson___Johnson>,
        <https://1145.am/db/2340071/Johnson___Johnson>,
        <https://1145.am/db/2341384/Johnson___Johnson>,
        <https://1145.am/db/2341850/Johnson___Johnson>,
        <https://1145.am/db/2344487/Johnson___Johnson>,
        <https://1145.am/db/2344683/Johnson___Johnson>,
        <https://1145.am/db/2347608/Johnson___Johnson>,
        <https://1145.am/db/2349121/Johnson___Johnson>,
        <https://1145.am/db/2350115/Johnson___Johnson>,
        <https://1145.am/db/2350116/Johnson___Johnson>,
        <https://1145.am/db/2350440/Johnson___Johnson_Inc>,
        <https://1145.am/db/2354402/Johnson___Johnson>,
        <https://1145.am/db/2354835/Johnson___Johnson>,
        <https://1145.am/db/2355411/Johnson___Johnson>,
        <https://1145.am/db/2358981/Johnson___Johnson>,
        <https://1145.am/db/2359302/Johnson___Johnson>,
        <https://1145.am/db/2359467/Johnson___Johnson>,
        <https://1145.am/db/2359489/Johnson___Johnson>,
        <https://1145.am/db/2360241/Johnson___Johnson>,
        <https://1145.am/db/2360256/Johnson___Johnson>,
        <https://1145.am/db/2360495/Johnson___Johnson>,
        <https://1145.am/db/2360754/Johnson___Johnson>,
        <https://1145.am/db/2360755/Johnson___Johnson>,
        <https://1145.am/db/2361612/Johnson___Johnson>,
        <https://1145.am/db/2362893/Johnson___Johnson>,
        <https://1145.am/db/2364593/Johnson___Johnson>,
        <https://1145.am/db/2364601/Johnson___Johnson>,
        <https://1145.am/db/2365300/Johnson___Johnson>,
        <https://1145.am/db/2366653/Johnson___Johnson>,
        <https://1145.am/db/2367616/Johnson___Johnson>,
        <https://1145.am/db/2367617/Johnson___Johnson>,
        <https://1145.am/db/2370259/Johnson___Johnson>,
        <https://1145.am/db/2370272/Johnson___Johnson>,
        <https://1145.am/db/2370771/Johnson___Johnson>,
        <https://1145.am/db/2370777/Johnson___Johnson>,
        <https://1145.am/db/2536264/Johnson___Johnson>,
        <https://1145.am/db/2541548/Johnson___Johnson>,
        <https://1145.am/db/2541966/Johnson___Johnson>,
        <https://1145.am/db/2543863/Johnson___Johnson>,
        <https://1145.am/db/2544755/Johnson___Johnson>,
        <https://1145.am/db/2545058/Johnson___Johnson>,
        <https://1145.am/db/2545522/Johnson___Johnson>,
        <https://1145.am/db/2546172/Johnson___Johnson>,
        <https://1145.am/db/2547152/Johnson___Johnson>,
        <https://1145.am/db/2548042/Johnson___Johnson>,
        <https://1145.am/db/2548361/Johnson___Johnson>,
        <https://1145.am/db/2548431/Johnson___Johnson>,
        <https://1145.am/db/2549346/Johnson___Johnson>,
        <https://1145.am/db/2549438/Johnson___Johnson>,
        <https://1145.am/db/2553024/Johnson___Johnson>,
        <https://1145.am/db/2553161/Johnson___Johnson>,
        <https://1145.am/db/2553852/Johnson___Johnson>,
        <https://1145.am/db/2557603/Johnson___Johnson>,
        <https://1145.am/db/2557900/Johnson___Johnson>,
        <https://1145.am/db/2558099/Johnson___Johnson>,
        <https://1145.am/db/2558689/Johnson___Johnson>,
        <https://1145.am/db/2560372/Johnson___Johnson>,
        <https://1145.am/db/2561491/Johnson___Johnson>,
        <https://1145.am/db/2561691/Johnson___Johnson>,
        <https://1145.am/db/2564032/Johnson___Johnson>,
        <https://1145.am/db/2566147/Johnson___Johnson>,
        <https://1145.am/db/2569069/Johnson___Johnson>,
        <https://1145.am/db/2570365/Johnson___Johnson>,
        <https://1145.am/db/2572160/Johnson___Johnson>,
        <https://1145.am/db/2572466/Johnson___Johnson>,
        <https://1145.am/db/2572655/Johnson___Johnson>,
        <https://1145.am/db/2573372/Johnson___Johnson>,
        <https://1145.am/db/2573373/Johnson___Johnson>,
        <https://1145.am/db/2573643/Johnson___Johnson>,
        <https://1145.am/db/2574347/Johnson___Johnson>,
        <https://1145.am/db/2574495/Johnson___Johnson>,
        <https://1145.am/db/2574907/Johnson___Johnson>,
        <https://1145.am/db/2575492/Johnson___Johnson>,
        <https://1145.am/db/2575496/Johnson___Johnson>,
        <https://1145.am/db/2576439/Johnson___Johnson>,
        <https://1145.am/db/2576962/Johnson___Johnson>,
        <https://1145.am/db/2577059/Johnson___Johnson>,
        <https://1145.am/db/2579209/Johnson___Johnson>,
        <https://1145.am/db/2580381/Johnson___Johnson>,
        <https://1145.am/db/2581480/Johnson___Johnson>,
        <https://1145.am/db/2582055/Johnson___Johnson>,
        <https://1145.am/db/2582468/Johnson___Johnson>,
        <https://1145.am/db/2583189/Johnson___Johnson>,
        <https://1145.am/db/2583233/Johnson___Johnson>,
        <https://1145.am/db/2583920/Johnson___Johnson>,
        <https://1145.am/db/2584383/Johnson___Johnson>,
        <https://1145.am/db/2584814/Johnson___Johnson>,
        <https://1145.am/db/2585185/Johnson___Johnson>,
        <https://1145.am/db/2585600/Johnson___Johnson>,
        <https://1145.am/db/2585710/Johnson___Johnson>,
        <https://1145.am/db/2586824/Johnson___Johnson>,
        <https://1145.am/db/2587125/Johnson___Johnson>,
        <https://1145.am/db/2587143/Johnson___Johnson>,
        <https://1145.am/db/2587177/Johnson___Johnson>,
        <https://1145.am/db/2587212/Johnson___Johnson>,
        <https://1145.am/db/2587626/Johnson___Johnson>,
        <https://1145.am/db/2588074/Johnson___Johnson>,
        <https://1145.am/db/2588718/Johnson___Johnson>,
        <https://1145.am/db/2589130/Johnson___Johnson>,
        <https://1145.am/db/2589402/Johnson___Johnson>,
        <https://1145.am/db/2589813/Johnson___Johnson>,
        <https://1145.am/db/2590047/Johnson___Johnson>,
        <https://1145.am/db/2591001/Johnson___Johnson>,
        <https://1145.am/db/2591073/Johnson___Johnson>,
        <https://1145.am/db/2591074/Johnson___Johnson>,
        <https://1145.am/db/2591076/Johnson___Johnson>,
        <https://1145.am/db/2592534/Johnson___Johnson>,
        <https://1145.am/db/2593889/Johnson___Johnson>,
        <https://1145.am/db/2594106/Johnson___Johnson>,
        <https://1145.am/db/2595685/Johnson___Johnson>,
        <https://1145.am/db/2596818/Johnson___Johnson>,
        <https://1145.am/db/2597086/Johnson___Johnson>,
        <https://1145.am/db/2597135/Johnson___Johnson>,
        <https://1145.am/db/2597794/Johnson___Johnson>,
        <https://1145.am/db/2597802/Johnson___Johnson>,
        <https://1145.am/db/2597824/Johnson___Johnson>,
        <https://1145.am/db/2598257/Johnson___Johnson>,
        <https://1145.am/db/2598439/Johnson___Johnson_Inc>,
        <https://1145.am/db/270375/Johnson___Johnson>,
        <https://1145.am/db/2718487/Johnson___Johnson>,
        <https://1145.am/db/2787550/Johnson___Johnson>,
        <https://1145.am/db/309395/Johnson___Johnson>,
        <https://1145.am/db/418587/Johnson___Johnson>,
        <https://1145.am/db/543112/Johnson___Johnson>,
        <https://1145.am/db/543155/Johnson___Johnson>,
        <https://1145.am/db/699695/Johnson___Johnson>,
        <https://1145.am/db/766907/Johnson___Johnson> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289470/Venture_Investment_Freedom_Meditech_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-08-06T14:32:56+00:00"^^xsd:dateTime ;
    ns1:documentExtract "San Diego startup Freedom Meditech has hauled in another $ 7 million in venture funding, cash the company will use to market a device that can screen for signs of diabetes through an eye scan." ;
    ns1:documentTitle "Freedom Meditech lands $7M for diabetes device" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/freedom-meditech-lands-7m-for-diabetes-device> ;
    ns1:foundName "funding",
        "launch" ;
    ns1:name "funding",
        "launch" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2289470/Freedom_Meditech> ;
    ns1:targetDetails "venture" ;
    ns1:valueRaw "$ 10 million",
        "$ 7 million" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "San Diego" .

<https://1145.am/db/2290258/Green_Park___Golf_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Texas" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:basedInHighRaw "Texas" ;
    ns1:description "healthcare investment fund" ;
    ns1:documentDate "2013-08-29T17:33:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Texas neurostim startup pulls in $3.4M for multiple trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/texas-neurostim-startup-pulls-3-4m-for-multiple-trials> ;
    ns1:foundName "Green" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2290258/Investment_Green_Park___Golf_Ventures_Microtransponder_Completed> ;
    ns1:name "Green Park & Golf Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1282282/Green_Park___Golf_Ventures>,
        <https://1145.am/db/1626537/Green_Park___Golf_Ventures>,
        <https://1145.am/db/1628472/Green_Park___Golf_Ventures>,
        <https://1145.am/db/2332448/Green_Park___Golf_Ventures>,
        <https://1145.am/db/958899/Green_Park___Golf_Ventures>,
        <https://1145.am/db/959915/Green_Park___Golf_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290737/Baxter> a org:Organization ;
    ns1:basedInLowRaw "Israel" ;
    ns1:buyer <https://1145.am/db/2290737/Flowsense_Acquisition>,
        <https://1145.am/db/2290737/Gambro_Startup_Acquisition> ;
    ns1:description "medical equipment and treatments" ;
    ns1:documentDate "2013-09-10T15:43:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UPDATED: Baxter buys $9.5M startup on heels of $4B Gambro deal" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/updated-baxter-buys-9-5m-startup-heels-4b-gambro-deal> ;
    ns1:foundName "Baxter" ;
    ns1:industry "medical equipment" ;
    ns1:investor <https://1145.am/db/2290737/Gambro_Startup_Acquisition> ;
    ns1:name "Baxter" ;
    ns1:sameAsHigh <https://1145.am/db/1625722/Baxter_International_Inc>,
        <https://1145.am/db/166496/Baxter_International_Inc>,
        <https://1145.am/db/1748890/Baxter>,
        <https://1145.am/db/1943061/Baxter_International_Inc>,
        <https://1145.am/db/1997451/Baxter_International_Inc>,
        <https://1145.am/db/1997970/Baxter_International_Inc>,
        <https://1145.am/db/1998744/Baxter_International_Inc>,
        <https://1145.am/db/1999800/Baxter_International_Inc>,
        <https://1145.am/db/2000474/Baxter_International_Inc>,
        <https://1145.am/db/2001027/Baxter_International>,
        <https://1145.am/db/2053360/Baxter_International_Inc>,
        <https://1145.am/db/2068105/Baxter_International_Inc>,
        <https://1145.am/db/2092837/Baxter_International_Inc>,
        <https://1145.am/db/2132018/Baxter_International_Inc>,
        <https://1145.am/db/2133696/Baxter_International_Inc>,
        <https://1145.am/db/2187070/Baxter_International>,
        <https://1145.am/db/2278929/Baxter>,
        <https://1145.am/db/2281429/Baxter>,
        <https://1145.am/db/2289136/Baxter>,
        <https://1145.am/db/2289776/Baxter>,
        <https://1145.am/db/2290136/Baxter_International>,
        <https://1145.am/db/2293904/Baxter>,
        <https://1145.am/db/2295427/Baxter>,
        <https://1145.am/db/2295497/Baxter_International>,
        <https://1145.am/db/2295646/Baxter_International>,
        <https://1145.am/db/2295938/Baxter>,
        <https://1145.am/db/2296958/Baxter_International>,
        <https://1145.am/db/2305834/Baxter_International>,
        <https://1145.am/db/2306412/Baxter>,
        <https://1145.am/db/2316505/Baxter_Healthcare_Corporation>,
        <https://1145.am/db/2319221/Baxter_International_Inc>,
        <https://1145.am/db/2319235/Baxter_International_Inc>,
        <https://1145.am/db/2319512/Baxter>,
        <https://1145.am/db/2325476/Baxter_International>,
        <https://1145.am/db/2336789/Baxter_International>,
        <https://1145.am/db/2341671/Baxter_International_Inc>,
        <https://1145.am/db/2343327/Baxter_International>,
        <https://1145.am/db/2346138/Baxter_International_Inc>,
        <https://1145.am/db/2346147/Baxter>,
        <https://1145.am/db/2352126/Baxter_International_Inc>,
        <https://1145.am/db/2354318/Baxter_International_Inc>,
        <https://1145.am/db/2361441/Baxter_International_Inc>,
        <https://1145.am/db/2366139/Baxter_International_Inc>,
        <https://1145.am/db/2366540/Baxter_International_Inc>,
        <https://1145.am/db/2370959/Baxter>,
        <https://1145.am/db/2540502/Baxter_International>,
        <https://1145.am/db/2541368/Baxter>,
        <https://1145.am/db/2541823/Baxter_Biopharma_Solutions>,
        <https://1145.am/db/2545444/Baxter>,
        <https://1145.am/db/2547136/Baxter>,
        <https://1145.am/db/2552077/Baxter_International>,
        <https://1145.am/db/2555342/Baxter_International>,
        <https://1145.am/db/2558806/Baxter>,
        <https://1145.am/db/2558813/Baxter>,
        <https://1145.am/db/2560251/Baxter_Corporation>,
        <https://1145.am/db/2560265/Baxter_International>,
        <https://1145.am/db/2562102/Baxter_International_Inc>,
        <https://1145.am/db/2563850/Baxter_International>,
        <https://1145.am/db/2566525/Baxter_Biopharma_Solutions>,
        <https://1145.am/db/2568922/Baxter_International_Inc>,
        <https://1145.am/db/2570054/Baxter>,
        <https://1145.am/db/2570080/Baxter>,
        <https://1145.am/db/2572570/Baxter_International_Inc>,
        <https://1145.am/db/2574461/Baxter_International_Inc>,
        <https://1145.am/db/2576790/Baxter>,
        <https://1145.am/db/2576801/Baxter>,
        <https://1145.am/db/2585618/Baxter>,
        <https://1145.am/db/2585871/Baxter_International>,
        <https://1145.am/db/2586033/Baxter>,
        <https://1145.am/db/2586046/Baxter_International_Inc>,
        <https://1145.am/db/2588251/Baxter_International_Inc>,
        <https://1145.am/db/2594742/Baxter_International>,
        <https://1145.am/db/2597180/Baxter_International_Inc>,
        <https://1145.am/db/2597186/Baxter>,
        <https://1145.am/db/435880/Baxter_International_Inc>,
        <https://1145.am/db/438971/Baxter_International>,
        <https://1145.am/db/446169/Baxter_International_Inc>,
        <https://1145.am/db/446405/Baxter_International>,
        <https://1145.am/db/447058/Baxter_International_Inc>,
        <https://1145.am/db/448129/Baxter_International_Inc>,
        <https://1145.am/db/450035/Baxter_International_Inc>,
        <https://1145.am/db/450185/Baxter_International_Inc>,
        <https://1145.am/db/451392/Baxter_International_Inc>,
        <https://1145.am/db/693233/Baxter_International_Inc>,
        <https://1145.am/db/694622/Baxter_International_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2280582/Baxter>,
        <https://1145.am/db/2287829/Baxter>,
        <https://1145.am/db/2288062/Baxter>,
        <https://1145.am/db/2288801/Baxter>,
        <https://1145.am/db/2290736/Baxter>,
        <https://1145.am/db/2293436/Baxter>,
        <https://1145.am/db/2293910/Baxter>,
        <https://1145.am/db/2353350/Baxter>,
        <https://1145.am/db/2554269/Baxter>,
        <https://1145.am/db/2563717/Baxter> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2292103/Florida_Opportunity_Funds> a org:Organization ;
    ns1:basedInLowRaw "Florida" ;
    ns1:documentDate "2013-10-03T12:42:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lensar hauls in $87M for laser eye surgery tech" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/lensar-hauls-87m-for-laser-eye-surgery-tech> ;
    ns1:foundName "Florida Opportunity Funds" ;
    ns1:investor <https://1145.am/db/2292103/Investment_Aisling_Capital_Florida_Opportunity_Funds_Lensar_Completed> ;
    ns1:name "Florida Opportunity Funds" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2292608/454_Life_Sciences_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "divestment" ;
    ns1:documentDate "2013-10-17T22:37:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Roche ($ RHHBY) is taking another step toward reducing its focus on gene sequencing by shutting down 454 Life Sciences, a subsidiary in the space it acquired from Curagen more than 6 years ago for $ 155 million." ;
    ns1:documentTitle "Roche to close 454 Life Sciences as it reduces gene sequencing focus" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/roche-to-close-454-life-sciences-as-it-reduces-gene-sequencing-focus> ;
    ns1:foundName "shutting down",
        "take over" ;
    ns1:name "shutting down",
        "take over" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2292608/454_Life_Sciences> ;
    ns1:targetName "454 Life Sciences" ;
    ns1:valueRaw "$ 155 million",
        "$ 6.7 billion" ;
    ns1:vendor <https://1145.am/db/2292608/Curagen>,
        <https://1145.am/db/2292608/Roche> .

<https://1145.am/db/2294520/S___n> a org:Organization ;
    ns1:basedInLowRaw "Brazil" ;
    ns1:buyer <https://1145.am/db/2294520/Politec_Sade_Share_Investment> ;
    ns1:documentDate "2013-11-26T14:10:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Smith & Nephew's M&A blitz rolls on with Brazilian buy" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/smith-nephew-s-m-a-blitz-rolls-brazilian-buy> ;
    ns1:foundName "S & N" ;
    ns1:industry "medical" ;
    ns1:name "S & N" ;
    ns1:sameAsHigh <https://1145.am/db/1135045/Adient_Medical>,
        <https://1145.am/db/2247790/Affilion>,
        <https://1145.am/db/2291375/Angeion>,
        <https://1145.am/db/2293251/Ansamed>,
        <https://1145.am/db/2296190/Accelmed>,
        <https://1145.am/db/2297010/Ornim>,
        <https://1145.am/db/2299179/Eveon>,
        <https://1145.am/db/2300343/Somanetics>,
        <https://1145.am/db/2300730/Sedline>,
        <https://1145.am/db/2302395/Matritech>,
        <https://1145.am/db/2326571/Evalve>,
        <https://1145.am/db/2326576/Evalve>,
        <https://1145.am/db/2441381/Advancedcath> ;
    ns1:sameAsMedium <https://1145.am/db/2288358/S___n>,
        <https://1145.am/db/2299796/S___n> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294543/Echo_Therapeutics> a org:Organization ;
    ns1:basedInLowRaw "CE mark" ;
    ns1:buyer <https://1145.am/db/2294543/Ipo_Echo_Therapeutics_Has_Not_Happened> ;
    ns1:description "developing medical devices" ;
    ns1:documentDate "2013-11-27T15:47:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Texas stent developer nears $30M funding round; Myriad Genetics sues another Dx rival;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/texas-stent-developer-nears-30m-funding-round-myriad-genetics-sues-another-dx-rival> ;
    ns1:foundName "Echo Therapeutics" ;
    ns1:name "Echo Therapeutics" ;
    ns1:sameAsMedium <https://1145.am/db/2289335/Echo_Therapeutics>,
        <https://1145.am/db/2289613/Echo_Therapeutics>,
        <https://1145.am/db/2342850/Echo_Therapeutics>,
        <https://1145.am/db/2345292/Echo_Therapeutics>,
        <https://1145.am/db/2347979/Echo_Therapeutics>,
        <https://1145.am/db/2351240/Echo_Therapeutics>,
        <https://1145.am/db/2354676/Echo_Therapeutics>,
        <https://1145.am/db/2364576/Echo_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294544/Myriad_Genetics> a org:Organization ;
    ns1:basedInHighGeoName "Utah" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5549030/about.rdf> ;
    ns1:basedInHighRaw "Utah" ;
    ns1:buyer <https://1145.am/db/2294544/Crescendo_Bioscience_Investment> ;
    ns1:description "Molecular diagnostic test maker" ;
    ns1:documentDate "2013-11-27T19:36:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Myriad Genetics inches closer to acquiring Crescendo Bioscience" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/myriad-genetics-inches-closer-to-acquiring-crescendo-bioscience> ;
    ns1:foundName "Myriad",
        "Myriad Genetics" ;
    ns1:investor <https://1145.am/db/2294544/Crescendo_Bioscience_Investment> ;
    ns1:name "Myriad Genetics" ;
    ns1:sameAsMedium <https://1145.am/db/1461868/Myriad_Genetics>,
        <https://1145.am/db/1463558/Myriad_Genetics>,
        <https://1145.am/db/1591123/Myriad_Genetics>,
        <https://1145.am/db/2288035/Myriad_Genetics>,
        <https://1145.am/db/2293308/Myriad_Genetics>,
        <https://1145.am/db/2296428/Myriad_Genetics>,
        <https://1145.am/db/2296937/Myriad_Genetics>,
        <https://1145.am/db/2296993/Myriad_Genetics>,
        <https://1145.am/db/2315046/Myriad_Genetics>,
        <https://1145.am/db/2320999/Myriad_Genetics>,
        <https://1145.am/db/2332792/Myriad_Genetics>,
        <https://1145.am/db/2332797/Myriad_Genetics>,
        <https://1145.am/db/2337718/Myriad_Genetics>,
        <https://1145.am/db/2340128/Myriad_Genetics>,
        <https://1145.am/db/2349519/Myriad_Genetics>,
        <https://1145.am/db/2360291/Myriad_Genetics>,
        <https://1145.am/db/2361752/Myriad_Genetics>,
        <https://1145.am/db/2370810/Myriad_Genetics_Gmbh>,
        <https://1145.am/db/2538017/Myriad_Genetics>,
        <https://1145.am/db/317075/Myriad_Genetics>,
        <https://1145.am/db/469186/Myriad_Genetics>,
        <https://1145.am/db/470126/Myriad_Genetics>,
        <https://1145.am/db/470228/Myriad_Genetics>,
        <https://1145.am/db/500061/Myriad_Genetics>,
        <https://1145.am/db/697868/Myriad_Genetics>,
        <https://1145.am/db/737295/Myriad_Genetics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294993/Aurora_Spine> a org:Organization ;
    ns1:basedInHighGeoName "California" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:basedInHighRaw "California" ;
    ns1:documentDate "2013-12-05T14:34:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cheney blasts device tax as one of 'the dumbest ideas' ever; Aurora Spine wins 510(k);" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cheney-blasts-device-tax-as-one-dumbest-ideas-ever-aurora-spine-wins-510-k> ;
    ns1:foundName "Aurora Spine" ;
    ns1:industry "medical device" ;
    ns1:investor <https://1145.am/db/2294993/Investment_Aurora_Spine_Diogenix_Completed> ;
    ns1:name "Aurora Spine" ;
    ns1:sameAsHigh <https://1145.am/db/474976/Aurora_Spine_Corporation>,
        <https://1145.am/db/486885/Aurora_Spine_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2295945/Becton_Dickinson> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2295945/Alverix_Share_Investment> ;
    ns1:documentDate "2014-01-07T15:25:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "BD trades $40M for diagnostics partner Alverix" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/bd-trades-40m-for-diagnostics-partner-alverix> ;
    ns1:foundName "Becton Dickinson" ;
    ns1:industry "Healthcare" ;
    ns1:name "Becton Dickinson" ;
    ns1:sameAsHigh <https://1145.am/db/1113754/Becton_Dickinson>,
        <https://1145.am/db/2182575/Becton_Dickinson_And_Company>,
        <https://1145.am/db/2269951/Becton_Dickinson___Company>,
        <https://1145.am/db/2286956/Becton_Dickinson_And_Company>,
        <https://1145.am/db/2288578/Becton_Dickinson>,
        <https://1145.am/db/2288610/Becton_Dickinson>,
        <https://1145.am/db/2289688/Becton_Dickinson_And_Company>,
        <https://1145.am/db/2293035/Becton_Dickinson>,
        <https://1145.am/db/2293472/Becton_Dickinson>,
        <https://1145.am/db/2295243/Becton_Dickinson>,
        <https://1145.am/db/2299259/Becton_Dickinson>,
        <https://1145.am/db/2300327/Becton_Dickinson_And_Company>,
        <https://1145.am/db/2300608/Becton_Dickinson>,
        <https://1145.am/db/2307433/Becton_Dickinson>,
        <https://1145.am/db/2317287/Becton_Dickinson>,
        <https://1145.am/db/2328729/Becton_Dickinson>,
        <https://1145.am/db/2447444/Becton_Dickinson_And_Company>,
        <https://1145.am/db/2536937/Becton_Dickinson>,
        <https://1145.am/db/2569214/Becton_Dickinson>,
        <https://1145.am/db/533993/Becton_Dickinson> ;
    ns1:sameAsMedium <https://1145.am/db/2295873/Becton_Dickinson>,
        <https://1145.am/db/2300156/Becton_Dickinson>,
        <https://1145.am/db/2306290/Becton-Dickinson>,
        <https://1145.am/db/2311775/Becton_Dickinson>,
        <https://1145.am/db/2362867/Becton_Dickinson>,
        <https://1145.am/db/2367450/Becton_Dickinson>,
        <https://1145.am/db/2565596/Becton_Dickinson>,
        <https://1145.am/db/2574936/Becton_Dickinson>,
        <https://1145.am/db/800628/Becton_Dickinson> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2296920/Ge_Healthcare> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:buyer <https://1145.am/db/2296920/Life_Technologies_Divisions_Acquisition> ;
    ns1:documentDate "2014-01-31T19:58:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "U.S. regulators clear Thermo Fisher's $13.6B Life Tech deal, with conditions attached" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/u-s-regulators-clear-thermo-fisher-s-13-6b-life-tech-deal-conditions-attached> ;
    ns1:foundName "GE Healthcare" ;
    ns1:name "GE Healthcare" ;
    ns1:sameAsMedium <https://1145.am/db/1050616/Ge_Healthcare>,
        <https://1145.am/db/1051769/Ge_Healthcare>,
        <https://1145.am/db/1165515/Ge_Healthcare>,
        <https://1145.am/db/1282835/Ge_Healthcare>,
        <https://1145.am/db/1334446/Ge_Healthcare>,
        <https://1145.am/db/1614892/Ge_Healthcare>,
        <https://1145.am/db/1614893/Ge_Healthcare>,
        <https://1145.am/db/1616226/Ge_Healthcare>,
        <https://1145.am/db/1616230/Ge_Healthcare>,
        <https://1145.am/db/1619074/Ge_Healthcare>,
        <https://1145.am/db/1620218/Ge_Healthcare>,
        <https://1145.am/db/1629241/Ge_Healthcare>,
        <https://1145.am/db/1630783/Ge_Healthcare>,
        <https://1145.am/db/1669823/Ge_Healthcare>,
        <https://1145.am/db/1929138/Ge_Healthcare>,
        <https://1145.am/db/2001061/Ge_Healthcare>,
        <https://1145.am/db/2027823/Ge_Healthcare>,
        <https://1145.am/db/2031133/Ge_Healthcare>,
        <https://1145.am/db/2190358/Ge_Healthcare>,
        <https://1145.am/db/2197346/Ge_Healthcare>,
        <https://1145.am/db/2203079/Ge_Healthcare>,
        <https://1145.am/db/2205205/Ge_Healthcare>,
        <https://1145.am/db/2206326/Ge_Healthcare>,
        <https://1145.am/db/2213051/Ge_Healthcare>,
        <https://1145.am/db/2221736/Ge_Healthcare>,
        <https://1145.am/db/2224049/Ge_Healthcare>,
        <https://1145.am/db/2226712/Ge_Healthcare>,
        <https://1145.am/db/2234723/Ge_Healthcare>,
        <https://1145.am/db/2235685/Ge_Healthcare>,
        <https://1145.am/db/2240574/Ge_Healthcare>,
        <https://1145.am/db/2248742/Ge_Healthcare>,
        <https://1145.am/db/2266115/Ge_Healthcare>,
        <https://1145.am/db/2271489/Ge_Healthcare>,
        <https://1145.am/db/2279663/Ge_Healthcare>,
        <https://1145.am/db/2280836/Ge_Healthcare>,
        <https://1145.am/db/2282534/Ge_Healthcare>,
        <https://1145.am/db/2283801/Ge_Healthcare>,
        <https://1145.am/db/2284098/Ge_Healthcare>,
        <https://1145.am/db/2286330/Ge_Healthcare>,
        <https://1145.am/db/2286774/Ge_Healthcare>,
        <https://1145.am/db/2287803/Ge_Healthcare>,
        <https://1145.am/db/2288416/Ge_Healthcare>,
        <https://1145.am/db/2288895/Ge_Healthcare>,
        <https://1145.am/db/2289251/Ge_Healthcare>,
        <https://1145.am/db/2292935/Ge_Healthcare>,
        <https://1145.am/db/2293446/Ge_Healthcare>,
        <https://1145.am/db/2293461/Ge_Healthcare>,
        <https://1145.am/db/2293899/Ge_Healthcare>,
        <https://1145.am/db/2293937/Ge_Healthcare>,
        <https://1145.am/db/2293946/Ge_Healthcare>,
        <https://1145.am/db/2294054/Ge_Healthcare>,
        <https://1145.am/db/2294319/Ge_Healthcare>,
        <https://1145.am/db/2294433/Ge_Healthcare>,
        <https://1145.am/db/2295927/Ge_Healthcare>,
        <https://1145.am/db/2295929/Ge_Healthcare>,
        <https://1145.am/db/2296936/Ge_Healthcare>,
        <https://1145.am/db/2297631/Ge_Healthcare>,
        <https://1145.am/db/2298659/Ge_Healthcare>,
        <https://1145.am/db/2298866/Ge_Healthcare>,
        <https://1145.am/db/2299265/Ge_Healthcare>,
        <https://1145.am/db/2299331/Ge_Healthcare>,
        <https://1145.am/db/2301111/Ge_Healthcare>,
        <https://1145.am/db/2309054/Ge_Healthcare>,
        <https://1145.am/db/2312054/Ge_Healthcare>,
        <https://1145.am/db/2321332/Ge_Healthcare>,
        <https://1145.am/db/2324874/Ge_Healthcare>,
        <https://1145.am/db/2330348/Ge_Healthcare>,
        <https://1145.am/db/2333413/Ge_Healthcare>,
        <https://1145.am/db/2333983/Ge_Healthcare>,
        <https://1145.am/db/2342728/Ge_Healthcare>,
        <https://1145.am/db/2342730/Ge_Healthcare>,
        <https://1145.am/db/2343207/Ge_Healthcare>,
        <https://1145.am/db/2353047/Ge_Healthcare>,
        <https://1145.am/db/2366046/Ge_Healthcare>,
        <https://1145.am/db/2366051/Ge_Healthcare>,
        <https://1145.am/db/2546580/Ge_Healthcare>,
        <https://1145.am/db/2546582/Ge_Healthcare>,
        <https://1145.am/db/2547542/Ge_Healthcare>,
        <https://1145.am/db/2550429/Ge_Healthcare>,
        <https://1145.am/db/2551460/Ge_Healthcare>,
        <https://1145.am/db/2562112/Ge_Healthcare>,
        <https://1145.am/db/2562215/Ge_Healthcare>,
        <https://1145.am/db/2562263/Ge_Healthcare>,
        <https://1145.am/db/2597309/Ge_Healthcare>,
        <https://1145.am/db/2598178/Ge_Healthcare> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2296920/Thermo_Fisher> a org:Organization ;
    ns1:basedInHighGeoName "Massachusetts" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6254926/about.rdf> ;
    ns1:basedInHighRaw "Massachusetts" ;
    ns1:buyer <https://1145.am/db/2296920/Life_Technologies_Divisions_Acquisition> ;
    ns1:description "laboratory equipment" ;
    ns1:documentDate "2014-01-31T19:58:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "U.S. regulators clear Thermo Fisher's $13.6B Life Tech deal, with conditions attached" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/u-s-regulators-clear-thermo-fisher-s-13-6b-life-tech-deal-conditions-attached> ;
    ns1:foundName "Thermo Fisher" ;
    ns1:industry "laboratory equipment" ;
    ns1:name "Thermo Fisher" ;
    ns1:sameAsHigh <https://1145.am/db/1462954/Thermo_Fisher_Scientific_Inc>,
        <https://1145.am/db/1943061/Thermo_Fisher_Scientific_Inc>,
        <https://1145.am/db/2153387/Thermo_Fisher_Scientific>,
        <https://1145.am/db/2289234/Thermo_Fisher>,
        <https://1145.am/db/2298815/Thermo_Fisher_Scientific>,
        <https://1145.am/db/2309645/Thermo_Fisher_Scientific>,
        <https://1145.am/db/308006/Thermo_Fisher_Scientific_Inc>,
        <https://1145.am/db/448129/Thermo_Fisher_Scientific_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/112703/Thermo_Fisher>,
        <https://1145.am/db/2285615/Thermo_Fisher>,
        <https://1145.am/db/2287839/Thermo_Fisher>,
        <https://1145.am/db/2288434/Thermo_Fisher>,
        <https://1145.am/db/2288992/Thermo_Fisher>,
        <https://1145.am/db/2289479/Thermo_Fisher>,
        <https://1145.am/db/2294528/Thermo_Fisher>,
        <https://1145.am/db/2295929/Thermo_Fisher>,
        <https://1145.am/db/2296025/Thermo_Fisher>,
        <https://1145.am/db/2296417/Thermo_Fisher>,
        <https://1145.am/db/2296642/Thermo_Fisher>,
        <https://1145.am/db/2298211/Thermo_Fisher>,
        <https://1145.am/db/2298696/Thermo_Fisher>,
        <https://1145.am/db/2299124/Thermo_Fisher>,
        <https://1145.am/db/2299129/Thermo_Fisher>,
        <https://1145.am/db/2299139/Thermo_Fisher>,
        <https://1145.am/db/2299612/Thermo_Fisher>,
        <https://1145.am/db/2300265/Thermo_Fisher>,
        <https://1145.am/db/2316475/Thermo_Fisher>,
        <https://1145.am/db/2319199/Thermo_Fisher>,
        <https://1145.am/db/2539524/Thermo_Fisher>,
        <https://1145.am/db/2546740/Thermo_Fisher>,
        <https://1145.am/db/400321/Thermo_Fisher> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2297836/Citic_Group> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:buyer <https://1145.am/db/2297836/Biosensors_International_Acquisition> ;
    ns1:description "state-supported conglomerate" ;
    ns1:documentDate "2014-02-18T14:15:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "A Chinese equity firm wants to take control of Biosensors International, report says" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/a-chinese-equity-firm-wants-to-take-control-biosensors-international-report-says> ;
    ns1:foundName "Citic Group" ;
    ns1:name "Citic Group" ;
    ns1:sameAsMedium <https://1145.am/db/2159062/Citic_Group>,
        <https://1145.am/db/2329249/Citic_Group>,
        <https://1145.am/db/2330325/Citic_Group>,
        <https://1145.am/db/2570177/Citic_Group>,
        <https://1145.am/db/2736409/Citic_Group>,
        <https://1145.am/db/631218/Citic_Group>,
        <https://1145.am/db/721102/Citic_Group_Corp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2297889/Investment_Bruin_Biometrics_Los_Angeles_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-02-27T16:53:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Bruin Biometrics (BBI) in Los Angeles, on the other hand, raised a $ 10 million financing, which it said was oversubscribed by nearly $ 2.7 million." ;
    ns1:documentTitle "NxThera and Bruin Biometrics nail new financings for device development work" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nxthera-and-bruin-biometrics-nail-new-financings-for-device-development-work> ;
    ns1:foundName "financing",
        "raised" ;
    ns1:name "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2297889/Bruin_Biometrics>,
        <https://1145.am/db/2297889/Los_Angeles> ;
    ns1:valueRaw "$ 10 million",
        "nearly $ 2.7 million" ;
    ns1:whenRaw "August" ;
    ns1:whereGeoName "Minnesota" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5037779/about.rdf> ;
    ns1:whereRaw "Minnesota" .

<https://1145.am/db/2297889/Series_C_Investment_Nxthera_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-02-27T16:53:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Minnesota - based NxThera is developing the Rezm System, a water vapor device designed to treat enlarged prostate." ;
    ns1:documentTitle "NxThera and Bruin Biometrics nail new financings for device development work" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nxthera-and-bruin-biometrics-nail-new-financings-for-device-development-work> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2297889/Nxthera> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 20 million" ;
    ns1:whenRaw "August" ;
    ns1:whereGeoName "Minnesota" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5037779/about.rdf> ;
    ns1:whereRaw "Minnesota" .

<https://1145.am/db/2304545/Ame_Cloud_Ventures> a org:Organization ;
    ns1:description "funding" ;
    ns1:documentDate "2013-07-31T11:52:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Bina Accelerates Growth with Fully Subscribed $8M Series B Round, Adds to Executive Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/bina-accelerates-growth-fully-subscribed-8m-series-b-round-adds-to-executive-team> ;
    ns1:foundName "AME Cloud Ventures" ;
    ns1:investor <https://1145.am/db/2304545/Series_B_Investment_Ame_Cloud_Ventures_Bina_Technologies_Columbus_Nova_Technology_Partners_Mohsen_Moazami_Completed> ;
    ns1:name "AME Cloud Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1106214/Ame_Cloud_Ventures>,
        <https://1145.am/db/1214380/Ame_Cloud_Ventures>,
        <https://1145.am/db/1791222/Ame_Cloud_Ventures>,
        <https://1145.am/db/1813216/Ame_Cloud_Ventures>,
        <https://1145.am/db/1829115/Ame_Cloud_Ventures>,
        <https://1145.am/db/1852806/Ame_Cloud_Ventures>,
        <https://1145.am/db/2183366/Ame_Cloud_Ventures>,
        <https://1145.am/db/2279933/Ame_Cloud_Ventures>,
        <https://1145.am/db/935872/Ame_Cloud_Ventures>,
        <https://1145.am/db/936578/Ame_Cloud_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1046072/Ame_Cloud_Ventures>,
        <https://1145.am/db/1138406/Ame_Cloud_Ventures>,
        <https://1145.am/db/1139091/Ame_Cloud_Ventures>,
        <https://1145.am/db/1214387/Ame_Cloud_Ventures>,
        <https://1145.am/db/1463829/Ame_Cloud_Ventures>,
        <https://1145.am/db/1617253/Ame_Cloud_Ventures>,
        <https://1145.am/db/1737871/Ame_Cloud_Ventures>,
        <https://1145.am/db/1738832/Ame_Cloud_Ventures>,
        <https://1145.am/db/1764255/Ame_Cloud_Ventures>,
        <https://1145.am/db/1774550/Ame_Cloud_Ventures>,
        <https://1145.am/db/1796648/Ame_Cloud_Ventures>,
        <https://1145.am/db/1836159/Ame_Cloud_Ventures>,
        <https://1145.am/db/1842342/Ame_Cloud_Ventures>,
        <https://1145.am/db/1857653/Ame_Cloud_Ventures>,
        <https://1145.am/db/1958084/Ame_Cloud_Ventures>,
        <https://1145.am/db/2116751/Ame_Cloud_Ventures>,
        <https://1145.am/db/2284483/Ame_Cloud_Ventures>,
        <https://1145.am/db/2308540/Ame_Cloud_Ventures>,
        <https://1145.am/db/2325015/Ame_Cloud_Ventures>,
        <https://1145.am/db/247960/Ame_Cloud_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2304545/Columbus_Nova_Technology_Partners> a org:Organization ;
    ns1:description "Investing in new technologies" ;
    ns1:documentDate "2013-07-31T11:52:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Bina Accelerates Growth with Fully Subscribed $8M Series B Round, Adds to Executive Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/bina-accelerates-growth-fully-subscribed-8m-series-b-round-adds-to-executive-team> ;
    ns1:foundName "Columbus Nova Technology Partners" ;
    ns1:investor <https://1145.am/db/2304545/Series_B_Investment_Ame_Cloud_Ventures_Bina_Technologies_Columbus_Nova_Technology_Partners_Mohsen_Moazami_Completed> ;
    ns1:name "Columbus Nova Technology Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1790986/Columbus_Nova_Technology_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1826446/Columbus_Nova_Technology_Partners>,
        <https://1145.am/db/1838364/Columbus_Nova_Technology_Partners>,
        <https://1145.am/db/1849606/Columbus_Nova_Technology_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2304545/Mohsen_Moazami> a org:Organization ;
    ns1:basedInLowRaw "Columbus" ;
    ns1:documentDate "2013-07-31T11:52:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Bina Accelerates Growth with Fully Subscribed $8M Series B Round, Adds to Executive Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/bina-accelerates-growth-fully-subscribed-8m-series-b-round-adds-to-executive-team> ;
    ns1:foundName "Mohsen Moazami" ;
    ns1:investor <https://1145.am/db/2304545/Series_B_Investment_Ame_Cloud_Ventures_Bina_Technologies_Columbus_Nova_Technology_Partners_Mohsen_Moazami_Completed> ;
    ns1:name "Mohsen Moazami" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305441/Abcam_Plc> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "bioinformatics" ;
    ns1:documentDate "2013-09-01T21:30:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Desktop Genetics Ltd Receives 375,000 Funding to Commercialize Genetic Engineering Platform AutoClone" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/desktop-genetics-ltd-receives-%C2%A3375-000-funding-to-commercialize-genetic-engineering-platform> ;
    ns1:foundName "AbCam Plc" ;
    ns1:investor <https://1145.am/db/2305441/Equity_Investment_Abcam_Plc_Boundary_Capital_Ltd_Desktop_Genetics_Ltd_Execute_Technologies_Inc_Horizon_Discovery_Ltd_Michael_Martin_Completed> ;
    ns1:name "AbCam Plc" ;
    ns1:sameAsHigh <https://1145.am/db/2331128/CLC>,
        <https://1145.am/db/2337045/Compendia> ;
    ns1:sameAsMedium <https://1145.am/db/1163902/Abcam_Plc>,
        <https://1145.am/db/2098388/Abcam>,
        <https://1145.am/db/2099443/Abcam>,
        <https://1145.am/db/2099848/Abcam_Plc>,
        <https://1145.am/db/2101204/Abcam>,
        <https://1145.am/db/2141791/Abcam>,
        <https://1145.am/db/2149143/Abcam>,
        <https://1145.am/db/2154080/Abcam>,
        <https://1145.am/db/2292687/Abcam>,
        <https://1145.am/db/2296725/Abcam>,
        <https://1145.am/db/2297190/Abcam>,
        <https://1145.am/db/2337422/Abcam_Plc>,
        <https://1145.am/db/2343164/Abcam>,
        <https://1145.am/db/2364319/Abcam_Plc>,
        <https://1145.am/db/247893/Abcam>,
        <https://1145.am/db/2567811/Abcam>,
        <https://1145.am/db/2717386/Abcam>,
        <https://1145.am/db/2796692/Abcam>,
        <https://1145.am/db/696928/Abcam> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305441/Boundary_Capital_Ltd> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-09-01T21:30:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Desktop Genetics Ltd Receives 375,000 Funding to Commercialize Genetic Engineering Platform AutoClone" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/desktop-genetics-ltd-receives-%C2%A3375-000-funding-to-commercialize-genetic-engineering-platform> ;
    ns1:foundName "Boundary Capital Ltd" ;
    ns1:investor <https://1145.am/db/2305441/Equity_Investment_Abcam_Plc_Boundary_Capital_Ltd_Desktop_Genetics_Ltd_Execute_Technologies_Inc_Horizon_Discovery_Ltd_Michael_Martin_Completed> ;
    ns1:name "Boundary Capital Ltd" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305441/Execute_Technologies_Inc> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "Investing" ;
    ns1:documentDate "2013-09-01T21:30:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Desktop Genetics Ltd Receives 375,000 Funding to Commercialize Genetic Engineering Platform AutoClone" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/desktop-genetics-ltd-receives-%C2%A3375-000-funding-to-commercialize-genetic-engineering-platform> ;
    ns1:foundName "Execute Technologies Inc" ;
    ns1:investor <https://1145.am/db/2305441/Equity_Investment_Abcam_Plc_Boundary_Capital_Ltd_Desktop_Genetics_Ltd_Execute_Technologies_Inc_Horizon_Discovery_Ltd_Michael_Martin_Completed> ;
    ns1:name "Execute Technologies Inc" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305441/Horizon_Discovery_Ltd> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "bioinformatics" ;
    ns1:documentDate "2013-09-01T21:30:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Desktop Genetics Ltd Receives 375,000 Funding to Commercialize Genetic Engineering Platform AutoClone" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/desktop-genetics-ltd-receives-%C2%A3375-000-funding-to-commercialize-genetic-engineering-platform> ;
    ns1:foundName "Horizon Discovery Ltd" ;
    ns1:investor <https://1145.am/db/2305441/Equity_Investment_Abcam_Plc_Boundary_Capital_Ltd_Desktop_Genetics_Ltd_Execute_Technologies_Inc_Horizon_Discovery_Ltd_Michael_Martin_Completed> ;
    ns1:name "Horizon Discovery Ltd" ;
    ns1:sameAsMedium <https://1145.am/db/2282405/Horizon_Discovery>,
        <https://1145.am/db/2284688/Horizon_Discovery>,
        <https://1145.am/db/2286890/Horizon_Discovery>,
        <https://1145.am/db/2296725/Horizon_Discovery>,
        <https://1145.am/db/2297183/Horizon_Discovery>,
        <https://1145.am/db/2297190/Horizon_Discovery>,
        <https://1145.am/db/2342820/Horizon_Discovery> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305441/Michael_Martin> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "angel investors" ;
    ns1:documentDate "2013-09-01T21:30:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Desktop Genetics Ltd Receives 375,000 Funding to Commercialize Genetic Engineering Platform AutoClone" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/desktop-genetics-ltd-receives-%C2%A3375-000-funding-to-commercialize-genetic-engineering-platform> ;
    ns1:foundName "Martin" ;
    ns1:investor <https://1145.am/db/2305441/Equity_Investment_Abcam_Plc_Boundary_Capital_Ltd_Desktop_Genetics_Ltd_Execute_Technologies_Inc_Horizon_Discovery_Ltd_Michael_Martin_Completed> ;
    ns1:name "Michael Martin" ;
    ns1:sameAsHigh <https://1145.am/db/1046072/Georges_Harik>,
        <https://1145.am/db/1061598/Nitesh_Banta>,
        <https://1145.am/db/1061598/Nivi>,
        <https://1145.am/db/1085256/Alastair_Trueger>,
        <https://1145.am/db/1085256/Illia_Polosukhin>,
        <https://1145.am/db/1085256/Moses_Lo>,
        <https://1145.am/db/1093238/Archana_Priyadarshini>,
        <https://1145.am/db/1117163/Jack_Altman>,
        <https://1145.am/db/1123407/Fred_Moll>,
        <https://1145.am/db/1139282/Benny_Schneider>,
        <https://1145.am/db/1139282/Dan_Adika>,
        <https://1145.am/db/1139282/Haim_Bar-On>,
        <https://1145.am/db/1139282/Yuval_Tal>,
        <https://1145.am/db/1178056/Interlace_Ventures>,
        <https://1145.am/db/1223652/Anthony_Sassano>,
        <https://1145.am/db/1223652/Evernew_Capital>,
        <https://1145.am/db/1223652/Jason_Choi>,
        <https://1145.am/db/1234097/Ed_Zimmerman>,
        <https://1145.am/db/1298104/Katrin_Ribant>,
        <https://1145.am/db/1351544/Toyin_Ajayi>,
        <https://1145.am/db/1352420/Able_Partners>,
        <https://1145.am/db/1352420/Erik_Ibarra>,
        <https://1145.am/db/1352420/Freada_Kapor_Klein>,
        <https://1145.am/db/1352420/Nikhil_Krishnan>,
        <https://1145.am/db/1352420/Toyin_Ajayi>,
        <https://1145.am/db/1378103/Ryan_Fang>,
        <https://1145.am/db/1378103/Sreeram_Kannan>,
        <https://1145.am/db/1394540/Richard_Dalzell>,
        <https://1145.am/db/1407553/Michael_Ovitz>,
        <https://1145.am/db/1428371/Andr_Swanston>,
        <https://1145.am/db/1428371/Owen_Van_Natta>,
        <https://1145.am/db/1428774/Elevation_Capital>,
        <https://1145.am/db/1448687/Jonathan_Azoff>,
        <https://1145.am/db/1448687/Nate_Salpeter>,
        <https://1145.am/db/1451944/Annette_Verschuren>,
        <https://1145.am/db/1451944/Leen_Li>,
        <https://1145.am/db/1455262/Leen_Li>,
        <https://1145.am/db/1455262/Verschuren>,
        <https://1145.am/db/1456703/Carsten_Thoma>,
        <https://1145.am/db/1503193/Andreessen_Horowitz>,
        <https://1145.am/db/1512500/Gushcloud_International>,
        <https://1145.am/db/1523935/Ken_Njoroge>,
        <https://1145.am/db/1529414/Matt_Robinson>,
        <https://1145.am/db/1552220/Peder_Holk_Nielsen>,
        <https://1145.am/db/1552573/Peder_Holk_Nielsen>,
        <https://1145.am/db/1569853/Harshil_Mathur>,
        <https://1145.am/db/160080/Jason_Calacanis>,
        <https://1145.am/db/1639496/Ariel_Maislos>,
        <https://1145.am/db/1639496/Natan_Linder>,
        <https://1145.am/db/1639496/Shlomo_Kremer>,
        <https://1145.am/db/1640628/Ariel_Maislos>,
        <https://1145.am/db/1640628/Natan_Linder>,
        <https://1145.am/db/1640628/Shlomo_Kremer>,
        <https://1145.am/db/1668508/Robin_Chan>,
        <https://1145.am/db/1693970/Alan_Wong>,
        <https://1145.am/db/1696291/Elad_Gil>,
        <https://1145.am/db/1696766/Frank_Asaro>,
        <https://1145.am/db/1696766/Jack_Corrao>,
        <https://1145.am/db/1698130/Andres_Kull>,
        <https://1145.am/db/1698130/Kristel_Kruustk>,
        <https://1145.am/db/1705818/Alex_Angels>,
        <https://1145.am/db/1708909/Byld_Ventures>,
        <https://1145.am/db/1714617/Tjaart_Van_Der_Walt>,
        <https://1145.am/db/1724247/Greg_Marsh>,
        <https://1145.am/db/1724252/Gaston_Aussems>,
        <https://1145.am/db/1724252/Robert_Kraal>,
        <https://1145.am/db/1735331/Andrea_Zitna>,
        <https://1145.am/db/1735331/Matt_Robinson>,
        <https://1145.am/db/1735331/Megumi_Ikeda>,
        <https://1145.am/db/1735849/Ashish_Gupta>,
        <https://1145.am/db/1735849/Federico_Castellucci>,
        <https://1145.am/db/1736186/Abdulaziz_Alrashed>,
        <https://1145.am/db/1736186/Gilad_Engel>,
        <https://1145.am/db/1739848/Magnus_Rausing>,
        <https://1145.am/db/1739862/Arctern_Ventures>,
        <https://1145.am/db/1739862/Magnus_Rausing>,
        <https://1145.am/db/1741575/Alexander_Nevinskiy>,
        <https://1145.am/db/1741575/Oskar_Hartmann>,
        <https://1145.am/db/1743746/Afore_Capital>,
        <https://1145.am/db/1744167/Michael_Levinthal>,
        <https://1145.am/db/1744932/Alessandro_Duri>,
        <https://1145.am/db/1744932/Alexander_Friedhoff>,
        <https://1145.am/db/1744932/Oliver_Mickler>,
        <https://1145.am/db/1744932/Seithe>,
        <https://1145.am/db/1744932/Thibaud_Lecuyer>,
        <https://1145.am/db/1747516/Robin_Tombs>,
        <https://1145.am/db/1749265/Josefin_Landgard>,
        <https://1145.am/db/1751215/Mattias_Ljungman>,
        <https://1145.am/db/1752912/Lachy_Groom>,
        <https://1145.am/db/1752912/Manik_Gupta>,
        <https://1145.am/db/1752912/Neeraj_Arora>,
        <https://1145.am/db/1754743/Alexander_Ljung>,
        <https://1145.am/db/1754743/David_Frenkiel>,
        <https://1145.am/db/1755202/Aman_Gupta>,
        <https://1145.am/db/1755914/Kevin_Weil>,
        <https://1145.am/db/1755914/Manik_Gupta>,
        <https://1145.am/db/1756094/Able>,
        <https://1145.am/db/1757131/Eynat_Guez>,
        <https://1145.am/db/1757131/Yinon_Costica>,
        <https://1145.am/db/1761168/Steve_Blank>,
        <https://1145.am/db/1762685/Philipp_Stauffer>,
        <https://1145.am/db/1763685/Charlie_Songhurst>,
        <https://1145.am/db/1763685/Elad_Gil>,
        <https://1145.am/db/1763685/Guy_Podjarny>,
        <https://1145.am/db/1763685/Matt_Robinson>,
        <https://1145.am/db/1764129/Kayvon_Deldar>,
        <https://1145.am/db/1764165/Victor_Asemota>,
        <https://1145.am/db/1765790/Alister_Moreno>,
        <https://1145.am/db/1765790/Arkadi_Jampolski>,
        <https://1145.am/db/1777542/Michael_Dubin>,
        <https://1145.am/db/1779605/Albert_Armengo>,
        <https://1145.am/db/1780722/Charlie_Songhurst>,
        <https://1145.am/db/1786995/Jonathan_Mckay>,
        <https://1145.am/db/1790215/Jay_Kassing>,
        <https://1145.am/db/1792353/Jonathan_Abrams>,
        <https://1145.am/db/1792353/Paul_Buchheit>,
        <https://1145.am/db/1800393/Juergen_Habichler>,
        <https://1145.am/db/1802308/Will_Sternlicht>,
        <https://1145.am/db/1804287/Michael_Hansen>,
        <https://1145.am/db/1804287/Tom_James>,
        <https://1145.am/db/1805666/Charles_Songhurst>,
        <https://1145.am/db/1805666/Chris_Mairs>,
        <https://1145.am/db/1805666/Simon_Rozas>,
        <https://1145.am/db/1808646/Josef_Brunner>,
        <https://1145.am/db/1808646/Tom_Noonan>,
        <https://1145.am/db/1810264/Cervin_Ventures>,
        <https://1145.am/db/1812183/Eyal_Shaked>,
        <https://1145.am/db/1820071/Albert_Ni>,
        <https://1145.am/db/1825214/Mario_Mariani>,
        <https://1145.am/db/1827905/Bryan_Johnson>,
        <https://1145.am/db/1827905/Mathias_Ackermand>,
        <https://1145.am/db/1827905/Richard_Bge>,
        <https://1145.am/db/1828108/Andy_Phillips>,
        <https://1145.am/db/1828992/Tytus_Michalski>,
        <https://1145.am/db/1833010/Andreessen_Horowitz>,
        <https://1145.am/db/1833010/Inspovation_Ventures>,
        <https://1145.am/db/1833010/Jonathan_Abrams>,
        <https://1145.am/db/1833010/Othman_Laraki>,
        <https://1145.am/db/1833010/Rick_Marini>,
        <https://1145.am/db/1833357/Mrt_Kelder>,
        <https://1145.am/db/1835867/Paolo_Guida>,
        <https://1145.am/db/1835867/Stefano_Calderano>,
        <https://1145.am/db/1836031/David_Cohen>,
        <https://1145.am/db/1837081/Jon_Craton>,
        <https://1145.am/db/1840836/Jl_Capital>,
        <https://1145.am/db/1849227/Christoph_Gelbmann>,
        <https://1145.am/db/1849227/Christoph_Prinz>,
        <https://1145.am/db/1849227/Johann_Jauk>,
        <https://1145.am/db/1849227/Martin_Dall>,
        <https://1145.am/db/1849227/Michael_Altrichter>,
        <https://1145.am/db/1849660/Owen_Van_Natta>,
        <https://1145.am/db/1852777/Justin_Peters>,
        <https://1145.am/db/1855864/Hiro_Maeda>,
        <https://1145.am/db/1855864/Ryota_Matsuzaki>,
        <https://1145.am/db/1860188/Bobby_Yazdani>,
        <https://1145.am/db/1860188/Howard_Lindzon>,
        <https://1145.am/db/1860188/Shervin_Pishevar>,
        <https://1145.am/db/1863389/Benaroya_Capital>,
        <https://1145.am/db/1866990/Interwest_Partners>,
        <https://1145.am/db/1874364/August_Capital>,
        <https://1145.am/db/1874951/Bobby_Yazdani>,
        <https://1145.am/db/1874951/Doug_Imbruce>,
        <https://1145.am/db/1877243/Raymond_Tonsing>,
        <https://1145.am/db/1877243/Seth_Goldstein>,
        <https://1145.am/db/1879679/Karl_Jacob>,
        <https://1145.am/db/1880187/Rikki_Tahta>,
        <https://1145.am/db/1886978/David_Li>,
        <https://1145.am/db/1887528/David_Tisch>,
        <https://1145.am/db/1887528/Josh_Auerbach>,
        <https://1145.am/db/1890254/Andreas_Ehn>,
        <https://1145.am/db/1891545/Ben_Narasin>,
        <https://1145.am/db/1891545/Bradley_Horowitz>,
        <https://1145.am/db/1891545/David_Cowan>,
        <https://1145.am/db/1891545/Mitch_Kapor>,
        <https://1145.am/db/1892079/Barry_Silbert>,
        <https://1145.am/db/1896185/David_Strohm>,
        <https://1145.am/db/1896185/George_Kadifa>,
        <https://1145.am/db/1896185/Maurice_Werdegar>,
        <https://1145.am/db/1920307/Allen_Morgan>,
        <https://1145.am/db/1930820/Joe_Lau>,
        <https://1145.am/db/1973758/Ziv_Paz>,
        <https://1145.am/db/2052613/Eamon_Jubbawy>,
        <https://1145.am/db/2134087/Martin_Madaus>,
        <https://1145.am/db/2181970/Hopelab_Ventures>,
        <https://1145.am/db/2277762/Jonathan_Sposato>,
        <https://1145.am/db/295448/Goldin_Ventures>,
        <https://1145.am/db/348633/Elie_Seidman>,
        <https://1145.am/db/388551/Darren_Lau>,
        <https://1145.am/db/402100/Benhamou_Global_Ventures>,
        <https://1145.am/db/402100/Saqib_Syed>,
        <https://1145.am/db/404998/Nima_Capital>,
        <https://1145.am/db/412403/Guillermo_Rauch>,
        <https://1145.am/db/413062/Stani_Kulechov>,
        <https://1145.am/db/415316/Guillermo_Rauch>,
        <https://1145.am/db/415535/Eliana_Murillo>,
        <https://1145.am/db/415535/Nathan_And_Sonia_Baschez>,
        <https://1145.am/db/415535/Nikhil_Krishnan>,
        <https://1145.am/db/417590/37angels>,
        <https://1145.am/db/447446/Andre_Igoudala>,
        <https://1145.am/db/586525/Alex_Kassan>,
        <https://1145.am/db/586525/Louis_Beryl>,
        <https://1145.am/db/612566/Andreas_Bodczek>,
        <https://1145.am/db/612566/Christian_Reber>,
        <https://1145.am/db/626399/David_Hodge>,
        <https://1145.am/db/772013/Adil_Syed>,
        <https://1145.am/db/772013/Joe_Kraus>,
        <https://1145.am/db/772013/Shoaib_Makani>,
        <https://1145.am/db/816795/Andrew_Artz>,
        <https://1145.am/db/816795/Bobby_Lo>,
        <https://1145.am/db/816795/Eduardo_Vilar>,
        <https://1145.am/db/816795/Joseph_Rubinsztain>,
        <https://1145.am/db/834470/Eynat_Guez>,
        <https://1145.am/db/889261/Michael_Pennington>,
        <https://1145.am/db/907814/Leyden>,
        <https://1145.am/db/907975/Gabriel_Weinberg>,
        <https://1145.am/db/908008/Leyden>,
        <https://1145.am/db/909436/Ram_Shriram>,
        <https://1145.am/db/935046/Bradley_Horowitz>,
        <https://1145.am/db/960286/Othman_Laraki>,
        <https://1145.am/db/979528/Mike_Dobbins>,
        <https://1145.am/db/987763/Acequia_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305443/Fuse_Capital> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2013-09-03T13:51:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Safeguard Scientifics Leads $10M Series B Financing for Quantia" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/safeguard-scientifics-leads-10m-series-b-financing-for-quantia> ;
    ns1:foundName "Fuse Capital" ;
    ns1:investor <https://1145.am/db/2305443/Series_B_Investment_Fuse_Capital_Quantia_Inc_Safeguard_Scientifics_Completed> ;
    ns1:name "Fuse Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1850787/Fuse_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305445/Jonathan_Milner> a org:Organization ;
    ns1:basedInLowRaw "Cambridge" ;
    ns1:description "angel investment" ;
    ns1:documentDate "2013-09-03T13:24:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Eagle Genomics secures 590,000 to expand its current bioinformatics offerings" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/eagle-genomics-secures-%C2%A3590-000-to-expand-its-current-bioinformatics-offerings> ;
    ns1:foundName "Jonathan Milner" ;
    ns1:investor <https://1145.am/db/2305445/Investment_Eagle_Genomics_Jonathan_Milner_Midven_Rainbow_Seed_Fund_Completed> ;
    ns1:name "Jonathan Milner" ;
    ns1:sameAsHigh <https://1145.am/db/1247479/Shifamed>,
        <https://1145.am/db/1739862/Lightbird_Ventures>,
        <https://1145.am/db/1750466/Eqt_Ventures>,
        <https://1145.am/db/1760200/Mazen_Al-Jubeir>,
        <https://1145.am/db/1792353/Jay_Jamison>,
        <https://1145.am/db/1792887/Leon_Waisbein>,
        <https://1145.am/db/1812183/Sam_Ben_Avraham>,
        <https://1145.am/db/1828876/David_Pritchard>,
        <https://1145.am/db/772013/Allen_Shim> ;
    ns1:sameAsMedium <https://1145.am/db/1735959/Jonathan_Milner>,
        <https://1145.am/db/1949332/Jonathan_Milner>,
        <https://1145.am/db/2131798/Jonathan_Milner>,
        <https://1145.am/db/2292687/Jonathan_Milner>,
        <https://1145.am/db/2292872/Jonathan_Milner>,
        <https://1145.am/db/696928/Jonathan_Milner>,
        <https://1145.am/db/959870/Jonathan_Milner> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305445/Rainbow_Seed_Fund> a org:Organization ;
    ns1:basedInLowRaw "Midven" ;
    ns1:description "angel investment" ;
    ns1:documentDate "2013-09-03T13:24:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Eagle Genomics secures 590,000 to expand its current bioinformatics offerings" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/eagle-genomics-secures-%C2%A3590-000-to-expand-its-current-bioinformatics-offerings> ;
    ns1:foundName "Rainbow Seed Fund" ;
    ns1:investor <https://1145.am/db/2305445/Investment_Eagle_Genomics_Jonathan_Milner_Midven_Rainbow_Seed_Fund_Completed> ;
    ns1:name "Rainbow Seed Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2299752/Rainbow_Seed_Fund>,
        <https://1145.am/db/2321542/Rainbow_Seed_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306519/Capital_Royalty_Partners_Lp> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "Financing",
        "Investing in companies" ;
    ns1:documentDate "2013-09-30T12:32:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RainDance Technologies Secures $35 Million in Financing from Capital Royalty Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/raindance-technologies-secures-35-million-financing-from-capital-royalty-partners> ;
    ns1:foundName "Capital Royalty Partners",
        "Capital Royalty Partners L.P" ;
    ns1:investor <https://1145.am/db/2306519/Investment_Capital_Royalty_Partners_Lp_Raindance_Technologies_Has_Not_Happened> ;
    ns1:name "Capital Royalty Partners",
        "Capital Royalty Partners L.P" ;
    ns1:protagonist <https://1145.am/db/2306519/Investment_Capital_Royalty_Partners_Lp_Raindance_Technologies_Has_Not_Happened> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306529/Arch_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "LOS ALTOS, Calif" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-10-07T12:15:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Boreal Genomics Secures $18 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/boreal-genomics-secures-18-million-series-c-financing> ;
    ns1:foundName "ARCH Venture Partners" ;
    ns1:investor <https://1145.am/db/2306529/Series_C_Investment_Arch_Venture_Partners_Boreal_Genomics_Kearny_Venture_Partners_Completed> ;
    ns1:name "ARCH Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1028744/Alpha_Wave_Ventures>,
        <https://1145.am/db/1029882/Alpha_Wave_Ventures>,
        <https://1145.am/db/1042554/Adara_Ventures>,
        <https://1145.am/db/1127410/Arca>,
        <https://1145.am/db/1151052/Adams_Street_Partners>,
        <https://1145.am/db/1269968/Avenue_Capital_Group>,
        <https://1145.am/db/1359473/Amboy_Street_Ventures>,
        <https://1145.am/db/1505630/Avenue_Growth_Partners>,
        <https://1145.am/db/1519613/Arch_Venture_Partners>,
        <https://1145.am/db/1519799/Arch_Venture_Partners>,
        <https://1145.am/db/1667738/Alteria_Capital>,
        <https://1145.am/db/1695849/Sapphire_Ventures>,
        <https://1145.am/db/1714553/Insignia_Ventures>,
        <https://1145.am/db/1723434/Alteria_Capital>,
        <https://1145.am/db/1741043/Sapphire_Ventures>,
        <https://1145.am/db/1741609/Adara_Ventures>,
        <https://1145.am/db/1742562/Insignia_Ventures>,
        <https://1145.am/db/1749316/Sapphire_Ventures_And_Alkeon>,
        <https://1145.am/db/1749645/Sapphire_Ventures>,
        <https://1145.am/db/1756326/Aspenwood_Ventures>,
        <https://1145.am/db/1758975/Sapphire_Ventures>,
        <https://1145.am/db/1759922/Allievo_Capital>,
        <https://1145.am/db/1759922/Elysian_Park_Ventures>,
        <https://1145.am/db/1762277/Affirma_Capital>,
        <https://1145.am/db/1766540/Great_Oaks_Capital>,
        <https://1145.am/db/1772282/Oakhouse_Partners>,
        <https://1145.am/db/1791220/Arch_Venture_Partners>,
        <https://1145.am/db/1796380/Adams_Street_Partners>,
        <https://1145.am/db/1799828/Arch_Venture_Partners>,
        <https://1145.am/db/1812681/Sapphire_Ventures>,
        <https://1145.am/db/1822403/Sapphire_Ventures>,
        <https://1145.am/db/1864601/Adams_Street_Partners>,
        <https://1145.am/db/1873252/Adams_Capital_Management>,
        <https://1145.am/db/1888995/Exa_Ventures>,
        <https://1145.am/db/1928208/Arch_Venture_Partners>,
        <https://1145.am/db/1928388/Alpha_Wave_Ventures>,
        <https://1145.am/db/2059371/Sapphire_Ventures>,
        <https://1145.am/db/2141055/Rosecliff_Ventures>,
        <https://1145.am/db/2151983/Arch_Venture_Partners>,
        <https://1145.am/db/2181184/Arch_Venture_Partners>,
        <https://1145.am/db/2305524/Arch_Venture_Partners>,
        <https://1145.am/db/2308828/Adams_Street_Partners>,
        <https://1145.am/db/2308841/Adams_Street_Partners>,
        <https://1145.am/db/2318934/Arch_Venrock>,
        <https://1145.am/db/2324015/Esprit_Capital_Partners_Llp>,
        <https://1145.am/db/2330075/Arch_Venture_Partners>,
        <https://1145.am/db/2331868/Arch_Venture_Partners>,
        <https://1145.am/db/2332659/Aravis_Venture>,
        <https://1145.am/db/2336126/Arch_Venture_Partners>,
        <https://1145.am/db/2337166/Adams_Street_Partners>,
        <https://1145.am/db/2341599/Arch_Venture_Partners>,
        <https://1145.am/db/2355706/Aravis_Venture>,
        <https://1145.am/db/2358725/Arch_Venture_Partners>,
        <https://1145.am/db/2366519/Adams_Street_Partners>,
        <https://1145.am/db/2366536/Arch_Venture_Partners>,
        <https://1145.am/db/2366539/Arch_Venture_Partners>,
        <https://1145.am/db/2454251/Battelle_Ventures_Lp>,
        <https://1145.am/db/396307/Sapphire_Ventures>,
        <https://1145.am/db/429179/Aspenwood_Ventures>,
        <https://1145.am/db/430553/Aspenwood_Ventures>,
        <https://1145.am/db/441490/Elysian_Park_Ventures>,
        <https://1145.am/db/441493/Elysian_Park_Ventures>,
        <https://1145.am/db/474123/Endeavor_Catalyst>,
        <https://1145.am/db/510279/Alteria_Capital>,
        <https://1145.am/db/564008/Alameda_Ventures>,
        <https://1145.am/db/593836/Sapphire_Ventures>,
        <https://1145.am/db/661275/Sapphire_Ventures>,
        <https://1145.am/db/682791/Congress_Avenue_Ventures>,
        <https://1145.am/db/684123/Congress_Avenue_Ventures>,
        <https://1145.am/db/749201/Congress_Avenue_Ventures>,
        <https://1145.am/db/769568/Arch_Venture_Partners>,
        <https://1145.am/db/773301/Alameda_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1042080/Arch_Venture_Partners>,
        <https://1145.am/db/1105790/Arch_Venture_Partners>,
        <https://1145.am/db/1108240/Arch_Venture_Partners>,
        <https://1145.am/db/1320499/Arch_Venture_Partners>,
        <https://1145.am/db/1334395/Arch_Venture_Partners>,
        <https://1145.am/db/1376077/Arch_Venture_Partners>,
        <https://1145.am/db/1406211/Arch_Venture_Partners>,
        <https://1145.am/db/1476658/Arch_Venture_Partners>,
        <https://1145.am/db/1553175/Arch_Venture_Partners>,
        <https://1145.am/db/1553459/Arch_Venture_Partners>,
        <https://1145.am/db/1582111/Arch_Venture_Partners>,
        <https://1145.am/db/1619794/Arch_Venture_Partners>,
        <https://1145.am/db/1663313/Arch_Venture_Partners>,
        <https://1145.am/db/1750401/Arch_Venture_Partners>,
        <https://1145.am/db/1984721/Arch_Venture_Partners>,
        <https://1145.am/db/2095032/Arch_Venture_Partners>,
        <https://1145.am/db/2280315/Arch_Venture_Partners>,
        <https://1145.am/db/2281905/Arch_Venture_Partners>,
        <https://1145.am/db/2282162/Arch_Venture_Partners>,
        <https://1145.am/db/2284585/Arch_Venture_Partners>,
        <https://1145.am/db/2292675/Arch_Venture_Partners>,
        <https://1145.am/db/2294815/Arch_Venture_Partners>,
        <https://1145.am/db/2296113/Arch_Venture_Partners>,
        <https://1145.am/db/2301122/Arch_Venture_Partners>,
        <https://1145.am/db/2302047/Arch_Venture_Partners>,
        <https://1145.am/db/2315446/Arch_Venture_Partners>,
        <https://1145.am/db/2328599/Arch_Venture_Partners>,
        <https://1145.am/db/2330712/Arch_Venture_Partners>,
        <https://1145.am/db/2330852/Arch_Venture_Partners>,
        <https://1145.am/db/2331754/Arch_Venture_Partners>,
        <https://1145.am/db/2335701/Arch_Venture_Partners>,
        <https://1145.am/db/2335714/Arch_Venture_Partners>,
        <https://1145.am/db/2335773/Arch_Venture_Partners>,
        <https://1145.am/db/2337140/Arch_Venture_Partners>,
        <https://1145.am/db/2339413/Arch_Venture_Partners>,
        <https://1145.am/db/2340344/Arch_Venture_Partners>,
        <https://1145.am/db/2340345/Arch_Venture_Partners>,
        <https://1145.am/db/2340348/Arch_Venture_Partners>,
        <https://1145.am/db/2345223/Arch_Venture_Partners>,
        <https://1145.am/db/2345769/Arch_Venture_Partners>,
        <https://1145.am/db/2347368/Arch_Venture_Partners>,
        <https://1145.am/db/2347469/Arch_Venture_Partners>,
        <https://1145.am/db/2348074/Arch_Venture_Partners>,
        <https://1145.am/db/2356066/Arch_Venture_Partners>,
        <https://1145.am/db/2357253/Arch_Venture_Partners>,
        <https://1145.am/db/2357256/Arch_Venture_Partners>,
        <https://1145.am/db/2359124/Arch_Venture_Partners>,
        <https://1145.am/db/2359447/Arch_Venture_Partners>,
        <https://1145.am/db/2359655/Arch_Venture_Partners>,
        <https://1145.am/db/2364332/Arch_Venture_Partners>,
        <https://1145.am/db/2364336/Arch_Venture_Partners>,
        <https://1145.am/db/2366654/Arch_Venture_Partners>,
        <https://1145.am/db/2368912/Arch_Venture_Partners>,
        <https://1145.am/db/2369000/Arch_Venture_Partners>,
        <https://1145.am/db/2369549/Arch_Venture_Partners>,
        <https://1145.am/db/2371167/Arch_Venture_Partners>,
        <https://1145.am/db/2592611/Arch_Venture_Partners>,
        <https://1145.am/db/430986/Arch_Venture_Partners>,
        <https://1145.am/db/531806/Arch_Venture_Partners>,
        <https://1145.am/db/847865/Arch_Venture_Partners>,
        <https://1145.am/db/900779/Arch_Venture_Partners>,
        <https://1145.am/db/900943/Arch_Venture_Partners>,
        <https://1145.am/db/922192/Arch_Venture_Partners>,
        <https://1145.am/db/944358/Arch_Venture_Partners>,
        <https://1145.am/db/979509/Arch_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306529/Kearny_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "LOS ALTOS, Calif" ;
    ns1:documentDate "2013-10-07T12:15:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Boreal Genomics Secures $18 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/boreal-genomics-secures-18-million-series-c-financing> ;
    ns1:foundName "Kearny Venture Partners" ;
    ns1:investor <https://1145.am/db/2306529/Series_C_Investment_Arch_Venture_Partners_Boreal_Genomics_Kearny_Venture_Partners_Completed> ;
    ns1:name "Kearny Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2300697/Kearny_Venture_Partners>,
        <https://1145.am/db/2303695/Kearny_Venture_Partners>,
        <https://1145.am/db/2335764/Kearny_Venture_Partners_Venture_Investors>,
        <https://1145.am/db/2354752/Kearny_Venture_Partners>,
        <https://1145.am/db/2354770/Kearny_Venture_Partners>,
        <https://1145.am/db/2361588/Kearny_Venture_Partners_Venture_Investors_Llc>,
        <https://1145.am/db/2367022/Kearny_Venture_Partners>,
        <https://1145.am/db/2367023/Kearny_Venture_Partners>,
        <https://1145.am/db/2367046/Kearny_Venture_Partners>,
        <https://1145.am/db/2367047/Kearny_Venture_Partners>,
        <https://1145.am/db/2575232/Kearny_Venture_Partners>,
        <https://1145.am/db/2588372/Kearny_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2310864/Investment_Validic_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-03-17T11:40:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "DURHAM, N.C., March 12, 2014 /PRNewswire/ - Validic, the healthcare industry's premier technology platform for accessing data from mobile health devices, wearables and patient applications, announced today that it has secured additional investment funding.",
        "Validic's total funding to date is $ 2.1million, as the company continues its mission to further bridge the gap between healthcare companies and mobile health data producers." ;
    ns1:documentTitle "Validic Secures $1.25 Million in New Funding, Adds Key Executives" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/validic-secures-1-25-million-new-funding-adds-key-executives> ;
    ns1:foundName "funding",
        "investment" ;
    ns1:name "funding",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2310864/Validic> ;
    ns1:valueRaw "$ 2.1million" ;
    ns1:when "2014-03-12T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "March 12, 2014" ;
    ns1:whereGeoName "Durham County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4464374/about.rdf> ;
    ns1:whereRaw "DURHAM, N.C." .

<https://1145.am/db/2312563/Eu> a org:Organization ;
    ns1:description "European Union" ;
    ns1:documentDate "2013-09-18T12:45:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EpimiRNA Consortium Receives 11.5 Million Funding by EU to Uncover the Effects of microRNA in Epilepsy" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/epimirna-consortium-receives-%E2%82%AC11-5-million-funding-by-eu-to-uncover-effects-of-microrna> ;
    ns1:foundName "EU" ;
    ns1:investor <https://1145.am/db/2312563/Investment_Framework_Programme_7_The_Epimirna_Consortium_Has_Not_Happened> ;
    ns1:name "EU" ;
    ns1:sameAsHigh <https://1145.am/db/1426302/European_Commission>,
        <https://1145.am/db/1428641/European_Commission>,
        <https://1145.am/db/1667520/European_Commission> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2312563/Framework_Programme_7> a org:Organization ;
    ns1:basedInLowRaw "European Union" ;
    ns1:description "investigating molecular mechanisms, diagnostics and treatments for epilepsy" ;
    ns1:documentDate "2013-09-18T12:45:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EpimiRNA Consortium Receives 11.5 Million Funding by EU to Uncover the Effects of microRNA in Epilepsy" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/epimirna-consortium-receives-%E2%82%AC11-5-million-funding-by-eu-to-uncover-effects-of-microrna> ;
    ns1:foundName "Framework Programme 7" ;
    ns1:investor <https://1145.am/db/2312563/Investment_Framework_Programme_7_The_Epimirna_Consortium_Has_Not_Happened> ;
    ns1:name "Framework Programme 7" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2312563/Joint_Venture_The_Epimirna_Consortium_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "joint venture" ;
    ns1:documentDate "2013-09-18T12:45:09+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The EpimiRNA Consortium, involving 16 partners from 8 European countries, the USA and Brazil has received 11.5 million funding from the European Union's Framework Programme 7 to investigate molecular mechanisms, diagnostics and treatments for epilepsy." ;
    ns1:documentTitle "EpimiRNA Consortium Receives 11.5 Million Funding by EU to Uncover the Effects of microRNA in Epilepsy" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/epimirna-consortium-receives-%E2%82%AC11-5-million-funding-by-eu-to-uncover-effects-of-microrna> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "11.5 million" ;
    ns1:vendor <https://1145.am/db/2312563/The_Epimirna_Consortium> ;
    ns1:whereGeoName "EU" ;
    ns1:whereRaw "EU" .

<https://1145.am/db/2317344/Pra_International> a org:Organization ;
    ns1:basedInHighGeoName "Raleigh" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4487042/about.rdf> ;
    ns1:basedInHighRaw "RALEIGH, N.C." ;
    ns1:description "Clinical research" ;
    ns1:documentDate "2013-09-25T17:50:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PRA and RPS Merger Completed" ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/pra-and-rps-merger-completed> ;
    ns1:foundName "PRA International" ;
    ns1:industry "Clinical research" ;
    ns1:name "PRA International" ;
    ns1:protagonist <https://1145.am/db/2317344/Research_Pharmaceutical_Services_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2285284/Namsa>,
        <https://1145.am/db/2285703/Pra>,
        <https://1145.am/db/2291716/Science_37>,
        <https://1145.am/db/2302049/Pra_International>,
        <https://1145.am/db/2304992/Pra_Health_Sciences>,
        <https://1145.am/db/2309710/Pra>,
        <https://1145.am/db/2314081/Pra_International>,
        <https://1145.am/db/2318468/Pra>,
        <https://1145.am/db/2321352/Pra_International>,
        <https://1145.am/db/2321356/Pra_International>,
        <https://1145.am/db/2328280/Science_37>,
        <https://1145.am/db/2329414/Pra_International>,
        <https://1145.am/db/2336420/Pra_International>,
        <https://1145.am/db/2345193/Pra_International>,
        <https://1145.am/db/441202/Science_37> ;
    ns1:sameAsMedium <https://1145.am/db/2302045/Pra_International>,
        <https://1145.am/db/2303464/Pra_International>,
        <https://1145.am/db/2316406/Pra_International>,
        <https://1145.am/db/2330989/Pra_International> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318450/Inventiv_Health> a org:Organization ;
    ns1:basedInLowRaw "the nation" ;
    ns1:buyer <https://1145.am/db/2318450/Catalina_Health_Acquisition> ;
    ns1:description "outsourcing" ;
    ns1:documentDate "2013-10-31T12:30:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "InVentiv grabs Catalina Health with eye on patient adherence" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/inventiv-grabs-catalina-health-eye-on-patient-adherence> ;
    ns1:foundName "Outsourcing magnate inVentiv Health" ;
    ns1:industry "Outsourcing" ;
    ns1:name "inVentiv Health" ;
    ns1:sameAsMedium <https://1145.am/db/2241174/Inventiv_Health>,
        <https://1145.am/db/2249263/Inventiv_Health>,
        <https://1145.am/db/2310765/Inventiv_Health>,
        <https://1145.am/db/2310799/Inventiv_Health>,
        <https://1145.am/db/2318436/Inventiv_Health>,
        <https://1145.am/db/2318447/Inventiv_Health>,
        <https://1145.am/db/2332515/Inventiv_Health>,
        <https://1145.am/db/2334324/Inventiv_Health>,
        <https://1145.am/db/2334334/Inventiv_Health>,
        <https://1145.am/db/2334591/Inventiv_Health>,
        <https://1145.am/db/2338799/Inventiv_Health>,
        <https://1145.am/db/2344145/Inventiv_Health>,
        <https://1145.am/db/2344146/Inventiv_Health>,
        <https://1145.am/db/2346316/Inventiv_Health>,
        <https://1145.am/db/2346317/Inventiv_Health>,
        <https://1145.am/db/2581316/Inventiv_Health>,
        <https://1145.am/db/2590348/Inventiv_Health>,
        <https://1145.am/db/2593060/Inventiv_Health> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318461/Capsugel> a org:Organization ;
    ns1:basedInLowRaw "Oregon" ;
    ns1:buyer <https://1145.am/db/2318461/Investment_Bend_Research_Capsugel_Has_Not_Happened>,
        <https://1145.am/db/2318461/Scotland_Acquisition> ;
    ns1:documentDate "2013-11-11T13:08:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Capsugel bets $20M on Bend's commercial manufacturing" ;
    ns1:documentURL <https://www.fiercebiotech.com/manufacturing/capsugel-bets-20m-on-bend-s-commercial-manufacturing> ;
    ns1:foundName "CMO Capsugel",
        "Capsugel" ;
    ns1:industry "contract manufacturing" ;
    ns1:investor <https://1145.am/db/2318461/Investment_Bend_Research_Capsugel_Has_Not_Happened> ;
    ns1:name "Capsugel" ;
    ns1:sameAsMedium <https://1145.am/db/2305866/Capsugel>,
        <https://1145.am/db/2309696/Capsugel>,
        <https://1145.am/db/2309697/Capsugel>,
        <https://1145.am/db/2316255/Capsugel>,
        <https://1145.am/db/2316262/Capsugel>,
        <https://1145.am/db/2347565/Capsugel>,
        <https://1145.am/db/2364161/Capsugel>,
        <https://1145.am/db/2536473/Capsugel>,
        <https://1145.am/db/2536474/Capsugel>,
        <https://1145.am/db/2540235/Capsugel>,
        <https://1145.am/db/2540356/Capsugel>,
        <https://1145.am/db/2540492/Capsugel>,
        <https://1145.am/db/2540931/Capsugel>,
        <https://1145.am/db/2541486/Capsugel>,
        <https://1145.am/db/2541489/Capsugel>,
        <https://1145.am/db/2545962/Capsugel>,
        <https://1145.am/db/2546137/Capsugel>,
        <https://1145.am/db/2546140/Capsugel>,
        <https://1145.am/db/2547142/Capsugel>,
        <https://1145.am/db/2548051/Capsugel>,
        <https://1145.am/db/2550232/Capsugel>,
        <https://1145.am/db/2558602/Capsugel>,
        <https://1145.am/db/2560766/Capsugel>,
        <https://1145.am/db/2562425/Capsugel>,
        <https://1145.am/db/2562434/Capsugel>,
        <https://1145.am/db/2564490/Capsugel>,
        <https://1145.am/db/2564708/Capsugel>,
        <https://1145.am/db/2574936/Capsugel>,
        <https://1145.am/db/2577634/Capsugel>,
        <https://1145.am/db/2583449/Capsugel>,
        <https://1145.am/db/2583451/Capsugel>,
        <https://1145.am/db/2586167/Capsugel>,
        <https://1145.am/db/2591081/Capsugel>,
        <https://1145.am/db/2593886/Capsugel> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318461/Encap_Drug_Delivery_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-11-11T13:08:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Over the past year, Capsugel has used its wallet to get a bigger stake in the contract manufacturing world, first buying Scotland's Encap Drug Delivery to add liquid and semi-solid encapsulations to its offerings, and then picking up Bend this fall, bringing in technologies for modified release, inhalation delivery and biotherapeutic processing." ;
    ns1:documentTitle "Capsugel bets $20M on Bend's commercial manufacturing" ;
    ns1:documentURL <https://www.fiercebiotech.com/manufacturing/capsugel-bets-20m-on-bend-s-commercial-manufacturing> ;
    ns1:foundName "buying" ;
    ns1:name "buying" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2318461/Encap_Drug_Delivery> ;
    ns1:targetName "Encap Drug Delivery" ;
    ns1:whereGeoName "Scotland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2638360/about.rdf> ;
    ns1:whereRaw "Scotland" .

<https://1145.am/db/2339894/Andrea_Holdings_International_Ltd> a org:Organization ;
    ns1:basedInLowRaw "Korea" ;
    ns1:documentDate "2013-07-18T15:55:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lithera Announces Second Closing of $27.3 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lithera-announces-second-closing-of-27-3-million-series-c-financing> ;
    ns1:foundName "Andrea Holdings International Ltd" ;
    ns1:investor <https://1145.am/db/2339894/Series_C_Preferred_Stock_Equity_Investment_Andrea_Holdings_International_Ltd_Lithera_Mirae_Asset_Venture_Investment_Rusnanomedinvest_Completed> ;
    ns1:name "Andrea Holdings International Ltd" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339894/Mirae_Asset_Venture_Investment> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Korea" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1835841/about.rdf> ;
    ns1:basedInHighRaw "Korea" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-07-18T15:55:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lithera Announces Second Closing of $27.3 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lithera-announces-second-closing-of-27-3-million-series-c-financing> ;
    ns1:foundName "Mirae Asset Venture Investment" ;
    ns1:investor <https://1145.am/db/2339894/Series_C_Preferred_Stock_Equity_Investment_Andrea_Holdings_International_Ltd_Lithera_Mirae_Asset_Venture_Investment_Rusnanomedinvest_Completed> ;
    ns1:name "Mirae Asset Venture Investment" ;
    ns1:sameAsHigh <https://1145.am/db/1120357/Mirae_Asset_Venture_Investment>,
        <https://1145.am/db/1323515/Mirae_Asset_Capital>,
        <https://1145.am/db/2169799/Mirae_Asset_Venture_Investment>,
        <https://1145.am/db/2281648/Mirae_Asset_Capital>,
        <https://1145.am/db/441319/Miramar_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1050358/Mirae_Asset_Venture_Investment>,
        <https://1145.am/db/1050487/Mirae_Asset_Venture_Investment>,
        <https://1145.am/db/1140286/Mirae_Asset_Venture_Investment>,
        <https://1145.am/db/1558580/Mirae_Asset_Venture_Investment>,
        <https://1145.am/db/1736531/Mirae_Asset_Venture_Investment>,
        <https://1145.am/db/1745467/Mirae_Asset_Venture_Investment>,
        <https://1145.am/db/1789342/Mirae_Asset_Venture_Investment>,
        <https://1145.am/db/1817108/Mirae_Asset_Venture_Investment>,
        <https://1145.am/db/2279205/Mirae_Asset_Venture_Investment>,
        <https://1145.am/db/835534/Mirae_Asset_Venture_Investment> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339925/Bessemer_Venture_Partners> a org:Organization ;
    ns1:description "Investing" ;
    ns1:documentDate "2013-07-22T09:44:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alcresta Secures $10 Million Series B Financing, Prepares for 2014 Commercial Launch of Novel Point-of-Care Nutritional Products" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/alcresta-secures-10-million-series-b-financing-prepares-for-2014-commercial-launch> ;
    ns1:foundName "Bessemer Venture Partners" ;
    ns1:investor <https://1145.am/db/2339925/Series_B_Investment_Alcresta_Bessemer_Venture_Partners_Frazier_Healthcare_Third_Rock_Ventures_Completed> ;
    ns1:name "Bessemer Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1006362/Bessemer_Ventures>,
        <https://1145.am/db/1007121/Bessemer_Ventures>,
        <https://1145.am/db/1140521/Bessemer_Venture_Partners>,
        <https://1145.am/db/1150887/Bessemer_Venture_Partners>,
        <https://1145.am/db/1153184/Bessemer_Venture_Partners>,
        <https://1145.am/db/1168925/Bessemer_Venture_Partners>,
        <https://1145.am/db/1171251/Bessemer_Venture_Partners>,
        <https://1145.am/db/1287496/Bessemer_Venture_Partners>,
        <https://1145.am/db/1297270/Bessemer_Venture_Partners>,
        <https://1145.am/db/1298072/Bessemer_Venture_Partners>,
        <https://1145.am/db/1311917/Bessemer_Venture_Partners>,
        <https://1145.am/db/1412727/Bessemer_Venture_Partners>,
        <https://1145.am/db/1445566/Bessemer_Venture_Partners>,
        <https://1145.am/db/1449740/Bessemer_Venture_Partners>,
        <https://1145.am/db/1490295/Bessemer_Venture_Partners>,
        <https://1145.am/db/1667738/Bessemer_Venture_Partners>,
        <https://1145.am/db/1703633/Bessemer_Venture_Partners>,
        <https://1145.am/db/1726088/Bessemer_Venture_Partners>,
        <https://1145.am/db/1731036/Bessemer_Venture_Partners>,
        <https://1145.am/db/1735755/Bessemer_Venture_Partners>,
        <https://1145.am/db/1736811/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744676/Bessemer_Venture_Partners>,
        <https://1145.am/db/1748765/Bessemer_Venture_Partners>,
        <https://1145.am/db/1749643/Bessemer_Venture_Partners>,
        <https://1145.am/db/1750217/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751506/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751790/Bessemer_Venture_Partners>,
        <https://1145.am/db/1751800/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1760614/Bessemer_Ventures>,
        <https://1145.am/db/1762343/Bessemer_Venture_Partners>,
        <https://1145.am/db/1763774/Bessemer_Venture_Partners>,
        <https://1145.am/db/1765092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1765646/Bessemer_Venture_Partners>,
        <https://1145.am/db/1772381/Bessemer_Venture_Partners>,
        <https://1145.am/db/1774323/Bessemer_Venture_Partners>,
        <https://1145.am/db/1775794/Bessemer_Venture_Partners>,
        <https://1145.am/db/1778844/Bessemer_Venture_Partners>,
        <https://1145.am/db/1779320/Bessemer_Venture_Partners>,
        <https://1145.am/db/1780998/Bessemer_Venture_Partners>,
        <https://1145.am/db/1795531/Bessemer_Venture_Partners>,
        <https://1145.am/db/1797945/Bessemer_Venture_Partners>,
        <https://1145.am/db/1801088/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802590/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802834/Bessemer_Venture_Partners>,
        <https://1145.am/db/1808735/Bessemer_Venture_Partners>,
        <https://1145.am/db/1813337/Bessemer_Venture_Partners>,
        <https://1145.am/db/1819651/Bessemer_Venture_Partners>,
        <https://1145.am/db/1820660/Bessemer_Venture_Partners>,
        <https://1145.am/db/1823001/Bessemer_Venture_Partners>,
        <https://1145.am/db/1823041/Bessemer_Ventures>,
        <https://1145.am/db/1826794/Bessemer_Ventures_Partners>,
        <https://1145.am/db/1833296/Bessemer_Venture_Partners>,
        <https://1145.am/db/1839990/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849606/Bessemer_Venture_Partners>,
        <https://1145.am/db/1851792/Bessemer_Venture_Partners>,
        <https://1145.am/db/1853292/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860406/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860637/Bessemer_Venture_Partners>,
        <https://1145.am/db/1866032/Bessemer_Venture_Partners>,
        <https://1145.am/db/1892105/Bessemer_Venture_Partners>,
        <https://1145.am/db/1893502/Bessemer_Venture_Partners>,
        <https://1145.am/db/1898837/Bessemer_Venture_Partners>,
        <https://1145.am/db/1904197/Bessemer_Venture_Partners>,
        <https://1145.am/db/1914189/Bessemer_Venture_Partners>,
        <https://1145.am/db/1917346/Bessemer_Venture_Partners>,
        <https://1145.am/db/1921374/Bessemer_Venture_Partners>,
        <https://1145.am/db/1947303/Bessemer_Venture_Partners>,
        <https://1145.am/db/1954147/Bessemer_Venture_Partners>,
        <https://1145.am/db/2013193/Bessemer_Venture_Partners>,
        <https://1145.am/db/2051110/Bessemer_Venture_Partners>,
        <https://1145.am/db/2059038/Bessemer_Venture_Partners>,
        <https://1145.am/db/2070098/Bessemer_Venture_Partners>,
        <https://1145.am/db/2125259/Bessemer_Venture_Partners>,
        <https://1145.am/db/2142825/Bessemer_Venture_Partners>,
        <https://1145.am/db/2181016/Bessemer_Venture_Partners>,
        <https://1145.am/db/221321/Bessemer_Venture_Partners>,
        <https://1145.am/db/2236188/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303251/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303257/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303675/Bessemer_Venture_Partners>,
        <https://1145.am/db/2317918/Bessemer_Venture_Partners>,
        <https://1145.am/db/2325326/Bessemer_Venture_Partners>,
        <https://1145.am/db/2338625/Bessemer_Venture_Partners>,
        <https://1145.am/db/2349437/Bessemer_Venture_Partners>,
        <https://1145.am/db/2362871/Bessemer_Venture_Partners>,
        <https://1145.am/db/2621506/Bessemer_Venture_Partners>,
        <https://1145.am/db/2766437/Bessemer_Venture_Partners>,
        <https://1145.am/db/293891/Bessemer_Venture_Partners>,
        <https://1145.am/db/325080/Bessemer_Venture_Partners>,
        <https://1145.am/db/472389/Bessemer_Venture_Partners>,
        <https://1145.am/db/473354/Bessemer_Venture_Partners>,
        <https://1145.am/db/507249/Bessemer_Venture_Partners>,
        <https://1145.am/db/508115/Bessemer_Venture_Partners>,
        <https://1145.am/db/511072/Bessemer_Venture_Partners>,
        <https://1145.am/db/513305/Bessemer_Venture_Partners>,
        <https://1145.am/db/575249/Bessemer_Venture_Partners>,
        <https://1145.am/db/606291/Bessemer_Venture_Partners>,
        <https://1145.am/db/676869/Bessemer_Venture_Partners>,
        <https://1145.am/db/678140/Bessemer_Venture_Partners>,
        <https://1145.am/db/694924/Bessemer_Venture_Partners>,
        <https://1145.am/db/803541/Bessemer_Venture_Partners>,
        <https://1145.am/db/8314/Bessemer_Venture_Partners>,
        <https://1145.am/db/847157/Bessemer_Venture_Partners>,
        <https://1145.am/db/862760/Bessemer_Venture_Partners>,
        <https://1145.am/db/862851/Bessemer_Venture_Partners>,
        <https://1145.am/db/884806/Bessemer_Venture_Partners>,
        <https://1145.am/db/924505/Bessemer_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1060146/Bessemer_Venture_Partners>,
        <https://1145.am/db/1061468/Bessemer_Venture_Partners>,
        <https://1145.am/db/1061911/Bessemer_Venture_Partners>,
        <https://1145.am/db/1064710/Bessemer_Venture_Partners>,
        <https://1145.am/db/1090262/Bessemer_Venture_Partners>,
        <https://1145.am/db/1480187/Bessemer_Venture_Partners>,
        <https://1145.am/db/1669991/Bessemer_Venture_Partners>,
        <https://1145.am/db/1697155/Bessemer_Venture_Partners>,
        <https://1145.am/db/1698509/Bessemer_Venture_Partners>,
        <https://1145.am/db/1706697/Bessemer_Venture_Partners>,
        <https://1145.am/db/1707187/Bessemer_Venture_Partners>,
        <https://1145.am/db/1712471/Bessemer_Venture_Partners>,
        <https://1145.am/db/1717313/Bessemer_Venture_Partners>,
        <https://1145.am/db/1718800/Bessemer_Venture_Partners>,
        <https://1145.am/db/1723948/Bessemer_Venture_Partners>,
        <https://1145.am/db/1725530/Bessemer_Venture_Partners>,
        <https://1145.am/db/1742802/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744158/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744201/Bessemer_Venture_Partners>,
        <https://1145.am/db/1744656/Bessemer_Venture_Partners>,
        <https://1145.am/db/1752609/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756150/Bessemer_Venture_Partners>,
        <https://1145.am/db/1756999/Bessemer_Venture_Partners>,
        <https://1145.am/db/1757845/Bessemer_Venture_Partners>,
        <https://1145.am/db/1758776/Bessemer_Venture_Partners>,
        <https://1145.am/db/1759851/Bessemer_Venture_Partners>,
        <https://1145.am/db/1759923/Bessemer_Venture_Partners>,
        <https://1145.am/db/1760213/Bessemer_Venture_Partners>,
        <https://1145.am/db/1763433/Bessemer_Venture_Partners>,
        <https://1145.am/db/1767075/Bessemer_Venture_Partners>,
        <https://1145.am/db/1771769/Bessemer_Venture_Partners>,
        <https://1145.am/db/1772047/Bessemer_Venture_Partners>,
        <https://1145.am/db/1776988/Bessemer_Venture_Partners>,
        <https://1145.am/db/1779634/Bessemer_Venture_Partners>,
        <https://1145.am/db/1800364/Bessemer_Venture_Partners>,
        <https://1145.am/db/1802034/Bessemer_Venture_Partners>,
        <https://1145.am/db/1806684/Bessemer_Venture_Partners>,
        <https://1145.am/db/1813349/Bessemer_Venture_Partners>,
        <https://1145.am/db/1814014/Bessemer_Venture_Partners>,
        <https://1145.am/db/1816701/Bessemer_Venture_Partners>,
        <https://1145.am/db/1818326/Bessemer_Venture_Partners>,
        <https://1145.am/db/1818535/Bessemer_Venture_Partners>,
        <https://1145.am/db/1821929/Bessemer_Venture_Partners>,
        <https://1145.am/db/1823415/Bessemer_Venture_Partners>,
        <https://1145.am/db/1825267/Bessemer_Venture_Partners>,
        <https://1145.am/db/1828092/Bessemer_Venture_Partners>,
        <https://1145.am/db/1836250/Bessemer_Venture_Partners>,
        <https://1145.am/db/1838678/Bessemer_Venture_Partners>,
        <https://1145.am/db/1843244/Bessemer_Venture_Partners>,
        <https://1145.am/db/1846957/Bessemer_Venture_Partners>,
        <https://1145.am/db/1847160/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849046/Bessemer_Venture_Partners>,
        <https://1145.am/db/1849746/Bessemer_Venture_Partners>,
        <https://1145.am/db/1850076/Bessemer_Venture_Partners>,
        <https://1145.am/db/1850727/Bessemer_Venture_Partners>,
        <https://1145.am/db/1856085/Bessemer_Venture_Partners>,
        <https://1145.am/db/1857212/Bessemer_Venture_Partners>,
        <https://1145.am/db/1857278/Bessemer_Venture_Partners>,
        <https://1145.am/db/1859331/Bessemer_Venture_Partners>,
        <https://1145.am/db/1860367/Bessemer_Venture_Partners>,
        <https://1145.am/db/1861518/Bessemer_Venture_Partners>,
        <https://1145.am/db/1876003/Bessemer_Venture_Partners>,
        <https://1145.am/db/1883858/Bessemer_Venture_Partners>,
        <https://1145.am/db/1885320/Bessemer_Venture_Partners>,
        <https://1145.am/db/1885998/Bessemer_Venture_Partners>,
        <https://1145.am/db/1889732/Bessemer_Venture_Partners>,
        <https://1145.am/db/1910644/Bessemer_Venture_Partners>,
        <https://1145.am/db/1921599/Bessemer_Venture_Partners>,
        <https://1145.am/db/2011521/Bessemer_Venture_Partners>,
        <https://1145.am/db/2031790/Bessemer_Venture_Partners>,
        <https://1145.am/db/2043214/Bessemer_Venture_Partners>,
        <https://1145.am/db/207823/Bessemer_Venture_Partners>,
        <https://1145.am/db/2127786/Bessemer_Venture_Partners>,
        <https://1145.am/db/2141061/Bessemer_Venture_Partners>,
        <https://1145.am/db/2173983/Bessemer_Venture_Partners>,
        <https://1145.am/db/2194210/Bessemer_Venture_Partners>,
        <https://1145.am/db/2197248/Bessemer_Venture_Partners>,
        <https://1145.am/db/2303250/Bessemer_Venture_Partners>,
        <https://1145.am/db/2311551/Bessemer_Venture_Partners>,
        <https://1145.am/db/2316356/Bessemer_Venture_Partners>,
        <https://1145.am/db/2324076/Bessemer_Venture_Partners>,
        <https://1145.am/db/2338633/Bessemer_Venture_Partners>,
        <https://1145.am/db/2339926/Bessemer_Venture_Partners>,
        <https://1145.am/db/2348448/Bessemer_Venture_Partners>,
        <https://1145.am/db/2351520/Bessemer_Venture_Partners>,
        <https://1145.am/db/2352414/Bessemer_Venture_Partners>,
        <https://1145.am/db/2353404/Bessemer_Venture_Partners>,
        <https://1145.am/db/2353415/Bessemer_Venture_Partners>,
        <https://1145.am/db/2363330/Bessemer_Venture_Partners>,
        <https://1145.am/db/2677219/Bessemer_Venture_Partners>,
        <https://1145.am/db/341984/Bessemer_Venture_Partners>,
        <https://1145.am/db/341990/Bessemer_Venture_Partners>,
        <https://1145.am/db/425262/Bessemer_Venture_Partners>,
        <https://1145.am/db/478025/Bessemer_Venture_Partners>,
        <https://1145.am/db/506309/Bessemer_Venture_Partners>,
        <https://1145.am/db/559318/Bessemer_Venture_Partners>,
        <https://1145.am/db/668230/Bessemer_Venture_Partners>,
        <https://1145.am/db/668965/Bessemer_Venture_Partners>,
        <https://1145.am/db/699860/Bessemer_Venture_Partners>,
        <https://1145.am/db/700171/Bessemer_Venture_Partners>,
        <https://1145.am/db/829118/Bessemer_Venture_Partners>,
        <https://1145.am/db/832264/Bessemer_Venture_Partners>,
        <https://1145.am/db/877618/Bessemer_Venture_Partners>,
        <https://1145.am/db/902390/Bessemer_Venture_Partners>,
        <https://1145.am/db/907582/Bessemer_Venture_Partners>,
        <https://1145.am/db/907975/Bessemer_Venture_Partners>,
        <https://1145.am/db/955858/Bessemer_Venture_Partners>,
        <https://1145.am/db/960320/Bessemer_Venture_Partners>,
        <https://1145.am/db/971418/Bessemer_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339925/Frazier_Healthcare> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2013-07-22T09:44:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alcresta Secures $10 Million Series B Financing, Prepares for 2014 Commercial Launch of Novel Point-of-Care Nutritional Products" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/alcresta-secures-10-million-series-b-financing-prepares-for-2014-commercial-launch> ;
    ns1:foundName "Frazier Healthcare" ;
    ns1:investor <https://1145.am/db/2339925/Series_B_Investment_Alcresta_Bessemer_Venture_Partners_Frazier_Healthcare_Third_Rock_Ventures_Completed> ;
    ns1:name "Frazier Healthcare" ;
    ns1:sameAsHigh <https://1145.am/db/2340207/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2366693/Frazier_Healthcare_And_Three_Arch_Partners>,
        <https://1145.am/db/2366700/Frazier_Healthcare> ;
    ns1:sameAsMedium <https://1145.am/db/1244886/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1245863/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1329605/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1374146/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1813040/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2152824/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2154276/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2189855/Frazier_Healthcare>,
        <https://1145.am/db/2196903/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2245812/Frazier_Healthcare>,
        <https://1145.am/db/2278780/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2292109/Frazier_Healthcare>,
        <https://1145.am/db/2294202/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2303250/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303251/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303257/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2305524/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2307824/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2307829/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2308855/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2310795/Frazier_Healthcare>,
        <https://1145.am/db/2310798/Frazier_Healthcare>,
        <https://1145.am/db/2311551/Frazier_Healthcare>,
        <https://1145.am/db/2316391/Frazier_Healthcare>,
        <https://1145.am/db/2318274/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318276/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318577/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318635/Frazier_Healthcare>,
        <https://1145.am/db/2321216/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2325326/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2326430/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2327441/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2327442/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330075/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330079/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2331784/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2334616/Frazier_Healthcare>,
        <https://1145.am/db/2334622/Frazier_Healthcare>,
        <https://1145.am/db/2334624/Frazier_Healthcare>,
        <https://1145.am/db/2335675/Frazier_Healthcare>,
        <https://1145.am/db/2335743/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2336032/Frazier_Healthcare>,
        <https://1145.am/db/2337166/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2338625/Frazier_Healthcare>,
        <https://1145.am/db/2338633/Frazier_Healthcare>,
        <https://1145.am/db/2339926/Frazier_Healthcare>,
        <https://1145.am/db/2340204/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2342352/Frazier_Healthcare>,
        <https://1145.am/db/2342629/Frazier_Healthcare>,
        <https://1145.am/db/2346532/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2346542/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2348754/Frazier_Healthcare>,
        <https://1145.am/db/2351519/Frazier_Healthcare>,
        <https://1145.am/db/2351520/Frazier_Healthcare>,
        <https://1145.am/db/2356269/Frazier_Healthcare>,
        <https://1145.am/db/2356306/Frazier_Healthcare>,
        <https://1145.am/db/2361549/Frazier_Healthcare>,
        <https://1145.am/db/2361551/Frazier_Healthcare>,
        <https://1145.am/db/2365700/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2366187/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2368333/Frazier_Healthcare>,
        <https://1145.am/db/2370761/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2537423/Frazier_Healthcare>,
        <https://1145.am/db/2553555/Frazier_Healthcare>,
        <https://1145.am/db/2584561/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2592685/Frazier_Healthcare>,
        <https://1145.am/db/490601/Frazier_Healthcare_Partners>,
        <https://1145.am/db/505366/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578056/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578059/Frazier_Healthcare_Partners>,
        <https://1145.am/db/699981/Frazier_Healthcare_Partners>,
        <https://1145.am/db/770024/Frazier_Healthcare_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340634/Alexandria_Venture_Investments> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-12-16T22:46:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen spinoff Atara banks $38.5M as it races ahead with CKD, cancer trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/amgen-spinoff-atara-banks-38-5m-as-it-races-ahead-ckd-cancer-trials> ;
    ns1:foundName "Alexandria Venture Investments" ;
    ns1:investor <https://1145.am/db/2340634/Series_B_Investment_Alexandria_Venture_Investments_Amgen_Atara_Biotherapeutics_Celgene_Dag_Ventures_Domain_Associates_Ecor1_Capital_Completed> ;
    ns1:name "Alexandria Venture Investments" ;
    ns1:sameAsHigh <https://1145.am/db/1042269/Alexandria_Venture_Investments>,
        <https://1145.am/db/1202633/Alexandria_Venture_Investments>,
        <https://1145.am/db/1203099/Alexandria_Venture_Investments>,
        <https://1145.am/db/1233008/Alexandria_Venture_Investments>,
        <https://1145.am/db/1238474/Alexandria_Venture_Investments>,
        <https://1145.am/db/1340338/Alexandria_Venture_Investments>,
        <https://1145.am/db/1416749/Alexandria_Venture_Investments>,
        <https://1145.am/db/1417475/Alexandria_Venture_Investments>,
        <https://1145.am/db/1536915/Alexandria_Venture_Investments>,
        <https://1145.am/db/1553175/Alexandria_Venture_Investments>,
        <https://1145.am/db/1553459/Alexandria_Venture_Investments>,
        <https://1145.am/db/1665536/Alexandria_Venture_Investments>,
        <https://1145.am/db/2073480/Alexandria_Venture_Investments>,
        <https://1145.am/db/2114450/Alexandria_Venture_Investments>,
        <https://1145.am/db/2152096/Alexandria_Venture_Investments>,
        <https://1145.am/db/2197183/Alexandria_Venture_Investments>,
        <https://1145.am/db/2279933/Alexandria_Venture_Investments>,
        <https://1145.am/db/2324756/Alexandria_Equities>,
        <https://1145.am/db/2341599/Alexandria_Venture_Investments>,
        <https://1145.am/db/2343595/Alexandria_Venture_Investments>,
        <https://1145.am/db/2369304/Alexandria_Venture_Investments>,
        <https://1145.am/db/4142/Alexandria_Venture_Investments_Llc>,
        <https://1145.am/db/471253/Alexandria_Venture_Investments>,
        <https://1145.am/db/531806/Alexandria_Venture_Investments>,
        <https://1145.am/db/571769/Alexandria_Venture_Investments> ;
    ns1:sameAsMedium <https://1145.am/db/1042080/Alexandria_Venture_Investments>,
        <https://1145.am/db/1087327/Alexandria_Venture_Investments>,
        <https://1145.am/db/1089424/Alexandria_Venture_Investments>,
        <https://1145.am/db/1156304/Alexandria_Venture_Investments>,
        <https://1145.am/db/1214380/Alexandria_Venture_Investments>,
        <https://1145.am/db/1214387/Alexandria_Venture_Investments>,
        <https://1145.am/db/1663572/Alexandria_Venture_Investments>,
        <https://1145.am/db/1754964/Alexandria_Venture_Investments>,
        <https://1145.am/db/1984721/Alexandria_Venture_Investments>,
        <https://1145.am/db/2279310/Alexandria_Venture_Investments>,
        <https://1145.am/db/2280707/Alexandria_Venture_Investments>,
        <https://1145.am/db/2281211/Alexandria_Venture_Investments>,
        <https://1145.am/db/2282162/Alexandria_Venture_Investments>,
        <https://1145.am/db/2285971/Alexandria_Venture_Investments>,
        <https://1145.am/db/2287244/Alexandria_Venture_Investments>,
        <https://1145.am/db/2287557/Alexandria_Venture_Investments>,
        <https://1145.am/db/2294202/Alexandria_Venture_Investments>,
        <https://1145.am/db/2296113/Alexandria_Venture_Investments>,
        <https://1145.am/db/2330338/Alexandria_Venture_Investment>,
        <https://1145.am/db/2337664/Alexandria_Venture_Investments>,
        <https://1145.am/db/2343592/Alexandria_Venture_Investments>,
        <https://1145.am/db/2344782/Alexandria_Venture_Investments>,
        <https://1145.am/db/2347368/Alexandria_Venture_Investments>,
        <https://1145.am/db/2356456/Alexandria_Venture_Investments>,
        <https://1145.am/db/2369000/Alexandria_Venture_Investments>,
        <https://1145.am/db/2369305/Alexandria_Venture_Investments>,
        <https://1145.am/db/2369549/Alexandria_Venture_Investments>,
        <https://1145.am/db/2787561/Alexandria_Venture_Investments>,
        <https://1145.am/db/504446/Alexandria_Venture_Investments>,
        <https://1145.am/db/506326/Alexandria_Venture_Investments>,
        <https://1145.am/db/587045/Alexandria_Venture_Investments>,
        <https://1145.am/db/591613/Alexandria_Venture_Investments>,
        <https://1145.am/db/601404/Alexandria_Venture_Investments>,
        <https://1145.am/db/923059/Alexandria_Venture_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340634/Celgene> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "business development" ;
    ns1:documentDate "2013-12-16T22:46:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen spinoff Atara banks $38.5M as it races ahead with CKD, cancer trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/amgen-spinoff-atara-banks-38-5m-as-it-races-ahead-ckd-cancer-trials> ;
    ns1:foundName "Celgene" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2340634/Series_B_Investment_Alexandria_Venture_Investments_Amgen_Atara_Biotherapeutics_Celgene_Dag_Ventures_Domain_Associates_Ecor1_Capital_Completed> ;
    ns1:name "Celgene" ;
    ns1:sameAsHigh <https://1145.am/db/2301990/Celgene>,
        <https://1145.am/db/2302006/Celgene_Corporation>,
        <https://1145.am/db/2302012/Celgene>,
        <https://1145.am/db/2304362/Celgene_Corporation>,
        <https://1145.am/db/2304831/Celgene_Corporation>,
        <https://1145.am/db/2305030/Celgene_Corporation>,
        <https://1145.am/db/2314474/Celgene>,
        <https://1145.am/db/2323370/Celgene>,
        <https://1145.am/db/2326490/Celgene>,
        <https://1145.am/db/2335700/Celgene>,
        <https://1145.am/db/2335769/Celgene>,
        <https://1145.am/db/2336238/Celgene>,
        <https://1145.am/db/2337453/Celgene>,
        <https://1145.am/db/2338420/Recro_Pharma>,
        <https://1145.am/db/2339413/Celgene>,
        <https://1145.am/db/2344782/Celgene_Corporation>,
        <https://1145.am/db/2347663/Celgene_Corporation>,
        <https://1145.am/db/2349202/Celgene_Corporation>,
        <https://1145.am/db/2349233/Celgene_Corporation>,
        <https://1145.am/db/2350231/Celgene>,
        <https://1145.am/db/2353225/Celsus_Therapeutics>,
        <https://1145.am/db/2356187/Recro_Pharma>,
        <https://1145.am/db/2361962/Celgene_Corporation>,
        <https://1145.am/db/2361967/Celgene_Corporation>,
        <https://1145.am/db/2364468/Celgene_Corporation>,
        <https://1145.am/db/2365987/Celgene_Corporation>,
        <https://1145.am/db/2368041/Celgene>,
        <https://1145.am/db/2368299/Celgene>,
        <https://1145.am/db/2369633/Celgene>,
        <https://1145.am/db/2539561/Celgene>,
        <https://1145.am/db/2539787/Celgene>,
        <https://1145.am/db/2542218/Celgene>,
        <https://1145.am/db/2543185/Celgene>,
        <https://1145.am/db/2543220/Celgene>,
        <https://1145.am/db/2543227/Celgene>,
        <https://1145.am/db/2543236/Celgene>,
        <https://1145.am/db/2543655/Celgene>,
        <https://1145.am/db/2551883/Celgene>,
        <https://1145.am/db/2553958/Celgene>,
        <https://1145.am/db/2565844/Credence_Medsystems>,
        <https://1145.am/db/2567124/Celgene>,
        <https://1145.am/db/2577644/Celgene>,
        <https://1145.am/db/2578498/Celgene>,
        <https://1145.am/db/2584056/Celgene>,
        <https://1145.am/db/2585607/Celgene>,
        <https://1145.am/db/2592505/Celgene>,
        <https://1145.am/db/2595340/Celgene>,
        <https://1145.am/db/720103/Nobelpharma_Co_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/2152096/Celgene>,
        <https://1145.am/db/2197183/Celgene>,
        <https://1145.am/db/2291277/Celgene>,
        <https://1145.am/db/2293123/Celgene_Corporation>,
        <https://1145.am/db/2301048/Celgene>,
        <https://1145.am/db/2301271/Celgene>,
        <https://1145.am/db/2301310/Celgene>,
        <https://1145.am/db/2302687/Celgene>,
        <https://1145.am/db/2304335/Celgene>,
        <https://1145.am/db/2304340/Celgene>,
        <https://1145.am/db/2308148/Celgene_Inc>,
        <https://1145.am/db/2322317/Celgene_Corporation>,
        <https://1145.am/db/2322323/Celgene>,
        <https://1145.am/db/2323746/Celgene>,
        <https://1145.am/db/2336511/Celgene_Corporation>,
        <https://1145.am/db/2337599/Celgene_Corporation>,
        <https://1145.am/db/2339707/Celgene_Corporation>,
        <https://1145.am/db/2340963/Celgene_Corporation>,
        <https://1145.am/db/2343605/Celgene_Corporation>,
        <https://1145.am/db/2346066/Celgene>,
        <https://1145.am/db/2347566/Celgene_Corporation>,
        <https://1145.am/db/2347844/Celgene_Corporation>,
        <https://1145.am/db/2364471/Celgene>,
        <https://1145.am/db/2366680/Celgene>,
        <https://1145.am/db/2366684/Celgene_Corporation>,
        <https://1145.am/db/2366690/Celgene>,
        <https://1145.am/db/2366896/Celgene_Corporation>,
        <https://1145.am/db/2368721/Celgene>,
        <https://1145.am/db/2369311/Celgene>,
        <https://1145.am/db/2369694/Celgene_Corporation>,
        <https://1145.am/db/2538738/Celgene>,
        <https://1145.am/db/2543648/Celgene>,
        <https://1145.am/db/2558927/Celgene>,
        <https://1145.am/db/2563139/Celgene>,
        <https://1145.am/db/2563587/Celgene>,
        <https://1145.am/db/2565753/Celgene>,
        <https://1145.am/db/2566605/Celgene>,
        <https://1145.am/db/2567006/Celgene>,
        <https://1145.am/db/2571869/Celgene>,
        <https://1145.am/db/2571871/Celgene>,
        <https://1145.am/db/2583298/Celgene_Corporation>,
        <https://1145.am/db/2585603/Celgene_Corporation>,
        <https://1145.am/db/2592040/Celgene>,
        <https://1145.am/db/2593298/Celgene>,
        <https://1145.am/db/2593520/Celgene_Corporation>,
        <https://1145.am/db/2593892/Celgene_Corporation>,
        <https://1145.am/db/870410/Celgene> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340634/Dag_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CA" ;
    ns1:documentDate "2013-12-16T22:46:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen spinoff Atara banks $38.5M as it races ahead with CKD, cancer trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/amgen-spinoff-atara-banks-38-5m-as-it-races-ahead-ckd-cancer-trials> ;
    ns1:foundName "DAG Ventures" ;
    ns1:investor <https://1145.am/db/2340634/Series_B_Investment_Alexandria_Venture_Investments_Amgen_Atara_Biotherapeutics_Celgene_Dag_Ventures_Domain_Associates_Ecor1_Capital_Completed> ;
    ns1:name "DAG Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1694471/Dag_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1719381/Dag_Ventures>,
        <https://1145.am/db/1768841/Dag_Ventures>,
        <https://1145.am/db/1802882/Dag_Ventures>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828087/Dag_Ventures>,
        <https://1145.am/db/1841061/Dag_Ventures>,
        <https://1145.am/db/1848043/Dag_Ventures>,
        <https://1145.am/db/1849684/Dag_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1860637/Dag_Ventures>,
        <https://1145.am/db/1864052/Dag_Ventures>,
        <https://1145.am/db/1874419/Dag_Ventures>,
        <https://1145.am/db/1875703/Dag_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878874/Dag_Ventures>,
        <https://1145.am/db/1880200/Dag_Ventures>,
        <https://1145.am/db/1880204/Dag_Ventures>,
        <https://1145.am/db/1886260/Dag_Ventures>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1896149/Dag_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1912076/Dag_Ventures>,
        <https://1145.am/db/1912756/Dag_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1917393/Dag_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1919868/Dag_Ventures>,
        <https://1145.am/db/1921438/Dag_Ventures>,
        <https://1145.am/db/1922037/Dag_Ventures>,
        <https://1145.am/db/1923566/Dag_Ventures>,
        <https://1145.am/db/2300306/Dag_Ventures>,
        <https://1145.am/db/2308420/Dag_Ventures>,
        <https://1145.am/db/2308423/Dag_Ventures>,
        <https://1145.am/db/2308429/Dag_Ventures>,
        <https://1145.am/db/2341484/Dag_Ventures>,
        <https://1145.am/db/2344782/Dag_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340634/Ecor1_Capital> a org:Organization ;
    ns1:documentDate "2013-12-16T22:46:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen spinoff Atara banks $38.5M as it races ahead with CKD, cancer trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/amgen-spinoff-atara-banks-38-5m-as-it-races-ahead-ckd-cancer-trials> ;
    ns1:foundName "EcoR1 Capital" ;
    ns1:investor <https://1145.am/db/2340634/Series_B_Investment_Alexandria_Venture_Investments_Amgen_Atara_Biotherapeutics_Celgene_Dag_Ventures_Domain_Associates_Ecor1_Capital_Completed> ;
    ns1:name "EcoR1 Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1752458/Ecor1_Capital>,
        <https://1145.am/db/2282162/Ecor1_Capital>,
        <https://1145.am/db/2285718/Ecor1_Capital>,
        <https://1145.am/db/2286541/Ecor1_Capital>,
        <https://1145.am/db/2287230/Ecor1_Capital>,
        <https://1145.am/db/2291277/Ecor1_Capital>,
        <https://1145.am/db/2338428/Ecor1_Capital>,
        <https://1145.am/db/2344044/Ecor1_Capital>,
        <https://1145.am/db/2344045/Ecor1_Capital>,
        <https://1145.am/db/2344782/Ecor1_Capital>,
        <https://1145.am/db/2361688/Ecor1_Capital>,
        <https://1145.am/db/2363330/Ecor1_Capital>,
        <https://1145.am/db/2364332/Ecor1_Capital>,
        <https://1145.am/db/2364336/Ecor1_Capital>,
        <https://1145.am/db/2368912/Ecor1_Capital>,
        <https://1145.am/db/2368913/Ecor1_Capital>,
        <https://1145.am/db/2369718/Ecor1_Capital>,
        <https://1145.am/db/75445/Ecor1_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340683/Osaka_Japan___Deerfield_Ill___New> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:description "Business" ;
    ns1:documentDate "2013-12-19T16:26:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Takeda Announces Exclusive License and Option Agreement with Natrogen for Development of Natura-alpha for Inflammatory Bowel Disease" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/takeda-announces-exclusive-license-and-option-agreement-natrogen-for-development-of-natura> ;
    ns1:foundName "OSAKA, Japan & DEERFIELD, Ill. & NEW YORK-Takeda Pharmaceutical Company Limited" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2340683/License_Investment_Natrogen_Therapeutics_International_Osaka_Japan___Deerfield_Ill___New_Takeda_Pharmaceutical_Company_Limited_Has_Not_Happened> ;
    ns1:name "OSAKA, Japan & DEERFIELD, Ill. & NEW" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340683/Takeda_Pharmaceutical_Company_Limited> a org:Organization ;
    ns1:basedInHighGeoName "Japan" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1861060/about.rdf> ;
    ns1:basedInHighRaw "Japan" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2013-12-19T16:26:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Takeda Announces Exclusive License and Option Agreement with Natrogen for Development of Natura-alpha for Inflammatory Bowel Disease" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/takeda-announces-exclusive-license-and-option-agreement-natrogen-for-development-of-natura> ;
    ns1:foundName "Takeda" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2340683/License_Investment_Natrogen_Therapeutics_International_Osaka_Japan___Deerfield_Ill___New_Takeda_Pharmaceutical_Company_Limited_Has_Not_Happened> ;
    ns1:name "Takeda Pharmaceutical Company Limited" ;
    ns1:sameAsHigh <https://1145.am/db/106729/Takeda_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/107857/Takeda_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/1150157/Takeda>,
        <https://1145.am/db/1151492/Takeda>,
        <https://1145.am/db/142937/Takeda_Pharmaceutical_Co>,
        <https://1145.am/db/1574488/Takeda>,
        <https://1145.am/db/1574492/Takeda>,
        <https://1145.am/db/1575638/Takeda_Pharmaceutical>,
        <https://1145.am/db/1668664/Takeda>,
        <https://1145.am/db/1668666/Takeda>,
        <https://1145.am/db/180188/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/1975094/Takeda_Pharmaceutical_Company>,
        <https://1145.am/db/1988943/Takeda_Pharmaceutical_Co>,
        <https://1145.am/db/215095/Takeda>,
        <https://1145.am/db/2153840/Takeda>,
        <https://1145.am/db/2155490/Takeda>,
        <https://1145.am/db/216525/Takeda>,
        <https://1145.am/db/217464/Takeda_Pharmaceutical_Co>,
        <https://1145.am/db/2197540/Takeda>,
        <https://1145.am/db/2198945/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2218929/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2278972/Takeda>,
        <https://1145.am/db/2279007/Takeda>,
        <https://1145.am/db/2279093/Takeda>,
        <https://1145.am/db/2280026/Takeda>,
        <https://1145.am/db/2283833/Takeda>,
        <https://1145.am/db/2288188/Takeda>,
        <https://1145.am/db/2292839/Takeda>,
        <https://1145.am/db/2296208/Takeda>,
        <https://1145.am/db/2296243/Takeda>,
        <https://1145.am/db/2301452/Takeda>,
        <https://1145.am/db/2302901/Takeda_Pharmaceutical>,
        <https://1145.am/db/2306582/Takeda>,
        <https://1145.am/db/2306598/Takeda_Pharmaceutical>,
        <https://1145.am/db/2308468/Takeda_Canada>,
        <https://1145.am/db/2309473/Takeda_Canada>,
        <https://1145.am/db/2309473/Takeda_Pharmaceutical>,
        <https://1145.am/db/2310517/Takeda>,
        <https://1145.am/db/2311296/Takeda>,
        <https://1145.am/db/2312787/Takeda>,
        <https://1145.am/db/2321910/Takeda>,
        <https://1145.am/db/2321912/Takeda_America_Holdings_Inc>,
        <https://1145.am/db/2321912/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2322135/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2322153/Takeda>,
        <https://1145.am/db/2322954/Takeda_Pharmaceuticals_North_America>,
        <https://1145.am/db/2323181/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2326403/Takeda>,
        <https://1145.am/db/2329621/Takeda>,
        <https://1145.am/db/2330973/Takeda_Pharmaceuticals>,
        <https://1145.am/db/2336287/Takeda_Pharmaceutical>,
        <https://1145.am/db/2336541/Takeda>,
        <https://1145.am/db/2342077/Takeda>,
        <https://1145.am/db/2344150/Takeda>,
        <https://1145.am/db/2344177/Takeda>,
        <https://1145.am/db/2344308/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2346017/Takeda>,
        <https://1145.am/db/2346025/Takeda_America_Holdings>,
        <https://1145.am/db/2350521/Takeda_America_Holdings>,
        <https://1145.am/db/2350531/Takeda_America_Holdings>,
        <https://1145.am/db/2350536/Takeda_America_Holdings>,
        <https://1145.am/db/2350537/Takeda_Pharmaceutical>,
        <https://1145.am/db/2352975/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2352987/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2354708/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2355270/Takeda_America_Holdings_Inc>,
        <https://1145.am/db/2355270/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2355271/Takeda>,
        <https://1145.am/db/2355308/Takeda>,
        <https://1145.am/db/2360132/Takeda>,
        <https://1145.am/db/2366698/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2369446/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2370761/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2371333/Takeda>,
        <https://1145.am/db/2536497/Takeda_Pharmaceuticals_International>,
        <https://1145.am/db/2536510/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2540077/Takeda>,
        <https://1145.am/db/2543228/Takeda>,
        <https://1145.am/db/2544087/Takeda_Ventures>,
        <https://1145.am/db/2544223/Takeda>,
        <https://1145.am/db/2544726/Takeda>,
        <https://1145.am/db/2544912/Takeda>,
        <https://1145.am/db/2546262/Takeda>,
        <https://1145.am/db/2546291/Takeda>,
        <https://1145.am/db/2546489/Takeda_Pharmaceutical>,
        <https://1145.am/db/2546495/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2547136/Takeda_Pharmaceutical>,
        <https://1145.am/db/2547277/Takeda>,
        <https://1145.am/db/2547420/Takeda_Pharmaceutical_Company>,
        <https://1145.am/db/2547508/Takeda_Pharmaceutical>,
        <https://1145.am/db/2547983/Takeda>,
        <https://1145.am/db/2548859/Takeda>,
        <https://1145.am/db/2548920/Takeda>,
        <https://1145.am/db/2548979/Takeda>,
        <https://1145.am/db/2549989/Takeda>,
        <https://1145.am/db/2550985/Takeda>,
        <https://1145.am/db/2551003/Takeda>,
        <https://1145.am/db/2551019/Takeda>,
        <https://1145.am/db/2551052/Takeda>,
        <https://1145.am/db/2551329/Takeda>,
        <https://1145.am/db/2551601/Takeda_Pharmaceutical>,
        <https://1145.am/db/2551607/Takeda_Pharmaceutical>,
        <https://1145.am/db/2551805/Takeda>,
        <https://1145.am/db/2552455/Takeda>,
        <https://1145.am/db/2552653/Takeda_Pharmaceuticals_Usa>,
        <https://1145.am/db/2552662/Takeda_Pharmaceuticals_Usa_Inc>,
        <https://1145.am/db/2552794/Takeda>,
        <https://1145.am/db/2553276/Takeda_Pharmaceutical>,
        <https://1145.am/db/2553676/Takeda_Pharmaceuticals>,
        <https://1145.am/db/2556816/Takeda>,
        <https://1145.am/db/2558648/Takeda>,
        <https://1145.am/db/2558927/Takeda>,
        <https://1145.am/db/2560469/Takeda>,
        <https://1145.am/db/2560737/Takeda_Pharmaceutical>,
        <https://1145.am/db/2561541/Takeda>,
        <https://1145.am/db/2562500/Takeda_Pharmaceutical>,
        <https://1145.am/db/2563175/Takeda>,
        <https://1145.am/db/2563623/Takeda>,
        <https://1145.am/db/2564191/Takeda>,
        <https://1145.am/db/2564200/Takeda>,
        <https://1145.am/db/2564268/Takeda>,
        <https://1145.am/db/2564427/Takeda_Pharmaceutical>,
        <https://1145.am/db/2564462/Takeda>,
        <https://1145.am/db/2564899/Takeda>,
        <https://1145.am/db/2566092/Takeda>,
        <https://1145.am/db/2566361/Takeda>,
        <https://1145.am/db/2566716/Takeda>,
        <https://1145.am/db/2566950/Takeda>,
        <https://1145.am/db/2568923/Takeda_Gmbh>,
        <https://1145.am/db/2568923/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2568927/Takeda>,
        <https://1145.am/db/2569709/Takeda>,
        <https://1145.am/db/2570052/Takeda>,
        <https://1145.am/db/2571277/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2573391/Takeda_Pharmaceutical>,
        <https://1145.am/db/2573392/Takeda_America_Holdings_Inc>,
        <https://1145.am/db/2573392/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2573404/Takeda_Pharmaceutical>,
        <https://1145.am/db/2574063/Takeda_Pharmaceuticals>,
        <https://1145.am/db/2575016/Takeda_Pharmaceutical>,
        <https://1145.am/db/2575051/Takeda>,
        <https://1145.am/db/2575986/Takeda_Pharmaceutical>,
        <https://1145.am/db/2575988/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2576284/Takeda>,
        <https://1145.am/db/2577736/Takeda_Pharmaceutical>,
        <https://1145.am/db/2583022/Takeda>,
        <https://1145.am/db/2583803/Takeda_Pharmaceutical>,
        <https://1145.am/db/2587155/Takeda_Pharmaceuticals>,
        <https://1145.am/db/2588017/Takeda_Pharmaceuticals_International_Gmbh>,
        <https://1145.am/db/2589969/Takeda>,
        <https://1145.am/db/2593463/Japans_Takeda_Pharmaceutical>,
        <https://1145.am/db/2595145/Takeda_Pharmaceutical>,
        <https://1145.am/db/2598589/Takeda_Pharmaceutical>,
        <https://1145.am/db/2803749/Takeda>,
        <https://1145.am/db/295168/Takeda>,
        <https://1145.am/db/2976/Takeda>,
        <https://1145.am/db/576631/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/745360/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/940930/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/944999/Takeda>,
        <https://1145.am/db/970732/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/973118/Takeda_Pharmaceutical_Company_Limited> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341701/Kreos_Capital> a org:Organization ;
    ns1:documentDate "2013-12-24T22:21:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TiGenix snags $13.7M for Phase III cell therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/tigenix-snags-13-7m-for-phase-iii-cell-therapy> ;
    ns1:foundName "Kreos Capital" ;
    ns1:industry "financier" ;
    ns1:investor <https://1145.am/db/2341701/Investment_Kreos_Capital_Tigenix_Has_Not_Happened> ;
    ns1:name "Kreos Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1696614/Globis_Capital_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1427657/Kreos_Capital>,
        <https://1145.am/db/1433098/Kreos_Capital>,
        <https://1145.am/db/1488713/Kreos_Capital>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1737550/Kreos_Capital>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1817627/Kreos_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1823137/Kreos_Capital>,
        <https://1145.am/db/1857213/Kreos_Capital>,
        <https://1145.am/db/2041058/Kreos_Capital>,
        <https://1145.am/db/2291206/Kreos_Capital>,
        <https://1145.am/db/2295144/Kreos_Capital>,
        <https://1145.am/db/2341700/Kreos_Capital>,
        <https://1145.am/db/703925/Kreos_Capital>,
        <https://1145.am/db/711329/Kreos_Capital>,
        <https://1145.am/db/725571/Kreos_Capital>,
        <https://1145.am/db/900421/Kreos_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341717/Series_A_Investment_Nexeption_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-01-02T12:38:22+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MALVERN, Pa.- (BUSINESS WIRE) -NeXeption, LLC, a biopharmaceutical management company that brings together product opportunities, management expertise and funding to reach compelling partnership milestones, announced today that it has secured $ 21.5 million in Series A financing to form Alexar Therapeutics, Inc. Alexar is focused on developing an innovative portfolio of Liver X receptor (LXR) agonists for both systemic and local use." ;
    ns1:documentTitle "NeXeption, LLC Forms New Company Alexar Therapeutics, Inc. to Develop Novel LXR Agonist Portfolio for Dermatologic Indications; Raises $21.5 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nexeption-llc-forms-new-company-alexar-therapeutics-inc-to-develop-novel-lxr-agonist> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2341717/Alexar>,
        <https://1145.am/db/2341717/Nexeption> ;
    ns1:targetDetails "Series A" ;
    ns1:targetName "Alexar" ;
    ns1:valueRaw "$ 21.5 million" ;
    ns1:whereGeoName "Palo Alto County",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4870630/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "Palo Alto",
        "United States" .

<https://1145.am/db/2341764/Cardinal_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2013-07-29T05:31:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "aTyr Pharma Completes $49 Million Oversubscribed Financing to Advance Rare Autoimmune Disease Therapeutic Pipeline from a Newly Discovered Class of Proteins, Physiocrines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/atyr-pharma-completes-49-million-oversubscribed-financing-to-advance-rare-autoimmune> ;
    ns1:foundName "Cardinal Partners" ;
    ns1:investor <https://1145.am/db/2341764/Investment_Alta_Partners_Cardinal_Partners_Domain_Associates_Polaris_Partners_Atyr_Pharma_Completed> ;
    ns1:name "Cardinal Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2240575/Cardinal_Partners>,
        <https://1145.am/db/2313127/Cardinal_Partners>,
        <https://1145.am/db/2344092/Cardinal_Partners>,
        <https://1145.am/db/2344100/Cardinal_Partners>,
        <https://1145.am/db/2353404/Cardinal_Partners>,
        <https://1145.am/db/2353415/Cardinal_Partners>,
        <https://1145.am/db/2362871/Cardinal_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341764/Polaris_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2013-07-29T05:31:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "aTyr Pharma Completes $49 Million Oversubscribed Financing to Advance Rare Autoimmune Disease Therapeutic Pipeline from a Newly Discovered Class of Proteins, Physiocrines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/atyr-pharma-completes-49-million-oversubscribed-financing-to-advance-rare-autoimmune> ;
    ns1:foundName "Polaris Partners" ;
    ns1:investor <https://1145.am/db/2341764/Investment_Alta_Partners_Cardinal_Partners_Domain_Associates_Polaris_Partners_Atyr_Pharma_Completed> ;
    ns1:name "Polaris Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1163164/Polaris_Partners>,
        <https://1145.am/db/1166225/Polaris_Partners>,
        <https://1145.am/db/1229314/Polaris_Partners>,
        <https://1145.am/db/127343/Polaris_Partners>,
        <https://1145.am/db/1340338/Polaris_Partners>,
        <https://1145.am/db/1406211/Polaris_Partners>,
        <https://1145.am/db/1412727/Polaris_Partners>,
        <https://1145.am/db/1545490/Polaris_Partners>,
        <https://1145.am/db/1793129/Polaris_Partners>,
        <https://1145.am/db/1796910/Polaris_Partners>,
        <https://1145.am/db/1803886/Polaris_Partners>,
        <https://1145.am/db/1813337/Polaris_Partners>,
        <https://1145.am/db/1817112/Polaris_Partners>,
        <https://1145.am/db/1830311/Polaris_Partners>,
        <https://1145.am/db/1834199/Polaris_Partners>,
        <https://1145.am/db/1835107/Polaris_Partners>,
        <https://1145.am/db/1845960/Polaris_Partners>,
        <https://1145.am/db/1854788/Polaris_Partners>,
        <https://1145.am/db/1858995/Polaris_Partners>,
        <https://1145.am/db/1947183/Polaris_Partners>,
        <https://1145.am/db/2181016/Polaris_Partners>,
        <https://1145.am/db/2187023/Polaris_Partners>,
        <https://1145.am/db/2193661/Polaris_Partners>,
        <https://1145.am/db/2194844/Polaris_Partners>,
        <https://1145.am/db/2196895/Polaris_Partners>,
        <https://1145.am/db/2198647/Polaris_Partners>,
        <https://1145.am/db/2223723/Polaris_Partners>,
        <https://1145.am/db/2282077/Polaris_Partners>,
        <https://1145.am/db/2282162/Polaris_Partners>,
        <https://1145.am/db/2318310/Polaris_Partners>,
        <https://1145.am/db/2335750/Polaris_Partners>,
        <https://1145.am/db/2335755/Polaris_Partners>,
        <https://1145.am/db/2341595/Polaris_Partners>,
        <https://1145.am/db/2341599/Polaris_Partners>,
        <https://1145.am/db/2345675/Polaris_Partners>,
        <https://1145.am/db/2346988/Polaris_Partners>,
        <https://1145.am/db/2354955/Polaris_Partners>,
        <https://1145.am/db/2364332/Polaris_Partners>,
        <https://1145.am/db/2364336/Polaris_Partners>,
        <https://1145.am/db/2368912/Polaris_Partners>,
        <https://1145.am/db/2368913/Polaris_Partners>,
        <https://1145.am/db/2369304/Polaris_Partners>,
        <https://1145.am/db/2369305/Polaris_Partners>,
        <https://1145.am/db/2370208/Polaris_Partners>,
        <https://1145.am/db/250010/Polaris_Partners>,
        <https://1145.am/db/2611628/Polaris_Partners>,
        <https://1145.am/db/2787561/Polaris_Partners>,
        <https://1145.am/db/364226/Polaris_Partners>,
        <https://1145.am/db/572097/Polaris_Partners>,
        <https://1145.am/db/612707/Polaris_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343847/European_Eurostars_Programme> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:documentDate "2013-08-07T11:35:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Telormedix Receives EU Funding for the Development of a New Treatment for Psoriasis" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/telormedix-receives-eu-funding-for-development-of-a-new-treatment-for-psoriasis> ;
    ns1:foundName "European Eurostars Programme" ;
    ns1:investor <https://1145.am/db/2343847/Investment_European_Eurostars_Programme_Telormedix_Sa_Has_Not_Happened> ;
    ns1:name "European Eurostars Programme" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343873/Ucl_Business> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:documentDate "2013-08-09T11:30:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endomagnetics in 2.1m Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/endomagnetics-%C2%A32-1m-fund-raising> ;
    ns1:foundName "UCL Business" ;
    ns1:investor <https://1145.am/db/2343873/Investment_Endomagnetics_Ucl_Business_Completed> ;
    ns1:name "UCL Business" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347977/Aurora_Funds> a org:Organization ;
    ns1:basedInLowRaw "Korea" ;
    ns1:description "investing" ;
    ns1:documentDate "2013-08-26T12:02:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argos-therapeutics-secures-42-5-million-financing-funds-pivotal-phase-3-adapt-trial-for> ;
    ns1:foundName "Aurora Funds" ;
    ns1:investor <https://1145.am/db/2347977/Series_E_Investment_Argos_Therapeutics_Inc_Aurora_Funds_Forbion_Capital_Green_Cross_Corporation_Of_Seoul_Korea_Intersouth_Partners_Caisse_De_Depot_Et_Placement_De_Quebec_Lumira_Capital_Morningside_Group_Tvm_Capital_Completed> ;
    ns1:name "Aurora Funds" ;
    ns1:sameAsHigh <https://1145.am/db/2328655/Aurora_Funds>,
        <https://1145.am/db/2344356/Aurora_Funds>,
        <https://1145.am/db/2347983/Aurora_Funds> ;
    ns1:sameAsMedium <https://1145.am/db/2303641/Aurora_Funds>,
        <https://1145.am/db/2303642/Aurora_Funds>,
        <https://1145.am/db/2309809/Aurora_Funds>,
        <https://1145.am/db/2353522/Aurora_Funds>,
        <https://1145.am/db/2353525/Aurora_Funds>,
        <https://1145.am/db/2358541/Aurora_Funds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347977/Forbion_Capital> a org:Organization ;
    ns1:basedInLowRaw "Korea" ;
    ns1:documentDate "2013-08-26T12:02:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argos-therapeutics-secures-42-5-million-financing-funds-pivotal-phase-3-adapt-trial-for> ;
    ns1:foundName "Forbion Capital" ;
    ns1:investor <https://1145.am/db/2347977/Series_E_Investment_Argos_Therapeutics_Inc_Aurora_Funds_Forbion_Capital_Green_Cross_Corporation_Of_Seoul_Korea_Intersouth_Partners_Caisse_De_Depot_Et_Placement_De_Quebec_Lumira_Capital_Morningside_Group_Tvm_Capital_Completed> ;
    ns1:name "Forbion Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2347983/Forbion_Capital>,
        <https://1145.am/db/2353522/Forbion_Capital>,
        <https://1145.am/db/2353525/Forbion_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347977/Green_Cross_Corporation_Of_Seoul_Korea> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Korea" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1835841/about.rdf> ;
    ns1:basedInHighRaw "Korea" ;
    ns1:description "Investing" ;
    ns1:documentDate "2013-08-26T12:02:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argos-therapeutics-secures-42-5-million-financing-funds-pivotal-phase-3-adapt-trial-for> ;
    ns1:foundName "Green Cross Corporation of Seoul, Korea" ;
    ns1:investor <https://1145.am/db/2347977/Series_E_Investment_Argos_Therapeutics_Inc_Aurora_Funds_Forbion_Capital_Green_Cross_Corporation_Of_Seoul_Korea_Intersouth_Partners_Caisse_De_Depot_Et_Placement_De_Quebec_Lumira_Capital_Morningside_Group_Tvm_Capital_Completed> ;
    ns1:name "Green Cross Corporation of Seoul, Korea" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347977/Intersouth_Partners_Caisse_De_Depot_Et_Placement_De_Quebec> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2013-08-26T12:02:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argos-therapeutics-secures-42-5-million-financing-funds-pivotal-phase-3-adapt-trial-for> ;
    ns1:foundName "Intersouth Partners, Caisse de depot et placement de Quebec" ;
    ns1:investor <https://1145.am/db/2347977/Series_E_Investment_Argos_Therapeutics_Inc_Aurora_Funds_Forbion_Capital_Green_Cross_Corporation_Of_Seoul_Korea_Intersouth_Partners_Caisse_De_Depot_Et_Placement_De_Quebec_Lumira_Capital_Morningside_Group_Tvm_Capital_Completed> ;
    ns1:name "Intersouth Partners, Caisse de depot et placement de Quebec" ;
    ns1:sameAsMedium <https://1145.am/db/2353522/Intersouth_Partners_Caisse_De_Depot_Et_Placement_Du_Quebec> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347977/Investment_Pharmstandard_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-08-26T12:02:17+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Lead Investor Pharmstandard Commits $ 30 Million and Receives Russian Commercialization Rights." ;
    ns1:documentTitle "Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argos-therapeutics-secures-42-5-million-financing-funds-pivotal-phase-3-adapt-trial-for> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2347977/Pharmstandard> ;
    ns1:valueRaw "$ 30 Million" ;
    ns1:whereGeoName "Russian Federation" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:whereRaw "Russia" .

<https://1145.am/db/2347977/Lumira_Capital> a org:Organization ;
    ns1:basedInLowRaw "Korea" ;
    ns1:documentDate "2013-08-26T12:02:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argos-therapeutics-secures-42-5-million-financing-funds-pivotal-phase-3-adapt-trial-for> ;
    ns1:foundName "Lumira Capital" ;
    ns1:investor <https://1145.am/db/2347977/Series_E_Investment_Argos_Therapeutics_Inc_Aurora_Funds_Forbion_Capital_Green_Cross_Corporation_Of_Seoul_Korea_Intersouth_Partners_Caisse_De_Depot_Et_Placement_De_Quebec_Lumira_Capital_Morningside_Group_Tvm_Capital_Completed> ;
    ns1:name "Lumira Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2298869/Lumira_Capital>,
        <https://1145.am/db/2300233/Lumira_Capital>,
        <https://1145.am/db/2341904/Lumira_Capital>,
        <https://1145.am/db/2347983/Lumira_Capital>,
        <https://1145.am/db/2353522/Lumira_Capital>,
        <https://1145.am/db/2359637/Lumira_Capital>,
        <https://1145.am/db/2360317/Lumira_Capital>,
        <https://1145.am/db/2363442/Lumira_Capital>,
        <https://1145.am/db/2369027/Lumira_Capital>,
        <https://1145.am/db/2572436/Lumira_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347977/Morningside_Group> a org:Organization ;
    ns1:basedInLowRaw "Korea" ;
    ns1:documentDate "2013-08-26T12:02:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argos-therapeutics-secures-42-5-million-financing-funds-pivotal-phase-3-adapt-trial-for> ;
    ns1:foundName "Morningside Group" ;
    ns1:investor <https://1145.am/db/2347977/Series_E_Investment_Argos_Therapeutics_Inc_Aurora_Funds_Forbion_Capital_Green_Cross_Corporation_Of_Seoul_Korea_Intersouth_Partners_Caisse_De_Depot_Et_Placement_De_Quebec_Lumira_Capital_Morningside_Group_Tvm_Capital_Completed> ;
    ns1:name "Morningside Group" ;
    ns1:sameAsMedium <https://1145.am/db/1739611/Morningside_Group>,
        <https://1145.am/db/1855817/Morningside_Group>,
        <https://1145.am/db/2190702/Morningside_Group>,
        <https://1145.am/db/2292616/Morningside_Group>,
        <https://1145.am/db/2325366/Morningside_Group>,
        <https://1145.am/db/2339427/Morningside_Groups>,
        <https://1145.am/db/2339428/Morningside_Groups>,
        <https://1145.am/db/2346532/Morningside_Group>,
        <https://1145.am/db/2346542/Morningside_Group>,
        <https://1145.am/db/2346972/Morningside_Group>,
        <https://1145.am/db/2346973/Morningside_Group>,
        <https://1145.am/db/2347983/Morningside_Group>,
        <https://1145.am/db/2353522/Morningside_Group>,
        <https://1145.am/db/2353525/Morningside_Group>,
        <https://1145.am/db/531354/Morningside_Group>,
        <https://1145.am/db/719976/Morningside_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347977/Tvm_Capital> a org:Organization ;
    ns1:basedInLowRaw "Korea" ;
    ns1:documentDate "2013-08-26T12:02:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argos-therapeutics-secures-42-5-million-financing-funds-pivotal-phase-3-adapt-trial-for> ;
    ns1:foundName "TVM Capital" ;
    ns1:investor <https://1145.am/db/2347977/Series_E_Investment_Argos_Therapeutics_Inc_Aurora_Funds_Forbion_Capital_Green_Cross_Corporation_Of_Seoul_Korea_Intersouth_Partners_Caisse_De_Depot_Et_Placement_De_Quebec_Lumira_Capital_Morningside_Group_Tvm_Capital_Completed> ;
    ns1:name "TVM Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1919300/Tvm_Capital>,
        <https://1145.am/db/2289349/Tvm_Capital>,
        <https://1145.am/db/2298846/Tvm_Capital>,
        <https://1145.am/db/2303598/Tvm_Capital>,
        <https://1145.am/db/2314674/Tvm_Capital>,
        <https://1145.am/db/2317779/Tvm_Capital>,
        <https://1145.am/db/2322531/Tvm_Capital>,
        <https://1145.am/db/2323243/Tvm_Capital>,
        <https://1145.am/db/2325366/Tvm_Capital>,
        <https://1145.am/db/2326376/Tvm_Capital>,
        <https://1145.am/db/2327406/Tvm_Capital>,
        <https://1145.am/db/2336126/Tvm_Capital>,
        <https://1145.am/db/2347983/Tvm_Capital>,
        <https://1145.am/db/2352814/Tvm_Capital>,
        <https://1145.am/db/2352819/Tvm_Capital>,
        <https://1145.am/db/2352820/Tvm_Capital>,
        <https://1145.am/db/2353522/Tvm_Capital>,
        <https://1145.am/db/2353525/Tvm_Capital>,
        <https://1145.am/db/2353607/Tvm_Capital>,
        <https://1145.am/db/2353610/Tvm_Capital>,
        <https://1145.am/db/2358268/Tvm_Capital>,
        <https://1145.am/db/2358269/Tvm_Capital>,
        <https://1145.am/db/2365103/Tvm_Capital>,
        <https://1145.am/db/2366539/Tvm_Capital>,
        <https://1145.am/db/2564563/Tvm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347984/Forward_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Russia" ;
    ns1:documentDate "2013-08-27T11:51:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/syndax-pharmaceuticals-secures-26-6-million-series-b-financing-for-advancement-of> ;
    ns1:foundName "Forward Ventures" ;
    ns1:investor <https://1145.am/db/2347984/Series_B_Investment_Domain_Associates_Forward_Ventures_Mpm_Capital_Rusnanomedinvest_Syndax_Pharmaceuticals_Inc_Completed> ;
    ns1:name "Forward Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2315932/Forward_Ventures>,
        <https://1145.am/db/2315934/Forward_Ventures>,
        <https://1145.am/db/2317737/Forward_Ventures>,
        <https://1145.am/db/2328030/Forward_Ventures>,
        <https://1145.am/db/2328034/Forward_Ventures>,
        <https://1145.am/db/2343723/Forward_Ventures>,
        <https://1145.am/db/2343724/Forward_Ventures>,
        <https://1145.am/db/2346030/Forward_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352442/Forward_Ventures>,
        <https://1145.am/db/2365748/Forward_Ventures>,
        <https://1145.am/db/2551315/Forward_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348967/Nea> a org:Organization ;
    ns1:documentDate "2014-02-04T16:40:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lumos Pharma Announces Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lumos-pharma-announces-series-a-financing> ;
    ns1:foundName "NEA" ;
    ns1:industry "Pharma" ;
    ns1:investor <https://1145.am/db/2348967/Series_A_Investment_Lumos_Pharma_New_Enterprise_Associates_Sante_Ventures_Completed> ;
    ns1:name "NEA" ;
    ns1:sameAsMedium <https://1145.am/db/1131171/Nea>,
        <https://1145.am/db/1137051/Nea>,
        <https://1145.am/db/1166550/Nea>,
        <https://1145.am/db/1169121/Nea>,
        <https://1145.am/db/1174277/Nea>,
        <https://1145.am/db/1174670/Nea>,
        <https://1145.am/db/129908/Nea>,
        <https://1145.am/db/1338464/Nea>,
        <https://1145.am/db/1362581/Nea>,
        <https://1145.am/db/1442931/Nea>,
        <https://1145.am/db/1445426/Nea>,
        <https://1145.am/db/1533327/Nea>,
        <https://1145.am/db/1533685/Nea>,
        <https://1145.am/db/1578326/Nea>,
        <https://1145.am/db/1694450/Nea>,
        <https://1145.am/db/1696426/Nea>,
        <https://1145.am/db/1699512/Nea>,
        <https://1145.am/db/1704817/Nea>,
        <https://1145.am/db/1708920/Nea>,
        <https://1145.am/db/1709685/Nea>,
        <https://1145.am/db/1716622/Nea>,
        <https://1145.am/db/1722914/Nea>,
        <https://1145.am/db/1734259/Nea>,
        <https://1145.am/db/1735722/Nea>,
        <https://1145.am/db/1737425/Nea>,
        <https://1145.am/db/1741791/Nea>,
        <https://1145.am/db/1741884/Nea>,
        <https://1145.am/db/1741929/Nea>,
        <https://1145.am/db/1742516/Nea>,
        <https://1145.am/db/1744029/Nea>,
        <https://1145.am/db/1744900/Nea>,
        <https://1145.am/db/1746577/Nea>,
        <https://1145.am/db/1747054/Nea>,
        <https://1145.am/db/1751877/Nea>,
        <https://1145.am/db/1752390/Nea>,
        <https://1145.am/db/1756163/Nea>,
        <https://1145.am/db/1761276/Nea>,
        <https://1145.am/db/1761402/Nea>,
        <https://1145.am/db/1767301/Nea>,
        <https://1145.am/db/1770553/Nea>,
        <https://1145.am/db/1770931/Nea>,
        <https://1145.am/db/1773703/Nea>,
        <https://1145.am/db/1774939/Nea>,
        <https://1145.am/db/1775434/Nea>,
        <https://1145.am/db/1776201/Nea>,
        <https://1145.am/db/1776613/Nea>,
        <https://1145.am/db/1776646/Nea>,
        <https://1145.am/db/1777232/Nea>,
        <https://1145.am/db/1778132/Nea>,
        <https://1145.am/db/1788267/Nea>,
        <https://1145.am/db/1790986/Nea>,
        <https://1145.am/db/1791640/Nea>,
        <https://1145.am/db/1791780/Nea>,
        <https://1145.am/db/1792401/Nea>,
        <https://1145.am/db/1795013/Nea>,
        <https://1145.am/db/1799888/Nea>,
        <https://1145.am/db/1801287/Nea>,
        <https://1145.am/db/1801621/Nea>,
        <https://1145.am/db/1801792/Nea>,
        <https://1145.am/db/1803774/Nea>,
        <https://1145.am/db/1804152/Nea>,
        <https://1145.am/db/1805468/Nea>,
        <https://1145.am/db/1807968/Nea>,
        <https://1145.am/db/1808099/Nea>,
        <https://1145.am/db/1809161/Nea>,
        <https://1145.am/db/1809853/Nea>,
        <https://1145.am/db/1811740/Nea>,
        <https://1145.am/db/1816840/Nea>,
        <https://1145.am/db/1817209/Nea>,
        <https://1145.am/db/1819956/Nea>,
        <https://1145.am/db/1823612/Nea>,
        <https://1145.am/db/1824137/Nea>,
        <https://1145.am/db/1827025/Nea>,
        <https://1145.am/db/1828441/Nea>,
        <https://1145.am/db/1830084/Nea>,
        <https://1145.am/db/1830819/Nea>,
        <https://1145.am/db/1833265/Nea>,
        <https://1145.am/db/1833278/Nea>,
        <https://1145.am/db/1833814/Nea>,
        <https://1145.am/db/1835007/Nea>,
        <https://1145.am/db/1835740/Nea>,
        <https://1145.am/db/1836989/Nea>,
        <https://1145.am/db/1840478/Nea>,
        <https://1145.am/db/1843003/Nea>,
        <https://1145.am/db/1848523/Nea>,
        <https://1145.am/db/1849606/Nea>,
        <https://1145.am/db/1849884/Nea>,
        <https://1145.am/db/1850271/Nea>,
        <https://1145.am/db/1850352/Nea>,
        <https://1145.am/db/1851595/Nea>,
        <https://1145.am/db/1854587/Nea>,
        <https://1145.am/db/1856900/Nea>,
        <https://1145.am/db/1867420/Nea>,
        <https://1145.am/db/1870426/Nea>,
        <https://1145.am/db/1875184/Nea>,
        <https://1145.am/db/1876063/Nea>,
        <https://1145.am/db/1877241/Nea>,
        <https://1145.am/db/1895232/Nea>,
        <https://1145.am/db/1896326/Nea>,
        <https://1145.am/db/1945485/Nea>,
        <https://1145.am/db/1960888/Nea>,
        <https://1145.am/db/2009539/Nea>,
        <https://1145.am/db/2062003/Nea>,
        <https://1145.am/db/2133555/Nea>,
        <https://1145.am/db/214119/Nea>,
        <https://1145.am/db/2196875/Nea>,
        <https://1145.am/db/2298510/Nea>,
        <https://1145.am/db/2303548/Nea>,
        <https://1145.am/db/2303560/Nea>,
        <https://1145.am/db/2323138/Nea>,
        <https://1145.am/db/2331700/Nea>,
        <https://1145.am/db/2336634/Nea>,
        <https://1145.am/db/2337972/Nea>,
        <https://1145.am/db/2348066/Nea>,
        <https://1145.am/db/2687902/Nea>,
        <https://1145.am/db/396154/Nea>,
        <https://1145.am/db/415557/Nea>,
        <https://1145.am/db/417606/Nea>,
        <https://1145.am/db/474783/Nea>,
        <https://1145.am/db/488687/Nea>,
        <https://1145.am/db/526175/Nea>,
        <https://1145.am/db/591538/Nea>,
        <https://1145.am/db/606235/Nea>,
        <https://1145.am/db/641613/Nea>,
        <https://1145.am/db/644429/Nea>,
        <https://1145.am/db/700388/Nea>,
        <https://1145.am/db/765986/Nea>,
        <https://1145.am/db/887690/Nea>,
        <https://1145.am/db/909436/Nea>,
        <https://1145.am/db/947292/Nea>,
        <https://1145.am/db/960286/Nea>,
        <https://1145.am/db/971811/Nea>,
        <https://1145.am/db/973579/Nea>,
        <https://1145.am/db/993478/Nea> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348967/Sante_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Austin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4671654/about.rdf> ;
    ns1:basedInHighRaw "AUSTIN" ;
    ns1:documentDate "2014-02-04T16:40:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lumos Pharma Announces Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lumos-pharma-announces-series-a-financing> ;
    ns1:foundName "Sant",
        "Sante Ventures" ;
    ns1:investor <https://1145.am/db/2348967/Series_A_Investment_Lumos_Pharma_New_Enterprise_Associates_Sante_Ventures_Completed> ;
    ns1:name "Sante Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1335370/Sant_Ventures>,
        <https://1145.am/db/1558876/Sant_Ventures>,
        <https://1145.am/db/2050386/Sante_Ventures>,
        <https://1145.am/db/2073480/Sant_Ventures>,
        <https://1145.am/db/2300218/Sant_Ventures>,
        <https://1145.am/db/2300746/Sant_Ventures>,
        <https://1145.am/db/2301736/Sant_Ventures>,
        <https://1145.am/db/2335675/Sante_Ventures>,
        <https://1145.am/db/2337106/Sante_Ventures>,
        <https://1145.am/db/494998/Sant_Ventures>,
        <https://1145.am/db/956417/Sant_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348968/Beacon_Angels> a org:Organization ;
    ns1:basedInHighGeoName "New England" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/11919979/about.rdf> ;
    ns1:basedInHighRaw "New England" ;
    ns1:documentDate "2014-02-05T13:44:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sialix Closes Oversubscribed Second Tranche of Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sialix-closes-oversubscribed-second-tranche-of-series-b-financing> ;
    ns1:foundName "Beacon" ;
    ns1:investor <https://1145.am/db/2348968/Investment_Beacon_Angels_Desert_Angels_Sialix_Inc_Completed> ;
    ns1:name "Beacon Angels" ;
    ns1:sameAsMedium <https://1145.am/db/2337765/Beacon_Angels>,
        <https://1145.am/db/2362638/Beacon_Angels>,
        <https://1145.am/db/2596451/Beacon_Angels> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348968/Desert_Angels> a org:Organization ;
    ns1:basedInHighGeoName "Tucson" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5318313/about.rdf> ;
    ns1:basedInHighRaw "Tucson, AZ" ;
    ns1:documentDate "2014-02-05T13:44:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sialix Closes Oversubscribed Second Tranche of Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sialix-closes-oversubscribed-second-tranche-of-series-b-financing> ;
    ns1:foundName "Desert" ;
    ns1:investor <https://1145.am/db/2348968/Investment_Beacon_Angels_Desert_Angels_Sialix_Inc_Completed> ;
    ns1:name "Desert Angels" ;
    ns1:sameAsMedium <https://1145.am/db/1696721/Desert_Angels> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350030/Perkins_Caufield___Byers> a org:Organization ;
    ns1:documentDate "2013-09-04T11:47:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "$30 Million Secured in iPierian Financing and Series A Financing for Launch of Spin-out, True North Therapeutics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/30-million-secured-ipierian-financing-and-series-a-financing-for-launch-of-spin-out-true> ;
    ns1:foundName "Perkins Caufield & Byers" ;
    ns1:investor <https://1145.am/db/2350030/Series_A_Investment_Sr_One_Ipierian_Ipierian_Completed> ;
    ns1:name "Perkins Caufield & Byers" ;
    ns1:sameAsMedium <https://1145.am/db/1838174/Perkins_Caufield___Byers>,
        <https://1145.am/db/1857690/Perkins_Caufield___Byers>,
        <https://1145.am/db/1870252/Perkins_Caufield___Byers>,
        <https://1145.am/db/1877473/Perkins_Caufield___Byers>,
        <https://1145.am/db/1877836/Perkins_Caufield___Byers>,
        <https://1145.am/db/1921318/Perkins_Caufield___Byers> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350030/Sr_One> a org:Organization ;
    ns1:documentDate "2013-09-04T11:47:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "$30 Million Secured in iPierian Financing and Series A Financing for Launch of Spin-out, True North Therapeutics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/30-million-secured-ipierian-financing-and-series-a-financing-for-launch-of-spin-out-true> ;
    ns1:foundName "SR One" ;
    ns1:investor <https://1145.am/db/2350030/Series_A_Investment_Sr_One_Ipierian_Ipierian_Completed> ;
    ns1:name "SR One" ;
    ns1:sameAsMedium <https://1145.am/db/1169952/Sr_One>,
        <https://1145.am/db/1334624/Sr_One>,
        <https://1145.am/db/1949427/Sr_One>,
        <https://1145.am/db/2095130/Sr_One>,
        <https://1145.am/db/2110113/Sr_One>,
        <https://1145.am/db/2280707/Sr_One>,
        <https://1145.am/db/2305791/Sr_One>,
        <https://1145.am/db/2317934/Sr_One>,
        <https://1145.am/db/2317951/Sr_One>,
        <https://1145.am/db/2318310/Sr_One>,
        <https://1145.am/db/2326222/Sr_One_Ltd>,
        <https://1145.am/db/2327305/Sr_One>,
        <https://1145.am/db/2327488/Sr_One_Ltd>,
        <https://1145.am/db/2331763/Sr_One>,
        <https://1145.am/db/2336328/Sr_One>,
        <https://1145.am/db/2337571/Sr_One>,
        <https://1145.am/db/2337577/Sr_One>,
        <https://1145.am/db/2340096/Sr_One>,
        <https://1145.am/db/2341904/Sr_One>,
        <https://1145.am/db/2342084/Sr_One>,
        <https://1145.am/db/2342983/Sr_One>,
        <https://1145.am/db/2343301/Sr_One>,
        <https://1145.am/db/2345675/Sr_One>,
        <https://1145.am/db/2347482/Sr_One>,
        <https://1145.am/db/2347594/Sr_One>,
        <https://1145.am/db/2349233/Sr_One>,
        <https://1145.am/db/2350364/Sr_One>,
        <https://1145.am/db/2353917/Sr_One>,
        <https://1145.am/db/2356402/Sr_One>,
        <https://1145.am/db/2356411/Sr_One>,
        <https://1145.am/db/2357676/Sr_One>,
        <https://1145.am/db/2357679/Sr_One>,
        <https://1145.am/db/2357682/Sr_One>,
        <https://1145.am/db/2358430/Sr_One>,
        <https://1145.am/db/2358860/Sr_One>,
        <https://1145.am/db/2359334/Sr_One>,
        <https://1145.am/db/2362533/Sr_One>,
        <https://1145.am/db/2362715/Sr_One>,
        <https://1145.am/db/2363947/Sr_One>,
        <https://1145.am/db/2363950/Sr_One>,
        <https://1145.am/db/2365103/Sr_One>,
        <https://1145.am/db/2365104/Sr_One>,
        <https://1145.am/db/2365105/Sr_One>,
        <https://1145.am/db/2365296/Sr_One>,
        <https://1145.am/db/2365300/Sr_One>,
        <https://1145.am/db/2367549/Sr_One>,
        <https://1145.am/db/2368501/Sr_One>,
        <https://1145.am/db/2371191/Sr_One>,
        <https://1145.am/db/2371304/Sr_One>,
        <https://1145.am/db/2544138/Sr_One>,
        <https://1145.am/db/2544140/Sr_One>,
        <https://1145.am/db/2546216/Sr_One>,
        <https://1145.am/db/2573068/Sr_One>,
        <https://1145.am/db/2595958/Sr_One> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351012/Investment_Rhenovia_Pharma_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-02-12T12:24:18+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Mulhouse, France, and Cambridge, Massachusetts, USA, February 12, 2014 - Rhenovia Pharma, a biotechnology company specialized in the application of biosimulation to the research and development of new medicinal products, today announces that it has raised EUR 540,000 (USD 738,000) from its historical shareholders in a second round of funding.",
        "Rhenovia, the world leader in biosimulation of the central nervous system, plans to raise a further EUR 2 million in 2014 to step up development in its three key markets of medicinal products, agrifood and neurotoxicity." ;
    ns1:documentTitle "Rhenovia Pharma secures Series B funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhenovia-pharma-secures-series-b-funding> ;
    ns1:foundName "funding",
        "raise",
        "raised" ;
    ns1:name "funding",
        "raise",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2351012/Rhenovia_Pharma> ;
    ns1:valueRaw "EUR 540,000",
        "USD 738,000" ;
    ns1:when "2014-02-12T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "February 12, 2014" ;
    ns1:whereGeoName "Republic of France" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:whereRaw "France" .

<https://1145.am/db/2352142/Index_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Pa" ;
    ns1:documentDate "2013-09-13T13:54:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Egalet Announces Financing to Fund Abuse-Deterrent Medications" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/egalet-announces-financing-to-fund-abuse-deterrent-medications> ;
    ns1:foundName "Index Ventures" ;
    ns1:investor <https://1145.am/db/2352142/Investment_Egalet_Ltd_Index_Ventures_Completed> ;
    ns1:name "Index Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1247967/Index_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1358814/Index_Ventures>,
        <https://1145.am/db/1490485/Index_Ventures>,
        <https://1145.am/db/1493654/Index_Ventures>,
        <https://1145.am/db/1553352/Index_Ventures>,
        <https://1145.am/db/1693951/Index_Ventures>,
        <https://1145.am/db/1694279/Index_Ventures>,
        <https://1145.am/db/1699089/Index_Ventures>,
        <https://1145.am/db/1704793/Index_Ventures>,
        <https://1145.am/db/1711587/Index_Ventures>,
        <https://1145.am/db/1711731/Index_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1712506/Index_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1717574/Index_Ventures>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1733028/Index_Ventures>,
        <https://1145.am/db/1735596/Index_Ventures>,
        <https://1145.am/db/1736117/Index_Ventures>,
        <https://1145.am/db/1737079/Index_Ventures>,
        <https://1145.am/db/1737527/Index_Ventures>,
        <https://1145.am/db/1737696/Index_Ventures>,
        <https://1145.am/db/1738402/Index_Ventures>,
        <https://1145.am/db/1738465/Index_Ventures>,
        <https://1145.am/db/1740781/Index_Ventures>,
        <https://1145.am/db/1742878/Index_Ventures>,
        <https://1145.am/db/1744753/Index_Ventures>,
        <https://1145.am/db/1745368/Index_Ventures>,
        <https://1145.am/db/1745702/Index_Ventures>,
        <https://1145.am/db/1746192/Index_Ventures>,
        <https://1145.am/db/1746800/Index_Ventures>,
        <https://1145.am/db/1746845/Index_Ventures>,
        <https://1145.am/db/1746947/Index_Ventures>,
        <https://1145.am/db/1747153/Index_Ventures>,
        <https://1145.am/db/1747208/Index_Ventures>,
        <https://1145.am/db/1748172/Index_Ventures>,
        <https://1145.am/db/1748621/Index_Ventures>,
        <https://1145.am/db/1750406/Index_Ventures>,
        <https://1145.am/db/1750420/Index_Ventures>,
        <https://1145.am/db/1750828/Index_Ventures>,
        <https://1145.am/db/1752154/Index_Ventures>,
        <https://1145.am/db/1755398/Index_Ventures>,
        <https://1145.am/db/1755899/Index_Ventures>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756768/Index_Ventures>,
        <https://1145.am/db/1756873/Index_Ventures>,
        <https://1145.am/db/1758069/Index_Ventures>,
        <https://1145.am/db/1758834/Index_Ventures>,
        <https://1145.am/db/1759939/Index_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760954/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761664/Index_Ventures>,
        <https://1145.am/db/1762988/Index_Ventures>,
        <https://1145.am/db/1763352/Index_Ventures>,
        <https://1145.am/db/1765809/Index_Ventures>,
        <https://1145.am/db/1765870/Index_Ventures>,
        <https://1145.am/db/1766059/Index_Ventures>,
        <https://1145.am/db/1766253/Index_Ventures>,
        <https://1145.am/db/1769654/Index_Ventures>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771672/Index_Ventures>,
        <https://1145.am/db/1771734/Index_Ventures>,
        <https://1145.am/db/1771773/Index_Ventures>,
        <https://1145.am/db/1775903/Index_Ventures>,
        <https://1145.am/db/1776139/Index_Ventures>,
        <https://1145.am/db/1776626/Index_Ventures>,
        <https://1145.am/db/1777546/Index_Ventures>,
        <https://1145.am/db/1778195/Index_Ventures>,
        <https://1145.am/db/1780507/Index_Ventures>,
        <https://1145.am/db/1780733/Index_Ventures>,
        <https://1145.am/db/1783754/Index_Ventures>,
        <https://1145.am/db/1787471/Index_Ventures>,
        <https://1145.am/db/1787621/Index_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1790777/Index_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791667/Index_Ventures>,
        <https://1145.am/db/1791743/Index_Ventures>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1796201/Index_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1798836/Index_Ventures>,
        <https://1145.am/db/1799293/Index_Ventures>,
        <https://1145.am/db/1800172/Index_Ventures>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800998/Index_Ventures>,
        <https://1145.am/db/1805201/Index_Ventures>,
        <https://1145.am/db/1805473/Index_Ventures>,
        <https://1145.am/db/1807173/Index_Ventures>,
        <https://1145.am/db/1808484/Index_Ventures>,
        <https://1145.am/db/1809821/Index_Ventures>,
        <https://1145.am/db/1810000/Index_Ventures>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812038/Index_Ventures>,
        <https://1145.am/db/1812890/Index_Ventures>,
        <https://1145.am/db/1813037/Index_Ventures>,
        <https://1145.am/db/1813404/Index_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1819133/Index_Ventures>,
        <https://1145.am/db/1819302/Index_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1823078/Index_Ventures>,
        <https://1145.am/db/1823141/Index_Ventures>,
        <https://1145.am/db/1824561/Index_Ventures>,
        <https://1145.am/db/1828638/Index_Ventures>,
        <https://1145.am/db/1829991/Index_Ventures>,
        <https://1145.am/db/1830023/Index_Ventures>,
        <https://1145.am/db/1831440/Index_Ventures>,
        <https://1145.am/db/1832655/Index_Ventures>,
        <https://1145.am/db/1832808/Index_Ventures>,
        <https://1145.am/db/1832926/Index_Ventures>,
        <https://1145.am/db/1835321/Index_Ventures>,
        <https://1145.am/db/1835516/Index_Ventures>,
        <https://1145.am/db/1836455/Index_Ventures>,
        <https://1145.am/db/1836572/Index_Ventures>,
        <https://1145.am/db/1837081/Index_Ventures>,
        <https://1145.am/db/1837143/Index_Ventures>,
        <https://1145.am/db/1839663/Index_Ventures>,
        <https://1145.am/db/1840137/Index_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1845548/Index_Ventures>,
        <https://1145.am/db/1845841/Index_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846794/Index_Ventures>,
        <https://1145.am/db/1847483/Index_Ventures>,
        <https://1145.am/db/1848631/Index_Ventures>,
        <https://1145.am/db/1849844/Index_Ventures>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849912/Index_Ventures>,
        <https://1145.am/db/1850428/Index_Ventures>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851744/Index_Ventures>,
        <https://1145.am/db/1853547/Index_Ventures>,
        <https://1145.am/db/1854191/Index_Ventures>,
        <https://1145.am/db/1856171/Index_Ventures>,
        <https://1145.am/db/1856191/Index_Ventures>,
        <https://1145.am/db/1856802/Index_Ventures>,
        <https://1145.am/db/1856967/Index_Ventures>,
        <https://1145.am/db/1857638/Index_Ventures>,
        <https://1145.am/db/1858520/Index_Ventures>,
        <https://1145.am/db/1858521/Index_Ventures>,
        <https://1145.am/db/1862594/Index_Ventures>,
        <https://1145.am/db/1863500/Index_Ventures>,
        <https://1145.am/db/1865106/Index_Ventures>,
        <https://1145.am/db/1865524/Index_Ventures>,
        <https://1145.am/db/1866804/Index_Ventures>,
        <https://1145.am/db/1868923/Index_Ventures>,
        <https://1145.am/db/1868935/Index_Ventures>,
        <https://1145.am/db/1870074/Index_Ventures>,
        <https://1145.am/db/1870079/Index_Ventures>,
        <https://1145.am/db/1870810/Index_Ventures>,
        <https://1145.am/db/1871091/Index_Ventures>,
        <https://1145.am/db/1876014/Index_Ventures>,
        <https://1145.am/db/1876914/Index_Ventures>,
        <https://1145.am/db/1878630/Index_Ventures>,
        <https://1145.am/db/1880386/Index_Ventures>,
        <https://1145.am/db/1881391/Index_Ventures>,
        <https://1145.am/db/1881430/Index_Ventures>,
        <https://1145.am/db/1882301/Index_Ventures>,
        <https://1145.am/db/1882686/Index_Ventures>,
        <https://1145.am/db/1884077/Index_Ventures>,
        <https://1145.am/db/1885147/Index_Ventures>,
        <https://1145.am/db/1890254/Index_Ventures>,
        <https://1145.am/db/1893255/Index_Ventures>,
        <https://1145.am/db/1894621/Index_Ventures>,
        <https://1145.am/db/1894627/Index_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1899697/Index_Ventures>,
        <https://1145.am/db/1900904/Index_Ventures>,
        <https://1145.am/db/1902032/Index_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1910957/Index_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915168/Index_Ventures>,
        <https://1145.am/db/1916258/Index_Ventures>,
        <https://1145.am/db/1916868/Index_Ventures>,
        <https://1145.am/db/1919238/Index_Ventures>,
        <https://1145.am/db/1967520/Index_Ventures>,
        <https://1145.am/db/1967683/Index_Ventures>,
        <https://1145.am/db/199212/Index_Ventures>,
        <https://1145.am/db/2028609/Index_Ventures>,
        <https://1145.am/db/2060465/Index_Ventures>,
        <https://1145.am/db/2062814/Index_Ventures>,
        <https://1145.am/db/2127786/Index_Ventures>,
        <https://1145.am/db/217906/Index_Ventures>,
        <https://1145.am/db/2198066/Index_Ventures>,
        <https://1145.am/db/2234558/Index_Ventures>,
        <https://1145.am/db/2290088/Index_Ventures>,
        <https://1145.am/db/2290200/Index_Ventures>,
        <https://1145.am/db/2297905/Index_Ventures>,
        <https://1145.am/db/2303009/Index_Ventures>,
        <https://1145.am/db/2303849/Index_Ventures>,
        <https://1145.am/db/2309490/Index_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2309847/Index_Ventures>,
        <https://1145.am/db/2313410/Index_Ventures>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325147/Index_Ventures>,
        <https://1145.am/db/2327222/Index_Ventures>,
        <https://1145.am/db/2333601/Index_Ventures>,
        <https://1145.am/db/2338079/Index_Ventures>,
        <https://1145.am/db/2338193/Index_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2344127/Index_Ventures>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2348012/Index_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2348620/Index_Ventures>,
        <https://1145.am/db/2350031/Index_Ventures>,
        <https://1145.am/db/2352145/Index_Ventures>,
        <https://1145.am/db/2355609/Index_Ventures>,
        <https://1145.am/db/2355952/Index_Ventures>,
        <https://1145.am/db/2357169/Index_Ventures>,
        <https://1145.am/db/2357356/Index_Ventures>,
        <https://1145.am/db/2358233/Index_Ventures>,
        <https://1145.am/db/2358246/Index_Ventures>,
        <https://1145.am/db/2362736/Index_Ventures>,
        <https://1145.am/db/2362737/Index_Ventures>,
        <https://1145.am/db/2364597/Index_Ventures>,
        <https://1145.am/db/2364600/Index_Ventures>,
        <https://1145.am/db/2507691/Index_Ventures>,
        <https://1145.am/db/2555540/Index_Ventures>,
        <https://1145.am/db/2589317/Index_Ventures>,
        <https://1145.am/db/2643797/Index_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/317470/Index_Ventures>,
        <https://1145.am/db/318142/Index_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/337401/Index_Ventures>,
        <https://1145.am/db/348633/Index_Ventures>,
        <https://1145.am/db/366983/Index_Ventures>,
        <https://1145.am/db/367008/Index_Ventures>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/475105/Index_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/539919/Index_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/578277/Index_Ventures>,
        <https://1145.am/db/633695/Index_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/707126/Index_Ventures>,
        <https://1145.am/db/709798/Index_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/768008/Index_Ventures>,
        <https://1145.am/db/789218/Index_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/854512/Index_Ventures>,
        <https://1145.am/db/868352/Index_Ventures>,
        <https://1145.am/db/893076/Index_Ventures>,
        <https://1145.am/db/893316/Index_Ventures>,
        <https://1145.am/db/909344/Index_Ventures>,
        <https://1145.am/db/957097/Index_Ventures>,
        <https://1145.am/db/980375/Index_Ventures>,
        <https://1145.am/db/981840/Index_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356283/Pdl_Biopharma> a org:Organization ;
    ns1:documentDate "2013-10-02T15:46:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PDL BioPharma Provides $60 Million in Financing to LENSAR" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pdl-biopharma-provides-60-million-financing-to-lensar> ;
    ns1:foundName "PDL",
        "PDL BioPharma" ;
    ns1:investor <https://1145.am/db/2356283/Investment_Lensar_Inc_Pdl_Biopharma_Has_Not_Happened> ;
    ns1:name "PDL BioPharma" ;
    ns1:sameAsMedium <https://1145.am/db/2291799/Pdl_Biopharma>,
        <https://1145.am/db/2293561/Pdl_Biopharma>,
        <https://1145.am/db/2310091/Pdl_Biopharma>,
        <https://1145.am/db/2310095/Pdl_Biopharma>,
        <https://1145.am/db/2310254/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2314489/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2314491/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2316533/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2317635/Pdl_Biopharma>,
        <https://1145.am/db/2325270/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2333513/Pdl_Biopharma>,
        <https://1145.am/db/2336435/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2338885/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2341757/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2354239/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2355333/Pdl_Biopharma>,
        <https://1145.am/db/2363628/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2367805/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2370335/Pdl_Biopharma_Inc>,
        <https://1145.am/db/2536960/Pdl_Biopharma>,
        <https://1145.am/db/2545058/Pdl_Biopharma> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356290/Aglaia_Oncology_Fund> a org:Organization ;
    ns1:basedInLowRaw "The Netherlands" ;
    ns1:description "cancer" ;
    ns1:documentDate "2013-10-03T11:35:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merus Secures 31 Million in Series B Round Extension" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merus-secures-%E2%82%AC31-million-series-b-round-extension> ;
    ns1:foundName "Aglaia Oncology Fund" ;
    ns1:investor <https://1145.am/db/2356290/Series_B_Investment_Aglaia_Oncology_Fund_Bay_City_Capital_Johnson___Johnson_Development_Corporation_Lsp_Merus_Bv_Novartis_Venture_Fund_Pfizer_Venture_Investments_Completed> ;
    ns1:name "Aglaia Oncology Fund" ;
    ns1:sameAsHigh <https://1145.am/db/531672/Aglaia_Oncology_Funds> ;
    ns1:sameAsMedium <https://1145.am/db/2311570/Aglaia_Oncology_Fund>,
        <https://1145.am/db/2368746/Aglaia_Oncology_Fund_Ii> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356290/Johnson___Johnson_Development_Corporation> a org:Organization ;
    ns1:basedInLowRaw "The Netherlands" ;
    ns1:documentDate "2013-10-03T11:35:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merus Secures 31 Million in Series B Round Extension" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merus-secures-%E2%82%AC31-million-series-b-round-extension> ;
    ns1:foundName "Johnson & Johnson Development Corporation" ;
    ns1:investor <https://1145.am/db/2356290/Series_B_Investment_Aglaia_Oncology_Fund_Bay_City_Capital_Johnson___Johnson_Development_Corporation_Lsp_Merus_Bv_Novartis_Venture_Fund_Pfizer_Venture_Investments_Completed> ;
    ns1:name "Johnson & Johnson Development Corporation" ;
    ns1:sameAsMedium <https://1145.am/db/1883008/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2291836/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292334/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292345/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292353/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292975/Johnson___Johnson_Development_Corp>,
        <https://1145.am/db/2299864/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2300306/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2300455/Johnson___Johnson_Development_Corp>,
        <https://1145.am/db/2303009/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2306163/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2308781/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2308791/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2311069/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2311075/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2316619/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2316624/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2317934/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2321856/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2327212/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2327227/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2336890/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2336943/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2337571/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2337577/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338236/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338237/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338527/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2341478/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2344597/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2344605/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2346978/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2350327/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2352357/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2352361/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358640/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358657/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358658/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358812/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2361581/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2363907/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364457/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364458/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2365296/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2546216/Johnson___Johnson_Development_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356290/LSP> a org:Organization ;
    ns1:basedInLowRaw "The Netherlands" ;
    ns1:description "Life Sciences Partners" ;
    ns1:documentDate "2013-10-03T11:35:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merus Secures 31 Million in Series B Round Extension" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merus-secures-%E2%82%AC31-million-series-b-round-extension> ;
    ns1:foundName "LSP (Life Sciences Partners)" ;
    ns1:industry "Life Sciences" ;
    ns1:investor <https://1145.am/db/2356290/Series_B_Investment_Aglaia_Oncology_Fund_Bay_City_Capital_Johnson___Johnson_Development_Corporation_Lsp_Merus_Bv_Novartis_Venture_Fund_Pfizer_Venture_Investments_Completed> ;
    ns1:name "LSP" ;
    ns1:sameAsHigh <https://1145.am/db/2311395/LSP>,
        <https://1145.am/db/2311570/LSP>,
        <https://1145.am/db/2317934/Lsp_(life_Science_Partners)>,
        <https://1145.am/db/2336810/Lsp_5>,
        <https://1145.am/db/2337308/Lsp_5>,
        <https://1145.am/db/2347574/Lsp_Life_Sciences_Partners>,
        <https://1145.am/db/2351224/LSP>,
        <https://1145.am/db/2363907/LSP> ;
    ns1:sameAsMedium <https://1145.am/db/2193677/LSP>,
        <https://1145.am/db/2289899/LSP>,
        <https://1145.am/db/2293593/LSP>,
        <https://1145.am/db/2296061/LSP>,
        <https://1145.am/db/2316478/LSP>,
        <https://1145.am/db/2321608/LSP>,
        <https://1145.am/db/2336812/LSP>,
        <https://1145.am/db/2343250/LSP>,
        <https://1145.am/db/2352357/LSP>,
        <https://1145.am/db/2352361/LSP>,
        <https://1145.am/db/426688/LSP>,
        <https://1145.am/db/564585/LSP>,
        <https://1145.am/db/566971/LSP>,
        <https://1145.am/db/571769/LSP> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356290/Novartis_Venture_Fund> a org:Organization ;
    ns1:basedInLowRaw "The Netherlands" ;
    ns1:documentDate "2013-10-03T11:35:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merus Secures 31 Million in Series B Round Extension" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merus-secures-%E2%82%AC31-million-series-b-round-extension> ;
    ns1:foundName "Novartis Venture Fund" ;
    ns1:investor <https://1145.am/db/2356290/Series_B_Investment_Aglaia_Oncology_Fund_Bay_City_Capital_Johnson___Johnson_Development_Corporation_Lsp_Merus_Bv_Novartis_Venture_Fund_Pfizer_Venture_Investments_Completed> ;
    ns1:name "Novartis Venture Fund" ;
    ns1:sameAsMedium <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/1523031/Novartis_Venture_Fund>,
        <https://1145.am/db/207823/Novartis_Venture_Fund>,
        <https://1145.am/db/2152422/Novartis_Venture_Fund>,
        <https://1145.am/db/2247240/Novartis_Venture_Funds>,
        <https://1145.am/db/2289983/Novartis_Venture_Funds>,
        <https://1145.am/db/2292300/Novartis_Venture_Funds>,
        <https://1145.am/db/2292345/Novartis_Venture_Funds>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2298176/Novartis_Venture_Fund>,
        <https://1145.am/db/2307682/Novartis_Venture_Fund>,
        <https://1145.am/db/2310905/Novartis_Venture_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2315943/Novartis_Venture_Fund>,
        <https://1145.am/db/2315957/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323210/Novartis_Venture_Funds>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323682/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327441/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331750/Novartis_Venture_Fund>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2336032/Novartis_Venture_Fund>,
        <https://1145.am/db/2336328/Novartis_Venture_Funds>,
        <https://1145.am/db/2337294/Novartis_Venture_Funds>,
        <https://1145.am/db/2337645/Novartis_Venture_Fund>,
        <https://1145.am/db/2338527/Novartis_Venture_Funds>,
        <https://1145.am/db/2339193/Novartis_Venture_Fund>,
        <https://1145.am/db/2339196/Novartis_Venture_Fund>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340612/Novartis_Venture_Fund>,
        <https://1145.am/db/2340942/Novartis_Venture_Fund>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2343493/Novartis_Venture_Funds>,
        <https://1145.am/db/2343966/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2348012/Novartis_Venture_Fund>,
        <https://1145.am/db/2348348/Novartis_Venture_Funds>,
        <https://1145.am/db/2348350/Novartis_Venture_Funds>,
        <https://1145.am/db/2351958/Novartis_Venture_Funds>,
        <https://1145.am/db/2351959/Novartis_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2352216/Novartis_Venture_Fund>,
        <https://1145.am/db/2353098/Novartis_Venture_Fund>,
        <https://1145.am/db/2356287/Novartis_Venture_Fund>,
        <https://1145.am/db/2356391/Novartis_Venture_Fund>,
        <https://1145.am/db/2356393/Novartis_Venture_Fund>,
        <https://1145.am/db/2356395/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358430/Novartis_Venture_Funds>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2358733/Novartis_Venture_Fund>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2362715/Novartis_Venture_Funds>,
        <https://1145.am/db/2363510/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2367046/Novartis_Venture_Fund>,
        <https://1145.am/db/2369548/Novartis_Venture_Fund>,
        <https://1145.am/db/2551315/Novartis_Venture_Fund>,
        <https://1145.am/db/2570481/Novartis_Venture_Fund>,
        <https://1145.am/db/2570483/Novartis_Venture_Fund>,
        <https://1145.am/db/2578837/Novartis_Venture_Funds>,
        <https://1145.am/db/2592611/Novartis_Venture_Funds>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356290/Pfizer_Venture_Investments> a org:Organization ;
    ns1:basedInLowRaw "The Netherlands" ;
    ns1:description "investing" ;
    ns1:documentDate "2013-10-03T11:35:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merus Secures 31 Million in Series B Round Extension" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merus-secures-%E2%82%AC31-million-series-b-round-extension> ;
    ns1:foundName "Pfizer Venture Investments" ;
    ns1:investor <https://1145.am/db/2356290/Series_B_Investment_Aglaia_Oncology_Fund_Bay_City_Capital_Johnson___Johnson_Development_Corporation_Lsp_Merus_Bv_Novartis_Venture_Fund_Pfizer_Venture_Investments_Completed> ;
    ns1:name "Pfizer Venture Investments" ;
    ns1:sameAsHigh <https://1145.am/db/1334624/Pfizer_Ventures>,
        <https://1145.am/db/2154844/Pfizer_Ventures>,
        <https://1145.am/db/2306549/Pfizer_Venture_Investments>,
        <https://1145.am/db/2318310/Pfizer_Venture_Investments>,
        <https://1145.am/db/2318333/Pfizer>,
        <https://1145.am/db/2319442/Pfizer_Venture_Investments>,
        <https://1145.am/db/2322984/Pfizer_Venture_Investments>,
        <https://1145.am/db/2323003/Pfizer_Venture_Investments>,
        <https://1145.am/db/2325726/Pfizer_Ventures>,
        <https://1145.am/db/2341896/Pfizer_Ventures>,
        <https://1145.am/db/2348066/Pfizer_Venture_Investments>,
        <https://1145.am/db/2354296/Pfizer_Venture_Investments>,
        <https://1145.am/db/2355043/Pfizer_Venture_Investments>,
        <https://1145.am/db/2359321/Pfizer_Venture_Investments>,
        <https://1145.am/db/2364458/Pfizer_Venture_Investments>,
        <https://1145.am/db/2369000/Pfizer_Venture_Investments>,
        <https://1145.am/db/587045/Pfizer_Ventures>,
        <https://1145.am/db/591613/Pfizer_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2299758/Pfizer_Venture_Investments>,
        <https://1145.am/db/2336335/Pfizer_Venture_Investments>,
        <https://1145.am/db/2337971/Pfizer_Venture_Investments>,
        <https://1145.am/db/2338527/Pfizer_Venture_Investments>,
        <https://1145.am/db/2338528/Pfizer_Venture_Investments>,
        <https://1145.am/db/2340096/Pfizer_Venture_Investments>,
        <https://1145.am/db/2346978/Pfizer_Venture_Investments>,
        <https://1145.am/db/2349143/Pfizer_Venture_Investments>,
        <https://1145.am/db/2352226/Pfizer_Venture_Investments>,
        <https://1145.am/db/2356287/Pfizer_Venture_Investments>,
        <https://1145.am/db/2362862/Pfizer_Venture_Investments>,
        <https://1145.am/db/2364457/Pfizer_Venture_Investments>,
        <https://1145.am/db/2367549/Pfizer_Venture_Investments>,
        <https://1145.am/db/2587938/Pfizer_Venture_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357260/Inserm_Transfert_Initiative> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:documentDate "2014-03-13T21:44:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "With $25M in the bank, French startup sets its sights on sepsis" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/25m-bank-french-startup-sets-its-sights-on-sepsis> ;
    ns1:foundName "Inserm Transfert Initiative" ;
    ns1:investor <https://1145.am/db/2357260/Investment_Inotrem_Inserm_Transfert_Initiative_Has_Not_Happened> ;
    ns1:name "Inserm Transfert Initiative" ;
    ns1:sameAsMedium <https://1145.am/db/2295270/Inserm_Transfert_Initiative>,
        <https://1145.am/db/2295713/Inserm_Transfert_Initiative>,
        <https://1145.am/db/2325232/Inserm-Transfert_Initiative>,
        <https://1145.am/db/2325234/Inserm-Transfert_Initiative>,
        <https://1145.am/db/2364480/Inserm_Transfert_Initiative>,
        <https://1145.am/db/2368517/Inserm_Transfert_Initiative>,
        <https://1145.am/db/2370799/Inserm_Transfert_Initiative> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357333/Industrifonden> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:description "venture investors" ;
    ns1:documentDate "2013-10-04T13:02:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PHARMALINK RAISES SEK96 MILLION TO UNDERTAKE PIVOTAL STUDIES WITH LEAD PROGRAMS IN CANCER THERAPY AND RENAL DISEASE" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pharmalink-raises-sek96-million-to-undertake-pivotal-studies-lead-programs-cancer-therapy> ;
    ns1:foundName "Industrifonden" ;
    ns1:investor <https://1145.am/db/2357333/Series_C_Investment_Industrifonden_Investinor_Pharmalink_Completed> ;
    ns1:name "Industrifonden" ;
    ns1:sameAsHigh <https://1145.am/db/2370798/Industrifonden> ;
    ns1:sameAsMedium <https://1145.am/db/1583413/Industrifonden>,
        <https://1145.am/db/1584328/Industrifonden>,
        <https://1145.am/db/1699203/Industrifonden>,
        <https://1145.am/db/1703315/Industrifonden>,
        <https://1145.am/db/1708592/Industrifonden>,
        <https://1145.am/db/1757590/Industrifonden>,
        <https://1145.am/db/1762583/Industrifonden>,
        <https://1145.am/db/1772429/Industrifonden>,
        <https://1145.am/db/1776452/Industrifonden>,
        <https://1145.am/db/1784881/Industrifonden>,
        <https://1145.am/db/1795283/Industrifonden>,
        <https://1145.am/db/1800176/Industrifonden>,
        <https://1145.am/db/1819437/Industrifonden>,
        <https://1145.am/db/1837910/Industrifonden>,
        <https://1145.am/db/1855181/Industrifonden>,
        <https://1145.am/db/1857635/Industrifonden>,
        <https://1145.am/db/2360922/Industrifonden>,
        <https://1145.am/db/2368273/Industrifonden>,
        <https://1145.am/db/2368278/Industrifonden>,
        <https://1145.am/db/545774/Industrifonden> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357333/Investinor> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:description "venture investors" ;
    ns1:documentDate "2013-10-04T13:02:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PHARMALINK RAISES SEK96 MILLION TO UNDERTAKE PIVOTAL STUDIES WITH LEAD PROGRAMS IN CANCER THERAPY AND RENAL DISEASE" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pharmalink-raises-sek96-million-to-undertake-pivotal-studies-lead-programs-cancer-therapy> ;
    ns1:foundName "Investinor" ;
    ns1:investor <https://1145.am/db/2357333/Series_C_Investment_Industrifonden_Investinor_Pharmalink_Completed> ;
    ns1:name "Investinor" ;
    ns1:sameAsHigh <https://1145.am/db/1754484/Top_Tier_Capital_Partners>,
        <https://1145.am/db/1755860/Vs_Partners>,
        <https://1145.am/db/1767026/Target_Partners>,
        <https://1145.am/db/1789767/Group_11>,
        <https://1145.am/db/1853417/New_Markets_Venture_Partners>,
        <https://1145.am/db/1855529/Target_Partners>,
        <https://1145.am/db/1856228/Venture_Partners>,
        <https://1145.am/db/1858991/Target_Partners>,
        <https://1145.am/db/1859494/Partners_Investment>,
        <https://1145.am/db/1928828/Top_Tier_Capital_Partners>,
        <https://1145.am/db/2222905/Venture_Capitalists>,
        <https://1145.am/db/2299743/Venture_Investors>,
        <https://1145.am/db/2309506/Prospect_Venture_Partners>,
        <https://1145.am/db/2330852/Prospect_Venture_Partners>,
        <https://1145.am/db/2331868/Prospect_Venture_Partners>,
        <https://1145.am/db/2337972/Venture_Investments>,
        <https://1145.am/db/2352804/Prospect_Venture_Partners>,
        <https://1145.am/db/2360006/Prospect_Venture_Partners>,
        <https://1145.am/db/2370798/Investinor>,
        <https://1145.am/db/396235/Top_Tier_Capital_Partners>,
        <https://1145.am/db/588551/Citi_Ventures>,
        <https://1145.am/db/704753/Target_Partners>,
        <https://1145.am/db/734448/Venture_Investments>,
        <https://1145.am/db/838181/Index_Venture_Capital>,
        <https://1145.am/db/893076/Top_Tier_Capital_Partners>,
        <https://1145.am/db/893316/Top_Tier_Capital_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1766933/Investinor>,
        <https://1145.am/db/1767996/Investinor>,
        <https://1145.am/db/2051536/Investinor>,
        <https://1145.am/db/525962/Investinor> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358297/Clal_Biotechnology> a org:Organization ;
    ns1:basedInHighGeoName "State of Israel" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:basedInHighRaw "Israel" ;
    ns1:description "Israeli biotech pies" ;
    ns1:documentDate "2014-03-18T12:36:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Novartis circles a deal to buy Gamida Cell in $600M deal" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/report-novartis-circles-a-deal-to-buy-gamida-cell-600m-deal> ;
    ns1:foundName "Clal Biotechnology" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2358297/Gamida_Cell_Acquisition> ;
    ns1:name "Clal Biotechnology" ;
    ns1:sameAsHigh <https://1145.am/db/1157465/Oragenics>,
        <https://1145.am/db/1158575/Oragenics>,
        <https://1145.am/db/1509809/Novigenix>,
        <https://1145.am/db/2078301/Oragenics>,
        <https://1145.am/db/2151717/Abcellera>,
        <https://1145.am/db/2152981/Vividion>,
        <https://1145.am/db/2154072/Caelum_Biosciences>,
        <https://1145.am/db/2280707/Dren_Bio>,
        <https://1145.am/db/2281936/Bioindustry_Association>,
        <https://1145.am/db/2288986/Novogen>,
        <https://1145.am/db/2290780/Medivir>,
        <https://1145.am/db/2291198/Novogen>,
        <https://1145.am/db/2292333/Biodesix>,
        <https://1145.am/db/2292843/Reviral>,
        <https://1145.am/db/2293654/Viventia>,
        <https://1145.am/db/2296000/Medivation>,
        <https://1145.am/db/2301648/Achillion>,
        <https://1145.am/db/2306118/Biovex_Inc>,
        <https://1145.am/db/2307654/Bioton_Sa>,
        <https://1145.am/db/2309865/Biovex_Inc>,
        <https://1145.am/db/2309872/Biovex>,
        <https://1145.am/db/2310072/Encysive>,
        <https://1145.am/db/2319956/Cytovance>,
        <https://1145.am/db/2322304/Biovex>,
        <https://1145.am/db/2322312/Biovex_Inc>,
        <https://1145.am/db/2323591/Promedior>,
        <https://1145.am/db/2326139/Biovex_Inc>,
        <https://1145.am/db/2327506/Esperion>,
        <https://1145.am/db/2331639/Bioprocessors_Corporation>,
        <https://1145.am/db/2341458/Coridon>,
        <https://1145.am/db/2343202/Promedior>,
        <https://1145.am/db/2344535/Biovex_Inc>,
        <https://1145.am/db/2345773/Exonhit>,
        <https://1145.am/db/2352382/Hbm_Bioventures>,
        <https://1145.am/db/2366924/Biovex_Inc>,
        <https://1145.am/db/2367150/Biovex_Inc>,
        <https://1145.am/db/2368688/Etubics_Corporation>,
        <https://1145.am/db/2369363/Volution>,
        <https://1145.am/db/2369703/Promedior>,
        <https://1145.am/db/2369982/Reviral>,
        <https://1145.am/db/2370423/Nuevolution_A_S>,
        <https://1145.am/db/2545426/Medivation>,
        <https://1145.am/db/2549151/Encysive>,
        <https://1145.am/db/2557249/Biontech>,
        <https://1145.am/db/2558655/Biondvax>,
        <https://1145.am/db/2565174/Biocon_Viatris>,
        <https://1145.am/db/2572695/Biovex_Inc>,
        <https://1145.am/db/411454/Ensysce>,
        <https://1145.am/db/679276/Biodesix_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2359165/Clal_Biotechnology> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358297/Novartis> a org:Organization ;
    ns1:basedInLowRaw "Israel" ;
    ns1:buyer <https://1145.am/db/2358297/Gamida_Cell_Acquisition> ;
    ns1:documentDate "2014-03-18T12:36:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Novartis circles a deal to buy Gamida Cell in $600M deal" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/report-novartis-circles-a-deal-to-buy-gamida-cell-600m-deal> ;
    ns1:foundName "Novartis" ;
    ns1:industry "biotech" ;
    ns1:name "Novartis" ;
    ns1:sameAsHigh <https://1145.am/db/1176158/Novartis>,
        <https://1145.am/db/1177562/Novartis>,
        <https://1145.am/db/131136/Novartis>,
        <https://1145.am/db/132002/Novartis>,
        <https://1145.am/db/1328753/Novartis>,
        <https://1145.am/db/1507918/Novartis_Ag>,
        <https://1145.am/db/156403/Novartis>,
        <https://1145.am/db/1567521/Novartis>,
        <https://1145.am/db/1578114/Novartis>,
        <https://1145.am/db/1628428/Novalgen_Ltd>,
        <https://1145.am/db/1629605/Novartis>,
        <https://1145.am/db/1629663/Novartis>,
        <https://1145.am/db/165056/Novartis>,
        <https://1145.am/db/176334/Novartis>,
        <https://1145.am/db/177096/Novartis>,
        <https://1145.am/db/1986468/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/2033677/Novartis>,
        <https://1145.am/db/2062728/Novan>,
        <https://1145.am/db/2107835/Novartis>,
        <https://1145.am/db/2129754/Novartis>,
        <https://1145.am/db/2152605/Novartis>,
        <https://1145.am/db/2152618/Novartis>,
        <https://1145.am/db/2153059/Novartis>,
        <https://1145.am/db/2154527/Novartis>,
        <https://1145.am/db/2155069/Novartis>,
        <https://1145.am/db/2155665/Novartis>,
        <https://1145.am/db/2190363/Novartis_Ag>,
        <https://1145.am/db/2194161/Novartis>,
        <https://1145.am/db/2279108/Novartis>,
        <https://1145.am/db/2279232/Novartis>,
        <https://1145.am/db/2279829/Novartis>,
        <https://1145.am/db/2280153/Novartis>,
        <https://1145.am/db/2280350/Novartis>,
        <https://1145.am/db/2283590/Novartis>,
        <https://1145.am/db/2283645/Novartis>,
        <https://1145.am/db/2285311/Novartis>,
        <https://1145.am/db/2286604/Novartis>,
        <https://1145.am/db/2288851/Novartis>,
        <https://1145.am/db/2289846/Novartis>,
        <https://1145.am/db/2290022/Novartis>,
        <https://1145.am/db/2293323/Novartis>,
        <https://1145.am/db/2293342/Novartis>,
        <https://1145.am/db/2293591/Novartis>,
        <https://1145.am/db/2294026/Novartis>,
        <https://1145.am/db/2294585/Novartis>,
        <https://1145.am/db/2296504/Novartis>,
        <https://1145.am/db/2296552/Novartis>,
        <https://1145.am/db/2298606/Novartis>,
        <https://1145.am/db/2301066/Novartis>,
        <https://1145.am/db/2301089/Novartis>,
        <https://1145.am/db/2301705/Novasep>,
        <https://1145.am/db/2301735/Novartis>,
        <https://1145.am/db/2301857/Novartis>,
        <https://1145.am/db/2302724/Novartis>,
        <https://1145.am/db/2302727/Novartis>,
        <https://1145.am/db/2303121/Novartis_Bioventures>,
        <https://1145.am/db/230344/Swiss_Drugmaker_Novartis>,
        <https://1145.am/db/2304113/Novartis>,
        <https://1145.am/db/2304373/Novartis>,
        <https://1145.am/db/2304374/Novartis>,
        <https://1145.am/db/2305192/Novartis>,
        <https://1145.am/db/2305244/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2307228/Novadel_Pharma_Inc>,
        <https://1145.am/db/2307347/Novartis>,
        <https://1145.am/db/2307847/Novartis>,
        <https://1145.am/db/2307863/Novartis>,
        <https://1145.am/db/2307998/Novartis>,
        <https://1145.am/db/2308010/Novartis>,
        <https://1145.am/db/2308298/Novartis>,
        <https://1145.am/db/2308765/Novartis>,
        <https://1145.am/db/2308812/Novartis>,
        <https://1145.am/db/2308946/Novartis_Ag>,
        <https://1145.am/db/2309065/Novartis_Intercell>,
        <https://1145.am/db/2310150/Novartis>,
        <https://1145.am/db/2312008/Novartis>,
        <https://1145.am/db/2312018/Novartis_International_Ag>,
        <https://1145.am/db/2312088/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2312436/Novartis>,
        <https://1145.am/db/2317845/Novadel>,
        <https://1145.am/db/2317949/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2317951/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2318994/Novadel>,
        <https://1145.am/db/2319412/Novartis>,
        <https://1145.am/db/2320828/Novartis>,
        <https://1145.am/db/2321067/Novartis>,
        <https://1145.am/db/2322266/Novartis>,
        <https://1145.am/db/2323188/Novartis>,
        <https://1145.am/db/2323692/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2325073/Novartis>,
        <https://1145.am/db/2325869/Novartis>,
        <https://1145.am/db/2326949/Novartis>,
        <https://1145.am/db/2327560/Novartis>,
        <https://1145.am/db/2329413/Novadel_Pharma_Inc>,
        <https://1145.am/db/2329475/Novadel_Pharma>,
        <https://1145.am/db/2329597/Novartis>,
        <https://1145.am/db/2330648/Novartis>,
        <https://1145.am/db/2331875/Novadel>,
        <https://1145.am/db/2332005/Novartis>,
        <https://1145.am/db/2332788/Novartis_Ag>,
        <https://1145.am/db/2332796/Novadel_Pharma_Inc>,
        <https://1145.am/db/2332872/Novartis>,
        <https://1145.am/db/2334206/Novartis>,
        <https://1145.am/db/2334645/Novast>,
        <https://1145.am/db/2336028/Novartis>,
        <https://1145.am/db/2336704/Novartis>,
        <https://1145.am/db/2339656/Novartis>,
        <https://1145.am/db/2339669/Novartis>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2340948/Novartis>,
        <https://1145.am/db/2344017/Novartis>,
        <https://1145.am/db/2344434/Novartis>,
        <https://1145.am/db/2346576/Novadel_Pharma_Inc>,
        <https://1145.am/db/2346629/Novartis>,
        <https://1145.am/db/2348176/Novartis>,
        <https://1145.am/db/2349068/Novartis>,
        <https://1145.am/db/2352045/Novartis>,
        <https://1145.am/db/2352046/Novartis>,
        <https://1145.am/db/2354148/Novartis>,
        <https://1145.am/db/2358273/Novartis>,
        <https://1145.am/db/2359165/Novartis>,
        <https://1145.am/db/2359179/Novartis>,
        <https://1145.am/db/2359915/Novadel_Pharma_Inc>,
        <https://1145.am/db/2360526/Novartis>,
        <https://1145.am/db/2360633/Novartis>,
        <https://1145.am/db/2362448/Novadel_Pharma_Inc>,
        <https://1145.am/db/2363618/Novartis_Uk>,
        <https://1145.am/db/2367118/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2367207/Novartis>,
        <https://1145.am/db/2367829/Novartis_International_Ag>,
        <https://1145.am/db/2367836/Novartis_International_Ag>,
        <https://1145.am/db/2367993/Novabay>,
        <https://1145.am/db/2368571/Novartis>,
        <https://1145.am/db/2368646/Novartis>,
        <https://1145.am/db/2368659/Novartis>,
        <https://1145.am/db/2369183/Novartis>,
        <https://1145.am/db/2369450/Novartis>,
        <https://1145.am/db/2369451/Novartis>,
        <https://1145.am/db/2369555/Swiss_Pharma_Giant_Novartis>,
        <https://1145.am/db/2369718/Novartis>,
        <https://1145.am/db/2370010/Novartis>,
        <https://1145.am/db/2370013/Novartis>,
        <https://1145.am/db/2370615/Novartis>,
        <https://1145.am/db/2370635/Novartis>,
        <https://1145.am/db/2371070/Novartis>,
        <https://1145.am/db/2371077/Novartis>,
        <https://1145.am/db/2371323/Novartis>,
        <https://1145.am/db/2371326/Novartis>,
        <https://1145.am/db/2434670/Novartis>,
        <https://1145.am/db/2536325/Novartis>,
        <https://1145.am/db/2536882/Novartis>,
        <https://1145.am/db/2536914/Novartis>,
        <https://1145.am/db/2537064/Novartis>,
        <https://1145.am/db/2537477/Novartis>,
        <https://1145.am/db/2537482/Novacea>,
        <https://1145.am/db/2538344/Novartis>,
        <https://1145.am/db/2538791/Novartis>,
        <https://1145.am/db/2539541/Novasep>,
        <https://1145.am/db/2539787/Novartis>,
        <https://1145.am/db/2539925/Novartis>,
        <https://1145.am/db/2540187/Novartis>,
        <https://1145.am/db/2541511/Novartis>,
        <https://1145.am/db/2542938/Novartis>,
        <https://1145.am/db/2543689/Novartis>,
        <https://1145.am/db/2544236/Novartis>,
        <https://1145.am/db/2544326/Novartis>,
        <https://1145.am/db/2545284/Novartis>,
        <https://1145.am/db/2545651/Novartis>,
        <https://1145.am/db/2545966/Novartis>,
        <https://1145.am/db/2545986/Novartis>,
        <https://1145.am/db/2546157/Novartis>,
        <https://1145.am/db/2546170/Novartis>,
        <https://1145.am/db/2546603/Novartis>,
        <https://1145.am/db/2547397/Novartis>,
        <https://1145.am/db/2548223/Novartis>,
        <https://1145.am/db/2548224/Novartis_Group>,
        <https://1145.am/db/2549043/Novartis>,
        <https://1145.am/db/2549631/Novast>,
        <https://1145.am/db/2550855/Novartis>,
        <https://1145.am/db/2551143/Novartis>,
        <https://1145.am/db/2551693/Novartis>,
        <https://1145.am/db/2551694/Novartis>,
        <https://1145.am/db/2552165/Novartis>,
        <https://1145.am/db/2552258/Novartis>,
        <https://1145.am/db/2553024/Novartis>,
        <https://1145.am/db/2553276/Novartis>,
        <https://1145.am/db/2553480/Novartis>,
        <https://1145.am/db/2553740/Novasep>,
        <https://1145.am/db/2553810/Novartis>,
        <https://1145.am/db/2553846/Novartis>,
        <https://1145.am/db/2554060/Novartis>,
        <https://1145.am/db/2554669/Novasep>,
        <https://1145.am/db/2555555/Novartis>,
        <https://1145.am/db/2555561/Novartis>,
        <https://1145.am/db/2556030/Novartis>,
        <https://1145.am/db/2556543/Novartis>,
        <https://1145.am/db/2557588/Novartis>,
        <https://1145.am/db/2558316/Novartis>,
        <https://1145.am/db/2558415/Novartis>,
        <https://1145.am/db/2558779/Novartis>,
        <https://1145.am/db/2558927/Novartis>,
        <https://1145.am/db/2559306/Novartis>,
        <https://1145.am/db/2559655/Novartis>,
        <https://1145.am/db/2559797/Novartis>,
        <https://1145.am/db/2559802/Novartis>,
        <https://1145.am/db/2559810/Switzerlands_Novartis>,
        <https://1145.am/db/2560023/Novartis>,
        <https://1145.am/db/2560079/Novartis>,
        <https://1145.am/db/2561162/Novasep>,
        <https://1145.am/db/2561268/Novartis>,
        <https://1145.am/db/2561541/Novartis>,
        <https://1145.am/db/2561955/Novartis>,
        <https://1145.am/db/2562202/Novartis>,
        <https://1145.am/db/2562695/Novartis>,
        <https://1145.am/db/2562951/Novartis>,
        <https://1145.am/db/2563497/Novartis>,
        <https://1145.am/db/2563987/Novartis>,
        <https://1145.am/db/2564141/Novartis>,
        <https://1145.am/db/2564268/Novartis>,
        <https://1145.am/db/2564695/Novartis>,
        <https://1145.am/db/2565142/Novartis>,
        <https://1145.am/db/2565794/Novartis>,
        <https://1145.am/db/2565844/Novartis>,
        <https://1145.am/db/2567283/Novartis>,
        <https://1145.am/db/2567300/Novartis>,
        <https://1145.am/db/2567942/Novartis>,
        <https://1145.am/db/2568308/Novartis>,
        <https://1145.am/db/2568932/Novartis>,
        <https://1145.am/db/2568968/Novartis>,
        <https://1145.am/db/2568973/Novartis>,
        <https://1145.am/db/2570214/Novartis>,
        <https://1145.am/db/2570791/Novartis>,
        <https://1145.am/db/2570932/Novartis>,
        <https://1145.am/db/2570937/Novartis_Uk>,
        <https://1145.am/db/2571513/Novartis>,
        <https://1145.am/db/2571519/Novartis>,
        <https://1145.am/db/2571527/Novartis>,
        <https://1145.am/db/2572713/Novartis>,
        <https://1145.am/db/2572904/Novartis_Group>,
        <https://1145.am/db/2572985/Novartis>,
        <https://1145.am/db/2573002/Novartis>,
        <https://1145.am/db/2573473/Novartis>,
        <https://1145.am/db/2573517/Novartis>,
        <https://1145.am/db/2573611/Novartis>,
        <https://1145.am/db/2574958/Novartis>,
        <https://1145.am/db/2575047/Novartis>,
        <https://1145.am/db/2575310/Novartis>,
        <https://1145.am/db/2575313/Novartis>,
        <https://1145.am/db/2575488/Novartis>,
        <https://1145.am/db/2575545/Novartis>,
        <https://1145.am/db/2575625/Novartis>,
        <https://1145.am/db/2575702/Novartis>,
        <https://1145.am/db/2575712/Novartis>,
        <https://1145.am/db/2575810/Novartis_Ag>,
        <https://1145.am/db/2575813/Novartis>,
        <https://1145.am/db/2576242/Novartis>,
        <https://1145.am/db/2576254/Novartis>,
        <https://1145.am/db/2576547/Novartis>,
        <https://1145.am/db/2576933/Novartis>,
        <https://1145.am/db/2577129/Novartis>,
        <https://1145.am/db/2577419/Novartis>,
        <https://1145.am/db/2577998/Novartis>,
        <https://1145.am/db/2579507/Novartis>,
        <https://1145.am/db/2579519/Novartis>,
        <https://1145.am/db/2580047/Novartis>,
        <https://1145.am/db/2580401/Novartis>,
        <https://1145.am/db/2580963/Novartis>,
        <https://1145.am/db/2581378/Novartis>,
        <https://1145.am/db/2581394/Novartis>,
        <https://1145.am/db/2581397/Novartis>,
        <https://1145.am/db/2581493/Novartis>,
        <https://1145.am/db/2581716/Novartis>,
        <https://1145.am/db/2582355/Novartis>,
        <https://1145.am/db/2582395/Novartis>,
        <https://1145.am/db/2582400/Novartis>,
        <https://1145.am/db/2582402/Novartis>,
        <https://1145.am/db/2582623/Novartis>,
        <https://1145.am/db/2582643/Novartis>,
        <https://1145.am/db/2583067/Novartis>,
        <https://1145.am/db/2584538/Novartis>,
        <https://1145.am/db/2585039/Novartis>,
        <https://1145.am/db/2585121/Novartis>,
        <https://1145.am/db/2586661/Novatis>,
        <https://1145.am/db/2586670/Novartis>,
        <https://1145.am/db/2587047/Novartis>,
        <https://1145.am/db/2587857/Novartis>,
        <https://1145.am/db/2588196/Novartis>,
        <https://1145.am/db/2589178/Novartis>,
        <https://1145.am/db/2589535/Novartis>,
        <https://1145.am/db/2591905/Novartis>,
        <https://1145.am/db/2592351/Novartis>,
        <https://1145.am/db/2592505/Novartis>,
        <https://1145.am/db/2592895/Novartis>,
        <https://1145.am/db/2592987/Novartis>,
        <https://1145.am/db/2593443/Novartis>,
        <https://1145.am/db/2594494/Novartis>,
        <https://1145.am/db/2594935/Novartis>,
        <https://1145.am/db/2594940/Novartis>,
        <https://1145.am/db/2595048/Novartis>,
        <https://1145.am/db/2595150/Novartis>,
        <https://1145.am/db/2595688/Novartis>,
        <https://1145.am/db/2596344/Novartis>,
        <https://1145.am/db/2597197/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2598636/Novartis>,
        <https://1145.am/db/2787530/Novartis>,
        <https://1145.am/db/282192/Novartis>,
        <https://1145.am/db/346162/Novartis>,
        <https://1145.am/db/488391/Novartis>,
        <https://1145.am/db/509708/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/595011/Novartis>,
        <https://1145.am/db/601300/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/637582/Novartis>,
        <https://1145.am/db/652831/Novartis>,
        <https://1145.am/db/661296/Novartis>,
        <https://1145.am/db/691279/Novartis>,
        <https://1145.am/db/712016/Novartis>,
        <https://1145.am/db/895235/Novan> ;
    ns1:sameAsMedium <https://1145.am/db/1151476/Novartis>,
        <https://1145.am/db/1629127/Novartis>,
        <https://1145.am/db/1630421/Novartis>,
        <https://1145.am/db/2033933/Novartis>,
        <https://1145.am/db/2036487/Novartis_Ag>,
        <https://1145.am/db/2065993/Novartis_Ag>,
        <https://1145.am/db/2076347/Novartis>,
        <https://1145.am/db/2155042/Novartis>,
        <https://1145.am/db/2186148/Novartis>,
        <https://1145.am/db/2290898/Novartis>,
        <https://1145.am/db/2291090/Novartis>,
        <https://1145.am/db/2291713/Novartis>,
        <https://1145.am/db/2293419/Novartis>,
        <https://1145.am/db/2294680/Novartis>,
        <https://1145.am/db/2299847/Novartis>,
        <https://1145.am/db/2307851/Novartis>,
        <https://1145.am/db/2309347/Novartis>,
        <https://1145.am/db/2321958/Novartis>,
        <https://1145.am/db/2325386/Novartis>,
        <https://1145.am/db/2332408/Novartis>,
        <https://1145.am/db/2333390/Novartis>,
        <https://1145.am/db/2336990/Novartis>,
        <https://1145.am/db/2337976/Novartis>,
        <https://1145.am/db/2342687/Novartis>,
        <https://1145.am/db/2343460/Novartis>,
        <https://1145.am/db/2352178/Novartis>,
        <https://1145.am/db/2358559/Novartis>,
        <https://1145.am/db/2358579/Novartis>,
        <https://1145.am/db/2361451/Novartis>,
        <https://1145.am/db/2369178/Novartis>,
        <https://1145.am/db/2371165/Novartis>,
        <https://1145.am/db/2371188/Novartis>,
        <https://1145.am/db/2371203/Novartis>,
        <https://1145.am/db/2536538/Novartis>,
        <https://1145.am/db/2537155/Novartis>,
        <https://1145.am/db/2544350/Novartis>,
        <https://1145.am/db/2544409/Novartis>,
        <https://1145.am/db/2550764/Novartis>,
        <https://1145.am/db/2551001/Novartis>,
        <https://1145.am/db/2551402/Novartis>,
        <https://1145.am/db/2552856/Novartis>,
        <https://1145.am/db/2553487/Novartis>,
        <https://1145.am/db/2557204/Novartis>,
        <https://1145.am/db/2560238/Novartis>,
        <https://1145.am/db/2562442/Novartis>,
        <https://1145.am/db/2565564/Novartis>,
        <https://1145.am/db/2566121/Novartis>,
        <https://1145.am/db/2568734/Novartis>,
        <https://1145.am/db/2569724/Novartis>,
        <https://1145.am/db/2570062/Novartis>,
        <https://1145.am/db/2570721/Novartis>,
        <https://1145.am/db/2571462/Novartis>,
        <https://1145.am/db/2573984/Novartis>,
        <https://1145.am/db/2574584/Novartis>,
        <https://1145.am/db/2574950/Novartis>,
        <https://1145.am/db/2575947/Novartis>,
        <https://1145.am/db/2576892/Novartis>,
        <https://1145.am/db/2578046/Novartis>,
        <https://1145.am/db/2579890/Novartis>,
        <https://1145.am/db/2581804/Novartis>,
        <https://1145.am/db/2582646/Novartis>,
        <https://1145.am/db/2583163/Novartis>,
        <https://1145.am/db/2584135/Novartis>,
        <https://1145.am/db/2584245/Novartis>,
        <https://1145.am/db/2587048/Novartis>,
        <https://1145.am/db/2587805/Novartis>,
        <https://1145.am/db/2588333/Novartis>,
        <https://1145.am/db/2588691/Novartis>,
        <https://1145.am/db/2589799/Novartis>,
        <https://1145.am/db/2590887/Novartis>,
        <https://1145.am/db/2593780/Novartis>,
        <https://1145.am/db/2595924/Novartis_Ag>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359433/Aratana_Therapeutics_Inc> a org:Organization ;
    ns1:basedInLowRaw "Eastern Time",
        "Kan" ;
    ns1:buyer <https://1145.am/db/2359433/Vet_Therapeutics_Inc_Acquisition> ;
    ns1:description "licensing, development and commercialization of innovative medications for pets" ;
    ns1:documentDate "2013-10-14T15:57:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aratana Agrees to Acquire Vet Therapeutics, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-agrees-to-acquire-vet-therapeutics-inc> ;
    ns1:foundName "Aratana",
        "Aratana Therapeutics, Inc. PETX +9.20 %" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Aratana",
        "Aratana Therapeutics, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2302608/Arana>,
        <https://1145.am/db/2302609/Arana>,
        <https://1145.am/db/2306283/Arana_Therapeutics>,
        <https://1145.am/db/2306284/Arana_Therapeutics>,
        <https://1145.am/db/2306684/Arana_Therapeutics_Limited>,
        <https://1145.am/db/2306694/Arana_Therapeutics_Limited>,
        <https://1145.am/db/2337545/Aratana_Therapeutics>,
        <https://1145.am/db/2342733/Aratana_Therapeutics>,
        <https://1145.am/db/2342737/Aratana_Therapeutics>,
        <https://1145.am/db/2345299/Aratana_Therapeutics>,
        <https://1145.am/db/2345317/Aratana_Therapeutics>,
        <https://1145.am/db/2345318/Aratana_Therapeutics>,
        <https://1145.am/db/2355692/Aravis_Therapeutics>,
        <https://1145.am/db/2363729/Aratana_Therapeutics>,
        <https://1145.am/db/2366744/Aratana_Therapeutics>,
        <https://1145.am/db/2369239/Aratana_Therapeutics>,
        <https://1145.am/db/2369321/Aratana_Therapeutics>,
        <https://1145.am/db/2547670/Arana_Therapeutics>,
        <https://1145.am/db/2585632/Aratana_Therapeutics>,
        <https://1145.am/db/2587577/Aratana_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2359431/Aratana_Therapeutics>,
        <https://1145.am/db/2360046/Aratana_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359468/Topspin_Fund> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2013-10-17T14:32:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Seragon Pharmaceuticals Raises $30M in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/seragon-pharmaceuticals-raises-30m-series-a-financing> ;
    ns1:foundName "Topspin Fund" ;
    ns1:investor <https://1145.am/db/2359468/Series_A_Investment_Aisling_Capital_Orbimed_Advisors_Seragon_Pharmaceuticals_Inc_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "Topspin Fund" ;
    ns1:sameAsMedium <https://1145.am/db/1653506/Topspin_Fund>,
        <https://1145.am/db/2336503/Topspin_Fund>,
        <https://1145.am/db/2336505/Topspin_Fund>,
        <https://1145.am/db/2336524/Topspin_Fund>,
        <https://1145.am/db/2339883/Topspin_Fund>,
        <https://1145.am/db/2583013/Topspin_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359468/Venbio> a org:Organization ;
    ns1:documentDate "2013-10-17T14:32:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Seragon Pharmaceuticals Raises $30M in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/seragon-pharmaceuticals-raises-30m-series-a-financing> ;
    ns1:foundName "venBio" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2359468/Series_A_Investment_Aisling_Capital_Orbimed_Advisors_Seragon_Pharmaceuticals_Inc_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "venBio" ;
    ns1:sameAsHigh <https://1145.am/db/1172738/Verrica_Pharmaceuticals_Inc>,
        <https://1145.am/db/1173163/Verrica_Pharmaceuticals_Inc>,
        <https://1145.am/db/1592042/Venatorx_Pharmaceuticals>,
        <https://1145.am/db/1928985/Venatorx_Pharmaceuticals>,
        <https://1145.am/db/1957136/Vect-Horus>,
        <https://1145.am/db/2015251/Vectivbio_Holding_Ag>,
        <https://1145.am/db/2015407/Vectivbio>,
        <https://1145.am/db/2040146/Vectivbio>,
        <https://1145.am/db/2307347/The_Vectura_Group>,
        <https://1145.am/db/2323288/Vectura>,
        <https://1145.am/db/2336503/Venbio>,
        <https://1145.am/db/2336505/Venbio>,
        <https://1145.am/db/2336524/Venbio>,
        <https://1145.am/db/2357248/Vectura>,
        <https://1145.am/db/2357255/Vectura_Group_Plc>,
        <https://1145.am/db/2367790/Vectura>,
        <https://1145.am/db/2370755/Vectura>,
        <https://1145.am/db/2537626/Vectura>,
        <https://1145.am/db/2549943/Vectura>,
        <https://1145.am/db/2550933/Vectura>,
        <https://1145.am/db/2555127/Vectura>,
        <https://1145.am/db/2572820/Vectura_Group_Plc>,
        <https://1145.am/db/2583013/Venbio>,
        <https://1145.am/db/341447/Vectura_Group>,
        <https://1145.am/db/341462/Vectura_Group>,
        <https://1145.am/db/391980/Vectura>,
        <https://1145.am/db/392803/Vectura>,
        <https://1145.am/db/393331/Vectura>,
        <https://1145.am/db/393962/Vectura>,
        <https://1145.am/db/951050/Venatorx_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2346293/Venbio>,
        <https://1145.am/db/2352349/Venbio>,
        <https://1145.am/db/2352350/Venbio>,
        <https://1145.am/db/2360647/Venbio>,
        <https://1145.am/db/2360667/Venbio>,
        <https://1145.am/db/2364514/Venbio>,
        <https://1145.am/db/2364518/Venbio>,
        <https://1145.am/db/2570520/Venbio>,
        <https://1145.am/db/2570523/Venbio>,
        <https://1145.am/db/2575687/Venbio>,
        <https://1145.am/db/428737/Venbio>,
        <https://1145.am/db/560096/Venbio>,
        <https://1145.am/db/704198/Venbio> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360415/Apposite_Capital> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2014-03-27T12:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RuiYi banks $15M from A-list backers to amp up Chinese R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/ruiyi-banks-15m-from-a-list-backers-to-amp-up-chinese-r-d> ;
    ns1:foundName "Apposite Capital" ;
    ns1:investor <https://1145.am/db/2360415/Venture_Cash_Investment_5am_Ventures_Apposite_Capital_Aravis_Sa_Ruiyi_Versant_Ventures_Completed> ;
    ns1:name "Apposite Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2344507/Apposite_Capital_Llp>,
        <https://1145.am/db/2352436/Apposite_Capital_Llp>,
        <https://1145.am/db/2352441/Apposite_Capital>,
        <https://1145.am/db/2352442/Apposite_Capital_Llp>,
        <https://1145.am/db/2366860/Apposite_Capital>,
        <https://1145.am/db/612252/Apposite_Capital_Llp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360415/Aravis_Sa> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2014-03-27T12:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RuiYi banks $15M from A-list backers to amp up Chinese R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/ruiyi-banks-15m-from-a-list-backers-to-amp-up-chinese-r-d> ;
    ns1:foundName "Aravis SA" ;
    ns1:investor <https://1145.am/db/2360415/Venture_Cash_Investment_5am_Ventures_Apposite_Capital_Aravis_Sa_Ruiyi_Versant_Ventures_Completed> ;
    ns1:name "Aravis SA" ;
    ns1:sameAsMedium <https://1145.am/db/2323705/Aravis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360521/Hatteras_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "BOSTON & GAINESVILLE, Fla" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-10-22T14:46:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sideris Pharmaceuticals Completes $32 Million Equity Financing and Signs Agreement With Global Pharmaceutical Company" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sideris-pharmaceuticals-completes-32-million-equity-financing-and-signs-agreement-global> ;
    ns1:foundName "Hatteras Venture Partners" ;
    ns1:investor <https://1145.am/db/2360521/Series_A_Investment_Hatteras_Venture_Partners_Osage_University_Partners_Sideris_Pharmaceuticals_Sunstates_Fund_Completed> ;
    ns1:name "Hatteras Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1115103/Hatteras_Venture_Partners>,
        <https://1145.am/db/1335370/Hatteras_Venture_Partners>,
        <https://1145.am/db/1464210/Hatteras_Venture_Partners>,
        <https://1145.am/db/1896251/Hatteras_Venture_Partners>,
        <https://1145.am/db/1957179/Hatteras_Venture_Partners>,
        <https://1145.am/db/2306163/Hatteras_Venture_Partners>,
        <https://1145.am/db/2315247/Hatteras_Venture_Partners>,
        <https://1145.am/db/2339206/Hatteras_Venture_Partners>,
        <https://1145.am/db/2351316/Hatteras_Venture_Partners>,
        <https://1145.am/db/2353671/Hatteras_Venture_Partners>,
        <https://1145.am/db/2353674/Hatteras_Venture_Partners>,
        <https://1145.am/db/2358657/Hatteras_Venture_Partners>,
        <https://1145.am/db/2358658/Hatteras_Venture_Partners>,
        <https://1145.am/db/2358812/Hatteras_Venture_Partners>,
        <https://1145.am/db/2363442/Hatteras_Venture_Partners>,
        <https://1145.am/db/601404/Hatteras_Venture_Partners>,
        <https://1145.am/db/885068/Hatteras_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1465033/Hatteras_Venture_Partners>,
        <https://1145.am/db/1565424/Hatteras_Venture_Partners>,
        <https://1145.am/db/2153141/Hatteras_Venture_Partners>,
        <https://1145.am/db/2224522/Hatteras_Venture_Partners>,
        <https://1145.am/db/2236817/Hatteras_Venture_Partners>,
        <https://1145.am/db/2284028/Hatteras_Venture_Partners>,
        <https://1145.am/db/2315248/Hatteras_Venture_Partners>,
        <https://1145.am/db/2319640/Hatteras_Venture_Partners>,
        <https://1145.am/db/2321694/Hatteras_Venture_Partners>,
        <https://1145.am/db/2323511/Hatteras_Venture_Partners>,
        <https://1145.am/db/2328194/Hatteras_Venture_Partners>,
        <https://1145.am/db/2328196/Hatteras_Venture_Partners>,
        <https://1145.am/db/2332459/Hatteras_Venture_Partners>,
        <https://1145.am/db/2349717/Hatteras_Venture_Partners>,
        <https://1145.am/db/2349722/Hatteras_Venture_Partners>,
        <https://1145.am/db/2353640/Hatteras_Venture_Partners>,
        <https://1145.am/db/2354648/Hatteras_Venture_Partners>,
        <https://1145.am/db/2358640/Hatteras_Venture_Partners>,
        <https://1145.am/db/2359452/Hatteras_Venture_Partners>,
        <https://1145.am/db/2360526/Hatteras_Venture_Partners>,
        <https://1145.am/db/2363396/Hatteras_Venture_Partners>,
        <https://1145.am/db/2364853/Hatteras_Venture_Partners>,
        <https://1145.am/db/2365171/Hatteras_Venture_Partners>,
        <https://1145.am/db/495996/Hatteras_Venture_Partners>,
        <https://1145.am/db/496377/Hatteras_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360521/Osage_University_Partners> a org:Organization ;
    ns1:basedInLowRaw "BOSTON & GAINESVILLE, Fla" ;
    ns1:documentDate "2013-10-22T14:46:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sideris Pharmaceuticals Completes $32 Million Equity Financing and Signs Agreement With Global Pharmaceutical Company" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sideris-pharmaceuticals-completes-32-million-equity-financing-and-signs-agreement-global> ;
    ns1:foundName "Osage University Partners" ;
    ns1:investor <https://1145.am/db/2360521/Series_A_Investment_Hatteras_Venture_Partners_Osage_University_Partners_Sideris_Pharmaceuticals_Sunstates_Fund_Completed> ;
    ns1:name "Osage University Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1441781/Osage_University_Partners>,
        <https://1145.am/db/1533327/Osage_University_Partners>,
        <https://1145.am/db/1533685/Osage_University_Partners>,
        <https://1145.am/db/1619110/Osage_University_Partners>,
        <https://1145.am/db/1696377/Osage_University_Partners>,
        <https://1145.am/db/1759759/Osage_University_Partners>,
        <https://1145.am/db/1774684/Osage_University_Partners>,
        <https://1145.am/db/1782234/Osage_University_Partners>,
        <https://1145.am/db/1802088/Osage_University_Partners>,
        <https://1145.am/db/1810714/Osage_University_Partners>,
        <https://1145.am/db/1823287/Osage_University_Partners>,
        <https://1145.am/db/1858399/Osage_University_Partners>,
        <https://1145.am/db/2153910/Osage_University_Partners>,
        <https://1145.am/db/2278799/Osage_University_Partners>,
        <https://1145.am/db/2292287/Osage_University_Partners>,
        <https://1145.am/db/2294753/Osage_University_Partners>,
        <https://1145.am/db/2301464/Osage_University_Partners>,
        <https://1145.am/db/2319360/Osage_University_Partners>,
        <https://1145.am/db/2336032/Osage_University_Partners>,
        <https://1145.am/db/2336221/Osage_University_Partners>,
        <https://1145.am/db/2340284/Osage_University_Partners>,
        <https://1145.am/db/2340888/Osage_University_Partners>,
        <https://1145.am/db/2341896/Osage_University_Partners>,
        <https://1145.am/db/2349691/Osage_University_Partners>,
        <https://1145.am/db/2349838/Osage_University_Partners>,
        <https://1145.am/db/2350044/Osage_University_Partners>,
        <https://1145.am/db/2350199/Osage_University_Partners>,
        <https://1145.am/db/2352349/Osage_University_Partners>,
        <https://1145.am/db/2352350/Osage_University_Partners>,
        <https://1145.am/db/2353771/Osage_University_Partners>,
        <https://1145.am/db/2353789/Osage_University_Partners>,
        <https://1145.am/db/2358430/Osage_University_Partners>,
        <https://1145.am/db/2359404/Osage_University_Partners>,
        <https://1145.am/db/2360526/Osage_University_Partners>,
        <https://1145.am/db/2368351/Osage_University_Partners>,
        <https://1145.am/db/2369165/Osage_University_Partners>,
        <https://1145.am/db/2369169/Osage_University_Partners>,
        <https://1145.am/db/2370626/Osage_University_Partners>,
        <https://1145.am/db/2569831/Osage_University_Partners>,
        <https://1145.am/db/425953/Osage_University_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360521/Sunstates_Fund> a org:Organization ;
    ns1:basedInLowRaw "BOSTON & GAINESVILLE, Fla" ;
    ns1:description "investment" ;
    ns1:documentDate "2013-10-22T14:46:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sideris Pharmaceuticals Completes $32 Million Equity Financing and Signs Agreement With Global Pharmaceutical Company" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sideris-pharmaceuticals-completes-32-million-equity-financing-and-signs-agreement-global> ;
    ns1:foundName "SunStates Fund" ;
    ns1:investor <https://1145.am/db/2360521/Series_A_Investment_Hatteras_Venture_Partners_Osage_University_Partners_Sideris_Pharmaceuticals_Sunstates_Fund_Completed> ;
    ns1:name "SunStates Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2360526/Sunstates_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362566/Osage_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "Investing" ;
    ns1:documentDate "2013-10-30T12:51:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immune Design Raises Up to $49 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immune-design-raises-up-to-49-million-series-c-financing> ;
    ns1:foundName "Osage Partners" ;
    ns1:investor <https://1145.am/db/2362566/Series_C_Investment_Alta_Partners_Immune_Design_Osage_Partners_Proquest_Investments_Sanofi-Genzyme_Bioventures_The_Column_Group_Topspin_Partners_Versant_Ventures_Completed> ;
    ns1:name "Osage Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2362565/Osage_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362566/Proquest_Investments> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-10-30T12:51:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immune Design Raises Up to $49 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immune-design-raises-up-to-49-million-series-c-financing> ;
    ns1:foundName "ProQuest Investments" ;
    ns1:investor <https://1145.am/db/2362566/Series_C_Investment_Alta_Partners_Immune_Design_Osage_Partners_Proquest_Investments_Sanofi-Genzyme_Bioventures_The_Column_Group_Topspin_Partners_Versant_Ventures_Completed> ;
    ns1:name "ProQuest Investments" ;
    ns1:sameAsHigh <https://1145.am/db/129908/Prologis_Ventures>,
        <https://1145.am/db/1736646/Prolog_Ventures>,
        <https://1145.am/db/1748942/Paua_Ventures>,
        <https://1145.am/db/2326362/Proquest_Investments> ;
    ns1:sameAsMedium <https://1145.am/db/2242614/Proquest_Investments>,
        <https://1145.am/db/2296169/Proquest_Investments>,
        <https://1145.am/db/2300340/Proquest_Investments>,
        <https://1145.am/db/2301790/Proquest_Investments>,
        <https://1145.am/db/2307644/Proquest_Investments>,
        <https://1145.am/db/2309506/Proquest_Investments>,
        <https://1145.am/db/2309507/Proquest_Investments>,
        <https://1145.am/db/2311011/Proquest_Investments>,
        <https://1145.am/db/2318851/Proquest_Investments>,
        <https://1145.am/db/2319029/Proquest_Investments>,
        <https://1145.am/db/2331048/Proquest_Investments>,
        <https://1145.am/db/2337971/Proquest_Investments>,
        <https://1145.am/db/2337972/Proquest_Investments>,
        <https://1145.am/db/2343547/Proquest_Investments>,
        <https://1145.am/db/2355706/Proquest_Investments>,
        <https://1145.am/db/2356721/Proquest_Investments>,
        <https://1145.am/db/2362565/Proquest_Investments>,
        <https://1145.am/db/2363475/Proquest_Investments>,
        <https://1145.am/db/2364422/Proquest_Investments>,
        <https://1145.am/db/2538407/Proquest_Investments>,
        <https://1145.am/db/2587938/Proquest_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362566/Topspin_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "financing" ;
    ns1:documentDate "2013-10-30T12:51:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immune Design Raises Up to $49 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immune-design-raises-up-to-49-million-series-c-financing> ;
    ns1:foundName "Topspin Partners" ;
    ns1:investor <https://1145.am/db/2362566/Series_C_Investment_Alta_Partners_Immune_Design_Osage_Partners_Proquest_Investments_Sanofi-Genzyme_Bioventures_The_Column_Group_Topspin_Partners_Versant_Ventures_Completed> ;
    ns1:name "Topspin Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1758719/Topspin_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/2362565/Topspin_Partners>,
        <https://1145.am/db/2368501/Topspin_Partners>,
        <https://1145.am/db/2370208/Topspin_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363607/Ippon_Capital_Sa> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:description "private equity firm" ;
    ns1:documentDate "2013-11-05T14:10:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Midatech Raises 10 Million to Advance Gold-nanoparticle Technology for Diabetes and Cancer Treatment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/midatech-raises-%C2%A310-million-to-advance-gold-nanoparticle-technology-for-diabetes-and-cancer> ;
    ns1:foundName "Ippon Capital SA" ;
    ns1:industry "private equity" ;
    ns1:investor <https://1145.am/db/2363607/New_Equity_Investment_Ippon_Capital_Sa_Midatech_Ltd_Completed> ;
    ns1:name "Ippon Capital SA" ;
    ns1:sameAsHigh <https://1145.am/db/2053672/Aip_Capital>,
        <https://1145.am/db/2310940/Aisling_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2476855/Worldview_Travel> a org:Organization ;
    ns1:basedInLowRaw "Bermuda" ;
    ns1:buyer <https://1145.am/db/2476855/Meyer-Franklin_Travel_Acquisition> ;
    ns1:description "Travel" ;
    ns1:documentDate "2013-09-05T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Worldview Travel Acquires Bermuda-Based Meyer-Franklin Travel" ;
    ns1:documentURL <https://www.travelagentcentral.com/running-your-business/worldview-travel-acquires-bermuda-based-meyer-franklin-travel> ;
    ns1:foundName "Worldview Travel",
        "Worldview Travel Bermuda" ;
    ns1:industry "Travel" ;
    ns1:name "Worldview Travel" ;
    ns1:protagonist <https://1145.am/db/2476855/Merger_Meyer-Franklin_Travel_Worldview_Travel_Worldview_Travel_Has_Not_Happened>,
        <https://1145.am/db/2476855/Meyer-Franklin_Travel_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2470688/Worldview_Travel>,
        <https://1145.am/db/2481804/Worldview_Travel>,
        <https://1145.am/db/2493829/Worldview_Travel>,
        <https://1145.am/db/2520113/Worldview_Travel> ;
    ns1:sourceName "Travel Agent Central" .

<https://1145.am/db/2539904/Blue_Ridge_Electric_Membership_Corporation> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:description "economic development" ;
    ns1:documentDate "2013-07-24T13:59:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blue Ridge Electric Approved for a $1 Million USDA Economic Development Loan for Local Company Expansion" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/blue-ridge-electric-approved-for-a-1-million-usda-economic-development-loan-for-local> ;
    ns1:foundName "Blue Ridge Electric Membership Corporation" ;
    ns1:investor <https://1145.am/db/2539904/Investment_Blue_Ridge_Electric_Membership_Corporation_Exela_Pharma_Sciences_Has_Not_Happened> ;
    ns1:name "Blue Ridge Electric Membership Corporation" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2541466/Cordenpharma> a org:Organization ;
    ns1:buyer <https://1145.am/db/2541466/Peptides_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2013-08-29T11:25:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CordenPharma to Acquire Peptisyntha from Solvay, Expanding Peptides Custom Synthesis Business" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/cordenpharma-to-acquire-peptisyntha-from-solvay-expanding-peptides-custom-synthesis> ;
    ns1:foundName "CordenPharma" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "CordenPharma" ;
    ns1:sameAsHigh <https://1145.am/db/2541465/Corden_Pharma_Group>,
        <https://1145.am/db/2545510/Cordenpharma_International_Us_Inc>,
        <https://1145.am/db/2545514/Cordenpharma>,
        <https://1145.am/db/2547058/Corden>,
        <https://1145.am/db/2551850/Cordenpharma>,
        <https://1145.am/db/2565140/Cordenpharma>,
        <https://1145.am/db/700933/Cordenpharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2541466/International_Chemical_Investors_Group> a org:Organization ;
    ns1:basedInHighGeoName "Plankstadt" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6555674/about.rdf> ;
    ns1:basedInHighRaw "PLANKSTADT, Germany" ;
    ns1:buyer <https://1145.am/db/2541466/Peptides_Acquisition> ;
    ns1:description "Business" ;
    ns1:documentDate "2013-08-29T11:25:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CordenPharma to Acquire Peptisyntha from Solvay, Expanding Peptides Custom Synthesis Business" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/cordenpharma-to-acquire-peptisyntha-from-solvay-expanding-peptides-custom-synthesis> ;
    ns1:foundName "ICIG",
        "PLANKSTADT, Germany-International Chemical Investors Group" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "International Chemical Investors Group" ;
    ns1:sameAsHigh <https://1145.am/db/2342434/International_Chemical_Investors_Group>,
        <https://1145.am/db/2541465/International_Chemical_Investors_Group>,
        <https://1145.am/db/2548223/International_Chemical_Investors_Group>,
        <https://1145.am/db/2548224/International_Chemical_Investors_Group>,
        <https://1145.am/db/2551850/International_Chemical_Investors_Group>,
        <https://1145.am/db/2553755/International_Chemical_Investors_Group>,
        <https://1145.am/db/2557012/International_Chemical_Investors_Group>,
        <https://1145.am/db/2561158/International_Chemical_Investors_Group>,
        <https://1145.am/db/2561162/International_Chemical_Investors_Group>,
        <https://1145.am/db/2572904/International_Chemical_Investors_Group> ;
    ns1:sameAsMedium <https://1145.am/db/2539683/International_Chemical_Investors_Group> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2544488/Aaipharma_Services> a org:Organization ;
    ns1:basedInHighGeoName "Wilmington" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4499379/about.rdf> ;
    ns1:basedInHighRaw "Wilmington, NC" ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "AAIPharma Services" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "AAIPharma Services" ;
    ns1:protagonist <https://1145.am/db/2544488/Cambridge_Major_Laboratories_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2303055/Aaipharma_Inc>,
        <https://1145.am/db/2303055/Aaipharma_Services_Corp>,
        <https://1145.am/db/2311264/Aaipharma>,
        <https://1145.am/db/2312421/Aaipharmas_Pharmaceutical_Division>,
        <https://1145.am/db/2318871/Ardana>,
        <https://1145.am/db/2337326/Aaipharma>,
        <https://1145.am/db/2347944/Aaipharma>,
        <https://1145.am/db/2354375/Nantpharma>,
        <https://1145.am/db/2354384/Nantpharma>,
        <https://1145.am/db/2361232/Aaipharma_Services_Corp>,
        <https://1145.am/db/2363260/Aaipharma_Services>,
        <https://1145.am/db/2363559/Aaipharma_Services_Corp>,
        <https://1145.am/db/2365689/Aaipharma_Services>,
        <https://1145.am/db/2369098/Nantpharma>,
        <https://1145.am/db/2537228/Aaipharma_Services>,
        <https://1145.am/db/2543464/Aaipharma_Services>,
        <https://1145.am/db/2543471/Aaipharma_Services_Corp>,
        <https://1145.am/db/2548385/Aaipharma>,
        <https://1145.am/db/2548394/Aaipharma_Services>,
        <https://1145.am/db/2586245/Aaipharma_Services>,
        <https://1145.am/db/2588001/Aaipharma_Services_Corp>,
        <https://1145.am/db/2588977/Aaipharma_Services>,
        <https://1145.am/db/2589169/Aaipharma_Services_Corp>,
        <https://1145.am/db/2589657/India>,
        <https://1145.am/db/2593850/Aaipharma_Services_Corp>,
        <https://1145.am/db/2595274/Aaipharma_Services_Corp>,
        <https://1145.am/db/774088/Ameet_Mallik>,
        <https://1145.am/db/914459/Ameet_Mallik> ;
    ns1:sameAsMedium <https://1145.am/db/2590884/Aaipharma_Services> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2544488/Actis_Capital> a org:Organization ;
    ns1:basedInHighGeoName "London" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:basedInHighRaw "London" ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "Actis Capital" ;
    ns1:industry "private equity" ;
    ns1:investor <https://1145.am/db/2544488/Symbiotec_Stake_Investment> ;
    ns1:name "Actis Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1018645/Actis>,
        <https://1145.am/db/1110227/Actis>,
        <https://1145.am/db/1168035/Actis_Llp>,
        <https://1145.am/db/2598064/Actis>,
        <https://1145.am/db/558843/Actis>,
        <https://1145.am/db/588424/Actis> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2544488/American_Capital> a org:Organization ;
    ns1:basedInLowRaw "American" ;
    ns1:buyer <https://1145.am/db/2544488/Cambridge_Major_Laboratories_Acquisition> ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "American Capital",
        "American Capital ($ ACAS)" ;
    ns1:investor <https://1145.am/db/2544488/Cambridge_Major_Laboratories_Acquisition> ;
    ns1:name "American Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2307566/American_Capital>,
        <https://1145.am/db/2547546/American_Capital>,
        <https://1145.am/db/2562245/American_Capital>,
        <https://1145.am/db/2562248/American_Capital>,
        <https://1145.am/db/2577081/American_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2550639/Amerisourcebergen_Corporation> a org:Organization ;
    ns1:basedInLowRaw "Brazil" ;
    ns1:buyer <https://1145.am/db/2550639/Profarma_Distribuidora_De_Produtos_Farmacuticos_Sa_Interest_Acquisition> ;
    ns1:description "pharmaceutical wholesaler" ;
    ns1:documentDate "2014-03-25T11:11:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AmerisourceBergen Acquires Minority Interest in Profarma Distribuidora de Produtos Farmacuticos S.A." ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/amerisourcebergen-acquires-minority-interest-profarma-distribuidora-de-produtos> ;
    ns1:foundName "AmerisourceBergen",
        "AmerisourceBergen Corporation" ;
    ns1:industry "pharmaceutical wholesaler" ;
    ns1:investor <https://1145.am/db/2550639/Profarma_Distribuidora_De_Produtos_Farmacuticos_Sa_Interest_Acquisition> ;
    ns1:name "AmerisourceBergen",
        "AmerisourceBergen Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/1333900/Amerisourcebergen_Corporation>,
        <https://1145.am/db/1506584/Amerisourcebergen_Corporation>,
        <https://1145.am/db/1509278/Amerisourcebergen_Corporation>,
        <https://1145.am/db/1566812/Amerisourcebergen_Corp>,
        <https://1145.am/db/1613688/Amerisourcebergen_Corporation>,
        <https://1145.am/db/1976360/Amerisourcebergen_Corp>,
        <https://1145.am/db/2065085/Amerisourcebergen>,
        <https://1145.am/db/2077002/Amerisourcebergen_Corp>,
        <https://1145.am/db/2182639/Amerisourcebergen_Corp>,
        <https://1145.am/db/2196882/Amerisourcebergen>,
        <https://1145.am/db/2309804/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2309854/Amerisourcebergen>,
        <https://1145.am/db/2310256/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2310798/Amerisourcebergen>,
        <https://1145.am/db/2310895/Amerisourcebergen>,
        <https://1145.am/db/2312009/Amerisourcebergen_Xcenda>,
        <https://1145.am/db/2320068/Amerisourcebergen>,
        <https://1145.am/db/2537424/Amerisourcebergen>,
        <https://1145.am/db/2538112/Amerisourcebergen>,
        <https://1145.am/db/2540138/Amerisourcebergen>,
        <https://1145.am/db/2543096/Amerisourcebergen>,
        <https://1145.am/db/2545094/Amerisourcebergen>,
        <https://1145.am/db/2545296/Amerisourcebergen>,
        <https://1145.am/db/2550426/Amerisourcebergen>,
        <https://1145.am/db/2550689/Amerisourcebergen>,
        <https://1145.am/db/2553555/Amerisourcebergen>,
        <https://1145.am/db/2560880/Amerisourcebergen>,
        <https://1145.am/db/2561120/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2562431/Amerisourcebergen>,
        <https://1145.am/db/2566777/Amerisourcebergen>,
        <https://1145.am/db/2571068/Amerisourcebergen>,
        <https://1145.am/db/2578889/Amerisourcebergen>,
        <https://1145.am/db/2585859/Amerisourcebergen_Global>,
        <https://1145.am/db/415326/Amerisourcebergen>,
        <https://1145.am/db/503434/Amerisourcebergen>,
        <https://1145.am/db/506505/Amerisourcebergen>,
        <https://1145.am/db/782058/Amerisourcebergen> ;
    ns1:sameAsMedium <https://1145.am/db/1334718/Amerisourcebergen_Corporation>,
        <https://1145.am/db/1335186/Amerisourcebergen_Corporation>,
        <https://1145.am/db/1340987/Amerisourcebergen>,
        <https://1145.am/db/1342768/Amerisourcebergen>,
        <https://1145.am/db/1975794/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2076847/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2076897/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2086835/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2189855/Amerisourcebergen>,
        <https://1145.am/db/2215976/Amerisourcebergen>,
        <https://1145.am/db/2310795/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2310796/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2325181/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2333415/Amerisourcebergen>,
        <https://1145.am/db/2343951/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2537417/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2537423/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2543108/Amerisourcebergen>,
        <https://1145.am/db/2543199/Amerisourcebergen>,
        <https://1145.am/db/2546536/Amerisourcebergen>,
        <https://1145.am/db/2550688/Amerisourcebergen>,
        <https://1145.am/db/2553550/Amerisourcebergen>,
        <https://1145.am/db/2562220/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2562925/Amerisourcebergen>,
        <https://1145.am/db/2578888/Amerisourcebergen>,
        <https://1145.am/db/2580845/Amerisourcebergen>,
        <https://1145.am/db/2587605/Amerisourcebergen>,
        <https://1145.am/db/2591432/Amerisourcebergen>,
        <https://1145.am/db/2595202/Amerisourcebergen>,
        <https://1145.am/db/2596115/Amerisourcebergen_Corporation>,
        <https://1145.am/db/2597702/Amerisourcebergen_Corporation>,
        <https://1145.am/db/287240/Amerisourcebergen_Corporation>,
        <https://1145.am/db/293738/Amerisourcebergen_Corporation> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2556669/State_Of_Wisconsin_Investment_Board> a org:Organization ;
    ns1:basedInLowRaw "Wisconsin" ;
    ns1:documentDate "2014-01-14T19:27:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Madison Vaccines Closes $8 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/madison-vaccines-closes-8-million-series-a-financing> ;
    ns1:foundName "State of Wisconsin Investment Board" ;
    ns1:investor <https://1145.am/db/2556669/Series_A_Investment_Madison_Vaccines_Incorporated_State_Of_Wisconsin_Investment_Board_Venture_Investors_Llc_Wisconsin_Alumni_Research_Foundation_(warf)_Venture_Management_Llc_Completed> ;
    ns1:name "State of Wisconsin Investment Board" ;
    ns1:sameAsMedium <https://1145.am/db/1794712/State_Of_Wisconsin_Investment_Board>,
        <https://1145.am/db/2343486/State_Of_Wisconsin_Investment_Board>,
        <https://1145.am/db/2356690/State_Of_Wisconsin_Investment_Board>,
        <https://1145.am/db/2369504/State_Of_Wisconsin_Investment_Board>,
        <https://1145.am/db/2583558/State_Of_Wisconsin_Investment_Board> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2556669/Venture_Investors_Llc> a org:Organization ;
    ns1:basedInLowRaw "Wisconsin" ;
    ns1:documentDate "2014-01-14T19:27:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Madison Vaccines Closes $8 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/madison-vaccines-closes-8-million-series-a-financing> ;
    ns1:foundName "Venture Investors LLC" ;
    ns1:investor <https://1145.am/db/2556669/Series_A_Investment_Madison_Vaccines_Incorporated_State_Of_Wisconsin_Investment_Board_Venture_Investors_Llc_Wisconsin_Alumni_Research_Foundation_(warf)_Venture_Management_Llc_Completed> ;
    ns1:name "Venture Investors LLC" ;
    ns1:sameAsMedium <https://1145.am/db/1105339/Venture_Investors>,
        <https://1145.am/db/2299743/Venture_Investors>,
        <https://1145.am/db/2301714/Venture_Investors>,
        <https://1145.am/db/2301715/Venture_Investors>,
        <https://1145.am/db/2303695/Venture_Investors_Llc>,
        <https://1145.am/db/2311076/Venture_Investors>,
        <https://1145.am/db/2321713/Venture_Investors>,
        <https://1145.am/db/2354752/Venture_Investors_Llc>,
        <https://1145.am/db/2354770/Venture_Investors_Llc>,
        <https://1145.am/db/2364827/Venture_Investors>,
        <https://1145.am/db/2365444/Venture_Investors>,
        <https://1145.am/db/2367046/Venture_Investors_Llc>,
        <https://1145.am/db/2369504/Venture_Investors_Llc>,
        <https://1145.am/db/2575232/Venture_Investors_Llc>,
        <https://1145.am/db/2583558/Venture_Investors_Llc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2556669/Wisconsin_Alumni_Research_Foundation_(warf)_Venture_Management_Llc> a org:Organization ;
    ns1:basedInLowRaw "Wisconsin" ;
    ns1:documentDate "2014-01-14T19:27:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Madison Vaccines Closes $8 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/madison-vaccines-closes-8-million-series-a-financing> ;
    ns1:foundName "Venture Management LLC",
        "Wisconsin Alumni Research Foundation",
        "Wisconsin Alumni Research Foundation (WARF) Venture Management LLC" ;
    ns1:investor <https://1145.am/db/2556669/Series_A_Investment_Madison_Vaccines_Incorporated_State_Of_Wisconsin_Investment_Board_Venture_Investors_Llc_Wisconsin_Alumni_Research_Foundation_(warf)_Venture_Management_Llc_Completed> ;
    ns1:name "Venture Management LLC",
        "Wisconsin Alumni Research Foundation",
        "Wisconsin Alumni Research Foundation (WARF) Venture Management LLC" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2558803/Creathor_Venture> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:documentDate "2014-03-27T11:44:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CAP-CMV GmbH Raises New Funds to Further Develop Its Novel hCMV Vaccine and Appoints New CEO" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/cap-cmv-gmbh-raises-new-funds-to-further-develop-its-novel-hcmv-vaccine-and-appoints-new> ;
    ns1:foundName "Creathor Venture",
        "Creathor Venture, KfW" ;
    ns1:investor <https://1145.am/db/2558803/Seed_Investment_Cap-Cmv_Gmbh_Creathor_Venture_Nrwbank_Peppermint_Venture_Partners_Has_Not_Happened> ;
    ns1:name "Creathor Venture" ;
    ns1:sameAsMedium <https://1145.am/db/1703888/Creathor_Venture>,
        <https://1145.am/db/1707492/Creathor_Venture>,
        <https://1145.am/db/1825402/Creathor_Venture>,
        <https://1145.am/db/1827184/Creathor_Venture>,
        <https://1145.am/db/1851472/Creathor_Venture>,
        <https://1145.am/db/1893236/Creathor_Venture>,
        <https://1145.am/db/1895169/Creathor_Venture>,
        <https://1145.am/db/2340185/Creathor_Venture>,
        <https://1145.am/db/2341034/Creathor_Venture>,
        <https://1145.am/db/2360425/Creathor_Venture> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2558803/KFW> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:documentDate "2014-03-27T11:44:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CAP-CMV GmbH Raises New Funds to Further Develop Its Novel hCMV Vaccine and Appoints New CEO" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/cap-cmv-gmbh-raises-new-funds-to-further-develop-its-novel-hcmv-vaccine-and-appoints-new> ;
    ns1:foundName "KfW" ;
    ns1:investor <https://1145.am/db/2558803/Seed_Investment_Cap-Cmv_Gmbh_Creathor_Venture_Nrwbank_Peppermint_Venture_Partners_Has_Not_Happened> ;
    ns1:name "KfW" ;
    ns1:sameAsMedium <https://1145.am/db/1115864/KFW>,
        <https://1145.am/db/1275433/KFW>,
        <https://1145.am/db/1291324/KFW>,
        <https://1145.am/db/1602418/KFW>,
        <https://1145.am/db/1667816/KFW>,
        <https://1145.am/db/1710755/KFW>,
        <https://1145.am/db/1754583/KFW>,
        <https://1145.am/db/1853264/KFW>,
        <https://1145.am/db/1898197/KFW>,
        <https://1145.am/db/1911897/KFW>,
        <https://1145.am/db/2296701/KFW>,
        <https://1145.am/db/2305628/KFW>,
        <https://1145.am/db/2347872/KFW>,
        <https://1145.am/db/2358030/KFW>,
        <https://1145.am/db/2360425/KFW>,
        <https://1145.am/db/2440017/KFW>,
        <https://1145.am/db/315335/KFW>,
        <https://1145.am/db/894768/KFW> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2558803/Nrwbank> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:documentDate "2014-03-27T11:44:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CAP-CMV GmbH Raises New Funds to Further Develop Its Novel hCMV Vaccine and Appoints New CEO" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/cap-cmv-gmbh-raises-new-funds-to-further-develop-its-novel-hcmv-vaccine-and-appoints-new> ;
    ns1:foundName "NRW.Bank" ;
    ns1:investor <https://1145.am/db/2558803/Seed_Investment_Cap-Cmv_Gmbh_Creathor_Venture_Nrwbank_Peppermint_Venture_Partners_Has_Not_Happened> ;
    ns1:name "NRW.Bank" ;
    ns1:sameAsMedium <https://1145.am/db/1443192/Nrwbank>,
        <https://1145.am/db/1444350/Nrwbank>,
        <https://1145.am/db/1786289/Nrwbank>,
        <https://1145.am/db/1909578/Nrw_Bank>,
        <https://1145.am/db/2305628/Nrwbank>,
        <https://1145.am/db/2314674/Nrwbank>,
        <https://1145.am/db/2322062/Nrw_Bank>,
        <https://1145.am/db/2338929/Nrw_Bank>,
        <https://1145.am/db/2341942/Nrwbank>,
        <https://1145.am/db/2358030/Nrwbank>,
        <https://1145.am/db/2360425/Nrwbank>,
        <https://1145.am/db/2364776/Nrwbank>,
        <https://1145.am/db/2365376/Nrwbank>,
        <https://1145.am/db/2537737/Nrwbank>,
        <https://1145.am/db/2569491/Nrwbank>,
        <https://1145.am/db/3450/Nrwbank>,
        <https://1145.am/db/545842/Nrwbank> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2558803/Peppermint_Venture_Partners> a org:Organization ;
    ns1:basedInHighGeoName "Kln" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6553049/about.rdf> ;
    ns1:basedInHighRaw "Cologne, Germany" ;
    ns1:documentDate "2014-03-27T11:44:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CAP-CMV GmbH Raises New Funds to Further Develop Its Novel hCMV Vaccine and Appoints New CEO" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/cap-cmv-gmbh-raises-new-funds-to-further-develop-its-novel-hcmv-vaccine-and-appoints-new> ;
    ns1:foundName "Peppermint Venture Partners",
        "Peppermint Venture Partners (PVP)" ;
    ns1:investor <https://1145.am/db/2558803/Seed_Investment_Cap-Cmv_Gmbh_Creathor_Venture_Nrwbank_Peppermint_Venture_Partners_Has_Not_Happened> ;
    ns1:name "Peppermint Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2360425/Peppermint_Venture_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2570961/Salix_Pharmaceuticals_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "Raleigh" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4487042/about.rdf> ;
    ns1:basedInHighRaw "RALEIGH, NC" ;
    ns1:basedInLowRaw "U.S" ;
    ns1:buyer <https://1145.am/db/2570961/Santarus_Acquisition> ;
    ns1:description "Gastroenterology",
        "pharmaceuticals" ;
    ns1:documentDate "2013-11-08T12:50:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Salix Pharmaceuticals to Acquire Santarus" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/salix-pharmaceuticals-to-acquire-santarus> ;
    ns1:foundName "Salix",
        "Salix Pharmaceuticals",
        "Salix Pharmaceuticals, Ltd",
        "Salix Pharmaceuticals, Ltd." ;
    ns1:industry "Pharmaceuticals",
        "pharmaceutical" ;
    ns1:name "Salix Pharmaceuticals",
        "Salix Pharmaceuticals, Ltd." ;
    ns1:sameAsHigh <https://1145.am/db/2304616/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2304619/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2311289/Salix_Pharmaceuticals>,
        <https://1145.am/db/2314324/Salix_Pharmaceuticals>,
        <https://1145.am/db/2314325/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2320470/Salix_Pharmaceuticals>,
        <https://1145.am/db/2336083/Salix_Pharmaceuticals>,
        <https://1145.am/db/2337348/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2350833/Salix_Pharmaceuticals>,
        <https://1145.am/db/2359194/Salix_Pharmaceuticals>,
        <https://1145.am/db/2363430/Salix_Pharmaceuticals>,
        <https://1145.am/db/2364374/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2568778/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2569444/Salix_Pharmaceuticals>,
        <https://1145.am/db/2569465/Salix_Pharmaceuticals>,
        <https://1145.am/db/2570121/Salix_Pharmaceuticals>,
        <https://1145.am/db/2570958/Salix_Pharmaceuticals>,
        <https://1145.am/db/2572965/Salix_Pharmaceuticals>,
        <https://1145.am/db/2573919/Salix_Pharmaceuticals>,
        <https://1145.am/db/2574443/Salix_Pharmaceuticals>,
        <https://1145.am/db/2577846/Salix_Pharmaceuticals>,
        <https://1145.am/db/2580318/Salix_Pharmaceuticals>,
        <https://1145.am/db/2583220/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2584250/Salix_Pharmaceuticals>,
        <https://1145.am/db/2584908/Salix_Pharmaceuticals>,
        <https://1145.am/db/2587094/Salix_Pharmaceuticals>,
        <https://1145.am/db/2591540/Salix_Pharmaceuticals>,
        <https://1145.am/db/2594497/Salix_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2597158/Salix_Pharmaceuticals>,
        <https://1145.am/db/2597769/Salix_Pharmaceuticals>,
        <https://1145.am/db/354036/Sgd_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/2335641/Salix_Pharmaceuticals>,
        <https://1145.am/db/2342058/Salix_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2573218/Avista_Capital_Partners> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:buyer <https://1145.am/db/2573218/Acquisition_Avista_Capital_Partners_Has_Not_Happened> ;
    ns1:documentDate "2013-11-26T15:34:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Nordic Capital, Wendel in two-way race for $1.6B LTS Lohmann deal" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/nordic-capital-wendel-two-way-race-for-1-6b-lts-lohmann-deal> ;
    ns1:foundName "Avista Capital Partners" ;
    ns1:industry "private equity" ;
    ns1:name "Avista Capital Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1011455/Avista_Capital_Partners>,
        <https://1145.am/db/1465233/Avista_Capital_Partners>,
        <https://1145.am/db/2289367/Avista_Capital_Partners>,
        <https://1145.am/db/2303130/Avista_Capital_Partners>,
        <https://1145.am/db/2329890/Avista_Capital_Partners>,
        <https://1145.am/db/2351860/Avista_Capital_Partners>,
        <https://1145.am/db/2545052/Avista_Capital_Partners>,
        <https://1145.am/db/2545539/Avista_Capital_Partners>,
        <https://1145.am/db/2571676/Avista_Capital_Partners>,
        <https://1145.am/db/2588060/Avista_Capital_Partners>,
        <https://1145.am/db/2588775/Avista_Capital_Partners>,
        <https://1145.am/db/2592876/Avista_Capital_Partners>,
        <https://1145.am/db/2596830/Avista_Capital_Partners>,
        <https://1145.am/db/400149/Avista_Capital_Partners>,
        <https://1145.am/db/400247/Avista_Capital_Partners>,
        <https://1145.am/db/884921/Avista_Capital_Partners>,
        <https://1145.am/db/886716/Avista_Capital_Partners>,
        <https://1145.am/db/894060/Avista_Capital_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1297539/Avista_Capital_Partners>,
        <https://1145.am/db/1464089/Avista_Capital_Partners>,
        <https://1145.am/db/1464408/Avista_Capital_Partners>,
        <https://1145.am/db/1584643/Avista_Capital_Partners>,
        <https://1145.am/db/2292812/Avista_Capital_Partners>,
        <https://1145.am/db/2328576/Avista_Capital_Partners>,
        <https://1145.am/db/2328577/Avista_Capital_Partners>,
        <https://1145.am/db/2548394/Avista_Capital_Partners>,
        <https://1145.am/db/2575310/Avista_Capital_Partners>,
        <https://1145.am/db/2590876/Avista_Capital_Partners>,
        <https://1145.am/db/2592874/Avista_Capital_Partners>,
        <https://1145.am/db/984301/Avista_Capital_Partners>,
        <https://1145.am/db/985746/Avista_Capital_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2573218/Nordic_Capital> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:buyer <https://1145.am/db/2573218/Lts_Lohmann_Acquisition> ;
    ns1:documentDate "2013-11-26T15:34:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Nordic Capital, Wendel in two-way race for $1.6B LTS Lohmann deal" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/nordic-capital-wendel-two-way-race-for-1-6b-lts-lohmann-deal> ;
    ns1:foundName "For Nordic Capital" ;
    ns1:industry "private equity" ;
    ns1:name "Nordic Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1031197/Nordic_Capital>,
        <https://1145.am/db/1031322/Nordic_Capital>,
        <https://1145.am/db/1462954/Nordic_Capital>,
        <https://1145.am/db/1613698/Nordic_Capital>,
        <https://1145.am/db/2057832/Nordic_Capital>,
        <https://1145.am/db/214079/Nordic_Capital>,
        <https://1145.am/db/2324915/Nordic_Capital>,
        <https://1145.am/db/2332522/Nordic_Capital>,
        <https://1145.am/db/2551694/Nordic_Capital>,
        <https://1145.am/db/2566482/Nordic_Capital>,
        <https://1145.am/db/2570007/Nordic_Capital>,
        <https://1145.am/db/2575310/Nordic_Capital>,
        <https://1145.am/db/2588775/Nordic_Capital>,
        <https://1145.am/db/2673008/Nordic_Investors> ;
    ns1:sameAsMedium <https://1145.am/db/2308030/Nordic_Capital>,
        <https://1145.am/db/2545539/Nordic_Capital>,
        <https://1145.am/db/2558189/Nordic_Capital>,
        <https://1145.am/db/2596830/Nordic_Capital>,
        <https://1145.am/db/417100/Nordic_Capital>,
        <https://1145.am/db/418025/Nordic_Capital>,
        <https://1145.am/db/418526/Nordic_Capital>,
        <https://1145.am/db/418570/Nordic_Capital>,
        <https://1145.am/db/423509/Nordic_Capital>,
        <https://1145.am/db/435630/Nordic_Capital>,
        <https://1145.am/db/437763/Nordic_Capital>,
        <https://1145.am/db/448320/Nordic_Capital>,
        <https://1145.am/db/493708/Nordic_Capital>,
        <https://1145.am/db/502651/Nordic_Capital>,
        <https://1145.am/db/648362/Nordic_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2577114/Shire> a org:Organization ;
    ns1:basedInLowRaw "Australia" ;
    ns1:buyer <https://1145.am/db/2577114/Viropharma_Acquisition> ;
    ns1:documentDate "2014-01-10T13:06:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Shire extends tender offer for ViroPharma" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/shire-extends-tender-offer-for-viropharma> ;
    ns1:foundName "Shire" ;
    ns1:name "Shire" ;
    ns1:participant <https://1145.am/db/2577114/Viropharma_Acquisition> ;
    ns1:sameAsMedium <https://1145.am/db/142937/Shire_Plc>,
        <https://1145.am/db/2155273/Shire>,
        <https://1145.am/db/2225348/Shire_Plc>,
        <https://1145.am/db/2225352/Shire_Plc>,
        <https://1145.am/db/2288537/Shire>,
        <https://1145.am/db/2290932/Shire>,
        <https://1145.am/db/2291354/Shire>,
        <https://1145.am/db/2292991/Shire>,
        <https://1145.am/db/2293472/Shire>,
        <https://1145.am/db/2296208/Shire>,
        <https://1145.am/db/2296243/Shire>,
        <https://1145.am/db/2297066/Shire>,
        <https://1145.am/db/2298391/Shire>,
        <https://1145.am/db/2300483/Shire>,
        <https://1145.am/db/2302783/Shire_Limited>,
        <https://1145.am/db/2303789/Shire>,
        <https://1145.am/db/2305581/Shire_Plc>,
        <https://1145.am/db/2306762/Shire>,
        <https://1145.am/db/2310002/Shire>,
        <https://1145.am/db/2314408/Shire_Limited>,
        <https://1145.am/db/2320137/Shire>,
        <https://1145.am/db/2320509/Shire>,
        <https://1145.am/db/2324621/Shire_Plc>,
        <https://1145.am/db/2326381/Shire_Plc>,
        <https://1145.am/db/2328189/Shire>,
        <https://1145.am/db/2328788/Shire_Plc>,
        <https://1145.am/db/2331795/Shire_Plc>,
        <https://1145.am/db/2332620/Shire>,
        <https://1145.am/db/2333419/Shire>,
        <https://1145.am/db/2335641/Shire>,
        <https://1145.am/db/2336126/Shire_Plc>,
        <https://1145.am/db/2336575/Shire>,
        <https://1145.am/db/2336581/Shire>,
        <https://1145.am/db/2336708/Shire>,
        <https://1145.am/db/2338009/Shire>,
        <https://1145.am/db/2338011/Shire>,
        <https://1145.am/db/2339117/Shire>,
        <https://1145.am/db/2339733/Shire_Plc>,
        <https://1145.am/db/2340560/Shire>,
        <https://1145.am/db/2340566/Shire_Plc>,
        <https://1145.am/db/2340575/Shire>,
        <https://1145.am/db/2341068/Shire>,
        <https://1145.am/db/2341074/Shire>,
        <https://1145.am/db/2341522/Shire>,
        <https://1145.am/db/2341828/Shire_Plc>,
        <https://1145.am/db/2341829/Shire>,
        <https://1145.am/db/2341838/Shire>,
        <https://1145.am/db/2341902/Shire>,
        <https://1145.am/db/2342514/Shire>,
        <https://1145.am/db/2342570/Shire>,
        <https://1145.am/db/2344160/Shire>,
        <https://1145.am/db/2344202/Shire>,
        <https://1145.am/db/2344205/Shire>,
        <https://1145.am/db/2344913/Shire>,
        <https://1145.am/db/2344914/Shire_Plc>,
        <https://1145.am/db/2344928/Shire_Plc>,
        <https://1145.am/db/2345096/Shire>,
        <https://1145.am/db/2345238/Shire>,
        <https://1145.am/db/2345248/Shire_Plc>,
        <https://1145.am/db/2345825/Shire_Plc>,
        <https://1145.am/db/2345826/Shire_Plc>,
        <https://1145.am/db/2346202/Shire>,
        <https://1145.am/db/2346640/Shire>,
        <https://1145.am/db/2346644/Shire_Plc>,
        <https://1145.am/db/2346646/Shire_Plc>,
        <https://1145.am/db/2346752/Shire_Plc>,
        <https://1145.am/db/2346863/Shire_Plc>,
        <https://1145.am/db/2346872/Shire_Plc>,
        <https://1145.am/db/2346879/Shire>,
        <https://1145.am/db/2347646/Shire_Plc>,
        <https://1145.am/db/2347772/Shire>,
        <https://1145.am/db/2348523/Shire>,
        <https://1145.am/db/2348661/Shire>,
        <https://1145.am/db/2348742/Shire>,
        <https://1145.am/db/2348750/Shire>,
        <https://1145.am/db/2348805/Shire>,
        <https://1145.am/db/2350265/Shire_Plc>,
        <https://1145.am/db/2351482/Shire>,
        <https://1145.am/db/2351483/Shire>,
        <https://1145.am/db/2351734/Shire_Llc>,
        <https://1145.am/db/2351737/Shire_Llc>,
        <https://1145.am/db/2351754/Shire>,
        <https://1145.am/db/2352906/Shire>,
        <https://1145.am/db/2353283/Shire_Plc>,
        <https://1145.am/db/2354266/Shire_Llc>,
        <https://1145.am/db/2354277/Shire>,
        <https://1145.am/db/2356384/Shire>,
        <https://1145.am/db/2357032/Shire>,
        <https://1145.am/db/2357116/Shire>,
        <https://1145.am/db/2357487/Shire>,
        <https://1145.am/db/2359634/Shire>,
        <https://1145.am/db/2359681/Shire>,
        <https://1145.am/db/2360712/Shire_Plc>,
        <https://1145.am/db/2361514/Shire_Plc>,
        <https://1145.am/db/2361640/Shire_Plc>,
        <https://1145.am/db/2361641/Shire>,
        <https://1145.am/db/2362744/Shire>,
        <https://1145.am/db/2364136/Shire_Plc>,
        <https://1145.am/db/2364149/Shire_Plc>,
        <https://1145.am/db/2364556/Shire>,
        <https://1145.am/db/2364813/Shire>,
        <https://1145.am/db/2365002/Shire_Plc>,
        <https://1145.am/db/2365826/Shire_Plc>,
        <https://1145.am/db/2366303/Shire>,
        <https://1145.am/db/2367132/Shire_Plc>,
        <https://1145.am/db/2367297/Shire>,
        <https://1145.am/db/2368144/Shire>,
        <https://1145.am/db/2368862/Shire>,
        <https://1145.am/db/2368885/Shire>,
        <https://1145.am/db/2368915/Shire>,
        <https://1145.am/db/2368936/Shire>,
        <https://1145.am/db/2369141/Shire>,
        <https://1145.am/db/2369701/Shire>,
        <https://1145.am/db/2369949/Shire>,
        <https://1145.am/db/2370010/Shire>,
        <https://1145.am/db/2370189/Shire>,
        <https://1145.am/db/2370358/Shire>,
        <https://1145.am/db/2370514/Shire>,
        <https://1145.am/db/2370740/Shire>,
        <https://1145.am/db/2371519/Shire>,
        <https://1145.am/db/2371522/Shire>,
        <https://1145.am/db/2537396/Shire>,
        <https://1145.am/db/2539292/Shire>,
        <https://1145.am/db/2541146/Shire>,
        <https://1145.am/db/2544223/Shire>,
        <https://1145.am/db/2544434/Shire>,
        <https://1145.am/db/2544459/Shire>,
        <https://1145.am/db/2544726/Shire>,
        <https://1145.am/db/2546262/Shire>,
        <https://1145.am/db/2546291/Shire>,
        <https://1145.am/db/2547036/Shire>,
        <https://1145.am/db/2547277/Shire>,
        <https://1145.am/db/2547575/Shire_Plc>,
        <https://1145.am/db/2548051/Shire>,
        <https://1145.am/db/2548805/Shire>,
        <https://1145.am/db/2548859/Shire>,
        <https://1145.am/db/2548979/Shire>,
        <https://1145.am/db/2550985/Shire>,
        <https://1145.am/db/2552180/Shire>,
        <https://1145.am/db/2552455/Shire>,
        <https://1145.am/db/2554269/Shire>,
        <https://1145.am/db/2554294/Shire>,
        <https://1145.am/db/2556988/Shire>,
        <https://1145.am/db/2558927/Shire>,
        <https://1145.am/db/2559769/Shire>,
        <https://1145.am/db/2561541/Shire>,
        <https://1145.am/db/2563175/Shire>,
        <https://1145.am/db/2564899/Shire>,
        <https://1145.am/db/2565613/Shire>,
        <https://1145.am/db/2566716/Shire>,
        <https://1145.am/db/2569388/Shire>,
        <https://1145.am/db/2569952/Shire>,
        <https://1145.am/db/2570020/Shire>,
        <https://1145.am/db/2570036/Shire>,
        <https://1145.am/db/2570363/Shire>,
        <https://1145.am/db/2570733/Shire_Plc>,
        <https://1145.am/db/2570807/Shire>,
        <https://1145.am/db/2571521/Shire>,
        <https://1145.am/db/2571526/Shire>,
        <https://1145.am/db/2572113/Shire_Plc>,
        <https://1145.am/db/2572335/Shire>,
        <https://1145.am/db/2572559/Shire>,
        <https://1145.am/db/2573463/Shire>,
        <https://1145.am/db/2573508/Shire>,
        <https://1145.am/db/2574443/Shire>,
        <https://1145.am/db/2574731/Shire>,
        <https://1145.am/db/2575050/Shire>,
        <https://1145.am/db/2575259/Shire>,
        <https://1145.am/db/2576815/Shire>,
        <https://1145.am/db/2576959/Shire>,
        <https://1145.am/db/2577117/Shire>,
        <https://1145.am/db/2577176/Shire_Plc>,
        <https://1145.am/db/2577652/Shire_Plc>,
        <https://1145.am/db/2577793/Shire_Plc>,
        <https://1145.am/db/2578085/Shire_Plc>,
        <https://1145.am/db/2578319/Shire>,
        <https://1145.am/db/2578503/Shire>,
        <https://1145.am/db/2578568/Shire>,
        <https://1145.am/db/2579035/Shire_Plc>,
        <https://1145.am/db/2579062/Shire_Plc>,
        <https://1145.am/db/2580279/Shire>,
        <https://1145.am/db/2580603/Shire>,
        <https://1145.am/db/2580620/Shire>,
        <https://1145.am/db/2580622/Shire>,
        <https://1145.am/db/2580747/Shire>,
        <https://1145.am/db/2581261/Shire>,
        <https://1145.am/db/2582265/Shire>,
        <https://1145.am/db/2583177/Shire>,
        <https://1145.am/db/2583624/Shire_Plc>,
        <https://1145.am/db/2583662/Shire>,
        <https://1145.am/db/2584216/Shire>,
        <https://1145.am/db/2585066/Shire>,
        <https://1145.am/db/2585132/Shire>,
        <https://1145.am/db/2586132/Shire>,
        <https://1145.am/db/2586884/Shire>,
        <https://1145.am/db/2586889/Shire>,
        <https://1145.am/db/2587094/Shire>,
        <https://1145.am/db/2587511/Shire>,
        <https://1145.am/db/2588152/Shire>,
        <https://1145.am/db/2589981/Shire_Plc>,
        <https://1145.am/db/2591412/Shire>,
        <https://1145.am/db/2592333/Shire>,
        <https://1145.am/db/2592336/Shire>,
        <https://1145.am/db/2592562/Shire>,
        <https://1145.am/db/2595190/Shire>,
        <https://1145.am/db/2595210/Shire>,
        <https://1145.am/db/2597158/Shire>,
        <https://1145.am/db/2598205/Shire>,
        <https://1145.am/db/2976/Shire> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2580038/Astrazeneca> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:buyer <https://1145.am/db/2580038/Acquisition_Astrazeneca_Bristol-Myers_Squibb_Completed>,
        <https://1145.am/db/2580038/Bristol-Myers_Squibb_Acquisition> ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2014-02-03T13:06:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AstraZeneca Completes the Acquistion of Bristol-Myers Squibb Share of Global Diabetes Alliance" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/astrazeneca-completes-acquistion-of-bristol-myers-squibb-share-of-global-diabetes-alliance> ;
    ns1:foundName "AstraZeneca" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "AstraZeneca" ;
    ns1:sameAsHigh <https://1145.am/db/1022806/Antares_Pharma>,
        <https://1145.am/db/1026859/Antares_Pharma>,
        <https://1145.am/db/1079444/Ascendis_Pharma_A_S>,
        <https://1145.am/db/1307202/Leo_Pharma>,
        <https://1145.am/db/1392122/Astrazeneca>,
        <https://1145.am/db/1633177/Astrazeneca>,
        <https://1145.am/db/171176/Astrazeneca>,
        <https://1145.am/db/172070/Astrazeneca>,
        <https://1145.am/db/173169/Astrazeneca>,
        <https://1145.am/db/1988637/Astellas_Pharma_Inc>,
        <https://1145.am/db/2010010/Astellas_Pharma_Inc>,
        <https://1145.am/db/2038202/Astellas_Pharma_Inc>,
        <https://1145.am/db/2039692/Rk_Pharma_Inc>,
        <https://1145.am/db/2071435/Astrazeneca>,
        <https://1145.am/db/2151794/Astrazeneca>,
        <https://1145.am/db/2154218/Astrazeneca>,
        <https://1145.am/db/2154845/Astellas_Pharma>,
        <https://1145.am/db/2201236/Astrazeneca>,
        <https://1145.am/db/2278880/Astrazeneca>,
        <https://1145.am/db/2279647/Astrazeneca>,
        <https://1145.am/db/2280668/Astrazeneca>,
        <https://1145.am/db/2282580/Astrazeneca>,
        <https://1145.am/db/2282957/Astrazeneca>,
        <https://1145.am/db/2283156/Astrazeneca>,
        <https://1145.am/db/2284338/Astrazeneca>,
        <https://1145.am/db/2285828/Astrazeneca>,
        <https://1145.am/db/2287488/Astrazeneca>,
        <https://1145.am/db/2290060/Astrazeneca>,
        <https://1145.am/db/2291200/Astellas_Pharma>,
        <https://1145.am/db/2292385/Astellas_Pharma>,
        <https://1145.am/db/2293132/Astrazeneca>,
        <https://1145.am/db/2299349/Astrazeneca>,
        <https://1145.am/db/2300810/Ea_Pharma>,
        <https://1145.am/db/2302117/Aton_Pharma>,
        <https://1145.am/db/2302618/Astellas_Pharma_Inc>,
        <https://1145.am/db/2303415/Astellas_Pharma>,
        <https://1145.am/db/2303920/Astrazeneca>,
        <https://1145.am/db/2304902/Astellas_Pharma>,
        <https://1145.am/db/2305152/Astrazeneca>,
        <https://1145.am/db/2305155/Astrazeneca>,
        <https://1145.am/db/2305866/Astrazeneca>,
        <https://1145.am/db/2306464/Asterand>,
        <https://1145.am/db/2306640/Leo_Pharma>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306905/Astrazeneca>,
        <https://1145.am/db/2307059/Astrazeneca>,
        <https://1145.am/db/2307068/Astrazeneca>,
        <https://1145.am/db/2307834/Astrazeneca>,
        <https://1145.am/db/2309183/Astrazeneca>,
        <https://1145.am/db/2310968/Astellas_Pharma_Inc>,
        <https://1145.am/db/2312088/Astellas_Pharma>,
        <https://1145.am/db/2312476/Astrazeneca>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2314217/Alliant_Pharmaceuticals>,
        <https://1145.am/db/2318484/Astrazeneca>,
        <https://1145.am/db/2318485/Astrazeneca>,
        <https://1145.am/db/2318609/Astrazeneca>,
        <https://1145.am/db/2319111/Astellas_Pharma>,
        <https://1145.am/db/2319208/Astellas_Pharma>,
        <https://1145.am/db/2319211/Astellas_Pharma_Inc>,
        <https://1145.am/db/2319675/Astrazeneca>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2325196/Astellas_Pharma_Inc>,
        <https://1145.am/db/2327304/Astellas_Pharma_Inc>,
        <https://1145.am/db/2328825/Ascendis_Pharma>,
        <https://1145.am/db/2331796/Astellas_Pharma_Inc>,
        <https://1145.am/db/2334131/Astrazeneca>,
        <https://1145.am/db/2335717/Astrazeneca>,
        <https://1145.am/db/2336050/Astrazeneca>,
        <https://1145.am/db/2338888/Cerulean_Pharma>,
        <https://1145.am/db/2339206/Astrazeneca>,
        <https://1145.am/db/2342367/Astellas_Pharma>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342722/Astrazeneca>,
        <https://1145.am/db/2342996/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2343568/Ascendis_Pharma_A_S>,
        <https://1145.am/db/2343632/Astrazeneca>,
        <https://1145.am/db/2343892/Astrazeneca>,
        <https://1145.am/db/2343913/Astrazeneca>,
        <https://1145.am/db/2343920/Astrazeneca>,
        <https://1145.am/db/2344057/Astrazeneca>,
        <https://1145.am/db/2345187/Astrazeneca>,
        <https://1145.am/db/2345375/Astex_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345426/Astrazeneca>,
        <https://1145.am/db/2345774/Aton_Pharma>,
        <https://1145.am/db/2345983/Astrazeneca>,
        <https://1145.am/db/2345996/Astrazeneca>,
        <https://1145.am/db/2347755/Leo_Pharma_Inc>,
        <https://1145.am/db/2347800/Astrazeneca>,
        <https://1145.am/db/2347970/Astrazeneca>,
        <https://1145.am/db/2347971/Astrazeneca>,
        <https://1145.am/db/2348851/Ascendis_Pharma>,
        <https://1145.am/db/2350134/Astellas_Pharma_Inc>,
        <https://1145.am/db/2352037/Alexion_Pharma>,
        <https://1145.am/db/2352067/Astrazeneca>,
        <https://1145.am/db/2352166/Acumen_Pharmaceuticals>,
        <https://1145.am/db/2352525/Astrazeneca>,
        <https://1145.am/db/2352532/Astrazeneca>,
        <https://1145.am/db/2352716/Astrazeneca>,
        <https://1145.am/db/2353153/Astrazeneca>,
        <https://1145.am/db/2353550/Astrazeneca>,
        <https://1145.am/db/2353551/Astrazeneca>,
        <https://1145.am/db/2353753/Astrazeneca>,
        <https://1145.am/db/2354064/Astellas_Pharma_Inc>,
        <https://1145.am/db/2354086/Astellas_Pharma_Inc>,
        <https://1145.am/db/2354978/Astrazeneca>,
        <https://1145.am/db/2355029/Astrazeneca>,
        <https://1145.am/db/2356384/Astrazeneca>,
        <https://1145.am/db/2356965/Astellas_Pharma_Inc>,
        <https://1145.am/db/2357230/Astrazeneca>,
        <https://1145.am/db/2357962/Astellas_Pharma>,
        <https://1145.am/db/2358193/Astellas_Pharma_Inc>,
        <https://1145.am/db/2358734/Astellas_Pharma_Inc>,
        <https://1145.am/db/2358768/Astrazeneca>,
        <https://1145.am/db/2359437/Astrazeneca>,
        <https://1145.am/db/2359439/Astrazeneca>,
        <https://1145.am/db/2359539/Astrazeneca>,
        <https://1145.am/db/2359745/Astellas_Pharma>,
        <https://1145.am/db/2360237/Astrazeneca>,
        <https://1145.am/db/2360371/Astellas_Pharma>,
        <https://1145.am/db/2360562/Astrazeneca>,
        <https://1145.am/db/2360683/Astrazeneca>,
        <https://1145.am/db/2362425/Astellas_Pharma_Inc>,
        <https://1145.am/db/2362667/Astrazeneca>,
        <https://1145.am/db/2362670/Astrazeneca>,
        <https://1145.am/db/2362966/Astrazeneca>,
        <https://1145.am/db/2363405/Astrazeneca>,
        <https://1145.am/db/2364184/Astex_Pharmaceuticals>,
        <https://1145.am/db/2364191/Astex_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364805/Astrazeneca>,
        <https://1145.am/db/2365403/Astrazeneca>,
        <https://1145.am/db/2366678/Astellas_Pharma_Inc>,
        <https://1145.am/db/2367645/Astrazeneca>,
        <https://1145.am/db/2367646/Astrazeneca>,
        <https://1145.am/db/2367730/Astellas_Pharma_Inc>,
        <https://1145.am/db/2367731/Astellas_Pharma>,
        <https://1145.am/db/2368632/Astrazeneca>,
        <https://1145.am/db/2368654/Astellas_Pharma>,
        <https://1145.am/db/2368742/Astrazeneca>,
        <https://1145.am/db/2368900/Astrazeneca>,
        <https://1145.am/db/2369491/Astrazeneca>,
        <https://1145.am/db/2369493/Astrazeneca>,
        <https://1145.am/db/2369520/Astellas_Pharma_Inc>,
        <https://1145.am/db/2369607/Astrazeneca>,
        <https://1145.am/db/2370029/Astellas_Pharma_Inc>,
        <https://1145.am/db/2370041/Astellas_Pharma_Inc>,
        <https://1145.am/db/2370174/Astrazeneca>,
        <https://1145.am/db/2370175/Astrazeneca>,
        <https://1145.am/db/2370274/Ascendis_Pharma_A_S>,
        <https://1145.am/db/2370409/Astellas_Pharma>,
        <https://1145.am/db/2371094/Astrazeneca>,
        <https://1145.am/db/2537410/Astrazeneca>,
        <https://1145.am/db/2538238/Astrazeneca>,
        <https://1145.am/db/2538239/Astrazeneca>,
        <https://1145.am/db/2538821/Astrazeneca>,
        <https://1145.am/db/2539508/Astrazeneca>,
        <https://1145.am/db/2539509/Astrazeneca>,
        <https://1145.am/db/2539517/Astrazeneca>,
        <https://1145.am/db/2540845/Astrazeneca>,
        <https://1145.am/db/2543372/Astellas_Pharma>,
        <https://1145.am/db/2543375/Astellas_Pharma_Inc>,
        <https://1145.am/db/2543378/Astellas_Pharma>,
        <https://1145.am/db/2544077/Astrazeneca>,
        <https://1145.am/db/2544536/Astrazeneca>,
        <https://1145.am/db/2545023/Astrazeneca>,
        <https://1145.am/db/2545125/Ascendis_Health>,
        <https://1145.am/db/2545184/Astrazeneca>,
        <https://1145.am/db/2545426/Astrazeneca>,
        <https://1145.am/db/2545610/Astellas_Pharma>,
        <https://1145.am/db/2546143/Astrazeneca>,
        <https://1145.am/db/2546314/Astrazeneca>,
        <https://1145.am/db/2547386/Astrazeneca>,
        <https://1145.am/db/2547785/Astrazeneca>,
        <https://1145.am/db/2548384/Astrazeneca>,
        <https://1145.am/db/2549670/Astellas_Pharma>,
        <https://1145.am/db/2549890/Astrazeneca>,
        <https://1145.am/db/2550962/Astrazeneca>,
        <https://1145.am/db/2551557/Aslan_Pharmaceuticals>,
        <https://1145.am/db/2553162/Astrazeneca>,
        <https://1145.am/db/2553168/Astrazeneca>,
        <https://1145.am/db/2553619/Astellas_Pharma>,
        <https://1145.am/db/2554064/Astrazeneca>,
        <https://1145.am/db/2554933/Astrazeneca>,
        <https://1145.am/db/2555142/Astrazeneca>,
        <https://1145.am/db/2556522/Astrazeneca>,
        <https://1145.am/db/2556536/Astrazeneca>,
        <https://1145.am/db/2556928/Astrazeneca>,
        <https://1145.am/db/2556979/Dream_Pharma>,
        <https://1145.am/db/2557406/Astrazeneca>,
        <https://1145.am/db/2558118/Astrazeneca>,
        <https://1145.am/db/2558133/Astellas_Pharma>,
        <https://1145.am/db/2559469/Astrazeneca>,
        <https://1145.am/db/2560865/Astellas_Pharma>,
        <https://1145.am/db/2561319/Astrazeneca>,
        <https://1145.am/db/2562249/Astrazeneca>,
        <https://1145.am/db/2563422/Astellas_Pharma>,
        <https://1145.am/db/2566037/Astrazeneca>,
        <https://1145.am/db/2566038/Astellas_Pharma>,
        <https://1145.am/db/2566415/Astrazeneca>,
        <https://1145.am/db/2566926/Astrazeneca>,
        <https://1145.am/db/2566929/Astrazeneca>,
        <https://1145.am/db/2567518/Astrazeneca>,
        <https://1145.am/db/2568895/Astrazeneca>,
        <https://1145.am/db/2569075/Astrazeneca_Plc>,
        <https://1145.am/db/2569356/Leo_Pharma_Inc>,
        <https://1145.am/db/2569709/Astrazeneca>,
        <https://1145.am/db/2570586/Astrazeneca>,
        <https://1145.am/db/2570592/Astrazeneca>,
        <https://1145.am/db/257192/Astrazeneca_Plc>,
        <https://1145.am/db/2572938/Astrazeneca>,
        <https://1145.am/db/2573339/Astellas_Pharma>,
        <https://1145.am/db/2573463/Astrazeneca>,
        <https://1145.am/db/2573978/Astrazeneca>,
        <https://1145.am/db/2573984/Astrazeneca>,
        <https://1145.am/db/2574096/Astrazeneca>,
        <https://1145.am/db/2575176/Astrazeneca>,
        <https://1145.am/db/2575183/Astrazeneca>,
        <https://1145.am/db/2575270/Astrazeneca>,
        <https://1145.am/db/257625/Astrazeneca_Plc>,
        <https://1145.am/db/2576923/Pharmgate>,
        <https://1145.am/db/2577419/Astellas_Pharma>,
        <https://1145.am/db/2577797/Astrazeneca>,
        <https://1145.am/db/2578213/Astrazeneca>,
        <https://1145.am/db/2578454/Astrazeneca>,
        <https://1145.am/db/2579507/Astrazeneca>,
        <https://1145.am/db/2579630/Astrazeneca>,
        <https://1145.am/db/2580053/Astrazeneca>,
        <https://1145.am/db/2580491/Astrazeneca>,
        <https://1145.am/db/2580556/Astrazeneca>,
        <https://1145.am/db/2580632/Astrazeneca>,
        <https://1145.am/db/2580642/Astrazeneca>,
        <https://1145.am/db/2582242/Astrazeneca>,
        <https://1145.am/db/2583124/Astrazeneca>,
        <https://1145.am/db/2583402/Astellas_Pharma>,
        <https://1145.am/db/2585819/Astrazeneca>,
        <https://1145.am/db/2585861/Astrazeneca_Kk>,
        <https://1145.am/db/2586257/Astrazeneca>,
        <https://1145.am/db/2587500/Astrazeneca>,
        <https://1145.am/db/2588049/Astrazeneca>,
        <https://1145.am/db/2588660/Astrazeneca>,
        <https://1145.am/db/2590009/Astrazeneca>,
        <https://1145.am/db/2590159/Astellas_Pharma_Inc>,
        <https://1145.am/db/2591384/Astrazeneca>,
        <https://1145.am/db/2591652/Astrazeneca>,
        <https://1145.am/db/2591691/Astrazeneca>,
        <https://1145.am/db/2592696/Alliance_Pharma>,
        <https://1145.am/db/2592696/Astrazeneca>,
        <https://1145.am/db/2593265/Astrazeneca>,
        <https://1145.am/db/2594107/Astrazeneca>,
        <https://1145.am/db/2594183/Astex_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594184/Astex_Pharmaceuticals>,
        <https://1145.am/db/2594365/Astrazeneca>,
        <https://1145.am/db/2594602/Astellas_Pharma>,
        <https://1145.am/db/2595368/Astellas_Pharma>,
        <https://1145.am/db/2595413/Astellas_Pharma_Inc>,
        <https://1145.am/db/2595981/Astrazeneca>,
        <https://1145.am/db/2596046/Astrazeneca>,
        <https://1145.am/db/2596053/Astrazeneca>,
        <https://1145.am/db/2596838/Astex_Pharmaceuticals>,
        <https://1145.am/db/2597175/Astrazeneca>,
        <https://1145.am/db/2597935/Astellas_Pharma>,
        <https://1145.am/db/2598202/Astrazeneca>,
        <https://1145.am/db/2789987/Astrazeneca>,
        <https://1145.am/db/340451/Astrazeneca>,
        <https://1145.am/db/340474/Astrazeneca>,
        <https://1145.am/db/347044/Astrazeneca>,
        <https://1145.am/db/381681/Astrazeneca_Plc>,
        <https://1145.am/db/441284/Bryn_Pharma>,
        <https://1145.am/db/488413/Astrazeneca>,
        <https://1145.am/db/510316/Astrazeneca>,
        <https://1145.am/db/624169/Astrazeneca> ;
    ns1:sameAsMedium <https://1145.am/db/1180597/Astrazeneca>,
        <https://1145.am/db/1241325/Astrazeneca>,
        <https://1145.am/db/1536697/Astrazeneca>,
        <https://1145.am/db/1539672/Astrazeneca>,
        <https://1145.am/db/1627652/Astrazeneca>,
        <https://1145.am/db/2041475/Astrazeneca>,
        <https://1145.am/db/2280289/Astrazeneca>,
        <https://1145.am/db/2282916/Astrazeneca>,
        <https://1145.am/db/2283309/Astrazeneca>,
        <https://1145.am/db/2290860/Astrazeneca>,
        <https://1145.am/db/2291860/Astrazeneca>,
        <https://1145.am/db/2294263/Astrazeneca>,
        <https://1145.am/db/2296196/Astrazeneca>,
        <https://1145.am/db/2305826/Astrazeneca>,
        <https://1145.am/db/2307913/Astrazeneca>,
        <https://1145.am/db/2315716/Astrazeneca>,
        <https://1145.am/db/2316364/Astrazeneca>,
        <https://1145.am/db/2329585/Astrazeneca>,
        <https://1145.am/db/2331622/Astrazeneca>,
        <https://1145.am/db/2335286/Astrazeneca>,
        <https://1145.am/db/2340097/Astrazeneca>,
        <https://1145.am/db/2342213/Astrazeneca>,
        <https://1145.am/db/2354112/Astrazeneca>,
        <https://1145.am/db/2354774/Astrazeneca>,
        <https://1145.am/db/2354998/Astrazeneca>,
        <https://1145.am/db/2356098/Astrazeneca>,
        <https://1145.am/db/2358228/Astrazeneca>,
        <https://1145.am/db/252780/Astrazeneca>,
        <https://1145.am/db/2539787/Astrazeneca>,
        <https://1145.am/db/2544701/Astrazeneca>,
        <https://1145.am/db/2545769/Astrazeneca>,
        <https://1145.am/db/2554571/Astrazeneca>,
        <https://1145.am/db/2555141/Astrazeneca>,
        <https://1145.am/db/2559649/Astrazeneca>,
        <https://1145.am/db/2562728/Astrazeneca>,
        <https://1145.am/db/2564897/Astrazeneca>,
        <https://1145.am/db/2565399/Astrazeneca>,
        <https://1145.am/db/2565682/Astrazeneca>,
        <https://1145.am/db/2565951/Astrazeneca>,
        <https://1145.am/db/2575269/Astrazeneca>,
        <https://1145.am/db/2582823/Astrazeneca>,
        <https://1145.am/db/2582826/Astrazeneca>,
        <https://1145.am/db/2588089/Astrazeneca>,
        <https://1145.am/db/376382/Astrazeneca> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2582969/Endo_Health_Solutions_Inc> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:buyer <https://1145.am/db/2582969/Paladin_Labs_Acquisition> ;
    ns1:description "health",
        "health care" ;
    ns1:documentDate "2014-02-27T12:34:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endo Announces Shareholder Approval of its Acquisition of Paladin Labs" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/endo-announces-shareholder-approval-of-its-acquisition-of-paladin-labs> ;
    ns1:foundName "Endo",
        "Endo Health Solutions Inc" ;
    ns1:name "Endo",
        "Endo Health Solutions Inc" ;
    ns1:sameAsHigh <https://1145.am/db/2295973/Endo_Health_Solutions>,
        <https://1145.am/db/2339855/Endo_Health_Solutions>,
        <https://1145.am/db/2339856/Endo_Health_Solutions>,
        <https://1145.am/db/2352123/Endo_Health_Solutions_Inc>,
        <https://1145.am/db/2575128/Endo_Health_Solutions>,
        <https://1145.am/db/2580057/Endo_Health_Solutions>,
        <https://1145.am/db/2593448/Endo_Health_Solutions> ;
    ns1:sameAsMedium <https://1145.am/db/2289784/Endo_Health_Solutions>,
        <https://1145.am/db/2291572/Endo_Health_Solutions>,
        <https://1145.am/db/2296931/Endo_Health_Solutions>,
        <https://1145.am/db/2339938/Endo_Health_Solutions_Inc>,
        <https://1145.am/db/2339959/Endo_Health_Solutions>,
        <https://1145.am/db/2341751/Endo_Health_Solutions_Inc>,
        <https://1145.am/db/2572224/Endo_Health_Solutions>,
        <https://1145.am/db/2574199/Endo_Health_Solutions>,
        <https://1145.am/db/2577091/Endo_Health_Solutions>,
        <https://1145.am/db/2578099/Endo_Health_Solutions>,
        <https://1145.am/db/2580040/Endo_Health_Solutions>,
        <https://1145.am/db/2586385/Endo_Health_Solutions>,
        <https://1145.am/db/2594336/Endo_Health_Solutions_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2582969/Endo_International_Plc> a org:Organization ;
    ns1:basedInHighGeoName "Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2963597/about.rdf> ;
    ns1:basedInHighRaw "Ireland" ;
    ns1:buyer <https://1145.am/db/2582969/Paladin_Labs_Acquisition> ;
    ns1:description "Acquisition" ;
    ns1:documentDate "2014-02-27T12:34:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endo Announces Shareholder Approval of its Acquisition of Paladin Labs" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/endo-announces-shareholder-approval-of-its-acquisition-of-paladin-labs> ;
    ns1:foundName "Endo International" ;
    ns1:name "Endo International plc" ;
    ns1:sameAsMedium <https://1145.am/db/1283969/Endo_International_Plc>,
        <https://1145.am/db/2069699/Endo_International>,
        <https://1145.am/db/2306352/Endo_International>,
        <https://1145.am/db/2309629/Endo_International>,
        <https://1145.am/db/2335603/Endo_International_Plc>,
        <https://1145.am/db/2335825/Endo_International_Plc>,
        <https://1145.am/db/2336726/Endo_International_Plc>,
        <https://1145.am/db/2338088/Endo_International_Plc>,
        <https://1145.am/db/2342524/Endo_International_Plc>,
        <https://1145.am/db/2350252/Endo_International_Plc>,
        <https://1145.am/db/2353315/Endo_International_Plc>,
        <https://1145.am/db/2356078/Endo_International_Plc>,
        <https://1145.am/db/2370088/Endo_International_Plc>,
        <https://1145.am/db/2568859/Endo_International>,
        <https://1145.am/db/2569348/Endo_International_Plc>,
        <https://1145.am/db/2569444/Endo_International_Plc>,
        <https://1145.am/db/2569465/Endo_International_Plc>,
        <https://1145.am/db/2570713/Endo_International_Plc>,
        <https://1145.am/db/2571189/Endo_International>,
        <https://1145.am/db/2573913/Endo_International_Plc>,
        <https://1145.am/db/2575868/Endo_International_Plc>,
        <https://1145.am/db/2575870/Endo_International_Plc>,
        <https://1145.am/db/2576849/Endo_International_Plc>,
        <https://1145.am/db/2581258/Endo_International_Plc>,
        <https://1145.am/db/2581266/Endo_International_Plc>,
        <https://1145.am/db/2581290/Endo_International_Plc>,
        <https://1145.am/db/2581294/Endo_International_Plc>,
        <https://1145.am/db/2581298/Endo_International>,
        <https://1145.am/db/2583621/Endo_International_Plc>,
        <https://1145.am/db/2584169/Endo_International_Plc>,
        <https://1145.am/db/2588511/Endo_International_Plc>,
        <https://1145.am/db/2588518/Endo_International_Plc>,
        <https://1145.am/db/2589255/Endo_International_Plc>,
        <https://1145.am/db/2593481/Endo_International_Plc>,
        <https://1145.am/db/2596899/Endo_International_Plc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2584394/Investment_Safeshot_Technologies_Inc_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-25T13:34:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MENLO PARK, Calif.- (BUSINESS WIRE) -SafeShot Technologies, Inc. (SafeShot) announced today the completion of a $ 6 million financing in addition to the $ 3 million closed in the fall of 2012.",
        "SafeShot Technologies Inc. Secures $ 9 Million Financing." ;
    ns1:documentTitle "SafeShot Technologies Inc. Secures $9 Million Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/safeshot-technologies-inc-secures-9-million-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2584394/Safeshot_Technologies_Inc> ;
    ns1:valueRaw "$ 3 million",
        "$ 6 million",
        "$ 9 Million" ;
    ns1:whereRaw "SafeShot Technologies Inc." .

<https://1145.am/db/2584900/Horizon_Pharma> a org:Organization ;
    ns1:basedInHighGeoName "Deerfield",
        "Dublin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2964574/about.rdf>,
        <https://sws.geonames.org/4889668/about.rdf> ;
    ns1:basedInHighRaw "DEERFIELD, IL and DUBLIN, IRELAND" ;
    ns1:buyer <https://1145.am/db/2584900/Vidara_Acquisition> ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2014-03-19T13:14:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/horizon-pharma-to-acquire-vidara-therapeutics-international-ltd-and-become-horizon-pharma> ;
    ns1:foundName "Horizon Pharma",
        "Horizon Pharma, Inc",
        "Horizon Pharma, Inc." ;
    ns1:industry "Pharma" ;
    ns1:name "Horizon Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1568872/Horizon_Therapeutics>,
        <https://1145.am/db/1573831/Horizon>,
        <https://1145.am/db/1575688/Horizon_Therapeutics_Public_Limited_Company>,
        <https://1145.am/db/1576668/Horizon_Therapeutics_Public_Limited_Company>,
        <https://1145.am/db/2046726/Horizon_Therapeutics>,
        <https://1145.am/db/2286372/Horizon_Therapeutics>,
        <https://1145.am/db/2337325/Horizon_Pharma_Plc>,
        <https://1145.am/db/2340250/Horizon_Pharma>,
        <https://1145.am/db/2341136/Horizon_Pharma>,
        <https://1145.am/db/2345086/Horizon_Pharma_Plc>,
        <https://1145.am/db/2356175/Horizon_Pharma>,
        <https://1145.am/db/2365843/Horizon_Pharma>,
        <https://1145.am/db/2368184/Horizon_Pharma_Plc>,
        <https://1145.am/db/2369244/Horizon_Pharma_Plc>,
        <https://1145.am/db/2555175/Horizon_Therapeutics>,
        <https://1145.am/db/2564899/Horizon_Therapeutics>,
        <https://1145.am/db/2567981/Horizon_Therapeutics>,
        <https://1145.am/db/2569423/Horizon_Pharma_Plc>,
        <https://1145.am/db/2570088/Horizon_Pharma>,
        <https://1145.am/db/2570092/Horizon_Pharma>,
        <https://1145.am/db/2579775/Horizon_Pharma>,
        <https://1145.am/db/2579783/Horizon_Pharma_Plc>,
        <https://1145.am/db/2580620/Horizon_Pharma>,
        <https://1145.am/db/2581709/Horizon_Pharma>,
        <https://1145.am/db/2582703/Horizon_Pharma_Plc>,
        <https://1145.am/db/2583646/Horizon_Pharma>,
        <https://1145.am/db/2596292/Horizon_Pharma>,
        <https://1145.am/db/2802001/Horizon_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2342980/Horizon_Pharma>,
        <https://1145.am/db/2343023/Horizon_Pharma>,
        <https://1145.am/db/2344648/Horizon_Pharma_Plc>,
        <https://1145.am/db/2344675/Horizon_Pharma>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2368098/Horizon_Pharma>,
        <https://1145.am/db/2541469/Horizon_Pharma>,
        <https://1145.am/db/2568905/Horizon_Pharma_Plc>,
        <https://1145.am/db/2582725/Horizon_Pharma>,
        <https://1145.am/db/2584647/Horizon_Pharma_Plc>,
        <https://1145.am/db/2584909/Horizon_Pharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586763/Cfr_Pharma> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Chile" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3895114/about.rdf> ;
    ns1:basedInHighRaw "Chile" ;
    ns1:buyer <https://1145.am/db/2586763/Adcock_Ingram_Acquisition> ;
    ns1:documentDate "2013-07-03T15:46:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merck pulls Recombivax lot on cracked-vial risk; India's Elder Pharma to buy OTC drugmaker;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/merck-pulls-recombivax-lot-on-cracked-vial-risk-india-s-elder-pharma-to-buy-otc-drugmaker> ;
    ns1:foundName "CFR Pharma" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "CFR Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/2540590/Cfr_Pharmaceuticals>,
        <https://1145.am/db/2570948/Cfr_Pharmaceuticals>,
        <https://1145.am/db/2571532/Cfr_Pharmaceutical>,
        <https://1145.am/db/2571549/Cfr_Pharmaceuticals>,
        <https://1145.am/db/2572325/Cfr_Pharmaceuticals>,
        <https://1145.am/db/2575130/Cfr_Pharmaceuticals>,
        <https://1145.am/db/2575183/Cfr_Pharmaceuticals>,
        <https://1145.am/db/2578325/Cfr_Pharmaceuticals_Sa>,
        <https://1145.am/db/2582263/Cfr_Pharmaceuticals>,
        <https://1145.am/db/2586759/Cfr_Pharmaceuticals>,
        <https://1145.am/db/2589632/Cfr_Pharmaceuticals>,
        <https://1145.am/db/2593473/Cfr_Pharmaceuticals>,
        <https://1145.am/db/2598064/Cfr_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586763/Elder_Pharma> a org:Organization ;
    ns1:basedInLowRaw "U.K." ;
    ns1:buyer <https://1145.am/db/2586763/Max_Healthcare_Acquisition> ;
    ns1:documentDate "2013-07-03T15:46:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merck pulls Recombivax lot on cracked-vial risk; India's Elder Pharma to buy OTC drugmaker;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/merck-pulls-recombivax-lot-on-cracked-vial-risk-india-s-elder-pharma-to-buy-otc-drugmaker> ;
    ns1:foundName "Elder Pharma" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Elder Pharma" ;
    ns1:participant <https://1145.am/db/2586763/Max_Healthcare_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2538171/Elder_Pharmaceuticals>,
        <https://1145.am/db/2547670/Elder_Pharmaceuticals>,
        <https://1145.am/db/2555883/Elder_Pharmaceuticals>,
        <https://1145.am/db/2589657/Elder_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593433/Robbins_Arroyo_Llp> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO and SAN FRANCISCO" ;
    ns1:description "Shareholder rights" ;
    ns1:documentDate "2013-08-27T07:00:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acquisition-of-onyx-pharmaceuticals-inc-by-amgen-inc-may-not-be-best-interests-of-onyx> ;
    ns1:foundName "Robbins Arroyo LLP" ;
    ns1:name "Robbins Arroyo LLP" ;
    ns1:participant <https://1145.am/db/2593433/Onyx_Pharmaceuticals_Inc_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/1273978/Robbins>,
        <https://1145.am/db/1274579/Robbins>,
        <https://1145.am/db/1527074/Robbins>,
        <https://1145.am/db/1528968/Robbins>,
        <https://1145.am/db/1538573/Robbins>,
        <https://1145.am/db/1567113/Robbins>,
        <https://1145.am/db/1570110/Robbins>,
        <https://1145.am/db/2055677/Robbins_Llp> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593457/Ooo_Gardenhills> a org:Organization ;
    ns1:basedInHighGeoName "Russian Federation" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:basedInHighRaw "Russia" ;
    ns1:description "Business" ;
    ns1:documentDate "2013-08-29T15:03:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pharmacy Chain 36.6 signs agreement to sell stake in Veropharm" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/pharmacy-chain-36-6-signs-agreement-to-sell-stake-veropharm> ;
    ns1:foundName "OOO GardenHills" ;
    ns1:investor <https://1145.am/db/2593457/Ojsc_Veropharm_Stake_Investment> ;
    ns1:name "OOO GardenHills" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595564/Perrigo> a org:Organization ;
    ns1:buyer <https://1145.am/db/2595564/Onyx_Acquisition> ;
    ns1:documentDate "2013-09-19T15:58:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "With $29B in deals so far, 2013 shaping up as big M&A year" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/29b-deals-so-far-2013-shaping-up-as-big-m-a-year> ;
    ns1:foundName "Perrigo" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Perrigo" ;
    ns1:sameAsHigh <https://1145.am/db/140347/Perrigo>,
        <https://1145.am/db/2301756/Pergamum_Ab>,
        <https://1145.am/db/2305515/Perrigo_Company>,
        <https://1145.am/db/2319220/Perrigo_Company>,
        <https://1145.am/db/2319399/Perrigo>,
        <https://1145.am/db/2319885/Perrigo_Company>,
        <https://1145.am/db/2322083/Perrigo>,
        <https://1145.am/db/2328536/Perrigo_Company>,
        <https://1145.am/db/2341767/Perrigo>,
        <https://1145.am/db/2349480/Perosphere_Inc>,
        <https://1145.am/db/2350515/Perosphere_Inc>,
        <https://1145.am/db/2355339/Perrigo_Pharmaceuticals>,
        <https://1145.am/db/2537398/Perrigo>,
        <https://1145.am/db/2538031/Perrigo>,
        <https://1145.am/db/2538653/Perrigo>,
        <https://1145.am/db/2540105/Perrigo>,
        <https://1145.am/db/2540521/Perrigo>,
        <https://1145.am/db/2541499/Perrigo>,
        <https://1145.am/db/2544762/Perrigo>,
        <https://1145.am/db/2546145/Perrigo>,
        <https://1145.am/db/2546149/Perrigo>,
        <https://1145.am/db/2546959/Perrigo>,
        <https://1145.am/db/2561423/Perrigo>,
        <https://1145.am/db/2562362/Perrigo>,
        <https://1145.am/db/2563325/Perrigo>,
        <https://1145.am/db/2563341/Perrigo>,
        <https://1145.am/db/2563450/Perrigo>,
        <https://1145.am/db/2569075/Perrigo>,
        <https://1145.am/db/2569076/Perrigo>,
        <https://1145.am/db/2570437/Perrigo>,
        <https://1145.am/db/2572985/Perrigo>,
        <https://1145.am/db/2575863/Perrigo>,
        <https://1145.am/db/2576144/Perrigo>,
        <https://1145.am/db/2577804/Perrigo>,
        <https://1145.am/db/2577810/Perrigo>,
        <https://1145.am/db/2578176/Perrigo>,
        <https://1145.am/db/2578808/Perrigo>,
        <https://1145.am/db/2578827/Perrigo>,
        <https://1145.am/db/2579630/Perrigo>,
        <https://1145.am/db/2581325/Perrigo>,
        <https://1145.am/db/2583414/Perrigo>,
        <https://1145.am/db/2584909/Perrigo>,
        <https://1145.am/db/2585327/Perrigo_Company>,
        <https://1145.am/db/2588053/Perrigo>,
        <https://1145.am/db/2589750/Perrigo>,
        <https://1145.am/db/2594992/Perrigo>,
        <https://1145.am/db/2595051/Perrigo>,
        <https://1145.am/db/2595684/Perrigo>,
        <https://1145.am/db/2595688/Perrigo>,
        <https://1145.am/db/2598736/Perrigo> ;
    ns1:sameAsMedium <https://1145.am/db/1466026/Perrigo>,
        <https://1145.am/db/2306691/Perrigo_Company>,
        <https://1145.am/db/2311233/Perrigo>,
        <https://1145.am/db/2322064/Perrigo_Company>,
        <https://1145.am/db/2325736/Perrigo_Company>,
        <https://1145.am/db/2334551/Perrigo>,
        <https://1145.am/db/2339612/Perrigo>,
        <https://1145.am/db/2343835/Perrigo>,
        <https://1145.am/db/2354155/Perrigo>,
        <https://1145.am/db/252316/Perrigo>,
        <https://1145.am/db/2538226/Perrigo>,
        <https://1145.am/db/2539012/Perrigo>,
        <https://1145.am/db/2549203/Perrigo>,
        <https://1145.am/db/2553219/Perrigo>,
        <https://1145.am/db/2555939/Perrigo>,
        <https://1145.am/db/2562354/Perrigo>,
        <https://1145.am/db/2564219/Perrigo>,
        <https://1145.am/db/2568858/Perrigo>,
        <https://1145.am/db/2571324/Perrigo>,
        <https://1145.am/db/2571355/Perrigo>,
        <https://1145.am/db/2572018/Perrigo>,
        <https://1145.am/db/2572085/Perrigo>,
        <https://1145.am/db/2572093/Perrigo>,
        <https://1145.am/db/2575861/Perrigo>,
        <https://1145.am/db/2576104/Perrigo>,
        <https://1145.am/db/2577809/Perrigo>,
        <https://1145.am/db/2578160/Perrigo>,
        <https://1145.am/db/2581804/Perrigo>,
        <https://1145.am/db/2583676/Perrigo>,
        <https://1145.am/db/2584589/Perrigo>,
        <https://1145.am/db/2584598/Perrigo>,
        <https://1145.am/db/2584603/Perrigo>,
        <https://1145.am/db/2585584/Perrigo>,
        <https://1145.am/db/2585604/Perrigo>,
        <https://1145.am/db/2585605/Perrigo>,
        <https://1145.am/db/2585606/Perrigo>,
        <https://1145.am/db/2586571/Perrigo>,
        <https://1145.am/db/2586572/Perrigo>,
        <https://1145.am/db/2587506/Perrigo>,
        <https://1145.am/db/2587513/Perrigo>,
        <https://1145.am/db/2587539/Perrigo>,
        <https://1145.am/db/2588051/Perrigo>,
        <https://1145.am/db/2590594/Perrigo>,
        <https://1145.am/db/2592352/Perrigo>,
        <https://1145.am/db/2593465/Perrigo>,
        <https://1145.am/db/2594877/Perrigo> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2597465/Gland_Pharma_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-10-11T15:13:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "After rumors ignited speculation last month, a KKR buyout of India's Gland Pharma may be on the way, according to Reuters' sources." ;
    ns1:documentTitle "KKR on verge of buying stake in India's Gland, sources say" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/kkr-on-verge-of-buying-stake-india-s-gland-sources-say> ;
    ns1:foundName "buyout" ;
    ns1:name "buyout" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2597465/Gland_Pharma> ;
    ns1:targetName "Gland Pharma" ;
    ns1:valueRaw "about $ 150 million" ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "India" .

<https://1145.am/db/2597465/Panasonics_Healthcare_Arm_Arm_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment",
        "merger" ;
    ns1:documentDate "2013-10-11T15:13:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Last month, it agreed to buy a $ 1.67 billion stake in Panasonic's healthcare arm and sealed a deal to buy and merge PRA and ReSearch Pharmaceutical Services, creating the world's fourth-largest CRO in the process." ;
    ns1:documentTitle "KKR on verge of buying stake in India's Gland, sources say" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/kkr-on-verge-of-buying-stake-india-s-gland-sources-say> ;
    ns1:foundName "buy",
        "merge" ;
    ns1:name "buy",
        "merge" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2597465/Panasonics_Healthcare_Arm> ;
    ns1:targetDetails "arm" ;
    ns1:targetName "Panasonic's healthcare arm" ;
    ns1:valueRaw "$ 1.67 billion" ;
    ns1:vendor <https://1145.am/db/2597465/Panasonics_Healthcare_Arm> .

<https://1145.am/db/2608080/Zayo> a org:Organization ;
    ns1:basedInLowRaw "Midwest" ;
    ns1:buyer <https://1145.am/db/2608080/Access_Communications_Acquisition>,
        <https://1145.am/db/2608080/Acquisition_Fiberlink_Zayo_Has_Not_Happened>,
        <https://1145.am/db/2608080/Fiberlink_Acquisition> ;
    ns1:description "dark fiber business model" ;
    ns1:documentDate "2013-10-07T13:45:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zayo acquires FiberLink, expands dark fiber network to 26,000 miles" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/zayo-acquires-fiberlink-expands-dark-fiber-network-to-26-000-miles> ;
    ns1:foundName "Zay",
        "Zayo" ;
    ns1:name "Zayo" ;
    ns1:sameAsMedium <https://1145.am/db/2600155/Zayo>,
        <https://1145.am/db/2600527/Zayo>,
        <https://1145.am/db/2600529/Zayo>,
        <https://1145.am/db/2601289/Zayo>,
        <https://1145.am/db/2601464/Zayo>,
        <https://1145.am/db/2602906/Zayo>,
        <https://1145.am/db/2603027/Zayo>,
        <https://1145.am/db/2605055/Zayo>,
        <https://1145.am/db/2605407/Zayo>,
        <https://1145.am/db/2605874/Zayo>,
        <https://1145.am/db/2606403/Zayo>,
        <https://1145.am/db/2606429/Zayo>,
        <https://1145.am/db/2606703/Zayo>,
        <https://1145.am/db/2606946/Zayo>,
        <https://1145.am/db/2607072/Zayo>,
        <https://1145.am/db/2607368/Zayo>,
        <https://1145.am/db/2609012/Zayo>,
        <https://1145.am/db/2609411/Zayo>,
        <https://1145.am/db/2609582/Zayo>,
        <https://1145.am/db/2610237/Zayo>,
        <https://1145.am/db/2610248/Zayo>,
        <https://1145.am/db/2610322/Zayo>,
        <https://1145.am/db/2611079/Zayo>,
        <https://1145.am/db/2611330/Zayo>,
        <https://1145.am/db/2611794/Zayo>,
        <https://1145.am/db/2612526/Zayo>,
        <https://1145.am/db/2613227/Zayo>,
        <https://1145.am/db/2613311/Zayo>,
        <https://1145.am/db/2614305/Zayo>,
        <https://1145.am/db/2614855/Zayo>,
        <https://1145.am/db/2615719/Zayo>,
        <https://1145.am/db/2616305/Zayo>,
        <https://1145.am/db/2616902/Zayo>,
        <https://1145.am/db/2616912/Zayo>,
        <https://1145.am/db/2617613/Zayo>,
        <https://1145.am/db/2618333/Zayo>,
        <https://1145.am/db/2618594/Zayo>,
        <https://1145.am/db/2619672/Zayo>,
        <https://1145.am/db/2620184/Zayo>,
        <https://1145.am/db/2620410/Zayo>,
        <https://1145.am/db/2649387/Zayo>,
        <https://1145.am/db/2663140/Zayo> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2651118/Acquisition_Dna_Stopped> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-07-17T14:56:49+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Finnish mobile operator DNA dropped plans to sell the company to private equity firms and said it may reconsider its options when the market improves." ;
    ns1:documentTitle "Growth returns in Spain; Etisalat may have a partner for Maroc Telecom stake" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/growth-returns-spain-etisalat-may-have-a-partner-for-maroc-telecom-stake> ;
    ns1:foundName "sell" ;
    ns1:name "sell" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "stopped" ;
    ns1:vendor <https://1145.am/db/2651118/Dna> ;
    ns1:whereGeoName "Republic of Finland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/660013/about.rdf> ;
    ns1:whereRaw "Finland" .

<https://1145.am/db/2651118/Ee_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "ipo" ;
    ns1:documentDate "2013-07-17T14:56:49+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Deutsche Telekom is keeping its options open as to whether it floats or sells EE, an executive said." ;
    ns1:documentTitle "Growth returns in Spain; Etisalat may have a partner for Maroc Telecom stake" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/growth-returns-spain-etisalat-may-have-a-partner-for-maroc-telecom-stake> ;
    ns1:foundName "floats",
        "sells" ;
    ns1:name "floats",
        "sells" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "stopped" ;
    ns1:target <https://1145.am/db/2651118/Ee> ;
    ns1:targetName "EE" ;
    ns1:vendor <https://1145.am/db/2651118/Deutsche_Telekom> ;
    ns1:whereGeoName "Kingdom of Spain" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:whereRaw "Spain" .

<https://1145.am/db/2662077/Batelco> a org:Organization ;
    ns1:basedInLowRaw "Seychelles" ;
    ns1:buyer <https://1145.am/db/2662077/Divestment_Batelco_Cable___Wireless_Communications_Has_Not_Happened> ;
    ns1:documentDate "2014-01-03T17:01:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Turkcell refutes 180M tax demand; KPN takes control of FTTH operator" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/turkcell-refutes-eu180m-tax-demand-kpn-takes-control-ftth-operator> ;
    ns1:foundName "Batelco" ;
    ns1:name "Batelco" ;
    ns1:sameAsMedium <https://1145.am/db/2611272/Batelco>,
        <https://1145.am/db/2664273/Batelco>,
        <https://1145.am/db/2664834/Batelco>,
        <https://1145.am/db/2667523/Batelco>,
        <https://1145.am/db/2669617/Batelco>,
        <https://1145.am/db/2670351/Batelco>,
        <https://1145.am/db/2672997/Batelco>,
        <https://1145.am/db/2674136/Batelco>,
        <https://1145.am/db/2676599/Batelco>,
        <https://1145.am/db/2680805/Batelco>,
        <https://1145.am/db/357303/Batelco> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2662077/Cable___Wireless_Communications> a org:Organization ;
    ns1:basedInLowRaw "Monaco" ;
    ns1:documentDate "2014-01-03T17:01:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Turkcell refutes 180M tax demand; KPN takes control of FTTH operator" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/turkcell-refutes-eu180m-tax-demand-kpn-takes-control-ftth-operator> ;
    ns1:foundName "Cable & Wireless Communications" ;
    ns1:name "Cable & Wireless Communications" ;
    ns1:protagonist <https://1145.am/db/2662077/Divestment_Batelco_Cable___Wireless_Communications_Has_Not_Happened> ;
    ns1:sameAsMedium <https://1145.am/db/2162111/Cable___Wireless_Communications>,
        <https://1145.am/db/2601480/Cable___Wireless_Communications>,
        <https://1145.am/db/2607479/Cable___Wireless_Communications>,
        <https://1145.am/db/2611272/Cable___Wireless_Communications>,
        <https://1145.am/db/2614188/Cable___Wireless_Communications>,
        <https://1145.am/db/2617934/Cable___Wireless_Communications>,
        <https://1145.am/db/2618598/Cable___Wireless_Communications>,
        <https://1145.am/db/2657880/Cable___Wireless_Communications>,
        <https://1145.am/db/2659958/Cable___Wireless_Communications>,
        <https://1145.am/db/2664151/Cable___Wireless_Communications>,
        <https://1145.am/db/2667523/Cable___Wireless_Communications>,
        <https://1145.am/db/2679067/Cable___Wireless_Communications> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663183/Hutchison_Whampoa> a org:Organization ;
    ns1:basedInLowRaw "Hong Kong" ;
    ns1:buyer <https://1145.am/db/2663183/E-Plus_Merger>,
        <https://1145.am/db/2663183/Telefnica_Ireland_Acquisition> ;
    ns1:documentDate "2014-01-28T21:03:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "As Vodafone closes its Verizon deal, the rumour mill goes into overdrive" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/as-vodafone-closes-its-verizon-deal-rumour-mill-goes-into-overdrive> ;
    ns1:foundName "Hutchison Whampoa" ;
    ns1:name "Hutchison Whampoa" ;
    ns1:sameAsMedium <https://1145.am/db/1800033/Hutchison_Whampoa>,
        <https://1145.am/db/1895346/Hutchison_Whampoa>,
        <https://1145.am/db/1895791/Hutchison_Whampoa>,
        <https://1145.am/db/2601305/Hutchison_Whampoa>,
        <https://1145.am/db/2602241/Hutchison_Whampoa>,
        <https://1145.am/db/2624724/Hutchison_Whampoa>,
        <https://1145.am/db/2642568/Hutchison_Whampoa>,
        <https://1145.am/db/2645112/Hutchison_Whampoa>,
        <https://1145.am/db/2645972/Hutchison_Whampoa>,
        <https://1145.am/db/2650867/Hutchison_Whampoa>,
        <https://1145.am/db/2651389/Hutchison_Whampoa>,
        <https://1145.am/db/2651408/Hutchison_Whampoa>,
        <https://1145.am/db/2651412/Hutchison_Whampoa>,
        <https://1145.am/db/2651420/Hutchison_Whampoa>,
        <https://1145.am/db/2651472/Hutchison_Whampoa>,
        <https://1145.am/db/2651481/Hutchison_Whampoa>,
        <https://1145.am/db/2651763/Hutchison_Whampoa>,
        <https://1145.am/db/2651770/Hutchison_Whampoa>,
        <https://1145.am/db/2651778/Hutchison_Whampoa>,
        <https://1145.am/db/2651999/Hutchison_Whampoa>,
        <https://1145.am/db/2652007/Hutchison_Whampoa>,
        <https://1145.am/db/2652389/Hutchison_Whampoa>,
        <https://1145.am/db/2652520/Hutchison_Whampoa>,
        <https://1145.am/db/2653163/Hutchison_Whampoa>,
        <https://1145.am/db/2653171/Hutchison_Whampoa>,
        <https://1145.am/db/2653724/Hutchison_Whampoa>,
        <https://1145.am/db/2653986/Hutchison_Whampoa>,
        <https://1145.am/db/2654031/Hutchison_Whampoa>,
        <https://1145.am/db/2654050/Hutchison_Whampoa>,
        <https://1145.am/db/2654071/Hutchison_Whampoa>,
        <https://1145.am/db/2654093/Hutchison_Whampoa>,
        <https://1145.am/db/2654860/Hutchison_Whampoa>,
        <https://1145.am/db/2654874/Hutchison_Whampoa>,
        <https://1145.am/db/2655754/Hutchison_Whampoa>,
        <https://1145.am/db/2656471/Hutchison_Whampoa>,
        <https://1145.am/db/2656911/Hutchison_Whampoa>,
        <https://1145.am/db/2657893/Hutchison_Whampoa>,
        <https://1145.am/db/2658692/Hutchison_Whampoa>,
        <https://1145.am/db/2658722/Hutchison_Whampoa>,
        <https://1145.am/db/2659767/Hutchison_Whampoa>,
        <https://1145.am/db/2659780/Hutchison_Whampoa>,
        <https://1145.am/db/2659872/Hutchison_Whampoa>,
        <https://1145.am/db/2659970/Hutchison_Whampoa>,
        <https://1145.am/db/2660604/Hutchison_Whampoa>,
        <https://1145.am/db/2661115/Hutchison_Whampoa>,
        <https://1145.am/db/2661611/Hutchison_Whampoa>,
        <https://1145.am/db/2661995/Hutchison_Whampoa>,
        <https://1145.am/db/2662060/Hutchison_Whampoa>,
        <https://1145.am/db/2662671/Hutchison_Whampoa>,
        <https://1145.am/db/2663091/Hutchison_Whampoa>,
        <https://1145.am/db/2663180/Hutchison_Whampoa>,
        <https://1145.am/db/2663765/Hutchison_Whampoa>,
        <https://1145.am/db/2663773/Hutchison_Whampoa>,
        <https://1145.am/db/2664160/Hutchison_Whampoa>,
        <https://1145.am/db/2664193/Hutchison_Whampoa>,
        <https://1145.am/db/2665345/Hutchison_Whampoa>,
        <https://1145.am/db/2666404/Hutchison_Whampoa>,
        <https://1145.am/db/2666405/Hutchison_Whampoa>,
        <https://1145.am/db/2666440/Hutchison_Whampoa>,
        <https://1145.am/db/2666446/Hutchison_Whampoa>,
        <https://1145.am/db/2667500/Hutchison_Whampoa>,
        <https://1145.am/db/2667525/Hutchison_Whampoa>,
        <https://1145.am/db/2668564/Hutchison_Whampoa>,
        <https://1145.am/db/2668609/Hutchison_Whampoa>,
        <https://1145.am/db/2669163/Hutchison_Whampoa>,
        <https://1145.am/db/2669627/Hutchison_Whampoa>,
        <https://1145.am/db/2669644/Hutchison_Whampoa>,
        <https://1145.am/db/2669657/Hutchison_Whampoa>,
        <https://1145.am/db/2669661/Hutchison_Whampoa>,
        <https://1145.am/db/2669679/Hutchison_Whampoa>,
        <https://1145.am/db/2669683/Hutchison_Whampoa>,
        <https://1145.am/db/2670738/Hutchison_Whampoa>,
        <https://1145.am/db/2670759/Hutchison_Whampoa>,
        <https://1145.am/db/2670760/Hutchison_Whampoa>,
        <https://1145.am/db/2671957/Hutchison_Whampoa>,
        <https://1145.am/db/2671975/Hutchison_Whampoa>,
        <https://1145.am/db/2674259/Hutchison_Whampoa>,
        <https://1145.am/db/2675045/Hutchison_Whampoa>,
        <https://1145.am/db/2675046/Hutchison_Whampoa>,
        <https://1145.am/db/2676214/Hutchison_Whampoa>,
        <https://1145.am/db/2676230/Hutchison_Whampoa>,
        <https://1145.am/db/2676888/Hutchison_Whampoa>,
        <https://1145.am/db/2677417/Hutchison_Whampoa>,
        <https://1145.am/db/2679024/Hutchison_Whampoa>,
        <https://1145.am/db/2680055/Hutchison_Whampoa>,
        <https://1145.am/db/2680659/Hutchison_Whampoa>,
        <https://1145.am/db/2681845/Hutchison_Whampoa> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2682450/At___T> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2682450/Leap_Acquisition> ;
    ns1:description "Business" ;
    ns1:documentDate "2013-08-12T14:10:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "M&A catches fire: 24M wireless subscribers moving from Tier 2 to Tier 1 carriers" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/m-a-catches-fire-24m-wireless-subscribers-moving-from-tier-2-to-tier-1-carriers> ;
    ns1:foundName "AT & T" ;
    ns1:name "AT & T" ;
    ns1:sameAsHigh <https://1145.am/db/1000082/At___T_Inc>,
        <https://1145.am/db/1822834/At___T>,
        <https://1145.am/db/1854000/At___T_*>,
        <https://1145.am/db/1862489/At___T>,
        <https://1145.am/db/1866809/At_T>,
        <https://1145.am/db/1899784/At___T_Inc>,
        <https://1145.am/db/211185/At___T_Inc>,
        <https://1145.am/db/2156880/At___T>,
        <https://1145.am/db/2159365/At_T>,
        <https://1145.am/db/2161513/At___T>,
        <https://1145.am/db/2163075/At_T>,
        <https://1145.am/db/2164453/At___T>,
        <https://1145.am/db/2165870/At___T>,
        <https://1145.am/db/2167508/At___T>,
        <https://1145.am/db/2171126/At___T>,
        <https://1145.am/db/2172351/At_T>,
        <https://1145.am/db/2172670/At_T>,
        <https://1145.am/db/2172901/At_T>,
        <https://1145.am/db/2172911/At_T>,
        <https://1145.am/db/2173620/At_T>,
        <https://1145.am/db/2175520/At_T>,
        <https://1145.am/db/2176832/At_T>,
        <https://1145.am/db/2598875/At___T>,
        <https://1145.am/db/2598969/At___T>,
        <https://1145.am/db/2604247/At_T>,
        <https://1145.am/db/2604314/At___T>,
        <https://1145.am/db/2604539/At_T>,
        <https://1145.am/db/2607386/At___T>,
        <https://1145.am/db/2610751/At___T>,
        <https://1145.am/db/2613122/At_T>,
        <https://1145.am/db/2615500/At_T>,
        <https://1145.am/db/2619593/At___T>,
        <https://1145.am/db/2627103/At_T>,
        <https://1145.am/db/2628029/At___T>,
        <https://1145.am/db/2628926/At_T>,
        <https://1145.am/db/2628936/At_T>,
        <https://1145.am/db/2628948/At_T>,
        <https://1145.am/db/2629910/At_T>,
        <https://1145.am/db/2632273/At_T>,
        <https://1145.am/db/2633827/At___T>,
        <https://1145.am/db/2636649/At___T>,
        <https://1145.am/db/2640140/At_T>,
        <https://1145.am/db/2641554/At_T>,
        <https://1145.am/db/2650269/At_T>,
        <https://1145.am/db/2652823/At_T>,
        <https://1145.am/db/2658220/At_T>,
        <https://1145.am/db/2658524/At___T>,
        <https://1145.am/db/2659075/At___T>,
        <https://1145.am/db/2659265/At_T>,
        <https://1145.am/db/2660524/At___T>,
        <https://1145.am/db/2664500/At_T>,
        <https://1145.am/db/2664505/At___Ts>,
        <https://1145.am/db/2664547/At_T>,
        <https://1145.am/db/2667130/At___T>,
        <https://1145.am/db/2667338/At___T>,
        <https://1145.am/db/2668814/At_T>,
        <https://1145.am/db/2676075/At_T>,
        <https://1145.am/db/2678753/At_T>,
        <https://1145.am/db/2680906/At___T>,
        <https://1145.am/db/2681695/At___T_Mobility>,
        <https://1145.am/db/2681734/At_T>,
        <https://1145.am/db/2684148/At_T>,
        <https://1145.am/db/2685930/At_T>,
        <https://1145.am/db/2685941/At_T>,
        <https://1145.am/db/335104/At___T_Inc>,
        <https://1145.am/db/713292/At___T_Inc>,
        <https://1145.am/db/796295/At___T> ;
    ns1:sameAsMedium <https://1145.am/db/1308612/At___T>,
        <https://1145.am/db/144483/At___T_Inc>,
        <https://1145.am/db/167287/At___T_Inc>,
        <https://1145.am/db/1677823/At___T_Inc>,
        <https://1145.am/db/1694065/At_T>,
        <https://1145.am/db/1707104/At___T>,
        <https://1145.am/db/1717987/At_T>,
        <https://1145.am/db/1751612/At___T>,
        <https://1145.am/db/1756446/At___T>,
        <https://1145.am/db/1760205/At_T>,
        <https://1145.am/db/1778517/At___T>,
        <https://1145.am/db/1778753/At___T>,
        <https://1145.am/db/1779566/At___T>,
        <https://1145.am/db/1785893/At_T>,
        <https://1145.am/db/1788936/At___T>,
        <https://1145.am/db/1789394/At___T>,
        <https://1145.am/db/1796420/At___T>,
        <https://1145.am/db/1799816/At_T>,
        <https://1145.am/db/1810646/At_T>,
        <https://1145.am/db/1812513/At___T>,
        <https://1145.am/db/1824992/At___T>,
        <https://1145.am/db/1826385/At_T>,
        <https://1145.am/db/1836084/At___T>,
        <https://1145.am/db/1850952/At___T>,
        <https://1145.am/db/1853716/At___T>,
        <https://1145.am/db/1859847/At___T>,
        <https://1145.am/db/1888480/At___T>,
        <https://1145.am/db/1901295/At___T>,
        <https://1145.am/db/1901770/At___T>,
        <https://1145.am/db/206449/At___T_Inc>,
        <https://1145.am/db/2157127/At___T>,
        <https://1145.am/db/2157161/At_T>,
        <https://1145.am/db/2157500/At___T>,
        <https://1145.am/db/2157633/At_T>,
        <https://1145.am/db/2157791/At___T>,
        <https://1145.am/db/2157795/At_T>,
        <https://1145.am/db/2157931/At_T>,
        <https://1145.am/db/2157947/At___T>,
        <https://1145.am/db/2157965/At___T>,
        <https://1145.am/db/2158219/At_T>,
        <https://1145.am/db/2158287/At___T>,
        <https://1145.am/db/2158505/At_T>,
        <https://1145.am/db/2158868/At_T>,
        <https://1145.am/db/2159143/At___T>,
        <https://1145.am/db/2159599/At___T>,
        <https://1145.am/db/2160074/At___T>,
        <https://1145.am/db/2162041/At_T>,
        <https://1145.am/db/2162163/At___T>,
        <https://1145.am/db/2162249/At___T>,
        <https://1145.am/db/2162280/At_T>,
        <https://1145.am/db/2162386/At_T>,
        <https://1145.am/db/2162741/At___T>,
        <https://1145.am/db/2162994/At___T>,
        <https://1145.am/db/2163699/At___T>,
        <https://1145.am/db/2163719/At_T>,
        <https://1145.am/db/2163888/At___T>,
        <https://1145.am/db/2163936/At___T>,
        <https://1145.am/db/2164870/At___T>,
        <https://1145.am/db/2165758/At___T>,
        <https://1145.am/db/2165984/At___T>,
        <https://1145.am/db/2166027/At_T>,
        <https://1145.am/db/2166622/At___T>,
        <https://1145.am/db/2167511/At___T>,
        <https://1145.am/db/2169802/At_T>,
        <https://1145.am/db/2169997/At___T>,
        <https://1145.am/db/2170598/At___T>,
        <https://1145.am/db/2170599/At___T>,
        <https://1145.am/db/2170755/At___T>,
        <https://1145.am/db/2171416/At_T>,
        <https://1145.am/db/2171918/At___T>,
        <https://1145.am/db/2172745/At___T>,
        <https://1145.am/db/2172998/At___T>,
        <https://1145.am/db/2173075/At___T>,
        <https://1145.am/db/2173138/At___T>,
        <https://1145.am/db/2173404/At___T>,
        <https://1145.am/db/2173415/At_T>,
        <https://1145.am/db/2173582/At___T>,
        <https://1145.am/db/2173586/At___T>,
        <https://1145.am/db/2173675/At_T>,
        <https://1145.am/db/2173980/At___T>,
        <https://1145.am/db/2174357/At_T>,
        <https://1145.am/db/2174408/At___T>,
        <https://1145.am/db/2174633/At_T>,
        <https://1145.am/db/2174986/At_T>,
        <https://1145.am/db/2175146/At___T>,
        <https://1145.am/db/2175475/At_T>,
        <https://1145.am/db/2175716/At_T>,
        <https://1145.am/db/2177450/At_T>,
        <https://1145.am/db/2177451/At_T>,
        <https://1145.am/db/2177458/At_T>,
        <https://1145.am/db/2177576/At___T>,
        <https://1145.am/db/2177636/At___T>,
        <https://1145.am/db/2179905/At_T>,
        <https://1145.am/db/2186280/At___T>,
        <https://1145.am/db/2229162/At___T>,
        <https://1145.am/db/2262401/At___T>,
        <https://1145.am/db/2266575/At_T>,
        <https://1145.am/db/2452684/At___T_Inc>,
        <https://1145.am/db/249455/At___T_Inc>,
        <https://1145.am/db/2598996/At_T>,
        <https://1145.am/db/2599069/At___T>,
        <https://1145.am/db/2599373/At___T>,
        <https://1145.am/db/2599572/At_T>,
        <https://1145.am/db/2599648/At___T>,
        <https://1145.am/db/2600001/At___T>,
        <https://1145.am/db/2600004/At___T>,
        <https://1145.am/db/2600202/At___T>,
        <https://1145.am/db/2600515/At___T>,
        <https://1145.am/db/2600548/At_T>,
        <https://1145.am/db/2600561/At_T>,
        <https://1145.am/db/2601297/At_T>,
        <https://1145.am/db/2601425/At_T>,
        <https://1145.am/db/2601887/At___T>,
        <https://1145.am/db/2602156/At___T>,
        <https://1145.am/db/2602281/At___T>,
        <https://1145.am/db/2602579/At_T>,
        <https://1145.am/db/2603377/At___T>,
        <https://1145.am/db/2603439/At___T>,
        <https://1145.am/db/2603531/At_T>,
        <https://1145.am/db/2603590/At___T>,
        <https://1145.am/db/2604223/At___T>,
        <https://1145.am/db/2604863/At___T>,
        <https://1145.am/db/2604967/At_T>,
        <https://1145.am/db/2604977/At___T>,
        <https://1145.am/db/2605006/At___T>,
        <https://1145.am/db/2605344/At_T>,
        <https://1145.am/db/2605760/At___T>,
        <https://1145.am/db/2606502/At___T>,
        <https://1145.am/db/2606612/At___T>,
        <https://1145.am/db/2606761/At___T>,
        <https://1145.am/db/2607794/At_T>,
        <https://1145.am/db/2607834/At_T>,
        <https://1145.am/db/2608701/At___T>,
        <https://1145.am/db/2608961/At_T>,
        <https://1145.am/db/2609030/At_T>,
        <https://1145.am/db/2609668/At_T>,
        <https://1145.am/db/2610620/At_T>,
        <https://1145.am/db/2611067/At_T>,
        <https://1145.am/db/2611202/At___T>,
        <https://1145.am/db/2611854/At___T>,
        <https://1145.am/db/2613066/At_T>,
        <https://1145.am/db/2614651/At___T>,
        <https://1145.am/db/2614719/At___T>,
        <https://1145.am/db/2614737/At___T>,
        <https://1145.am/db/2614886/At_T>,
        <https://1145.am/db/2615213/At_T>,
        <https://1145.am/db/2615516/At_T>,
        <https://1145.am/db/2616317/At_T>,
        <https://1145.am/db/2616340/At___T>,
        <https://1145.am/db/2617072/At___T>,
        <https://1145.am/db/2617377/At___T>,
        <https://1145.am/db/2617606/At_T>,
        <https://1145.am/db/2617838/At___T>,
        <https://1145.am/db/2619115/At_T>,
        <https://1145.am/db/2619421/At_T>,
        <https://1145.am/db/2619596/At___T>,
        <https://1145.am/db/2619745/At___T>,
        <https://1145.am/db/2620484/At___T>,
        <https://1145.am/db/2620838/At_T>,
        <https://1145.am/db/2622833/At___T>,
        <https://1145.am/db/2623193/At___T>,
        <https://1145.am/db/2623936/At___T>,
        <https://1145.am/db/2624400/At_T>,
        <https://1145.am/db/2624431/At_T>,
        <https://1145.am/db/2625058/At_T>,
        <https://1145.am/db/2625764/At_T>,
        <https://1145.am/db/2625808/At_T>,
        <https://1145.am/db/2626750/At___T>,
        <https://1145.am/db/2627018/At___T>,
        <https://1145.am/db/2627470/At___T>,
        <https://1145.am/db/2627982/At_T>,
        <https://1145.am/db/2628482/At_T>,
        <https://1145.am/db/2629447/At___T>,
        <https://1145.am/db/2630839/At_T>,
        <https://1145.am/db/2631175/At___T>,
        <https://1145.am/db/2631207/At___T>,
        <https://1145.am/db/2632121/At___T>,
        <https://1145.am/db/2632131/At___T>,
        <https://1145.am/db/2633416/At___T>,
        <https://1145.am/db/2633504/At_T>,
        <https://1145.am/db/2634130/At___T>,
        <https://1145.am/db/2634349/At_T>,
        <https://1145.am/db/2635751/At___T>,
        <https://1145.am/db/2636028/At___T>,
        <https://1145.am/db/2636629/At___T>,
        <https://1145.am/db/2636927/At___T>,
        <https://1145.am/db/2637568/At___T>,
        <https://1145.am/db/2637597/At_T>,
        <https://1145.am/db/2637732/At___T>,
        <https://1145.am/db/2638620/At___T>,
        <https://1145.am/db/2639462/At_T>,
        <https://1145.am/db/2639641/At_T>,
        <https://1145.am/db/2640631/At___T>,
        <https://1145.am/db/2640947/At_T>,
        <https://1145.am/db/2640950/At_T>,
        <https://1145.am/db/2641156/At_T>,
        <https://1145.am/db/2641303/At_T>,
        <https://1145.am/db/2642326/At___T>,
        <https://1145.am/db/2642638/At_T>,
        <https://1145.am/db/2643619/At_T>,
        <https://1145.am/db/2644481/At___T>,
        <https://1145.am/db/2646315/At___T>,
        <https://1145.am/db/2648327/At___T>,
        <https://1145.am/db/2648632/At_T>,
        <https://1145.am/db/2649776/At___T>,
        <https://1145.am/db/2649914/At_T>,
        <https://1145.am/db/2651977/At_T>,
        <https://1145.am/db/2652105/At___T>,
        <https://1145.am/db/2652671/At___T>,
        <https://1145.am/db/2652765/At___T>,
        <https://1145.am/db/2652834/At_T>,
        <https://1145.am/db/2652840/At_T>,
        <https://1145.am/db/2653426/At_T>,
        <https://1145.am/db/2653492/At_T>,
        <https://1145.am/db/2653594/At___T>,
        <https://1145.am/db/2653676/At___T>,
        <https://1145.am/db/2654379/At___T>,
        <https://1145.am/db/2654386/At_T>,
        <https://1145.am/db/2655150/At___T>,
        <https://1145.am/db/2655429/At___T>,
        <https://1145.am/db/2655954/At___T>,
        <https://1145.am/db/2656604/At___T>,
        <https://1145.am/db/2657126/At___T>,
        <https://1145.am/db/2657127/At___T>,
        <https://1145.am/db/2657140/At___T>,
        <https://1145.am/db/2657220/At___T>,
        <https://1145.am/db/2658006/At___T>,
        <https://1145.am/db/2658238/At___T>,
        <https://1145.am/db/2658539/At___T>,
        <https://1145.am/db/2659619/At_T>,
        <https://1145.am/db/2660189/At_T>,
        <https://1145.am/db/2660328/At_T>,
        <https://1145.am/db/2660785/At___T>,
        <https://1145.am/db/2661120/At___T>,
        <https://1145.am/db/2661159/At_T>,
        <https://1145.am/db/2661168/At___T>,
        <https://1145.am/db/2661274/At_T>,
        <https://1145.am/db/2661290/At_T>,
        <https://1145.am/db/2661418/At___T>,
        <https://1145.am/db/2661680/At_T>,
        <https://1145.am/db/2662193/At___T>,
        <https://1145.am/db/2662354/At_T>,
        <https://1145.am/db/2662383/At___T>,
        <https://1145.am/db/2663214/At___T>,
        <https://1145.am/db/2663406/At_T>,
        <https://1145.am/db/2663421/At___T>,
        <https://1145.am/db/2664378/At_T>,
        <https://1145.am/db/2664517/At_T>,
        <https://1145.am/db/2664691/At___T>,
        <https://1145.am/db/2664887/At___T>,
        <https://1145.am/db/2665469/At___T>,
        <https://1145.am/db/2665579/At_T>,
        <https://1145.am/db/2665710/At___T>,
        <https://1145.am/db/2665731/At_T>,
        <https://1145.am/db/2666095/At_T>,
        <https://1145.am/db/2666575/At___T>,
        <https://1145.am/db/2666714/At_T>,
        <https://1145.am/db/2667132/At___T>,
        <https://1145.am/db/2668714/At_T>,
        <https://1145.am/db/2668735/At___T>,
        <https://1145.am/db/2669621/At___T>,
        <https://1145.am/db/2669628/At_T>,
        <https://1145.am/db/2669920/At_T>,
        <https://1145.am/db/2669926/At_T>,
        <https://1145.am/db/2671029/At_T>,
        <https://1145.am/db/2671484/At_T>,
        <https://1145.am/db/2671605/At_T>,
        <https://1145.am/db/2671920/At_T>,
        <https://1145.am/db/2672079/At_T>,
        <https://1145.am/db/2672172/At___T>,
        <https://1145.am/db/2672184/At_T>,
        <https://1145.am/db/2673753/At___T>,
        <https://1145.am/db/2673923/At___T>,
        <https://1145.am/db/2674316/At_T>,
        <https://1145.am/db/2674918/At___T>,
        <https://1145.am/db/2677102/At___T>,
        <https://1145.am/db/2677549/At_T>,
        <https://1145.am/db/2677987/At___T>,
        <https://1145.am/db/2678311/At_T>,
        <https://1145.am/db/2679157/At___T>,
        <https://1145.am/db/2679240/At_T>,
        <https://1145.am/db/2679476/At_T>,
        <https://1145.am/db/2679803/At___T>,
        <https://1145.am/db/2680232/At___T>,
        <https://1145.am/db/2680246/At_T>,
        <https://1145.am/db/2680251/At_T>,
        <https://1145.am/db/2680761/At___T>,
        <https://1145.am/db/2680894/At_T>,
        <https://1145.am/db/2680897/At___T>,
        <https://1145.am/db/2680905/At___T>,
        <https://1145.am/db/2681046/At___T>,
        <https://1145.am/db/2681072/At___T>,
        <https://1145.am/db/2681074/At___T>,
        <https://1145.am/db/2681829/At___T>,
        <https://1145.am/db/2682409/At_T>,
        <https://1145.am/db/2682447/At___T>,
        <https://1145.am/db/2682574/At___T>,
        <https://1145.am/db/2682630/At___T>,
        <https://1145.am/db/2682698/At___T>,
        <https://1145.am/db/2682715/At_T>,
        <https://1145.am/db/2683008/At___T>,
        <https://1145.am/db/2683098/At___T>,
        <https://1145.am/db/2683420/At___T>,
        <https://1145.am/db/2683473/At_T>,
        <https://1145.am/db/2683713/At___T>,
        <https://1145.am/db/2683735/At___T>,
        <https://1145.am/db/2684028/At___T>,
        <https://1145.am/db/2684435/At_T>,
        <https://1145.am/db/2684439/At___T>,
        <https://1145.am/db/2684475/At___T>,
        <https://1145.am/db/2684713/At___T>,
        <https://1145.am/db/2684726/At___T>,
        <https://1145.am/db/2685112/At___T>,
        <https://1145.am/db/2685243/At___T>,
        <https://1145.am/db/2685245/At___T>,
        <https://1145.am/db/2685254/At___T>,
        <https://1145.am/db/2685271/At___T>,
        <https://1145.am/db/2685285/At___T>,
        <https://1145.am/db/2685505/At_T>,
        <https://1145.am/db/2685526/At___T>,
        <https://1145.am/db/2685618/At_T>,
        <https://1145.am/db/2685640/At_T>,
        <https://1145.am/db/2685654/At___T>,
        <https://1145.am/db/2685762/At_T>,
        <https://1145.am/db/2685811/At_T>,
        <https://1145.am/db/2685903/At___T>,
        <https://1145.am/db/2685940/At_T>,
        <https://1145.am/db/2686475/At_T>,
        <https://1145.am/db/2686540/At___T>,
        <https://1145.am/db/334907/At_T>,
        <https://1145.am/db/401388/At___T>,
        <https://1145.am/db/470135/At___T_Inc>,
        <https://1145.am/db/485256/At_T>,
        <https://1145.am/db/513323/At___T>,
        <https://1145.am/db/6235/At___T>,
        <https://1145.am/db/710355/At___T_Inc>,
        <https://1145.am/db/710798/At___T_Inc>,
        <https://1145.am/db/715099/At___T_Inc>,
        <https://1145.am/db/715441/At___T_Inc>,
        <https://1145.am/db/724048/At___T>,
        <https://1145.am/db/725944/At___T>,
        <https://1145.am/db/737813/At___T_Inc>,
        <https://1145.am/db/897774/At___T>,
        <https://1145.am/db/966560/At___T_Inc> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2682450/T-Mobile_Us> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:buyer <https://1145.am/db/2682450/Clearwire_Acquisition>,
        <https://1145.am/db/2682450/Metropcs_Acquisition> ;
    ns1:description "mergers and acquisitions" ;
    ns1:documentDate "2013-08-12T14:10:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "M&A catches fire: 24M wireless subscribers moving from Tier 2 to Tier 1 carriers" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/m-a-catches-fire-24m-wireless-subscribers-moving-from-tier-2-to-tier-1-carriers> ;
    ns1:foundName "T-Mobile US" ;
    ns1:industry "wireless carriers" ;
    ns1:name "T-Mobile US" ;
    ns1:sameAsHigh <https://1145.am/db/1706069/T-Mobile>,
        <https://1145.am/db/1729077/T-Mobile_Uk>,
        <https://1145.am/db/1786440/T-Mobile>,
        <https://1145.am/db/1845755/T-Mobile_Us>,
        <https://1145.am/db/1849778/T-Mobile_Usa>,
        <https://1145.am/db/1938719/T-Mobile_Us_Inc>,
        <https://1145.am/db/2160856/T-Mobile_Us>,
        <https://1145.am/db/2162996/T-Mobile>,
        <https://1145.am/db/2625764/T-Mobile_Usa>,
        <https://1145.am/db/2626176/T-Mobile>,
        <https://1145.am/db/2633551/T-Mobile>,
        <https://1145.am/db/2636340/T-Mobile>,
        <https://1145.am/db/2640032/T-Mobile>,
        <https://1145.am/db/2640339/T-Mobile>,
        <https://1145.am/db/2646574/T-Mobile_And_Sprint>,
        <https://1145.am/db/2646883/T-Mobile>,
        <https://1145.am/db/2648336/T-Mobile>,
        <https://1145.am/db/2650593/T-Mobile_Us>,
        <https://1145.am/db/2655150/T-Mobile_Us>,
        <https://1145.am/db/2655430/T-Mobile>,
        <https://1145.am/db/2656030/T-Mobile_Us>,
        <https://1145.am/db/2657573/T-Mobile_Usa>,
        <https://1145.am/db/2661274/T-Mobile_Usa>,
        <https://1145.am/db/2661405/T-Mobile_Us>,
        <https://1145.am/db/2662383/T-Mobile>,
        <https://1145.am/db/2662808/T-Mobile_Usa>,
        <https://1145.am/db/2663473/T-Mobile_Usa>,
        <https://1145.am/db/2664505/T-Mobile_Usa>,
        <https://1145.am/db/2665477/T-Mobile_Us>,
        <https://1145.am/db/2667222/T-Mobile>,
        <https://1145.am/db/2667612/T-Mobile>,
        <https://1145.am/db/2669926/T-Mobile_Usa>,
        <https://1145.am/db/2670397/T-Mobile_Usa>,
        <https://1145.am/db/2671623/T-Mobile_Usa>,
        <https://1145.am/db/2671629/T-Mobile_Usa>,
        <https://1145.am/db/2672184/T-Mobile_Usa>,
        <https://1145.am/db/2676846/T-Mobile_Us>,
        <https://1145.am/db/2681407/T-Mobile_Us>,
        <https://1145.am/db/2685243/T-Mobile>,
        <https://1145.am/db/2685271/T-Mobile_Usa>,
        <https://1145.am/db/2685285/T-Mobile_Usa>,
        <https://1145.am/db/2685526/T-Mobile>,
        <https://1145.am/db/453209/T-Mobile>,
        <https://1145.am/db/461272/T-Mobile_Us_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1325578/T-Mobile_Us_Inc>,
        <https://1145.am/db/1333909/T-Mobile_Us>,
        <https://1145.am/db/1335192/T-Mobile_Usa>,
        <https://1145.am/db/1335249/T-Mobile_Usa>,
        <https://1145.am/db/1338725/T-Mobile_Us>,
        <https://1145.am/db/1673449/T-Mobile_Us>,
        <https://1145.am/db/1682956/T-Mobile_Us>,
        <https://1145.am/db/2050728/T-Mobile_Us>,
        <https://1145.am/db/2113124/T-Mobile_Usa>,
        <https://1145.am/db/2113624/T-Mobile_Us>,
        <https://1145.am/db/2156872/T-Mobile_Us>,
        <https://1145.am/db/2624400/T-Mobile_Usa>,
        <https://1145.am/db/2625058/T-Mobile_Usa>,
        <https://1145.am/db/2625808/T-Mobile_Usa>,
        <https://1145.am/db/2627253/T-Mobile_Usa>,
        <https://1145.am/db/2627982/T-Mobile_Usa>,
        <https://1145.am/db/2628029/T-Mobile_Usa>,
        <https://1145.am/db/2628936/T-Mobile_Usa>,
        <https://1145.am/db/2628948/T-Mobile_Usa>,
        <https://1145.am/db/2629910/T-Mobile_Usa>,
        <https://1145.am/db/2630839/T-Mobile_Usa>,
        <https://1145.am/db/2639641/T-Mobile_Usa>,
        <https://1145.am/db/2640440/T-Mobile_Usa>,
        <https://1145.am/db/2640631/T-Mobile_Usa>,
        <https://1145.am/db/2643007/T-Mobile_Usa>,
        <https://1145.am/db/2644928/T-Mobile_Us>,
        <https://1145.am/db/2645879/T-Mobile_Us>,
        <https://1145.am/db/2651447/T-Mobile_Usa>,
        <https://1145.am/db/2653683/T-Mobile_Us>,
        <https://1145.am/db/2653777/T-Mobile_Usa>,
        <https://1145.am/db/2654246/T-Mobile_Us>,
        <https://1145.am/db/2654263/T-Mobile_Us>,
        <https://1145.am/db/2655154/T-Mobile_Us>,
        <https://1145.am/db/2656226/T-Mobile_Us>,
        <https://1145.am/db/2656851/T-Mobile_Usa>,
        <https://1145.am/db/2658024/T-Mobile_Us>,
        <https://1145.am/db/2658043/T-Mobile_Us>,
        <https://1145.am/db/2658068/T-Mobile_Us>,
        <https://1145.am/db/2658213/T-Mobile_Us>,
        <https://1145.am/db/2658466/T-Mobile_Usa>,
        <https://1145.am/db/2658550/T-Mobile_Usa>,
        <https://1145.am/db/2658574/T-Mobile_Usa>,
        <https://1145.am/db/2658575/T-Mobile_Usa>,
        <https://1145.am/db/2659586/T-Mobile_Usa>,
        <https://1145.am/db/2659597/T-Mobile_Usa>,
        <https://1145.am/db/2661143/T-Mobile_Us>,
        <https://1145.am/db/2661290/T-Mobile_Usa>,
        <https://1145.am/db/2661443/T-Mobile_Us>,
        <https://1145.am/db/2661680/T-Mobile_Usa>,
        <https://1145.am/db/2662860/T-Mobile_Usa>,
        <https://1145.am/db/2663146/T-Mobile_Us>,
        <https://1145.am/db/2663406/T-Mobile_Usa>,
        <https://1145.am/db/2663421/T-Mobile_Usa>,
        <https://1145.am/db/2663892/T-Mobile_Usa>,
        <https://1145.am/db/2664422/T-Mobile_Us>,
        <https://1145.am/db/2664500/T-Mobile_Usa>,
        <https://1145.am/db/2664517/T-Mobile_Usa>,
        <https://1145.am/db/2664547/T-Mobile_Usa>,
        <https://1145.am/db/2664692/T-Mobile_Us>,
        <https://1145.am/db/2665579/T-Mobile_Usa>,
        <https://1145.am/db/2666714/T-Mobile_Usa>,
        <https://1145.am/db/2667620/T-Mobile_Us>,
        <https://1145.am/db/2668208/T-Mobile_Usa>,
        <https://1145.am/db/2668212/T-Mobile_Usa>,
        <https://1145.am/db/2668226/T-Mobile_Usa>,
        <https://1145.am/db/2668687/T-Mobile_Us>,
        <https://1145.am/db/2668814/T-Mobile_Usa>,
        <https://1145.am/db/2669319/T-Mobile_Usa>,
        <https://1145.am/db/2669321/T-Mobile_Usa>,
        <https://1145.am/db/2669338/T-Mobile_Usa>,
        <https://1145.am/db/2669512/T-Mobile_Us>,
        <https://1145.am/db/2669881/T-Mobile_Usa>,
        <https://1145.am/db/2669920/T-Mobile_Usa>,
        <https://1145.am/db/2671029/T-Mobile_Usa>,
        <https://1145.am/db/2671585/T-Mobile_Usa>,
        <https://1145.am/db/2672172/T-Mobile_Usa>,
        <https://1145.am/db/2673934/T-Mobile_Usa>,
        <https://1145.am/db/2674405/T-Mobile_Us>,
        <https://1145.am/db/2675647/T-Mobile_Us>,
        <https://1145.am/db/2677262/T-Mobile_Usa>,
        <https://1145.am/db/2677564/T-Mobile_Us>,
        <https://1145.am/db/2677884/T-Mobile_Us>,
        <https://1145.am/db/2678023/T-Mobile_Us>,
        <https://1145.am/db/2679803/T-Mobile_Usa>,
        <https://1145.am/db/2679871/T-Mobile_Us>,
        <https://1145.am/db/2680365/T-Mobile_Usa>,
        <https://1145.am/db/2681282/T-Mobile_Usa>,
        <https://1145.am/db/2681734/T-Mobile_Us>,
        <https://1145.am/db/2681889/T-Mobile_Us>,
        <https://1145.am/db/2682066/T-Mobile_Usa>,
        <https://1145.am/db/2682698/T-Mobile_Usa>,
        <https://1145.am/db/2683912/T-Mobile_Usa>,
        <https://1145.am/db/2684079/T-Mobile_Usa>,
        <https://1145.am/db/2684148/T-Mobile_Us>,
        <https://1145.am/db/2684705/T-Mobile_Usa>,
        <https://1145.am/db/2685202/T-Mobile_Usa>,
        <https://1145.am/db/2685245/T-Mobile_Usa>,
        <https://1145.am/db/2685254/T-Mobile_Usa>,
        <https://1145.am/db/2685267/T-Mobile_Usa>,
        <https://1145.am/db/2685505/T-Mobile_Usa>,
        <https://1145.am/db/2685618/T-Mobile_Usa>,
        <https://1145.am/db/2685624/T-Mobile_Usa>,
        <https://1145.am/db/2685654/T-Mobile_Usa>,
        <https://1145.am/db/2685762/T-Mobile_Usa>,
        <https://1145.am/db/2685783/T-Mobile_Usa>,
        <https://1145.am/db/2685799/T-Mobile_Usa>,
        <https://1145.am/db/2685811/T-Mobile_Usa>,
        <https://1145.am/db/2685884/T-Mobile_Usa>,
        <https://1145.am/db/2685930/T-Mobile_Usa>,
        <https://1145.am/db/2685940/T-Mobile_Usa>,
        <https://1145.am/db/2686023/T-Mobile_Usa>,
        <https://1145.am/db/2686200/T-Mobile_Usa>,
        <https://1145.am/db/398217/T-Mobile_Us>,
        <https://1145.am/db/479322/T-Mobile_Us>,
        <https://1145.am/db/480217/T-Mobile_Us>,
        <https://1145.am/db/662586/T-Mobile_Usa>,
        <https://1145.am/db/665472/T-Mobile_Usa>,
        <https://1145.am/db/667175/T-Mobile_Usa>,
        <https://1145.am/db/97818/T-Mobile_Us> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2683079/Blackberry_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "ipo" ;
    ns1:documentDate "2013-09-04T21:18:47+00:00"^^xsd:dateTime ;
    ns1:documentExtract "BlackBerry (NASDAQ: BBRY) hopes to conclude a sale of the company by November, according to a Wall Street Journal report, an indication that an auction of the company is the most likely \"strategic alternative\" that the company's board has been exploring." ;
    ns1:documentTitle "Report: BlackBerry hopes to wrap up sales process by November" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-blackberry-hopes-to-wrap-up-sales-process-by-november> ;
    ns1:foundName "auction",
        "sale" ;
    ns1:name "auction",
        "sale" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2683079/Blackberry> ;
    ns1:targetName "BlackBerry" .

<https://1145.am/db/2684131/Fairfax_Financial_Holdings> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:buyer <https://1145.am/db/2684131/Blackberry_Acquisition> ;
    ns1:description "investing" ;
    ns1:documentDate "2013-10-07T14:25:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: BlackBerry in talks with Google, Cisco, SAP" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-blackberry-talks-google-cisco-sap> ;
    ns1:foundName "Fairfax Financial Holdings" ;
    ns1:investor <https://1145.am/db/2684131/Blackberry_Acquisition> ;
    ns1:name "Fairfax Financial Holdings" ;
    ns1:sameAsHigh <https://1145.am/db/1146873/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/1147654/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/1147663/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/1259809/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/1267846/Fairfax_Financial_Holdings_Ltd>,
        <https://1145.am/db/1274437/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/1370088/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/1370456/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/1370586/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/1628444/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/417474/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/422862/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/824937/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/930308/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/932948/Fairfax_Financial_Holdings_Limited> ;
    ns1:sameAsMedium <https://1145.am/db/1398591/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/1400155/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/1400170/Fairfax_Financial_Holdings_Limited>,
        <https://1145.am/db/2683804/Fairfax_Financial_Holdings> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2684180/Gungho_Online_Entertainment> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:buyer <https://1145.am/db/2684180/Supercell_Stake_Acquisition> ;
    ns1:description "game developer" ;
    ns1:documentDate "2013-10-16T14:58:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SoftBank eyeing a stake in wireless distributor Brightstar" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/softbank-eyeing-a-stake-wireless-distributor-brightstar> ;
    ns1:foundName "GungHo Online Entertainment" ;
    ns1:industry "game developer" ;
    ns1:name "GungHo Online Entertainment" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2684180/Softbank> a org:Organization ;
    ns1:basedInHighGeoName "Tokyo" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1850147/about.rdf> ;
    ns1:basedInHighRaw "Tokyo" ;
    ns1:buyer <https://1145.am/db/2684180/Brightstar_Corp_Stake_Acquisition> ;
    ns1:description "mobile game" ;
    ns1:documentDate "2013-10-16T14:58:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SoftBank eyeing a stake in wireless distributor Brightstar" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/softbank-eyeing-a-stake-wireless-distributor-brightstar> ;
    ns1:foundName "SoftBank" ;
    ns1:investor <https://1145.am/db/2684180/Brightstar_Corp_Stake_Acquisition> ;
    ns1:name "SoftBank" ;
    ns1:participant <https://1145.am/db/2684180/Supercell_Stake_Acquisition> ;
    ns1:sameAsMedium <https://1145.am/db/103808/Softbank_Corp>,
        <https://1145.am/db/1129671/Softbank>,
        <https://1145.am/db/1130952/Softbank>,
        <https://1145.am/db/1140286/Softbank>,
        <https://1145.am/db/116996/Softbank>,
        <https://1145.am/db/1179523/Softbank>,
        <https://1145.am/db/1193504/Softbank>,
        <https://1145.am/db/1215073/Softbank>,
        <https://1145.am/db/1255221/Softbank>,
        <https://1145.am/db/1347499/Softbank>,
        <https://1145.am/db/1492141/Softbank>,
        <https://1145.am/db/1558864/Softbank>,
        <https://1145.am/db/1566837/Softbank>,
        <https://1145.am/db/1684127/Softbank>,
        <https://1145.am/db/1694388/Softbank>,
        <https://1145.am/db/1734925/Softbank>,
        <https://1145.am/db/1735554/Softbank>,
        <https://1145.am/db/1735679/Softbank>,
        <https://1145.am/db/1739469/Softbank>,
        <https://1145.am/db/1740946/Softbank>,
        <https://1145.am/db/1742129/Softbank>,
        <https://1145.am/db/1742163/Softbank>,
        <https://1145.am/db/1742280/Softbank>,
        <https://1145.am/db/1748253/Softbank_Corp>,
        <https://1145.am/db/1748731/Softbank>,
        <https://1145.am/db/1750206/Softbank>,
        <https://1145.am/db/1750248/Softbank>,
        <https://1145.am/db/1753451/Softbank>,
        <https://1145.am/db/1754897/Softbank>,
        <https://1145.am/db/1755776/Softbank>,
        <https://1145.am/db/1756852/Softbank>,
        <https://1145.am/db/1758188/Softbank>,
        <https://1145.am/db/1758916/Softbank>,
        <https://1145.am/db/1759748/Softbank>,
        <https://1145.am/db/1759802/Softbank>,
        <https://1145.am/db/1760606/Softbank>,
        <https://1145.am/db/1763417/Softbank>,
        <https://1145.am/db/1766871/Softbank>,
        <https://1145.am/db/1766892/Softbank>,
        <https://1145.am/db/1767668/Softbank>,
        <https://1145.am/db/1768278/Softbank>,
        <https://1145.am/db/1769212/Softbank>,
        <https://1145.am/db/1769550/Softbank>,
        <https://1145.am/db/1770897/Softbank>,
        <https://1145.am/db/1772843/Softbank>,
        <https://1145.am/db/1775977/Softbank>,
        <https://1145.am/db/1776410/Softbank>,
        <https://1145.am/db/1779650/Softbank>,
        <https://1145.am/db/1782128/Softbank>,
        <https://1145.am/db/1786903/Softbank>,
        <https://1145.am/db/1787663/Softbank>,
        <https://1145.am/db/1787801/Softbank>,
        <https://1145.am/db/1788297/Softbank>,
        <https://1145.am/db/1788831/Softbank>,
        <https://1145.am/db/1789602/Softbank>,
        <https://1145.am/db/1790374/Softbank>,
        <https://1145.am/db/1792881/Softbank>,
        <https://1145.am/db/1795875/Softbank>,
        <https://1145.am/db/1797477/Softbank>,
        <https://1145.am/db/1798154/Softbank>,
        <https://1145.am/db/1803340/Softbank>,
        <https://1145.am/db/1804251/Softbank>,
        <https://1145.am/db/1804413/Softbank>,
        <https://1145.am/db/1805577/Softbank>,
        <https://1145.am/db/1806191/Softbank>,
        <https://1145.am/db/1807737/Softbank>,
        <https://1145.am/db/1808504/Softbank>,
        <https://1145.am/db/1808604/Softbank>,
        <https://1145.am/db/1809360/Softbank>,
        <https://1145.am/db/1811437/Softbank>,
        <https://1145.am/db/1811458/Softbank>,
        <https://1145.am/db/1815886/Softbank>,
        <https://1145.am/db/1816406/Softbank>,
        <https://1145.am/db/1816990/Softbank>,
        <https://1145.am/db/1818582/Softbank>,
        <https://1145.am/db/1818992/Softbank>,
        <https://1145.am/db/1819190/Softbank>,
        <https://1145.am/db/1821102/Softbank>,
        <https://1145.am/db/1822498/Softbank>,
        <https://1145.am/db/1822884/Softbank>,
        <https://1145.am/db/1823172/Softbank>,
        <https://1145.am/db/1827733/Softbank>,
        <https://1145.am/db/1835740/Softbank>,
        <https://1145.am/db/1835811/Softbank_Corp>,
        <https://1145.am/db/1837864/Softbank>,
        <https://1145.am/db/1839534/Softbank_Corp>,
        <https://1145.am/db/1846380/Softbank>,
        <https://1145.am/db/1852090/Softbank>,
        <https://1145.am/db/1853730/Softbank>,
        <https://1145.am/db/1858650/Softbank>,
        <https://1145.am/db/1860196/Softbank>,
        <https://1145.am/db/1860815/Softbank>,
        <https://1145.am/db/1868572/Softbank>,
        <https://1145.am/db/1870857/Softbank>,
        <https://1145.am/db/1875218/Softbank>,
        <https://1145.am/db/1879401/Softbank>,
        <https://1145.am/db/1893839/Softbank>,
        <https://1145.am/db/1921528/Softbank>,
        <https://1145.am/db/1950339/Softbank>,
        <https://1145.am/db/1956539/Softbank_Corp>,
        <https://1145.am/db/2056248/Softbank>,
        <https://1145.am/db/2059616/Softbank>,
        <https://1145.am/db/2084597/Softbank>,
        <https://1145.am/db/2107274/Softbank>,
        <https://1145.am/db/210986/Softbank_Corp>,
        <https://1145.am/db/2119946/Softbank>,
        <https://1145.am/db/2159062/Softbank_Corp>,
        <https://1145.am/db/2164394/Softbank>,
        <https://1145.am/db/2164415/Softbank_Corp>,
        <https://1145.am/db/2185522/Softbank>,
        <https://1145.am/db/2287135/Softbank>,
        <https://1145.am/db/2295289/Softbank>,
        <https://1145.am/db/2407089/Softbank>,
        <https://1145.am/db/2410135/Softbank>,
        <https://1145.am/db/2410849/Softbank>,
        <https://1145.am/db/2412438/Softbank>,
        <https://1145.am/db/2412439/Softbank>,
        <https://1145.am/db/2425544/Softbank_Corp>,
        <https://1145.am/db/2430024/Softbank>,
        <https://1145.am/db/244985/Softbank>,
        <https://1145.am/db/2616385/Softbank_Corp>,
        <https://1145.am/db/2616774/Softbank>,
        <https://1145.am/db/2618577/Softbank_Corp>,
        <https://1145.am/db/2629357/Softbank>,
        <https://1145.am/db/2630698/Softbank>,
        <https://1145.am/db/2633199/Softbank>,
        <https://1145.am/db/2643948/Softbank>,
        <https://1145.am/db/2648388/Softbank>,
        <https://1145.am/db/2648461/Softbank>,
        <https://1145.am/db/2653485/Softbank>,
        <https://1145.am/db/2654774/Softbank>,
        <https://1145.am/db/2655150/Softbank>,
        <https://1145.am/db/2655930/Softbank>,
        <https://1145.am/db/2655974/Softbank>,
        <https://1145.am/db/2656904/Softbank>,
        <https://1145.am/db/2656997/Softbank>,
        <https://1145.am/db/2658979/Softbank>,
        <https://1145.am/db/2658990/Softbank>,
        <https://1145.am/db/2659014/Softbank>,
        <https://1145.am/db/2659276/Softbank>,
        <https://1145.am/db/2659492/Softbank>,
        <https://1145.am/db/2659586/Softbank>,
        <https://1145.am/db/2659587/Softbank>,
        <https://1145.am/db/2659591/Softbank>,
        <https://1145.am/db/2659594/Softbank>,
        <https://1145.am/db/2659601/Softbank>,
        <https://1145.am/db/2659612/Softbank>,
        <https://1145.am/db/2659619/Softbank>,
        <https://1145.am/db/2659620/Softbank>,
        <https://1145.am/db/2659633/Softbank>,
        <https://1145.am/db/2661725/Softbank>,
        <https://1145.am/db/2663254/Softbank>,
        <https://1145.am/db/2664293/Softbank>,
        <https://1145.am/db/2664422/Softbank>,
        <https://1145.am/db/2665296/Softbank>,
        <https://1145.am/db/2666063/Softbank>,
        <https://1145.am/db/2666088/Softbank>,
        <https://1145.am/db/2666839/Softbank>,
        <https://1145.am/db/2667152/Softbank>,
        <https://1145.am/db/2669621/Softbank>,
        <https://1145.am/db/2670440/Softbank>,
        <https://1145.am/db/2670872/Softbank>,
        <https://1145.am/db/2671590/Softbank>,
        <https://1145.am/db/2675650/Softbank>,
        <https://1145.am/db/2675856/Softbank>,
        <https://1145.am/db/2676358/Softbank>,
        <https://1145.am/db/2676370/Softbank>,
        <https://1145.am/db/2676565/Softbank>,
        <https://1145.am/db/2677542/Softbank>,
        <https://1145.am/db/2678734/Softbank>,
        <https://1145.am/db/2678752/Softbank>,
        <https://1145.am/db/2678777/Softbank>,
        <https://1145.am/db/2679862/Softbank>,
        <https://1145.am/db/2679897/Softbank>,
        <https://1145.am/db/2680061/Softbank>,
        <https://1145.am/db/2684436/Softbank>,
        <https://1145.am/db/2749329/Softbank>,
        <https://1145.am/db/277038/Softbank>,
        <https://1145.am/db/283626/Softbank>,
        <https://1145.am/db/302450/Softbank>,
        <https://1145.am/db/328776/Softbank_Corp>,
        <https://1145.am/db/328788/Softbank_Corp>,
        <https://1145.am/db/329019/Softbank>,
        <https://1145.am/db/329219/Softbank>,
        <https://1145.am/db/329220/Softbank>,
        <https://1145.am/db/331680/Softbank>,
        <https://1145.am/db/343587/Softbank>,
        <https://1145.am/db/344177/Softbank>,
        <https://1145.am/db/357570/Softbank>,
        <https://1145.am/db/359190/Softbank>,
        <https://1145.am/db/368673/Softbank>,
        <https://1145.am/db/368676/Softbank>,
        <https://1145.am/db/369042/Softbank>,
        <https://1145.am/db/370085/Softbank>,
        <https://1145.am/db/377807/Softbank>,
        <https://1145.am/db/387932/Softbank>,
        <https://1145.am/db/394986/Softbank>,
        <https://1145.am/db/395563/Softbank>,
        <https://1145.am/db/437556/Softbank>,
        <https://1145.am/db/438632/Softbank>,
        <https://1145.am/db/439819/Softbank>,
        <https://1145.am/db/477269/Softbank>,
        <https://1145.am/db/488382/Softbank>,
        <https://1145.am/db/531806/Softbank>,
        <https://1145.am/db/559220/Softbank>,
        <https://1145.am/db/592879/Softbank_Corp>,
        <https://1145.am/db/638401/Softbank>,
        <https://1145.am/db/653010/Softbank>,
        <https://1145.am/db/667957/Softbank>,
        <https://1145.am/db/668011/Softbank>,
        <https://1145.am/db/670806/Softbank>,
        <https://1145.am/db/685688/Softbank>,
        <https://1145.am/db/745714/Softbank>,
        <https://1145.am/db/747644/Softbank>,
        <https://1145.am/db/752217/Softbank>,
        <https://1145.am/db/753020/Softbank>,
        <https://1145.am/db/778652/Softbank>,
        <https://1145.am/db/799047/Softbank>,
        <https://1145.am/db/799292/Softbank>,
        <https://1145.am/db/8080/Softbank>,
        <https://1145.am/db/813667/Softbank>,
        <https://1145.am/db/857493/Softbank>,
        <https://1145.am/db/886532/Softbank>,
        <https://1145.am/db/915106/Softbank>,
        <https://1145.am/db/930512/Softbank>,
        <https://1145.am/db/976375/Softbank>,
        <https://1145.am/db/999577/Softbank> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2175059/Tv_Everywhere_Completed> a ns1:CorporateFinanceActivity ;
    ns1:documentDate "2013-10-14T15:14:12+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> DOCOMO PACIFIC launched TV Everywhere services that allow its cable TV subscribers to watch shows on their Wi-Fi-capable devices including personal computers, laptops, tablets and smartphones." ;
    ns1:documentTitle "Aereo set to launch Android app; Vodafone closes Kabel Deutschland deal" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/aereo-set-to-launch-android-app-vodafone-closes-kabel-deutschland-deal> ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Pacific County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5806002/about.rdf> ;
    ns1:whereRaw "PACIFIC" .

<https://1145.am/db/2175059/Uk_Internet_Television_Service> a org:Organization ;
    ns1:basedInLowRaw "U.K." ;
    ns1:description "Internet television service" ;
    ns1:documentDate "2013-10-14T15:14:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aereo set to launch Android app; Vodafone closes Kabel Deutschland deal" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/aereo-set-to-launch-android-app-vodafone-closes-kabel-deutschland-deal> ;
    ns1:foundName "TVCatchup" ;
    ns1:name "U.K. Internet television service" ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2229117/Health_Catalyst> a org:Organization ;
    ns1:basedInHighGeoName "Salt Lake City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5780993/about.rdf> ;
    ns1:basedInHighRaw "Salt Lake City" ;
    ns1:documentDate "2014-01-29T18:46:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Health Catalyst raises $41 million for product development; Austin City Council raises concerns over athenahealth deal;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/health-catalyst-raises-41-million-for-product-development-austin-city-council-raises-concerns> ;
    ns1:foundName "Health Catalyst" ;
    ns1:industry "healthcare" ;
    ns1:name "Health Catalyst" ;
    ns1:sameAsHigh <https://1145.am/db/1266067/Health_Catalyst>,
        <https://1145.am/db/1832611/Health_Catalyst>,
        <https://1145.am/db/2195750/Health_Catalyst>,
        <https://1145.am/db/2231871/Catalyst_Health_Solutions>,
        <https://1145.am/db/2263100/Catalyst_Health_Solutions>,
        <https://1145.am/db/2590051/Catalyst_Health_Solutions>,
        <https://1145.am/db/398486/Health_Catalyst>,
        <https://1145.am/db/401282/Health_Catalyst>,
        <https://1145.am/db/740140/Catalyst_Healthcare> ;
    ns1:sameAsMedium <https://1145.am/db/1828383/Health_Catalyst>,
        <https://1145.am/db/2195893/Health_Catalyst>,
        <https://1145.am/db/2205421/Health_Catalyst> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2242437/Glenwood_Regional_Medical_Center> a org:Organization ;
    ns1:basedInHighGeoName "West Monroe" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4345850/about.rdf> ;
    ns1:basedInHighRaw "West Monroe, LA" ;
    ns1:description "healthcare services" ;
    ns1:documentDate "2013-08-14T13:00:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "IASIS Healthcare Executes Real Estate Transaction as Part of Long-Term Strategic Growth Plan" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/iasis-healthcare-executes-real-estate-transaction-as-part-long-term-strategic-growth> ;
    ns1:foundName "Glenwood Regional Medical Center" ;
    ns1:industry "healthcare" ;
    ns1:name "Glenwood Regional Medical Center" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2242437/The_Medical_Center_Of_Southeast_Texas> a org:Organization ;
    ns1:basedInHighGeoName "Port Arthur" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4720039/about.rdf> ;
    ns1:basedInHighRaw "Port Arthur, TX" ;
    ns1:description "healthcare services" ;
    ns1:documentDate "2013-08-14T13:00:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "IASIS Healthcare Executes Real Estate Transaction as Part of Long-Term Strategic Growth Plan" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/iasis-healthcare-executes-real-estate-transaction-as-part-long-term-strategic-growth> ;
    ns1:foundName "The Medical Center of Southeast Texas" ;
    ns1:industry "healthcare" ;
    ns1:name "The Medical Center of Southeast Texas" ;
    ns1:sameAsHigh <https://1145.am/db/2182610/Healthcare_Associates_Of_Texas>,
        <https://1145.am/db/2194425/Texas_Medical_Center>,
        <https://1145.am/db/2203420/Houston_Northwest_Medical_Center>,
        <https://1145.am/db/2232103/Dallas_Medical_Center>,
        <https://1145.am/db/2234079/Central_Texas_Medical_Center>,
        <https://1145.am/db/2234650/Central_Texas_Medical_Center>,
        <https://1145.am/db/2239611/Pampa_(texas)_Regional_Medical_Center>,
        <https://1145.am/db/2251418/Houston_Northwest_Medical_Center>,
        <https://1145.am/db/2253888/Dallas_(texas)_Medical_Center>,
        <https://1145.am/db/2270292/Texas_Regional_Medical_Center>,
        <https://1145.am/db/2271028/Houston_Northwest_Medical_Center>,
        <https://1145.am/db/900414/Texas_Medical_Center>,
        <https://1145.am/db/901261/Texas_Medical_Center> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2245294/Crescent_City_Surgical_Centre_Facility> a org:Organization ;
    ns1:description "Surgical procedures" ;
    ns1:documentDate "2013-09-30T22:00:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Physicians Realty Trust Completes $37.5 Million Transaction with Crescent City Surgical Centre Facility" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/physicians-realty-trust-completes-37-5-million-transaction-crescent-city-surgical-centre> ;
    ns1:foundName "Crescent City Surgical Centre Facility",
        "Crescent City Surgical Centre Facility, LLC" ;
    ns1:industry "healthcare" ;
    ns1:name "Crescent City Surgical Centre Facility" ;
    ns1:protagonist <https://1145.am/db/2245294/Investment_Crescent_City_Surgical_Centre_Facility_Physicians_Realty_Trust_Completed> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2245294/Crescent_City_Surgical_Centre_Facility_Divestment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "divestment",
        "investment" ;
    ns1:documentDate "2013-09-30T22:00:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Physicians Realty Trust (NYSE: DOC) (the \"Company\") , a self-managed healthcare properties REIT, announced today that 29 physicians have contributed their membership interest in Crescent City Surgical Centre Facility, LLC (\"CCSC Facility\") to a limited liability company wholly owned by the Company's operating partnership, Physicians Realty L.P. (the \"Company's Operating Partnership\") ." ;
    ns1:documentTitle "Physicians Realty Trust Completes $37.5 Million Transaction with Crescent City Surgical Centre Facility" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/physicians-realty-trust-completes-37-5-million-transaction-crescent-city-surgical-centre> ;
    ns1:foundName "contributed" ;
    ns1:name "contributed" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2245294/Crescent_City_Surgical_Centre_Facility> ;
    ns1:targetName "Crescent City Surgical Centre Facility" ;
    ns1:valueRaw "$ 37.5 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2245304/Foundation_Outpatient_Care_Building> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "healthcare" ;
    ns1:documentDate "2013-10-01T13:00:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Physicians Realty Trust Completes $15.6 Million Acquisition of Foundation Outpatient Care Building" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/physicians-realty-trust-completes-15-6-million-acquisition-foundation-outpatient-care> ;
    ns1:foundName "Foundation Outpatient Care Building" ;
    ns1:industry "healthcare" ;
    ns1:name "Foundation Outpatient Care Building" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2257142/Cleveland_Clinic_Florida> a org:Organization ;
    ns1:basedInLowRaw "Florida" ;
    ns1:description "medical" ;
    ns1:documentDate "2013-11-18T15:00:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cleveland Clinic Florida Receives Transformational $30 Million Gift to Establish Neurological Center" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/cleveland-clinic-florida-receives-transformational-30-million-gift-to-establish> ;
    ns1:foundName "Cleveland Clinic Florida" ;
    ns1:name "Cleveland Clinic Florida" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2257142/Establish_Neurological_Center> a org:Organization ;
    ns1:basedInLowRaw "Florida" ;
    ns1:description "Neurological" ;
    ns1:documentDate "2013-11-18T15:00:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cleveland Clinic Florida Receives Transformational $30 Million Gift to Establish Neurological Center" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/cleveland-clinic-florida-receives-transformational-30-million-gift-to-establish> ;
    ns1:foundName "Establish Neurological Center" ;
    ns1:name "Establish Neurological Center" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2263251/St_Marys_Health_Wagon> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "reducing the risk of heart disease among participants living with metabolic disorder, diabetes and non-alcoholic" ;
    ns1:documentDate "2014-02-12T00:00:11+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AstraZeneca HealthCare Foundation Awards $200,000 Grant to St. Mary's Health Wagon" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/astrazeneca-healthcare-foundation-awards-200-000-grant-to-st-mary-s-health-wagon> ;
    ns1:foundName "St. Mary's Health Wagon" ;
    ns1:name "St. Mary's Health Wagon" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2288454/Mdxhealth> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Belgium" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:basedInHighRaw "Belgium" ;
    ns1:description "diagnostics" ;
    ns1:documentDate "2013-06-28T15:11:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MDxHealth hauls in $23.5M for cancer test" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/mdxhealth-hauls-23-5m-for-cancer-test> ;
    ns1:foundName "MDxHealth" ;
    ns1:industry "diagnostics" ;
    ns1:name "MDxHealth" ;
    ns1:sameAsHigh <https://1145.am/db/1230454/Pro_Diagnostics_Group>,
        <https://1145.am/db/1249145/Mdxhealth_Sa>,
        <https://1145.am/db/1313006/Gestalt_Diagnostics>,
        <https://1145.am/db/1633951/Lex_Diagnostics>,
        <https://1145.am/db/2288428/Cml_Healthcare>,
        <https://1145.am/db/2289011/Medtox>,
        <https://1145.am/db/2293840/Integrated_Diagnostics>,
        <https://1145.am/db/2299265/Ge_Healthcare>,
        <https://1145.am/db/2314640/Healthlinx>,
        <https://1145.am/db/545860/Mdxhealth>,
        <https://1145.am/db/575470/Versant_Diagnostics>,
        <https://1145.am/db/607644/Mdxhealth> ;
    ns1:sameAsMedium <https://1145.am/db/2288280/Mdxhealth>,
        <https://1145.am/db/2288282/Mdxhealth>,
        <https://1145.am/db/2292096/Mdxhealth>,
        <https://1145.am/db/2324869/Mdxhealth>,
        <https://1145.am/db/2324877/Mdxhealth>,
        <https://1145.am/db/2368438/Mdxhealth_Sa> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2288758/Bausch_+_Lomb> a org:Organization ;
    ns1:description "eye care" ;
    ns1:documentDate "2013-07-02T19:19:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biomet could be next on the billion-dollar block" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/biomet-could-be-next-billion-dollar-block> ;
    ns1:foundName "Bausch + Lomb" ;
    ns1:industry "eye care" ;
    ns1:name "Bausch + Lomb" ;
    ns1:sameAsHigh <https://1145.am/db/1158677/Bausch_+_Lomb_Corporation>,
        <https://1145.am/db/1219613/Bausch_+_Lomb_Corporation>,
        <https://1145.am/db/1600136/Bausch_+_Lomb_Corporation>,
        <https://1145.am/db/1649635/Bausch_+_Lomb>,
        <https://1145.am/db/1650588/Bausch_+_Lomb>,
        <https://1145.am/db/2076347/Bausch_+_Lomb>,
        <https://1145.am/db/2096476/Bausch_+_Lomb_Corporation>,
        <https://1145.am/db/2109653/Bausch_+_Lomb_Corporation>,
        <https://1145.am/db/2113007/Bausch_+_Lomb_Corporation>,
        <https://1145.am/db/2129754/Bausch_+_Lomb_Corporation>,
        <https://1145.am/db/2283046/Bausch_+_Lomb>,
        <https://1145.am/db/2288428/Bausch_+_Lomb>,
        <https://1145.am/db/2295812/Bausch_+_Lomb>,
        <https://1145.am/db/2316851/Bausch___Lomb>,
        <https://1145.am/db/2328143/Bausch_+_Lomb>,
        <https://1145.am/db/2330204/Bausch___Lomb>,
        <https://1145.am/db/2347171/Bausch_+_Lomb>,
        <https://1145.am/db/2347227/Bausch_+_Lomb>,
        <https://1145.am/db/2347350/Bausch_+_Lomb>,
        <https://1145.am/db/2357607/Bausch_+_Lomb>,
        <https://1145.am/db/2364718/Bausch_+_Lomb>,
        <https://1145.am/db/2553024/Bausch_+_Lomb>,
        <https://1145.am/db/2554060/Bausch_+_Lomb>,
        <https://1145.am/db/2582894/Bausch_+_Lomb>,
        <https://1145.am/db/2583843/Bausch_+_Lomb>,
        <https://1145.am/db/2592575/Bausch_+_Lomb>,
        <https://1145.am/db/2593443/Bausch_+_Lomb>,
        <https://1145.am/db/2595708/Bausch_+_Lomb>,
        <https://1145.am/db/295206/Bausch_+_Lomb> ;
    ns1:sameAsMedium <https://1145.am/db/1014989/Bausch_+_Lomb>,
        <https://1145.am/db/1014991/Bausch_+_Lomb>,
        <https://1145.am/db/1035674/Bausch_+_Lomb>,
        <https://1145.am/db/1046609/Bausch_+_Lomb>,
        <https://1145.am/db/1675233/Bausch_+_Lomb>,
        <https://1145.am/db/2057335/Bausch_+_Lomb>,
        <https://1145.am/db/2292925/Bausch_+_Lomb>,
        <https://1145.am/db/2323579/Bausch_+_Lomb>,
        <https://1145.am/db/2550471/Bausch_+_Lomb>,
        <https://1145.am/db/2572460/Bausch_+_Lomb>,
        <https://1145.am/db/2584818/Bausch_+_Lomb>,
        <https://1145.am/db/2590589/Bausch_+_Lomb>,
        <https://1145.am/db/757517/Bausch_+_Lomb> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2288758/Bausch_+_Lomb_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "ipo" ;
    ns1:documentDate "2013-07-02T19:19:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Biomet's private equity masters are considering getting out of the hip and knee business, weighing either an IPO for the once-public devicemaker or an outright sale, The Financial Times reports.",
        "That method seemed to work for Warburg Pincus when, unsatisfied with bids for Bausch + Lomb, the company took a step toward an IPO and wound up selling the eye care giant to Valeant ($ VRX) for $ 8.7 billion." ;
    ns1:documentTitle "Biomet could be next on the billion-dollar block" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/biomet-could-be-next-billion-dollar-block> ;
    ns1:foundName "IPO",
        "selling" ;
    ns1:name "IPO",
        "selling" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2288758/Bausch_+_Lomb> ;
    ns1:targetName "Bausch + Lomb" ;
    ns1:valueRaw "$ 8.7 billion" ;
    ns1:vendor <https://1145.am/db/2288758/Warburg_Pincus> .

<https://1145.am/db/2288758/Biomet> a org:Organization ;
    ns1:description "hip and knee business" ;
    ns1:documentDate "2013-07-02T19:19:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biomet could be next on the billion-dollar block" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/biomet-could-be-next-billion-dollar-block> ;
    ns1:foundName "Biomet" ;
    ns1:industry "hip and knee business" ;
    ns1:name "Biomet" ;
    ns1:sameAsMedium <https://1145.am/db/2288382/Biomet>,
        <https://1145.am/db/2289043/Biomet>,
        <https://1145.am/db/2289074/Biomet>,
        <https://1145.am/db/2289275/Biomet>,
        <https://1145.am/db/2289714/Biomet>,
        <https://1145.am/db/2292126/Biomet>,
        <https://1145.am/db/2293024/Biomet>,
        <https://1145.am/db/2293282/Biomet>,
        <https://1145.am/db/2293492/Biomet>,
        <https://1145.am/db/2294441/Biomet>,
        <https://1145.am/db/2294958/Biomet>,
        <https://1145.am/db/2296368/Biomet>,
        <https://1145.am/db/2297612/Biomet>,
        <https://1145.am/db/2297797/Biomet>,
        <https://1145.am/db/2298532/Biomet>,
        <https://1145.am/db/2299743/Biomet>,
        <https://1145.am/db/2300267/Biomet>,
        <https://1145.am/db/2300380/Biomet>,
        <https://1145.am/db/2300429/Biomet>,
        <https://1145.am/db/2300619/Biomet>,
        <https://1145.am/db/2300658/Biomet>,
        <https://1145.am/db/2300834/Biomet>,
        <https://1145.am/db/2307473/Biomet>,
        <https://1145.am/db/2311838/Biomet>,
        <https://1145.am/db/2311846/Biomet>,
        <https://1145.am/db/2315085/Biomet>,
        <https://1145.am/db/2336656/Biomet>,
        <https://1145.am/db/2550471/Biomet>,
        <https://1145.am/db/2550584/Biomet>,
        <https://1145.am/db/2579209/Biomet> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2288758/Biomet_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "ipo" ;
    ns1:documentDate "2013-07-02T19:19:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Biomet's private equity masters are considering getting out of the hip and knee business, weighing either an IPO for the once-public devicemaker or an outright sale, The Financial Times reports." ;
    ns1:documentTitle "Biomet could be next on the billion-dollar block" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/biomet-could-be-next-billion-dollar-block> ;
    ns1:foundName "IPO",
        "sale" ;
    ns1:name "IPO",
        "sale" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2288758/Biomet> ;
    ns1:targetName "Biomet" ;
    ns1:valueRaw "$ 8.7 billion" ;
    ns1:vendor <https://1145.am/db/2288758/Warburg_Pincus> .

<https://1145.am/db/2288800/CVRX> a org:Organization ;
    ns1:documentDate "2013-07-11T12:30:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CVRx raises $29.6M for hypertension device" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cvrx-raises-29-6m-for-hypertension-device> ;
    ns1:foundName "CVRx" ;
    ns1:name "CVRx" ;
    ns1:sameAsMedium <https://1145.am/db/1596439/CVRX>,
        <https://1145.am/db/2288799/CVRX>,
        <https://1145.am/db/2317202/CVRX>,
        <https://1145.am/db/2583130/CVRX> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2289470/Freedom_Meditech> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "San Diego" ;
    ns1:documentDate "2013-08-06T14:32:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Freedom Meditech lands $7M for diabetes device" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/freedom-meditech-lands-7m-for-diabetes-device> ;
    ns1:foundName "Freedom",
        "Freedom Meditech" ;
    ns1:name "Freedom",
        "Freedom Meditech" ;
    ns1:sameAsMedium <https://1145.am/db/2294238/Freedom_Meditech>,
        <https://1145.am/db/2311825/Freedom_Meditech>,
        <https://1145.am/db/2356488/Freedom_Meditech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290258/Investment_Green_Park___Golf_Ventures_Microtransponder_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-08-29T17:33:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Texas device startup MicroTransponder pulled in nearly $ 3.4 million in new funding to back additional clinical trials using its neurostimulation technology to treat stroke and tinnitus patients." ;
    ns1:documentTitle "Texas neurostim startup pulls in $3.4M for multiple trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/texas-neurostim-startup-pulls-3-4m-for-multiple-trials> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2290258/Microtransponder> ;
    ns1:valueRaw "nearly $ 3.4 million" ;
    ns1:whereGeoName "Texas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:whereRaw "Texas" .

<https://1145.am/db/2290258/Investment_Neuropace_St_Jude_Medical_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-08-29T17:33:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "California's NeuroPace, for example, has so far raised $ 18 million of a hoped-for $ 50 million funding round, with plans to use the money to speed development of its antiepilepsy neurostimulation device implant." ;
    ns1:documentTitle "Texas neurostim startup pulls in $3.4M for multiple trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/texas-neurostim-startup-pulls-3-4m-for-multiple-trials> ;
    ns1:foundName "funding",
        "investment" ;
    ns1:name "funding",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2290258/Neuropace> ;
    ns1:valueRaw "$ 18 million",
        "$ 40 million",
        "$ 50 million" ;
    ns1:whereGeoName "Texas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:whereRaw "Texas" .

<https://1145.am/db/2290258/Microtransponder> a org:Organization ;
    ns1:basedInHighGeoName "Texas" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:basedInHighRaw "Texas" ;
    ns1:documentDate "2013-08-29T17:33:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Texas neurostim startup pulls in $3.4M for multiple trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/texas-neurostim-startup-pulls-3-4m-for-multiple-trials> ;
    ns1:foundName "MicroTransponder" ;
    ns1:industry "healthcare" ;
    ns1:name "MicroTransponder" ;
    ns1:sameAsMedium <https://1145.am/db/1147854/Microtransponder_Inc>,
        <https://1145.am/db/1360394/Microtransponder>,
        <https://1145.am/db/1633003/Microtransponder>,
        <https://1145.am/db/2278799/Microtransponder>,
        <https://1145.am/db/2332448/Microtransponder> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290258/Neuropace> a org:Organization ;
    ns1:basedInHighGeoName "California" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:basedInHighRaw "California" ;
    ns1:documentDate "2013-08-29T17:33:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Texas neurostim startup pulls in $3.4M for multiple trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/texas-neurostim-startup-pulls-3-4m-for-multiple-trials> ;
    ns1:foundName "NeuroPace" ;
    ns1:name "NeuroPace" ;
    ns1:sameAsMedium <https://1145.am/db/2286088/Neuropace>,
        <https://1145.am/db/2288790/Neuropace>,
        <https://1145.am/db/2292246/Neuropace>,
        <https://1145.am/db/560568/Neuropace_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290258/St_Jude_Medical> a org:Organization ;
    ns1:basedInHighGeoName "Minnesota" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5037779/about.rdf> ;
    ns1:basedInHighRaw "Minnesota" ;
    ns1:documentDate "2013-08-29T17:33:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Texas neurostim startup pulls in $3.4M for multiple trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/texas-neurostim-startup-pulls-3-4m-for-multiple-trials> ;
    ns1:foundName "St. Jude Medical" ;
    ns1:industry "medical" ;
    ns1:investor <https://1145.am/db/2290258/Investment_Neuropace_St_Jude_Medical_Completed> ;
    ns1:name "St. Jude Medical" ;
    ns1:sameAsHigh <https://1145.am/db/2288068/St_Jude>,
        <https://1145.am/db/2288265/St_Jude_Medical>,
        <https://1145.am/db/2288388/St_Jude_Medical>,
        <https://1145.am/db/2288560/St_Jude_Medical>,
        <https://1145.am/db/2288600/St_Jude_Medical>,
        <https://1145.am/db/2289653/St_Jude_Medical>,
        <https://1145.am/db/2289745/St_Jude_Medical>,
        <https://1145.am/db/2289808/St_Jude_Medical>,
        <https://1145.am/db/2290679/St_Jude_Medical>,
        <https://1145.am/db/2291576/St_Jude_Medical>,
        <https://1145.am/db/2292563/St_Jude_Medical>,
        <https://1145.am/db/2294749/St_Jude_Medical>,
        <https://1145.am/db/2299772/St_Jude_Medical>,
        <https://1145.am/db/2300380/St_Jude_Medical>,
        <https://1145.am/db/2307472/St_Jude_Medical>,
        <https://1145.am/db/2307488/St_Jude_Medical>,
        <https://1145.am/db/2317322/St_Jude_Medical>,
        <https://1145.am/db/2318361/St_Jude_Medical>,
        <https://1145.am/db/2318402/St_Jude_Medical>,
        <https://1145.am/db/2322732/St_Jude_Medical>,
        <https://1145.am/db/2322753/St_Jude_Medical>,
        <https://1145.am/db/2323823/St_Jude>,
        <https://1145.am/db/2327051/St_Jude_Medical>,
        <https://1145.am/db/2331820/St_Jude_Medical>,
        <https://1145.am/db/2351671/St_Jude_Medical>,
        <https://1145.am/db/2370161/St_Jude_Medical>,
        <https://1145.am/db/2436546/St_Jude_Medical>,
        <https://1145.am/db/2449866/St_Jude_Medical_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2288530/St_Jude_Medical>,
        <https://1145.am/db/2292351/St_Jude_Medical>,
        <https://1145.am/db/2294098/St_Jude_Medical>,
        <https://1145.am/db/2300717/St_Jude_Medical>,
        <https://1145.am/db/2325968/St_Jude_Medical>,
        <https://1145.am/db/2370165/St_Jude_Medical>,
        <https://1145.am/db/2562249/St_Jude_Medical> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290737/Flowsense> a org:Organization ;
    ns1:basedInHighGeoName "State of Israel" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:basedInHighRaw "Israel" ;
    ns1:documentDate "2013-09-10T15:43:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UPDATED: Baxter buys $9.5M startup on heels of $4B Gambro deal" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/updated-baxter-buys-9-5m-startup-heels-4b-gambro-deal> ;
    ns1:foundName "FlowSense" ;
    ns1:industry "medical equipment" ;
    ns1:name "FlowSense" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2290737/Flowsense_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-09-10T15:43:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Baxter, an Illinois - based marker of renal devices and other medical equipment and treatments paid $ 9.5 million for FlowSense, an Israeli startup launched in 2009 that makes medical equipment designed to monitor urine output." ;
    ns1:documentTitle "UPDATED: Baxter buys $9.5M startup on heels of $4B Gambro deal" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/updated-baxter-buys-9-5m-startup-heels-4b-gambro-deal> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2290737/Flowsense> ;
    ns1:targetName "FlowSense" ;
    ns1:valueRaw "$ 9.5 million" ;
    ns1:whenRaw "2009" ;
    ns1:whereGeoName "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Israel" .

<https://1145.am/db/2290737/Gambro> a org:Organization ;
    ns1:basedInLowRaw "Israel" ;
    ns1:documentDate "2013-09-10T15:43:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UPDATED: Baxter buys $9.5M startup on heels of $4B Gambro deal" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/updated-baxter-buys-9-5m-startup-heels-4b-gambro-deal> ;
    ns1:foundName "Gambro" ;
    ns1:name "Gambro" ;
    ns1:sameAsMedium <https://1145.am/db/2287829/Gambro>,
        <https://1145.am/db/2288062/Gambro_Ab>,
        <https://1145.am/db/2288801/Gambro_Ab>,
        <https://1145.am/db/2289136/Gambro>,
        <https://1145.am/db/2289776/Gambro>,
        <https://1145.am/db/2290136/Gambro>,
        <https://1145.am/db/2290736/Gambro>,
        <https://1145.am/db/2293436/Gambro_Ab>,
        <https://1145.am/db/2293904/Gambro>,
        <https://1145.am/db/2293910/Gambro>,
        <https://1145.am/db/2295497/Gambro>,
        <https://1145.am/db/2295938/Gambro>,
        <https://1145.am/db/2354318/Gambro> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2292103/Aisling_Capital> a org:Organization ;
    ns1:basedInLowRaw "Ireland" ;
    ns1:documentDate "2013-10-03T12:42:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lensar hauls in $87M for laser eye surgery tech" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/lensar-hauls-87m-for-laser-eye-surgery-tech> ;
    ns1:foundName "Aisling Capital, Florida Growth" ;
    ns1:investor <https://1145.am/db/2292103/Investment_Aisling_Capital_Florida_Opportunity_Funds_Lensar_Completed> ;
    ns1:name "Aisling Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1334160/Aisling_Capital>,
        <https://1145.am/db/1334934/Aisling_Capital>,
        <https://1145.am/db/1665536/Aisling_Capital>,
        <https://1145.am/db/2280707/Aisling_Capital>,
        <https://1145.am/db/2291277/Aisling_Capital>,
        <https://1145.am/db/2292800/Aisling_Capital>,
        <https://1145.am/db/2294156/Aisling_Capital>,
        <https://1145.am/db/2297408/Aisling_Capital>,
        <https://1145.am/db/2307476/Aisling_Capital>,
        <https://1145.am/db/2310940/Aisling_Capital>,
        <https://1145.am/db/2317775/Aisling_Capital>,
        <https://1145.am/db/2319433/Aisling_Capital>,
        <https://1145.am/db/2320852/Aisling_Capital>,
        <https://1145.am/db/2320853/Aisling_Capital>,
        <https://1145.am/db/2324244/Aisling_Capital>,
        <https://1145.am/db/2324255/Aisling_Capital>,
        <https://1145.am/db/2325553/Aisling_Capital>,
        <https://1145.am/db/2326576/Aisling_Capital>,
        <https://1145.am/db/2328388/Aisling_Capital>,
        <https://1145.am/db/2332753/Aisling_Capital>,
        <https://1145.am/db/2336503/Aisling_Capital>,
        <https://1145.am/db/2336505/Aisling_Capital>,
        <https://1145.am/db/2336524/Aisling_Capital>,
        <https://1145.am/db/2337250/Aisling_Capital>,
        <https://1145.am/db/2337254/Aisling_Capital>,
        <https://1145.am/db/2339214/Aisling_Capital>,
        <https://1145.am/db/2339223/Aisling_Capital>,
        <https://1145.am/db/2341595/Aisling_Capital>,
        <https://1145.am/db/2341599/Aisling_Capital>,
        <https://1145.am/db/2344735/Aisling_Capital>,
        <https://1145.am/db/2344739/Aisling_Capital>,
        <https://1145.am/db/2344874/Aisling_Capital>,
        <https://1145.am/db/2346030/Aisling_Capital>,
        <https://1145.am/db/2346293/Aisling_Capital>,
        <https://1145.am/db/2348754/Aisling_Capital>,
        <https://1145.am/db/2352059/Aisling_Capital>,
        <https://1145.am/db/2352167/Aisling_Capital>,
        <https://1145.am/db/2352170/Aisling_Capital>,
        <https://1145.am/db/2356297/Aisling_Capital>,
        <https://1145.am/db/2357356/Aisling_Capital>,
        <https://1145.am/db/2359185/Aisling_Capital>,
        <https://1145.am/db/2359468/Aisling_Capital>,
        <https://1145.am/db/2362736/Aisling_Capital>,
        <https://1145.am/db/2362737/Aisling_Capital>,
        <https://1145.am/db/2367022/Aisling_Capital>,
        <https://1145.am/db/2367023/Aisling_Capital>,
        <https://1145.am/db/2369304/Aisling_Capital>,
        <https://1145.am/db/2369305/Aisling_Capital>,
        <https://1145.am/db/2539913/Aisling_Capital>,
        <https://1145.am/db/2583013/Aisling_Capital>,
        <https://1145.am/db/2588372/Aisling_Capital>,
        <https://1145.am/db/2591606/Aisling_Capital>,
        <https://1145.am/db/802321/Aisling_Capital>,
        <https://1145.am/db/803398/Aisling_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2292563/Nanostim> a org:Organization ;
    ns1:basedInHighGeoName "California" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:basedInHighRaw "California" ;
    ns1:description "cardiac pacemaker" ;
    ns1:documentDate "2013-10-14T13:32:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "St. Jude Medical grabs Nanostim for $123.5M, gaining CE marked leadless pacer" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/st-jude-medical-grabs-nanostim-for-123-5m-gaining-ce-marked-leadless-pacer> ;
    ns1:foundName "Nanostim" ;
    ns1:industry "Medical" ;
    ns1:name "Nanostim" ;
    ns1:sameAsHigh <https://1145.am/db/1024948/Nanosynex_Ltd>,
        <https://1145.am/db/1106604/Nanosynex_Ltd>,
        <https://1145.am/db/1243127/Nanomix>,
        <https://1145.am/db/1331719/Nanobiotix>,
        <https://1145.am/db/1333469/Nanobiotix>,
        <https://1145.am/db/1379725/Nanoligent_Sl>,
        <https://1145.am/db/1603748/Nanobiotix>,
        <https://1145.am/db/2292839/Nanobiotix>,
        <https://1145.am/db/2301713/Nanobio>,
        <https://1145.am/db/2322631/Nanotherapies>,
        <https://1145.am/db/2324092/Nanotherapies>,
        <https://1145.am/db/2336068/Nanobiotix>,
        <https://1145.am/db/2339951/Nanobiosym>,
        <https://1145.am/db/2341484/Nanodimension>,
        <https://1145.am/db/2349782/Nanomix_Inc>,
        <https://1145.am/db/2357026/Nanobiotix>,
        <https://1145.am/db/2548585/Nanomi>,
        <https://1145.am/db/2587312/Nanomi>,
        <https://1145.am/db/2803012/Nanosyrinx>,
        <https://1145.am/db/995597/Nanotics>,
        <https://1145.am/db/996567/Nanotics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2292563/St_Jude_Medical> a org:Organization ;
    ns1:basedInHighGeoName "Minnesota" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5037779/about.rdf> ;
    ns1:basedInHighRaw "Minnesota" ;
    ns1:buyer <https://1145.am/db/2292563/Nanostim_Acquisition> ;
    ns1:description "medical" ;
    ns1:documentDate "2013-10-14T13:32:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "St. Jude Medical grabs Nanostim for $123.5M, gaining CE marked leadless pacer" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/st-jude-medical-grabs-nanostim-for-123-5m-gaining-ce-marked-leadless-pacer> ;
    ns1:foundName "St. Jude",
        "St. Jude Medical" ;
    ns1:industry "medical" ;
    ns1:investor <https://1145.am/db/2292563/Nanostim_Acquisition> ;
    ns1:name "St. Jude",
        "St. Jude Medical" ;
    ns1:sameAsHigh <https://1145.am/db/2288068/St_Jude>,
        <https://1145.am/db/2288265/St_Jude_Medical>,
        <https://1145.am/db/2288388/St_Jude_Medical>,
        <https://1145.am/db/2288560/St_Jude_Medical>,
        <https://1145.am/db/2288600/St_Jude_Medical>,
        <https://1145.am/db/2289653/St_Jude_Medical>,
        <https://1145.am/db/2289745/St_Jude_Medical>,
        <https://1145.am/db/2289808/St_Jude_Medical>,
        <https://1145.am/db/2290258/St_Jude_Medical>,
        <https://1145.am/db/2290679/St_Jude_Medical>,
        <https://1145.am/db/2291576/St_Jude_Medical>,
        <https://1145.am/db/2294749/St_Jude_Medical>,
        <https://1145.am/db/2299772/St_Jude_Medical>,
        <https://1145.am/db/2300380/St_Jude_Medical>,
        <https://1145.am/db/2307472/St_Jude_Medical>,
        <https://1145.am/db/2307488/St_Jude_Medical>,
        <https://1145.am/db/2317322/St_Jude_Medical>,
        <https://1145.am/db/2318361/St_Jude_Medical>,
        <https://1145.am/db/2318402/St_Jude_Medical>,
        <https://1145.am/db/2322732/St_Jude_Medical>,
        <https://1145.am/db/2322753/St_Jude_Medical>,
        <https://1145.am/db/2323823/St_Jude>,
        <https://1145.am/db/2327051/St_Jude_Medical>,
        <https://1145.am/db/2331820/St_Jude_Medical>,
        <https://1145.am/db/2351671/St_Jude_Medical>,
        <https://1145.am/db/2370161/St_Jude_Medical>,
        <https://1145.am/db/2370165/St_Jude_Medical>,
        <https://1145.am/db/2436546/St_Jude_Medical>,
        <https://1145.am/db/2449866/St_Jude_Medical_Inc>,
        <https://1145.am/db/2562249/St_Jude_Medical> ;
    ns1:sameAsMedium <https://1145.am/db/2288530/St_Jude_Medical>,
        <https://1145.am/db/2292351/St_Jude_Medical>,
        <https://1145.am/db/2294098/St_Jude_Medical>,
        <https://1145.am/db/2300717/St_Jude_Medical>,
        <https://1145.am/db/2325968/St_Jude_Medical> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2292608/454_Life_Sciences> a org:Organization ;
    ns1:documentDate "2013-10-17T22:37:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Roche to close 454 Life Sciences as it reduces gene sequencing focus" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/roche-to-close-454-life-sciences-as-it-reduces-gene-sequencing-focus> ;
    ns1:foundName "454 Life Sciences" ;
    ns1:industry "Gene sequencing" ;
    ns1:name "454 Life Sciences" ;
    ns1:sameAsHigh <https://1145.am/db/1339613/Illumina>,
        <https://1145.am/db/1974886/Illumina_Inc>,
        <https://1145.am/db/2019335/Illumina_Inc>,
        <https://1145.am/db/2033324/Illumina_Inc>,
        <https://1145.am/db/2033519/Illumina>,
        <https://1145.am/db/2083048/Illumina>,
        <https://1145.am/db/2279826/Illumina>,
        <https://1145.am/db/2296171/Illumina>,
        <https://1145.am/db/2296180/Illumina>,
        <https://1145.am/db/2296600/Illumina>,
        <https://1145.am/db/2297472/Illumina>,
        <https://1145.am/db/2571613/Illumina>,
        <https://1145.am/db/2572452/Illumina>,
        <https://1145.am/db/2573339/Illumina>,
        <https://1145.am/db/2593666/Illumina>,
        <https://1145.am/db/2597109/Illumina> ;
    ns1:sameAsMedium <https://1145.am/db/2292593/454_Life_Sciences>,
        <https://1145.am/db/2309816/454_Life_Sciences>,
        <https://1145.am/db/2362865/454_Life_Sciences>,
        <https://1145.am/db/2586700/454_Life_Sciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2292608/Curagen> a org:Organization ;
    ns1:documentDate "2013-10-17T22:37:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Roche to close 454 Life Sciences as it reduces gene sequencing focus" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/roche-to-close-454-life-sciences-as-it-reduces-gene-sequencing-focus> ;
    ns1:foundName "Curagen" ;
    ns1:name "Curagen" ;
    ns1:sameAsMedium <https://1145.am/db/2309816/Curagen>,
        <https://1145.am/db/2322938/Curagen>,
        <https://1145.am/db/2324094/Curagen_Corporation>,
        <https://1145.am/db/2324096/Curagen>,
        <https://1145.am/db/2325335/Curagen>,
        <https://1145.am/db/2325344/Curagen_Corporation>,
        <https://1145.am/db/2325367/Curagen_Corporation>,
        <https://1145.am/db/2329745/Curagen_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2292608/Roche> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:documentDate "2013-10-17T22:37:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Roche to close 454 Life Sciences as it reduces gene sequencing focus" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/roche-to-close-454-life-sciences-as-it-reduces-gene-sequencing-focus> ;
    ns1:foundName "Roche" ;
    ns1:industry "Gene sequencing" ;
    ns1:name "Roche" ;
    ns1:sameAsHigh <https://1145.am/db/2296180/Roche>,
        <https://1145.am/db/2296600/Roche> ;
    ns1:sameAsMedium <https://1145.am/db/1322436/Roche>,
        <https://1145.am/db/1334866/Roche>,
        <https://1145.am/db/1570526/Roche>,
        <https://1145.am/db/1767410/Roche>,
        <https://1145.am/db/1998785/Roche>,
        <https://1145.am/db/2061027/Roche>,
        <https://1145.am/db/2152005/Roche>,
        <https://1145.am/db/2152475/Roche>,
        <https://1145.am/db/2152787/Roche>,
        <https://1145.am/db/2154526/Roche>,
        <https://1145.am/db/2154736/Roche>,
        <https://1145.am/db/2187676/Roche>,
        <https://1145.am/db/2223188/Roche>,
        <https://1145.am/db/2232759/Roche>,
        <https://1145.am/db/2244622/Roche>,
        <https://1145.am/db/2254658/Roche>,
        <https://1145.am/db/2279060/Roche>,
        <https://1145.am/db/2279266/Roche>,
        <https://1145.am/db/2280847/Roche>,
        <https://1145.am/db/2281213/Roche>,
        <https://1145.am/db/2286404/Roche>,
        <https://1145.am/db/2286671/Roche>,
        <https://1145.am/db/2286719/Roche>,
        <https://1145.am/db/2287064/Roche>,
        <https://1145.am/db/2287171/Roche>,
        <https://1145.am/db/2287956/Roche>,
        <https://1145.am/db/2288237/Roche>,
        <https://1145.am/db/2289977/Roche>,
        <https://1145.am/db/2290009/Roche>,
        <https://1145.am/db/2290817/Roche>,
        <https://1145.am/db/2292337/Roche>,
        <https://1145.am/db/2292593/Roche>,
        <https://1145.am/db/2294783/Roche>,
        <https://1145.am/db/2295842/Roche>,
        <https://1145.am/db/2295853/Roche>,
        <https://1145.am/db/2295854/Roche>,
        <https://1145.am/db/2295907/Roche>,
        <https://1145.am/db/2296164/Roche>,
        <https://1145.am/db/2296171/Roche>,
        <https://1145.am/db/2296371/Roche>,
        <https://1145.am/db/2297072/Roche>,
        <https://1145.am/db/2297131/Roche>,
        <https://1145.am/db/2297300/Roche>,
        <https://1145.am/db/2297593/Roche>,
        <https://1145.am/db/2297619/Roche>,
        <https://1145.am/db/2298070/Roche>,
        <https://1145.am/db/2298237/Roche>,
        <https://1145.am/db/2298297/Roche>,
        <https://1145.am/db/2298766/Roche>,
        <https://1145.am/db/2299175/Roche>,
        <https://1145.am/db/2299764/Roche>,
        <https://1145.am/db/2299784/Roche>,
        <https://1145.am/db/2299867/Roche>,
        <https://1145.am/db/2300140/Roche>,
        <https://1145.am/db/2300897/Roche>,
        <https://1145.am/db/2303352/Roche>,
        <https://1145.am/db/2303385/Roche>,
        <https://1145.am/db/2303398/Roche>,
        <https://1145.am/db/2303402/Roche>,
        <https://1145.am/db/2303873/Roche>,
        <https://1145.am/db/2303880/Roche>,
        <https://1145.am/db/2305192/Roche>,
        <https://1145.am/db/2305545/Roche>,
        <https://1145.am/db/2305578/Roche_Ag>,
        <https://1145.am/db/2305582/Roche>,
        <https://1145.am/db/2306401/Roche>,
        <https://1145.am/db/2306858/Roche>,
        <https://1145.am/db/2307022/Roche>,
        <https://1145.am/db/2308972/Roche>,
        <https://1145.am/db/2309816/Roche>,
        <https://1145.am/db/2309846/Roche>,
        <https://1145.am/db/2309947/Roche>,
        <https://1145.am/db/2309962/Roche>,
        <https://1145.am/db/2309988/Roche>,
        <https://1145.am/db/2309993/Roche>,
        <https://1145.am/db/2310005/Roche>,
        <https://1145.am/db/2310015/Roche>,
        <https://1145.am/db/2310906/Roche>,
        <https://1145.am/db/2311026/Roche>,
        <https://1145.am/db/2311682/Roche>,
        <https://1145.am/db/2312193/Roche>,
        <https://1145.am/db/2312481/Roche>,
        <https://1145.am/db/2313073/Roche>,
        <https://1145.am/db/2313320/Roche>,
        <https://1145.am/db/2313324/Roche>,
        <https://1145.am/db/2313872/Roche>,
        <https://1145.am/db/2314398/Roche>,
        <https://1145.am/db/2319577/Roche>,
        <https://1145.am/db/2320592/Roche>,
        <https://1145.am/db/2320930/Roche>,
        <https://1145.am/db/2321676/Roche>,
        <https://1145.am/db/2321701/Roche>,
        <https://1145.am/db/2323214/Roche>,
        <https://1145.am/db/2323221/Roche>,
        <https://1145.am/db/2324237/Roche>,
        <https://1145.am/db/2330483/Roche>,
        <https://1145.am/db/2330486/Roche>,
        <https://1145.am/db/2331558/Roche>,
        <https://1145.am/db/2335338/Roche>,
        <https://1145.am/db/2336767/Roche>,
        <https://1145.am/db/2337234/Roche>,
        <https://1145.am/db/2338682/Roche>,
        <https://1145.am/db/2340363/Roche>,
        <https://1145.am/db/2340626/Roche_Ag>,
        <https://1145.am/db/2341621/Roche>,
        <https://1145.am/db/2341630/Roche>,
        <https://1145.am/db/2342211/Roche>,
        <https://1145.am/db/2342417/Roche>,
        <https://1145.am/db/2343658/Roche>,
        <https://1145.am/db/2344272/Roche>,
        <https://1145.am/db/2344534/Roche>,
        <https://1145.am/db/2344754/Roche>,
        <https://1145.am/db/2344807/Roche>,
        <https://1145.am/db/2345550/Roche>,
        <https://1145.am/db/2346072/Roche>,
        <https://1145.am/db/2346076/Roche>,
        <https://1145.am/db/2346819/Roche>,
        <https://1145.am/db/2346852/Roche>,
        <https://1145.am/db/2348776/Roche>,
        <https://1145.am/db/2349537/Roche>,
        <https://1145.am/db/2352841/Roche>,
        <https://1145.am/db/2352976/Roche>,
        <https://1145.am/db/2352978/Roche>,
        <https://1145.am/db/2352993/Roche>,
        <https://1145.am/db/2353986/Roche>,
        <https://1145.am/db/2353992/Roche>,
        <https://1145.am/db/2356012/Roche>,
        <https://1145.am/db/2356014/Roche>,
        <https://1145.am/db/2357054/Roche>,
        <https://1145.am/db/2358186/Roche>,
        <https://1145.am/db/2359957/Roche>,
        <https://1145.am/db/2359959/Roche>,
        <https://1145.am/db/2359963/Roche>,
        <https://1145.am/db/2359965/Roche>,
        <https://1145.am/db/2360246/Roche>,
        <https://1145.am/db/2360248/Roche>,
        <https://1145.am/db/2360249/Roche>,
        <https://1145.am/db/2360539/Roche>,
        <https://1145.am/db/2360982/Roche>,
        <https://1145.am/db/2360997/Roche>,
        <https://1145.am/db/2360999/Roche>,
        <https://1145.am/db/2361632/Roche>,
        <https://1145.am/db/2361994/Roche>,
        <https://1145.am/db/2361998/Roche>,
        <https://1145.am/db/2362001/Roche>,
        <https://1145.am/db/2362065/Roche>,
        <https://1145.am/db/2362113/Roche>,
        <https://1145.am/db/2362305/Roche>,
        <https://1145.am/db/2362730/Roche>,
        <https://1145.am/db/2363726/Roche>,
        <https://1145.am/db/2364074/Roche>,
        <https://1145.am/db/2365305/Roche>,
        <https://1145.am/db/2366649/Roche>,
        <https://1145.am/db/2366853/Roche>,
        <https://1145.am/db/2366885/Roche>,
        <https://1145.am/db/2368653/Roche>,
        <https://1145.am/db/2369197/Roche>,
        <https://1145.am/db/2369199/Roche>,
        <https://1145.am/db/2371046/Roche>,
        <https://1145.am/db/2371047/Roche>,
        <https://1145.am/db/2371314/Roche>,
        <https://1145.am/db/2537591/Roche>,
        <https://1145.am/db/2538424/Roche>,
        <https://1145.am/db/2538826/Roche>,
        <https://1145.am/db/2539298/Roche>,
        <https://1145.am/db/2540755/Roche>,
        <https://1145.am/db/2541555/Roche>,
        <https://1145.am/db/2541672/Roche>,
        <https://1145.am/db/2543605/Roche>,
        <https://1145.am/db/2544409/Roche>,
        <https://1145.am/db/2545574/Roche>,
        <https://1145.am/db/2545742/Roche>,
        <https://1145.am/db/2545952/Roche>,
        <https://1145.am/db/2546646/Roche>,
        <https://1145.am/db/2547098/Roche>,
        <https://1145.am/db/2547770/Roche>,
        <https://1145.am/db/2547998/Roche>,
        <https://1145.am/db/2548696/Roche>,
        <https://1145.am/db/2549102/Roche>,
        <https://1145.am/db/2549670/Roche>,
        <https://1145.am/db/2551122/Roche>,
        <https://1145.am/db/2551716/Roche>,
        <https://1145.am/db/2553276/Roche>,
        <https://1145.am/db/2553947/Roche>,
        <https://1145.am/db/2558080/Roche>,
        <https://1145.am/db/2558313/Roche>,
        <https://1145.am/db/2559230/Roche>,
        <https://1145.am/db/2559655/Roche>,
        <https://1145.am/db/2560865/Roche>,
        <https://1145.am/db/2563029/Roche>,
        <https://1145.am/db/2565142/Roche>,
        <https://1145.am/db/2565794/Roche>,
        <https://1145.am/db/2567367/Roche>,
        <https://1145.am/db/2571045/Roche>,
        <https://1145.am/db/2571613/Roche>,
        <https://1145.am/db/2572452/Roche>,
        <https://1145.am/db/2573339/Roche>,
        <https://1145.am/db/2573395/Roche>,
        <https://1145.am/db/2573397/Roche>,
        <https://1145.am/db/2574245/Roche>,
        <https://1145.am/db/2574281/Roche>,
        <https://1145.am/db/2575289/Roche>,
        <https://1145.am/db/2578312/Roche>,
        <https://1145.am/db/2578313/Roche>,
        <https://1145.am/db/2579314/Roche>,
        <https://1145.am/db/2579320/Roche>,
        <https://1145.am/db/2580384/Roche>,
        <https://1145.am/db/2581493/Roche>,
        <https://1145.am/db/2582270/Roche>,
        <https://1145.am/db/2582355/Roche>,
        <https://1145.am/db/2582468/Roche>,
        <https://1145.am/db/2584101/Roche>,
        <https://1145.am/db/2587653/Roche>,
        <https://1145.am/db/2587657/Roche>,
        <https://1145.am/db/2592126/Roche>,
        <https://1145.am/db/2592803/Roche>,
        <https://1145.am/db/2593007/Roche>,
        <https://1145.am/db/2593713/Roche>,
        <https://1145.am/db/2593760/Roche>,
        <https://1145.am/db/2594870/Roche>,
        <https://1145.am/db/2595237/Roche>,
        <https://1145.am/db/2596333/Roche>,
        <https://1145.am/db/2597109/Roche>,
        <https://1145.am/db/2597648/Roche>,
        <https://1145.am/db/2597732/Roche>,
        <https://1145.am/db/2598072/Roche>,
        <https://1145.am/db/271528/Roche>,
        <https://1145.am/db/304559/Roche>,
        <https://1145.am/db/304740/Roche>,
        <https://1145.am/db/320219/Roche>,
        <https://1145.am/db/595011/Roche>,
        <https://1145.am/db/652831/Roche> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294520/Politec_Sade> a org:Organization ;
    ns1:basedInHighGeoName "Federative Republic of Brazil" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:basedInHighRaw "Brazil" ;
    ns1:documentDate "2013-11-26T14:10:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Smith & Nephew's M&A blitz rolls on with Brazilian buy" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/smith-nephew-s-m-a-blitz-rolls-brazilian-buy> ;
    ns1:foundName "Politec Sade" ;
    ns1:industry "medical" ;
    ns1:name "Politec Sade" ;
    ns1:sameAsMedium <https://1145.am/db/2288358/Politec_Saude>,
        <https://1145.am/db/2299796/Politec_Saude> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294520/Smith___Nephew> a org:Organization ;
    ns1:basedInLowRaw "U.K" ;
    ns1:description "medical" ;
    ns1:documentDate "2013-11-26T14:10:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Smith & Nephew's M&A blitz rolls on with Brazilian buy" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/smith-nephew-s-m-a-blitz-rolls-brazilian-buy> ;
    ns1:foundName "Smith & Nephew" ;
    ns1:industry "medical" ;
    ns1:investor <https://1145.am/db/2294520/Politec_Sade_Share_Investment> ;
    ns1:name "Smith & Nephew" ;
    ns1:sameAsHigh <https://1145.am/db/1098849/Smith+nephew>,
        <https://1145.am/db/2153538/Smith___Nephew>,
        <https://1145.am/db/2154238/Smith___Nephew>,
        <https://1145.am/db/2284728/Smith___Nephew>,
        <https://1145.am/db/2287115/Smith___Nephew>,
        <https://1145.am/db/2288016/Smith___Nephew>,
        <https://1145.am/db/2288358/Smith___Nephew>,
        <https://1145.am/db/2288707/Smith___Nephew>,
        <https://1145.am/db/2289604/Smith___Nephew>,
        <https://1145.am/db/2289605/Smiths_Medical>,
        <https://1145.am/db/2292239/Smith___Nephew>,
        <https://1145.am/db/2293884/Smith___Nephew>,
        <https://1145.am/db/2297377/Smith___Nephew>,
        <https://1145.am/db/2297423/Smith___Nephew>,
        <https://1145.am/db/2298811/Smith___Nephew>,
        <https://1145.am/db/2299038/Smith___Nephew>,
        <https://1145.am/db/2299650/Smith___Nephew>,
        <https://1145.am/db/2313988/Smith___Nephew>,
        <https://1145.am/db/2319490/Smiths_Medical>,
        <https://1145.am/db/2328026/Smith___Nephew>,
        <https://1145.am/db/2329268/Smith___Nephew>,
        <https://1145.am/db/2545574/Smith___Nephew>,
        <https://1145.am/db/2551751/Smith___Nephew>,
        <https://1145.am/db/2596595/Smith___Nephew>,
        <https://1145.am/db/846910/Smith+nephew> ;
    ns1:sameAsMedium <https://1145.am/db/2288382/Smith___Nephew>,
        <https://1145.am/db/2288385/Smith___Nephew>,
        <https://1145.am/db/2289251/Smith___Nephew>,
        <https://1145.am/db/2289275/Smith___Nephew>,
        <https://1145.am/db/2289714/Smith___Nephew>,
        <https://1145.am/db/2290894/Smith___Nephew>,
        <https://1145.am/db/2295387/Smith___Nephew>,
        <https://1145.am/db/2295394/Smith___Nephew>,
        <https://1145.am/db/2295687/Smith___Nephew>,
        <https://1145.am/db/2296368/Smith___Nephew>,
        <https://1145.am/db/2296925/Smith___Nephew>,
        <https://1145.am/db/2297818/Smith___Nephew>,
        <https://1145.am/db/2297857/Smith___Nephew>,
        <https://1145.am/db/2298663/Smith___Nephew>,
        <https://1145.am/db/2299796/Smith___Nephew>,
        <https://1145.am/db/2299861/Smith___Nephew>,
        <https://1145.am/db/2315085/Smith___Nephew>,
        <https://1145.am/db/2329255/Smith___Nephew>,
        <https://1145.am/db/2334989/Smith___Nephew>,
        <https://1145.am/db/2352259/Smith___Nephew>,
        <https://1145.am/db/2580381/Smith___Nephew> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294543/Clr_Medicals> a org:Organization ;
    ns1:basedInHighGeoName "California" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:basedInHighRaw "California" ;
    ns1:documentDate "2013-11-27T15:47:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Texas stent developer nears $30M funding round; Myriad Genetics sues another Dx rival;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/texas-stent-developer-nears-30m-funding-round-myriad-genetics-sues-another-dx-rival> ;
    ns1:foundName "CLR Medicals" ;
    ns1:industry "medical" ;
    ns1:name "CLR Medicals" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294543/Investment_Clr_Medicals_Palmaz_Scientific_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-11-27T15:47:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Texas cardiovascular stent maker Palmaz Scientific is close to completing a $ 30 million funding round." ;
    ns1:documentTitle "Texas stent developer nears $30M funding round; Myriad Genetics sues another Dx rival;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/texas-stent-developer-nears-30m-funding-round-myriad-genetics-sues-another-dx-rival> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2294543/Clr_Medicals>,
        <https://1145.am/db/2294543/Palmaz_Scientific> ;
    ns1:valueRaw "$ 30 million" ;
    ns1:whereGeoName "Texas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:whereRaw "Texas" .

<https://1145.am/db/2294543/Ipo_Echo_Therapeutics_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "ipo" ;
    ns1:documentDate "2013-11-27T15:47:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Echo Therapeutics ($ ECTE) said it is on track for a 2013 fourth-quarter CE mark submission for its Symphony wireless continuous glucose monitoring system, following positive results from a multi-center trial." ;
    ns1:documentTitle "Texas stent developer nears $30M funding round; Myriad Genetics sues another Dx rival;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/texas-stent-developer-nears-30m-funding-round-myriad-genetics-sues-another-dx-rival> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Texas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:whereRaw "Texas" .

<https://1145.am/db/2294543/Palmaz_Scientific> a org:Organization ;
    ns1:basedInHighGeoName "Texas" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:basedInHighRaw "Texas" ;
    ns1:description "cardiovascular stent" ;
    ns1:documentDate "2013-11-27T15:47:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Texas stent developer nears $30M funding round; Myriad Genetics sues another Dx rival;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/texas-stent-developer-nears-30m-funding-round-myriad-genetics-sues-another-dx-rival> ;
    ns1:foundName "Palmaz Scientific" ;
    ns1:industry "medical" ;
    ns1:investor <https://1145.am/db/2294543/Investment_Clr_Medicals_Palmaz_Scientific_Completed> ;
    ns1:name "Palmaz Scientific" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294544/Crescendo_Bioscience> a org:Organization ;
    ns1:basedInHighGeoName "South San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:basedInHighRaw "South San Francisco" ;
    ns1:description "Molecular diagnostic test maker",
        "rheumatoid arthritis" ;
    ns1:documentDate "2013-11-27T19:36:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Myriad Genetics inches closer to acquiring Crescendo Bioscience" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/myriad-genetics-inches-closer-to-acquiring-crescendo-bioscience> ;
    ns1:foundName "Crescendo",
        "Crescendo Bioscience" ;
    ns1:industry "Molecular diagnostic test maker" ;
    ns1:name "Crescendo",
        "Crescendo Bioscience" ;
    ns1:sameAsMedium <https://1145.am/db/2294871/Crescendo_Bioscience>,
        <https://1145.am/db/2294902/Crescendo_Bioscience>,
        <https://1145.am/db/2296937/Crescendo_Bioscience>,
        <https://1145.am/db/2349519/Crescendo_Bioscience>,
        <https://1145.am/db/2369844/Crescendo_Bioscience> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294993/Diogenix> a org:Organization ;
    ns1:description "medical" ;
    ns1:documentDate "2013-12-05T14:34:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cheney blasts device tax as one of 'the dumbest ideas' ever; Aurora Spine wins 510(k);" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cheney-blasts-device-tax-as-one-dumbest-ideas-ever-aurora-spine-wins-510-k> ;
    ns1:foundName "DioGenix" ;
    ns1:industry "medical device" ;
    ns1:name "DioGenix" ;
    ns1:sameAsHigh <https://1145.am/db/750000/Disior_Oy> ;
    ns1:sameAsMedium <https://1145.am/db/2297293/Diogenix> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294993/Investment_Aurora_Spine_Diogenix_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-12-05T14:34:23+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> DioGenix pulled in $ 3.2 million in a new private financing designed to fund an ongoing clinical trial of its new multiple sclerosis diagnostic." ;
    ns1:documentTitle "Cheney blasts device tax as one of 'the dumbest ideas' ever; Aurora Spine wins 510(k);" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cheney-blasts-device-tax-as-one-dumbest-ideas-ever-aurora-spine-wins-510-k> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2294993/Diogenix> ;
    ns1:valueRaw "$ 3.2 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S." .

<https://1145.am/db/2295945/Alverix> a org:Organization ;
    ns1:basedInHighGeoName "San Jos" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3621849/about.rdf> ;
    ns1:basedInHighRaw "San Jose" ;
    ns1:documentDate "2014-01-07T15:25:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "BD trades $40M for diagnostics partner Alverix" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/bd-trades-40m-for-diagnostics-partner-alverix> ;
    ns1:foundName "Alverix" ;
    ns1:industry "Life sciences" ;
    ns1:name "Alverix" ;
    ns1:sameAsMedium <https://1145.am/db/2242819/Alverix> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2295945/Safeguard_Scientifics> a org:Organization ;
    ns1:description "Life sciences" ;
    ns1:documentDate "2014-01-07T15:25:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "BD trades $40M for diagnostics partner Alverix" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/bd-trades-40m-for-diagnostics-partner-alverix> ;
    ns1:foundName "Safeguard Scientifics" ;
    ns1:industry "Life sciences" ;
    ns1:investor <https://1145.am/db/2295945/Alverix_Share_Investment> ;
    ns1:name "Safeguard Scientifics" ;
    ns1:sameAsHigh <https://1145.am/db/2290453/Safeguard_Scientifics>,
        <https://1145.am/db/2305609/Safeguard_Scientifics>,
        <https://1145.am/db/2307837/Safeguard_Scientifics>,
        <https://1145.am/db/2322984/Safeguard_Scientifics>,
        <https://1145.am/db/2323003/Safeguard_Scientifics>,
        <https://1145.am/db/2354706/Safeguard_Scientifics>,
        <https://1145.am/db/2576460/Safeguard_Scientifics> ;
    ns1:sameAsMedium <https://1145.am/db/1232627/Safeguard_Scientifics>,
        <https://1145.am/db/1383287/Safeguard_Scientifics>,
        <https://1145.am/db/1801934/Safeguard_Scientifics>,
        <https://1145.am/db/1843216/Safeguard_Scientifics>,
        <https://1145.am/db/1855887/Safeguard_Scientifics>,
        <https://1145.am/db/1873156/Safeguard_Scientifics>,
        <https://1145.am/db/1914893/Safeguard_Scientifics>,
        <https://1145.am/db/2147446/Safeguard_Scientifics>,
        <https://1145.am/db/2182583/Safeguard_Scientifics>,
        <https://1145.am/db/2291872/Safeguard_Scientifics>,
        <https://1145.am/db/2292039/Safeguard_Scientifics>,
        <https://1145.am/db/2297604/Safeguard_Scientifics>,
        <https://1145.am/db/2298535/Safeguard_Scientifics>,
        <https://1145.am/db/2304598/Safeguard_Scientifics>,
        <https://1145.am/db/2304605/Safeguard_Scientifics_Inc>,
        <https://1145.am/db/2305443/Safeguard_Scientifics>,
        <https://1145.am/db/2316302/Safeguard_Scientifics>,
        <https://1145.am/db/2317455/Safeguard_Scientifics_Inc>,
        <https://1145.am/db/2319506/Safeguard_Scientifics>,
        <https://1145.am/db/2323336/Safeguard_Scientifics>,
        <https://1145.am/db/2325237/Safeguard_Scientifics>,
        <https://1145.am/db/2359125/Safeguard_Scientifics>,
        <https://1145.am/db/2436408/Safeguard_Scientifics_Inc>,
        <https://1145.am/db/2447203/Safeguard_Scientifics_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2296920/Life_Technologies> a org:Organization ;
    ns1:basedInHighGeoName "Massachusetts" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6254926/about.rdf> ;
    ns1:basedInHighRaw "Massachusetts" ;
    ns1:description "laboratory equipment" ;
    ns1:documentDate "2014-01-31T19:58:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "U.S. regulators clear Thermo Fisher's $13.6B Life Tech deal, with conditions attached" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/u-s-regulators-clear-thermo-fisher-s-13-6b-life-tech-deal-conditions-attached> ;
    ns1:foundName "Life Technologies" ;
    ns1:industry "laboratory equipment" ;
    ns1:name "Life Technologies" ;
    ns1:sameAsHigh <https://1145.am/db/2298815/Life_Technologies>,
        <https://1145.am/db/2574083/Life_Technologies> ;
    ns1:sameAsMedium <https://1145.am/db/1728598/Life_Technologies_Corporation>,
        <https://1145.am/db/2287839/Life_Technologies>,
        <https://1145.am/db/2288640/Life_Technologies>,
        <https://1145.am/db/2289479/Life_Technologies>,
        <https://1145.am/db/2291513/Life_Technologies>,
        <https://1145.am/db/2294528/Life_Technologies>,
        <https://1145.am/db/2295929/Life_Technologies>,
        <https://1145.am/db/2296261/Life_Technologies>,
        <https://1145.am/db/2296417/Life_Technologies>,
        <https://1145.am/db/2297264/Life_Technologies>,
        <https://1145.am/db/2298237/Life_Technologies>,
        <https://1145.am/db/2298270/Life_Technologies>,
        <https://1145.am/db/2298696/Life_Technologies>,
        <https://1145.am/db/2298709/Life_Technologies>,
        <https://1145.am/db/2299124/Life_Technologies>,
        <https://1145.am/db/2299139/Life_Technologies>,
        <https://1145.am/db/2299612/Life_Technologies>,
        <https://1145.am/db/2300265/Life_Technologies>,
        <https://1145.am/db/2306511/Life_Technologies>,
        <https://1145.am/db/2306535/Life_Technologies>,
        <https://1145.am/db/2309321/Life_Technologies>,
        <https://1145.am/db/2313983/Life_Technologies>,
        <https://1145.am/db/2316481/Life_Technologies>,
        <https://1145.am/db/2328026/Life_Technologies>,
        <https://1145.am/db/2328028/Life_Technologies_Corporation>,
        <https://1145.am/db/2332195/Life_Technologies>,
        <https://1145.am/db/2332200/Life_Technologies>,
        <https://1145.am/db/2332668/Life_Technologies_Corporation>,
        <https://1145.am/db/2337045/Life_Technologies>,
        <https://1145.am/db/2351845/Life_Technologies_Corporation>,
        <https://1145.am/db/2351853/Life_Technologies>,
        <https://1145.am/db/2360368/Life_Technologies_Corporation>,
        <https://1145.am/db/2363019/Life_Technologies_Corporation>,
        <https://1145.am/db/2364025/Life_Technologies_Corporation>,
        <https://1145.am/db/2366638/Life_Technologies_Corporation>,
        <https://1145.am/db/2551499/Life_Technologies>,
        <https://1145.am/db/2594467/Life_Technologies_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2297836/Biosensors_International> a org:Organization ;
    ns1:basedInHighGeoName "Beijing",
        "Republic of Singapore" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1816670/about.rdf>,
        <https://sws.geonames.org/1880251/about.rdf> ;
    ns1:basedInHighRaw "Beijing",
        "Singapore" ;
    ns1:description "medical device company" ;
    ns1:documentDate "2014-02-18T14:15:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "A Chinese equity firm wants to take control of Biosensors International, report says" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/a-chinese-equity-firm-wants-to-take-control-biosensors-international-report-says> ;
    ns1:foundName "Biosensors",
        "Biosensors International" ;
    ns1:industry "medical",
        "medical device" ;
    ns1:name "Biosensors",
        "Biosensors International" ;
    ns1:sameAsHigh <https://1145.am/db/2288384/Biosensors_International>,
        <https://1145.am/db/2330325/Biosensors_International> ;
    ns1:sameAsMedium <https://1145.am/db/2300109/Biosensors_International> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2297836/Biosensors_International_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2014-02-18T14:15:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "According to the story, the Beijing - based arm of China's Citic Group (a state-supported conglomerate) grabbed 22 % of Biosensors from Shandong Weigao Group Medical Polymer Co. last November for $ 312.3 million.",
        "Singapore's Biosensors International has reportedly become an acquisition target." ;
    ns1:documentTitle "A Chinese equity firm wants to take control of Biosensors International, report says" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/a-chinese-equity-firm-wants-to-take-control-biosensors-international-report-says> ;
    ns1:foundName "acquisition",
        "grabbed" ;
    ns1:name "acquisition",
        "grabbed" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2297836/Biosensors_International> ;
    ns1:targetName "Biosensors",
        "Biosensors International" ;
    ns1:valueRaw "$ 312.3 million" ;
    ns1:vendor <https://1145.am/db/2297836/Shandong_Weigao_Group_Medical_Polymer_Co> ;
    ns1:whenRaw "November" ;
    ns1:whereGeoName "Peoples Republic of China",
        "Republic of Singapore" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf>,
        <https://sws.geonames.org/1880251/about.rdf> ;
    ns1:whereRaw "China",
        "Singapore" .

<https://1145.am/db/2297836/Shandong_Weigao_Group_Medical_Polymer_Co> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:documentDate "2014-02-18T14:15:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "A Chinese equity firm wants to take control of Biosensors International, report says" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/a-chinese-equity-firm-wants-to-take-control-biosensors-international-report-says> ;
    ns1:foundName "Shandong Weigao Group Medical Polymer Co." ;
    ns1:name "Shandong Weigao Group Medical Polymer Co." ;
    ns1:sameAsMedium <https://1145.am/db/2329249/Shandong_Weigao_Group_Medical_Polymer> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2297889/Bruin_Biometrics> a org:Organization ;
    ns1:basedInHighGeoName "Los Angeles County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5368381/about.rdf> ;
    ns1:basedInHighRaw "Los Angeles" ;
    ns1:description "developing biometric medical devices" ;
    ns1:documentDate "2014-02-27T16:53:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NxThera and Bruin Biometrics nail new financings for device development work" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nxthera-and-bruin-biometrics-nail-new-financings-for-device-development-work> ;
    ns1:foundName "Bruin Biometrics",
        "in Los Angeles" ;
    ns1:industry "medical devices" ;
    ns1:name "Bruin Biometrics" ;
    ns1:sameAsHigh <https://1145.am/db/2361515/Bruin_Biometrics_Llc> ;
    ns1:sameAsMedium <https://1145.am/db/2333989/Bruin_Biometrics>,
        <https://1145.am/db/2334478/Bruin_Biometrics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2297889/Los_Angeles> a org:Organization ;
    ns1:documentDate "2014-02-27T16:53:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NxThera and Bruin Biometrics nail new financings for device development work" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nxthera-and-bruin-biometrics-nail-new-financings-for-device-development-work> ;
    ns1:foundName "Los Angeles" ;
    ns1:name "Los Angeles" ;
    ns1:sameAsMedium <https://1145.am/db/2396339/Los_Angeles>,
        <https://1145.am/db/2509068/Los_Angeles> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2297889/Nxthera> a org:Organization ;
    ns1:basedInHighGeoName "Minnesota" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5037779/about.rdf> ;
    ns1:basedInHighRaw "Minnesota" ;
    ns1:documentDate "2014-02-27T16:53:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NxThera and Bruin Biometrics nail new financings for device development work" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/nxthera-and-bruin-biometrics-nail-new-financings-for-device-development-work> ;
    ns1:foundName "NxThera" ;
    ns1:name "NxThera" ;
    ns1:sameAsMedium <https://1145.am/db/2289793/Nxthera>,
        <https://1145.am/db/2290964/Nxthera>,
        <https://1145.am/db/2299552/Nxthera>,
        <https://1145.am/db/2332413/Nxthera> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2298811/Arthrocare> a org:Organization ;
    ns1:basedInHighGeoName "Austin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4671654/about.rdf> ;
    ns1:basedInHighRaw "Austin" ;
    ns1:description "sports medicine joint repair" ;
    ns1:documentDate "2014-03-17T13:16:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Smith & Nephew clears a major U.S. regulatory hurdle for ArthroCare merger" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/smith-nephew-clears-a-major-u-s-regulatory-hurdle-for-arthrocare-merger> ;
    ns1:foundName "ArthroCare" ;
    ns1:industry "medical" ;
    ns1:name "ArthroCare" ;
    ns1:sameAsHigh <https://1145.am/db/2288474/Arthrocare>,
        <https://1145.am/db/2297377/Arthrocare>,
        <https://1145.am/db/2297423/Arthrocare>,
        <https://1145.am/db/2300289/Ats_Medical> ;
    ns1:sameAsMedium <https://1145.am/db/2288016/Arthrocare>,
        <https://1145.am/db/2296925/Arthrocare>,
        <https://1145.am/db/2297850/Arthrocare>,
        <https://1145.am/db/2297857/Arthrocare>,
        <https://1145.am/db/2299796/Arthrocare> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2298811/Arthrocare_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2014-03-17T13:16:09+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Smith & Nephew ($ SNN) cleared a major regulatory hurdle to acquiring ArthroCare ($ ARTC) .",
        "U.K. - based Smith & Nephew agreed to pay $ 1.7 billion in February for ArthroCare, a Texas device company that specializes in sports medicine joint repair." ;
    ns1:documentTitle "Smith & Nephew clears a major U.S. regulatory hurdle for ArthroCare merger" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/smith-nephew-clears-a-major-u-s-regulatory-hurdle-for-arthrocare-merger> ;
    ns1:foundName "acquiring",
        "merger",
        "pay" ;
    ns1:name "acquiring",
        "merger",
        "pay" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2298811/Arthrocare> ;
    ns1:targetName "ArthroCare" ;
    ns1:valueRaw "$ 1.7 billion" ;
    ns1:whereGeoName "Austin" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4671654/about.rdf> ;
    ns1:whereRaw "Austin" .

<https://1145.am/db/2298811/Smith___Nephew> a org:Organization ;
    ns1:basedInLowRaw "U.K." ;
    ns1:buyer <https://1145.am/db/2298811/Arthrocare_Acquisition> ;
    ns1:documentDate "2014-03-17T13:16:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Smith & Nephew clears a major U.S. regulatory hurdle for ArthroCare merger" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/smith-nephew-clears-a-major-u-s-regulatory-hurdle-for-arthrocare-merger> ;
    ns1:foundName "Smith & Nephew" ;
    ns1:industry "medical" ;
    ns1:name "Smith & Nephew" ;
    ns1:sameAsHigh <https://1145.am/db/1098849/Smith+nephew>,
        <https://1145.am/db/2153538/Smith___Nephew>,
        <https://1145.am/db/2154238/Smith___Nephew>,
        <https://1145.am/db/2284728/Smith___Nephew>,
        <https://1145.am/db/2288016/Smith___Nephew>,
        <https://1145.am/db/2288358/Smith___Nephew>,
        <https://1145.am/db/2288707/Smith___Nephew>,
        <https://1145.am/db/2289605/Smiths_Medical>,
        <https://1145.am/db/2292239/Smith___Nephew>,
        <https://1145.am/db/2293884/Smith___Nephew>,
        <https://1145.am/db/2294520/Smith___Nephew>,
        <https://1145.am/db/2297377/Smith___Nephew>,
        <https://1145.am/db/2297423/Smith___Nephew>,
        <https://1145.am/db/2299038/Smith___Nephew>,
        <https://1145.am/db/2299650/Smith___Nephew>,
        <https://1145.am/db/2313988/Smith___Nephew>,
        <https://1145.am/db/2319490/Smiths_Medical>,
        <https://1145.am/db/2329268/Smith___Nephew>,
        <https://1145.am/db/2545574/Smith___Nephew>,
        <https://1145.am/db/2551751/Smith___Nephew>,
        <https://1145.am/db/2596595/Smith___Nephew>,
        <https://1145.am/db/846910/Smith+nephew> ;
    ns1:sameAsMedium <https://1145.am/db/2287115/Smith___Nephew>,
        <https://1145.am/db/2288382/Smith___Nephew>,
        <https://1145.am/db/2288385/Smith___Nephew>,
        <https://1145.am/db/2289251/Smith___Nephew>,
        <https://1145.am/db/2289275/Smith___Nephew>,
        <https://1145.am/db/2289604/Smith___Nephew>,
        <https://1145.am/db/2289714/Smith___Nephew>,
        <https://1145.am/db/2290894/Smith___Nephew>,
        <https://1145.am/db/2295387/Smith___Nephew>,
        <https://1145.am/db/2295394/Smith___Nephew>,
        <https://1145.am/db/2295687/Smith___Nephew>,
        <https://1145.am/db/2296368/Smith___Nephew>,
        <https://1145.am/db/2296925/Smith___Nephew>,
        <https://1145.am/db/2297818/Smith___Nephew>,
        <https://1145.am/db/2297857/Smith___Nephew>,
        <https://1145.am/db/2298663/Smith___Nephew>,
        <https://1145.am/db/2299796/Smith___Nephew>,
        <https://1145.am/db/2299861/Smith___Nephew>,
        <https://1145.am/db/2315085/Smith___Nephew>,
        <https://1145.am/db/2328026/Smith___Nephew>,
        <https://1145.am/db/2329255/Smith___Nephew>,
        <https://1145.am/db/2334989/Smith___Nephew>,
        <https://1145.am/db/2352259/Smith___Nephew>,
        <https://1145.am/db/2580381/Smith___Nephew> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2304545/Bina_Technologies> a org:Organization ;
    ns1:description "genomic analysis",
        "healthcare" ;
    ns1:documentDate "2013-07-31T11:52:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Bina Accelerates Growth with Fully Subscribed $8M Series B Round, Adds to Executive Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/bina-accelerates-growth-fully-subscribed-8m-series-b-round-adds-to-executive-team> ;
    ns1:foundName "Bina",
        "Bina Technologies" ;
    ns1:industry "healthcare" ;
    ns1:name "Bina",
        "Bina Technologies" ;
    ns1:sameAsHigh <https://1145.am/db/2254658/Bina_Technologies>,
        <https://1145.am/db/2353986/Bina_Technologies>,
        <https://1145.am/db/2593760/Bina_Technologies> ;
    ns1:sameAsMedium <https://1145.am/db/2334748/Bina_Technologies>,
        <https://1145.am/db/2335160/Bina_Technologies>,
        <https://1145.am/db/2353992/Bina_Technologies_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305441/Desktop_Genetics_Ltd> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "genetic engineering" ;
    ns1:documentDate "2013-09-01T21:30:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Desktop Genetics Ltd Receives 375,000 Funding to Commercialize Genetic Engineering Platform AutoClone" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/desktop-genetics-ltd-receives-%C2%A3375-000-funding-to-commercialize-genetic-engineering-platform> ;
    ns1:foundName "Desktop Genetics Ltd",
        "Desktop Genetics Ltd (DeskGen)" ;
    ns1:name "Desktop Genetics Ltd" ;
    ns1:sameAsMedium <https://1145.am/db/2329403/Desktop_Genetics>,
        <https://1145.am/db/2329404/Desktop_Genetics_Ltd> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305443/Quantia_Inc> a org:Organization ;
    ns1:description "Scientifics",
        "healthcare" ;
    ns1:documentDate "2013-09-03T13:51:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Safeguard Scientifics Leads $10M Series B Financing for Quantia" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/safeguard-scientifics-leads-10m-series-b-financing-for-quantia> ;
    ns1:foundName "Quantia, Inc",
        "Quantia, Inc.",
        "Quantia." ;
    ns1:industry "Healthcare" ;
    ns1:name "Quantia",
        "Quantia, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1850787/Quantiamd>,
        <https://1145.am/db/2200374/Quantros>,
        <https://1145.am/db/2205138/Quantim>,
        <https://1145.am/db/2209892/Quantros>,
        <https://1145.am/db/2238409/Quantros>,
        <https://1145.am/db/2241303/Quantros>,
        <https://1145.am/db/2246618/Quantros>,
        <https://1145.am/db/2247487/Quantros>,
        <https://1145.am/db/2247521/Quantiamd>,
        <https://1145.am/db/2290786/Quantib>,
        <https://1145.am/db/2570971/Quantiamd>,
        <https://1145.am/db/2573805/Quantia_Inc>,
        <https://1145.am/db/2573811/Quantia> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305445/Eagle_Genomics> a org:Organization ;
    ns1:description "life science" ;
    ns1:documentDate "2013-09-03T13:24:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Eagle Genomics secures 590,000 to expand its current bioinformatics offerings" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/eagle-genomics-secures-%C2%A3590-000-to-expand-its-current-bioinformatics-offerings> ;
    ns1:foundName "Eagle Genomics" ;
    ns1:industry "life science" ;
    ns1:name "Eagle Genomics" ;
    ns1:sameAsMedium <https://1145.am/db/1460938/Eagle_Genomics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305445/Midven> a org:Organization ;
    ns1:basedInLowRaw "Cambridge" ;
    ns1:description "investment" ;
    ns1:documentDate "2013-09-03T13:24:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Eagle Genomics secures 590,000 to expand its current bioinformatics offerings" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/eagle-genomics-secures-%C2%A3590-000-to-expand-its-current-bioinformatics-offerings> ;
    ns1:foundName "Midven" ;
    ns1:investor <https://1145.am/db/2305445/Investment_Eagle_Genomics_Jonathan_Milner_Midven_Rainbow_Seed_Fund_Completed> ;
    ns1:name "Midven" ;
    ns1:sameAsMedium <https://1145.am/db/1894719/Midven> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306519/Raindance_Technologies> a org:Organization ;
    ns1:description "Digital PCR and Next-Gen Sequencing Products" ;
    ns1:documentDate "2013-09-30T12:32:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RainDance Technologies Secures $35 Million in Financing from Capital Royalty Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/raindance-technologies-secures-35-million-financing-from-capital-royalty-partners> ;
    ns1:foundName "RainDance",
        "RainDance Technologies",
        "RainDance Technologies, Inc." ;
    ns1:name "RainDance Technologies" ;
    ns1:sameAsMedium <https://1145.am/db/2289564/Raindance_Technologies>,
        <https://1145.am/db/2299625/Raindance_Technologies>,
        <https://1145.am/db/2321707/Raindance_Technologies>,
        <https://1145.am/db/2321785/Raindance_Technologies>,
        <https://1145.am/db/2336262/Raindance_Technologies>,
        <https://1145.am/db/2338153/Raindance_Technologies>,
        <https://1145.am/db/2340429/Raindance_Technologies>,
        <https://1145.am/db/2359729/Raindance_Technologies>,
        <https://1145.am/db/2370559/Raindance_Technologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306529/Boreal_Genomics> a org:Organization ;
    ns1:description "life science research" ;
    ns1:documentDate "2013-10-07T12:15:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Boreal Genomics Secures $18 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/boreal-genomics-secures-18-million-series-c-financing> ;
    ns1:foundName "Boreal Genomics" ;
    ns1:industry "life science research" ;
    ns1:name "Boreal Genomics" ;
    ns1:sameAsHigh <https://1145.am/db/2292117/Boreal_Genomics>,
        <https://1145.am/db/2358752/Boreal_Genomics> ;
    ns1:sameAsMedium <https://1145.am/db/2292122/Boreal_Genomics>,
        <https://1145.am/db/2306527/Boreal_Genomics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306551/5am_Ventures> a org:Organization ;
    ns1:documentDate "2013-10-21T08:04:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pfizer and Roche back protein shape change monitoring startup" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/pfizer-and-roche-back-protein-shape-change-monitoring-startup> ;
    ns1:foundName "5AM Ventures" ;
    ns1:investor <https://1145.am/db/2306551/Series_A_Investment_5am_Ventures_Biodesy_Completed> ;
    ns1:name "5AM Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1157541/5am_Ventures>,
        <https://1145.am/db/1533327/5am_Ventures>,
        <https://1145.am/db/1533685/5am_Ventures>,
        <https://1145.am/db/1608803/5am_Ventures>,
        <https://1145.am/db/1669813/5am_Ventures>,
        <https://1145.am/db/2152422/5am_Ventures>,
        <https://1145.am/db/2153726/5am_Ventures>,
        <https://1145.am/db/2153910/5am_Ventures>,
        <https://1145.am/db/2283394/5am_Ventures>,
        <https://1145.am/db/2286204/5am_Ventures>,
        <https://1145.am/db/2286665/5am_Ventures>,
        <https://1145.am/db/2288016/5am_Ventures>,
        <https://1145.am/db/2298404/5am_Ventures>,
        <https://1145.am/db/2298642/5am_Ventures>,
        <https://1145.am/db/2306549/5am_Ventures>,
        <https://1145.am/db/2306754/5am_Ventures>,
        <https://1145.am/db/2311595/5am_Ventures>,
        <https://1145.am/db/2313985/5am_Ventures>,
        <https://1145.am/db/2317919/5am_Ventures>,
        <https://1145.am/db/2318733/5am_Ventures>,
        <https://1145.am/db/2319784/5am_Ventures>,
        <https://1145.am/db/2322646/5am_Ventures>,
        <https://1145.am/db/2323210/5am_Ventures>,
        <https://1145.am/db/2323226/5am_Ventures>,
        <https://1145.am/db/2324195/5am_Ventures>,
        <https://1145.am/db/2328146/5am_Ventures>,
        <https://1145.am/db/2328338/5am_Ventures>,
        <https://1145.am/db/2329778/5am_Ventures>,
        <https://1145.am/db/2332322/5am_Ventures>,
        <https://1145.am/db/2339885/5am_Ventures>,
        <https://1145.am/db/2339886/5am_Ventures>,
        <https://1145.am/db/2340344/5am_Ventures>,
        <https://1145.am/db/2340345/5am_Ventures>,
        <https://1145.am/db/2340348/5am_Ventures>,
        <https://1145.am/db/2341003/5am_Ventures>,
        <https://1145.am/db/2342352/5am_Ventures>,
        <https://1145.am/db/2347885/5am_Ventures>,
        <https://1145.am/db/2348754/5am_Ventures>,
        <https://1145.am/db/2348857/5am_Ventures>,
        <https://1145.am/db/2349120/5am_Ventures>,
        <https://1145.am/db/2349834/5am_Ventures>,
        <https://1145.am/db/2351316/5am_Ventures>,
        <https://1145.am/db/2351683/5am_Ventures>,
        <https://1145.am/db/2351684/5am_Ventures>,
        <https://1145.am/db/2354296/5am_Ventures>,
        <https://1145.am/db/2355238/5am_Ventures>,
        <https://1145.am/db/2357858/5am_Ventures>,
        <https://1145.am/db/2359401/5am_Ventures>,
        <https://1145.am/db/2359864/5am_Ventures>,
        <https://1145.am/db/2360174/5am_Ventures>,
        <https://1145.am/db/2360415/5am_Ventures>,
        <https://1145.am/db/2362475/5am_Ventures>,
        <https://1145.am/db/2362481/5am_Ventures>,
        <https://1145.am/db/2364492/5am_Ventures>,
        <https://1145.am/db/2367275/5am_Ventures>,
        <https://1145.am/db/2370609/5am_Ventures>,
        <https://1145.am/db/2371160/5am_Ventures>,
        <https://1145.am/db/2371163/5am_Ventures>,
        <https://1145.am/db/2538476/5am_Ventures>,
        <https://1145.am/db/2569220/5am_Ventures>,
        <https://1145.am/db/2572398/5am_Ventures>,
        <https://1145.am/db/2587596/5am_Ventures>,
        <https://1145.am/db/2592685/5am_Ventures>,
        <https://1145.am/db/359190/5am_Ventures>,
        <https://1145.am/db/428737/5am_Ventures>,
        <https://1145.am/db/509733/5am_Ventures>,
        <https://1145.am/db/558016/5am_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306551/Biodesy> a org:Organization ;
    ns1:description "developing and commercializing its second-harmonic generation (SHG) technology" ;
    ns1:documentDate "2013-10-21T08:04:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pfizer and Roche back protein shape change monitoring startup" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/pfizer-and-roche-back-protein-shape-change-monitoring-startup> ;
    ns1:foundName "Biodesy" ;
    ns1:name "Biodesy" ;
    ns1:sameAsMedium <https://1145.am/db/2306549/Biodesy_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306551/Series_A_Investment_5am_Ventures_Biodesy_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-21T08:04:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Pfizer and Roche were joined by 5AM Ventures in a $ 15 million Series A financing round that will give Biodesy the cash to further develop and commercialize its second-harmonic generation (SHG) technology." ;
    ns1:documentTitle "Pfizer and Roche back protein shape change monitoring startup" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/pfizer-and-roche-back-protein-shape-change-monitoring-startup> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2306551/Biodesy> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 15 million" .

<https://1145.am/db/2310864/Validic> a org:Organization ;
    ns1:basedInHighGeoName "Durham County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4464374/about.rdf> ;
    ns1:basedInHighRaw "DURHAM, N.C." ;
    ns1:description "healthcare" ;
    ns1:documentDate "2014-03-17T11:40:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Validic Secures $1.25 Million in New Funding, Adds Key Executives" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/validic-secures-1-25-million-new-funding-adds-key-executives> ;
    ns1:foundName "Validic" ;
    ns1:industry "healthcare" ;
    ns1:name "Validic" ;
    ns1:sameAsHigh <https://1145.am/db/2199828/Validic>,
        <https://1145.am/db/2254556/Validic>,
        <https://1145.am/db/2308556/Validic> ;
    ns1:sameAsMedium <https://1145.am/db/2322915/Validic> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2317344/Acquisition_Kkr_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-09-25T17:50:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "RALEIGH, N.C. - PRA International (\"PRA\") , a leading clinical research organization, today announced the completion of its merger with ReSearch Pharmaceutical Services (\"RPS\") and the closing of the acquisition by KKR." ;
    ns1:documentTitle "PRA and RPS Merger Completed" ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/pra-and-rps-merger-completed> ;
    ns1:foundName "merger" ;
    ns1:name "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:whereGeoName "North Carolina" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4482348/about.rdf> ;
    ns1:whereRaw "N.C." .

<https://1145.am/db/2317344/Investment_Kkr_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-25T17:50:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "RALEIGH, N.C. - PRA International (\"PRA\") , a leading clinical research organization, today announced the completion of its merger with ReSearch Pharmaceutical Services (\"RPS\") and the closing of the acquisition by KKR." ;
    ns1:documentTitle "PRA and RPS Merger Completed" ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/pra-and-rps-merger-completed> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:whereGeoName "North Carolina" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4482348/about.rdf> ;
    ns1:whereRaw "N.C." .

<https://1145.am/db/2318450/Catalina_Health> a org:Organization ;
    ns1:basedInLowRaw "the nation" ;
    ns1:description "patient" ;
    ns1:documentDate "2013-10-31T12:30:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "InVentiv grabs Catalina Health with eye on patient adherence" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/inventiv-grabs-catalina-health-eye-on-patient-adherence> ;
    ns1:foundName "Catalina Health" ;
    ns1:name "Catalina Health" ;
    ns1:sameAsMedium <https://1145.am/db/2362598/Catalina_Health> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318450/Catalina_Health_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2013-10-31T12:30:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Outsourcing magnate inVentiv Health ($ VTIV) is padding its patient-adherence offerings, snapping up Catalina Health and merging the company with its Adheris subsidiary, a move it said creates the nation's largest provider of such services." ;
    ns1:documentTitle "InVentiv grabs Catalina Health with eye on patient adherence" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/inventiv-grabs-catalina-health-eye-on-patient-adherence> ;
    ns1:foundName "merging",
        "snapping" ;
    ns1:name "merging",
        "snapping" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2318450/Catalina_Health> ;
    ns1:targetName "Catalina Health" .

<https://1145.am/db/2318461/Bend_Research> a org:Organization ;
    ns1:basedInHighGeoName "Oregon" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5744337/about.rdf> ;
    ns1:basedInHighRaw "Oregon" ;
    ns1:basedInLowRaw "Scotland" ;
    ns1:description "modified release, inhalation delivery and biotherapeutic processing" ;
    ns1:documentDate "2013-11-11T13:08:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Capsugel bets $20M on Bend's commercial manufacturing" ;
    ns1:documentURL <https://www.fiercebiotech.com/manufacturing/capsugel-bets-20m-on-bend-s-commercial-manufacturing> ;
    ns1:foundName "Bend",
        "Bend Research" ;
    ns1:industry "contract manufacturing" ;
    ns1:name "Bend",
        "Bend Research" ;
    ns1:sameAsHigh <https://1145.am/db/2556796/Bend_Research> ;
    ns1:sameAsMedium <https://1145.am/db/2316255/Bend_Research>,
        <https://1145.am/db/2316262/Bend_Research>,
        <https://1145.am/db/2541486/Bend_Research>,
        <https://1145.am/db/2541489/Bend_Research>,
        <https://1145.am/db/2583449/Bend_Research>,
        <https://1145.am/db/2583451/Bend_Research> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318461/Cros_Pra> a org:Organization ;
    ns1:documentDate "2013-11-11T13:08:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Capsugel bets $20M on Bend's commercial manufacturing" ;
    ns1:documentURL <https://www.fiercebiotech.com/manufacturing/capsugel-bets-20m-on-bend-s-commercial-manufacturing> ;
    ns1:foundName "CROs PRA" ;
    ns1:industry "healthcare" ;
    ns1:name "CROs PRA" ;
    ns1:sameAsHigh <https://1145.am/db/2019905/CRG>,
        <https://1145.am/db/2220625/Mro_Corp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318461/Cros_Pra_Stake_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-11-11T13:08:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "And KKR has been bullish about healthcare dealmaking in its own right, this year spending more than $ 1.3 billion to buy up CROs PRA and ReSearch Pharmaceutical Services and spending about $ 1.7 billion on a majority stake of Panasonic's medical arm." ;
    ns1:documentTitle "Capsugel bets $20M on Bend's commercial manufacturing" ;
    ns1:documentURL <https://www.fiercebiotech.com/manufacturing/capsugel-bets-20m-on-bend-s-commercial-manufacturing> ;
    ns1:foundName "buy" ;
    ns1:name "buy" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2318461/Cros_Pra>,
        <https://1145.am/db/2318461/Panasonic> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "CROs PRA" ;
    ns1:valueRaw "about $ 1.7 billion",
        "more than $ 1.3 billion" .

<https://1145.am/db/2318461/Encap_Drug_Delivery> a org:Organization ;
    ns1:basedInHighGeoName "Scotland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2638360/about.rdf> ;
    ns1:basedInHighRaw "Scotland" ;
    ns1:description "contract manufacturing" ;
    ns1:documentDate "2013-11-11T13:08:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Capsugel bets $20M on Bend's commercial manufacturing" ;
    ns1:documentURL <https://www.fiercebiotech.com/manufacturing/capsugel-bets-20m-on-bend-s-commercial-manufacturing> ;
    ns1:foundName "Encap Drug Delivery" ;
    ns1:industry "contract manufacturing" ;
    ns1:name "Encap Drug Delivery" ;
    ns1:sameAsMedium <https://1145.am/db/2536474/Encap_Drug_Delivery>,
        <https://1145.am/db/2577634/Encap_Drug_Delivery> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318461/Scotland> a org:Organization ;
    ns1:basedInLowRaw "Encap Drug Delivery" ;
    ns1:documentDate "2013-11-11T13:08:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Capsugel bets $20M on Bend's commercial manufacturing" ;
    ns1:documentURL <https://www.fiercebiotech.com/manufacturing/capsugel-bets-20m-on-bend-s-commercial-manufacturing> ;
    ns1:foundName "Scotland" ;
    ns1:industry "contract manufacturing" ;
    ns1:name "Scotland" ;
    ns1:sameAsMedium <https://1145.am/db/1801942/Scotland> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318461/Scotland_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-11-11T13:08:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Over the past year, Capsugel has used its wallet to get a bigger stake in the contract manufacturing world, first buying Scotland's Encap Drug Delivery to add liquid and semi-solid encapsulations to its offerings, and then picking up Bend this fall, bringing in technologies for modified release, inhalation delivery and biotherapeutic processing." ;
    ns1:documentTitle "Capsugel bets $20M on Bend's commercial manufacturing" ;
    ns1:documentURL <https://www.fiercebiotech.com/manufacturing/capsugel-bets-20m-on-bend-s-commercial-manufacturing> ;
    ns1:foundName "buying" ;
    ns1:name "buying" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2318461/Scotland> ;
    ns1:targetName "Scotland" .

<https://1145.am/db/2339894/Lithera> a org:Organization ;
    ns1:description "pharmaceutical" ;
    ns1:documentDate "2013-07-18T15:55:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lithera Announces Second Closing of $27.3 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lithera-announces-second-closing-of-27-3-million-series-c-financing> ;
    ns1:foundName "Lithera",
        "Lithera, Inc",
        "Lithera, Inc." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Lithera" ;
    ns1:sameAsHigh <https://1145.am/db/2336873/Lithera>,
        <https://1145.am/db/2583621/Litha_Healthcare_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339894/Rusnanomedinvest> a org:Organization ;
    ns1:basedInLowRaw "Russia" ;
    ns1:description "Investing" ;
    ns1:documentDate "2013-07-18T15:55:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lithera Announces Second Closing of $27.3 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lithera-announces-second-closing-of-27-3-million-series-c-financing> ;
    ns1:foundName "RusnanoMedInvest" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2339894/Series_C_Preferred_Stock_Equity_Investment_Andrea_Holdings_International_Ltd_Lithera_Mirae_Asset_Venture_Investment_Rusnanomedinvest_Completed> ;
    ns1:name "RusnanoMedInvest" ;
    ns1:sameAsHigh <https://1145.am/db/1761089/Kaszek>,
        <https://1145.am/db/2347984/Rusnanomedinvest>,
        <https://1145.am/db/2361625/Rusnanomedinvest>,
        <https://1145.am/db/868933/Kaszek> ;
    ns1:sameAsMedium <https://1145.am/db/2297408/Rusnanomedinvest>,
        <https://1145.am/db/2336125/Rusnanomedinvest>,
        <https://1145.am/db/2356301/Rusnanomedinvest>,
        <https://1145.am/db/2357325/Rusnanomedinvest>,
        <https://1145.am/db/2358541/Rusnanomedinvest>,
        <https://1145.am/db/2360258/Rusnanomedinvest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339925/Alcresta> a org:Organization ;
    ns1:description "Nutritional Products" ;
    ns1:documentDate "2013-07-22T09:44:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alcresta Secures $10 Million Series B Financing, Prepares for 2014 Commercial Launch of Novel Point-of-Care Nutritional Products" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/alcresta-secures-10-million-series-b-financing-prepares-for-2014-commercial-launch> ;
    ns1:foundName "Alcresta",
        "Alcresta" ;
    ns1:industry "medical nutrition" ;
    ns1:name "Alcresta" ;
    ns1:sameAsHigh <https://1145.am/db/2319444/Alcresta>,
        <https://1145.am/db/2362654/Alcresta> ;
    ns1:sameAsMedium <https://1145.am/db/2339926/Alcresta>,
        <https://1145.am/db/2351519/Alcresta>,
        <https://1145.am/db/2351520/Alcresta>,
        <https://1145.am/db/2368600/Alcresta> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339925/Third_Rock_Ventures> a org:Organization ;
    ns1:description "Investing" ;
    ns1:documentDate "2013-07-22T09:44:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alcresta Secures $10 Million Series B Financing, Prepares for 2014 Commercial Launch of Novel Point-of-Care Nutritional Products" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/alcresta-secures-10-million-series-b-financing-prepares-for-2014-commercial-launch> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:investor <https://1145.am/db/2339925/Series_B_Investment_Alcresta_Bessemer_Venture_Partners_Frazier_Healthcare_Third_Rock_Ventures_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/1782938/Third_Kind_Venture_Capital>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340634/Atara_Biotherapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Thousand Oaks" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5402405/about.rdf> ;
    ns1:basedInHighRaw "Thousand Oaks, CA" ;
    ns1:description "a biotech venture" ;
    ns1:documentDate "2013-12-16T22:46:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen spinoff Atara banks $38.5M as it races ahead with CKD, cancer trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/amgen-spinoff-atara-banks-38-5m-as-it-races-ahead-ckd-cancer-trials> ;
    ns1:foundName "Atara Biotherapeutics" ;
    ns1:industry "Biotech" ;
    ns1:name "Atara Biotherapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1002518/Novatarg_Therapeutics>,
        <https://1145.am/db/1002537/Novatarg_Therapeutics>,
        <https://1145.am/db/1198421/Pliant_Therapeutics>,
        <https://1145.am/db/1202209/Pliant_Therapeutics_Inc>,
        <https://1145.am/db/1210849/Pliant_Therapeutics>,
        <https://1145.am/db/1551329/Horizon_Therapeutics>,
        <https://1145.am/db/1568872/Horizon_Therapeutics>,
        <https://1145.am/db/1583818/Atara_Biotherapeutics>,
        <https://1145.am/db/1585091/Atara_Biotherapeutics>,
        <https://1145.am/db/1632002/Nextpoint_Therapeutics>,
        <https://1145.am/db/1632028/Nextpoint_Therapeutics>,
        <https://1145.am/db/1632131/Nextpoint_Therapeutics>,
        <https://1145.am/db/1632156/Nextpoint_Therapeutics>,
        <https://1145.am/db/164887/Atara_Biotherapeutics_Inc>,
        <https://1145.am/db/1673901/Horizon_Therapeutics>,
        <https://1145.am/db/1679473/Nextpoint_Therapeutics>,
        <https://1145.am/db/2151730/Repare_Therapeutics>,
        <https://1145.am/db/2152273/Engrail_Therapeutics>,
        <https://1145.am/db/2152618/Atara_Biotherapeutics>,
        <https://1145.am/db/2154007/Enterprise_Therapeutics>,
        <https://1145.am/db/2154158/Century_Therapeutics>,
        <https://1145.am/db/2154521/Cirius_Therapeutics>,
        <https://1145.am/db/2204366/Cell_Therapeutics>,
        <https://1145.am/db/2279029/Nimbus_Therapeutics>,
        <https://1145.am/db/2279886/Signet_Therapeutics>,
        <https://1145.am/db/2282091/Fore_Biotherapeutics>,
        <https://1145.am/db/2283389/Corlieve_Therapeutics>,
        <https://1145.am/db/2283728/Bioniz_Therapeutics>,
        <https://1145.am/db/2284474/Moma_Therapeutics>,
        <https://1145.am/db/2285385/Villaris_Therapeutics>,
        <https://1145.am/db/2286372/Horizon_Therapeutics>,
        <https://1145.am/db/2287290/Nimbus_Therapeutics>,
        <https://1145.am/db/2290926/Imcheck_Therapeutics>,
        <https://1145.am/db/2293241/Rubius_Therapeutics>,
        <https://1145.am/db/2293373/Pliant_Therapeutics>,
        <https://1145.am/db/2297545/Rubius_Therapeutics>,
        <https://1145.am/db/2298897/Sapience_Therapeutics>,
        <https://1145.am/db/2298956/Tp_Therapeutics>,
        <https://1145.am/db/2300054/Nimbus_Therapeutics>,
        <https://1145.am/db/2300987/Arcturus_Therapeutics>,
        <https://1145.am/db/2310068/Ocera_Therapeutics>,
        <https://1145.am/db/2314988/Biotherapeutics_Inc>,
        <https://1145.am/db/2320482/Repros_Therapeutics>,
        <https://1145.am/db/2336441/Juventas_Therapeutics>,
        <https://1145.am/db/2337682/Atara_Biotherapeutics>,
        <https://1145.am/db/2340067/Moderna_Therapeutics>,
        <https://1145.am/db/2340087/Nimbus_Therapeutics>,
        <https://1145.am/db/2342717/Alexar_Therapeutics>,
        <https://1145.am/db/2343987/Cornerstone_Therapeutics>,
        <https://1145.am/db/2344782/Atara_Biotherapeutics>,
        <https://1145.am/db/2345662/Sage_Therapeutics>,
        <https://1145.am/db/2345894/Arcturus_Therapeutics>,
        <https://1145.am/db/2348148/Dimension_Therapeutics>,
        <https://1145.am/db/2350164/Intarcia_Therapeutics>,
        <https://1145.am/db/2350167/Intarcia_Therapeutics>,
        <https://1145.am/db/2352308/Intarcia_Therapeutics>,
        <https://1145.am/db/2352515/Cell_Therapeutics>,
        <https://1145.am/db/2353129/Cornerstone_Therapeutics>,
        <https://1145.am/db/2353339/Juventas_Therapeutics>,
        <https://1145.am/db/2353939/Juventas_Therapeutics>,
        <https://1145.am/db/2357256/Sage_Therapeutics>,
        <https://1145.am/db/2360382/Ascenta_Therapeutics>,
        <https://1145.am/db/2361426/Intarcia_Therapeutics>,
        <https://1145.am/db/2364820/Juventas_Therapeutics>,
        <https://1145.am/db/2367067/Juventas_Therapeutics>,
        <https://1145.am/db/2369785/Galera_Therapeutics>,
        <https://1145.am/db/2371165/Galera_Therapeutics>,
        <https://1145.am/db/2371166/Galera_Therapeutics>,
        <https://1145.am/db/2558017/Juventas_Therapeutics>,
        <https://1145.am/db/2789236/Horizon_Therapeutics>,
        <https://1145.am/db/401206/Atara_Biotherapeutics>,
        <https://1145.am/db/442506/Etern_Therapeutics>,
        <https://1145.am/db/586343/Entrada_Therapeutics_Inc>,
        <https://1145.am/db/701826/Kriya_Therapeutics>,
        <https://1145.am/db/835459/Horizon_Therapeutics_Plc> ;
    ns1:sameAsMedium <https://1145.am/db/1592772/Atara_Biotherapeutics>,
        <https://1145.am/db/1596582/Atara_Biotherapeutics>,
        <https://1145.am/db/2297156/Atara_Biotherapeutics>,
        <https://1145.am/db/2561057/Atara_Biotherapeutics>,
        <https://1145.am/db/2562583/Atara_Biotherapeutics>,
        <https://1145.am/db/784295/Atara_Biotherapeutics>,
        <https://1145.am/db/787996/Atara_Biotherapeutics>,
        <https://1145.am/db/788035/Atara_Biotherapeutics>,
        <https://1145.am/db/951785/Atara_Biotherapeutics>,
        <https://1145.am/db/953507/Atara_Biotherapeutics>,
        <https://1145.am/db/953523/Atara_Biotherapeutics>,
        <https://1145.am/db/956773/Atara_Biotherapeutics>,
        <https://1145.am/db/957092/Atara_Biotherapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340683/Natrogen_Therapeutics_International> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:description "Pharmaceutical" ;
    ns1:documentDate "2013-12-19T16:26:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Takeda Announces Exclusive License and Option Agreement with Natrogen for Development of Natura-alpha for Inflammatory Bowel Disease" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/takeda-announces-exclusive-license-and-option-agreement-natrogen-for-development-of-natura> ;
    ns1:foundName "Natrogen" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Natrogen Therapeutics International" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341701/Investment_Kreos_Capital_Tigenix_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-12-24T22:21:44+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Belgium's TiGenix has hauled in about $ 13.7 million in debt financing, piling up cash as it works through Phase III with a stem cell treatment.",
        "Under the four-year deal, financier Kreos Capital will pay out $ 6.9 million in February, $ 3.4 million in May and another $ 3.4 million by September, the companies said, giving TiGenix the money it needs to advance Cx601 through late-stage trials." ;
    ns1:documentTitle "TiGenix snags $13.7M for Phase III cell therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/tigenix-snags-13-7m-for-phase-iii-cell-therapy> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2341701/Tigenix> ;
    ns1:valueRaw "$ 13.7 million",
        "$ 3.4 million",
        "$ 6.9 million",
        "another $ 3.4 million" ;
    ns1:whereGeoName "Kingdom of Belgium" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:whereRaw "Belgium" .

<https://1145.am/db/2341701/Tigenix> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Belgium" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:basedInHighRaw "Belgium" ;
    ns1:documentDate "2013-12-24T22:21:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TiGenix snags $13.7M for Phase III cell therapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/tigenix-snags-13-7m-for-phase-iii-cell-therapy> ;
    ns1:foundName "TiGenix" ;
    ns1:name "TiGenix" ;
    ns1:sameAsMedium <https://1145.am/db/2289219/Tigenix>,
        <https://1145.am/db/2292839/Tigenix>,
        <https://1145.am/db/2301450/Tigenix>,
        <https://1145.am/db/2301452/Tigenix>,
        <https://1145.am/db/2324990/Tigenix>,
        <https://1145.am/db/2338164/Tigenix>,
        <https://1145.am/db/2341700/Tigenix>,
        <https://1145.am/db/2349695/Tigenix>,
        <https://1145.am/db/2362328/Tigenix_Nv>,
        <https://1145.am/db/2540077/Tigenix> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341717/Alexar> a org:Organization ;
    ns1:basedInLowRaw "Pa" ;
    ns1:description "a biopharmaceutical management company" ;
    ns1:documentDate "2014-01-02T12:38:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NeXeption, LLC Forms New Company Alexar Therapeutics, Inc. to Develop Novel LXR Agonist Portfolio for Dermatologic Indications; Raises $21.5 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nexeption-llc-forms-new-company-alexar-therapeutics-inc-to-develop-novel-lxr-agonist> ;
    ns1:foundName "Alexar Therapeutics, Inc" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Alexar" ;
    ns1:sameAsHigh <https://1145.am/db/2320884/Avila_Therapeutics>,
        <https://1145.am/db/2360875/Avila_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341717/Nexeption> a org:Organization ;
    ns1:basedInHighGeoName "Malvern" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/11495083/about.rdf> ;
    ns1:basedInHighRaw "MALVERN" ;
    ns1:description "bringing together product opportunities, management expertise and funding to reach compelling partnership milestones" ;
    ns1:documentDate "2014-01-02T12:38:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NeXeption, LLC Forms New Company Alexar Therapeutics, Inc. to Develop Novel LXR Agonist Portfolio for Dermatologic Indications; Raises $21.5 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nexeption-llc-forms-new-company-alexar-therapeutics-inc-to-develop-novel-lxr-agonist> ;
    ns1:foundName "NeXeption, LLC" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "NeXeption" ;
    ns1:sameAsHigh <https://1145.am/db/2069394/Nexo>,
        <https://1145.am/db/2309351/Nexbio>,
        <https://1145.am/db/2344526/Nexmed> ;
    ns1:sameAsMedium <https://1145.am/db/2342717/Nexeption> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341764/Alta_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2013-07-29T05:31:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "aTyr Pharma Completes $49 Million Oversubscribed Financing to Advance Rare Autoimmune Disease Therapeutic Pipeline from a Newly Discovered Class of Proteins, Physiocrines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/atyr-pharma-completes-49-million-oversubscribed-financing-to-advance-rare-autoimmune> ;
    ns1:foundName "Alta Partners" ;
    ns1:investor <https://1145.am/db/2341764/Investment_Alta_Partners_Cardinal_Partners_Domain_Associates_Polaris_Partners_Atyr_Pharma_Completed> ;
    ns1:name "Alta Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1156304/Alta_Partners>,
        <https://1145.am/db/1230022/Alta_Partners>,
        <https://1145.am/db/1333948/Altas_Partners>,
        <https://1145.am/db/1334727/Altas_Partners>,
        <https://1145.am/db/2303810/Alta_Partners>,
        <https://1145.am/db/2303814/Alta_Partners>,
        <https://1145.am/db/2304769/Alta_Partners>,
        <https://1145.am/db/2304870/Alta_Partners>,
        <https://1145.am/db/2305729/Alta_Partners>,
        <https://1145.am/db/2305745/Alta_Partners>,
        <https://1145.am/db/2306281/Alta_Partners>,
        <https://1145.am/db/2306568/Alta_Partners>,
        <https://1145.am/db/2307682/Alta_Partners>,
        <https://1145.am/db/2307691/Alta_Partners>,
        <https://1145.am/db/2307824/Alta_Partners>,
        <https://1145.am/db/2307829/Alta_Partners>,
        <https://1145.am/db/2308855/Alta_Partners>,
        <https://1145.am/db/2311011/Alta_Partners>,
        <https://1145.am/db/2313143/Alta_Partners>,
        <https://1145.am/db/2313405/Alta_Partners>,
        <https://1145.am/db/2316391/Alta_Partners>,
        <https://1145.am/db/2318577/Alta_Partners>,
        <https://1145.am/db/2318635/Alta_Partners>,
        <https://1145.am/db/2322984/Alta_Partners>,
        <https://1145.am/db/2323003/Alta_Partners>,
        <https://1145.am/db/2323243/Alta_Partners>,
        <https://1145.am/db/2324012/Alta_Partners>,
        <https://1145.am/db/2324015/Alta_Partners>,
        <https://1145.am/db/2326176/Alta_Partners>,
        <https://1145.am/db/2326903/Alta_Partners>,
        <https://1145.am/db/2327441/Alta_Partners>,
        <https://1145.am/db/2327442/Alta_Partners>,
        <https://1145.am/db/2327677/Alta_Partners>,
        <https://1145.am/db/2328815/Alta_Partners>,
        <https://1145.am/db/2330075/Alta_Partners>,
        <https://1145.am/db/2330079/Alta_Partners>,
        <https://1145.am/db/2338126/Alta_Partners>,
        <https://1145.am/db/2338127/Alta_Partners>,
        <https://1145.am/db/2340887/Alta_Partners>,
        <https://1145.am/db/2343547/Alta_Partners>,
        <https://1145.am/db/2344092/Alta_Partners>,
        <https://1145.am/db/2344100/Alta_Partners>,
        <https://1145.am/db/2346542/Alta_Partners>,
        <https://1145.am/db/2351224/Alta_Partners>,
        <https://1145.am/db/2351897/Alta_Partners>,
        <https://1145.am/db/2352167/Alta_Partners>,
        <https://1145.am/db/2352170/Alta_Partners>,
        <https://1145.am/db/2352362/Alta_Partners>,
        <https://1145.am/db/2352831/Alta_Partners>,
        <https://1145.am/db/2353439/Alta_Partners>,
        <https://1145.am/db/2353771/Alta_Partners>,
        <https://1145.am/db/2353789/Alta_Partners>,
        <https://1145.am/db/2354299/Alta_Partners>,
        <https://1145.am/db/2354307/Alta_Partners>,
        <https://1145.am/db/2354314/Alta_Partners>,
        <https://1145.am/db/2355183/Alta_Partners>,
        <https://1145.am/db/2355274/Alta_Partners>,
        <https://1145.am/db/2355586/Alta_Partners>,
        <https://1145.am/db/2356216/Alta_Partners>,
        <https://1145.am/db/2358496/Alta_Partners>,
        <https://1145.am/db/2358502/Alta_Partners>,
        <https://1145.am/db/2362565/Alta_Partners>,
        <https://1145.am/db/2362566/Alta_Partners>,
        <https://1145.am/db/2362902/Alta_Partners>,
        <https://1145.am/db/2362909/Alta_Partners>,
        <https://1145.am/db/2362910/Alta_Partners>,
        <https://1145.am/db/2363364/Alta_Partners>,
        <https://1145.am/db/2363510/Alta_Partners>,
        <https://1145.am/db/2365748/Alta_Partners>,
        <https://1145.am/db/2366693/Alta_Partners>,
        <https://1145.am/db/2366700/Alta_Partners>,
        <https://1145.am/db/2367497/Alta_Partners>,
        <https://1145.am/db/328387/Altas_Partners>,
        <https://1145.am/db/443962/Altas_Partners>,
        <https://1145.am/db/750997/Alta_Partners>,
        <https://1145.am/db/979509/Alta_Partners>,
        <https://1145.am/db/987929/Alta_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341764/Atyr_Pharma> a org:Organization ;
    ns1:description "pharmaceutical" ;
    ns1:documentDate "2013-07-29T05:31:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "aTyr Pharma Completes $49 Million Oversubscribed Financing to Advance Rare Autoimmune Disease Therapeutic Pipeline from a Newly Discovered Class of Proteins, Physiocrines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/atyr-pharma-completes-49-million-oversubscribed-financing-to-advance-rare-autoimmune> ;
    ns1:foundName "aTyr Pharma" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "aTyr Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/2283415/Athira_Pharma>,
        <https://1145.am/db/2287321/Athira_Pharma>,
        <https://1145.am/db/2290937/Atreca>,
        <https://1145.am/db/2302117/Aton_Pharma>,
        <https://1145.am/db/2303684/Atyr_Pharma>,
        <https://1145.am/db/2303693/Atyr_Pharma>,
        <https://1145.am/db/2303694/Atyr_Pharma>,
        <https://1145.am/db/2314814/Aton_Pharma>,
        <https://1145.am/db/2314837/Aton_Pharma>,
        <https://1145.am/db/2315924/Aton_Pharma>,
        <https://1145.am/db/2341576/Atyr_Pharma>,
        <https://1145.am/db/2341774/Atyr_Pharma>,
        <https://1145.am/db/2342998/Atyr_Pharma>,
        <https://1145.am/db/2344046/Atyr_Pharma>,
        <https://1145.am/db/2344334/Atyr_Pharma>,
        <https://1145.am/db/2344670/Atyr_Pharma>,
        <https://1145.am/db/2345088/Atyr_Pharma>,
        <https://1145.am/db/2345728/Atterocor>,
        <https://1145.am/db/2345774/Aton_Pharma>,
        <https://1145.am/db/2345905/Atyr_Pharma>,
        <https://1145.am/db/2348864/Aton_Pharma>,
        <https://1145.am/db/2349984/Atyr_Pharma>,
        <https://1145.am/db/2357233/Atyr>,
        <https://1145.am/db/2369056/Atyr_Pharma>,
        <https://1145.am/db/2370807/Atterocor>,
        <https://1145.am/db/2596072/Atyr>,
        <https://1145.am/db/750204/Athenex>,
        <https://1145.am/db/968352/Athira_Pharma>,
        <https://1145.am/db/973026/Athira_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/2313118/Atyr_Pharma>,
        <https://1145.am/db/2313127/Atyr_Pharma>,
        <https://1145.am/db/2344092/Atyr_Pharma>,
        <https://1145.am/db/2344100/Atyr_Pharma>,
        <https://1145.am/db/476668/Atyr_Pharma>,
        <https://1145.am/db/487439/Atyr_Pharma>,
        <https://1145.am/db/718569/Atyr_Pharma> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341792/Edimer_Pharmaceuticals> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge, Mass." ;
    ns1:description "developing an innovative therapy for the rare genetic disorder",
        "pharmaceutical" ;
    ns1:documentDate "2013-07-30T12:24:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Edimer Secures $18M Series B Financing Led by New Enterprise Associates" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/edimer-secures-18m-series-b-financing-led-by-new-enterprise-associates> ;
    ns1:foundName "Edimer",
        "Edimer Pharmaceuticals" ;
    ns1:industry "biotechnology" ;
    ns1:name "Edimer",
        "Edimer Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1105083/Pharmacyte_Biotech>,
        <https://1145.am/db/1106504/Pharmacyte_Biotech>,
        <https://1145.am/db/1194874/Emerald_Health_Pharmaceuticals_Inc>,
        <https://1145.am/db/1378519/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/1401764/Pharmacyte_Biotech>,
        <https://1145.am/db/2009873/Ochre_Bio>,
        <https://1145.am/db/2110130/Allay_Therapeutics>,
        <https://1145.am/db/2303804/Access_Pharmaceuticals>,
        <https://1145.am/db/2314347/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2336239/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2340755/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2343800/Sideris_Pharmaceuticals>,
        <https://1145.am/db/2348620/Diartis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349844/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2352045/Costim_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353647/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2360709/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363331/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2365082/Aveo_Pharmaceuticals>,
        <https://1145.am/db/2365628/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2366102/Rxi_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2366948/Alnara_Pharmaceuticals>,
        <https://1145.am/db/2366953/Alnara_Pharmaceuticals>,
        <https://1145.am/db/2367807/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2368847/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2572711/Alnara_Pharmaceuticals>,
        <https://1145.am/db/2579346/Momenta_Pharmaceuticals>,
        <https://1145.am/db/401518/Pharmacyte_Biotech>,
        <https://1145.am/db/405493/Pharmacyte_Biotech>,
        <https://1145.am/db/423412/Pharmacyte_Biotech>,
        <https://1145.am/db/424843/Pharmacyte_Biotech>,
        <https://1145.am/db/474783/Allay_Therapeutics>,
        <https://1145.am/db/739207/Allay_Therapeutics>,
        <https://1145.am/db/886466/Avm_Biotechnology> ;
    ns1:sameAsMedium <https://1145.am/db/2341800/Edimer_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341792/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge, Mass." ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-07-30T12:24:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Edimer Secures $18M Series B Financing Led by New Enterprise Associates" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/edimer-secures-18m-series-b-financing-led-by-new-enterprise-associates> ;
    ns1:foundName "New Enterprise Associates",
        "New Enterprise Associates (NEA)" ;
    ns1:investor <https://1145.am/db/2341792/Series_B_Investment_Edimer_Pharmaceuticals_New_Enterprise_Associates_Sanofi-Genzyme_Bioventures_Third_Rock_Ventures_Vi_Partners_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsHigh <https://1145.am/db/1061564/Evonik_Venture_Capital>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1768899/Eventures>,
        <https://1145.am/db/1786672/Eventures>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1806644/Eventures>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2170734/Eventures>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/330761/Emv_Capital>,
        <https://1145.am/db/490907/Echelon_Capital>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/936724/Efung_Capital>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341792/Sanofi-Genzyme_Bioventures> a org:Organization ;
    ns1:description "Investing in biotechnology" ;
    ns1:documentDate "2013-07-30T12:24:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Edimer Secures $18M Series B Financing Led by New Enterprise Associates" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/edimer-secures-18m-series-b-financing-led-by-new-enterprise-associates> ;
    ns1:foundName "Sanofi-Genzyme BioVentures" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2341792/Series_B_Investment_Edimer_Pharmaceuticals_New_Enterprise_Associates_Sanofi-Genzyme_Bioventures_Third_Rock_Ventures_Vi_Partners_Completed> ;
    ns1:name "Sanofi-Genzyme BioVentures" ;
    ns1:sameAsHigh <https://1145.am/db/1110205/Sanofi_Sa>,
        <https://1145.am/db/1114745/Sanofi>,
        <https://1145.am/db/1116151/Sanofi>,
        <https://1145.am/db/1177954/Sanofi>,
        <https://1145.am/db/1252297/Sanofi>,
        <https://1145.am/db/1317517/Sanofi>,
        <https://1145.am/db/137297/Sanofi>,
        <https://1145.am/db/138669/Sanofi>,
        <https://1145.am/db/1533327/Sanofi_Ventures>,
        <https://1145.am/db/1533685/Sanofi_Ventures>,
        <https://1145.am/db/1541946/Sanofi>,
        <https://1145.am/db/1548955/Sanofi>,
        <https://1145.am/db/1931929/Sanofi>,
        <https://1145.am/db/1935113/Sanofi>,
        <https://1145.am/db/194991/Sanofi>,
        <https://1145.am/db/195055/Sanofi>,
        <https://1145.am/db/1953742/Sanofi>,
        <https://1145.am/db/1985052/Sanofi>,
        <https://1145.am/db/2137147/Sanofi>,
        <https://1145.am/db/2152605/Sanofi>,
        <https://1145.am/db/2152611/Sanofi>,
        <https://1145.am/db/2154031/Sanofi>,
        <https://1145.am/db/2154432/Sanofi>,
        <https://1145.am/db/2154444/Sanofi>,
        <https://1145.am/db/2154660/Sanofi>,
        <https://1145.am/db/2154812/Sanofi>,
        <https://1145.am/db/2154850/Sanofi>,
        <https://1145.am/db/2155307/Sanofi>,
        <https://1145.am/db/2241046/Sanofi-Aventis>,
        <https://1145.am/db/2278957/Sanofi>,
        <https://1145.am/db/2279007/Sanofi>,
        <https://1145.am/db/2280255/Sanofi>,
        <https://1145.am/db/2282197/Sanofi>,
        <https://1145.am/db/2282344/Sanofi>,
        <https://1145.am/db/2285905/Sanofi>,
        <https://1145.am/db/2286521/Sanofi>,
        <https://1145.am/db/2286823/Sanofi>,
        <https://1145.am/db/2286894/Sanofi>,
        <https://1145.am/db/2287400/Sanofi>,
        <https://1145.am/db/2290842/Sanofi>,
        <https://1145.am/db/2293342/Sanofi>,
        <https://1145.am/db/2296552/Sanofi_Genzyme>,
        <https://1145.am/db/2297648/Sanofi>,
        <https://1145.am/db/2300140/Sanofi>,
        <https://1145.am/db/2301137/Sanofi>,
        <https://1145.am/db/2301170/Sanofi>,
        <https://1145.am/db/2303989/Sanofi-Aventis>,
        <https://1145.am/db/2303991/Sanofi-Aventis>,
        <https://1145.am/db/2303992/Sanofi-Aventis>,
        <https://1145.am/db/2304313/Sanofi-Aventis>,
        <https://1145.am/db/2304370/Sanofi>,
        <https://1145.am/db/2304646/Sanofi-Aventis>,
        <https://1145.am/db/2306290/Sanofi-Aventis>,
        <https://1145.am/db/2307903/Sanofi>,
        <https://1145.am/db/2308778/Sanofi-Aventis>,
        <https://1145.am/db/2309866/Sanofi>,
        <https://1145.am/db/2311677/Sanofi-Aventis_Us>,
        <https://1145.am/db/2312115/Sanofi-Aventis>,
        <https://1145.am/db/2313209/Sanofi-Aventis>,
        <https://1145.am/db/2313287/Sanofi-Aventis>,
        <https://1145.am/db/2315315/Sanofi-Aventis>,
        <https://1145.am/db/2319330/Sanofi-Aventis>,
        <https://1145.am/db/2319334/Sanofi>,
        <https://1145.am/db/2319764/Sanofi-Aventis_Us>,
        <https://1145.am/db/2319769/Sanofi>,
        <https://1145.am/db/2319773/Sanofi-Aventis_Us>,
        <https://1145.am/db/2319838/Sanofi-Aventis>,
        <https://1145.am/db/2320000/Sanofi-Aventis>,
        <https://1145.am/db/2321466/Sanofi-Aventis>,
        <https://1145.am/db/2321557/Sanofi-Aventis>,
        <https://1145.am/db/2322297/Sanofi-Aventis>,
        <https://1145.am/db/2322509/Sanofi-Aventis>,
        <https://1145.am/db/2324095/Sanofi-Aventis>,
        <https://1145.am/db/2325835/Sanofi-Aventis>,
        <https://1145.am/db/2326978/Sanofi>,
        <https://1145.am/db/2328712/Sanofi-Aventis>,
        <https://1145.am/db/2328729/Sanofi-Aventis>,
        <https://1145.am/db/2331206/Sanofi>,
        <https://1145.am/db/2333555/Sanofi>,
        <https://1145.am/db/2334183/Sanofi-Aventis>,
        <https://1145.am/db/2336075/Sanofi>,
        <https://1145.am/db/2336811/Sanofi>,
        <https://1145.am/db/2337279/Sanofi>,
        <https://1145.am/db/2337501/Sanofi>,
        <https://1145.am/db/2339639/Sanofi-Aventis>,
        <https://1145.am/db/2340923/Sanofi>,
        <https://1145.am/db/2341620/Sanofi>,
        <https://1145.am/db/2341800/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2341959/Sanofi>,
        <https://1145.am/db/2342823/Sanofi>,
        <https://1145.am/db/2344788/Sanofi>,
        <https://1145.am/db/2344918/Sanofi>,
        <https://1145.am/db/2345128/Sanofi-Aventis>,
        <https://1145.am/db/2345144/Sanofi-Aventis>,
        <https://1145.am/db/2345275/Sanofi>,
        <https://1145.am/db/2347557/Sanofi-Aventis>,
        <https://1145.am/db/2348041/Sanofi>,
        <https://1145.am/db/2350149/Sanofi>,
        <https://1145.am/db/2350156/Sanofi>,
        <https://1145.am/db/2350188/Sanofi>,
        <https://1145.am/db/2350290/Sanofi>,
        <https://1145.am/db/2353778/Sanofi-Aventis>,
        <https://1145.am/db/2356384/Sanofi-Aventis>,
        <https://1145.am/db/2356453/Sanofi>,
        <https://1145.am/db/2358227/Sanofi>,
        <https://1145.am/db/2360382/Sanofi-Aventis>,
        <https://1145.am/db/2361756/Sanofi>,
        <https://1145.am/db/2361762/Sanofi-Aventis>,
        <https://1145.am/db/2362809/Sanofi-Aventis>,
        <https://1145.am/db/2362893/Sanofi>,
        <https://1145.am/db/2364295/Sanofi-Aventis>,
        <https://1145.am/db/2364717/Sanofi-Aventis>,
        <https://1145.am/db/2365152/Sanofi>,
        <https://1145.am/db/2366608/Sanofi-Aventis>,
        <https://1145.am/db/2366682/Sanofi>,
        <https://1145.am/db/2366691/Sanofi-Aventis>,
        <https://1145.am/db/2366935/Sanofi>,
        <https://1145.am/db/2367188/Sanofi>,
        <https://1145.am/db/2367537/Sanofi>,
        <https://1145.am/db/2368181/Sanofi_Group>,
        <https://1145.am/db/2369920/Sanofi>,
        <https://1145.am/db/2370852/Sanofi>,
        <https://1145.am/db/2370897/Sanofi>,
        <https://1145.am/db/2370991/Sanofi>,
        <https://1145.am/db/2536247/Sanofi>,
        <https://1145.am/db/2537459/Sanofi>,
        <https://1145.am/db/2537482/Sanofi-Aventis>,
        <https://1145.am/db/2538082/Sanofi>,
        <https://1145.am/db/2538595/Sanofi-Aventis>,
        <https://1145.am/db/2538666/Sanofi>,
        <https://1145.am/db/2538728/Sanofi>,
        <https://1145.am/db/2538761/Sanofi>,
        <https://1145.am/db/2539788/Sanofi>,
        <https://1145.am/db/2540527/Sanofi>,
        <https://1145.am/db/2541684/Sanofi>,
        <https://1145.am/db/2542471/Sanofi>,
        <https://1145.am/db/2542477/Sanofi>,
        <https://1145.am/db/2543989/Sanofi>,
        <https://1145.am/db/2544435/Sanofi>,
        <https://1145.am/db/2544525/Sanofi>,
        <https://1145.am/db/2544560/Sanofi>,
        <https://1145.am/db/2544596/Sanofi-Aventis>,
        <https://1145.am/db/2544788/Sanofi>,
        <https://1145.am/db/2546160/Sanofi>,
        <https://1145.am/db/2546321/Sanofi>,
        <https://1145.am/db/2546603/Sanofi-Aventis>,
        <https://1145.am/db/2546629/Sanofi-Aventis>,
        <https://1145.am/db/2547653/Sanofi-Aventis>,
        <https://1145.am/db/2548674/Sanofi-Aventis>,
        <https://1145.am/db/2548677/Sanofi-Aventis>,
        <https://1145.am/db/2549121/Sanofi-Aventis>,
        <https://1145.am/db/2549313/Sanofi_Pasteur>,
        <https://1145.am/db/2549862/Sanofi_India>,
        <https://1145.am/db/2549933/Sanofi>,
        <https://1145.am/db/2550420/Sanofi>,
        <https://1145.am/db/2550719/Sanofi>,
        <https://1145.am/db/2550743/Sanofi>,
        <https://1145.am/db/2550868/Sanofi>,
        <https://1145.am/db/2551966/Sanofi>,
        <https://1145.am/db/2552490/Sanofi>,
        <https://1145.am/db/2552794/Sanofi-Aventis>,
        <https://1145.am/db/2553131/Sanofi>,
        <https://1145.am/db/2553354/Sanofi-Aventis>,
        <https://1145.am/db/2553497/Sanofi>,
        <https://1145.am/db/2553799/Sanofi-Aventis>,
        <https://1145.am/db/2553978/Sanofi>,
        <https://1145.am/db/2554814/Sanofi>,
        <https://1145.am/db/2556017/Sanofi>,
        <https://1145.am/db/2557509/Sanofi>,
        <https://1145.am/db/2558115/Sanofi>,
        <https://1145.am/db/2558679/Sanofi>,
        <https://1145.am/db/2558927/Sanofi>,
        <https://1145.am/db/2559069/Sanofi-Aventis>,
        <https://1145.am/db/2559247/Sanofi>,
        <https://1145.am/db/2559471/Sanofi>,
        <https://1145.am/db/2560854/Sanofi>,
        <https://1145.am/db/2560886/Sanofi_Pasteur>,
        <https://1145.am/db/2561700/Sanofi>,
        <https://1145.am/db/2562230/Sanofi>,
        <https://1145.am/db/2562306/Sanofi>,
        <https://1145.am/db/2562482/Sanofi-Aventis>,
        <https://1145.am/db/2566057/Sanofi>,
        <https://1145.am/db/2566482/Sanofi>,
        <https://1145.am/db/2567475/Sanofi>,
        <https://1145.am/db/2567517/Sanofi>,
        <https://1145.am/db/2568031/Sanofi>,
        <https://1145.am/db/2568144/Sanofi>,
        <https://1145.am/db/2571093/Sanofi>,
        <https://1145.am/db/2571467/Sanofi>,
        <https://1145.am/db/2572739/Sanofi-Aventis>,
        <https://1145.am/db/2573878/Sanofi>,
        <https://1145.am/db/2574505/Sanofi-Aventis>,
        <https://1145.am/db/2575450/Sanofi-Aventis>,
        <https://1145.am/db/2575623/Sanofi-Aventis>,
        <https://1145.am/db/2576254/Sanofi>,
        <https://1145.am/db/2576512/Sanofi-Aventis>,
        <https://1145.am/db/2576516/Sanofi>,
        <https://1145.am/db/2577419/Sanofi-Aventis>,
        <https://1145.am/db/2578346/Sanofi>,
        <https://1145.am/db/2578503/Sanofi-Aventis>,
        <https://1145.am/db/2578550/Sanofi-Aventis>,
        <https://1145.am/db/2578745/Sanofi>,
        <https://1145.am/db/2581176/Sanofi>,
        <https://1145.am/db/2581325/Sanofi>,
        <https://1145.am/db/2581432/Sanofi>,
        <https://1145.am/db/2583301/Sanofi-Aventis>,
        <https://1145.am/db/2585710/Sanofi>,
        <https://1145.am/db/2585746/Sanofi>,
        <https://1145.am/db/2586373/Sanofi>,
        <https://1145.am/db/2586657/Sanofi>,
        <https://1145.am/db/2586658/Sanofi>,
        <https://1145.am/db/2587087/Sanofi>,
        <https://1145.am/db/2588362/Sanofi>,
        <https://1145.am/db/2588622/Sanofi>,
        <https://1145.am/db/2589423/Sanofi>,
        <https://1145.am/db/2589657/Sanofi>,
        <https://1145.am/db/2590017/Sanofi-Aventis>,
        <https://1145.am/db/2590137/Sanofi-Aventis>,
        <https://1145.am/db/2591938/Sanofi>,
        <https://1145.am/db/2592083/Sanofi-Aventis>,
        <https://1145.am/db/2592093/Sanofi-Aventis>,
        <https://1145.am/db/2592987/Sanofi-Aventis>,
        <https://1145.am/db/2593103/Sanofi>,
        <https://1145.am/db/2593819/Sanofi-Aventis>,
        <https://1145.am/db/2594116/Sanofi>,
        <https://1145.am/db/2595039/Sanofi>,
        <https://1145.am/db/2595050/Sanofi>,
        <https://1145.am/db/2595051/Sanofi>,
        <https://1145.am/db/2595150/Sanofi>,
        <https://1145.am/db/2595303/Sanofi-Aventis>,
        <https://1145.am/db/2595389/Sanofi-Aventis_Sp_Z_Oo>,
        <https://1145.am/db/2595483/Sanofi>,
        <https://1145.am/db/2595685/Sanofi>,
        <https://1145.am/db/2596034/Sanofi-Aventis>,
        <https://1145.am/db/2597433/Sanofi>,
        <https://1145.am/db/2597899/Sanofi-Aventis>,
        <https://1145.am/db/2598231/Sanofi>,
        <https://1145.am/db/2598237/Sanofi>,
        <https://1145.am/db/2598478/Sanofi-Aventis>,
        <https://1145.am/db/2767240/Sanofi>,
        <https://1145.am/db/2790381/Sanofi>,
        <https://1145.am/db/364048/Sanofi>,
        <https://1145.am/db/389077/Sanofi>,
        <https://1145.am/db/389114/Sanofi>,
        <https://1145.am/db/389294/Sanofi>,
        <https://1145.am/db/389303/Sanofi>,
        <https://1145.am/db/389554/Sanofi>,
        <https://1145.am/db/389590/Sanofi>,
        <https://1145.am/db/455480/Sanofi>,
        <https://1145.am/db/471607/Sanofi>,
        <https://1145.am/db/601458/Sanofi>,
        <https://1145.am/db/627105/Sanofi>,
        <https://1145.am/db/664174/Sanofi>,
        <https://1145.am/db/664442/Sanofi>,
        <https://1145.am/db/700482/Sanofi_Sa>,
        <https://1145.am/db/708041/Sanofi_Sa>,
        <https://1145.am/db/712037/Sanofi>,
        <https://1145.am/db/713105/Sanofi_Sa>,
        <https://1145.am/db/713127/Sanofi_Sa> ;
    ns1:sameAsMedium <https://1145.am/db/2340581/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2359683/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2362565/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2362566/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2363396/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2367541/Sanofi_Genzyme_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341792/Third_Rock_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-07-30T12:24:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Edimer Secures $18M Series B Financing Led by New Enterprise Associates" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/edimer-secures-18m-series-b-financing-led-by-new-enterprise-associates> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:investor <https://1145.am/db/2341792/Series_B_Investment_Edimer_Pharmaceuticals_New_Enterprise_Associates_Sanofi-Genzyme_Bioventures_Third_Rock_Ventures_Vi_Partners_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1352190/Third_Prime_Ventures>,
        <https://1145.am/db/1412391/Third_Point_Ventures>,
        <https://1145.am/db/1739929/K3_Ventures>,
        <https://1145.am/db/1753054/Third_Point_Ventures>,
        <https://1145.am/db/1765385/K3_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/620653/K3_Ventures>,
        <https://1145.am/db/633929/Trilogy_Equity_Partners>,
        <https://1145.am/db/773235/Third_Point_Ventures>,
        <https://1145.am/db/866101/Third_Point_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341792/Vi_Partners> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-07-30T12:24:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Edimer Secures $18M Series B Financing Led by New Enterprise Associates" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/edimer-secures-18m-series-b-financing-led-by-new-enterprise-associates> ;
    ns1:foundName "VI Partners" ;
    ns1:investor <https://1145.am/db/2341792/Series_B_Investment_Edimer_Pharmaceuticals_New_Enterprise_Associates_Sanofi-Genzyme_Bioventures_Third_Rock_Ventures_Vi_Partners_Completed> ;
    ns1:name "VI Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1060146/Bbg_Ventures>,
        <https://1145.am/db/1061911/Bbg_Ventures>,
        <https://1145.am/db/1070729/Blue_Bay_Ventures>,
        <https://1145.am/db/1129561/Fbg_Capital>,
        <https://1145.am/db/1130744/Fbg_Capital>,
        <https://1145.am/db/1175576/Blackhorn_Ventures>,
        <https://1145.am/db/1287989/Bda_Partners>,
        <https://1145.am/db/1370222/Blackbird_Ventures>,
        <https://1145.am/db/1370885/Blackbird_Ventures>,
        <https://1145.am/db/1461683/Bbg_Ventures>,
        <https://1145.am/db/1523231/Bdc_Capital>,
        <https://1145.am/db/1557877/Bluerun_Venture>,
        <https://1145.am/db/1559824/Bluerun_Venture>,
        <https://1145.am/db/1578327/Fbg_Capital>,
        <https://1145.am/db/1579792/Fbg_Capital>,
        <https://1145.am/db/1597608/Bdc_Capital>,
        <https://1145.am/db/1598335/Bdc_Capital>,
        <https://1145.am/db/1693922/Blackhorn_Ventures>,
        <https://1145.am/db/169580/Blackbird_Ventures>,
        <https://1145.am/db/1708495/Blume_Ventures>,
        <https://1145.am/db/1709473/Blue_Run_Ventures>,
        <https://1145.am/db/1731295/Kpg_Ventures>,
        <https://1145.am/db/1739064/Blume_Ventures>,
        <https://1145.am/db/1740945/Btov_Partners>,
        <https://1145.am/db/1752902/Blackbird_Ventures>,
        <https://1145.am/db/1754242/Blume_Ventures>,
        <https://1145.am/db/1754595/Beco_Capital>,
        <https://1145.am/db/1756474/Jbv_Capital>,
        <https://1145.am/db/1761126/Crv_Ivp>,
        <https://1145.am/db/1770788/Gobi_Ventures>,
        <https://1145.am/db/1774002/Bbg_Ventures>,
        <https://1145.am/db/1780705/Bleu_Capital>,
        <https://1145.am/db/1787703/Blue_Run_Ventures>,
        <https://1145.am/db/1799113/Bbg_Ventures>,
        <https://1145.am/db/1803590/Ggv_Capital>,
        <https://1145.am/db/1805666/Bgf_Ventures>,
        <https://1145.am/db/1810093/Blume_Ventures>,
        <https://1145.am/db/1811853/Brooklyn_Bridge_Ventures>,
        <https://1145.am/db/1812267/Blue_Run_Ventures>,
        <https://1145.am/db/1815449/Bbg_Ventures>,
        <https://1145.am/db/1838412/Bbva_Ventures>,
        <https://1145.am/db/1880200/Dag_Ventures>,
        <https://1145.am/db/2143283/Btomorrow_Ventures>,
        <https://1145.am/db/2185936/B_Capital_Group>,
        <https://1145.am/db/2281648/Gv>,
        <https://1145.am/db/2291277/Bvf_Partners_Lp>,
        <https://1145.am/db/2296842/B-to-V_Partners>,
        <https://1145.am/db/2311128/Bdc_Capital>,
        <https://1145.am/db/2313438/Vi_Partners>,
        <https://1145.am/db/2324195/Gbs_Ventures>,
        <https://1145.am/db/2333504/Bdc_Venture_Capital>,
        <https://1145.am/db/2334481/Brm_Group>,
        <https://1145.am/db/2341800/Vi_Partners>,
        <https://1145.am/db/2344786/Bdc_Venture_Capital>,
        <https://1145.am/db/2346973/Morningside_Group>,
        <https://1145.am/db/2355034/Bdc_Venture_Capital>,
        <https://1145.am/db/2763747/Ggv_Capital>,
        <https://1145.am/db/2765030/Blackbird_Ventures>,
        <https://1145.am/db/2790795/Blackwood_Ventures>,
        <https://1145.am/db/684369/Gpg_Ventures>,
        <https://1145.am/db/761862/Fbg_Capital>,
        <https://1145.am/db/763252/Fbg_Capital>,
        <https://1145.am/db/813790/Btomorrow_Ventures>,
        <https://1145.am/db/819495/Blume_Ventures>,
        <https://1145.am/db/865934/Golden_Gate_Capital>,
        <https://1145.am/db/885181/B_Capital_Group>,
        <https://1145.am/db/935322/Vi_Partners>,
        <https://1145.am/db/938108/Bunge_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1386529/Vi_Partners>,
        <https://1145.am/db/1388463/Vi_Partners>,
        <https://1145.am/db/2154009/Vi_Partners>,
        <https://1145.am/db/2313124/Vi_Partners>,
        <https://1145.am/db/2313322/Vi_Partners>,
        <https://1145.am/db/2322761/Vi_Partners>,
        <https://1145.am/db/2324792/Vi_Partners_Ag>,
        <https://1145.am/db/2339295/Vi_Partners>,
        <https://1145.am/db/2347574/Vi_Partners_Ag>,
        <https://1145.am/db/2352382/Vi_Partners>,
        <https://1145.am/db/2352383/Vi_Partners>,
        <https://1145.am/db/2370979/Vi_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343847/Investment_European_Eurostars_Programme_Telormedix_Sa_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-08-07T11:35:40+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Bioggio, Switzerland, August 07, 2013 - Telormedix SA, a clinical stage biopharmaceutical company focusing on toll-like receptor 7 (TLR7) small molecules in the treatment of cancer and inflammatory diseases, today announced that it has raised funding from the European Eurostars Programme to coordinate an international research project involving a consortium of companies aimed at developing new formulations of one of the Company's promising drug candidates, TMX-302, for the treatment of psoriasis.",
        "Telormedix Receives EU Funding for the Development of a New Treatment for Psoriasis." ;
    ns1:documentTitle "Telormedix Receives EU Funding for the Development of a New Treatment for Psoriasis" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/telormedix-receives-eu-funding-for-development-of-a-new-treatment-for-psoriasis> ;
    ns1:foundName "funding",
        "raised" ;
    ns1:name "funding",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2343847/Telormedix_Sa> ;
    ns1:valueRaw "1.77 M" ;
    ns1:whereGeoName "EU" ;
    ns1:whereRaw "EU" .

<https://1145.am/db/2343847/Telormedix_Sa> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:basedInLowRaw "EU" ;
    ns1:description "Research" ;
    ns1:documentDate "2013-08-07T11:35:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Telormedix Receives EU Funding for the Development of a New Treatment for Psoriasis" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/telormedix-receives-eu-funding-for-development-of-a-new-treatment-for-psoriasis> ;
    ns1:foundName "Telormedix",
        "Telormedix SA" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Telormedix",
        "Telormedix SA" ;
    ns1:sameAsHigh <https://1145.am/db/2326362/Telormedix_Sa>,
        <https://1145.am/db/2355706/Telormedix>,
        <https://1145.am/db/2356721/Telormedix> ;
    ns1:sameAsMedium <https://1145.am/db/2326376/Telormedix> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343873/Endomagnetics> a org:Organization ;
    ns1:basedInHighGeoName "Cambridgeshire" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2653940/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, UK" ;
    ns1:description "breast cancer management" ;
    ns1:documentDate "2013-08-09T11:30:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endomagnetics in 2.1m Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/endomagnetics-%C2%A32-1m-fund-raising> ;
    ns1:foundName "Endomagnetics" ;
    ns1:name "Endomagnetics" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343873/Investment_Endomagnetics_Ucl_Business_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-08-09T11:30:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "9th August 2013 - CAMBRIDGE, UK - Endomagnetics, the company developing a portfolio of products to improve the standard of breast cancer management, has successfully closed an investment round totalling 2.1 million ($ 3.2m US) ." ;
    ns1:documentTitle "Endomagnetics in 2.1m Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/endomagnetics-%C2%A32-1m-fund-raising> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2343873/Endomagnetics> ;
    ns1:valueRaw "$ 3.2m US",
        "2.1 million" ;
    ns1:when "2013-08-09T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "9th August 2013" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2344786/Bdc_Venture_Capital> a org:Organization ;
    ns1:basedInLowRaw "MONTREAL, QC" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2014-01-10T16:03:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "OrbiMed Advisors leads Series A round for Clementia Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/orbimed-advisors-leads-series-a-round-for-clementia-pharmaceuticals> ;
    ns1:foundName "BDC Venture Capital" ;
    ns1:investor <https://1145.am/db/2344786/Rights_Investment_Bdc_Venture_Capital_Clementia_Pharmaceuticals_Completed>,
        <https://1145.am/db/2344786/Rights_Investment_Bdc_Venture_Capital_Roche_Pharmaceuticals_Completed> ;
    ns1:name "BDC Venture Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1060146/Bbg_Ventures>,
        <https://1145.am/db/1061911/Bbg_Ventures>,
        <https://1145.am/db/1070729/Blue_Bay_Ventures>,
        <https://1145.am/db/1129561/Fbg_Capital>,
        <https://1145.am/db/1130744/Fbg_Capital>,
        <https://1145.am/db/1175576/Blackhorn_Ventures>,
        <https://1145.am/db/1287989/Bda_Partners>,
        <https://1145.am/db/1370222/Blackbird_Ventures>,
        <https://1145.am/db/1370885/Blackbird_Ventures>,
        <https://1145.am/db/1461683/Bbg_Ventures>,
        <https://1145.am/db/1523231/Bdc_Capital>,
        <https://1145.am/db/1557877/Bluerun_Venture>,
        <https://1145.am/db/1559824/Bluerun_Venture>,
        <https://1145.am/db/1578327/Fbg_Capital>,
        <https://1145.am/db/1579792/Fbg_Capital>,
        <https://1145.am/db/1597608/Bdc_Capital>,
        <https://1145.am/db/1598335/Bdc_Capital>,
        <https://1145.am/db/1693922/Blackhorn_Ventures>,
        <https://1145.am/db/169580/Blackbird_Ventures>,
        <https://1145.am/db/1708495/Blume_Ventures>,
        <https://1145.am/db/1709473/Blue_Run_Ventures>,
        <https://1145.am/db/1731295/Kpg_Ventures>,
        <https://1145.am/db/1739064/Blume_Ventures>,
        <https://1145.am/db/1740945/Btov_Partners>,
        <https://1145.am/db/1752902/Blackbird_Ventures>,
        <https://1145.am/db/1754242/Blume_Ventures>,
        <https://1145.am/db/1754595/Beco_Capital>,
        <https://1145.am/db/1756474/Jbv_Capital>,
        <https://1145.am/db/1761126/Crv_Ivp>,
        <https://1145.am/db/1770788/Gobi_Ventures>,
        <https://1145.am/db/1774002/Bbg_Ventures>,
        <https://1145.am/db/1780705/Bleu_Capital>,
        <https://1145.am/db/1787703/Blue_Run_Ventures>,
        <https://1145.am/db/1799113/Bbg_Ventures>,
        <https://1145.am/db/1803590/Ggv_Capital>,
        <https://1145.am/db/1805666/Bgf_Ventures>,
        <https://1145.am/db/1810093/Blume_Ventures>,
        <https://1145.am/db/1811853/Brooklyn_Bridge_Ventures>,
        <https://1145.am/db/1812267/Blue_Run_Ventures>,
        <https://1145.am/db/1815449/Bbg_Ventures>,
        <https://1145.am/db/1838412/Bbva_Ventures>,
        <https://1145.am/db/1880200/Dag_Ventures>,
        <https://1145.am/db/2143283/Btomorrow_Ventures>,
        <https://1145.am/db/2185936/B_Capital_Group>,
        <https://1145.am/db/2281648/Gv>,
        <https://1145.am/db/2291277/Bvf_Partners_Lp>,
        <https://1145.am/db/2296842/B-to-V_Partners>,
        <https://1145.am/db/2311128/Bdc_Capital>,
        <https://1145.am/db/2313438/Vi_Partners>,
        <https://1145.am/db/2324195/Gbs_Ventures>,
        <https://1145.am/db/2333504/Bdc_Venture_Capital>,
        <https://1145.am/db/2334481/Brm_Group>,
        <https://1145.am/db/2341792/Vi_Partners>,
        <https://1145.am/db/2341800/Vi_Partners>,
        <https://1145.am/db/2346973/Morningside_Group>,
        <https://1145.am/db/2355034/Bdc_Venture_Capital>,
        <https://1145.am/db/2763747/Ggv_Capital>,
        <https://1145.am/db/2765030/Blackbird_Ventures>,
        <https://1145.am/db/2790795/Blackwood_Ventures>,
        <https://1145.am/db/684369/Gpg_Ventures>,
        <https://1145.am/db/761862/Fbg_Capital>,
        <https://1145.am/db/763252/Fbg_Capital>,
        <https://1145.am/db/813790/Btomorrow_Ventures>,
        <https://1145.am/db/819495/Blume_Ventures>,
        <https://1145.am/db/865934/Golden_Gate_Capital>,
        <https://1145.am/db/885181/B_Capital_Group>,
        <https://1145.am/db/935322/Vi_Partners>,
        <https://1145.am/db/938108/Bunge_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1697910/Bdc_Venture_Capital>,
        <https://1145.am/db/1729122/Bdc_Venture_Capital>,
        <https://1145.am/db/1828449/Bdc_Venture_Capital>,
        <https://1145.am/db/1830077/Bdc_Venture_Capital>,
        <https://1145.am/db/1852909/Bdc_Venture_Capital>,
        <https://1145.am/db/1890839/Bdc_Venture_Capital>,
        <https://1145.am/db/1906920/Bdc_Venture_Capital>,
        <https://1145.am/db/2163356/Bdc_Venture_Capital>,
        <https://1145.am/db/2293047/Bdc_Venture_Capital>,
        <https://1145.am/db/2317961/Bdc_Venture_Capital>,
        <https://1145.am/db/2318781/Bdc_Venture_Capital_Inc>,
        <https://1145.am/db/2318796/Bdc_Venture_Capital_Inc>,
        <https://1145.am/db/2333525/Bdc_Venture_Capital>,
        <https://1145.am/db/2345002/Bdc_Venture_Capital>,
        <https://1145.am/db/2355936/Bdc_Venture_Capital>,
        <https://1145.am/db/2355938/Bdc_Venture_Capital>,
        <https://1145.am/db/2358031/Bdc_Venture_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344786/Clementia_Pharmaceuticals> a org:Organization ;
    ns1:description "Biotechnology" ;
    ns1:documentDate "2014-01-10T16:03:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "OrbiMed Advisors leads Series A round for Clementia Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/orbimed-advisors-leads-series-a-round-for-clementia-pharmaceuticals> ;
    ns1:foundName "Clementia Pharmaceuticals",
        "Clementia Pharmaceuticals, Inc." ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Clementia Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2153682/Clementia_Pharmaceuticals>,
        <https://1145.am/db/2153782/Clementia_Pharmaceuticals>,
        <https://1145.am/db/2153982/Clementia_Pharmaceuticals>,
        <https://1145.am/db/2355034/Clementia_Pharmaceuticals_Inc>,
        <https://1145.am/db/2367678/Clementia_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344786/Orbimed_Advisors> a org:Organization ;
    ns1:documentDate "2014-01-10T16:03:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "OrbiMed Advisors leads Series A round for Clementia Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/orbimed-advisors-leads-series-a-round-for-clementia-pharmaceuticals> ;
    ns1:foundName "OrbiMed Advisors" ;
    ns1:industry "pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2344786/Rights_Investment_Bdc_Venture_Capital_Clementia_Pharmaceuticals_Completed> ;
    ns1:name "OrbiMed Advisors" ;
    ns1:sameAsHigh <https://1145.am/db/1004121/Orbimed>,
        <https://1145.am/db/1426073/Orbimed>,
        <https://1145.am/db/1426943/Orbimed>,
        <https://1145.am/db/1608803/Orbimed>,
        <https://1145.am/db/194149/Orbimed>,
        <https://1145.am/db/2151717/Orbimed>,
        <https://1145.am/db/2280770/Orbimed>,
        <https://1145.am/db/2286207/Orbimed>,
        <https://1145.am/db/2290069/Orbimed>,
        <https://1145.am/db/2290337/Orbimed>,
        <https://1145.am/db/2290766/Orbimed>,
        <https://1145.am/db/2293503/Orbimed>,
        <https://1145.am/db/2295713/Orbimed>,
        <https://1145.am/db/2298642/Orbimed>,
        <https://1145.am/db/2344044/Orbimed>,
        <https://1145.am/db/2349834/Orbimed>,
        <https://1145.am/db/2349838/Orbimed>,
        <https://1145.am/db/2363947/Orbimed>,
        <https://1145.am/db/2369135/Orbimed>,
        <https://1145.am/db/2369140/Orbimed>,
        <https://1145.am/db/2369202/Orbimed>,
        <https://1145.am/db/2370208/Orbimed>,
        <https://1145.am/db/2370295/Orbimed>,
        <https://1145.am/db/2370782/Orbimed>,
        <https://1145.am/db/2371160/Orbimed>,
        <https://1145.am/db/2547469/Orbimed>,
        <https://1145.am/db/2548437/Orbimed>,
        <https://1145.am/db/402604/Orbimed>,
        <https://1145.am/db/581662/Orbimed>,
        <https://1145.am/db/583614/Orbimed>,
        <https://1145.am/db/676857/Orbimed> ;
    ns1:sameAsMedium <https://1145.am/db/1665536/Orbimed_Advisors>,
        <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2198816/Orbimed_Advisors>,
        <https://1145.am/db/2245885/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2284506/Orbimed_Advisors>,
        <https://1145.am/db/2289056/Orbimed_Advisors>,
        <https://1145.am/db/2290078/Orbimed_Advisors>,
        <https://1145.am/db/2290200/Orbimed_Advisors>,
        <https://1145.am/db/2290444/Orbimed_Advisors>,
        <https://1145.am/db/2297604/Orbimed_Advisors>,
        <https://1145.am/db/2298956/Orbimed_Advisors>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2304242/Orbimed_Advisors>,
        <https://1145.am/db/2305656/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306251/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306705/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2309491/Orbimed_Advisors>,
        <https://1145.am/db/2310922/Orbimed_Advisors>,
        <https://1145.am/db/2312233/Orbimed_Advisors>,
        <https://1145.am/db/2317918/Orbimed_Advisors>,
        <https://1145.am/db/2318133/Orbimed_Advisors>,
        <https://1145.am/db/2318829/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2318832/Orbimed_Advisers>,
        <https://1145.am/db/2318851/Orbimed_Advisors>,
        <https://1145.am/db/2319338/Orbimed_Advisors>,
        <https://1145.am/db/2320914/Orbimed_Advisors>,
        <https://1145.am/db/2322345/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2324226/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2325880/Orbimed_Advisors>,
        <https://1145.am/db/2328599/Orbimed_Advisors>,
        <https://1145.am/db/2328700/Orbimed_Advisors>,
        <https://1145.am/db/2329260/Orbimed_Advisors>,
        <https://1145.am/db/2330799/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2330920/Orbimed_Advisors>,
        <https://1145.am/db/2332120/Orbimed_Advisors>,
        <https://1145.am/db/2333495/Orbimed_Advisors>,
        <https://1145.am/db/2333504/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2333966/Orbimed_Advisors>,
        <https://1145.am/db/2335743/Orbimed_Advisors>,
        <https://1145.am/db/2336221/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2336503/Orbimed_Advisors>,
        <https://1145.am/db/2336505/Orbimed_Advisors>,
        <https://1145.am/db/2336524/Orbimed_Advisors>,
        <https://1145.am/db/2337166/Orbimed_Advisors>,
        <https://1145.am/db/2337250/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2337254/Orbimed_Advisors>,
        <https://1145.am/db/2339885/Orbimed_Advisors>,
        <https://1145.am/db/2339886/Orbimed_Advisors>,
        <https://1145.am/db/2342862/Orbimed_Advisors>,
        <https://1145.am/db/2342925/Orbimed_Advisors>,
        <https://1145.am/db/2342937/Orbimed_Advisors>,
        <https://1145.am/db/2343244/Orbimed_Advisors>,
        <https://1145.am/db/2344735/Orbimed_Advisors>,
        <https://1145.am/db/2345435/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345453/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345456/Orbimed_Advisors>,
        <https://1145.am/db/2346030/Orbimed_Advisors>,
        <https://1145.am/db/2350034/Orbimed_Advisors>,
        <https://1145.am/db/2350044/Orbimed_Advisors>,
        <https://1145.am/db/2352436/Orbimed_Advisors>,
        <https://1145.am/db/2352441/Orbimed_Advisors>,
        <https://1145.am/db/2352442/Orbimed_Advisors>,
        <https://1145.am/db/2352701/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2352804/Orbimed_Advisors>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2355034/Orbimed_Advisors>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2356420/Orbimed_Advisors>,
        <https://1145.am/db/2357253/Orbimed_Advisors>,
        <https://1145.am/db/2357256/Orbimed_Advisors>,
        <https://1145.am/db/2357858/Orbimed_Advisors>,
        <https://1145.am/db/2359125/Orbimed_Advisors>,
        <https://1145.am/db/2359468/Orbimed_Advisors>,
        <https://1145.am/db/2359864/Orbimed_Advisors>,
        <https://1145.am/db/2360174/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2361018/Orbimed_Advisors>,
        <https://1145.am/db/2361022/Orbimed_Advisors>,
        <https://1145.am/db/2361027/Orbimed_Advisors>,
        <https://1145.am/db/2362475/Orbimed_Advisors>,
        <https://1145.am/db/2362481/Orbimed_Advisors>,
        <https://1145.am/db/2363339/Orbimed_Advisors>,
        <https://1145.am/db/2365679/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2365868/Orbimed_Advisors>,
        <https://1145.am/db/2366519/Orbimed_Advisors>,
        <https://1145.am/db/2574232/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2583013/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/456081/Orbimed_Advisors>,
        <https://1145.am/db/456089/Orbimed_Advisors>,
        <https://1145.am/db/458377/Orbimed_Advisors>,
        <https://1145.am/db/674484/Orbimed_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344786/Rights_Investment_Bdc_Venture_Capital_Roche_Pharmaceuticals_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-01-10T16:03:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MONTREAL, QC - (Marketwired - January 09, 2014) - Clementia Pharmaceuticals, Inc., a privately held clinical stage biotechnology company dedicated to the development and delivery of treatments for people living with rare diseases, announced today the closing of a $ 22.5 million Series A financing led by OrbiMed Advisors with participation by existing investor BDC Venture Capital." ;
    ns1:documentTitle "OrbiMed Advisors leads Series A round for Clementia Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/orbimed-advisors-leads-series-a-round-for-clementia-pharmaceuticals> ;
    ns1:foundName "acquire" ;
    ns1:name "acquire" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2344786/Roche_Pharmaceuticals> ;
    ns1:targetDetails "rights" ;
    ns1:valueRaw "$ 22.5 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2344786/Roche_Pharmaceuticals> a org:Organization ;
    ns1:basedInLowRaw "MONTREAL, QC" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2014-01-10T16:03:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "OrbiMed Advisors leads Series A round for Clementia Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/orbimed-advisors-leads-series-a-round-for-clementia-pharmaceuticals> ;
    ns1:foundName "Roche Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Roche Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1322436/Roche>,
        <https://1145.am/db/1334866/Roche>,
        <https://1145.am/db/1389324/Roche_Holding>,
        <https://1145.am/db/1570526/Roche>,
        <https://1145.am/db/1767410/Roche>,
        <https://1145.am/db/1998785/Roche>,
        <https://1145.am/db/2024372/Roche_Holding_Ag>,
        <https://1145.am/db/2061027/Roche>,
        <https://1145.am/db/2152005/Roche>,
        <https://1145.am/db/2154526/Roche>,
        <https://1145.am/db/2154736/Roche>,
        <https://1145.am/db/2187676/Roche>,
        <https://1145.am/db/2193442/Roche_Group>,
        <https://1145.am/db/2223188/Roche>,
        <https://1145.am/db/2244622/Roche>,
        <https://1145.am/db/2279060/Roche>,
        <https://1145.am/db/2279266/Roche>,
        <https://1145.am/db/2281213/Roche>,
        <https://1145.am/db/2286404/Roche>,
        <https://1145.am/db/2286719/Roche>,
        <https://1145.am/db/2287064/Roche>,
        <https://1145.am/db/2287171/Roche>,
        <https://1145.am/db/2289977/Roche>,
        <https://1145.am/db/2290009/Roche>,
        <https://1145.am/db/2292337/Roche>,
        <https://1145.am/db/2292593/Roche>,
        <https://1145.am/db/2294783/Roche>,
        <https://1145.am/db/2295842/Roche>,
        <https://1145.am/db/2295853/Roche>,
        <https://1145.am/db/2296171/Roche>,
        <https://1145.am/db/2296371/Roche>,
        <https://1145.am/db/2296600/Roche>,
        <https://1145.am/db/2297131/Roche>,
        <https://1145.am/db/2297300/Roche>,
        <https://1145.am/db/2297593/Roche>,
        <https://1145.am/db/2297619/Roche>,
        <https://1145.am/db/2299175/Roche>,
        <https://1145.am/db/2299784/Roche>,
        <https://1145.am/db/2300140/Roche>,
        <https://1145.am/db/2300897/Roche>,
        <https://1145.am/db/2303385/Roche>,
        <https://1145.am/db/2303398/Roche>,
        <https://1145.am/db/2303402/Roche>,
        <https://1145.am/db/2303873/Roche>,
        <https://1145.am/db/2303880/Roche>,
        <https://1145.am/db/2305192/Roche>,
        <https://1145.am/db/2305545/Roche>,
        <https://1145.am/db/2305578/Roche_Ag>,
        <https://1145.am/db/2305582/Roche>,
        <https://1145.am/db/2306401/Roche>,
        <https://1145.am/db/2307022/Roche>,
        <https://1145.am/db/2308972/Roche>,
        <https://1145.am/db/2309846/Roche>,
        <https://1145.am/db/2309947/Roche>,
        <https://1145.am/db/2309962/Roche>,
        <https://1145.am/db/2309988/Roche>,
        <https://1145.am/db/2309993/Roche>,
        <https://1145.am/db/2310015/Roche>,
        <https://1145.am/db/2311026/Roche>,
        <https://1145.am/db/2312193/Roche>,
        <https://1145.am/db/2313073/Roche>,
        <https://1145.am/db/2313320/Roche>,
        <https://1145.am/db/2313324/Roche>,
        <https://1145.am/db/2313503/Roche_Holding>,
        <https://1145.am/db/2313872/Roche>,
        <https://1145.am/db/2319577/Roche>,
        <https://1145.am/db/2323214/Roche>,
        <https://1145.am/db/2323221/Roche>,
        <https://1145.am/db/2330483/Roche>,
        <https://1145.am/db/2335338/Roche>,
        <https://1145.am/db/2336767/Roche>,
        <https://1145.am/db/2337234/Roche>,
        <https://1145.am/db/2340363/Roche>,
        <https://1145.am/db/2340626/Roche_Ag>,
        <https://1145.am/db/2341621/Roche>,
        <https://1145.am/db/2341630/Roche>,
        <https://1145.am/db/2342211/Roche>,
        <https://1145.am/db/2342417/Roche>,
        <https://1145.am/db/2344272/Roche>,
        <https://1145.am/db/2344534/Roche>,
        <https://1145.am/db/2344754/Roche>,
        <https://1145.am/db/2344807/Roche>,
        <https://1145.am/db/2346072/Roche>,
        <https://1145.am/db/2346819/Roche>,
        <https://1145.am/db/2346852/Roche>,
        <https://1145.am/db/2348776/Roche>,
        <https://1145.am/db/2349537/Roche>,
        <https://1145.am/db/2352841/Roche>,
        <https://1145.am/db/2352976/Roche>,
        <https://1145.am/db/2352978/Roche>,
        <https://1145.am/db/2352993/Roche>,
        <https://1145.am/db/2353992/Roche>,
        <https://1145.am/db/2355181/Roche_Pharma_Research_And_Early_Development>,
        <https://1145.am/db/2356012/Roche>,
        <https://1145.am/db/2356014/Roche>,
        <https://1145.am/db/2356189/Roche_Pharma_Research_And_Early_Development>,
        <https://1145.am/db/2357054/Roche>,
        <https://1145.am/db/2358186/Roche>,
        <https://1145.am/db/2359957/Roche>,
        <https://1145.am/db/2359959/Roche>,
        <https://1145.am/db/2359963/Roche>,
        <https://1145.am/db/2359965/Roche>,
        <https://1145.am/db/2360246/Roche>,
        <https://1145.am/db/2360248/Roche>,
        <https://1145.am/db/2360249/Roche>,
        <https://1145.am/db/2360539/Roche>,
        <https://1145.am/db/2360997/Roche>,
        <https://1145.am/db/2360999/Roche>,
        <https://1145.am/db/2361632/Roche>,
        <https://1145.am/db/2362001/Roche>,
        <https://1145.am/db/2362113/Roche>,
        <https://1145.am/db/2362305/Roche>,
        <https://1145.am/db/2362730/Roche>,
        <https://1145.am/db/2362732/Roches_Pharma_Research___Early_Development>,
        <https://1145.am/db/2363726/Roche>,
        <https://1145.am/db/2364074/Roche>,
        <https://1145.am/db/2365305/Roche>,
        <https://1145.am/db/2366649/Roche>,
        <https://1145.am/db/2366853/Roche>,
        <https://1145.am/db/2366885/Roche>,
        <https://1145.am/db/2368653/Roche>,
        <https://1145.am/db/2369197/Roche>,
        <https://1145.am/db/2369199/Roche>,
        <https://1145.am/db/2371046/Roche>,
        <https://1145.am/db/2371047/Roche>,
        <https://1145.am/db/2371314/Roche>,
        <https://1145.am/db/2537591/Roche>,
        <https://1145.am/db/2538424/Roche>,
        <https://1145.am/db/2538826/Roche>,
        <https://1145.am/db/2540755/Roche>,
        <https://1145.am/db/2541555/Roche>,
        <https://1145.am/db/2543605/Roche>,
        <https://1145.am/db/2545574/Roche>,
        <https://1145.am/db/2545742/Roche>,
        <https://1145.am/db/2545952/Roche>,
        <https://1145.am/db/2546646/Roche>,
        <https://1145.am/db/2547098/Roche>,
        <https://1145.am/db/2547770/Roche>,
        <https://1145.am/db/2547998/Roche>,
        <https://1145.am/db/2548696/Roche>,
        <https://1145.am/db/2549102/Roche>,
        <https://1145.am/db/2549670/Roche>,
        <https://1145.am/db/2551122/Roche>,
        <https://1145.am/db/2553276/Roche>,
        <https://1145.am/db/2553947/Roche>,
        <https://1145.am/db/2558080/Roche>,
        <https://1145.am/db/2558313/Roche>,
        <https://1145.am/db/2559230/Roche>,
        <https://1145.am/db/2560865/Roche>,
        <https://1145.am/db/2563029/Roche>,
        <https://1145.am/db/2565142/Roche>,
        <https://1145.am/db/2567367/Roche>,
        <https://1145.am/db/2571045/Roche>,
        <https://1145.am/db/2571613/Roche>,
        <https://1145.am/db/2572452/Roche>,
        <https://1145.am/db/2573339/Roche>,
        <https://1145.am/db/2573395/Roche>,
        <https://1145.am/db/2573397/Roche>,
        <https://1145.am/db/2573412/Roche_Holding_Ag>,
        <https://1145.am/db/2574245/Roche>,
        <https://1145.am/db/2574281/Roche>,
        <https://1145.am/db/2578312/Roche>,
        <https://1145.am/db/2578313/Roche>,
        <https://1145.am/db/2579314/Roche>,
        <https://1145.am/db/2579320/Roche>,
        <https://1145.am/db/2580384/Roche>,
        <https://1145.am/db/2581493/Roche>,
        <https://1145.am/db/2582270/Roche>,
        <https://1145.am/db/2582355/Roche>,
        <https://1145.am/db/2582468/Roche>,
        <https://1145.am/db/2584101/Roche>,
        <https://1145.am/db/2587657/Roche>,
        <https://1145.am/db/2592126/Roche>,
        <https://1145.am/db/2592803/Roche>,
        <https://1145.am/db/2593007/Roche>,
        <https://1145.am/db/2593713/Roche>,
        <https://1145.am/db/2594870/Roche>,
        <https://1145.am/db/2595237/Roche>,
        <https://1145.am/db/2596333/Roche>,
        <https://1145.am/db/2597648/Roche>,
        <https://1145.am/db/2597732/Roche>,
        <https://1145.am/db/2598066/F_Hoffmann-La_Roche>,
        <https://1145.am/db/2598072/Roche>,
        <https://1145.am/db/271528/Roche>,
        <https://1145.am/db/595011/Roche>,
        <https://1145.am/db/652831/Roche> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347977/Argos_Therapeutics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Durham County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4464374/about.rdf> ;
    ns1:basedInHighRaw "DURHAM, N.C." ;
    ns1:basedInLowRaw "Russian" ;
    ns1:description "pharmaceuticals",
        "the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases" ;
    ns1:documentDate "2013-08-26T12:02:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argos-therapeutics-secures-42-5-million-financing-funds-pivotal-phase-3-adapt-trial-for> ;
    ns1:foundName "Argos Therapeutics",
        "Argos Therapeutics Inc." ;
    ns1:industry "Pharmaceutical",
        "biopharmaceutical" ;
    ns1:name "Argos Therapeutics",
        "Argos Therapeutics Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2213473/Arno_Therapeutics_Inc>,
        <https://1145.am/db/2320472/Aryx_Therapeutics_Inc>,
        <https://1145.am/db/2336844/Argos_Therapeutics_Inc>,
        <https://1145.am/db/2337706/Arno_Therapeutics>,
        <https://1145.am/db/2338254/Elcelyx_Therapeutics>,
        <https://1145.am/db/2342845/Argos_Therapeutics_Inc>,
        <https://1145.am/db/2345831/Arno_Therapeutics_Inc>,
        <https://1145.am/db/2346087/Argos_Therapeutics>,
        <https://1145.am/db/2350043/Elcelyx_Therapeutics>,
        <https://1145.am/db/2354125/Arno_Therapeutics>,
        <https://1145.am/db/2360213/Arno_Therapeutics>,
        <https://1145.am/db/2362563/Arno_Therapeutics>,
        <https://1145.am/db/2367611/Arog_Pharmaceuticals>,
        <https://1145.am/db/2370779/Elcelyx_Therapeutics>,
        <https://1145.am/db/2551380/Argos_Therapeutics_Inc>,
        <https://1145.am/db/2559208/Argos_Therapeutics>,
        <https://1145.am/db/588256/Arrevus>,
        <https://1145.am/db/677973/Arrakis_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2308914/Argos_Therapeutics>,
        <https://1145.am/db/2325366/Argos_Therapeutics>,
        <https://1145.am/db/2345712/Argos_Therapeutics_Inc>,
        <https://1145.am/db/2347983/Argos_Therapeutics>,
        <https://1145.am/db/2350002/Argos_Therapeutics>,
        <https://1145.am/db/2353522/Argos_Therapeutics_Inc>,
        <https://1145.am/db/2353525/Argos_Therapeutics>,
        <https://1145.am/db/2365891/Argos_Therapeutics>,
        <https://1145.am/db/2370565/Argos_Therapeutics_Inc>,
        <https://1145.am/db/2370600/Argos_Therapeutics>,
        <https://1145.am/db/2552553/Argos_Therapeutics>,
        <https://1145.am/db/2561312/Argos_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347977/Pharmstandard> a org:Organization ;
    ns1:basedInLowRaw "Russia" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2013-08-26T12:02:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argos-therapeutics-secures-42-5-million-financing-funds-pivotal-phase-3-adapt-trial-for> ;
    ns1:foundName "Pharmstandard" ;
    ns1:name "Pharmstandard" ;
    ns1:sameAsHigh <https://1145.am/db/1042008/Jazz_Pharmaceuticals>,
        <https://1145.am/db/1203801/Theravance_Biopharma>,
        <https://1145.am/db/1205635/Theravance_Biopharma>,
        <https://1145.am/db/1205649/Theravance_Biopharma>,
        <https://1145.am/db/1282163/Pharmasimple>,
        <https://1145.am/db/1283229/Pharmasimple>,
        <https://1145.am/db/1443968/Pharmajet>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1537336/Pharmajet>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/2035521/Civica>,
        <https://1145.am/db/2062728/Novan>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2303008/Access_Pharmaceuticals>,
        <https://1145.am/db/2303352/Mgi_Pharma>,
        <https://1145.am/db/2303791/Inspire_Pharmaceuticals>,
        <https://1145.am/db/2303804/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2313320/Nycomed>,
        <https://1145.am/db/2313323/Nycomed_Us>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2316658/Medidur__Fa>,
        <https://1145.am/db/2317917/Nycomed_Us_Inc>,
        <https://1145.am/db/2323783/Jazz_Pharmaceuticals>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2327264/Inspire_Pharmaceuticals>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2336923/Complix>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2339816/Nuevolution_A_S>,
        <https://1145.am/db/2342100/Inspire_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344318/Theraclone_Sciences>,
        <https://1145.am/db/2344820/Jazz_Pharmaceuticals>,
        <https://1145.am/db/2347882/Medigene_Ag>,
        <https://1145.am/db/2348785/Jazz_Pharmaceuticals_Plc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350626/Epicept_Corporation>,
        <https://1145.am/db/2353565/Jazz_Pharmaceuticals>,
        <https://1145.am/db/2354582/Action_Pharma>,
        <https://1145.am/db/2355925/Inspire_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357823/Map_Pharmaceuticals>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2362453/Action_Pharma>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2538908/Mission_Pharmacal_Company>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2540578/Bever_Pharmaceutical_Pte_Ltd>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544721/Imcopharma>,
        <https://1145.am/db/2548593/Jazz_Pharmaceuticals>,
        <https://1145.am/db/2550148/Organon_Biosciences>,
        <https://1145.am/db/2550758/Medley>,
        <https://1145.am/db/2558955/Amdipharm>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2574077/Inspire_Pharmaceuticals_Inc>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2576103/Jazz_Pharmaceuticals>,
        <https://1145.am/db/2577958/Specifar>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2586802/Pharma_Healthcare_Pte_Ltd>,
        <https://1145.am/db/2586804/Pharma_Healthcare>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2596632/Nycomed>,
        <https://1145.am/db/426114/Novan>,
        <https://1145.am/db/934888/Jazz_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2585785/Pharmstandard>,
        <https://1145.am/db/2587709/Pharmstandard>,
        <https://1145.am/db/2591609/Pharmstandard>,
        <https://1145.am/db/2591622/Pharmstandard>,
        <https://1145.am/db/2593529/Pharmstandard> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347984/Mpm_Capital> a org:Organization ;
    ns1:basedInLowRaw "WALTHAM, Mass" ;
    ns1:documentDate "2013-08-27T11:51:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/syndax-pharmaceuticals-secures-26-6-million-series-b-financing-for-advancement-of> ;
    ns1:foundName "MPM Capital" ;
    ns1:investor <https://1145.am/db/2347984/Series_B_Investment_Domain_Associates_Forward_Ventures_Mpm_Capital_Rusnanomedinvest_Syndax_Pharmaceuticals_Inc_Completed> ;
    ns1:name "MPM Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1325968/Mpm_Capital>,
        <https://1145.am/db/1752458/Mpm_Capital>,
        <https://1145.am/db/2285876/Mpm_Capital>,
        <https://1145.am/db/2287191/Mpm_Capital>,
        <https://1145.am/db/2292334/Mpm_Capital>,
        <https://1145.am/db/2292353/Mpm_Capital>,
        <https://1145.am/db/2300455/Mpm_Capital>,
        <https://1145.am/db/2301901/Mpm_Capital>,
        <https://1145.am/db/2303391/Mpm_Capital>,
        <https://1145.am/db/2303833/Mpm_Capital>,
        <https://1145.am/db/2303855/Mpm_Capital>,
        <https://1145.am/db/2304634/Mpm_Capital>,
        <https://1145.am/db/2305503/Mpm_Capital>,
        <https://1145.am/db/2305656/Mpm_Capital>,
        <https://1145.am/db/2306705/Mpm_Capital>,
        <https://1145.am/db/2308887/Mpm_Capital>,
        <https://1145.am/db/2309845/Mpm_Capital>,
        <https://1145.am/db/2311551/Mpm_Capital>,
        <https://1145.am/db/2312285/Mpm_Capital>,
        <https://1145.am/db/2312309/Mpm_Capital>,
        <https://1145.am/db/2316391/Mpm_Capital>,
        <https://1145.am/db/2323055/Mpm_Capital>,
        <https://1145.am/db/2323066/Mpm_Capital>,
        <https://1145.am/db/2323094/Mpm_Capital>,
        <https://1145.am/db/2323563/Mpm_Capital>,
        <https://1145.am/db/2323568/Mpm_Capital>,
        <https://1145.am/db/2324195/Mpm_Capital>,
        <https://1145.am/db/2324226/Mpm_Capital>,
        <https://1145.am/db/2328338/Mpm_Capital>,
        <https://1145.am/db/2333119/Mpm_Capital>,
        <https://1145.am/db/2333525/Mpm_Capital>,
        <https://1145.am/db/2335701/Mpm_Capital>,
        <https://1145.am/db/2335714/Mpm_Capital>,
        <https://1145.am/db/2337140/Mpm_Capital>,
        <https://1145.am/db/2340957/Mpm_Capital>,
        <https://1145.am/db/2345299/Mpm_Capital>,
        <https://1145.am/db/2345318/Mpm_Capital>,
        <https://1145.am/db/2346204/Mpm_Capital>,
        <https://1145.am/db/2347140/Mpm_Capital>,
        <https://1145.am/db/2347469/Mpm_Capital>,
        <https://1145.am/db/2348484/Mpm_Capital>,
        <https://1145.am/db/2350030/Mpm_Capital>,
        <https://1145.am/db/2352172/Mpm_Capital>,
        <https://1145.am/db/2352362/Mpm_Capital>,
        <https://1145.am/db/2352899/Mpm_Capital>,
        <https://1145.am/db/2353365/Mpm_Capital>,
        <https://1145.am/db/2353404/Mpm_Capital>,
        <https://1145.am/db/2353413/Mpm_Capital>,
        <https://1145.am/db/2353415/Mpm_Capital>,
        <https://1145.am/db/2356396/Mpm_Capital>,
        <https://1145.am/db/2358979/Mpm_Capital>,
        <https://1145.am/db/2359001/Mpm_Capital>,
        <https://1145.am/db/2359873/Mpm_Capital>,
        <https://1145.am/db/2359875/Mpm_Capital>,
        <https://1145.am/db/2360526/Mpm_Capital>,
        <https://1145.am/db/2362871/Mpm_Capital>,
        <https://1145.am/db/2364492/Mpm_Capital>,
        <https://1145.am/db/2365098/Mpm_Capital>,
        <https://1145.am/db/2366744/Mpm_Capital>,
        <https://1145.am/db/2367199/Mpm_Capital>,
        <https://1145.am/db/2369202/Mpm_Capital>,
        <https://1145.am/db/2370582/Mpm_Capital>,
        <https://1145.am/db/2541350/Mpm_Capital>,
        <https://1145.am/db/677075/Mpm_Capital>,
        <https://1145.am/db/678997/Mpm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347984/Rusnanomedinvest> a org:Organization ;
    ns1:basedInLowRaw "Russia" ;
    ns1:description "investing" ;
    ns1:documentDate "2013-08-27T11:51:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/syndax-pharmaceuticals-secures-26-6-million-series-b-financing-for-advancement-of> ;
    ns1:foundName "RusnanoMedInvest (RMI)" ;
    ns1:investor <https://1145.am/db/2347984/Series_B_Investment_Domain_Associates_Forward_Ventures_Mpm_Capital_Rusnanomedinvest_Syndax_Pharmaceuticals_Inc_Completed> ;
    ns1:name "RusnanoMedInvest" ;
    ns1:sameAsHigh <https://1145.am/db/1761089/Kaszek>,
        <https://1145.am/db/2339894/Rusnanomedinvest>,
        <https://1145.am/db/868933/Kaszek> ;
    ns1:sameAsMedium <https://1145.am/db/2297408/Rusnanomedinvest>,
        <https://1145.am/db/2336125/Rusnanomedinvest>,
        <https://1145.am/db/2356301/Rusnanomedinvest>,
        <https://1145.am/db/2357325/Rusnanomedinvest>,
        <https://1145.am/db/2358541/Rusnanomedinvest>,
        <https://1145.am/db/2360258/Rusnanomedinvest>,
        <https://1145.am/db/2361625/Rusnanomedinvest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347984/Syndax_Pharmaceuticals_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Waltham" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4954380/about.rdf> ;
    ns1:basedInHighRaw "WALTHAM, Mass." ;
    ns1:description "Pharmaceuticals",
        "developing epigenetic therapies for treatment-resistant cancers" ;
    ns1:documentDate "2013-08-27T11:51:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/syndax-pharmaceuticals-secures-26-6-million-series-b-financing-for-advancement-of> ;
    ns1:foundName "Syndax Pharmaceuticals",
        "Syndax Pharmaceuticals Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Syndax Pharmaceuticals",
        "Syndax Pharmaceuticals Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1018912/Syneos_Health>,
        <https://1145.am/db/1130807/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1142583/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1418427/Syneos_Health>,
        <https://1145.am/db/1549319/Syndax_Pharmaceuticals>,
        <https://1145.am/db/1556582/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1559723/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1566029/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1581300/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/1630772/Syneos_Health>,
        <https://1145.am/db/1651972/Synokem_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2290002/Synlogic>,
        <https://1145.am/db/2302213/Syndexa_Pharmaceuticals_Corp>,
        <https://1145.am/db/2308945/Synta_Pharmaceuticals>,
        <https://1145.am/db/2310275/Synvista_Therapeutics>,
        <https://1145.am/db/2310891/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2313221/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2319795/Synteract_Corporation>,
        <https://1145.am/db/2323676/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2324324/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2326590/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2328043/Synta_Pharmaceuticals>,
        <https://1145.am/db/2329577/Synta_Pharmaceuticals>,
        <https://1145.am/db/2329776/Syntonix_Pharmaceuticals>,
        <https://1145.am/db/2330601/Synta_Pharmaceuticals>,
        <https://1145.am/db/2332873/Synta_Pharmaceuticals>,
        <https://1145.am/db/2336266/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2342853/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2345412/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2346874/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347993/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2349211/Synta_Pharmaceuticals>,
        <https://1145.am/db/2349213/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2349994/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350262/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2352462/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2353622/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2354619/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2354673/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2355443/Synereca_Pharmaceuticals>,
        <https://1145.am/db/2356177/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2356706/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2357037/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2357438/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2358009/Synageva_Biopharma>,
        <https://1145.am/db/2358011/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2360435/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2360728/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2365533/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2365922/Synageva_Biopharma_Corp>,
        <https://1145.am/db/2365933/Synageva>,
        <https://1145.am/db/2366169/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2367544/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/2367558/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2369523/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2369837/Syndax_Pharmaceuticals>,
        <https://1145.am/db/2370085/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2370094/Synlogic>,
        <https://1145.am/db/2370293/Synlogic>,
        <https://1145.am/db/2370319/Synlogic>,
        <https://1145.am/db/240858/Synedgen>,
        <https://1145.am/db/2576372/Synta_Pharmaceuticals>,
        <https://1145.am/db/2576382/Synta_Pharmaceuticals_Corp>,
        <https://1145.am/db/2595501/Synageva_Biopharma_Corp>,
        <https://1145.am/db/476676/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/705534/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/808631/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/868994/Syndax_Pharmaceuticals_Inc>,
        <https://1145.am/db/878342/Syndax_Pharmaceuticals_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2369431/Syndax_Syndax_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348967/Lumos_Pharma> a org:Organization ;
    ns1:basedInHighGeoName "Austin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4671654/about.rdf> ;
    ns1:basedInHighRaw "AUSTIN, Texas" ;
    ns1:description "Biopharmaceutical" ;
    ns1:documentDate "2014-02-04T16:40:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lumos Pharma Announces Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lumos-pharma-announces-series-a-financing> ;
    ns1:foundName "Lumos Pharma" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Lumos Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/2338009/Lumena_Pharmaceuticals>,
        <https://1145.am/db/2348956/Lumos_Pharmaceuticals>,
        <https://1145.am/db/2361298/Luye_Pharma_Group>,
        <https://1145.am/db/2560179/Luye_Pharma_Group>,
        <https://1145.am/db/2560187/Luye_Pharma_Group_Ltd>,
        <https://1145.am/db/2592562/Lumena_Pharmaceuticals>,
        <https://1145.am/db/935110/Lumanity> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348967/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInHighGeoName "Austin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4671654/about.rdf> ;
    ns1:basedInHighRaw "AUSTIN, Texas" ;
    ns1:documentDate "2014-02-04T16:40:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lumos Pharma Announces Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lumos-pharma-announces-series-a-financing> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2348967/Series_A_Investment_Lumos_Pharma_New_Enterprise_Associates_Sante_Ventures_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348968/Sialix_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge, Massachusetts",
        "New England - based syndicate of angel investors;" ;
    ns1:description "Financing led by New England - based syndicate of angel investors;",
        "developing products for the treatment and prevention of cancer" ;
    ns1:documentDate "2014-02-05T13:44:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sialix Closes Oversubscribed Second Tranche of Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sialix-closes-oversubscribed-second-tranche-of-series-b-financing> ;
    ns1:foundName "Sialix",
        "Sialix, Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Sialix",
        "Sialix, Inc." ;
    ns1:sameAsMedium <https://1145.am/db/2336496/Sialix>,
        <https://1145.am/db/2336519/Sialix>,
        <https://1145.am/db/2342772/Sialix> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350030/Ipierian> a org:Organization ;
    ns1:description "drug development" ;
    ns1:documentDate "2013-09-04T11:47:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "$30 Million Secured in iPierian Financing and Series A Financing for Launch of Spin-out, True North Therapeutics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/30-million-secured-ipierian-financing-and-series-a-financing-for-launch-of-spin-out-true> ;
    ns1:foundName "iPierian",
        "iPierian, Inc." ;
    ns1:industry "pharma industry" ;
    ns1:name "iPierian" ;
    ns1:sameAsHigh <https://1145.am/db/2301716/Ipierian>,
        <https://1145.am/db/2318112/Ipierian_Inc>,
        <https://1145.am/db/2336202/Ipierian>,
        <https://1145.am/db/2344043/Ipierian>,
        <https://1145.am/db/2347430/Ipierian>,
        <https://1145.am/db/2356677/Ipierian>,
        <https://1145.am/db/2367199/Ipierian>,
        <https://1145.am/db/2367201/Ipierian> ;
    ns1:sameAsMedium <https://1145.am/db/2336201/Ipierian>,
        <https://1145.am/db/2342101/Ipierian> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350030/Mpm_Capital> a org:Organization ;
    ns1:documentDate "2013-09-04T11:47:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "$30 Million Secured in iPierian Financing and Series A Financing for Launch of Spin-out, True North Therapeutics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/30-million-secured-ipierian-financing-and-series-a-financing-for-launch-of-spin-out-true> ;
    ns1:foundName "MPM Capital" ;
    ns1:investor <https://1145.am/db/2350030/Series_A_Investment_Sr_One_Ipierian_Ipierian_Completed> ;
    ns1:name "MPM Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1325968/Mpm_Capital>,
        <https://1145.am/db/1752458/Mpm_Capital>,
        <https://1145.am/db/2285876/Mpm_Capital>,
        <https://1145.am/db/2287191/Mpm_Capital>,
        <https://1145.am/db/2292334/Mpm_Capital>,
        <https://1145.am/db/2292353/Mpm_Capital>,
        <https://1145.am/db/2300455/Mpm_Capital>,
        <https://1145.am/db/2301901/Mpm_Capital>,
        <https://1145.am/db/2303391/Mpm_Capital>,
        <https://1145.am/db/2303833/Mpm_Capital>,
        <https://1145.am/db/2303855/Mpm_Capital>,
        <https://1145.am/db/2304634/Mpm_Capital>,
        <https://1145.am/db/2305503/Mpm_Capital>,
        <https://1145.am/db/2305656/Mpm_Capital>,
        <https://1145.am/db/2306705/Mpm_Capital>,
        <https://1145.am/db/2308887/Mpm_Capital>,
        <https://1145.am/db/2309845/Mpm_Capital>,
        <https://1145.am/db/2311551/Mpm_Capital>,
        <https://1145.am/db/2312285/Mpm_Capital>,
        <https://1145.am/db/2312309/Mpm_Capital>,
        <https://1145.am/db/2316391/Mpm_Capital>,
        <https://1145.am/db/2323055/Mpm_Capital>,
        <https://1145.am/db/2323066/Mpm_Capital>,
        <https://1145.am/db/2323094/Mpm_Capital>,
        <https://1145.am/db/2323563/Mpm_Capital>,
        <https://1145.am/db/2323568/Mpm_Capital>,
        <https://1145.am/db/2324195/Mpm_Capital>,
        <https://1145.am/db/2324226/Mpm_Capital>,
        <https://1145.am/db/2328338/Mpm_Capital>,
        <https://1145.am/db/2333119/Mpm_Capital>,
        <https://1145.am/db/2333525/Mpm_Capital>,
        <https://1145.am/db/2335701/Mpm_Capital>,
        <https://1145.am/db/2335714/Mpm_Capital>,
        <https://1145.am/db/2337140/Mpm_Capital>,
        <https://1145.am/db/2340957/Mpm_Capital>,
        <https://1145.am/db/2345299/Mpm_Capital>,
        <https://1145.am/db/2345318/Mpm_Capital>,
        <https://1145.am/db/2346204/Mpm_Capital>,
        <https://1145.am/db/2347140/Mpm_Capital>,
        <https://1145.am/db/2347469/Mpm_Capital>,
        <https://1145.am/db/2347984/Mpm_Capital>,
        <https://1145.am/db/2348484/Mpm_Capital>,
        <https://1145.am/db/2352172/Mpm_Capital>,
        <https://1145.am/db/2352362/Mpm_Capital>,
        <https://1145.am/db/2352899/Mpm_Capital>,
        <https://1145.am/db/2353365/Mpm_Capital>,
        <https://1145.am/db/2353404/Mpm_Capital>,
        <https://1145.am/db/2353413/Mpm_Capital>,
        <https://1145.am/db/2353415/Mpm_Capital>,
        <https://1145.am/db/2356396/Mpm_Capital>,
        <https://1145.am/db/2358979/Mpm_Capital>,
        <https://1145.am/db/2359001/Mpm_Capital>,
        <https://1145.am/db/2359873/Mpm_Capital>,
        <https://1145.am/db/2359875/Mpm_Capital>,
        <https://1145.am/db/2360526/Mpm_Capital>,
        <https://1145.am/db/2362871/Mpm_Capital>,
        <https://1145.am/db/2364492/Mpm_Capital>,
        <https://1145.am/db/2365098/Mpm_Capital>,
        <https://1145.am/db/2366744/Mpm_Capital>,
        <https://1145.am/db/2367199/Mpm_Capital>,
        <https://1145.am/db/2369202/Mpm_Capital>,
        <https://1145.am/db/2370582/Mpm_Capital>,
        <https://1145.am/db/2541350/Mpm_Capital>,
        <https://1145.am/db/677075/Mpm_Capital>,
        <https://1145.am/db/678997/Mpm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350030/True_North_Therapeutics> a org:Organization ;
    ns1:description "drug development" ;
    ns1:documentDate "2013-09-04T11:47:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "$30 Million Secured in iPierian Financing and Series A Financing for Launch of Spin-out, True North Therapeutics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/30-million-secured-ipierian-financing-and-series-a-financing-for-launch-of-spin-out-true> ;
    ns1:foundName "True North Therapeutics" ;
    ns1:industry "pharma industry" ;
    ns1:name "True North Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1593051/Northsea_Therapeutics_Bv>,
        <https://1145.am/db/1593434/Northsea_Therapeutics_Bv>,
        <https://1145.am/db/2154415/Northsea_Therapeutics>,
        <https://1145.am/db/704198/Northsea_Therapeutics_Bv> ;
    ns1:sameAsMedium <https://1145.am/db/2292160/True_North_Therapeutics>,
        <https://1145.am/db/2298948/True_North_Therapeutics>,
        <https://1145.am/db/2345649/True_North_Therapeutics>,
        <https://1145.am/db/2345652/True_North_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351012/Rhenovia_Pharma> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:description "biosimulation of the central nervous system",
        "research and development of new medicinal products" ;
    ns1:documentDate "2014-02-12T12:24:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rhenovia Pharma secures Series B funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhenovia-pharma-secures-series-b-funding> ;
    ns1:foundName "Rhenovia",
        "Rhenovia Pharma" ;
    ns1:industry "biotechnology" ;
    ns1:name "Rhenovia",
        "Rhenovia Pharma" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351129/Alkermes_Plc> a org:Organization ;
    ns1:description "biopharmaceutical company" ;
    ns1:documentDate "2013-09-11T12:33:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Alkermes plc" ;
    ns1:industry "biopharmaceutical" ;
    ns1:investor <https://1145.am/db/2351129/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "Alkermes plc" ;
    ns1:sameAsHigh <https://1145.am/db/1354528/Alzheon_Inc>,
        <https://1145.am/db/1980328/Alphinity_Usa>,
        <https://1145.am/db/2302333/Alder_Biopharmaceuticals_Inc>,
        <https://1145.am/db/2323102/Alk-Abello>,
        <https://1145.am/db/2328312/Arpida>,
        <https://1145.am/db/2337285/Alder_Biopharmaceuticals_Inc>,
        <https://1145.am/db/2337638/Alkahest>,
        <https://1145.am/db/2344055/Alzheon>,
        <https://1145.am/db/2344056/Alzheon>,
        <https://1145.am/db/2357408/Alkermes_Plc>,
        <https://1145.am/db/2360266/Alkermes_Plc>,
        <https://1145.am/db/2368518/Alzheon>,
        <https://1145.am/db/2370086/Alzheon>,
        <https://1145.am/db/2370563/Albireo_Limited>,
        <https://1145.am/db/2542430/Alvogen>,
        <https://1145.am/db/2583466/Alkermes_Plc>,
        <https://1145.am/db/468193/Alzheon>,
        <https://1145.am/db/979483/Alzheon>,
        <https://1145.am/db/979486/Alzheon> ;
    ns1:sameAsMedium <https://1145.am/db/2036830/Alkermes>,
        <https://1145.am/db/2044268/Alkermes>,
        <https://1145.am/db/2053753/Alkermes>,
        <https://1145.am/db/2313926/Alkermes_Inc>,
        <https://1145.am/db/2314985/Alkermes_Inc>,
        <https://1145.am/db/2331000/Alkermes>,
        <https://1145.am/db/2331010/Alkermes>,
        <https://1145.am/db/2336475/Alkermes>,
        <https://1145.am/db/2337141/Alkermes_Plc>,
        <https://1145.am/db/2338420/Alkermes>,
        <https://1145.am/db/2338421/Alkermes>,
        <https://1145.am/db/2340188/Alkermes>,
        <https://1145.am/db/2340189/Alkermes>,
        <https://1145.am/db/2344809/Alkermes>,
        <https://1145.am/db/2347453/Alkermes_Plc>,
        <https://1145.am/db/2357312/Alkermes_Plc>,
        <https://1145.am/db/2359802/Alkermes>,
        <https://1145.am/db/2536596/Alkermes>,
        <https://1145.am/db/2536597/Alkermes>,
        <https://1145.am/db/2542518/Alkermes>,
        <https://1145.am/db/2545314/Alkermes>,
        <https://1145.am/db/2548137/Alkermes>,
        <https://1145.am/db/2571613/Alkermes>,
        <https://1145.am/db/2573130/Alkermes>,
        <https://1145.am/db/2587657/Alkermes>,
        <https://1145.am/db/2592186/Alkermes>,
        <https://1145.am/db/2596135/Alkermes> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351129/Canaan_Partners> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-09-11T12:33:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Canaan Partners" ;
    ns1:investor <https://1145.am/db/2351129/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "Canaan Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1043342/Canaan_Partners>,
        <https://1145.am/db/1427471/Potentum_Partners>,
        <https://1145.am/db/1695894/Canaan_Partners>,
        <https://1145.am/db/1697131/Canaan_Partners>,
        <https://1145.am/db/1724566/Canaan_Partners>,
        <https://1145.am/db/1735660/Forward_Partners>,
        <https://1145.am/db/1747333/Framework_Venture_Partners>,
        <https://1145.am/db/1770648/Canaan_Partners>,
        <https://1145.am/db/1776537/Partech_Partners>,
        <https://1145.am/db/1791628/Canaan_Partners>,
        <https://1145.am/db/1819543/Canaan_Partners>,
        <https://1145.am/db/1842466/Canaan_Partners>,
        <https://1145.am/db/1863401/Canaan_Partners>,
        <https://1145.am/db/1910644/Canaan_Partners>,
        <https://1145.am/db/2141055/Excell_Partners>,
        <https://1145.am/db/2297592/Canaan_Partners>,
        <https://1145.am/db/2301765/Canaan_Partners>,
        <https://1145.am/db/2309376/Canaan_Partners>,
        <https://1145.am/db/2309387/Canaan_Partners>,
        <https://1145.am/db/2355043/Canaan_Partners>,
        <https://1145.am/db/2355715/Canaan_Partners>,
        <https://1145.am/db/2363535/Canaan_Partners>,
        <https://1145.am/db/2366187/Canaan_Partners>,
        <https://1145.am/db/2370802/Canaan_Partners>,
        <https://1145.am/db/2370834/Canaan_Partners>,
        <https://1145.am/db/2583466/Canaan_Partners>,
        <https://1145.am/db/3043/Elsewhere_Partners>,
        <https://1145.am/db/645540/Envisioning_Partners>,
        <https://1145.am/db/935302/Framework_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/146274/Canaan_Partners>,
        <https://1145.am/db/1696766/Canaan_Partners>,
        <https://1145.am/db/1702857/Canaan_Partners>,
        <https://1145.am/db/1711633/Canaan_Partners>,
        <https://1145.am/db/1734259/Canaan_Partners>,
        <https://1145.am/db/1741014/Canaan_Partners>,
        <https://1145.am/db/1741105/Canaan_Partners>,
        <https://1145.am/db/1741424/Canaan_Partners>,
        <https://1145.am/db/1749744/Canaan_Partners>,
        <https://1145.am/db/1754820/Canaan_Partners>,
        <https://1145.am/db/1768400/Canaan_Partners>,
        <https://1145.am/db/1792426/Canaan_Partners>,
        <https://1145.am/db/1793543/Canaan_Partners>,
        <https://1145.am/db/1796375/Canaan_Partners>,
        <https://1145.am/db/1814413/Canaan_Partners>,
        <https://1145.am/db/1827240/Canaan_Partners>,
        <https://1145.am/db/1829078/Canaan_Partners>,
        <https://1145.am/db/1829544/Canaan_Partners>,
        <https://1145.am/db/1836578/Canaan_Partners>,
        <https://1145.am/db/1845119/Canaan_Partners>,
        <https://1145.am/db/1852066/Canaan_Partners>,
        <https://1145.am/db/1858762/Canaan_Partners>,
        <https://1145.am/db/1866968/Canaan_Partners>,
        <https://1145.am/db/1894670/Canaan_Partners>,
        <https://1145.am/db/1897255/Canaan_Partners>,
        <https://1145.am/db/1900458/Canaan_Partners>,
        <https://1145.am/db/1906336/Canaan_Partners>,
        <https://1145.am/db/1907151/Canaan_Partners>,
        <https://1145.am/db/1907762/Canaan_Partners>,
        <https://1145.am/db/1919135/Canaan_Partners>,
        <https://1145.am/db/1920478/Canaan_Partners>,
        <https://1145.am/db/2164798/Canaan_Partners>,
        <https://1145.am/db/2164838/Canaan_Partners>,
        <https://1145.am/db/2210939/Canaan_Partners>,
        <https://1145.am/db/2238667/Canaan_Partners>,
        <https://1145.am/db/2287025/Canaan_Partners>,
        <https://1145.am/db/2287777/Canaan_Partners>,
        <https://1145.am/db/2298642/Canaan_Partners>,
        <https://1145.am/db/2304587/Canaan_Partners>,
        <https://1145.am/db/2304605/Canaan_Partners>,
        <https://1145.am/db/2306281/Canaan_Partners>,
        <https://1145.am/db/2308329/Canaan_Partners>,
        <https://1145.am/db/2313171/Canaan_Partners>,
        <https://1145.am/db/2320925/Canaan_Partners>,
        <https://1145.am/db/2322231/Canaan_Partners>,
        <https://1145.am/db/2329010/Canaan_Partners>,
        <https://1145.am/db/2329011/Canaan_Partners>,
        <https://1145.am/db/2329531/Canaan_Partners>,
        <https://1145.am/db/2332322/Canaan_Partners>,
        <https://1145.am/db/2337958/Canaan_Partners>,
        <https://1145.am/db/2337974/Canaan_Partners>,
        <https://1145.am/db/2346532/Canaan_Partners>,
        <https://1145.am/db/2347469/Canaan_Partners>,
        <https://1145.am/db/2351316/Canaan_Partners>,
        <https://1145.am/db/2351684/Canaan_Partners>,
        <https://1145.am/db/2353588/Canaan_Partners>,
        <https://1145.am/db/2353608/Canaan_Partners>,
        <https://1145.am/db/2355238/Canaan_Partners>,
        <https://1145.am/db/2358378/Canaan_Partners>,
        <https://1145.am/db/2359185/Canaan_Partners>,
        <https://1145.am/db/2360258/Canaan_Partners>,
        <https://1145.am/db/2360266/Canaan_Partners>,
        <https://1145.am/db/2360647/Canaan_Partners>,
        <https://1145.am/db/2365700/Canaan_Partners>,
        <https://1145.am/db/2366753/Canaan_Partners>,
        <https://1145.am/db/2368322/Canaan_Partners>,
        <https://1145.am/db/2368973/Canaan_Partners>,
        <https://1145.am/db/2368982/Canaan_Partners>,
        <https://1145.am/db/2370582/Canaan_Partners>,
        <https://1145.am/db/2572398/Canaan_Partners>,
        <https://1145.am/db/2635439/Canaan_Partners>,
        <https://1145.am/db/316299/Canaan_Partners>,
        <https://1145.am/db/319155/Canaan_Partners>,
        <https://1145.am/db/353476/Canaan_Partners>,
        <https://1145.am/db/411041/Canaan_Partners>,
        <https://1145.am/db/523179/Canaan_Partners>,
        <https://1145.am/db/564082/Canaan_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351129/Fountain_Healthcare_Partners> a org:Organization ;
    ns1:description "healthcare" ;
    ns1:documentDate "2013-09-11T12:33:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Fountain Healthcare Partners" ;
    ns1:investor <https://1145.am/db/2351129/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "Fountain Healthcare Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2288529/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2298125/Fountain_Healthcare>,
        <https://1145.am/db/2299803/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2330711/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2330799/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2352204/Fountain_Healthcare_Partners>,
        <https://1145.am/db/236357/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2583466/Fountain_Healthcare_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1061564/Fountain_Healthcare_Partners>,
        <https://1145.am/db/1173939/Fountain_Healthcare_Partners>,
        <https://1145.am/db/1219334/Fountain_Healthcare_Partners>,
        <https://1145.am/db/1219771/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2152706/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2228342/Fountain_Healthcare_Partners_I>,
        <https://1145.am/db/2288332/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2291023/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2294585/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2296850/Fountain_Healthcare>,
        <https://1145.am/db/2327485/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2327490/Fountain_Healthcare_Partners_I>,
        <https://1145.am/db/2331750/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2352203/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2352216/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2358172/Fountain_Healthcare_Partners_Ii>,
        <https://1145.am/db/2360266/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2569220/Fountain_Healthcare_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351129/Longitude_Capital> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-09-11T12:33:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Longitude Capital" ;
    ns1:investor <https://1145.am/db/2351129/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "Longitude Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1503165/Longitude_Capital>,
        <https://1145.am/db/1519688/Longitude_Capital>,
        <https://1145.am/db/1520070/Longitude_Capital>,
        <https://1145.am/db/2288251/Longitude_Capital>,
        <https://1145.am/db/2305615/Longitude_Venture_Partners>,
        <https://1145.am/db/2305625/Longitude_Venture_Partners>,
        <https://1145.am/db/2323797/Longitude_Venture_Partners_Iii>,
        <https://1145.am/db/2339214/Longitude_Capital>,
        <https://1145.am/db/2339223/Longitude_Capital>,
        <https://1145.am/db/2352170/Longitude_Capital>,
        <https://1145.am/db/2365501/Longitude_Capital>,
        <https://1145.am/db/2583466/Longitude_Capital>,
        <https://1145.am/db/955355/Longitude_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1467975/Longitude_Capital>,
        <https://1145.am/db/1482048/Longitude_Capital>,
        <https://1145.am/db/2075754/Longitude_Capital>,
        <https://1145.am/db/2152399/Longitude_Capital>,
        <https://1145.am/db/2155668/Longitude_Capital>,
        <https://1145.am/db/2182698/Longitude_Capital>,
        <https://1145.am/db/2198647/Longitude_Capital>,
        <https://1145.am/db/2290453/Longitude_Capital>,
        <https://1145.am/db/2297930/Longitude_Capital>,
        <https://1145.am/db/2298634/Longitude_Capital>,
        <https://1145.am/db/2300708/Longitude_Capital>,
        <https://1145.am/db/2330799/Longitude_Capital>,
        <https://1145.am/db/2337591/Longitude_Capital>,
        <https://1145.am/db/2338428/Longitude_Capital>,
        <https://1145.am/db/2340204/Longitude_Capital>,
        <https://1145.am/db/2340207/Longitude_Capital>,
        <https://1145.am/db/2352167/Longitude_Capital>,
        <https://1145.am/db/2366753/Longitude_Capital>,
        <https://1145.am/db/2368232/Longitude_Capital>,
        <https://1145.am/db/2369359/Longitude_Capital>,
        <https://1145.am/db/2564563/Longitude_Capital>,
        <https://1145.am/db/958767/Longitude_Capital>,
        <https://1145.am/db/959519/Longitude_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351129/Ra_Capital> a org:Organization ;
    ns1:description "public investment fund" ;
    ns1:documentDate "2013-09-11T12:33:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "RA Capital" ;
    ns1:investor <https://1145.am/db/2351129/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "RA Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1164709/Ra_Capital_Management>,
        <https://1145.am/db/1166452/Ra_Capital_Management>,
        <https://1145.am/db/1219334/Ra_Capital_Management>,
        <https://1145.am/db/1219771/Ra_Capital_Management>,
        <https://1145.am/db/1503165/Ra_Capital_Management>,
        <https://1145.am/db/1926411/Ra_Capital_Management>,
        <https://1145.am/db/1928388/Ra_Capital_Management>,
        <https://1145.am/db/2011094/Ra_Capital_Management>,
        <https://1145.am/db/2075754/Ra_Capital_Management>,
        <https://1145.am/db/2089412/Ra_Capital_Management>,
        <https://1145.am/db/2109798/Ra_Capital_Management>,
        <https://1145.am/db/2286204/Ra_Capital_Management>,
        <https://1145.am/db/413303/Radian_Capital>,
        <https://1145.am/db/441151/Ra_Capital_Management>,
        <https://1145.am/db/509733/Ra_Capital_Management>,
        <https://1145.am/db/572554/Ra_Capital_Management>,
        <https://1145.am/db/820519/Ra_Capital_Management_Lp>,
        <https://1145.am/db/828843/Radian_Capital_Partners>,
        <https://1145.am/db/922552/Ra_Capital_Management>,
        <https://1145.am/db/979509/Ra_Capital_Management> ;
    ns1:sameAsMedium <https://1145.am/db/1340338/Ra_Capital>,
        <https://1145.am/db/2182698/Ra_Capital>,
        <https://1145.am/db/2280061/Ra_Capital>,
        <https://1145.am/db/2285938/Ra_Capital>,
        <https://1145.am/db/2292800/Ra_Capital>,
        <https://1145.am/db/2336126/Ra_Capital>,
        <https://1145.am/db/2349437/Ra_Capital>,
        <https://1145.am/db/2354376/Ra_Capital>,
        <https://1145.am/db/2355183/Ra_Capital>,
        <https://1145.am/db/2361416/Ra_Capital>,
        <https://1145.am/db/2369967/Ra_Capital>,
        <https://1145.am/db/2583466/Ra_Capital>,
        <https://1145.am/db/968301/Ra_Capital>,
        <https://1145.am/db/972968/Ra_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352142/Egalet_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "Malvern" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5199600/about.rdf> ;
    ns1:basedInHighRaw "MALVERN, Pa." ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "pharmaceutical company" ;
    ns1:documentDate "2013-09-13T13:54:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Egalet Announces Financing to Fund Abuse-Deterrent Medications" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/egalet-announces-financing-to-fund-abuse-deterrent-medications> ;
    ns1:foundName "Egalet",
        "Egalet Ltd." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Egalet",
        "Egalet Ltd." ;
    ns1:sameAsHigh <https://1145.am/db/2305958/Esprit>,
        <https://1145.am/db/2309847/Egalet>,
        <https://1145.am/db/2333601/Egalet>,
        <https://1145.am/db/2347136/Egalet_Corporation>,
        <https://1145.am/db/2355608/Egalet>,
        <https://1145.am/db/2355609/Egalet_Ltd>,
        <https://1145.am/db/2356308/Egalet_Ltd>,
        <https://1145.am/db/2368009/Egalet_Corporation>,
        <https://1145.am/db/2371064/Egalet>,
        <https://1145.am/db/2558566/Egalet> ;
    ns1:sameAsMedium <https://1145.am/db/2309840/Egalet>,
        <https://1145.am/db/2349969/Egalet_Corporation>,
        <https://1145.am/db/2355984/Egalet> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352142/Investment_Egalet_Ltd_Index_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-13T13:54:40+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Egalet has received $ 10 million initially, with an option for an additional $ 10 million investment under pre-specified conditions.",
        "MALVERN, Pa., Sept. 12, 2013 /PRNewswire/ - Egalet Ltd., a specialty pharmaceutical company developing and planning to commercialize abuse-deterrent oral products for the treatment of pain and other indications, announced today that it has closed a financing of up to $ 20 million led by Index Ventures with participation from other existing investors." ;
    ns1:documentTitle "Egalet Announces Financing to Fund Abuse-Deterrent Medications" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/egalet-announces-financing-to-fund-abuse-deterrent-medications> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2352142/Egalet_Ltd> ;
    ns1:valueRaw "$ 10 million",
        "up to $ 20 million" ;
    ns1:when "2013-09-12T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Sept. 12, 2013" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2353123/Andromeda_Biotech_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "Yavn" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/293222/about.rdf> ;
    ns1:basedInHighRaw "YAVNE, Israel" ;
    ns1:buyer <https://1145.am/db/2353123/Diapep277_Rights_Rights_Acquisition> ;
    ns1:description "pharmaceutical" ;
    ns1:documentDate "2014-02-26T12:07:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Andromeda Acquires DiaPep277 Rights From Teva" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/andromeda-acquires-diapep277-rights-from-teva> ;
    ns1:foundName "Andromeda",
        "Andromeda Biotech Ltd.",
        "Teva" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Andromeda",
        "Andromeda Biotech Ltd." ;
    ns1:sameAsHigh <https://1145.am/db/2335775/Andromeda_Biotech_Ltd>,
        <https://1145.am/db/2335777/Andromeda>,
        <https://1145.am/db/2336157/Andromeda_Biotech_Ltd>,
        <https://1145.am/db/2364463/Andromeda_Biotech_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/2353121/Andromeda_Biotech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353123/Diapep277> a org:Organization ;
    ns1:description "Type 1 Diabetes" ;
    ns1:documentDate "2014-02-26T12:07:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Andromeda Acquires DiaPep277 Rights From Teva" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/andromeda-acquires-diapep277-rights-from-teva> ;
    ns1:foundName "DiaPep277",
        "DiaPep277 (R)" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "DiaPep277" ;
    ns1:sameAsHigh <https://1145.am/db/2353121/Diapep277> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353123/Diapep277_Rights_Rights_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2014-02-26T12:07:26+00:00"^^xsd:dateTime ;
    ns1:documentExtract "According to the Agreement, Teva shall transfer its rights in DiaPep277 (R) and all of its shares in Andromeda to Andromeda, for total consideration of approximately $ 72 million, payable in installments through future payments based on Andromeda's revenues or on proceeds payable to its shareholders.",
        "Andromeda Acquires DiaPep277 Rights From Teva.",
        "YAVNE, Israel, Feb 24, 2014 (GLOBE NEWSWIRE via COMTEX) - Andromeda Biotech Ltd. announces that it entered into an agreement with Teva Pharmaceutical Industries Ltd. for the acquisition of Teva's rights for Andromeda's drug, DiaPep277, for the treatment of Type 1 Diabetes." ;
    ns1:documentTitle "Andromeda Acquires DiaPep277 Rights From Teva" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/andromeda-acquires-diapep277-rights-from-teva> ;
    ns1:foundName "Acquires",
        "acquisition",
        "transfer" ;
    ns1:name "Acquires",
        "acquisition",
        "transfer" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2353123/Diapep277> ;
    ns1:targetDetails "Rights",
        "rights" ;
    ns1:targetName "DiaPep277" ;
    ns1:valueRaw "approximately $ 72 million" ;
    ns1:vendor <https://1145.am/db/2353123/Andromeda_Biotech_Ltd> ;
    ns1:whereGeoName "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Israel" .

<https://1145.am/db/2356283/Investment_Lensar_Inc_Pdl_Biopharma_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-02T15:46:04+00:00"^^xsd:dateTime ;
    ns1:documentExtract "INCLINE VILLAGE, Nev., Oct. 2, 2013 /PRNewswire via COMTEX/ - PDL BioPharma, Inc. (PDL) PDLI -0.99 % announced today that it closed a financing transaction with LENSAR, Inc., a leader in next-generation femtosecond laser technology for refractive cataract surgery, in which PDL will provide LENSAR with up to $ 60 million of debt financing, as part of an $ 87 million total financing for LENSAR.",
        "PDL BioPharma Provides $ 60 Million in Financing to LENSAR." ;
    ns1:documentTitle "PDL BioPharma Provides $60 Million in Financing to LENSAR" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pdl-biopharma-provides-60-million-financing-to-lensar> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2356283/Lensar_Inc> ;
    ns1:targetName "LENSAR, Inc." ;
    ns1:valueRaw "$ 60 Million",
        "$ 60 million",
        "$ 87 million" ;
    ns1:when "2013-10-02T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct. 2, 2013" ;
    ns1:whereGeoName "Incline Village",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5505963/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "INCLINE VILLAGE, Nev.",
        "United States" .

<https://1145.am/db/2356290/Merus_Bv> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of the Netherlands" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2750405/about.rdf> ;
    ns1:basedInHighRaw "The Netherlands" ;
    ns1:description "Biopharmaceutical",
        "Johnson & Johnson Development Corporation joins as new investor; receives board seat." ;
    ns1:documentDate "2013-10-03T11:35:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merus Secures 31 Million in Series B Round Extension" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merus-secures-%E2%82%AC31-million-series-b-round-extension> ;
    ns1:foundName "Merus",
        "Merus B.V." ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Merus",
        "Merus B.V." ;
    ns1:sameAsHigh <https://1145.am/db/2356383/Merus_Bv> ;
    ns1:sameAsMedium <https://1145.am/db/2288836/Merus>,
        <https://1145.am/db/2311570/Merus>,
        <https://1145.am/db/2311571/Merus>,
        <https://1145.am/db/2323795/Merus>,
        <https://1145.am/db/2356287/Merus>,
        <https://1145.am/db/598100/Merus>,
        <https://1145.am/db/599002/Merus_Nv>,
        <https://1145.am/db/784717/Merus_Nv> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357260/Inotrem> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:description "biotech" ;
    ns1:documentDate "2014-03-13T21:44:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "With $25M in the bank, French startup sets its sights on sepsis" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/25m-bank-french-startup-sets-its-sights-on-sepsis> ;
    ns1:foundName "Inotrem" ;
    ns1:industry "biotech" ;
    ns1:name "Inotrem" ;
    ns1:sameAsHigh <https://1145.am/db/1422234/Inversago>,
        <https://1145.am/db/1422725/Inversago>,
        <https://1145.am/db/1441535/Micreos>,
        <https://1145.am/db/1626385/Inotrem>,
        <https://1145.am/db/1627827/Inotrem>,
        <https://1145.am/db/1629754/Aivita_Biomedical>,
        <https://1145.am/db/1629918/Novotech>,
        <https://1145.am/db/1634976/Biontech>,
        <https://1145.am/db/1696213/23andme_Inc>,
        <https://1145.am/db/1696213/Genentech>,
        <https://1145.am/db/1696383/Instadeep>,
        <https://1145.am/db/1697281/Instadeep>,
        <https://1145.am/db/1950266/Concentra_Biosciences>,
        <https://1145.am/db/2049549/Biogen>,
        <https://1145.am/db/2079910/Sk_Bioscience>,
        <https://1145.am/db/2152261/Inventiva>,
        <https://1145.am/db/2153375/Imara>,
        <https://1145.am/db/2154521/Baergic_Bio>,
        <https://1145.am/db/2154835/Insitro>,
        <https://1145.am/db/2154913/Idorsia>,
        <https://1145.am/db/2156117/Themis>,
        <https://1145.am/db/2156304/Puretech>,
        <https://1145.am/db/2279108/Anaveon>,
        <https://1145.am/db/2279310/Senda_Biosciences>,
        <https://1145.am/db/2279595/Erytech>,
        <https://1145.am/db/2279911/Genetx>,
        <https://1145.am/db/2280734/Forte_Biosciences>,
        <https://1145.am/db/2282558/Vedanta_Biosciences>,
        <https://1145.am/db/2285390/Cellarity>,
        <https://1145.am/db/2286040/Inotrem>,
        <https://1145.am/db/2290381/Life_Sciences>,
        <https://1145.am/db/2290974/Inscripta>,
        <https://1145.am/db/2292367/Acorda>,
        <https://1145.am/db/2293654/Eleven_Bio>,
        <https://1145.am/db/2297083/Biogen_Idec>,
        <https://1145.am/db/2297963/Biogen>,
        <https://1145.am/db/2300483/Caladrius_Biosciences>,
        <https://1145.am/db/2300532/Inscripta>,
        <https://1145.am/db/2301170/Ablynx>,
        <https://1145.am/db/2301983/Biogen_Idec>,
        <https://1145.am/db/2302002/Biogen_Idec>,
        <https://1145.am/db/2304208/Pra_Health_Sciences>,
        <https://1145.am/db/2308022/Cogenesys>,
        <https://1145.am/db/2313760/Sistemic_Ltd>,
        <https://1145.am/db/2315615/Anormed>,
        <https://1145.am/db/2320138/Biogen_Idec>,
        <https://1145.am/db/2320754/Ily101>,
        <https://1145.am/db/2322693/Selecta_Biosciences>,
        <https://1145.am/db/2325718/Biogen>,
        <https://1145.am/db/2326588/Gpc_Biotech>,
        <https://1145.am/db/2331994/3sbio>,
        <https://1145.am/db/2332003/Neose>,
        <https://1145.am/db/2332883/Gpc_Biotech>,
        <https://1145.am/db/2335908/Athera_Biotechnologies>,
        <https://1145.am/db/2336383/Biocrates_Life_Sciences_Ag>,
        <https://1145.am/db/2339734/Selecta_Biosciences>,
        <https://1145.am/db/2341010/GTC>,
        <https://1145.am/db/2342629/Imago_Biosciences>,
        <https://1145.am/db/2346300/Myr>,
        <https://1145.am/db/2351883/Immatics>,
        <https://1145.am/db/2355236/Stellar_Biotechnologies_Inc>,
        <https://1145.am/db/2355423/Biontech>,
        <https://1145.am/db/2357252/Inotrem_Sa>,
        <https://1145.am/db/2359440/Immatics>,
        <https://1145.am/db/2359756/Acorda>,
        <https://1145.am/db/2359865/Igenica>,
        <https://1145.am/db/2360127/Biomedinvest>,
        <https://1145.am/db/2361416/Intarcia>,
        <https://1145.am/db/2362543/Micurx>,
        <https://1145.am/db/2363275/Immatics>,
        <https://1145.am/db/2366365/Insmed>,
        <https://1145.am/db/2367816/Conkwest>,
        <https://1145.am/db/2369363/Volution>,
        <https://1145.am/db/2370223/Ignyta>,
        <https://1145.am/db/2370753/Vedanta_Biosciences>,
        <https://1145.am/db/2370806/Alvotech>,
        <https://1145.am/db/2538176/Matritech>,
        <https://1145.am/db/2542993/Biogen_Idec>,
        <https://1145.am/db/2546456/3sbio>,
        <https://1145.am/db/2550495/Bioatla>,
        <https://1145.am/db/2554066/Erytech>,
        <https://1145.am/db/2562086/Immatics>,
        <https://1145.am/db/2562577/Biogen>,
        <https://1145.am/db/2718306/Senda_Biosciences>,
        <https://1145.am/db/2795044/Inotrem>,
        <https://1145.am/db/539018/Interna_Technologies>,
        <https://1145.am/db/540784/Coherus_Biosciences_Inc>,
        <https://1145.am/db/602287/Inotrem>,
        <https://1145.am/db/661747/Aanika_Biosciences>,
        <https://1145.am/db/663618/Aanika_Biosciences>,
        <https://1145.am/db/74943/Imago_Biosciences>,
        <https://1145.am/db/767994/Biotech_Prokidney_Lp>,
        <https://1145.am/db/940935/Mabxience> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357260/Investment_Inotrem_Inserm_Transfert_Initiative_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-03-13T21:44:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "France's Inotrem is working up a novel approach to the global scourge of sepsis, and now, thanks to some high-profile investors, the biotech has $ 25 million to take its immunotherapy from the benchtop to the clinic." ;
    ns1:documentTitle "With $25M in the bank, French startup sets its sights on sepsis" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/25m-bank-french-startup-sets-its-sights-on-sepsis> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2357260/Inotrem> ;
    ns1:valueRaw "$ 25 million" ;
    ns1:whereGeoName "Republic of France" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:whereRaw "France" .

<https://1145.am/db/2358297/Gamida_Cell> a org:Organization ;
    ns1:basedInHighGeoName "State of Israel" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:basedInHighRaw "Israel" ;
    ns1:description "stem cell biotech" ;
    ns1:documentDate "2014-03-18T12:36:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: Novartis circles a deal to buy Gamida Cell in $600M deal" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/report-novartis-circles-a-deal-to-buy-gamida-cell-600m-deal> ;
    ns1:foundName "Gamida Cell" ;
    ns1:industry "stem cell biotech" ;
    ns1:name "Gamida Cell" ;
    ns1:sameAsHigh <https://1145.am/db/2290821/Gamida_Cell>,
        <https://1145.am/db/2297561/Gamida_Cell>,
        <https://1145.am/db/2336028/Gamida_Cell>,
        <https://1145.am/db/2359165/Gamida_Cell>,
        <https://1145.am/db/2359178/Gamida_Cell>,
        <https://1145.am/db/2359179/Gamida_Cell>,
        <https://1145.am/db/2371070/Gamida_Cell>,
        <https://1145.am/db/2371188/Gamida_Cell>,
        <https://1145.am/db/2577349/Gamida_Cell>,
        <https://1145.am/db/795785/Gamida_Cell_Ltd>,
        <https://1145.am/db/798062/Gamida_Cell_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/1126294/Gamida_Cell_Ltd>,
        <https://1145.am/db/1126812/Gamida_Cell_Ltd>,
        <https://1145.am/db/116908/Gamida_Cell_Ltd>,
        <https://1145.am/db/1351502/Gamida_Cell_Ltd>,
        <https://1145.am/db/1352315/Gamida_Cell_Ltd>,
        <https://1145.am/db/1374001/Gamida_Cell>,
        <https://1145.am/db/1374011/Gamida_Cell_Ltd>,
        <https://1145.am/db/1378888/Gamida_Cell>,
        <https://1145.am/db/1571043/Gamida_Cell_Ltd>,
        <https://1145.am/db/1571252/Gamida_Cell>,
        <https://1145.am/db/174550/Gamida_Cell>,
        <https://1145.am/db/176569/Gamida_Cell>,
        <https://1145.am/db/180537/Gamida_Cell_Ltd>,
        <https://1145.am/db/1973867/Gamida_Cell>,
        <https://1145.am/db/2290005/Gamida_Cell>,
        <https://1145.am/db/2358559/Gamida_Cell>,
        <https://1145.am/db/2358579/Gamida_Cell>,
        <https://1145.am/db/236253/Gamida_Cell_Ltd>,
        <https://1145.am/db/2371077/Gamida_Cell>,
        <https://1145.am/db/2371203/Gamida_Cell> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359433/Vet_Therapeutics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "San Diego" ;
    ns1:description "Biologics",
        "a San Diego - based company with a proprietary antibody - based biologic" ;
    ns1:documentDate "2013-10-14T15:57:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aratana Agrees to Acquire Vet Therapeutics, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-agrees-to-acquire-vet-therapeutics-inc> ;
    ns1:foundName "Vet Therapeutics, Inc",
        "Vet Therapeutics, Inc." ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Vet Therapeutics",
        "Vet Therapeutics, Inc" ;
    ns1:sameAsHigh <https://1145.am/db/2570023/Huvepharma> ;
    ns1:sameAsMedium <https://1145.am/db/2342733/Vet_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359433/Vet_Therapeutics_Inc_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2013-10-14T15:57:12+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aratana Agrees to Acquire Vet Therapeutics, Inc.",
        "KANSAS CITY, Kan. and BOSTON, Oct. 14, 2013 /PRNewswire via COMTEX/ - Aratana Therapeutics, Inc. PETX +9.20 %, a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets (pet therapeutics) , today announced that it has entered into a merger agreement providing for the strategic acquisition of Vet Therapeutics, Inc., a San Diego - based company with a proprietary antibody - based biologics platform." ;
    ns1:documentTitle "Aratana Agrees to Acquire Vet Therapeutics, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aratana-agrees-to-acquire-vet-therapeutics-inc> ;
    ns1:foundName "Acquire",
        "acquisition" ;
    ns1:name "Acquire",
        "acquisition" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2359433/Vet_Therapeutics_Inc> ;
    ns1:targetName "Vet Therapeutics",
        "Vet Therapeutics, Inc" ;
    ns1:whereGeoName "San Diego County",
        "Time" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3134627/about.rdf>,
        <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "Eastern Time",
        "San Diego" .

<https://1145.am/db/2359468/Aisling_Capital> a org:Organization ;
    ns1:basedInLowRaw "Ireland" ;
    ns1:description "financing" ;
    ns1:documentDate "2013-10-17T14:32:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Seragon Pharmaceuticals Raises $30M in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/seragon-pharmaceuticals-raises-30m-series-a-financing> ;
    ns1:foundName "Aisling Capital" ;
    ns1:investor <https://1145.am/db/2359468/Series_A_Investment_Aisling_Capital_Orbimed_Advisors_Seragon_Pharmaceuticals_Inc_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "Aisling Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2280707/Aisling_Capital>,
        <https://1145.am/db/2310940/Aisling_Capital>,
        <https://1145.am/db/2324255/Aisling_Capital>,
        <https://1145.am/db/2337250/Aisling_Capital>,
        <https://1145.am/db/2346293/Aisling_Capital>,
        <https://1145.am/db/2356297/Aisling_Capital>,
        <https://1145.am/db/2539913/Aisling_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1334160/Aisling_Capital>,
        <https://1145.am/db/1334934/Aisling_Capital>,
        <https://1145.am/db/1665536/Aisling_Capital>,
        <https://1145.am/db/2291277/Aisling_Capital>,
        <https://1145.am/db/2292103/Aisling_Capital>,
        <https://1145.am/db/2292800/Aisling_Capital>,
        <https://1145.am/db/2294156/Aisling_Capital>,
        <https://1145.am/db/2297408/Aisling_Capital>,
        <https://1145.am/db/2307476/Aisling_Capital>,
        <https://1145.am/db/2317775/Aisling_Capital>,
        <https://1145.am/db/2319433/Aisling_Capital>,
        <https://1145.am/db/2320852/Aisling_Capital>,
        <https://1145.am/db/2320853/Aisling_Capital>,
        <https://1145.am/db/2324244/Aisling_Capital>,
        <https://1145.am/db/2325553/Aisling_Capital>,
        <https://1145.am/db/2326576/Aisling_Capital>,
        <https://1145.am/db/2328388/Aisling_Capital>,
        <https://1145.am/db/2332753/Aisling_Capital>,
        <https://1145.am/db/2336503/Aisling_Capital>,
        <https://1145.am/db/2336505/Aisling_Capital>,
        <https://1145.am/db/2336524/Aisling_Capital>,
        <https://1145.am/db/2337254/Aisling_Capital>,
        <https://1145.am/db/2339214/Aisling_Capital>,
        <https://1145.am/db/2339223/Aisling_Capital>,
        <https://1145.am/db/2341595/Aisling_Capital>,
        <https://1145.am/db/2341599/Aisling_Capital>,
        <https://1145.am/db/2344735/Aisling_Capital>,
        <https://1145.am/db/2344739/Aisling_Capital>,
        <https://1145.am/db/2344874/Aisling_Capital>,
        <https://1145.am/db/2346030/Aisling_Capital>,
        <https://1145.am/db/2348754/Aisling_Capital>,
        <https://1145.am/db/2352059/Aisling_Capital>,
        <https://1145.am/db/2352167/Aisling_Capital>,
        <https://1145.am/db/2352170/Aisling_Capital>,
        <https://1145.am/db/2357356/Aisling_Capital>,
        <https://1145.am/db/2359185/Aisling_Capital>,
        <https://1145.am/db/2362736/Aisling_Capital>,
        <https://1145.am/db/2362737/Aisling_Capital>,
        <https://1145.am/db/2367022/Aisling_Capital>,
        <https://1145.am/db/2367023/Aisling_Capital>,
        <https://1145.am/db/2369304/Aisling_Capital>,
        <https://1145.am/db/2369305/Aisling_Capital>,
        <https://1145.am/db/2583013/Aisling_Capital>,
        <https://1145.am/db/2588372/Aisling_Capital>,
        <https://1145.am/db/2591606/Aisling_Capital>,
        <https://1145.am/db/802321/Aisling_Capital>,
        <https://1145.am/db/803398/Aisling_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359468/Orbimed_Advisors> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2013-10-17T14:32:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Seragon Pharmaceuticals Raises $30M in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/seragon-pharmaceuticals-raises-30m-series-a-financing> ;
    ns1:foundName "OrbiMed Advisors" ;
    ns1:investor <https://1145.am/db/2359468/Series_A_Investment_Aisling_Capital_Orbimed_Advisors_Seragon_Pharmaceuticals_Inc_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "OrbiMed Advisors" ;
    ns1:sameAsHigh <https://1145.am/db/1426073/Orbimed>,
        <https://1145.am/db/1426943/Orbimed>,
        <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2080575/Orbimed>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2350720/Orbimed>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2356420/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/770684/Orbimed>,
        <https://1145.am/db/791742/Orbimed> ;
    ns1:sameAsMedium <https://1145.am/db/1665536/Orbimed_Advisors>,
        <https://1145.am/db/2198816/Orbimed_Advisors>,
        <https://1145.am/db/2245885/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2284506/Orbimed_Advisors>,
        <https://1145.am/db/2289056/Orbimed_Advisors>,
        <https://1145.am/db/2290078/Orbimed_Advisors>,
        <https://1145.am/db/2290200/Orbimed_Advisors>,
        <https://1145.am/db/2290444/Orbimed_Advisors>,
        <https://1145.am/db/2297604/Orbimed_Advisors>,
        <https://1145.am/db/2298956/Orbimed_Advisors>,
        <https://1145.am/db/2304242/Orbimed_Advisors>,
        <https://1145.am/db/2305656/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306251/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306705/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2309491/Orbimed_Advisors>,
        <https://1145.am/db/2310922/Orbimed_Advisors>,
        <https://1145.am/db/2312233/Orbimed_Advisors>,
        <https://1145.am/db/2317918/Orbimed_Advisors>,
        <https://1145.am/db/2318133/Orbimed_Advisors>,
        <https://1145.am/db/2318829/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2318832/Orbimed_Advisers>,
        <https://1145.am/db/2318851/Orbimed_Advisors>,
        <https://1145.am/db/2319338/Orbimed_Advisors>,
        <https://1145.am/db/2320914/Orbimed_Advisors>,
        <https://1145.am/db/2322345/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2324226/Orbimed_Advisors>,
        <https://1145.am/db/2325880/Orbimed_Advisors>,
        <https://1145.am/db/2328599/Orbimed_Advisors>,
        <https://1145.am/db/2328700/Orbimed_Advisors>,
        <https://1145.am/db/2329260/Orbimed_Advisors>,
        <https://1145.am/db/2330799/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2330920/Orbimed_Advisors>,
        <https://1145.am/db/2332120/Orbimed_Advisors>,
        <https://1145.am/db/2333495/Orbimed_Advisors>,
        <https://1145.am/db/2333504/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2333966/Orbimed_Advisors>,
        <https://1145.am/db/2335743/Orbimed_Advisors>,
        <https://1145.am/db/2336221/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2336503/Orbimed_Advisors>,
        <https://1145.am/db/2336505/Orbimed_Advisors>,
        <https://1145.am/db/2336524/Orbimed_Advisors>,
        <https://1145.am/db/2337166/Orbimed_Advisors>,
        <https://1145.am/db/2337250/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2337254/Orbimed_Advisors>,
        <https://1145.am/db/2339885/Orbimed_Advisors>,
        <https://1145.am/db/2339886/Orbimed_Advisors>,
        <https://1145.am/db/2342862/Orbimed_Advisors>,
        <https://1145.am/db/2342925/Orbimed_Advisors>,
        <https://1145.am/db/2342937/Orbimed_Advisors>,
        <https://1145.am/db/2343244/Orbimed_Advisors>,
        <https://1145.am/db/2344735/Orbimed_Advisors>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2345435/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345453/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345456/Orbimed_Advisors>,
        <https://1145.am/db/2346030/Orbimed_Advisors>,
        <https://1145.am/db/2350034/Orbimed_Advisors>,
        <https://1145.am/db/2350044/Orbimed_Advisors>,
        <https://1145.am/db/2352436/Orbimed_Advisors>,
        <https://1145.am/db/2352441/Orbimed_Advisors>,
        <https://1145.am/db/2352442/Orbimed_Advisors>,
        <https://1145.am/db/2352701/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2352804/Orbimed_Advisors>,
        <https://1145.am/db/2355034/Orbimed_Advisors>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2357253/Orbimed_Advisors>,
        <https://1145.am/db/2357256/Orbimed_Advisors>,
        <https://1145.am/db/2357858/Orbimed_Advisors>,
        <https://1145.am/db/2359125/Orbimed_Advisors>,
        <https://1145.am/db/2359864/Orbimed_Advisors>,
        <https://1145.am/db/2360174/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2361018/Orbimed_Advisors>,
        <https://1145.am/db/2361022/Orbimed_Advisors>,
        <https://1145.am/db/2361027/Orbimed_Advisors>,
        <https://1145.am/db/2362475/Orbimed_Advisors>,
        <https://1145.am/db/2362481/Orbimed_Advisors>,
        <https://1145.am/db/2363339/Orbimed_Advisors>,
        <https://1145.am/db/2365679/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2365868/Orbimed_Advisors>,
        <https://1145.am/db/2366519/Orbimed_Advisors>,
        <https://1145.am/db/2574232/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2583013/Orbimed_Advisors>,
        <https://1145.am/db/456081/Orbimed_Advisors>,
        <https://1145.am/db/456089/Orbimed_Advisors>,
        <https://1145.am/db/458377/Orbimed_Advisors>,
        <https://1145.am/db/674484/Orbimed_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359468/Seragon_Pharmaceuticals_Inc> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "San Diego, CA." ;
    ns1:basedInLowRaw "Canada" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2013-10-17T14:32:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Seragon Pharmaceuticals Raises $30M in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/seragon-pharmaceuticals-raises-30m-series-a-financing> ;
    ns1:foundName "Seragon Pharmaceuticals",
        "Seragon Pharmaceuticals Inc." ;
    ns1:industry "Pharmaceuticals",
        "pharmaceuticals" ;
    ns1:name "Seragon Pharmaceuticals",
        "Seragon Pharmaceuticals Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2348776/Seragon_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359468/The_Column_Group> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2013-10-17T14:32:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Seragon Pharmaceuticals Raises $30M in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/seragon-pharmaceuticals-raises-30m-series-a-financing> ;
    ns1:foundName "The Column Group" ;
    ns1:investor <https://1145.am/db/2359468/Series_A_Investment_Aisling_Capital_Orbimed_Advisors_Seragon_Pharmaceuticals_Inc_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "The Column Group" ;
    ns1:sameAsHigh <https://1145.am/db/1503058/The_Column_Group>,
        <https://1145.am/db/1536915/The_Column_Group>,
        <https://1145.am/db/2304340/The_Column_Group>,
        <https://1145.am/db/425281/The_Column_Group>,
        <https://1145.am/db/426160/The_Column_Group> ;
    ns1:sameAsMedium <https://1145.am/db/1533327/The_Column_Group>,
        <https://1145.am/db/1533685/The_Column_Group>,
        <https://1145.am/db/1624208/The_Column_Group>,
        <https://1145.am/db/2283431/The_Column_Group>,
        <https://1145.am/db/2287253/The_Column_Group>,
        <https://1145.am/db/2291277/The_Column_Group>,
        <https://1145.am/db/2294202/The_Column_Group>,
        <https://1145.am/db/2304335/The_Column_Group>,
        <https://1145.am/db/2304769/The_Column_Group>,
        <https://1145.am/db/2305256/The_Column_Group>,
        <https://1145.am/db/2327474/The_Column_Group>,
        <https://1145.am/db/2335700/The_Column_Group>,
        <https://1145.am/db/2336503/The_Column_Group>,
        <https://1145.am/db/2336505/The_Column_Group>,
        <https://1145.am/db/2336524/The_Column_Group>,
        <https://1145.am/db/2339704/The_Column_Group>,
        <https://1145.am/db/2339883/The_Column_Group>,
        <https://1145.am/db/2344735/The_Column_Group>,
        <https://1145.am/db/2347885/The_Column_Group>,
        <https://1145.am/db/2350364/The_Column_Group>,
        <https://1145.am/db/2351394/The_Column_Group>,
        <https://1145.am/db/2351397/The_Column_Group>,
        <https://1145.am/db/2359334/The_Column_Group>,
        <https://1145.am/db/2359864/The_Column_Group>,
        <https://1145.am/db/2362475/The_Column_Group>,
        <https://1145.am/db/2362481/The_Column_Group>,
        <https://1145.am/db/2362565/The_Column_Group>,
        <https://1145.am/db/2362566/The_Column_Group>,
        <https://1145.am/db/2365363/The_Column_Group>,
        <https://1145.am/db/2368280/The_Column_Group>,
        <https://1145.am/db/2368501/The_Column_Group>,
        <https://1145.am/db/2583013/The_Column_Group>,
        <https://1145.am/db/2584056/The_Column_Group>,
        <https://1145.am/db/2584561/The_Column_Group>,
        <https://1145.am/db/490696/The_Column_Group>,
        <https://1145.am/db/75445/The_Column_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360415/5am_Ventures> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2014-03-27T12:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RuiYi banks $15M from A-list backers to amp up Chinese R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/ruiyi-banks-15m-from-a-list-backers-to-amp-up-chinese-r-d> ;
    ns1:foundName "5AM Ventures" ;
    ns1:investor <https://1145.am/db/2360415/Venture_Cash_Investment_5am_Ventures_Apposite_Capital_Aravis_Sa_Ruiyi_Versant_Ventures_Completed> ;
    ns1:name "5AM Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1157541/5am_Ventures>,
        <https://1145.am/db/1533327/5am_Ventures>,
        <https://1145.am/db/1533685/5am_Ventures>,
        <https://1145.am/db/1608803/5am_Ventures>,
        <https://1145.am/db/1669813/5am_Ventures>,
        <https://1145.am/db/2152422/5am_Ventures>,
        <https://1145.am/db/2153726/5am_Ventures>,
        <https://1145.am/db/2153910/5am_Ventures>,
        <https://1145.am/db/2283394/5am_Ventures>,
        <https://1145.am/db/2286204/5am_Ventures>,
        <https://1145.am/db/2286665/5am_Ventures>,
        <https://1145.am/db/2288016/5am_Ventures>,
        <https://1145.am/db/2298404/5am_Ventures>,
        <https://1145.am/db/2298642/5am_Ventures>,
        <https://1145.am/db/2306549/5am_Ventures>,
        <https://1145.am/db/2306551/5am_Ventures>,
        <https://1145.am/db/2306754/5am_Ventures>,
        <https://1145.am/db/2311595/5am_Ventures>,
        <https://1145.am/db/2313985/5am_Ventures>,
        <https://1145.am/db/2317919/5am_Ventures>,
        <https://1145.am/db/2318733/5am_Ventures>,
        <https://1145.am/db/2319784/5am_Ventures>,
        <https://1145.am/db/2322646/5am_Ventures>,
        <https://1145.am/db/2323210/5am_Ventures>,
        <https://1145.am/db/2323226/5am_Ventures>,
        <https://1145.am/db/2324195/5am_Ventures>,
        <https://1145.am/db/2328146/5am_Ventures>,
        <https://1145.am/db/2328338/5am_Ventures>,
        <https://1145.am/db/2329778/5am_Ventures>,
        <https://1145.am/db/2332322/5am_Ventures>,
        <https://1145.am/db/2339885/5am_Ventures>,
        <https://1145.am/db/2339886/5am_Ventures>,
        <https://1145.am/db/2340344/5am_Ventures>,
        <https://1145.am/db/2340345/5am_Ventures>,
        <https://1145.am/db/2340348/5am_Ventures>,
        <https://1145.am/db/2341003/5am_Ventures>,
        <https://1145.am/db/2342352/5am_Ventures>,
        <https://1145.am/db/2347885/5am_Ventures>,
        <https://1145.am/db/2348754/5am_Ventures>,
        <https://1145.am/db/2348857/5am_Ventures>,
        <https://1145.am/db/2349120/5am_Ventures>,
        <https://1145.am/db/2349834/5am_Ventures>,
        <https://1145.am/db/2351316/5am_Ventures>,
        <https://1145.am/db/2351683/5am_Ventures>,
        <https://1145.am/db/2351684/5am_Ventures>,
        <https://1145.am/db/2354296/5am_Ventures>,
        <https://1145.am/db/2355238/5am_Ventures>,
        <https://1145.am/db/2357858/5am_Ventures>,
        <https://1145.am/db/2359401/5am_Ventures>,
        <https://1145.am/db/2359864/5am_Ventures>,
        <https://1145.am/db/2360174/5am_Ventures>,
        <https://1145.am/db/2362475/5am_Ventures>,
        <https://1145.am/db/2362481/5am_Ventures>,
        <https://1145.am/db/2364492/5am_Ventures>,
        <https://1145.am/db/2367275/5am_Ventures>,
        <https://1145.am/db/2370609/5am_Ventures>,
        <https://1145.am/db/2371160/5am_Ventures>,
        <https://1145.am/db/2371163/5am_Ventures>,
        <https://1145.am/db/2538476/5am_Ventures>,
        <https://1145.am/db/2569220/5am_Ventures>,
        <https://1145.am/db/2572398/5am_Ventures>,
        <https://1145.am/db/2587596/5am_Ventures>,
        <https://1145.am/db/2592685/5am_Ventures>,
        <https://1145.am/db/359190/5am_Ventures>,
        <https://1145.am/db/428737/5am_Ventures>,
        <https://1145.am/db/509733/5am_Ventures>,
        <https://1145.am/db/558016/5am_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360415/Ruiyi> a org:Organization ;
    ns1:basedInHighGeoName "California",
        "Shanghai" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1796236/about.rdf>,
        <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:basedInHighRaw "California and Shanghai" ;
    ns1:description "drugmakers" ;
    ns1:documentDate "2014-03-27T12:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RuiYi banks $15M from A-list backers to amp up Chinese R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/ruiyi-banks-15m-from-a-list-backers-to-amp-up-chinese-r-d> ;
    ns1:foundName "RuiYi" ;
    ns1:industry "biotech" ;
    ns1:name "RuiYi" ;
    ns1:sameAsHigh <https://1145.am/db/1187955/Zhiyi>,
        <https://1145.am/db/1544248/Aziyo>,
        <https://1145.am/db/1546549/Aziyo>,
        <https://1145.am/db/2344593/Ruiyi> ;
    ns1:sameAsMedium <https://1145.am/db/2347324/Ruiyi_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360415/Versant_Ventures> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2014-03-27T12:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RuiYi banks $15M from A-list backers to amp up Chinese R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/ruiyi-banks-15m-from-a-list-backers-to-amp-up-chinese-r-d> ;
    ns1:foundName "Versant Ventures" ;
    ns1:investor <https://1145.am/db/2360415/Venture_Cash_Investment_5am_Ventures_Apposite_Capital_Aravis_Sa_Ruiyi_Versant_Ventures_Completed> ;
    ns1:name "Versant Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1540787/Versant_Ventures>,
        <https://1145.am/db/1541055/Versant_Ventures>,
        <https://1145.am/db/1571794/Versant_Ventures>,
        <https://1145.am/db/1928388/Versant_Ventures>,
        <https://1145.am/db/1975490/Versant_Ventures>,
        <https://1145.am/db/2069394/Versant_Ventures>,
        <https://1145.am/db/2110276/Versant_Ventures>,
        <https://1145.am/db/2151802/Versant_Ventures>,
        <https://1145.am/db/2154338/Versant_Ventures>,
        <https://1145.am/db/2154566/Versant_Ventures>,
        <https://1145.am/db/2281211/Versant_Ventures>,
        <https://1145.am/db/2287023/Versant_Ventures>,
        <https://1145.am/db/2288016/Versant_Ventures>,
        <https://1145.am/db/2290283/Versant_Ventures>,
        <https://1145.am/db/2291315/Versant_Ventures>,
        <https://1145.am/db/2291344/Versant_Ventures>,
        <https://1145.am/db/2293059/Versant_Ventures>,
        <https://1145.am/db/2293893/Versant_Ventures>,
        <https://1145.am/db/2294202/Versant_Ventures>,
        <https://1145.am/db/2296209/Versant_Ventures>,
        <https://1145.am/db/2298176/Versant_Ventures>,
        <https://1145.am/db/2299080/Versant_Ventures>,
        <https://1145.am/db/2299776/Versant_Ventures>,
        <https://1145.am/db/2300337/Versant_Ventures>,
        <https://1145.am/db/2303767/Versant_Ventures>,
        <https://1145.am/db/2304598/Versant_Ventures>,
        <https://1145.am/db/2304606/Versant_Ventures>,
        <https://1145.am/db/2304769/Versant_Ventures>,
        <https://1145.am/db/2305015/Versant_Ventures>,
        <https://1145.am/db/2308758/Versant_Ventures>,
        <https://1145.am/db/2310285/Versant_Ventures>,
        <https://1145.am/db/2310302/Versant_Ventures>,
        <https://1145.am/db/2311353/Versant_Ventures>,
        <https://1145.am/db/2313143/Versant_Ventures>,
        <https://1145.am/db/2317750/Versant_Ventures>,
        <https://1145.am/db/2317753/Versant_Ventures>,
        <https://1145.am/db/2318733/Versant_Ventures>,
        <https://1145.am/db/2319784/Versant_Ventures>,
        <https://1145.am/db/2322646/Versant_Ventures>,
        <https://1145.am/db/2323226/Versant_Ventures>,
        <https://1145.am/db/2324226/Versant_Ventures>,
        <https://1145.am/db/2325681/Versant_Ventures>,
        <https://1145.am/db/2326361/Versant_Ventures>,
        <https://1145.am/db/2326373/Versant_Ventures>,
        <https://1145.am/db/2326903/Versant_Ventures>,
        <https://1145.am/db/2330075/Versant_Ventures>,
        <https://1145.am/db/2330712/Versant_Ventures>,
        <https://1145.am/db/2330852/Versant_Ventures>,
        <https://1145.am/db/2331754/Versant_Ventures>,
        <https://1145.am/db/2331868/Versant_Ventures>,
        <https://1145.am/db/2335675/Versant_Ventures>,
        <https://1145.am/db/2335760/Versant_Ventures>,
        <https://1145.am/db/2339885/Versant_Ventures>,
        <https://1145.am/db/2339886/Versant_Ventures>,
        <https://1145.am/db/2342445/Versant_Ventures>,
        <https://1145.am/db/2343184/Versant_Ventures>,
        <https://1145.am/db/2343185/Versant_Ventures>,
        <https://1145.am/db/2343206/Versant_Ventures>,
        <https://1145.am/db/2343467/Versant_Ventures>,
        <https://1145.am/db/2343547/Versant_Ventures>,
        <https://1145.am/db/2343641/Versant_Ventures>,
        <https://1145.am/db/2343647/Versant_Ventures>,
        <https://1145.am/db/2344915/Versant_Ventures>,
        <https://1145.am/db/2344916/Versant_Ventures>,
        <https://1145.am/db/2344922/Versant_Ventures>,
        <https://1145.am/db/2344926/Versant_Ventures>,
        <https://1145.am/db/2345769/Versant_Ventures>,
        <https://1145.am/db/2347368/Versant_Ventures>,
        <https://1145.am/db/2348012/Versant_Ventures>,
        <https://1145.am/db/2348857/Versant_Ventures>,
        <https://1145.am/db/2349233/Versant_Ventures>,
        <https://1145.am/db/2349834/Versant_Ventures>,
        <https://1145.am/db/2350917/Versant_Ventures>,
        <https://1145.am/db/2351904/Versant_Ventures>,
        <https://1145.am/db/2354296/Versant_Ventures>,
        <https://1145.am/db/2360189/Versant_Ventures>,
        <https://1145.am/db/2360191/Versant_Ventures>,
        <https://1145.am/db/2362457/Versant_Ventures>,
        <https://1145.am/db/2362527/Versant_Ventures>,
        <https://1145.am/db/2362528/Versant_Ventures>,
        <https://1145.am/db/2362565/Versant_Ventures>,
        <https://1145.am/db/2362566/Versant_Ventures>,
        <https://1145.am/db/2364480/Versant_Ventures>,
        <https://1145.am/db/2365134/Versant_Ventures>,
        <https://1145.am/db/2365135/Versant_Ventures>,
        <https://1145.am/db/2367275/Versant_Ventures>,
        <https://1145.am/db/2368517/Versant_Ventures>,
        <https://1145.am/db/2370609/Versant_Ventures>,
        <https://1145.am/db/2370782/Versant_Ventures>,
        <https://1145.am/db/2370799/Versant_Ventures>,
        <https://1145.am/db/2371160/Versant_Ventures>,
        <https://1145.am/db/2371163/Versant_Ventures>,
        <https://1145.am/db/2541575/Versant_Ventures>,
        <https://1145.am/db/2584561/Versant_Ventures>,
        <https://1145.am/db/456081/Versant_Ventures>,
        <https://1145.am/db/488687/Versant_Ventures>,
        <https://1145.am/db/547640/Versant_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360521/Sideris_Pharmaceuticals> a org:Organization ;
    ns1:documentDate "2013-10-22T14:46:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sideris Pharmaceuticals Completes $32 Million Equity Financing and Signs Agreement With Global Pharmaceutical Company" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sideris-pharmaceuticals-completes-32-million-equity-financing-and-signs-agreement-global> ;
    ns1:foundName "Sideris Pharmaceuticals",
        "Sideris Pharmaceuticals, Inc." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Sideris Pharmaceuticals" ;
    ns1:sameAsMedium <https://1145.am/db/2343800/Sideris_Pharmaceuticals>,
        <https://1145.am/db/2360526/Sideris_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362552/Calithera_Biosciences> a org:Organization ;
    ns1:basedInHighGeoName "South San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:basedInHighRaw "South San Francisco" ;
    ns1:description "a biotech" ;
    ns1:documentDate "2013-10-29T13:45:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UPDATED: Calithera grabs $35M round to fund first slate of cancer drug studies" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/updated-calithera-grabs-35m-round-to-fund-first-slate-of-cancer-drug-studies> ;
    ns1:foundName "Calithera Biosciences" ;
    ns1:industry "Biotech" ;
    ns1:name "Calithera Biosciences" ;
    ns1:sameAsHigh <https://1145.am/db/1954170/Citryll>,
        <https://1145.am/db/2100514/Citryll>,
        <https://1145.am/db/2286644/Cg0070>,
        <https://1145.am/db/2295158/Cavion>,
        <https://1145.am/db/2367979/Yuval_Cabilly> ;
    ns1:sameAsMedium <https://1145.am/db/2287873/Calithera_Biosciences>,
        <https://1145.am/db/2336826/Calithera_Biosciences_Inc>,
        <https://1145.am/db/2336828/Calithera_Biosciences>,
        <https://1145.am/db/2360451/Calithera_Biosciences>,
        <https://1145.am/db/2362553/Calithera_Biosciences>,
        <https://1145.am/db/2367204/Calithera_Biosciences>,
        <https://1145.am/db/595445/Calithera_Biosciences>,
        <https://1145.am/db/940723/Calithera_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362552/Investment_Amgen_Calithera_Biosciences_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-29T13:45:42+00:00"^^xsd:dateTime ;
    ns1:documentExtract "South San Francisco - based Calithera Biosciences has landed a $ 35 million round that will be largely earmarked to fund its first clinical cancer drug program." ;
    ns1:documentTitle "UPDATED: Calithera grabs $35M round to fund first slate of cancer drug studies" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/updated-calithera-grabs-35m-round-to-fund-first-slate-of-cancer-drug-studies> ;
    ns1:foundName "round" ;
    ns1:name "round" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2362552/Calithera_Biosciences> ;
    ns1:valueRaw "$ 35 million" ;
    ns1:whereGeoName "South San Francisco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:whereRaw "South San Francisco" .

<https://1145.am/db/2362566/Alta_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-10-30T12:51:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immune Design Raises Up to $49 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immune-design-raises-up-to-49-million-series-c-financing> ;
    ns1:foundName "Alta Partners" ;
    ns1:investor <https://1145.am/db/2362566/Series_C_Investment_Alta_Partners_Immune_Design_Osage_Partners_Proquest_Investments_Sanofi-Genzyme_Bioventures_The_Column_Group_Topspin_Partners_Versant_Ventures_Completed> ;
    ns1:name "Alta Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1738305/Ac_Ventures>,
        <https://1145.am/db/1796988/Abc_Capital>,
        <https://1145.am/db/2306568/Alta_Partners>,
        <https://1145.am/db/2307829/Alta_Partners>,
        <https://1145.am/db/2327442/Alta_Partners>,
        <https://1145.am/db/2354307/Alta_Partners>,
        <https://1145.am/db/2354314/Alta_Partners>,
        <https://1145.am/db/2366700/Alta_Partners>,
        <https://1145.am/db/404702/Acvc_Ventures>,
        <https://1145.am/db/988703/Acorn_Pacific_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1156304/Alta_Partners>,
        <https://1145.am/db/1230022/Alta_Partners>,
        <https://1145.am/db/1333948/Altas_Partners>,
        <https://1145.am/db/1334727/Altas_Partners>,
        <https://1145.am/db/2303810/Alta_Partners>,
        <https://1145.am/db/2303814/Alta_Partners>,
        <https://1145.am/db/2304769/Alta_Partners>,
        <https://1145.am/db/2304870/Alta_Partners>,
        <https://1145.am/db/2305729/Alta_Partners>,
        <https://1145.am/db/2305745/Alta_Partners>,
        <https://1145.am/db/2306281/Alta_Partners>,
        <https://1145.am/db/2307682/Alta_Partners>,
        <https://1145.am/db/2307691/Alta_Partners>,
        <https://1145.am/db/2307824/Alta_Partners>,
        <https://1145.am/db/2308855/Alta_Partners>,
        <https://1145.am/db/2311011/Alta_Partners>,
        <https://1145.am/db/2313143/Alta_Partners>,
        <https://1145.am/db/2313405/Alta_Partners>,
        <https://1145.am/db/2316391/Alta_Partners>,
        <https://1145.am/db/2318577/Alta_Partners>,
        <https://1145.am/db/2318635/Alta_Partners>,
        <https://1145.am/db/2322984/Alta_Partners>,
        <https://1145.am/db/2323003/Alta_Partners>,
        <https://1145.am/db/2323243/Alta_Partners>,
        <https://1145.am/db/2324012/Alta_Partners>,
        <https://1145.am/db/2324015/Alta_Partners>,
        <https://1145.am/db/2326176/Alta_Partners>,
        <https://1145.am/db/2326903/Alta_Partners>,
        <https://1145.am/db/2327441/Alta_Partners>,
        <https://1145.am/db/2327677/Alta_Partners>,
        <https://1145.am/db/2328815/Alta_Partners>,
        <https://1145.am/db/2330075/Alta_Partners>,
        <https://1145.am/db/2330079/Alta_Partners>,
        <https://1145.am/db/2338126/Alta_Partners>,
        <https://1145.am/db/2338127/Alta_Partners>,
        <https://1145.am/db/2340887/Alta_Partners>,
        <https://1145.am/db/2341764/Alta_Partners>,
        <https://1145.am/db/2343547/Alta_Partners>,
        <https://1145.am/db/2344092/Alta_Partners>,
        <https://1145.am/db/2344100/Alta_Partners>,
        <https://1145.am/db/2346542/Alta_Partners>,
        <https://1145.am/db/2351224/Alta_Partners>,
        <https://1145.am/db/2351897/Alta_Partners>,
        <https://1145.am/db/2352167/Alta_Partners>,
        <https://1145.am/db/2352170/Alta_Partners>,
        <https://1145.am/db/2352362/Alta_Partners>,
        <https://1145.am/db/2352831/Alta_Partners>,
        <https://1145.am/db/2353439/Alta_Partners>,
        <https://1145.am/db/2353771/Alta_Partners>,
        <https://1145.am/db/2353789/Alta_Partners>,
        <https://1145.am/db/2354299/Alta_Partners>,
        <https://1145.am/db/2355183/Alta_Partners>,
        <https://1145.am/db/2355274/Alta_Partners>,
        <https://1145.am/db/2355586/Alta_Partners>,
        <https://1145.am/db/2356216/Alta_Partners>,
        <https://1145.am/db/2358496/Alta_Partners>,
        <https://1145.am/db/2358502/Alta_Partners>,
        <https://1145.am/db/2362565/Alta_Partners>,
        <https://1145.am/db/2362902/Alta_Partners>,
        <https://1145.am/db/2362909/Alta_Partners>,
        <https://1145.am/db/2362910/Alta_Partners>,
        <https://1145.am/db/2363364/Alta_Partners>,
        <https://1145.am/db/2363510/Alta_Partners>,
        <https://1145.am/db/2365748/Alta_Partners>,
        <https://1145.am/db/2366693/Alta_Partners>,
        <https://1145.am/db/2367497/Alta_Partners>,
        <https://1145.am/db/328387/Altas_Partners>,
        <https://1145.am/db/443962/Altas_Partners>,
        <https://1145.am/db/750997/Alta_Partners>,
        <https://1145.am/db/979509/Alta_Partners>,
        <https://1145.am/db/987929/Alta_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362566/Immune_Design> a org:Organization ;
    ns1:description "cancer" ;
    ns1:documentDate "2013-10-30T12:51:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immune Design Raises Up to $49 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immune-design-raises-up-to-49-million-series-c-financing> ;
    ns1:foundName "Immune Design" ;
    ns1:industry "biotechnology" ;
    ns1:name "Immune Design" ;
    ns1:sameAsHigh <https://1145.am/db/2340917/Immune_Design>,
        <https://1145.am/db/2357313/Immune_Design> ;
    ns1:sameAsMedium <https://1145.am/db/2153637/Immune_Design>,
        <https://1145.am/db/2153796/Immune_Design>,
        <https://1145.am/db/2304769/Immune_Design>,
        <https://1145.am/db/2343547/Immune_Design>,
        <https://1145.am/db/2352911/Immune_Design>,
        <https://1145.am/db/2353927/Immune_Design>,
        <https://1145.am/db/2361507/Immune_Design>,
        <https://1145.am/db/2367072/Immune_Design> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362566/Sanofi-Genzyme_Bioventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "Investing" ;
    ns1:documentDate "2013-10-30T12:51:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immune Design Raises Up to $49 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immune-design-raises-up-to-49-million-series-c-financing> ;
    ns1:foundName "Sanofi-Genzyme BioVentures" ;
    ns1:investor <https://1145.am/db/2362566/Series_C_Investment_Alta_Partners_Immune_Design_Osage_Partners_Proquest_Investments_Sanofi-Genzyme_Bioventures_The_Column_Group_Topspin_Partners_Versant_Ventures_Completed> ;
    ns1:name "Sanofi-Genzyme BioVentures" ;
    ns1:sameAsHigh <https://1145.am/db/2359683/Sanofi-Genzyme_Bioventures> ;
    ns1:sameAsMedium <https://1145.am/db/2340581/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2341792/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2341800/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2362565/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2363396/Sanofi-Genzyme_Bioventures>,
        <https://1145.am/db/2367541/Sanofi_Genzyme_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362566/The_Column_Group> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "Investing" ;
    ns1:documentDate "2013-10-30T12:51:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immune Design Raises Up to $49 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immune-design-raises-up-to-49-million-series-c-financing> ;
    ns1:foundName "The Column Group" ;
    ns1:investor <https://1145.am/db/2362566/Series_C_Investment_Alta_Partners_Immune_Design_Osage_Partners_Proquest_Investments_Sanofi-Genzyme_Bioventures_The_Column_Group_Topspin_Partners_Versant_Ventures_Completed> ;
    ns1:name "The Column Group" ;
    ns1:sameAsHigh <https://1145.am/db/1347054/Column_Capital_Corp>,
        <https://1145.am/db/1533327/The_Column_Group>,
        <https://1145.am/db/2347885/The_Column_Group>,
        <https://1145.am/db/2368501/The_Column_Group>,
        <https://1145.am/db/490696/The_Column_Group>,
        <https://1145.am/db/75445/The_Column_Group> ;
    ns1:sameAsMedium <https://1145.am/db/1503058/The_Column_Group>,
        <https://1145.am/db/1533685/The_Column_Group>,
        <https://1145.am/db/1536915/The_Column_Group>,
        <https://1145.am/db/1624208/The_Column_Group>,
        <https://1145.am/db/2283431/The_Column_Group>,
        <https://1145.am/db/2287253/The_Column_Group>,
        <https://1145.am/db/2291277/The_Column_Group>,
        <https://1145.am/db/2294202/The_Column_Group>,
        <https://1145.am/db/2304335/The_Column_Group>,
        <https://1145.am/db/2304340/The_Column_Group>,
        <https://1145.am/db/2304769/The_Column_Group>,
        <https://1145.am/db/2305256/The_Column_Group>,
        <https://1145.am/db/2327474/The_Column_Group>,
        <https://1145.am/db/2335700/The_Column_Group>,
        <https://1145.am/db/2336503/The_Column_Group>,
        <https://1145.am/db/2336505/The_Column_Group>,
        <https://1145.am/db/2336524/The_Column_Group>,
        <https://1145.am/db/2339704/The_Column_Group>,
        <https://1145.am/db/2339883/The_Column_Group>,
        <https://1145.am/db/2344735/The_Column_Group>,
        <https://1145.am/db/2350364/The_Column_Group>,
        <https://1145.am/db/2351394/The_Column_Group>,
        <https://1145.am/db/2351397/The_Column_Group>,
        <https://1145.am/db/2359334/The_Column_Group>,
        <https://1145.am/db/2359468/The_Column_Group>,
        <https://1145.am/db/2359864/The_Column_Group>,
        <https://1145.am/db/2362475/The_Column_Group>,
        <https://1145.am/db/2362481/The_Column_Group>,
        <https://1145.am/db/2362565/The_Column_Group>,
        <https://1145.am/db/2365363/The_Column_Group>,
        <https://1145.am/db/2368280/The_Column_Group>,
        <https://1145.am/db/2583013/The_Column_Group>,
        <https://1145.am/db/2584056/The_Column_Group>,
        <https://1145.am/db/2584561/The_Column_Group>,
        <https://1145.am/db/425281/The_Column_Group>,
        <https://1145.am/db/426160/The_Column_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362566/Versant_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-10-30T12:51:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immune Design Raises Up to $49 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immune-design-raises-up-to-49-million-series-c-financing> ;
    ns1:foundName "Versant Ventures" ;
    ns1:investor <https://1145.am/db/2362566/Series_C_Investment_Alta_Partners_Immune_Design_Osage_Partners_Proquest_Investments_Sanofi-Genzyme_Bioventures_The_Column_Group_Topspin_Partners_Versant_Ventures_Completed> ;
    ns1:name "Versant Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1928388/Versant_Ventures>,
        <https://1145.am/db/1975490/Versant_Ventures>,
        <https://1145.am/db/2110276/Versant_Ventures>,
        <https://1145.am/db/2154566/Versant_Ventures>,
        <https://1145.am/db/2288016/Versant_Ventures>,
        <https://1145.am/db/2290283/Versant_Ventures>,
        <https://1145.am/db/2291315/Versant_Ventures>,
        <https://1145.am/db/2294202/Versant_Ventures>,
        <https://1145.am/db/2300337/Versant_Ventures>,
        <https://1145.am/db/2303767/Versant_Ventures>,
        <https://1145.am/db/2304606/Versant_Ventures>,
        <https://1145.am/db/2305015/Versant_Ventures>,
        <https://1145.am/db/2308758/Versant_Ventures>,
        <https://1145.am/db/2313143/Versant_Ventures>,
        <https://1145.am/db/2318934/Versant>,
        <https://1145.am/db/2319784/Versant_Ventures>,
        <https://1145.am/db/2326361/Versant_Ventures>,
        <https://1145.am/db/2326373/Versant_Ventures>,
        <https://1145.am/db/2330852/Versant_Ventures>,
        <https://1145.am/db/2331754/Versant_Ventures>,
        <https://1145.am/db/2331868/Versant_Ventures>,
        <https://1145.am/db/2339886/Versant_Ventures>,
        <https://1145.am/db/2343184/Versant_Ventures>,
        <https://1145.am/db/2344916/Versant_Ventures>,
        <https://1145.am/db/2345769/Versant_Ventures>,
        <https://1145.am/db/2348857/Versant_Ventures>,
        <https://1145.am/db/2349233/Versant_Ventures>,
        <https://1145.am/db/2350915/Versant_Venture_Capital_V_Lp>,
        <https://1145.am/db/2362527/Versant_Ventures>,
        <https://1145.am/db/2364480/Versant_Ventures>,
        <https://1145.am/db/2365135/Versant_Ventures>,
        <https://1145.am/db/2367275/Versant_Ventures>,
        <https://1145.am/db/2371163/Versant_Ventures>,
        <https://1145.am/db/547640/Versant_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1540787/Versant_Ventures>,
        <https://1145.am/db/1541055/Versant_Ventures>,
        <https://1145.am/db/1571794/Versant_Ventures>,
        <https://1145.am/db/2069394/Versant_Ventures>,
        <https://1145.am/db/2151802/Versant_Ventures>,
        <https://1145.am/db/2154338/Versant_Ventures>,
        <https://1145.am/db/2281211/Versant_Ventures>,
        <https://1145.am/db/2287023/Versant_Ventures>,
        <https://1145.am/db/2291344/Versant_Ventures>,
        <https://1145.am/db/2293059/Versant_Ventures>,
        <https://1145.am/db/2293893/Versant_Ventures>,
        <https://1145.am/db/2296209/Versant_Ventures>,
        <https://1145.am/db/2298176/Versant_Ventures>,
        <https://1145.am/db/2299080/Versant_Ventures>,
        <https://1145.am/db/2299776/Versant_Ventures>,
        <https://1145.am/db/2304598/Versant_Ventures>,
        <https://1145.am/db/2304769/Versant_Ventures>,
        <https://1145.am/db/2310285/Versant_Ventures>,
        <https://1145.am/db/2310302/Versant_Ventures>,
        <https://1145.am/db/2311353/Versant_Ventures>,
        <https://1145.am/db/2317750/Versant_Ventures>,
        <https://1145.am/db/2317753/Versant_Ventures>,
        <https://1145.am/db/2318733/Versant_Ventures>,
        <https://1145.am/db/2322646/Versant_Ventures>,
        <https://1145.am/db/2323226/Versant_Ventures>,
        <https://1145.am/db/2324226/Versant_Ventures>,
        <https://1145.am/db/2325681/Versant_Ventures>,
        <https://1145.am/db/2326903/Versant_Ventures>,
        <https://1145.am/db/2330075/Versant_Ventures>,
        <https://1145.am/db/2330712/Versant_Ventures>,
        <https://1145.am/db/2335675/Versant_Ventures>,
        <https://1145.am/db/2335760/Versant_Ventures>,
        <https://1145.am/db/2339885/Versant_Ventures>,
        <https://1145.am/db/2342445/Versant_Ventures>,
        <https://1145.am/db/2343185/Versant_Ventures>,
        <https://1145.am/db/2343206/Versant_Ventures>,
        <https://1145.am/db/2343467/Versant_Ventures>,
        <https://1145.am/db/2343547/Versant_Ventures>,
        <https://1145.am/db/2343641/Versant_Ventures>,
        <https://1145.am/db/2343647/Versant_Ventures>,
        <https://1145.am/db/2344915/Versant_Ventures>,
        <https://1145.am/db/2344922/Versant_Ventures>,
        <https://1145.am/db/2344926/Versant_Ventures>,
        <https://1145.am/db/2347368/Versant_Ventures>,
        <https://1145.am/db/2348012/Versant_Ventures>,
        <https://1145.am/db/2349834/Versant_Ventures>,
        <https://1145.am/db/2350917/Versant_Ventures>,
        <https://1145.am/db/2351904/Versant_Ventures>,
        <https://1145.am/db/2354296/Versant_Ventures>,
        <https://1145.am/db/2360189/Versant_Ventures>,
        <https://1145.am/db/2360191/Versant_Ventures>,
        <https://1145.am/db/2360415/Versant_Ventures>,
        <https://1145.am/db/2362457/Versant_Ventures>,
        <https://1145.am/db/2362528/Versant_Ventures>,
        <https://1145.am/db/2362565/Versant_Ventures>,
        <https://1145.am/db/2365134/Versant_Ventures>,
        <https://1145.am/db/2368517/Versant_Ventures>,
        <https://1145.am/db/2370609/Versant_Ventures>,
        <https://1145.am/db/2370782/Versant_Ventures>,
        <https://1145.am/db/2370799/Versant_Ventures>,
        <https://1145.am/db/2371160/Versant_Ventures>,
        <https://1145.am/db/2541575/Versant_Ventures>,
        <https://1145.am/db/2584561/Versant_Ventures>,
        <https://1145.am/db/456081/Versant_Ventures>,
        <https://1145.am/db/488687/Versant_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363607/Midatech_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "Abingdon" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/7292133/about.rdf> ;
    ns1:basedInHighRaw "ABINGDON, England" ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:description "Science/Tech",
        "design, synthesis and manufacture of nanomedicines" ;
    ns1:documentDate "2013-11-05T14:10:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Midatech Raises 10 Million to Advance Gold-nanoparticle Technology for Diabetes and Cancer Treatment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/midatech-raises-%C2%A310-million-to-advance-gold-nanoparticle-technology-for-diabetes-and-cancer> ;
    ns1:foundName "Midatech",
        "Midatech Ltd." ;
    ns1:name "Midatech",
        "Midatech Ltd." ;
    ns1:sameAsHigh <https://1145.am/db/2350907/Midatech>,
        <https://1145.am/db/2353633/Midatech_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/2350906/Midatech>,
        <https://1145.am/db/2350926/Midatech>,
        <https://1145.am/db/2358581/Midatech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2363607/New_Equity_Investment_Ippon_Capital_Sa_Midatech_Ltd_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-11-05T14:10:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on its unique biocompatible gold-nanoparticles (GNP) , is pleased to announce that is has successfully raised 10 million through the issue of new equity.",
        "Midatech Raises 10 Million to Advance Gold-nanoparticle Technology for Diabetes and Cancer Treatment." ;
    ns1:documentTitle "Midatech Raises 10 Million to Advance Gold-nanoparticle Technology for Diabetes and Cancer Treatment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/midatech-raises-%C2%A310-million-to-advance-gold-nanoparticle-technology-for-diabetes-and-cancer> ;
    ns1:foundName "Raises",
        "raised" ;
    ns1:name "Raises",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2363607/Midatech_Ltd> ;
    ns1:targetDetails "new equity" ;
    ns1:valueRaw "10 Million",
        "10 million",
        "7.6 million" ;
    ns1:when "2013-11-05T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "November 5, 2013" ;
    ns1:whereGeoName "England" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6269131/about.rdf> ;
    ns1:whereRaw "England" .

<https://1145.am/db/2476855/Meyer-Franklin_Travel> a org:Organization ;
    ns1:basedInHighGeoName "Bermuda" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3573345/about.rdf> ;
    ns1:basedInHighRaw "Bermuda" ;
    ns1:description "Travel" ;
    ns1:documentDate "2013-09-05T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Worldview Travel Acquires Bermuda-Based Meyer-Franklin Travel" ;
    ns1:documentURL <https://www.travelagentcentral.com/running-your-business/worldview-travel-acquires-bermuda-based-meyer-franklin-travel> ;
    ns1:foundName "Meyer-Franklin Travel" ;
    ns1:industry "travel" ;
    ns1:name "Meyer-Franklin Travel" ;
    ns1:protagonist <https://1145.am/db/2476855/Merger_Meyer-Franklin_Travel_Worldview_Travel_Worldview_Travel_Has_Not_Happened> ;
    ns1:sameAsHigh <https://1145.am/db/2493829/Meyer-Franklin_Travel> ;
    ns1:sourceName "Travel Agent Central" .

<https://1145.am/db/2539904/Exela_Pharma_Sciences> a org:Organization ;
    ns1:basedInHighGeoName "Caldwell County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4458601/about.rdf> ;
    ns1:basedInHighRaw "Caldwell County" ;
    ns1:description "pharmaceutical manufacturing" ;
    ns1:documentDate "2013-07-24T13:59:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blue Ridge Electric Approved for a $1 Million USDA Economic Development Loan for Local Company Expansion" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/blue-ridge-electric-approved-for-a-1-million-usda-economic-development-loan-for-local> ;
    ns1:foundName "Exela Pharma Sciences, LLC" ;
    ns1:industry "pharmaceutical manufacturing" ;
    ns1:name "Exela Pharma Sciences" ;
    ns1:sameAsHigh <https://1145.am/db/457417/Exela_Holdings_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2539904/Investment_Blue_Ridge_Electric_Membership_Corporation_Exela_Pharma_Sciences_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-07-24T13:59:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Blue Ridge Electric Membership Corporation was recently approved by the U.S. Department of Agriculture (USDA) to receive a $ 1 million economic development loan for Exela Pharma Sciences, LLC, a pharmaceutical manufacturing company seeking to expand to save positions and create additional jobs in Caldwell County-an area devastated by loss of furniture manufacturing jobs in recent years." ;
    ns1:documentTitle "Blue Ridge Electric Approved for a $1 Million USDA Economic Development Loan for Local Company Expansion" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/blue-ridge-electric-approved-for-a-1-million-usda-economic-development-loan-for-local> ;
    ns1:foundName "loan" ;
    ns1:name "loan" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2539904/Exela_Pharma_Sciences> ;
    ns1:targetDetails "loan" ;
    ns1:targetName "Exela Pharma Sciences" ;
    ns1:valueRaw "$ 1 million" ;
    ns1:whereGeoName "Caldwell County",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4458601/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "Caldwell County",
        "United States" .

<https://1145.am/db/2541466/Peptides> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Belgium" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:basedInHighRaw "Belgium" ;
    ns1:description "Custom Synthesis",
        "pharmaceutical use" ;
    ns1:documentDate "2013-08-29T11:25:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CordenPharma to Acquire Peptisyntha from Solvay, Expanding Peptides Custom Synthesis Business" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/cordenpharma-to-acquire-peptisyntha-from-solvay-expanding-peptides-custom-synthesis> ;
    ns1:foundName "Peptisyntha",
        "Peptisyntha SA" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Peptides",
        "Peptisyntha" ;
    ns1:sameAsHigh <https://1145.am/db/2541465/Peptisyntha>,
        <https://1145.am/db/2553755/Peptisyntha> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2541466/Solvay_Group> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Belgium" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:basedInHighRaw "Belgium" ;
    ns1:basedInLowRaw "Belgium" ;
    ns1:description "Pharmaceutical" ;
    ns1:documentDate "2013-08-29T11:25:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CordenPharma to Acquire Peptisyntha from Solvay, Expanding Peptides Custom Synthesis Business" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/cordenpharma-to-acquire-peptisyntha-from-solvay-expanding-peptides-custom-synthesis> ;
    ns1:foundName "Solvay",
        "the Solvay Group" ;
    ns1:name "Solvay",
        "Solvay Group" ;
    ns1:participant <https://1145.am/db/2541466/Peptides_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2317185/Solvay_Sa>,
        <https://1145.am/db/2326414/Solvay_Pharmaceuticals_Sa>,
        <https://1145.am/db/2327450/Solvay_Pharmaceuticals>,
        <https://1145.am/db/2552776/Solvay>,
        <https://1145.am/db/2552796/Solvay_Pharmaceuticals>,
        <https://1145.am/db/2564013/Solvay_Pharma>,
        <https://1145.am/db/2582468/Solvay_Pharma_India> ;
    ns1:sameAsMedium <https://1145.am/db/2550717/Solvay_Group>,
        <https://1145.am/db/2557012/Solvay_Group> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2544488/Cambridge_Major_Laboratories> a org:Organization ;
    ns1:basedInHighGeoName "Germantown" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5254218/about.rdf> ;
    ns1:basedInHighRaw "Germantown, WI" ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "Cambridge Major Laboratories" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Cambridge Major Laboratories" ;
    ns1:sameAsHigh <https://1145.am/db/2303690/Cambridge_Major_Laboratories>,
        <https://1145.am/db/2323097/Cambridge_Biotechnology>,
        <https://1145.am/db/2362605/Cambridge_Major_Laboratories>,
        <https://1145.am/db/2543464/Cambridge_Major_Laboratories>,
        <https://1145.am/db/2543471/Cambridge_Major_Laboratories>,
        <https://1145.am/db/2562245/Cambridge_Major_Laboratories_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2307566/Cambridge_Major_Laboratories>,
        <https://1145.am/db/2547546/Cambridge_Major_Laboratories>,
        <https://1145.am/db/2562248/Cambridge_Major_Laboratories>,
        <https://1145.am/db/2562410/Cambridge_Major_Laboratories> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2544488/Gland_Pharma_Stake_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Earlier this month, citing sources, Reuters said that investment firm KKR was on the cusp of buying a 30 % stake in India's Gland Pharma for about $ 150 million." ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "buying" ;
    ns1:name "buying" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2544488/Gland_Pharma> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Gland Pharma" ;
    ns1:valueRaw "about $ 150 million" ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "India" .

<https://1145.am/db/2544488/Jhp_Pharmaceuticals> a org:Organization ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "JHP Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "JHP Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2311359/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2327224/Jhp_Pharmaceuticals_Llc>,
        <https://1145.am/db/2538861/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2539516/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2540151/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2543471/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2547130/Huvepharma>,
        <https://1145.am/db/2547593/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2547596/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2548585/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2562224/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2562228/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2578095/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2579025/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2589536/Huvepharma>,
        <https://1145.am/db/366235/Huvepharma>,
        <https://1145.am/db/558618/Hemogenyx_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2250700/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2308601/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2320947/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2360639/Jhp_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2544488/Jhp_Pharmaceuticals_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In January, Warburg Pincus paid $ 195 million to buy JHP Pharmaceuticals, the majority of which was owned by Morgan Stanley Principal Investments." ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "buy" ;
    ns1:name "buy" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2544488/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2544488/Morgan_Stanley_Principal_Investments> ;
    ns1:targetName "JHP Pharmaceuticals" ;
    ns1:valueRaw "$ 195 million" .

<https://1145.am/db/2544488/Morgan_Stanley_Principal_Investments> a org:Organization ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "Morgan Stanley Principal Investments" ;
    ns1:name "Morgan Stanley Principal Investments" ;
    ns1:sameAsMedium <https://1145.am/db/2543471/Morgan_Stanley_Principal_Investments>,
        <https://1145.am/db/2562224/Morgan_Stanley_Principal_Investments> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2544488/Symbiotec> a org:Organization ;
    ns1:basedInHighGeoName "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:basedInHighRaw "India" ;
    ns1:description "steroid-hormone active ingredient producer" ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "Symbiotec Pharmalab" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Symbiotec" ;
    ns1:sameAsHigh <https://1145.am/db/2363436/Symbiosis_Pharmaceutical_Services>,
        <https://1145.am/db/2367654/Symbiosis_Pharmaceutical_Services>,
        <https://1145.am/db/2544487/Symbiotec>,
        <https://1145.am/db/2545134/Symbiosis_Pharmaceutical_Services>,
        <https://1145.am/db/2597161/Symbiosis_Pharmaceutical_Services> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2544488/Symbiotec_Stake_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Now, the London - based private equity investor Actis Capital is shelling out $ 48 million for what it calls a \"significant stake\" in Indian API maker Symbiotec Pharmalab." ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "buy",
        "shelling" ;
    ns1:name "buy",
        "shelling" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2544488/Symbiotec> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Symbiotec" ;
    ns1:valueRaw "$ 48 million" ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "India" .

<https://1145.am/db/2544488/Warburg_Pincus> a org:Organization ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "Warburg Pincus" ;
    ns1:investor <https://1145.am/db/2544488/Jhp_Pharmaceuticals_Investment> ;
    ns1:name "Warburg Pincus" ;
    ns1:sameAsMedium <https://1145.am/db/107233/Warburg_Pincus>,
        <https://1145.am/db/1077261/Warburg_Pincus>,
        <https://1145.am/db/108315/Warburg_Pincus>,
        <https://1145.am/db/1106851/Warburg_Pincus>,
        <https://1145.am/db/1121839/Warburg_Pincus>,
        <https://1145.am/db/1138823/Warburg_Pincus>,
        <https://1145.am/db/1141070/Warburg_Pincus>,
        <https://1145.am/db/1149542/Warburg_Pincus>,
        <https://1145.am/db/1153239/Warburg_Pincus>,
        <https://1145.am/db/1153356/Warburg_Pincus>,
        <https://1145.am/db/1216854/Warburg_Pincus>,
        <https://1145.am/db/1244609/Warburg_Pincus>,
        <https://1145.am/db/1245131/Warburg_Pincus>,
        <https://1145.am/db/129974/Warburg_Pincus>,
        <https://1145.am/db/1317266/Warburg_Pincus>,
        <https://1145.am/db/1349968/Warburg_Pincus_Llc>,
        <https://1145.am/db/1361475/Warburg_Pincus>,
        <https://1145.am/db/1405696/Warburg_Pincus>,
        <https://1145.am/db/1655979/Warburg_Pincus>,
        <https://1145.am/db/1656176/Warburg_Pincus>,
        <https://1145.am/db/1674046/Warbug_Pincus>,
        <https://1145.am/db/1676487/Warburg_Pincus>,
        <https://1145.am/db/1716813/Warburg_Pincus>,
        <https://1145.am/db/1721480/Warburg_Pincus>,
        <https://1145.am/db/1722916/Warburg_Pincus>,
        <https://1145.am/db/1742050/Warburg_Pincus>,
        <https://1145.am/db/1742981/Warburg_Pincus>,
        <https://1145.am/db/1748765/Warburg_Pincus>,
        <https://1145.am/db/1754511/Warburg_Pincus>,
        <https://1145.am/db/1758165/Warburg_Pincus>,
        <https://1145.am/db/1762611/Warburg_Pincus>,
        <https://1145.am/db/1766425/Warburg_Pincus>,
        <https://1145.am/db/1777495/Warburg_Pincus>,
        <https://1145.am/db/1783572/Warburg_Pincus>,
        <https://1145.am/db/1788883/Warburg_Pincus>,
        <https://1145.am/db/1789335/Warburg_Pincus>,
        <https://1145.am/db/1790731/Warburg_Pincus>,
        <https://1145.am/db/1802244/Warburg_Pincus>,
        <https://1145.am/db/1807465/Warburg_Pincus>,
        <https://1145.am/db/1812233/Warburg_Pincus>,
        <https://1145.am/db/1831318/Warburg_Pincus>,
        <https://1145.am/db/1854800/Warburg_Pincus>,
        <https://1145.am/db/1862907/Warburg_Pincus>,
        <https://1145.am/db/1870054/Warburg_Pincus>,
        <https://1145.am/db/1874806/Warburg_Pincus>,
        <https://1145.am/db/1887816/Warburg_Pincus>,
        <https://1145.am/db/1969536/Warburg_Pincus>,
        <https://1145.am/db/196955/Warburg_Pincus>,
        <https://1145.am/db/1993235/Warburg_Pincus>,
        <https://1145.am/db/1997451/Warburg_Pincus>,
        <https://1145.am/db/1997970/Warburg_Pincus>,
        <https://1145.am/db/1998744/Warburg_Pincus>,
        <https://1145.am/db/2001027/Warburg_Pincus>,
        <https://1145.am/db/2065567/Warburg_Pincus>,
        <https://1145.am/db/2069862/Warburg_Pincus>,
        <https://1145.am/db/2076122/Warburg_Pincus>,
        <https://1145.am/db/2081192/Warburg_Pincus>,
        <https://1145.am/db/2097376/Warburg_Pincus>,
        <https://1145.am/db/2132018/Warburg_Pincus>,
        <https://1145.am/db/2134779/Warburg_Pincus>,
        <https://1145.am/db/2183196/Warburg_Pincus>,
        <https://1145.am/db/2183330/Warburg_Pincus>,
        <https://1145.am/db/2207195/Warburg_Pincus>,
        <https://1145.am/db/2238793/Warburg_Pincus>,
        <https://1145.am/db/2270672/Warburg_Pincus>,
        <https://1145.am/db/2288758/Warburg_Pincus>,
        <https://1145.am/db/2291095/Warburg_Pincus>,
        <https://1145.am/db/2296562/Warburg_Pincus>,
        <https://1145.am/db/2300064/Warburg_Pincus>,
        <https://1145.am/db/2300214/Warburg_Pincus>,
        <https://1145.am/db/2308601/Warburg_Pincus>,
        <https://1145.am/db/2309051/Warburg_Pincus>,
        <https://1145.am/db/2315159/Warburg_Pincus>,
        <https://1145.am/db/2318581/Warburg_Pincus>,
        <https://1145.am/db/2319236/Warburg_Pincus>,
        <https://1145.am/db/2319237/Warburg_Pincus>,
        <https://1145.am/db/2324159/Warburg_Pincus>,
        <https://1145.am/db/2326119/Warburg_Pincus>,
        <https://1145.am/db/2327248/Warburg_Pincus>,
        <https://1145.am/db/2327264/Warburg_Pincus>,
        <https://1145.am/db/2348272/Warburg_Pincus_Llc>,
        <https://1145.am/db/2352277/Warburg_Pincus>,
        <https://1145.am/db/2353256/Warburg_Pincus>,
        <https://1145.am/db/2353260/Warburg_Pincus>,
        <https://1145.am/db/235654/Warburg_Pincus_Llc>,
        <https://1145.am/db/2360639/Warburg_Pincus>,
        <https://1145.am/db/2362453/Warburg_Pincus>,
        <https://1145.am/db/2367969/Warburg_Pincus>,
        <https://1145.am/db/2367976/Warburg_Pincus>,
        <https://1145.am/db/238604/Warburg_Pincus>,
        <https://1145.am/db/2543471/Warburg_Pincus>,
        <https://1145.am/db/2547596/Warburg_Pincus>,
        <https://1145.am/db/254889/Warburg_Pincus>,
        <https://1145.am/db/2560285/Warburg_Pincus>,
        <https://1145.am/db/2562224/Warburg_Pincus>,
        <https://1145.am/db/2579025/Warburg_Pincus>,
        <https://1145.am/db/2596296/Warburg_Pincus>,
        <https://1145.am/db/2638371/Warburg_Pincus>,
        <https://1145.am/db/2668430/Warburg_Pincus>,
        <https://1145.am/db/268598/Warburg_Pincus>,
        <https://1145.am/db/2688027/Warburg_Pincus>,
        <https://1145.am/db/2695363/Warburg_Pincus>,
        <https://1145.am/db/271314/Warburg_Pincus>,
        <https://1145.am/db/2722001/Warburg_Pincus>,
        <https://1145.am/db/272400/Warburg_Pincus>,
        <https://1145.am/db/2732060/Warburg_Pincus>,
        <https://1145.am/db/2735857/Warburg_Pincus>,
        <https://1145.am/db/2747164/Warburg_Pincus>,
        <https://1145.am/db/2800144/Warburg_Pincus>,
        <https://1145.am/db/299488/Warburg_Pincus>,
        <https://1145.am/db/359185/Warburg_Pincus>,
        <https://1145.am/db/405249/Warburg_Pincus>,
        <https://1145.am/db/455601/Warburg_Pincus_Llc>,
        <https://1145.am/db/460556/Warburg_Pincus>,
        <https://1145.am/db/463733/Warburg_Pincus>,
        <https://1145.am/db/478732/Warburg_Pincus>,
        <https://1145.am/db/489663/Warburg_Pincus>,
        <https://1145.am/db/505222/Warburg_Pincus>,
        <https://1145.am/db/539514/Warburg_Pincus>,
        <https://1145.am/db/542434/Warburg_Pincus>,
        <https://1145.am/db/547444/Warburg_Pincus>,
        <https://1145.am/db/556611/Warburg_Pincus>,
        <https://1145.am/db/582835/Warburg_Pincus>,
        <https://1145.am/db/601860/Warburg_Pincus>,
        <https://1145.am/db/606291/Warburg_Pincus>,
        <https://1145.am/db/627360/Warburg_Pincus>,
        <https://1145.am/db/721581/Warburg_Pincus>,
        <https://1145.am/db/745350/Warburg_Pincus_Llc>,
        <https://1145.am/db/768222/Warburg_Pincus>,
        <https://1145.am/db/817588/Warburg_Pincus>,
        <https://1145.am/db/823283/Warburg_Pincus>,
        <https://1145.am/db/829348/Warburg_Pincus>,
        <https://1145.am/db/85758/Warburg_Pincus>,
        <https://1145.am/db/867907/Warburg_Pincus>,
        <https://1145.am/db/934889/Warburg_Pincus>,
        <https://1145.am/db/944277/Warburg_Pincus>,
        <https://1145.am/db/962121/Warburg_Pincus>,
        <https://1145.am/db/963964/Warburg_Pincus> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2550639/Profarma_Distribuidora_De_Produtos_Farmacuticos_Sa> a org:Organization ;
    ns1:basedInHighGeoName "Federative Republic of Brazil" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:basedInHighRaw "Brazil",
        "Brazil." ;
    ns1:description "distribution of pharmaceutical products",
        "pharmaceutical wholesaler" ;
    ns1:documentDate "2014-03-25T11:11:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AmerisourceBergen Acquires Minority Interest in Profarma Distribuidora de Produtos Farmacuticos S.A." ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/amerisourcebergen-acquires-minority-interest-profarma-distribuidora-de-produtos> ;
    ns1:foundName "Profarma",
        "Profarma Distribuidora de Produtos Farmacuticos S.A",
        "Profarma Distribuidora de Produtos Farmacuticos S.A." ;
    ns1:industry "pharmaceutical wholesaler" ;
    ns1:name "Profarma Distribuidora de Produtos Farmacutico",
        "Profarma Distribuidora de Produtos Farmacuticos S.A." ;
    ns1:protagonist <https://1145.am/db/2550639/Profarma_Distribuidora_De_Produtos_Farmacuticos_Sa_Interest_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2562431/Profarma_Distribuidora_De_Produtos_Farmacutico>,
        <https://1145.am/db/2585859/Profarma_Distribuidora_De_Produtos_Farmacutico> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2556669/Madison_Vaccines_Incorporated> a org:Organization ;
    ns1:basedInLowRaw "Wisconsin" ;
    ns1:description "advancing innovative therapies for prostate cancer" ;
    ns1:documentDate "2014-01-14T19:27:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Madison Vaccines Closes $8 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/madison-vaccines-closes-8-million-series-a-financing> ;
    ns1:foundName "Madison Vaccines",
        "Madison Vaccines Incorporated" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Madison Vaccines",
        "Madison Vaccines Incorporated" ;
    ns1:sameAsHigh <https://1145.am/db/2556665/Madison_Vaccines_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2558803/Cap-Cmv_Gmbh> a org:Organization ;
    ns1:description "developing a vaccine" ;
    ns1:documentDate "2014-03-27T11:44:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CAP-CMV GmbH Raises New Funds to Further Develop Its Novel hCMV Vaccine and Appoints New CEO" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/cap-cmv-gmbh-raises-new-funds-to-further-develop-its-novel-hcmv-vaccine-and-appoints-new> ;
    ns1:foundName "CAP-CMV GmbH" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "CAP-CMV GmbH" ;
    ns1:sameAsHigh <https://1145.am/db/2302883/Capua>,
        <https://1145.am/db/2305866/Capsugel>,
        <https://1145.am/db/2309696/Capsugel>,
        <https://1145.am/db/2309697/Capsugel>,
        <https://1145.am/db/2340001/Caprotec>,
        <https://1145.am/db/2347565/Capsugel>,
        <https://1145.am/db/2360425/Cap-Cmv_Gmbh>,
        <https://1145.am/db/2364161/Capsugel>,
        <https://1145.am/db/2536473/Capsugel>,
        <https://1145.am/db/2536474/Capsugel>,
        <https://1145.am/db/2540230/Capua>,
        <https://1145.am/db/2540356/Capsugel>,
        <https://1145.am/db/2540492/Capsugel>,
        <https://1145.am/db/2540931/Capsugel>,
        <https://1145.am/db/2546140/Capsugel>,
        <https://1145.am/db/2547142/Capsugel>,
        <https://1145.am/db/2548051/Capsugel>,
        <https://1145.am/db/2550232/Capsugel>,
        <https://1145.am/db/2558602/Capsugel>,
        <https://1145.am/db/2560766/Capsugel>,
        <https://1145.am/db/2562425/Capsugel>,
        <https://1145.am/db/2562434/Capsugel>,
        <https://1145.am/db/2564490/Capsugel>,
        <https://1145.am/db/2574936/Capsugel>,
        <https://1145.am/db/2577634/Capsugel>,
        <https://1145.am/db/2586167/Capsugel>,
        <https://1145.am/db/2593886/Capsugel> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2570961/Santarus> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:description "Gastroenterology" ;
    ns1:documentDate "2013-11-08T12:50:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Salix Pharmaceuticals to Acquire Santarus" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/salix-pharmaceuticals-to-acquire-santarus> ;
    ns1:foundName "Santarus" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Santarus" ;
    ns1:sameAsHigh <https://1145.am/db/2315422/Santarus>,
        <https://1145.am/db/2360160/Santarus>,
        <https://1145.am/db/2570958/Santarus>,
        <https://1145.am/db/2584908/Santarus> ;
    ns1:sameAsMedium <https://1145.am/db/2356319/Santarus>,
        <https://1145.am/db/2360164/Santarus>,
        <https://1145.am/db/2360204/Santarus> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2570961/Santarus_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2013-11-08T12:50:21+00:00"^^xsd:dateTime ;
    ns1:documentExtract "RALEIGH, NC and SAN DIEGO, CA, November 7, 2013 - Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) and Santarus, Inc. (NASDAQ: SNTS) today announced that the companies have entered into a definitive merger agreement under which Salix will acquire all of the outstanding common stock of Santarus for $ 32.00 per share in cash (without interest) .",
        "RALEIGH, NC and SAN DIEGO, CA, November 7, 2013 - Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) and Santarus, Inc. (NASDAQ: SNTS) today announced that the companies have entered into a definitive merger agreement under which Salix will acquire all of the outstanding common stock of Santarus for $ 32.00 per share in cash (without interest).",
        "Salix Pharmaceuticals to Acquire Santarus. Solidifies Position as Largest U.S. Gastroenterology - Focused Specialty Pharmaceutical Company." ;
    ns1:documentTitle "Salix Pharmaceuticals to Acquire Santarus" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/salix-pharmaceuticals-to-acquire-santarus> ;
    ns1:foundName "Acquire",
        "acquire",
        "merger" ;
    ns1:name "Acquire",
        "acquire",
        "merger" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2570961/Santarus> ;
    ns1:targetName "Santarus" ;
    ns1:valueRaw "$ 2.6 billion",
        "approximately $ 2.6 billion" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S" .

<https://1145.am/db/2573218/Acquisition_Avista_Capital_Partners_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-11-26T15:34:04+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Nordic and private equity partner Avista Capital Partners together bought Switzerland - based Acino, which turns out a birth-control patch for Bayer, among other products." ;
    ns1:documentTitle "Nordic Capital, Wendel in two-way race for $1.6B LTS Lohmann deal" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/nordic-capital-wendel-two-way-race-for-1-6b-lts-lohmann-deal> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Switzerland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:whereRaw "Switzerland" .

<https://1145.am/db/2573218/Lts_Lohmann> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:description "nicotine patches and other transdermal drugs" ;
    ns1:documentDate "2013-11-26T15:34:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Nordic Capital, Wendel in two-way race for $1.6B LTS Lohmann deal" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/nordic-capital-wendel-two-way-race-for-1-6b-lts-lohmann-deal> ;
    ns1:foundName "LTS Lohmann" ;
    ns1:industry "drug-patch maker" ;
    ns1:name "LTS Lohmann" ;
    ns1:sameAsHigh <https://1145.am/db/2551694/LTS>,
        <https://1145.am/db/2575136/Lts_Lohmann> ;
    ns1:sameAsMedium <https://1145.am/db/2545539/Lts_Lohmann>,
        <https://1145.am/db/2567526/Lts_Lohmann>,
        <https://1145.am/db/2588775/Lts_Lohmann> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2573218/Lts_Lohmann_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2013-11-26T15:34:04+00:00"^^xsd:dateTime ;
    ns1:documentExtract "For Nordic Capital, buying LTS Lohmann would offer the opportunity to merge its operations with a skin-patch maker it bought last month.",
        "Two buyout firms are duking it out for LTS Lohmann, a drug-patch maker partly owned by Novartis ($ NVS) , Reuters reports." ;
    ns1:documentTitle "Nordic Capital, Wendel in two-way race for $1.6B LTS Lohmann deal" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/nordic-capital-wendel-two-way-race-for-1-6b-lts-lohmann-deal> ;
    ns1:foundName "buying" ;
    ns1:name "buying" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2573218/Lts_Lohmann> ;
    ns1:targetName "LTS Lohmann" ;
    ns1:valueRaw "about $ 1.6 billion" .

<https://1145.am/db/2577114/Viropharma> a org:Organization ;
    ns1:basedInLowRaw "Australia" ;
    ns1:documentDate "2014-01-10T13:06:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Shire extends tender offer for ViroPharma" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/shire-extends-tender-offer-for-viropharma> ;
    ns1:foundName "ViroPharma",
        "ViroPharma Incorporated" ;
    ns1:name "ViroPharma" ;
    ns1:sameAsMedium <https://1145.am/db/2302151/Viropharma>,
        <https://1145.am/db/2307894/Viropharma>,
        <https://1145.am/db/2308922/Viropharma>,
        <https://1145.am/db/2332978/Viropharma_Incorporated>,
        <https://1145.am/db/2336709/Viropharma>,
        <https://1145.am/db/2341522/Viropharma>,
        <https://1145.am/db/2342570/Viropharma>,
        <https://1145.am/db/2349818/Viropharma>,
        <https://1145.am/db/2364071/Viropharma>,
        <https://1145.am/db/2364076/Viropharma>,
        <https://1145.am/db/2364554/Viropharma>,
        <https://1145.am/db/2364556/Viropharma>,
        <https://1145.am/db/2541146/Viropharma>,
        <https://1145.am/db/2544588/Viropharma>,
        <https://1145.am/db/2556988/Viropharma>,
        <https://1145.am/db/2561438/Viropharma>,
        <https://1145.am/db/2569952/Viropharma>,
        <https://1145.am/db/2571521/Viropharma>,
        <https://1145.am/db/2571526/Viropharma>,
        <https://1145.am/db/2572335/Viropharma>,
        <https://1145.am/db/2577117/Viropharma>,
        <https://1145.am/db/2578086/Viropharma>,
        <https://1145.am/db/2579062/Viropharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2580038/Acquisition_Astrazeneca_Bristol-Myers_Squibb_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2014-02-03T13:06:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "AstraZeneca today announced that it completed, on 1 February 2014, the acquisition of the entirety of Bristol-Myers Squibb's interests in the companies' diabetes alliance." ;
    ns1:documentTitle "AstraZeneca Completes the Acquistion of Bristol-Myers Squibb Share of Global Diabetes Alliance" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/astrazeneca-completes-acquistion-of-bristol-myers-squibb-share-of-global-diabetes-alliance> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:vendor <https://1145.am/db/2580038/Bristol-Myers_Squibb> ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "US" .

<https://1145.am/db/2580038/Bristol-Myers_Squibb_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2014-02-03T13:06:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "AstraZeneca Completes the Acquistion of Bristol-Myers Squibb Share of Global Diabetes Alliance.",
        "AstraZeneca today announced that it completed, on 1 February 2014, the acquisition of the entirety of Bristol-Myers Squibb's interests in the companies' diabetes alliance." ;
    ns1:documentTitle "AstraZeneca Completes the Acquistion of Bristol-Myers Squibb Share of Global Diabetes Alliance" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/astrazeneca-completes-acquistion-of-bristol-myers-squibb-share-of-global-diabetes-alliance> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2580038/Bristol-Myers_Squibb> ;
    ns1:targetName "Bristol-Myers Squibb" ;
    ns1:when "2014-02-01T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "1 February 2014" .

<https://1145.am/db/2582969/Paladin_Labs> a org:Organization ;
    ns1:basedInHighGeoName "Canada" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:basedInHighRaw "Canada" ;
    ns1:documentDate "2014-02-27T12:34:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Endo Announces Shareholder Approval of its Acquisition of Paladin Labs" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/endo-announces-shareholder-approval-of-its-acquisition-of-paladin-labs> ;
    ns1:foundName "Paladin Labs",
        "Paladin Labs Inc" ;
    ns1:name "Paladin",
        "Paladin Labs" ;
    ns1:sameAsMedium <https://1145.am/db/2291572/Paladin_Labs>,
        <https://1145.am/db/2295973/Paladin_Labs>,
        <https://1145.am/db/2313367/Paladin_Labs_Inc>,
        <https://1145.am/db/2314217/Paladin_Labs>,
        <https://1145.am/db/2315308/Paladin_Labs>,
        <https://1145.am/db/2315664/Paladin_Labs>,
        <https://1145.am/db/2317622/Paladin_Labs_Inc>,
        <https://1145.am/db/2319656/Paladin_Labs_Inc>,
        <https://1145.am/db/2335600/Paladin_Labs>,
        <https://1145.am/db/2338090/Paladin_Labs>,
        <https://1145.am/db/2339487/Paladin_Labs>,
        <https://1145.am/db/2339856/Paladin_Labs>,
        <https://1145.am/db/2353646/Paladin_Labs>,
        <https://1145.am/db/2555487/Paladin_Labs>,
        <https://1145.am/db/2557083/Paladin_Labs>,
        <https://1145.am/db/2571068/Paladin_Labs>,
        <https://1145.am/db/2575133/Paladin_Labs>,
        <https://1145.am/db/2594087/Paladin_Labs>,
        <https://1145.am/db/2594116/Paladin_Labs>,
        <https://1145.am/db/2597086/Paladin_Labs>,
        <https://1145.am/db/2598012/Paladin_Labs> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2583466/Alkermes_Plc> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "pharmaceutical" ;
    ns1:documentDate "2013-09-11T14:12:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Alkermes plc" ;
    ns1:industry "biopharmaceutical" ;
    ns1:investor <https://1145.am/db/2583466/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "Alkermes plc" ;
    ns1:sameAsHigh <https://1145.am/db/1354528/Alzheon_Inc>,
        <https://1145.am/db/1980328/Alphinity_Usa>,
        <https://1145.am/db/2044268/Alkermes>,
        <https://1145.am/db/2302333/Alder_Biopharmaceuticals_Inc>,
        <https://1145.am/db/2323102/Alk-Abello>,
        <https://1145.am/db/2328312/Arpida>,
        <https://1145.am/db/2331010/Alkermes>,
        <https://1145.am/db/2337141/Alkermes_Plc>,
        <https://1145.am/db/2337285/Alder_Biopharmaceuticals_Inc>,
        <https://1145.am/db/2337638/Alkahest>,
        <https://1145.am/db/2340189/Alkermes>,
        <https://1145.am/db/2344055/Alzheon>,
        <https://1145.am/db/2344056/Alzheon>,
        <https://1145.am/db/2344809/Alkermes>,
        <https://1145.am/db/2347453/Alkermes_Plc>,
        <https://1145.am/db/2351129/Alkermes_Plc>,
        <https://1145.am/db/2357312/Alkermes_Plc>,
        <https://1145.am/db/2357408/Alkermes_Plc>,
        <https://1145.am/db/2360266/Alkermes_Plc>,
        <https://1145.am/db/2368518/Alzheon>,
        <https://1145.am/db/2370086/Alzheon>,
        <https://1145.am/db/2370563/Albireo_Limited>,
        <https://1145.am/db/2536597/Alkermes>,
        <https://1145.am/db/2542430/Alvogen>,
        <https://1145.am/db/2542518/Alkermes>,
        <https://1145.am/db/468193/Alzheon>,
        <https://1145.am/db/979483/Alzheon>,
        <https://1145.am/db/979486/Alzheon> ;
    ns1:sameAsMedium <https://1145.am/db/2036830/Alkermes>,
        <https://1145.am/db/2053753/Alkermes>,
        <https://1145.am/db/2313926/Alkermes_Inc>,
        <https://1145.am/db/2314985/Alkermes_Inc>,
        <https://1145.am/db/2331000/Alkermes>,
        <https://1145.am/db/2336475/Alkermes>,
        <https://1145.am/db/2338420/Alkermes>,
        <https://1145.am/db/2338421/Alkermes>,
        <https://1145.am/db/2340188/Alkermes>,
        <https://1145.am/db/2359802/Alkermes>,
        <https://1145.am/db/2536596/Alkermes>,
        <https://1145.am/db/2545314/Alkermes>,
        <https://1145.am/db/2548137/Alkermes>,
        <https://1145.am/db/2571613/Alkermes>,
        <https://1145.am/db/2573130/Alkermes>,
        <https://1145.am/db/2587657/Alkermes>,
        <https://1145.am/db/2592186/Alkermes>,
        <https://1145.am/db/2596135/Alkermes> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2583466/Canaan_Partners> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-09-11T14:12:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Canaan Partners" ;
    ns1:investor <https://1145.am/db/2583466/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "Canaan Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1043342/Canaan_Partners>,
        <https://1145.am/db/1427471/Potentum_Partners>,
        <https://1145.am/db/1695894/Canaan_Partners>,
        <https://1145.am/db/1697131/Canaan_Partners>,
        <https://1145.am/db/1724566/Canaan_Partners>,
        <https://1145.am/db/1735660/Forward_Partners>,
        <https://1145.am/db/1747333/Framework_Venture_Partners>,
        <https://1145.am/db/1770648/Canaan_Partners>,
        <https://1145.am/db/1776537/Partech_Partners>,
        <https://1145.am/db/1791628/Canaan_Partners>,
        <https://1145.am/db/1819543/Canaan_Partners>,
        <https://1145.am/db/1842466/Canaan_Partners>,
        <https://1145.am/db/1863401/Canaan_Partners>,
        <https://1145.am/db/1910644/Canaan_Partners>,
        <https://1145.am/db/2141055/Excell_Partners>,
        <https://1145.am/db/2297592/Canaan_Partners>,
        <https://1145.am/db/2301765/Canaan_Partners>,
        <https://1145.am/db/2309376/Canaan_Partners>,
        <https://1145.am/db/2309387/Canaan_Partners>,
        <https://1145.am/db/2351129/Canaan_Partners>,
        <https://1145.am/db/2355043/Canaan_Partners>,
        <https://1145.am/db/2355715/Canaan_Partners>,
        <https://1145.am/db/2363535/Canaan_Partners>,
        <https://1145.am/db/2366187/Canaan_Partners>,
        <https://1145.am/db/2370802/Canaan_Partners>,
        <https://1145.am/db/2370834/Canaan_Partners>,
        <https://1145.am/db/3043/Elsewhere_Partners>,
        <https://1145.am/db/645540/Envisioning_Partners>,
        <https://1145.am/db/935302/Framework_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/146274/Canaan_Partners>,
        <https://1145.am/db/1696766/Canaan_Partners>,
        <https://1145.am/db/1702857/Canaan_Partners>,
        <https://1145.am/db/1711633/Canaan_Partners>,
        <https://1145.am/db/1734259/Canaan_Partners>,
        <https://1145.am/db/1741014/Canaan_Partners>,
        <https://1145.am/db/1741105/Canaan_Partners>,
        <https://1145.am/db/1741424/Canaan_Partners>,
        <https://1145.am/db/1749744/Canaan_Partners>,
        <https://1145.am/db/1754820/Canaan_Partners>,
        <https://1145.am/db/1768400/Canaan_Partners>,
        <https://1145.am/db/1792426/Canaan_Partners>,
        <https://1145.am/db/1793543/Canaan_Partners>,
        <https://1145.am/db/1796375/Canaan_Partners>,
        <https://1145.am/db/1814413/Canaan_Partners>,
        <https://1145.am/db/1827240/Canaan_Partners>,
        <https://1145.am/db/1829078/Canaan_Partners>,
        <https://1145.am/db/1829544/Canaan_Partners>,
        <https://1145.am/db/1836578/Canaan_Partners>,
        <https://1145.am/db/1845119/Canaan_Partners>,
        <https://1145.am/db/1852066/Canaan_Partners>,
        <https://1145.am/db/1858762/Canaan_Partners>,
        <https://1145.am/db/1866968/Canaan_Partners>,
        <https://1145.am/db/1894670/Canaan_Partners>,
        <https://1145.am/db/1897255/Canaan_Partners>,
        <https://1145.am/db/1900458/Canaan_Partners>,
        <https://1145.am/db/1906336/Canaan_Partners>,
        <https://1145.am/db/1907151/Canaan_Partners>,
        <https://1145.am/db/1907762/Canaan_Partners>,
        <https://1145.am/db/1919135/Canaan_Partners>,
        <https://1145.am/db/1920478/Canaan_Partners>,
        <https://1145.am/db/2164798/Canaan_Partners>,
        <https://1145.am/db/2164838/Canaan_Partners>,
        <https://1145.am/db/2210939/Canaan_Partners>,
        <https://1145.am/db/2238667/Canaan_Partners>,
        <https://1145.am/db/2287025/Canaan_Partners>,
        <https://1145.am/db/2287777/Canaan_Partners>,
        <https://1145.am/db/2298642/Canaan_Partners>,
        <https://1145.am/db/2304587/Canaan_Partners>,
        <https://1145.am/db/2304605/Canaan_Partners>,
        <https://1145.am/db/2306281/Canaan_Partners>,
        <https://1145.am/db/2308329/Canaan_Partners>,
        <https://1145.am/db/2313171/Canaan_Partners>,
        <https://1145.am/db/2320925/Canaan_Partners>,
        <https://1145.am/db/2322231/Canaan_Partners>,
        <https://1145.am/db/2329010/Canaan_Partners>,
        <https://1145.am/db/2329011/Canaan_Partners>,
        <https://1145.am/db/2329531/Canaan_Partners>,
        <https://1145.am/db/2332322/Canaan_Partners>,
        <https://1145.am/db/2337958/Canaan_Partners>,
        <https://1145.am/db/2337974/Canaan_Partners>,
        <https://1145.am/db/2346532/Canaan_Partners>,
        <https://1145.am/db/2347469/Canaan_Partners>,
        <https://1145.am/db/2351316/Canaan_Partners>,
        <https://1145.am/db/2351684/Canaan_Partners>,
        <https://1145.am/db/2353588/Canaan_Partners>,
        <https://1145.am/db/2353608/Canaan_Partners>,
        <https://1145.am/db/2355238/Canaan_Partners>,
        <https://1145.am/db/2358378/Canaan_Partners>,
        <https://1145.am/db/2359185/Canaan_Partners>,
        <https://1145.am/db/2360258/Canaan_Partners>,
        <https://1145.am/db/2360266/Canaan_Partners>,
        <https://1145.am/db/2360647/Canaan_Partners>,
        <https://1145.am/db/2365700/Canaan_Partners>,
        <https://1145.am/db/2366753/Canaan_Partners>,
        <https://1145.am/db/2368322/Canaan_Partners>,
        <https://1145.am/db/2368973/Canaan_Partners>,
        <https://1145.am/db/2368982/Canaan_Partners>,
        <https://1145.am/db/2370582/Canaan_Partners>,
        <https://1145.am/db/2572398/Canaan_Partners>,
        <https://1145.am/db/2635439/Canaan_Partners>,
        <https://1145.am/db/316299/Canaan_Partners>,
        <https://1145.am/db/319155/Canaan_Partners>,
        <https://1145.am/db/353476/Canaan_Partners>,
        <https://1145.am/db/411041/Canaan_Partners>,
        <https://1145.am/db/523179/Canaan_Partners>,
        <https://1145.am/db/564082/Canaan_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2583466/Fountain_Healthcare_Partners> a org:Organization ;
    ns1:description "healthcare" ;
    ns1:documentDate "2013-09-11T14:12:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Fountain Healthcare Partners" ;
    ns1:investor <https://1145.am/db/2583466/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "Fountain Healthcare Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2288529/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2298125/Fountain_Healthcare>,
        <https://1145.am/db/2299803/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2330711/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2330799/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2351129/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2352204/Fountain_Healthcare_Partners>,
        <https://1145.am/db/236357/Fountain_Healthcare_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1061564/Fountain_Healthcare_Partners>,
        <https://1145.am/db/1173939/Fountain_Healthcare_Partners>,
        <https://1145.am/db/1219334/Fountain_Healthcare_Partners>,
        <https://1145.am/db/1219771/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2152706/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2228342/Fountain_Healthcare_Partners_I>,
        <https://1145.am/db/2288332/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2291023/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2294585/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2296850/Fountain_Healthcare>,
        <https://1145.am/db/2327485/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2327490/Fountain_Healthcare_Partners_I>,
        <https://1145.am/db/2331750/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2352203/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2352216/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2358172/Fountain_Healthcare_Partners_Ii>,
        <https://1145.am/db/2360266/Fountain_Healthcare_Partners>,
        <https://1145.am/db/2569220/Fountain_Healthcare_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2583466/Longitude_Capital> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-09-11T14:12:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Longitude Capital" ;
    ns1:investor <https://1145.am/db/2583466/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "Longitude Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1503165/Longitude_Capital>,
        <https://1145.am/db/1519688/Longitude_Capital>,
        <https://1145.am/db/1520070/Longitude_Capital>,
        <https://1145.am/db/2288251/Longitude_Capital>,
        <https://1145.am/db/2305615/Longitude_Venture_Partners>,
        <https://1145.am/db/2305625/Longitude_Venture_Partners>,
        <https://1145.am/db/2323797/Longitude_Venture_Partners_Iii>,
        <https://1145.am/db/2339214/Longitude_Capital>,
        <https://1145.am/db/2339223/Longitude_Capital>,
        <https://1145.am/db/2351129/Longitude_Capital>,
        <https://1145.am/db/2352170/Longitude_Capital>,
        <https://1145.am/db/2365501/Longitude_Capital>,
        <https://1145.am/db/955355/Longitude_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1467975/Longitude_Capital>,
        <https://1145.am/db/1482048/Longitude_Capital>,
        <https://1145.am/db/2075754/Longitude_Capital>,
        <https://1145.am/db/2152399/Longitude_Capital>,
        <https://1145.am/db/2155668/Longitude_Capital>,
        <https://1145.am/db/2182698/Longitude_Capital>,
        <https://1145.am/db/2198647/Longitude_Capital>,
        <https://1145.am/db/2290453/Longitude_Capital>,
        <https://1145.am/db/2297930/Longitude_Capital>,
        <https://1145.am/db/2298634/Longitude_Capital>,
        <https://1145.am/db/2300708/Longitude_Capital>,
        <https://1145.am/db/2330799/Longitude_Capital>,
        <https://1145.am/db/2337591/Longitude_Capital>,
        <https://1145.am/db/2338428/Longitude_Capital>,
        <https://1145.am/db/2340204/Longitude_Capital>,
        <https://1145.am/db/2340207/Longitude_Capital>,
        <https://1145.am/db/2352167/Longitude_Capital>,
        <https://1145.am/db/2366753/Longitude_Capital>,
        <https://1145.am/db/2368232/Longitude_Capital>,
        <https://1145.am/db/2369359/Longitude_Capital>,
        <https://1145.am/db/2564563/Longitude_Capital>,
        <https://1145.am/db/958767/Longitude_Capital>,
        <https://1145.am/db/959519/Longitude_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2583466/Ra_Capital> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-09-11T14:12:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "RA Capital" ;
    ns1:investor <https://1145.am/db/2583466/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "RA Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1038108/Revel_Partners>,
        <https://1145.am/db/1198548/Ra_Capital_Management>,
        <https://1145.am/db/1204750/Revaia>,
        <https://1145.am/db/1564078/Rtx_Ventures>,
        <https://1145.am/db/1682224/R-Squared_Ventures>,
        <https://1145.am/db/1690324/Rtx_Ventures>,
        <https://1145.am/db/1699434/Republic_Capital>,
        <https://1145.am/db/1745840/Rebright_Partners>,
        <https://1145.am/db/1751361/Jme_Ventures>,
        <https://1145.am/db/1782413/Jme_Ventures>,
        <https://1145.am/db/1810093/Rebright_Partners>,
        <https://1145.am/db/1827771/Redpoint_Eventures>,
        <https://1145.am/db/1838458/Rebright_Partners>,
        <https://1145.am/db/1839119/Red_Dot_Ventures>,
        <https://1145.am/db/1843031/Rre>,
        <https://1145.am/db/1848432/Red_Dot_Ventures>,
        <https://1145.am/db/1896419/Resonant_Venture_Partners>,
        <https://1145.am/db/2153910/Ra_Capital_Management>,
        <https://1145.am/db/2154009/RMM>,
        <https://1145.am/db/2292800/Ra_Capital>,
        <https://1145.am/db/2353921/Remiges_Fund>,
        <https://1145.am/db/2369967/Ra_Capital>,
        <https://1145.am/db/458087/Rhia_Ventures>,
        <https://1145.am/db/831537/Rr_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1340338/Ra_Capital>,
        <https://1145.am/db/2182698/Ra_Capital>,
        <https://1145.am/db/2280061/Ra_Capital>,
        <https://1145.am/db/2285938/Ra_Capital>,
        <https://1145.am/db/2336126/Ra_Capital>,
        <https://1145.am/db/2349437/Ra_Capital>,
        <https://1145.am/db/2351129/Ra_Capital>,
        <https://1145.am/db/2354376/Ra_Capital>,
        <https://1145.am/db/2355183/Ra_Capital>,
        <https://1145.am/db/2361416/Ra_Capital>,
        <https://1145.am/db/968301/Ra_Capital>,
        <https://1145.am/db/972968/Ra_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2584394/Safeshot_Technologies_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Menlo Park" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5372223/about.rdf> ;
    ns1:basedInHighRaw "MENLO PARK" ;
    ns1:description "Business",
        "a pharmaceutical company" ;
    ns1:documentDate "2013-09-25T13:34:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SafeShot Technologies Inc. Secures $9 Million Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/safeshot-technologies-inc-secures-9-million-financing> ;
    ns1:foundName "SafeShot Technologies Inc.",
        "SafeShot Technologies, Inc",
        "SafeShot Technologies, Inc." ;
    ns1:name "SafeShot Technologies",
        "SafeShot Technologies Inc." ;
    ns1:sameAsMedium <https://1145.am/db/2291618/Safeshot_Technologies> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2584900/Vidara> a org:Organization ;
    ns1:basedInHighGeoName "Dublin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2964574/about.rdf> ;
    ns1:basedInHighRaw "DUBLIN, IRELAND" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2014-03-19T13:14:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/horizon-pharma-to-acquire-vidara-therapeutics-international-ltd-and-become-horizon-pharma> ;
    ns1:foundName "Vidara" ;
    ns1:industry "Pharma" ;
    ns1:name "Vidara" ;
    ns1:sameAsHigh <https://1145.am/db/2153295/Vidara_Therapeutics>,
        <https://1145.am/db/2318313/Vidac_Pharma>,
        <https://1145.am/db/2357704/Vidara_Therapeutics_International_Limited>,
        <https://1145.am/db/2357705/Vidara_Therapeutics>,
        <https://1145.am/db/2584909/Vidara> ;
    ns1:sameAsMedium <https://1145.am/db/2362525/Vidara> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2584900/Vidara_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2014-03-19T13:14:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "DEERFIELD, IL and DUBLIN, IRELAND- (Marketwired - Mar 19, 2014) - Horizon Pharma, Inc. (HZNP) and Vidara Therapeutics International Ltd. (Vidara) today announced they have entered into a definitive agreement under which Horizon Pharma will acquire Vidara through a reverse merger for stock and cash valued at approximately $ 660 million." ;
    ns1:documentTitle "Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/horizon-pharma-to-acquire-vidara-therapeutics-international-ltd-and-become-horizon-pharma> ;
    ns1:foundName "acquire",
        "merger",
        "reverse merger" ;
    ns1:name "acquire",
        "merger",
        "reverse merger" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2584900/Vidara> ;
    ns1:targetName "Vidara" ;
    ns1:valueRaw "approximately $ 660 million" ;
    ns1:whereGeoName "Dublin" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2964574/about.rdf> ;
    ns1:whereRaw "DUBLIN, IRELAND" .

<https://1145.am/db/2586763/King_Pharmaceuticals> a org:Organization ;
    ns1:basedInLowRaw "Chile" ;
    ns1:documentDate "2013-07-03T15:46:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merck pulls Recombivax lot on cracked-vial risk; India's Elder Pharma to buy OTC drugmaker;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/merck-pulls-recombivax-lot-on-cracked-vial-risk-india-s-elder-pharma-to-buy-otc-drugmaker> ;
    ns1:foundName "King Pharmaceuticals" ;
    ns1:industry "drug maker" ;
    ns1:name "King Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2303132/King_Pharmaceuticals>,
        <https://1145.am/db/2304228/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2309924/King_Pharmaceuticals>,
        <https://1145.am/db/2311359/King_Pharmaceuticals>,
        <https://1145.am/db/2316576/King_Pharmaceuticals>,
        <https://1145.am/db/2316578/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2317595/King_Pharmaceuticals>,
        <https://1145.am/db/2317597/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318689/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318984/King_Pharmaceuticals>,
        <https://1145.am/db/2320998/King_Pharmaceuticals>,
        <https://1145.am/db/2321010/King_Pharmaceuticals>,
        <https://1145.am/db/2322039/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322272/King_Pharmaceuticals>,
        <https://1145.am/db/2325296/King_Pharmaceuticals>,
        <https://1145.am/db/2326314/King_Pharmaceuticals>,
        <https://1145.am/db/2326323/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2327224/King_Pharmaceuticals>,
        <https://1145.am/db/2330766/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330774/King_Pharmaceuticals>,
        <https://1145.am/db/2339627/King_Pharmaceuticals>,
        <https://1145.am/db/2339633/King_Pharmaceuticals>,
        <https://1145.am/db/2341372/King_Pharmaceuticals>,
        <https://1145.am/db/2341377/King_Pharmaceuticals>,
        <https://1145.am/db/2351730/King_Pharmaceuticals>,
        <https://1145.am/db/2354914/King_Pharmaceuticals>,
        <https://1145.am/db/2355472/King_Pharmaceuticals>,
        <https://1145.am/db/2362851/King_Pharmaceuticals>,
        <https://1145.am/db/2367283/King_Pharmaceuticals>,
        <https://1145.am/db/2537542/King_Pharmaceuticals>,
        <https://1145.am/db/2539292/King_Pharmaceuticals>,
        <https://1145.am/db/2539298/King_Pharmaceuticals>,
        <https://1145.am/db/2541548/King_Pharmaceuticals>,
        <https://1145.am/db/2542509/King_Pharmaceuticals>,
        <https://1145.am/db/2543554/King_Pharmaceuticals>,
        <https://1145.am/db/2547068/King_Pharmaceuticals>,
        <https://1145.am/db/2549687/King_Pharmaceuticals>,
        <https://1145.am/db/2550685/King_Pharmaceuticals_Plant>,
        <https://1145.am/db/2563450/King_Pharmaceuticals>,
        <https://1145.am/db/2571798/King_Pharmaceuticals>,
        <https://1145.am/db/2575505/King_Pharmaceuticals>,
        <https://1145.am/db/2580401/King_Pharmaceuticals>,
        <https://1145.am/db/2581331/King_Pharmaceuticals>,
        <https://1145.am/db/2581334/King_Pharmaceuticals>,
        <https://1145.am/db/2581339/King_Pharmaceuticals>,
        <https://1145.am/db/2582343/King_Pharmaceuticals>,
        <https://1145.am/db/2583242/King_Pharmaceuticals>,
        <https://1145.am/db/2587387/King_Pharmaceutical>,
        <https://1145.am/db/2588134/King_Pharmaceuticals>,
        <https://1145.am/db/2589055/King_Pharmaceuticals_Inc>,
        <https://1145.am/db/2592975/King_Pharmaceuticals>,
        <https://1145.am/db/2592977/King_Pharmaceuticals>,
        <https://1145.am/db/2592980/King_Pharmaceuticals>,
        <https://1145.am/db/2592990/King_Pharmaceuticals>,
        <https://1145.am/db/2592992/King_Pharmaceuticals>,
        <https://1145.am/db/2595320/King_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2327609/King_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586763/Max_Healthcare> a org:Organization ;
    ns1:basedInLowRaw "U.K." ;
    ns1:documentDate "2013-07-03T15:46:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merck pulls Recombivax lot on cracked-vial risk; India's Elder Pharma to buy OTC drugmaker;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/merck-pulls-recombivax-lot-on-cracked-vial-risk-india-s-elder-pharma-to-buy-otc-drugmaker> ;
    ns1:foundName "Max Healthcare" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Max Healthcare" ;
    ns1:sameAsHigh <https://1145.am/db/2362525/Infinity_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593433/Onyx_Pharmaceuticals_Inc> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO and SAN FRANCISCO" ;
    ns1:description "Business",
        "pharmaceuticals" ;
    ns1:documentDate "2013-08-27T07:00:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acquisition-of-onyx-pharmaceuticals-inc-by-amgen-inc-may-not-be-best-interests-of-onyx> ;
    ns1:foundName "Onyx",
        "Onyx Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Onyx Pharmaceuticals",
        "Onyx Pharmaceuticals, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1441206/Omniab_Inc>,
        <https://1145.am/db/1446295/Omniab_Inc>,
        <https://1145.am/db/2078551/Omniab>,
        <https://1145.am/db/2293861/Ablynx>,
        <https://1145.am/db/2301137/Ablynx>,
        <https://1145.am/db/2301170/Ablynx>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2311202/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2311341/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2312479/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2312678/Onyx_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312685/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2316545/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2321048/Abraxis_Bioscience>,
        <https://1145.am/db/2321056/Abraxis_Bioscience>,
        <https://1145.am/db/2321535/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2322093/Ovation_Pharmaceuticals_Inc>,
        <https://1145.am/db/2325078/Abraxis_Bioscience>,
        <https://1145.am/db/2326533/Abgenix>,
        <https://1145.am/db/2330532/Abraxis_Bioscience>,
        <https://1145.am/db/2330833/Xanthus_Pharmaceuticals>,
        <https://1145.am/db/2337435/Onyx_Pharmaceuticals_Inc>,
        <https://1145.am/db/2343428/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2343862/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2344864/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2345886/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2347663/Abraxis_Bioscience>,
        <https://1145.am/db/2347976/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2350029/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2351091/Orca_Pharmaceuticals>,
        <https://1145.am/db/2353167/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2357303/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2368375/Ablynx>,
        <https://1145.am/db/2368378/Ablynx>,
        <https://1145.am/db/2553841/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2558927/Ablynx>,
        <https://1145.am/db/2571452/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2591594/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2593423/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2593426/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2593434/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2593465/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2595017/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2595340/Abraxis_Bioscience>,
        <https://1145.am/db/2595466/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2595549/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2596819/Onyx_Pharmaceuticals>,
        <https://1145.am/db/295168/Orifarm>,
        <https://1145.am/db/723883/Oravax_Medical_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2321536/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2357792/Onyx_Pharmaceuticals>,
        <https://1145.am/db/2591587/Onyx_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593445/Simcere_Acquisition_Limited> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:description "mergers" ;
    ns1:documentDate "2013-08-28T11:55:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Simcere Pharmaceutical Group Enters Into Definitive Merger Agreement for Going Private Transaction" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/simcere-pharmaceutical-group-enters-into-definitive-merger-agreement-for-going-private> ;
    ns1:foundName "Simcere Acquisition Limited" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Simcere Acquisition Limited" ;
    ns1:protagonist <https://1145.am/db/2593445/Simcere_Pharmaceutical_Group_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2593445/Simcere_Holding_Limited> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593445/Simcere_Holding_Limited> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:buyer <https://1145.am/db/2593445/Simcere_Pharmaceutical_Group_Acquisition> ;
    ns1:description "mergers" ;
    ns1:documentDate "2013-08-28T11:55:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Simcere Pharmaceutical Group Enters Into Definitive Merger Agreement for Going Private Transaction" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/simcere-pharmaceutical-group-enters-into-definitive-merger-agreement-for-going-private> ;
    ns1:foundName "Parent",
        "Simcere Holding Limited" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Simcere Holding Limited" ;
    ns1:protagonist <https://1145.am/db/2593445/Simcere_Pharmaceutical_Group_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2308761/Simcere_Pharma>,
        <https://1145.am/db/2593445/Simcere_Acquisition_Limited> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593445/Simcere_Pharmaceutical_Group> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:description "development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China" ;
    ns1:documentDate "2013-08-28T11:55:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Simcere Pharmaceutical Group Enters Into Definitive Merger Agreement for Going Private Transaction" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/simcere-pharmaceutical-group-enters-into-definitive-merger-agreement-for-going-private> ;
    ns1:foundName "Simcere",
        "Simcere Pharmaceutical Group" ;
    ns1:industry "Pharmaceutical",
        "pharmaceutical" ;
    ns1:name "Simcere",
        "Simcere Pharmaceutical Group" ;
    ns1:protagonist <https://1145.am/db/2593445/Simcere_Pharmaceutical_Group_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/1316555/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2225406/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2309185/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2320311/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2321868/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2321885/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2321953/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2324067/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2338347/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2359485/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2369034/Simcere_Pharmaceutical>,
        <https://1145.am/db/2547453/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2572442/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2578162/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2578167/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/2587281/Simcere_Pharmaceutical>,
        <https://1145.am/db/2597905/Simcere_Pharmaceutical_Group>,
        <https://1145.am/db/814484/Simcere_Pharmaceutical_Group> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593457/Ojsc_Veropharm> a org:Organization ;
    ns1:basedInHighGeoName "Russian Federation" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:basedInHighRaw "Russia" ;
    ns1:description "pharmaceutical manufacturers" ;
    ns1:documentDate "2013-08-29T15:03:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pharmacy Chain 36.6 signs agreement to sell stake in Veropharm" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/pharmacy-chain-36-6-signs-agreement-to-sell-stake-veropharm> ;
    ns1:foundName "OJSC Veropharm",
        "Veropharm" ;
    ns1:industry "Pharmacy",
        "pharmaceutical" ;
    ns1:name "OJSC Veropharm",
        "Veropharm" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593457/Ojsc_Veropharm_Stake_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-08-29T15:03:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "August 29, 2013, Moscow - Pharmacy Chain 36.6 [ : RU14APTK1007 ], a national leader in beauty and health retail goods, is announcing a deal on the sale of the Group's 52 % stake in OJSC Veropharm [ : VRPH ], one of the largest pharmaceutical manufacturers in Russia.",
        "Pharmacy Chain 36.6 signs agreement to sell stake in Veropharm." ;
    ns1:documentTitle "Pharmacy Chain 36.6 signs agreement to sell stake in Veropharm" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/pharmacy-chain-36-6-signs-agreement-to-sell-stake-veropharm> ;
    ns1:foundName "sale" ;
    ns1:name "sale" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2593457/Ojsc_Veropharm>,
        <https://1145.am/db/2593457/Pharmacy_Chain_366> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "OJSC Veropharm",
        "Veropharm" ;
    ns1:valueRaw "RUB 5.0 billion" ;
    ns1:when "2013-08-29T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "August 29, 2013" ;
    ns1:whereGeoName "Russian Federation" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:whereRaw "Russia" .

<https://1145.am/db/2593457/Pharmacy_Chain_366> a org:Organization ;
    ns1:basedInHighGeoName "Russian Federation" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:basedInHighRaw "Russia" ;
    ns1:description "beauty and health retail goods" ;
    ns1:documentDate "2013-08-29T15:03:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pharmacy Chain 36.6 signs agreement to sell stake in Veropharm" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/pharmacy-chain-36-6-signs-agreement-to-sell-stake-veropharm> ;
    ns1:foundName "Pharmacy Chain 36.6" ;
    ns1:industry "beauty and health retail goods" ;
    ns1:name "Pharmacy Chain 36.6" ;
    ns1:sameAsMedium <https://1145.am/db/2593463/Pharmacy_Chain_366> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595564/Onyx> a org:Organization ;
    ns1:documentDate "2013-09-19T15:58:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "With $29B in deals so far, 2013 shaping up as big M&A year" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/29b-deals-so-far-2013-shaping-up-as-big-m-a-year> ;
    ns1:foundName "Onyx" ;
    ns1:industry "drug approvals" ;
    ns1:name "Onyx" ;
    ns1:sameAsMedium <https://1145.am/db/2014263/Onyx_Private>,
        <https://1145.am/db/2292922/Onyx>,
        <https://1145.am/db/2292928/Onyx>,
        <https://1145.am/db/2293417/Onyx>,
        <https://1145.am/db/2336702/Onyx>,
        <https://1145.am/db/2337433/Onyx>,
        <https://1145.am/db/2337452/Onyx>,
        <https://1145.am/db/2339863/Onyx>,
        <https://1145.am/db/2340669/Onyx>,
        <https://1145.am/db/2349030/Onyx>,
        <https://1145.am/db/2357336/Onyx>,
        <https://1145.am/db/2358051/Onyx> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2608080/Access_Communications> a org:Organization ;
    ns1:basedInHighGeoName "Minnesota" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5037779/about.rdf> ;
    ns1:basedInHighRaw "Minnesota" ;
    ns1:description "telecom" ;
    ns1:documentDate "2013-10-07T13:45:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zayo acquires FiberLink, expands dark fiber network to 26,000 miles" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/zayo-acquires-fiberlink-expands-dark-fiber-network-to-26-000-miles> ;
    ns1:foundName "Access Communications" ;
    ns1:name "Access Communications" ;
    ns1:sameAsHigh <https://1145.am/db/1537154/Consolidated_Communications>,
        <https://1145.am/db/1537960/Consolidated_Communications>,
        <https://1145.am/db/2601827/Level_3_Communications>,
        <https://1145.am/db/2602900/Consolidated_Communications>,
        <https://1145.am/db/2604354/D___E_Communications>,
        <https://1145.am/db/2605230/Level_3_Communications>,
        <https://1145.am/db/2606887/Level_3_Communications>,
        <https://1145.am/db/2607243/Level_3_Communications>,
        <https://1145.am/db/2610972/Level_3_Communications>,
        <https://1145.am/db/2617108/Level_3_Communications>,
        <https://1145.am/db/2653537/Innovative_Communications> ;
    ns1:sameAsMedium <https://1145.am/db/2605055/Access_Communications>,
        <https://1145.am/db/2607368/Access_Communications> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2608080/Fiberlink> a org:Organization ;
    ns1:basedInHighGeoName "Midwest" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/11887750/about.rdf> ;
    ns1:basedInHighRaw "Midwest" ;
    ns1:buyer <https://1145.am/db/2608080/Access_Communications_Acquisition>,
        <https://1145.am/db/2608080/Acquisition_Fiberlink_Zayo_Has_Not_Happened> ;
    ns1:description "dark fiber business model" ;
    ns1:documentDate "2013-10-07T13:45:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zayo acquires FiberLink, expands dark fiber network to 26,000 miles" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/zayo-acquires-fiberlink-expands-dark-fiber-network-to-26-000-miles> ;
    ns1:foundName "FiberLink" ;
    ns1:name "FiberLink" ;
    ns1:sameAsHigh <https://1145.am/db/1594360/Bandwidth_Infrastructure_Group>,
        <https://1145.am/db/2599359/Geo_Networks_Ltd>,
        <https://1145.am/db/2600662/Agl_Networks>,
        <https://1145.am/db/2601447/Fibergate>,
        <https://1145.am/db/2605055/Access_Communications>,
        <https://1145.am/db/2605296/Usa_Fiber>,
        <https://1145.am/db/2605883/Agl_Networks>,
        <https://1145.am/db/2607368/Access_Communications>,
        <https://1145.am/db/2615332/Dark_Fiber_And_Infrastructure>,
        <https://1145.am/db/2616286/Fibertech>,
        <https://1145.am/db/2616631/Cross_River_Fiber> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2608080/Fiberlink_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-10-07T13:45:18+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Zayo has added FiberLink, a Midwest - based service provider to its growing acquisition shopping basket, a move that immediately enhances its dark fiber service set." ;
    ns1:documentTitle "Zayo acquires FiberLink, expands dark fiber network to 26,000 miles" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/zayo-acquires-fiberlink-expands-dark-fiber-network-to-26-000-miles> ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2608080/Fiberlink> ;
    ns1:targetName "FiberLink" ;
    ns1:whereGeoName "Midwest" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/11887750/about.rdf> ;
    ns1:whereRaw "Midwest" .

<https://1145.am/db/2651118/Caisse_De_Depot_Et_De_Gestion> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Morocco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2542007/about.rdf> ;
    ns1:basedInHighRaw "Morocco" ;
    ns1:buyer <https://1145.am/db/2651118/Maroc_Telecom_Stake_Acquisition> ;
    ns1:description "Business" ;
    ns1:documentDate "2013-07-17T14:56:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Growth returns in Spain; Etisalat may have a partner for Maroc Telecom stake" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/growth-returns-spain-etisalat-may-have-a-partner-for-maroc-telecom-stake> ;
    ns1:foundName "Caisse de Depot et de Gestion" ;
    ns1:name "Caisse de Depot et de Gestion" ;
    ns1:sameAsMedium <https://1145.am/db/2651156/Caisse_De_Depot_Et_De_Gestion> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2651118/Deutsche_Telekom> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:description "business" ;
    ns1:documentDate "2013-07-17T14:56:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Growth returns in Spain; Etisalat may have a partner for Maroc Telecom stake" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/growth-returns-spain-etisalat-may-have-a-partner-for-maroc-telecom-stake> ;
    ns1:foundName "Deutsche Telekom" ;
    ns1:name "Deutsche Telekom" ;
    ns1:sameAsHigh <https://1145.am/db/1177231/Deutsche_Telekom>,
        <https://1145.am/db/1204904/Deutsche_Telekom>,
        <https://1145.am/db/1205338/Deutsche_Telekom>,
        <https://1145.am/db/1339791/Deutsche_Telekom>,
        <https://1145.am/db/1754033/Deutsche_Telekom>,
        <https://1145.am/db/1841425/Deutsche_Telekom>,
        <https://1145.am/db/194838/Deutsche_Telekom>,
        <https://1145.am/db/194855/Deutsche_Telekom>,
        <https://1145.am/db/1961170/Deutsche>,
        <https://1145.am/db/202888/Deutsche_Telekom>,
        <https://1145.am/db/2606974/Deutsche_Telekom>,
        <https://1145.am/db/2614200/Deutsche_Telekom>,
        <https://1145.am/db/2624446/Deutsche_Telekom>,
        <https://1145.am/db/2628029/Deutsche_Telekom>,
        <https://1145.am/db/2629337/Deutsche_Telekom>,
        <https://1145.am/db/2631186/Deutsche_Telekom>,
        <https://1145.am/db/2640243/Deutsche_Telekom>,
        <https://1145.am/db/2643007/Deutsche_Telekom>,
        <https://1145.am/db/2651025/Telefnica_Deutschland>,
        <https://1145.am/db/2651511/Telefnica_Deutschland>,
        <https://1145.am/db/2651808/Deutsche_Telekom>,
        <https://1145.am/db/2652793/Deutsche_Telekom>,
        <https://1145.am/db/2653257/Deutsche_Telekom>,
        <https://1145.am/db/2653978/Deutsche_Telekom>,
        <https://1145.am/db/2655754/Telefnica_Deutschland>,
        <https://1145.am/db/2655776/Deutsche_Telekom>,
        <https://1145.am/db/2656752/Deutsche_Telekom>,
        <https://1145.am/db/2656845/Deutsche_Telekom>,
        <https://1145.am/db/2656851/Deutsche_Telekom>,
        <https://1145.am/db/2657928/Deutsche_Telekom>,
        <https://1145.am/db/2659597/Deutsche_Telekom>,
        <https://1145.am/db/2659631/Deutsche_Telekom>,
        <https://1145.am/db/2660467/Deutsche_Telekom>,
        <https://1145.am/db/2662264/Deutsche_Telekom>,
        <https://1145.am/db/2664232/Deutsche_Telekom>,
        <https://1145.am/db/2664873/Deutsche_Telekom>,
        <https://1145.am/db/2665038/Deutsche_Telekom>,
        <https://1145.am/db/2665382/Deutsche_Telekom>,
        <https://1145.am/db/2666440/Telefnica_Deutschland>,
        <https://1145.am/db/2666650/Deutsche_Telekom_Ag>,
        <https://1145.am/db/2666767/Deutsche_Telekom>,
        <https://1145.am/db/2666977/Deutsche_Telekom>,
        <https://1145.am/db/2667483/Deutsche_Telekom>,
        <https://1145.am/db/2668148/Deutsche_Telekom>,
        <https://1145.am/db/2668430/Deutsche_Telekom>,
        <https://1145.am/db/2669553/Deutsche_Telekom>,
        <https://1145.am/db/2669627/Telefnica_Deutschland>,
        <https://1145.am/db/2669661/Telefnica_Deutschland>,
        <https://1145.am/db/2669665/Deutsche_Telekom>,
        <https://1145.am/db/2669701/Deutsche_Telekom>,
        <https://1145.am/db/2669829/Deutsche_Telekom>,
        <https://1145.am/db/2669859/Deutsche_Telekom>,
        <https://1145.am/db/2670741/Deutsche_Telekom>,
        <https://1145.am/db/2670759/Telefnica_Deutschland>,
        <https://1145.am/db/2670930/Deutsche_Telekom>,
        <https://1145.am/db/2673920/Deutsche_Telekom>,
        <https://1145.am/db/2674057/Deutsche_Telekom>,
        <https://1145.am/db/2674215/Deutsche_Telekom>,
        <https://1145.am/db/2675183/Deutsche_Telekom>,
        <https://1145.am/db/2675329/Deutsche_Telekom>,
        <https://1145.am/db/2675380/Deutsche_Telekom>,
        <https://1145.am/db/2676572/Deutsche_Telekom>,
        <https://1145.am/db/2676632/Deutsche_Telekom>,
        <https://1145.am/db/2676662/Telefnica_Deutschland>,
        <https://1145.am/db/2677616/Deutsche_Telekom>,
        <https://1145.am/db/2677617/Deutsche_Telekom>,
        <https://1145.am/db/2678023/Deutsche_Telekom>,
        <https://1145.am/db/2680106/Telefnica_Deutschland>,
        <https://1145.am/db/2681082/Deutsche_Telekom>,
        <https://1145.am/db/2681489/Deutsche_Telekom>,
        <https://1145.am/db/338081/Deutsche_Telekom>,
        <https://1145.am/db/455601/Deutsche_Telekom>,
        <https://1145.am/db/599311/Deutsche_Telekom>,
        <https://1145.am/db/895888/Deutsche_Telekom>,
        <https://1145.am/db/976442/Deutsche_Telekom> ;
    ns1:sameAsMedium <https://1145.am/db/1200070/Deutsche_Telekom>,
        <https://1145.am/db/1204075/Deutsche_Telekom_Ag>,
        <https://1145.am/db/1204728/Deutsche_Telekom>,
        <https://1145.am/db/1205180/Deutsche_Telekom_Ag>,
        <https://1145.am/db/1432446/Deutsche_Telekom>,
        <https://1145.am/db/1703907/Deutsche_Telekom>,
        <https://1145.am/db/1755882/Deutsche_Telekom>,
        <https://1145.am/db/1798764/Deutsche_Telekom>,
        <https://1145.am/db/1847752/Deutsche_Telekom>,
        <https://1145.am/db/1849761/Deutsche_Telekom>,
        <https://1145.am/db/1857982/Deutsche_Telekom>,
        <https://1145.am/db/1868921/Deutsche_Telekom>,
        <https://1145.am/db/1874419/Deutsche_Telekom>,
        <https://1145.am/db/1906790/Deutsche_Telekom>,
        <https://1145.am/db/1945321/Deutsche_Telekom>,
        <https://1145.am/db/2156872/Deutsche_Telekom>,
        <https://1145.am/db/2222550/Deutsche_Telekom>,
        <https://1145.am/db/2599629/Deutsche_Telekom>,
        <https://1145.am/db/2606781/Deutsche_Telekom>,
        <https://1145.am/db/2608515/Deutsche_Telekom>,
        <https://1145.am/db/2609688/Deutsche_Telekom>,
        <https://1145.am/db/2610028/Deutsche_Telekom>,
        <https://1145.am/db/2611152/Deutsche_Telekom>,
        <https://1145.am/db/2615830/Deutsche_Telekom>,
        <https://1145.am/db/2622122/Deutsche_Telekom>,
        <https://1145.am/db/2622558/Deutsche_Telekom>,
        <https://1145.am/db/2630698/Deutsche_Telekom>,
        <https://1145.am/db/2631705/Deutsche_Telekom>,
        <https://1145.am/db/2631973/Deutsche_Telekom>,
        <https://1145.am/db/2632088/Deutsche_Telekom>,
        <https://1145.am/db/2632668/Deutsche_Telekom>,
        <https://1145.am/db/2634933/Deutsche_Telekom>,
        <https://1145.am/db/2644699/Deutsche_Telekom>,
        <https://1145.am/db/2649221/Deutsche_Telekom>,
        <https://1145.am/db/2650041/Deutsche_Telekom>,
        <https://1145.am/db/2651098/Deutsche_Telekom>,
        <https://1145.am/db/2651353/Deutsche_Telekom>,
        <https://1145.am/db/2652170/Deutsche_Telekom>,
        <https://1145.am/db/2652628/Deutsche_Telekom>,
        <https://1145.am/db/2654875/Deutsche_Telekom>,
        <https://1145.am/db/2655766/Deutsche_Telekom>,
        <https://1145.am/db/2655910/Deutsche_Telekom>,
        <https://1145.am/db/2657105/Deutsche_Telekom>,
        <https://1145.am/db/2658104/Deutsche_Telekom>,
        <https://1145.am/db/2658569/Deutsche_Telekom>,
        <https://1145.am/db/2658575/Deutsche_Telekom>,
        <https://1145.am/db/2658580/Deutsche_Telekom>,
        <https://1145.am/db/2658755/Deutsche_Telekom>,
        <https://1145.am/db/2659591/Deutsche_Telekom>,
        <https://1145.am/db/266035/Deutsche_Telekom>,
        <https://1145.am/db/2660472/Deutsche_Telekom>,
        <https://1145.am/db/2660499/Deutsche_Telekom>,
        <https://1145.am/db/2661225/Deutsche_Telekom>,
        <https://1145.am/db/2661660/Deutsche_Telekom>,
        <https://1145.am/db/2662456/Deutsche_Telekom>,
        <https://1145.am/db/2663041/Deutsche_Telekom>,
        <https://1145.am/db/2663133/Deutsche_Telekom>,
        <https://1145.am/db/2663146/Deutsche_Telekom>,
        <https://1145.am/db/2663873/Deutsche_Telekom>,
        <https://1145.am/db/2664134/Deutsche_Telekom>,
        <https://1145.am/db/2664255/Deutsche_Telekom>,
        <https://1145.am/db/2664887/Deutsche_Telekom>,
        <https://1145.am/db/2666759/Deutsche_Telekom>,
        <https://1145.am/db/2666968/Deutsche_Telekom>,
        <https://1145.am/db/2667499/Deutsche_Telekom>,
        <https://1145.am/db/2668196/Deutsche_Telekom>,
        <https://1145.am/db/2669110/Deutsche_Telekom>,
        <https://1145.am/db/2669512/Deutsche_Telekom>,
        <https://1145.am/db/2671188/Deutsche_Telekom>,
        <https://1145.am/db/2671623/Deutsche_Telekom>,
        <https://1145.am/db/2672660/Deutsche_Telekom>,
        <https://1145.am/db/2672903/Deutsche_Telekom>,
        <https://1145.am/db/2673296/Deutsche_Telekom>,
        <https://1145.am/db/2673336/Deutsche_Telekom>,
        <https://1145.am/db/2674444/Deutsche_Telekom>,
        <https://1145.am/db/2675377/Deutsche_Telekom>,
        <https://1145.am/db/2676653/Deutsche_Telekom>,
        <https://1145.am/db/2677655/Deutsche_Telekom>,
        <https://1145.am/db/2677854/Deutsche_Telekom>,
        <https://1145.am/db/2678018/Deutsche_Telekom>,
        <https://1145.am/db/2679698/Deutsche_Telekom>,
        <https://1145.am/db/2680746/Deutsche_Telekom>,
        <https://1145.am/db/2680760/Deutsche_Telekom>,
        <https://1145.am/db/2680879/Deutsche_Telekom>,
        <https://1145.am/db/2681407/Deutsche_Telekom>,
        <https://1145.am/db/2681486/Deutsche_Telekom>,
        <https://1145.am/db/2681971/Deutsche_Telekom>,
        <https://1145.am/db/2682116/Deutsche_Telekom>,
        <https://1145.am/db/2682125/Deutsche_Telekom>,
        <https://1145.am/db/2684592/Deutsche_Telekom>,
        <https://1145.am/db/2685113/Deutsche_Telekom>,
        <https://1145.am/db/2685202/Deutsche_Telekom>,
        <https://1145.am/db/310186/Deutsche_Telekom>,
        <https://1145.am/db/310814/Deutsche_Telekom>,
        <https://1145.am/db/461272/Deutsche_Telekom>,
        <https://1145.am/db/627492/Deutsche_Telekom>,
        <https://1145.am/db/673281/Deutsche_Telekom>,
        <https://1145.am/db/676008/Deutsche_Telekom>,
        <https://1145.am/db/699276/Deutsche_Telekom>,
        <https://1145.am/db/704303/Deutsche_Telekom>,
        <https://1145.am/db/97818/Deutsche_Telekom> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2651118/Dna> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Finland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/660013/about.rdf> ;
    ns1:basedInHighRaw "Finland" ;
    ns1:documentDate "2013-07-17T14:56:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Growth returns in Spain; Etisalat may have a partner for Maroc Telecom stake" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/growth-returns-spain-etisalat-may-have-a-partner-for-maroc-telecom-stake> ;
    ns1:foundName "DNA" ;
    ns1:name "DNA" ;
    ns1:sameAsMedium <https://1145.am/db/2659924/Dna>,
        <https://1145.am/db/2668550/Dna>,
        <https://1145.am/db/2676595/Dna>,
        <https://1145.am/db/2678993/Dna> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2651118/Ee> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:documentDate "2013-07-17T14:56:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Growth returns in Spain; Etisalat may have a partner for Maroc Telecom stake" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/growth-returns-spain-etisalat-may-have-a-partner-for-maroc-telecom-stake> ;
    ns1:foundName "EE" ;
    ns1:name "EE" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2651118/Etisalat> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Morocco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2542007/about.rdf> ;
    ns1:basedInHighRaw "Morocco" ;
    ns1:buyer <https://1145.am/db/2651118/Maroc_Telecom_Stake_Acquisition> ;
    ns1:documentDate "2013-07-17T14:56:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Growth returns in Spain; Etisalat may have a partner for Maroc Telecom stake" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/growth-returns-spain-etisalat-may-have-a-partner-for-maroc-telecom-stake> ;
    ns1:foundName "Etisalat" ;
    ns1:industry "telecom" ;
    ns1:name "Etisalat" ;
    ns1:sameAsHigh <https://1145.am/db/2169195/Etisalat>,
        <https://1145.am/db/2650898/Etisalat>,
        <https://1145.am/db/2651156/Etisalat>,
        <https://1145.am/db/2651496/Etisalat>,
        <https://1145.am/db/2651782/Etisalat>,
        <https://1145.am/db/2654132/Etisalat>,
        <https://1145.am/db/2656748/Etisalat>,
        <https://1145.am/db/2658486/Etisalat>,
        <https://1145.am/db/2658891/Etisalat>,
        <https://1145.am/db/2659971/Etisalat>,
        <https://1145.am/db/2665333/Etisalat>,
        <https://1145.am/db/2667532/Etisalat>,
        <https://1145.am/db/2668561/Etisalat>,
        <https://1145.am/db/2668596/Etisalat>,
        <https://1145.am/db/2669629/Etisalat>,
        <https://1145.am/db/2669641/Etisalat>,
        <https://1145.am/db/2671057/Etisalat>,
        <https://1145.am/db/2673070/Etisalat>,
        <https://1145.am/db/2674199/Etisalat>,
        <https://1145.am/db/2676614/Etisalat>,
        <https://1145.am/db/2677850/Etisalat>,
        <https://1145.am/db/2678814/Etisalat>,
        <https://1145.am/db/2679013/Etisalat>,
        <https://1145.am/db/907149/Etihad_Etisalat> ;
    ns1:sameAsMedium <https://1145.am/db/1071658/Etisalat>,
        <https://1145.am/db/1571236/Etisalat>,
        <https://1145.am/db/2651501/Etisalat>,
        <https://1145.am/db/2652986/Etisalat>,
        <https://1145.am/db/2655001/Etisalat>,
        <https://1145.am/db/2659538/Etisalat>,
        <https://1145.am/db/2660597/Etisalat>,
        <https://1145.am/db/2668121/Etisalat>,
        <https://1145.am/db/2670741/Etisalat>,
        <https://1145.am/db/2676997/Etisalat>,
        <https://1145.am/db/2678849/Etisalat> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2651156/Caisse_De_Depot_Et_De_Gestion> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Morocco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2542007/about.rdf> ;
    ns1:basedInHighRaw "Morocco" ;
    ns1:buyer <https://1145.am/db/2651156/Maroc_Telecom_Stake_Acquisition> ;
    ns1:description "investment" ;
    ns1:documentDate "2013-07-24T11:16:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vivendi pushes ahead with plan to offload Maroc Telecom" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/vivendi-pushes-ahead-plan-to-offload-maroc-telecom> ;
    ns1:foundName "CDG",
        "Caisse de Depot et de Gestion" ;
    ns1:name "Caisse de Depot et de Gestion" ;
    ns1:sameAsMedium <https://1145.am/db/2651118/Caisse_De_Depot_Et_De_Gestion> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2651156/Etisalat> a org:Organization ;
    ns1:basedInLowRaw "Morocco" ;
    ns1:buyer <https://1145.am/db/2651156/Maroc_Telecom_Stake_Acquisition> ;
    ns1:documentDate "2013-07-24T11:16:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vivendi pushes ahead with plan to offload Maroc Telecom" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/vivendi-pushes-ahead-plan-to-offload-maroc-telecom> ;
    ns1:foundName "Etisalat" ;
    ns1:industry "telecom" ;
    ns1:name "Etisalat" ;
    ns1:protagonist <https://1145.am/db/2651156/Maroc_Telecom_Stake_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2169195/Etisalat>,
        <https://1145.am/db/2650898/Etisalat>,
        <https://1145.am/db/2651118/Etisalat>,
        <https://1145.am/db/2651496/Etisalat>,
        <https://1145.am/db/2651782/Etisalat>,
        <https://1145.am/db/2654132/Etisalat>,
        <https://1145.am/db/2656748/Etisalat>,
        <https://1145.am/db/2658486/Etisalat>,
        <https://1145.am/db/2658891/Etisalat>,
        <https://1145.am/db/2659971/Etisalat>,
        <https://1145.am/db/2665333/Etisalat>,
        <https://1145.am/db/2667532/Etisalat>,
        <https://1145.am/db/2668561/Etisalat>,
        <https://1145.am/db/2668596/Etisalat>,
        <https://1145.am/db/2669629/Etisalat>,
        <https://1145.am/db/2669641/Etisalat>,
        <https://1145.am/db/2671057/Etisalat>,
        <https://1145.am/db/2673070/Etisalat>,
        <https://1145.am/db/2674199/Etisalat>,
        <https://1145.am/db/2676614/Etisalat>,
        <https://1145.am/db/2677850/Etisalat>,
        <https://1145.am/db/2678814/Etisalat>,
        <https://1145.am/db/2679013/Etisalat>,
        <https://1145.am/db/907149/Etihad_Etisalat> ;
    ns1:sameAsMedium <https://1145.am/db/1071658/Etisalat>,
        <https://1145.am/db/1571236/Etisalat>,
        <https://1145.am/db/2651501/Etisalat>,
        <https://1145.am/db/2652986/Etisalat>,
        <https://1145.am/db/2655001/Etisalat>,
        <https://1145.am/db/2659538/Etisalat>,
        <https://1145.am/db/2660597/Etisalat>,
        <https://1145.am/db/2668121/Etisalat>,
        <https://1145.am/db/2670741/Etisalat>,
        <https://1145.am/db/2676997/Etisalat>,
        <https://1145.am/db/2678849/Etisalat> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2651156/Vivendi> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:description "media" ;
    ns1:documentDate "2013-07-24T11:16:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vivendi pushes ahead with plan to offload Maroc Telecom" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/vivendi-pushes-ahead-plan-to-offload-maroc-telecom> ;
    ns1:foundName "Vivendi" ;
    ns1:industry "media" ;
    ns1:name "Vivendi" ;
    ns1:sameAsHigh <https://1145.am/db/1387326/Vivendi>,
        <https://1145.am/db/1446747/Vivendi>,
        <https://1145.am/db/1478723/Vivendi>,
        <https://1145.am/db/1526556/Vivendi>,
        <https://1145.am/db/1627765/Vivendi>,
        <https://1145.am/db/172306/Vivendi>,
        <https://1145.am/db/1747495/Vivendi_Sa>,
        <https://1145.am/db/1813320/Vivendi>,
        <https://1145.am/db/1872318/Vivendi>,
        <https://1145.am/db/1930787/Vivendi>,
        <https://1145.am/db/1936074/Vivendi>,
        <https://1145.am/db/1960685/Vivendi>,
        <https://1145.am/db/1966172/Vivendi>,
        <https://1145.am/db/1974476/Vivendi>,
        <https://1145.am/db/1978622/Vivendi>,
        <https://1145.am/db/1996629/Vivendi>,
        <https://1145.am/db/2032696/Vivendi>,
        <https://1145.am/db/2039210/Vivendi>,
        <https://1145.am/db/2055330/Vivendi>,
        <https://1145.am/db/205539/Vivendi>,
        <https://1145.am/db/213110/Vivendi>,
        <https://1145.am/db/2136594/Vivendi>,
        <https://1145.am/db/214621/Vivendi>,
        <https://1145.am/db/215138/Vivendi>,
        <https://1145.am/db/2168368/Vivendi>,
        <https://1145.am/db/235506/Vivendi>,
        <https://1145.am/db/2506820/Vivendi>,
        <https://1145.am/db/257168/Vivendi>,
        <https://1145.am/db/2602077/Vivendi>,
        <https://1145.am/db/2604246/Vivendi>,
        <https://1145.am/db/2604382/Vivendi>,
        <https://1145.am/db/2605925/Vivendi>,
        <https://1145.am/db/2605929/Vivendi>,
        <https://1145.am/db/2606695/Vivendi>,
        <https://1145.am/db/2610422/Vivendi>,
        <https://1145.am/db/2611263/Vivendi>,
        <https://1145.am/db/2613866/Vivendi>,
        <https://1145.am/db/2614862/Vivendi>,
        <https://1145.am/db/2617187/Vivendi>,
        <https://1145.am/db/2617717/Vivendi>,
        <https://1145.am/db/2651496/Vivendi>,
        <https://1145.am/db/2651782/Vivendi>,
        <https://1145.am/db/2652387/Vivendi>,
        <https://1145.am/db/2654132/Vivendi>,
        <https://1145.am/db/2654812/Vivendi>,
        <https://1145.am/db/2655800/Vivendi>,
        <https://1145.am/db/2656193/Vivendi>,
        <https://1145.am/db/2657814/Vivendi>,
        <https://1145.am/db/2658891/Vivendi>,
        <https://1145.am/db/2659542/Vivendi>,
        <https://1145.am/db/2659919/Vivendi>,
        <https://1145.am/db/2660795/Vivendi>,
        <https://1145.am/db/2663159/Vivendi>,
        <https://1145.am/db/2664250/Vivendi>,
        <https://1145.am/db/2666389/Vivendi>,
        <https://1145.am/db/2666429/Vivendi>,
        <https://1145.am/db/2666923/Vivendi>,
        <https://1145.am/db/2667465/Vivendi>,
        <https://1145.am/db/2667476/Vivendi>,
        <https://1145.am/db/2668299/Vivendi>,
        <https://1145.am/db/2674300/Vivendi>,
        <https://1145.am/db/2675499/Vivendi>,
        <https://1145.am/db/2677625/Vivendi>,
        <https://1145.am/db/2678113/Vivendi>,
        <https://1145.am/db/2681332/Vivendi>,
        <https://1145.am/db/2719659/Vivendi>,
        <https://1145.am/db/310170/Vivendi>,
        <https://1145.am/db/345500/Vivendi>,
        <https://1145.am/db/350901/Vivendi>,
        <https://1145.am/db/352665/Vivendi>,
        <https://1145.am/db/352726/Vivendi>,
        <https://1145.am/db/353883/Vivendi>,
        <https://1145.am/db/357976/Vivendi>,
        <https://1145.am/db/358143/Vivendi>,
        <https://1145.am/db/358454/Vivendi>,
        <https://1145.am/db/385184/Vivendi>,
        <https://1145.am/db/477953/Vivendi>,
        <https://1145.am/db/480972/Vivendi>,
        <https://1145.am/db/682474/Vivendi>,
        <https://1145.am/db/685343/Vivendi>,
        <https://1145.am/db/763147/Vivendi>,
        <https://1145.am/db/844041/Vivendi>,
        <https://1145.am/db/844185/Vivendi>,
        <https://1145.am/db/85758/Vivendi_Sa> ;
    ns1:sameAsMedium <https://1145.am/db/1040495/Vivendi>,
        <https://1145.am/db/1149070/Vivendi>,
        <https://1145.am/db/1512124/Vivendi>,
        <https://1145.am/db/1543097/Vivendi>,
        <https://1145.am/db/179572/Vivendi>,
        <https://1145.am/db/183768/Vivendi>,
        <https://1145.am/db/183813/Vivendi>,
        <https://1145.am/db/1952876/Vivendi>,
        <https://1145.am/db/1998852/Vivendi>,
        <https://1145.am/db/2040974/Vivendi>,
        <https://1145.am/db/2041760/Vivendi>,
        <https://1145.am/db/2071102/Vivendi>,
        <https://1145.am/db/2163038/Vivendi>,
        <https://1145.am/db/2167707/Vivendi>,
        <https://1145.am/db/2169413/Vivendi>,
        <https://1145.am/db/2172051/Vivendi>,
        <https://1145.am/db/2172059/Vivendi>,
        <https://1145.am/db/2607297/Vivendi>,
        <https://1145.am/db/2607476/Vivendi>,
        <https://1145.am/db/2610513/Vivendi>,
        <https://1145.am/db/2613293/Vivendi>,
        <https://1145.am/db/2616305/Vivendi>,
        <https://1145.am/db/2616537/Vivendi>,
        <https://1145.am/db/2631186/Vivendi>,
        <https://1145.am/db/2650838/Vivendi>,
        <https://1145.am/db/2650898/Vivendi>,
        <https://1145.am/db/2651657/Vivendi>,
        <https://1145.am/db/2653966/Vivendi>,
        <https://1145.am/db/2654609/Vivendi>,
        <https://1145.am/db/2654869/Vivendi>,
        <https://1145.am/db/2655001/Vivendi>,
        <https://1145.am/db/2655569/Vivendi>,
        <https://1145.am/db/2655927/Vivendi>,
        <https://1145.am/db/2661968/Vivendi>,
        <https://1145.am/db/2662747/Vivendi>,
        <https://1145.am/db/2662802/Vivendi>,
        <https://1145.am/db/2663091/Vivendi>,
        <https://1145.am/db/2665318/Vivendi>,
        <https://1145.am/db/2665333/Vivendi>,
        <https://1145.am/db/2666400/Vivendi>,
        <https://1145.am/db/2667532/Vivendi>,
        <https://1145.am/db/2668596/Vivendi>,
        <https://1145.am/db/2668926/Vivendi>,
        <https://1145.am/db/2669512/Vivendi>,
        <https://1145.am/db/2669629/Vivendi>,
        <https://1145.am/db/2670684/Vivendi>,
        <https://1145.am/db/2671927/Vivendi>,
        <https://1145.am/db/2674199/Vivendi>,
        <https://1145.am/db/2674236/Vivendi>,
        <https://1145.am/db/2677655/Vivendi>,
        <https://1145.am/db/2677850/Vivendi>,
        <https://1145.am/db/2679034/Vivendi>,
        <https://1145.am/db/269889/Vivendi>,
        <https://1145.am/db/2715752/Vivendi>,
        <https://1145.am/db/2717950/Vivendi>,
        <https://1145.am/db/2796223/Vivendi>,
        <https://1145.am/db/357136/Vivendi_Se>,
        <https://1145.am/db/357140/Vivendi>,
        <https://1145.am/db/357152/Vivendi>,
        <https://1145.am/db/378467/Vivendi>,
        <https://1145.am/db/395427/Vivendi>,
        <https://1145.am/db/395435/Vivendi>,
        <https://1145.am/db/439737/Vivendi>,
        <https://1145.am/db/470995/Vivendi>,
        <https://1145.am/db/638445/Vivendi>,
        <https://1145.am/db/764637/Vivendi>,
        <https://1145.am/db/767649/Vivendi> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2662077/KPN> a org:Organization ;
    ns1:basedInLowRaw "Denmark" ;
    ns1:buyer <https://1145.am/db/2662077/Reggefiber_Acquisition> ;
    ns1:description "Business" ;
    ns1:documentDate "2014-01-03T17:01:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Turkcell refutes 180M tax demand; KPN takes control of FTTH operator" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/turkcell-refutes-eu180m-tax-demand-kpn-takes-control-ftth-operator> ;
    ns1:foundName "KPN" ;
    ns1:investor <https://1145.am/db/2662077/Reggefiber_Acquisition> ;
    ns1:name "KPN" ;
    ns1:sameAsMedium <https://1145.am/db/1916132/KPN>,
        <https://1145.am/db/2600194/KPN>,
        <https://1145.am/db/2604431/KPN>,
        <https://1145.am/db/2605931/KPN>,
        <https://1145.am/db/2610488/KPN>,
        <https://1145.am/db/2610810/KPN>,
        <https://1145.am/db/2611767/KPN>,
        <https://1145.am/db/2611935/KPN>,
        <https://1145.am/db/2615841/KPN>,
        <https://1145.am/db/2616385/KPN>,
        <https://1145.am/db/2632668/KPN>,
        <https://1145.am/db/2643393/KPN>,
        <https://1145.am/db/2651025/KPN>,
        <https://1145.am/db/2651143/KPN>,
        <https://1145.am/db/2651152/KPN>,
        <https://1145.am/db/2651365/KPN>,
        <https://1145.am/db/2651498/KPN>,
        <https://1145.am/db/2651511/KPN>,
        <https://1145.am/db/2651887/KPN>,
        <https://1145.am/db/2651900/KPN>,
        <https://1145.am/db/2651912/KPN>,
        <https://1145.am/db/2652053/KPN>,
        <https://1145.am/db/2652442/KPN>,
        <https://1145.am/db/2652516/KPN>,
        <https://1145.am/db/2652548/KPN>,
        <https://1145.am/db/2652570/KPN>,
        <https://1145.am/db/2652729/KPN>,
        <https://1145.am/db/2653256/KPN>,
        <https://1145.am/db/2653270/KPN>,
        <https://1145.am/db/2653291/KPN>,
        <https://1145.am/db/2654021/KPN>,
        <https://1145.am/db/2655000/KPN>,
        <https://1145.am/db/2655513/KPN>,
        <https://1145.am/db/2655934/KPN>,
        <https://1145.am/db/2656778/KPN>,
        <https://1145.am/db/2656878/KPN>,
        <https://1145.am/db/2658223/KPN>,
        <https://1145.am/db/2658756/KPN>,
        <https://1145.am/db/2658872/KPN>,
        <https://1145.am/db/2658917/KPN>,
        <https://1145.am/db/2659872/KPN>,
        <https://1145.am/db/2659938/KPN>,
        <https://1145.am/db/2660513/KPN>,
        <https://1145.am/db/2660832/KPN>,
        <https://1145.am/db/2660906/KPN>,
        <https://1145.am/db/2660929/KPN>,
        <https://1145.am/db/2661011/KPN>,
        <https://1145.am/db/2661991/KPN>,
        <https://1145.am/db/2662050/KPN>,
        <https://1145.am/db/2662065/KPN>,
        <https://1145.am/db/2663183/KPN>,
        <https://1145.am/db/2663189/KPN>,
        <https://1145.am/db/2664165/KPN>,
        <https://1145.am/db/2664273/KPN>,
        <https://1145.am/db/2665177/KPN>,
        <https://1145.am/db/2665887/KPN>,
        <https://1145.am/db/2666440/KPN>,
        <https://1145.am/db/2667481/KPN>,
        <https://1145.am/db/2667525/KPN>,
        <https://1145.am/db/2668553/KPN>,
        <https://1145.am/db/2668563/KPN>,
        <https://1145.am/db/2668591/KPN>,
        <https://1145.am/db/2670667/KPN>,
        <https://1145.am/db/2670751/KPN>,
        <https://1145.am/db/2670756/KPN>,
        <https://1145.am/db/2670785/KPN>,
        <https://1145.am/db/2671812/KPN>,
        <https://1145.am/db/2671930/KPN>,
        <https://1145.am/db/2671934/KPN>,
        <https://1145.am/db/2671957/KPN>,
        <https://1145.am/db/2672644/KPN>,
        <https://1145.am/db/2672655/KPN>,
        <https://1145.am/db/2673088/KPN>,
        <https://1145.am/db/2673855/KPN>,
        <https://1145.am/db/2674207/KPN>,
        <https://1145.am/db/2674299/KPN>,
        <https://1145.am/db/2675473/KPN>,
        <https://1145.am/db/2675499/KPN>,
        <https://1145.am/db/2676204/KPN>,
        <https://1145.am/db/2676705/KPN>,
        <https://1145.am/db/2678643/KPN>,
        <https://1145.am/db/2678648/KPN>,
        <https://1145.am/db/2679767/KPN>,
        <https://1145.am/db/2679770/KPN>,
        <https://1145.am/db/2680106/KPN>,
        <https://1145.am/db/2680795/KPN>,
        <https://1145.am/db/2680826/KPN>,
        <https://1145.am/db/302501/KPN>,
        <https://1145.am/db/322674/KPN> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2662077/Reggefiber> a org:Organization ;
    ns1:description "FTTH operator" ;
    ns1:documentDate "2014-01-03T17:01:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Turkcell refutes 180M tax demand; KPN takes control of FTTH operator" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/turkcell-refutes-eu180m-tax-demand-kpn-takes-control-ftth-operator> ;
    ns1:foundName "Reggefiber" ;
    ns1:industry "FTTH operator" ;
    ns1:name "Reggefiber" ;
    ns1:sameAsMedium <https://1145.am/db/2611767/Reggefiber> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663183/E-Plus> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:description "M & A" ;
    ns1:documentDate "2014-01-28T21:03:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "As Vodafone closes its Verizon deal, the rumour mill goes into overdrive" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/as-vodafone-closes-its-verizon-deal-rumour-mill-goes-into-overdrive> ;
    ns1:foundName "E-Plus" ;
    ns1:name "E-Plus" ;
    ns1:sameAsHigh <https://1145.am/db/2653986/E-Plus>,
        <https://1145.am/db/2655000/E-Plus>,
        <https://1145.am/db/2667481/E-Plus> ;
    ns1:sameAsMedium <https://1145.am/db/2651073/E-Plus>,
        <https://1145.am/db/2651152/E-Plus>,
        <https://1145.am/db/2651365/E-Plus>,
        <https://1145.am/db/2651498/E-Plus>,
        <https://1145.am/db/2651511/E-Plus>,
        <https://1145.am/db/2651778/E-Plus>,
        <https://1145.am/db/2651900/E-Plus>,
        <https://1145.am/db/2654999/E-Plus>,
        <https://1145.am/db/2655754/E-Plus>,
        <https://1145.am/db/2656911/E-Plus>,
        <https://1145.am/db/2659938/E-Plus>,
        <https://1145.am/db/2661011/E-Plus>,
        <https://1145.am/db/2662065/E-Plus>,
        <https://1145.am/db/2663189/E-Plus>,
        <https://1145.am/db/2664251/E-Plus>,
        <https://1145.am/db/2666404/E-Plus>,
        <https://1145.am/db/2666440/E-Plus>,
        <https://1145.am/db/2666446/E-Plus>,
        <https://1145.am/db/2667525/E-Plus>,
        <https://1145.am/db/2668553/E-Plus>,
        <https://1145.am/db/2668563/E-Plus>,
        <https://1145.am/db/2668591/E-Plus>,
        <https://1145.am/db/2669627/E-Plus>,
        <https://1145.am/db/2669644/E-Plus>,
        <https://1145.am/db/2669661/E-Plus>,
        <https://1145.am/db/2669679/E-Plus>,
        <https://1145.am/db/2670729/E-Plus>,
        <https://1145.am/db/2670751/E-Plus>,
        <https://1145.am/db/2670756/E-Plus>,
        <https://1145.am/db/2670778/E-Plus>,
        <https://1145.am/db/2670779/E-Plus>,
        <https://1145.am/db/2670785/E-Plus>,
        <https://1145.am/db/2671930/E-Plus>,
        <https://1145.am/db/2671934/E-Plus>,
        <https://1145.am/db/2671957/E-Plus>,
        <https://1145.am/db/2672922/E-Plus>,
        <https://1145.am/db/2674299/E-Plus>,
        <https://1145.am/db/2675473/E-Plus>,
        <https://1145.am/db/2675499/E-Plus>,
        <https://1145.am/db/2676662/E-Plus>,
        <https://1145.am/db/2676705/E-Plus>,
        <https://1145.am/db/2678643/E-Plus>,
        <https://1145.am/db/2680795/E-Plus> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663183/Telefnica_Ireland> a org:Organization ;
    ns1:basedInLowRaw "Ireland" ;
    ns1:buyer <https://1145.am/db/2663183/E-Plus_Merger>,
        <https://1145.am/db/2663183/Telefnica_Ireland_Acquisition> ;
    ns1:description "M & A" ;
    ns1:documentDate "2014-01-28T21:03:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "As Vodafone closes its Verizon deal, the rumour mill goes into overdrive" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/as-vodafone-closes-its-verizon-deal-rumour-mill-goes-into-overdrive> ;
    ns1:foundName "Telefnica",
        "Telefnica Ireland" ;
    ns1:name "Telefnica",
        "Telefnica Ireland" ;
    ns1:sameAsMedium <https://1145.am/db/2657907/Telefnica_Ireland>,
        <https://1145.am/db/2663204/Telefnica_Ireland>,
        <https://1145.am/db/2669657/Telefnica_Ireland>,
        <https://1145.am/db/2669679/Telefnica_Ireland>,
        <https://1145.am/db/2670775/Telefnica_Ireland>,
        <https://1145.am/db/2670778/Telefnica_Ireland> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2682450/Leap> a org:Organization ;
    ns1:description "Business" ;
    ns1:documentDate "2013-08-12T14:10:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "M&A catches fire: 24M wireless subscribers moving from Tier 2 to Tier 1 carriers" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/m-a-catches-fire-24m-wireless-subscribers-moving-from-tier-2-to-tier-1-carriers> ;
    ns1:foundName "Leap Wireless" ;
    ns1:name "Leap" ;
    ns1:sameAsMedium <https://1145.am/db/1740314/Leap>,
        <https://1145.am/db/1752668/Leap>,
        <https://1145.am/db/2075344/Leap>,
        <https://1145.am/db/2639630/Leap>,
        <https://1145.am/db/2639641/Leap>,
        <https://1145.am/db/2640631/Leap>,
        <https://1145.am/db/2641156/Leap>,
        <https://1145.am/db/2661120/Leap>,
        <https://1145.am/db/2669935/Leap>,
        <https://1145.am/db/540219/Leap>,
        <https://1145.am/db/890289/Leap>,
        <https://1145.am/db/955084/Leap>,
        <https://1145.am/db/955780/Leap> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2682450/Leap_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-08-12T14:10:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "AT & T (NYSE: T) also announced the purchase of Leap Wireless (NASDAQ: LEAP) , but that deal has n't yet closed (though everyone expects that it will) ." ;
    ns1:documentTitle "M&A catches fire: 24M wireless subscribers moving from Tier 2 to Tier 1 carriers" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/m-a-catches-fire-24m-wireless-subscribers-moving-from-tier-2-to-tier-1-carriers> ;
    ns1:foundName "purchase" ;
    ns1:name "purchase" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2682450/Leap> ;
    ns1:targetName "Leap" ;
    ns1:whereRaw "None of the above choices." .

<https://1145.am/db/2682450/Metropcs> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:description "business" ;
    ns1:documentDate "2013-08-12T14:10:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "M&A catches fire: 24M wireless subscribers moving from Tier 2 to Tier 1 carriers" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/m-a-catches-fire-24m-wireless-subscribers-moving-from-tier-2-to-tier-1-carriers> ;
    ns1:foundName "MetroPCS" ;
    ns1:industry "wireless carriers" ;
    ns1:name "MetroPCS" ;
    ns1:sameAsHigh <https://1145.am/db/2658575/Metropcs>,
        <https://1145.am/db/2659591/Metropcs>,
        <https://1145.am/db/2659631/Metropcs>,
        <https://1145.am/db/2662860/Metropcs>,
        <https://1145.am/db/2668226/Metropcs>,
        <https://1145.am/db/2668762/Metropcs_Communications>,
        <https://1145.am/db/2670397/Metropcs>,
        <https://1145.am/db/2676975/Metropcs>,
        <https://1145.am/db/2681584/Metropcs>,
        <https://1145.am/db/2685314/Metropcs> ;
    ns1:sameAsMedium <https://1145.am/db/2625808/Metropcs>,
        <https://1145.am/db/2626494/Metropcs>,
        <https://1145.am/db/2631033/Metropcs>,
        <https://1145.am/db/2640440/Metropcs>,
        <https://1145.am/db/2650228/Metropcs>,
        <https://1145.am/db/2656845/Metropcs>,
        <https://1145.am/db/2656851/Metropcs>,
        <https://1145.am/db/2658569/Metropcs>,
        <https://1145.am/db/2658580/Metropcs>,
        <https://1145.am/db/2658589/Metropcs>,
        <https://1145.am/db/2659586/Metropcs>,
        <https://1145.am/db/2659597/Metropcs>,
        <https://1145.am/db/2662872/Metropcs>,
        <https://1145.am/db/2663892/Metropcs>,
        <https://1145.am/db/2664500/Metropcs>,
        <https://1145.am/db/2664986/Metropcs>,
        <https://1145.am/db/2666714/Metropcs>,
        <https://1145.am/db/2668208/Metropcs>,
        <https://1145.am/db/2669319/Metropcs>,
        <https://1145.am/db/2669321/Metropcs>,
        <https://1145.am/db/2669338/Metropcs>,
        <https://1145.am/db/2670454/Metropcs>,
        <https://1145.am/db/2671585/Metropcs>,
        <https://1145.am/db/2671623/Metropcs>,
        <https://1145.am/db/2671629/Metropcs>,
        <https://1145.am/db/2673938/Metropcs>,
        <https://1145.am/db/2681282/Metropcs>,
        <https://1145.am/db/2681285/Metropcs>,
        <https://1145.am/db/2683705/Metropcs>,
        <https://1145.am/db/2685799/Metropcs>,
        <https://1145.am/db/2686488/Metropcs> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2682450/Metropcs_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-08-12T14:10:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "After years of talking about mergers and acquisitions, the nation's top wireless carriers got down to business during the second quarter of this year, with T-Mobile US (NYSE: TMUS) working to integrate its purchase of MetroPCS and Sprint (NYSE: S) closing on its purchase of Clearwire and netting an investment from Japan's SoftBank." ;
    ns1:documentTitle "M&A catches fire: 24M wireless subscribers moving from Tier 2 to Tier 1 carriers" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/m-a-catches-fire-24m-wireless-subscribers-moving-from-tier-2-to-tier-1-carriers> ;
    ns1:foundName "purchase" ;
    ns1:name "purchase" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2682450/Metropcs> ;
    ns1:targetName "MetroPCS" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "US" .

<https://1145.am/db/2683079/Business_Acquisition_Microsoft_Nokia_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-09-04T21:18:47+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The report also comes days after Microsoft (NASDAQ: MSFT) announced it will pay around $ 7.2 billion for Nokia's (NYSE: NOK) handset business, a move many analysts have seen as cementing Microsoft's Windows Phone as a the third leading smartphone platform, albeit a distant third behind Google's (NASDAQ: GOOG) Android and Apple's (NASDAQ: AAPL) iOS." ;
    ns1:documentTitle "Report: BlackBerry hopes to wrap up sales process by November" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-blackberry-hopes-to-wrap-up-sales-process-by-november> ;
    ns1:foundName "pay" ;
    ns1:name "pay" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "business" ;
    ns1:valueRaw "around $ 7.2 billion" ;
    ns1:vendor <https://1145.am/db/2683079/Nokia> .

<https://1145.am/db/2683818/Alcatel-Lucent> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:documentDate "2013-09-26T13:47:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Reports: Nokia's board considering NSN deal with Alcatel-Lucent" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/reports-nokia-s-board-considering-nsn-deal-alcatel-lucent> ;
    ns1:foundName "Alcatel-Lucent" ;
    ns1:name "Alcatel-Lucent" ;
    ns1:protagonist <https://1145.am/db/2683818/Nokia_Solutions_And_Networks_Unit_Acquisition> ;
    ns1:sameAsMedium <https://1145.am/db/1790667/Alcatel-Lucent>,
        <https://1145.am/db/1790669/Alcatel-Lucent>,
        <https://1145.am/db/1790693/Alcatel-Lucent>,
        <https://1145.am/db/1795878/Alcatel-Lucent>,
        <https://1145.am/db/1819651/Alcatel-Lucent>,
        <https://1145.am/db/1855135/Alcatel-Lucent>,
        <https://1145.am/db/1875987/Alcatel-Lucent>,
        <https://1145.am/db/1885641/Alcatel-Lucent>,
        <https://1145.am/db/2174456/Alcatel-Lucent>,
        <https://1145.am/db/2449514/Alcatel-Lucent>,
        <https://1145.am/db/2599088/Alcatel-Lucent>,
        <https://1145.am/db/2599392/Alcatel-Lucent>,
        <https://1145.am/db/2599632/Alcatel-Lucent>,
        <https://1145.am/db/2599798/Alcatel-Lucent>,
        <https://1145.am/db/2600870/Alcatel-Lucent>,
        <https://1145.am/db/2601072/Alcatel-Lucent>,
        <https://1145.am/db/2601349/Alcatel-Lucent>,
        <https://1145.am/db/2601506/Alcatel-Lucent>,
        <https://1145.am/db/2601537/Alcatel-Lucent>,
        <https://1145.am/db/2601910/Alcatel-Lucent>,
        <https://1145.am/db/2602219/Alcatel-Lucent>,
        <https://1145.am/db/2602933/Alcatel-Lucent>,
        <https://1145.am/db/2604986/Alcatel-Lucent>,
        <https://1145.am/db/2604991/Alcatel-Lucent>,
        <https://1145.am/db/2606223/Alcatel-Lucent>,
        <https://1145.am/db/2606495/Alcatel-Lucent>,
        <https://1145.am/db/2606731/Alcatel-Lucent>,
        <https://1145.am/db/2607244/Alcatel-Lucent>,
        <https://1145.am/db/2607408/Alcatel-Lucent>,
        <https://1145.am/db/2607614/Alcatel-Lucent>,
        <https://1145.am/db/2609611/Alcatel-Lucent>,
        <https://1145.am/db/2609629/Alcatel-Lucent>,
        <https://1145.am/db/2609645/Alcatel-Lucent>,
        <https://1145.am/db/2609817/Alcatel-Lucent>,
        <https://1145.am/db/2610550/Alcatel-Lucent>,
        <https://1145.am/db/2610915/Alcatel-Lucent>,
        <https://1145.am/db/2611850/Alcatel-Lucent>,
        <https://1145.am/db/2611855/Alcatel-Lucent>,
        <https://1145.am/db/2612045/Alcatel-Lucent>,
        <https://1145.am/db/2612072/Alcatel-Lucent>,
        <https://1145.am/db/2612273/Alcatel-Lucent>,
        <https://1145.am/db/2612583/Alcatel-Lucent>,
        <https://1145.am/db/2612780/Alcatel-Lucent>,
        <https://1145.am/db/2613443/Alcatel-Lucent>,
        <https://1145.am/db/2614261/Alcatel-Lucent>,
        <https://1145.am/db/2614782/Alcatel-Lucent>,
        <https://1145.am/db/2614789/Alcatel-Lucent>,
        <https://1145.am/db/2614792/Alcatel-Lucent>,
        <https://1145.am/db/2614999/Alcatel-Lucent>,
        <https://1145.am/db/2615500/Alcatel-Lucent>,
        <https://1145.am/db/2617770/Alcatel-Lucent>,
        <https://1145.am/db/2620115/Alcatel-Lucent>,
        <https://1145.am/db/2624637/Alcatel-Lucent>,
        <https://1145.am/db/2625358/Alcatel-Lucent>,
        <https://1145.am/db/2633937/Alcatel-Lucent>,
        <https://1145.am/db/2635749/Alcatel-Lucent>,
        <https://1145.am/db/2636765/Alcatel-Lucent>,
        <https://1145.am/db/2636778/Alcatel-Lucent>,
        <https://1145.am/db/2638547/Alcatel-Lucent>,
        <https://1145.am/db/2639975/Alcatel-Lucent>,
        <https://1145.am/db/2641663/Alcatel-Lucent>,
        <https://1145.am/db/2642991/Alcatel-Lucent>,
        <https://1145.am/db/2651008/Alcatel-Lucent>,
        <https://1145.am/db/2651521/Alcatel-Lucent>,
        <https://1145.am/db/2651685/Alcatel-Lucent>,
        <https://1145.am/db/2652551/Alcatel-Lucent>,
        <https://1145.am/db/2653427/Alcatel-Lucent>,
        <https://1145.am/db/2654012/Alcatel-Lucent>,
        <https://1145.am/db/2654017/Alcatel-Lucent>,
        <https://1145.am/db/2654155/Alcatel-Lucent>,
        <https://1145.am/db/2654238/Alcatel-Lucent>,
        <https://1145.am/db/2654528/Alcatel_Lucent>,
        <https://1145.am/db/2655001/Alcatel-Lucent>,
        <https://1145.am/db/2655372/Alcatel-Lucent>,
        <https://1145.am/db/2655622/Alcatel-Lucent>,
        <https://1145.am/db/2655768/Alcatel-Lucent>,
        <https://1145.am/db/2655792/Alcatel-Lucent>,
        <https://1145.am/db/2656166/Alcatel-Lucent>,
        <https://1145.am/db/2656737/Alcatel-Lucent>,
        <https://1145.am/db/2656749/Alcatel-Lucent>,
        <https://1145.am/db/2656808/Alcatel-Lucent>,
        <https://1145.am/db/2656920/Alcatel-Lucent>,
        <https://1145.am/db/2657196/Alcatel-Lucent>,
        <https://1145.am/db/2657268/Alcatel-Lucent>,
        <https://1145.am/db/2657902/Alcatel-Lucent>,
        <https://1145.am/db/2658200/Alcatel-Lucent>,
        <https://1145.am/db/2658774/Alcatel-Lucent>,
        <https://1145.am/db/2659374/Alcatel-Lucent>,
        <https://1145.am/db/2660932/Alcatel-Lucent>,
        <https://1145.am/db/2661927/Alcatel-Lucent>,
        <https://1145.am/db/2663033/Alcatel-Lucent>,
        <https://1145.am/db/2663052/Alcatel-Lucent>,
        <https://1145.am/db/2663073/Alcatel-Lucent>,
        <https://1145.am/db/2663106/Alcatel-Lucent>,
        <https://1145.am/db/2663114/Alcatel-Lucent>,
        <https://1145.am/db/2663834/Alcatel-Lucent>,
        <https://1145.am/db/2663941/Alcatel-Lucent>,
        <https://1145.am/db/2664215/Alcatel-Lucent>,
        <https://1145.am/db/2664225/Alcatel-Lucent>,
        <https://1145.am/db/2664922/Alcatel-Lucent>,
        <https://1145.am/db/2665201/Alcatel-Lucent>,
        <https://1145.am/db/2665703/Alcatel-Lucent>,
        <https://1145.am/db/2665720/Alcatel-Lucent>,
        <https://1145.am/db/2665866/Alcatel-Lucent>,
        <https://1145.am/db/2666163/Alcatel-Lucent>,
        <https://1145.am/db/2666280/Alcatel-Lucent>,
        <https://1145.am/db/2666307/Alcatel-Lucent>,
        <https://1145.am/db/2666346/Alcatel-Lucent>,
        <https://1145.am/db/2666366/Alcatel-Lucent>,
        <https://1145.am/db/2666375/Alcatel-Lucent>,
        <https://1145.am/db/2666563/Alcatel-Lucent>,
        <https://1145.am/db/2666729/Alcatel_Lucent>,
        <https://1145.am/db/2666818/Alcatel-Lucent>,
        <https://1145.am/db/2667186/Alcatel-Lucent>,
        <https://1145.am/db/2667192/Alcatel-Lucent>,
        <https://1145.am/db/2667452/Alcatel-Lucent>,
        <https://1145.am/db/2668257/Alcatel-Lucent>,
        <https://1145.am/db/2668422/Alcatel-Lucent>,
        <https://1145.am/db/2668973/Alcatel-Lucent>,
        <https://1145.am/db/2668986/Alcatel-Lucent>,
        <https://1145.am/db/2670204/Alcatel-Lucent>,
        <https://1145.am/db/2670501/Alcatel-Lucent>,
        <https://1145.am/db/2670547/Alcatel-Lucent>,
        <https://1145.am/db/2670735/Alcatel-Lucent>,
        <https://1145.am/db/2670748/Alcatel-Lucent>,
        <https://1145.am/db/2671140/Alcatel-Lucent>,
        <https://1145.am/db/2671336/Alcatel-Lucent>,
        <https://1145.am/db/2671922/Alcatel-Lucent>,
        <https://1145.am/db/2672328/Alcatel-Lucent>,
        <https://1145.am/db/2672337/Alcatel-Lucent>,
        <https://1145.am/db/2672864/Alcatel-Lucent>,
        <https://1145.am/db/2672932/Alcatel-Lucent>,
        <https://1145.am/db/2674110/Alcatel_Lucent>,
        <https://1145.am/db/2675256/Alcatel-Lucent>,
        <https://1145.am/db/2676711/Alcatel-Lucent>,
        <https://1145.am/db/2676997/Alcatel-Lucent>,
        <https://1145.am/db/2678826/Alcatel-Lucent>,
        <https://1145.am/db/2678859/Alcatel-Lucent>,
        <https://1145.am/db/2679013/Alcatel-Lucent>,
        <https://1145.am/db/2679049/Alcatel-Lucent>,
        <https://1145.am/db/2679386/Alcatel-Lucent>,
        <https://1145.am/db/2679680/Alcatel-Lucent>,
        <https://1145.am/db/2680847/Alcatel-Lucent>,
        <https://1145.am/db/2681373/Alcatel-Lucent>,
        <https://1145.am/db/2681782/Alcatel-Lucent>,
        <https://1145.am/db/2682873/Alcatel-Lucent>,
        <https://1145.am/db/2683040/Alcatel-Lucent>,
        <https://1145.am/db/2684278/Alcatel-Lucent> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2683818/Microsoft> a org:Organization ;
    ns1:buyer <https://1145.am/db/2683818/Nokia_Solutions_And_Networks_Unit_Acquisition> ;
    ns1:documentDate "2013-09-26T13:47:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Reports: Nokia's board considering NSN deal with Alcatel-Lucent" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/reports-nokia-s-board-considering-nsn-deal-alcatel-lucent> ;
    ns1:foundName "Microsoft" ;
    ns1:name "Microsoft" ;
    ns1:sameAsMedium <https://1145.am/db/1017437/Microsoft_Corp>,
        <https://1145.am/db/1025001/Microsoft_Corp>,
        <https://1145.am/db/1092654/Microsoft>,
        <https://1145.am/db/1190136/Microsoft>,
        <https://1145.am/db/1311662/Microsoft_Corp>,
        <https://1145.am/db/1314290/Microsoft>,
        <https://1145.am/db/1343611/Microsoft_Corp>,
        <https://1145.am/db/1346180/Microsoft>,
        <https://1145.am/db/1382052/Microsoft_Corp>,
        <https://1145.am/db/1398821/Microsoft>,
        <https://1145.am/db/1428802/Microsoft>,
        <https://1145.am/db/1487902/Microsoft>,
        <https://1145.am/db/1527244/Microsoft_Corp>,
        <https://1145.am/db/1558774/Microsoft>,
        <https://1145.am/db/1566732/Microsoft>,
        <https://1145.am/db/1571096/Microsoft>,
        <https://1145.am/db/1600830/Microsoft_Corp>,
        <https://1145.am/db/1617851/Microsoft>,
        <https://1145.am/db/1618044/Microsoft_Corp>,
        <https://1145.am/db/161893/Microsoft>,
        <https://1145.am/db/1631476/Microsoft_Corp>,
        <https://1145.am/db/1633549/Microsoft>,
        <https://1145.am/db/1654251/Microsoft>,
        <https://1145.am/db/1655883/Microsoft>,
        <https://1145.am/db/1678251/Microsoft>,
        <https://1145.am/db/1689071/Microsoft>,
        <https://1145.am/db/1691718/Microsoft_Corp>,
        <https://1145.am/db/1695812/Microsoft>,
        <https://1145.am/db/1697158/Microsoft>,
        <https://1145.am/db/1697321/Microsoft>,
        <https://1145.am/db/1697590/Microsoft>,
        <https://1145.am/db/1698342/Microsoft>,
        <https://1145.am/db/1699320/Microsoft>,
        <https://1145.am/db/1699790/Microsoft>,
        <https://1145.am/db/1701497/Microsoft>,
        <https://1145.am/db/1703728/Microsoft_Corporation>,
        <https://1145.am/db/1706033/Microsoft>,
        <https://1145.am/db/1708523/Microsoft>,
        <https://1145.am/db/1708611/Microsoft>,
        <https://1145.am/db/1709652/Microsoft>,
        <https://1145.am/db/1709976/Microsoft>,
        <https://1145.am/db/1710427/Microsoft>,
        <https://1145.am/db/1710962/Microsoft>,
        <https://1145.am/db/1711305/Microsoft>,
        <https://1145.am/db/1712686/Microsoft_Corp>,
        <https://1145.am/db/1712862/Microsoft>,
        <https://1145.am/db/1714418/Microsoft>,
        <https://1145.am/db/1716650/Microsoft>,
        <https://1145.am/db/1717533/Microsoft>,
        <https://1145.am/db/1718033/Microsoft>,
        <https://1145.am/db/1718245/Microsoft>,
        <https://1145.am/db/1719232/Microsoft>,
        <https://1145.am/db/1721134/Microsoft>,
        <https://1145.am/db/1723140/Microsoft_Corp>,
        <https://1145.am/db/1726210/Microsoft>,
        <https://1145.am/db/1727481/Microsoft>,
        <https://1145.am/db/1734650/Microsoft>,
        <https://1145.am/db/1734778/Microsoft>,
        <https://1145.am/db/1734931/Microsoft>,
        <https://1145.am/db/1735301/Microsoft>,
        <https://1145.am/db/1737935/Microsoft>,
        <https://1145.am/db/1741120/Microsoft>,
        <https://1145.am/db/1741140/Microsoft>,
        <https://1145.am/db/1742118/Microsoft>,
        <https://1145.am/db/1746848/Microsoft>,
        <https://1145.am/db/1746971/Microsoft>,
        <https://1145.am/db/1747044/Microsoft>,
        <https://1145.am/db/1747812/Microsoft>,
        <https://1145.am/db/1748887/Microsoft>,
        <https://1145.am/db/1749016/Microsoft>,
        <https://1145.am/db/1751726/Microsoft>,
        <https://1145.am/db/1752062/Microsoft>,
        <https://1145.am/db/1754464/Microsoft>,
        <https://1145.am/db/1755059/Microsoft>,
        <https://1145.am/db/1755209/Microsoft>,
        <https://1145.am/db/1758390/Microsoft>,
        <https://1145.am/db/1758900/Microsoft>,
        <https://1145.am/db/1758924/Microsoft>,
        <https://1145.am/db/1759192/Microsoft>,
        <https://1145.am/db/1759760/Microsoft>,
        <https://1145.am/db/1759766/Microsoft>,
        <https://1145.am/db/1760029/Microsoft>,
        <https://1145.am/db/1760205/Microsoft>,
        <https://1145.am/db/1760729/Microsoft>,
        <https://1145.am/db/1760981/Microsoft>,
        <https://1145.am/db/1762702/Microsoft>,
        <https://1145.am/db/1763332/Microsoft>,
        <https://1145.am/db/1764427/Microsoft>,
        <https://1145.am/db/1768188/Microsoft>,
        <https://1145.am/db/1768388/Microsoft>,
        <https://1145.am/db/1769233/Microsoft>,
        <https://1145.am/db/1770225/Microsoft>,
        <https://1145.am/db/1770401/Microsoft>,
        <https://1145.am/db/1771744/Microsoft>,
        <https://1145.am/db/1772579/Microsoft>,
        <https://1145.am/db/1772600/Microsoft>,
        <https://1145.am/db/1773454/Microsoft>,
        <https://1145.am/db/1777695/Microsoft>,
        <https://1145.am/db/1778043/Microsoft>,
        <https://1145.am/db/1778089/Microsoft>,
        <https://1145.am/db/1778879/Microsoft>,
        <https://1145.am/db/1780530/Microsoft>,
        <https://1145.am/db/1781499/Microsoft>,
        <https://1145.am/db/1782580/Microsoft>,
        <https://1145.am/db/1783135/Microsoft>,
        <https://1145.am/db/1786640/Microsoft>,
        <https://1145.am/db/1786753/Microsoft>,
        <https://1145.am/db/1786991/Microsoft>,
        <https://1145.am/db/1788358/Microsoft>,
        <https://1145.am/db/1790700/Microsoft>,
        <https://1145.am/db/1791808/Microsoft>,
        <https://1145.am/db/1792227/Microsoft>,
        <https://1145.am/db/1792368/Microsoft>,
        <https://1145.am/db/1792666/Microsoft>,
        <https://1145.am/db/1792965/Microsoft>,
        <https://1145.am/db/1793015/Microsoft>,
        <https://1145.am/db/1794612/Microsoft>,
        <https://1145.am/db/1795244/Microsoft>,
        <https://1145.am/db/1795255/Microsoft>,
        <https://1145.am/db/1795869/Microsoft>,
        <https://1145.am/db/1795925/Microsoft>,
        <https://1145.am/db/1796232/Microsoft>,
        <https://1145.am/db/1796259/Microsoft>,
        <https://1145.am/db/1796273/Microsoft>,
        <https://1145.am/db/1798246/Microsoft>,
        <https://1145.am/db/1798437/Microsoft>,
        <https://1145.am/db/1800013/Microsoft>,
        <https://1145.am/db/1801241/Microsoft>,
        <https://1145.am/db/1802129/Microsoft>,
        <https://1145.am/db/1803214/Microsoft>,
        <https://1145.am/db/1807226/Microsoft>,
        <https://1145.am/db/1808409/Microsoft>,
        <https://1145.am/db/1809462/Microsoft>,
        <https://1145.am/db/1810877/Microsoft>,
        <https://1145.am/db/1811070/Microsoft>,
        <https://1145.am/db/1811482/Microsoft>,
        <https://1145.am/db/1813957/Microsoft>,
        <https://1145.am/db/1814632/Microsoft>,
        <https://1145.am/db/1814865/Microsoft>,
        <https://1145.am/db/1816265/Microsoft>,
        <https://1145.am/db/1816532/Microsoft>,
        <https://1145.am/db/1817819/Microsoft>,
        <https://1145.am/db/1818394/Microsoft>,
        <https://1145.am/db/1818533/Microsoft>,
        <https://1145.am/db/1818534/Microsoft>,
        <https://1145.am/db/1819909/Microsoft>,
        <https://1145.am/db/1820048/Microsoft>,
        <https://1145.am/db/1822222/Microsoft>,
        <https://1145.am/db/1823778/Microsoft>,
        <https://1145.am/db/1824780/Microsoft>,
        <https://1145.am/db/1825996/Microsoft>,
        <https://1145.am/db/1826121/Microsoft>,
        <https://1145.am/db/1827341/Microsoft>,
        <https://1145.am/db/1828648/Microsoft>,
        <https://1145.am/db/1828902/Microsoft>,
        <https://1145.am/db/1830298/Microsoft>,
        <https://1145.am/db/1831301/Microsoft>,
        <https://1145.am/db/1832770/Microsoft>,
        <https://1145.am/db/1833510/Microsoft>,
        <https://1145.am/db/1834475/Microsoft>,
        <https://1145.am/db/1835226/Microsoft>,
        <https://1145.am/db/1835448/Microsoft>,
        <https://1145.am/db/1838210/Microsoft>,
        <https://1145.am/db/1838478/Microsoft>,
        <https://1145.am/db/1839207/Microsoft>,
        <https://1145.am/db/1841018/Microsoft_Corp>,
        <https://1145.am/db/1842562/Microsoft>,
        <https://1145.am/db/1842887/Microsoft>,
        <https://1145.am/db/1843454/Microsoft>,
        <https://1145.am/db/1843539/Microsoft>,
        <https://1145.am/db/1843972/Microsoft>,
        <https://1145.am/db/1852125/Microsoft>,
        <https://1145.am/db/1853227/Microsoft>,
        <https://1145.am/db/1854780/Microsoft>,
        <https://1145.am/db/1854945/Microsoft>,
        <https://1145.am/db/1855966/Microsoft>,
        <https://1145.am/db/1856684/Microsoft>,
        <https://1145.am/db/1858254/Microsoft>,
        <https://1145.am/db/1858451/Microsoft>,
        <https://1145.am/db/1858692/Microsoft>,
        <https://1145.am/db/1860773/Microsoft>,
        <https://1145.am/db/1861339/Microsoft>,
        <https://1145.am/db/1871130/Microsoft>,
        <https://1145.am/db/1871611/Microsoft>,
        <https://1145.am/db/1874678/Microsoft>,
        <https://1145.am/db/1875189/Microsoft>,
        <https://1145.am/db/1879673/Microsoft>,
        <https://1145.am/db/1879985/Microsoft>,
        <https://1145.am/db/1881214/Microsoft>,
        <https://1145.am/db/1882058/Microsoft>,
        <https://1145.am/db/1882161/Microsoft>,
        <https://1145.am/db/1884277/Microsoft>,
        <https://1145.am/db/1885560/Microsoft>,
        <https://1145.am/db/1888008/Microsoft>,
        <https://1145.am/db/1895009/Microsoft>,
        <https://1145.am/db/1897581/Microsoft>,
        <https://1145.am/db/1901098/Microsoft>,
        <https://1145.am/db/1902016/Microsoft>,
        <https://1145.am/db/1902079/Microsoft>,
        <https://1145.am/db/1902847/Microsoft>,
        <https://1145.am/db/1903669/Microsoft>,
        <https://1145.am/db/1903721/Microsoft>,
        <https://1145.am/db/1905425/Microsoft>,
        <https://1145.am/db/1909119/Microsoft_Corp>,
        <https://1145.am/db/1910290/Microsoft_Corp>,
        <https://1145.am/db/1914747/Microsoft>,
        <https://1145.am/db/1915432/Microsoft>,
        <https://1145.am/db/1915560/Microsoft>,
        <https://1145.am/db/1941048/Microsoft_Corp>,
        <https://1145.am/db/1942901/Microsoft_Corp>,
        <https://1145.am/db/1943925/Microsoft_Corp>,
        <https://1145.am/db/1947749/Microsoft>,
        <https://1145.am/db/1947898/Microsoft>,
        <https://1145.am/db/1948338/Microsoft>,
        <https://1145.am/db/1961649/Microsoft>,
        <https://1145.am/db/1974598/Microsoft>,
        <https://1145.am/db/1981521/Microsoft>,
        <https://1145.am/db/1982175/Microsoft>,
        <https://1145.am/db/1984927/Microsoft>,
        <https://1145.am/db/1986630/Microsoft>,
        <https://1145.am/db/1987503/Microsoft>,
        <https://1145.am/db/1993523/Microsoft>,
        <https://1145.am/db/199718/Microsoft>,
        <https://1145.am/db/199816/Microsoft>,
        <https://1145.am/db/2002065/Microsoft_Corp>,
        <https://1145.am/db/2004213/Microsoft_Corp>,
        <https://1145.am/db/2006775/Microsoft>,
        <https://1145.am/db/2007265/Microsoft>,
        <https://1145.am/db/2008078/Microsoft_Corp>,
        <https://1145.am/db/2011789/Microsoft>,
        <https://1145.am/db/2013724/Microsoft>,
        <https://1145.am/db/2015713/Microsoft_Corp>,
        <https://1145.am/db/2015981/Microsoft>,
        <https://1145.am/db/2029229/Microsoft>,
        <https://1145.am/db/2033848/Microsoft>,
        <https://1145.am/db/2034613/Microsoft>,
        <https://1145.am/db/2034974/Microsoft_Corp>,
        <https://1145.am/db/2036186/Microsoft>,
        <https://1145.am/db/2036982/Microsoft_Corp>,
        <https://1145.am/db/2037760/Microsoft>,
        <https://1145.am/db/2039253/Microsoft>,
        <https://1145.am/db/2040859/Microsoft>,
        <https://1145.am/db/2045433/Microsoft>,
        <https://1145.am/db/2047060/Microsoft>,
        <https://1145.am/db/2050229/Microsoft>,
        <https://1145.am/db/2053053/Microsoft>,
        <https://1145.am/db/2053123/Microsoft>,
        <https://1145.am/db/2053654/Microsoft>,
        <https://1145.am/db/2059318/Microsoft>,
        <https://1145.am/db/2059491/Microsoft>,
        <https://1145.am/db/2059502/Microsoft>,
        <https://1145.am/db/2059547/Microsoft>,
        <https://1145.am/db/2060416/Microsoft>,
        <https://1145.am/db/2060997/Microsoft>,
        <https://1145.am/db/2062372/Microsoft>,
        <https://1145.am/db/2063305/Microsoft>,
        <https://1145.am/db/2063335/Microsoft_Corp>,
        <https://1145.am/db/2063909/Microsoft>,
        <https://1145.am/db/2064352/Microsoft>,
        <https://1145.am/db/2065497/Microsoft>,
        <https://1145.am/db/2067787/Microsoft>,
        <https://1145.am/db/2072814/Microsoft>,
        <https://1145.am/db/2083718/Microsoft>,
        <https://1145.am/db/2093298/Microsoft>,
        <https://1145.am/db/2094024/Microsoft>,
        <https://1145.am/db/2109233/Microsoft>,
        <https://1145.am/db/2120040/Microsoft>,
        <https://1145.am/db/2122854/Microsoft>,
        <https://1145.am/db/2127651/Microsoft>,
        <https://1145.am/db/2144448/Microsoft>,
        <https://1145.am/db/2145163/Microsoft>,
        <https://1145.am/db/2148259/Microsoft>,
        <https://1145.am/db/2162386/Microsoft>,
        <https://1145.am/db/217185/Microsoft>,
        <https://1145.am/db/2172604/Microsoft>,
        <https://1145.am/db/2173138/Microsoft>,
        <https://1145.am/db/2174297/Microsoft>,
        <https://1145.am/db/2178519/Microsoft>,
        <https://1145.am/db/2180858/Microsoft>,
        <https://1145.am/db/2187630/Microsoft>,
        <https://1145.am/db/2197267/Microsoft>,
        <https://1145.am/db/2198071/Microsoft>,
        <https://1145.am/db/2198670/Microsoft>,
        <https://1145.am/db/2207923/Microsoft>,
        <https://1145.am/db/2225131/Microsoft>,
        <https://1145.am/db/2278997/Microsoft>,
        <https://1145.am/db/2279241/Microsoft>,
        <https://1145.am/db/228046/Microsoft>,
        <https://1145.am/db/2284483/Microsoft>,
        <https://1145.am/db/232308/Microsoft_Corp>,
        <https://1145.am/db/232337/Microsoft_Corp>,
        <https://1145.am/db/2326224/Microsoft_Corp>,
        <https://1145.am/db/2508969/Microsoft>,
        <https://1145.am/db/2601736/Microsoft>,
        <https://1145.am/db/2602130/Microsoft>,
        <https://1145.am/db/2602724/Microsoft>,
        <https://1145.am/db/2602863/Microsoft>,
        <https://1145.am/db/2602958/Microsoft>,
        <https://1145.am/db/2603484/Microsoft>,
        <https://1145.am/db/2604604/Microsoft>,
        <https://1145.am/db/2606540/Microsoft>,
        <https://1145.am/db/2611328/Microsoft>,
        <https://1145.am/db/2611331/Microsoft>,
        <https://1145.am/db/2611481/Microsoft>,
        <https://1145.am/db/2612223/Microsoft>,
        <https://1145.am/db/2612606/Microsoft>,
        <https://1145.am/db/2613829/Microsoft>,
        <https://1145.am/db/2617989/Microsoft>,
        <https://1145.am/db/2620025/Microsoft>,
        <https://1145.am/db/2620026/Microsoft>,
        <https://1145.am/db/2622354/Microsoft>,
        <https://1145.am/db/2623559/Microsoft>,
        <https://1145.am/db/2626449/Microsoft>,
        <https://1145.am/db/2627269/Microsoft>,
        <https://1145.am/db/2628760/Microsoft>,
        <https://1145.am/db/2634465/Microsoft>,
        <https://1145.am/db/2634487/Microsoft>,
        <https://1145.am/db/2636189/Microsoft>,
        <https://1145.am/db/2636234/Microsoft>,
        <https://1145.am/db/2639094/Microsoft>,
        <https://1145.am/db/2640110/Microsoft>,
        <https://1145.am/db/2640182/Microsoft>,
        <https://1145.am/db/2644494/Microsoft>,
        <https://1145.am/db/2648410/Microsoft>,
        <https://1145.am/db/2648535/Microsoft>,
        <https://1145.am/db/2648546/Microsoft>,
        <https://1145.am/db/2651427/Microsoft>,
        <https://1145.am/db/2651769/Microsoft>,
        <https://1145.am/db/2652890/Microsoft>,
        <https://1145.am/db/2653297/Microsoft>,
        <https://1145.am/db/2653310/Microsoft>,
        <https://1145.am/db/2653481/Microsoft>,
        <https://1145.am/db/2653908/Microsoft>,
        <https://1145.am/db/2654138/Microsoft>,
        <https://1145.am/db/2654146/Microsoft>,
        <https://1145.am/db/2654238/Microsoft>,
        <https://1145.am/db/2654294/Microsoft>,
        <https://1145.am/db/2654510/Microsoft>,
        <https://1145.am/db/2654524/Microsoft>,
        <https://1145.am/db/2655064/Microsoft>,
        <https://1145.am/db/2655146/Microsoft>,
        <https://1145.am/db/2655423/Microsoft>,
        <https://1145.am/db/2655439/Microsoft>,
        <https://1145.am/db/2655461/Microsoft>,
        <https://1145.am/db/2656101/Microsoft>,
        <https://1145.am/db/2656359/Microsoft>,
        <https://1145.am/db/2656986/Microsoft>,
        <https://1145.am/db/2657038/Microsoft>,
        <https://1145.am/db/2658038/Microsoft>,
        <https://1145.am/db/2658913/Microsoft>,
        <https://1145.am/db/2659072/Microsoft>,
        <https://1145.am/db/2659897/Microsoft>,
        <https://1145.am/db/2659924/Microsoft>,
        <https://1145.am/db/2659958/Microsoft>,
        <https://1145.am/db/2661009/Microsoft>,
        <https://1145.am/db/2661125/Microsoft>,
        <https://1145.am/db/2661187/Microsoft>,
        <https://1145.am/db/2662106/Microsoft>,
        <https://1145.am/db/2662211/Microsoft>,
        <https://1145.am/db/2662486/Microsoft>,
        <https://1145.am/db/2663295/Microsoft>,
        <https://1145.am/db/2663557/Microsoft>,
        <https://1145.am/db/2664293/Microsoft>,
        <https://1145.am/db/2664464/Microsoft>,
        <https://1145.am/db/2666156/Microsoft>,
        <https://1145.am/db/2667065/Microsoft>,
        <https://1145.am/db/2667078/Microsoft>,
        <https://1145.am/db/2667474/Microsoft>,
        <https://1145.am/db/2667526/Microsoft>,
        <https://1145.am/db/2667660/Microsoft>,
        <https://1145.am/db/2669494/Microsoft>,
        <https://1145.am/db/2670705/Microsoft>,
        <https://1145.am/db/2671587/Microsoft>,
        <https://1145.am/db/2671878/Microsoft>,
        <https://1145.am/db/2672066/Microsoft>,
        <https://1145.am/db/2672194/Microsoft>,
        <https://1145.am/db/2672819/Microsoft>,
        <https://1145.am/db/2673373/Microsoft>,
        <https://1145.am/db/2673385/Microsoft>,
        <https://1145.am/db/2673437/Microsoft>,
        <https://1145.am/db/2673898/Microsoft>,
        <https://1145.am/db/2675617/Microsoft>,
        <https://1145.am/db/2679159/Microsoft>,
        <https://1145.am/db/2679256/Microsoft>,
        <https://1145.am/db/2679342/Microsoft>,
        <https://1145.am/db/2681897/Microsoft>,
        <https://1145.am/db/2682508/Microsoft>,
        <https://1145.am/db/2683061/Microsoft>,
        <https://1145.am/db/2683066/Microsoft>,
        <https://1145.am/db/2683067/Microsoft>,
        <https://1145.am/db/2683069/Microsoft>,
        <https://1145.am/db/2683074/Microsoft>,
        <https://1145.am/db/2683077/Microsoft>,
        <https://1145.am/db/2683079/Microsoft>,
        <https://1145.am/db/2683451/Microsoft>,
        <https://1145.am/db/2683465/Microsoft>,
        <https://1145.am/db/2686285/Microsoft>,
        <https://1145.am/db/2686301/Microsoft>,
        <https://1145.am/db/2686449/Microsoft>,
        <https://1145.am/db/2700623/Microsoft>,
        <https://1145.am/db/2738271/Microsoft>,
        <https://1145.am/db/2754611/Microsoft>,
        <https://1145.am/db/2760139/Microsoft_Corp>,
        <https://1145.am/db/2761530/Microsoft_Corp>,
        <https://1145.am/db/2762134/Microsoft>,
        <https://1145.am/db/2762347/Microsoft_Corp>,
        <https://1145.am/db/2762562/Microsoft>,
        <https://1145.am/db/2776232/Microsoft>,
        <https://1145.am/db/2782429/Microsoft>,
        <https://1145.am/db/2801091/Microsoft_Corporation>,
        <https://1145.am/db/282538/Microsoft_Corp>,
        <https://1145.am/db/305288/Microsoft_Corp>,
        <https://1145.am/db/305594/Microsoft_Corp>,
        <https://1145.am/db/347978/Microsoft_Corp>,
        <https://1145.am/db/348031/Microsoft_Corp>,
        <https://1145.am/db/355324/Microsoft_Corp>,
        <https://1145.am/db/355332/Microsoft_Corp>,
        <https://1145.am/db/361491/Microsoft>,
        <https://1145.am/db/365521/Microsoft_Corp>,
        <https://1145.am/db/387846/Microsoft_Corp>,
        <https://1145.am/db/505767/Microsoft_Corp>,
        <https://1145.am/db/544757/Microsoft>,
        <https://1145.am/db/549213/Microsoft_Corp>,
        <https://1145.am/db/644370/Microsoft_Corp>,
        <https://1145.am/db/692886/Microsoft_Corp>,
        <https://1145.am/db/698837/Microsoft>,
        <https://1145.am/db/710355/Microsoft>,
        <https://1145.am/db/710798/Microsoft>,
        <https://1145.am/db/765281/Microsoft_Corp>,
        <https://1145.am/db/766576/Microsoft_Corp>,
        <https://1145.am/db/767841/Microsoft>,
        <https://1145.am/db/767857/Microsoft_Corp>,
        <https://1145.am/db/771073/Microsoft>,
        <https://1145.am/db/771474/Microsoft>,
        <https://1145.am/db/771701/Microsoft_Corp>,
        <https://1145.am/db/771800/Microsoft_Corp>,
        <https://1145.am/db/772395/Microsoft>,
        <https://1145.am/db/774623/Microsoft_Corp>,
        <https://1145.am/db/784797/Microsoft>,
        <https://1145.am/db/798667/Microsoft_Corp>,
        <https://1145.am/db/798704/Microsoft>,
        <https://1145.am/db/798950/Microsoft_Corp>,
        <https://1145.am/db/816467/Microsoft_Corp>,
        <https://1145.am/db/817822/Microsoft_Corp>,
        <https://1145.am/db/829840/Microsoft_Corp>,
        <https://1145.am/db/85685/Microsoft_Corp>,
        <https://1145.am/db/867602/Microsoft_Corporation>,
        <https://1145.am/db/871474/Microsoft_Corporation>,
        <https://1145.am/db/877583/Microsoft_Corp>,
        <https://1145.am/db/879601/Microsoft>,
        <https://1145.am/db/880066/Microsoft_Corp>,
        <https://1145.am/db/907229/Microsoft>,
        <https://1145.am/db/920712/Microsoft>,
        <https://1145.am/db/969129/Microsoft>,
        <https://1145.am/db/973870/Microsoft> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2684180/Brightstar_Corp> a org:Organization ;
    ns1:basedInLowRaw "Japanese",
        "U.S" ;
    ns1:documentDate "2013-10-16T14:58:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SoftBank eyeing a stake in wireless distributor Brightstar" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/softbank-eyeing-a-stake-wireless-distributor-brightstar> ;
    ns1:foundName "Brightstar",
        "Brightstar Corp" ;
    ns1:industry "wireless device distributor" ;
    ns1:name "Brightstar",
        "Brightstar Corp" ;
    ns1:sameAsHigh <https://1145.am/db/2637621/Brightpoint>,
        <https://1145.am/db/2655930/Brightstar_Corp>,
        <https://1145.am/db/2684436/Brightstar> ;
    ns1:sameAsMedium <https://1145.am/db/187973/Brightstar_Corp>,
        <https://1145.am/db/199463/Brightstar_Corp>,
        <https://1145.am/db/2678510/Brightstar> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2684180/Supercell> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Finland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/660013/about.rdf> ;
    ns1:basedInHighRaw "Finland" ;
    ns1:description "game developer" ;
    ns1:documentDate "2013-10-16T14:58:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "SoftBank eyeing a stake in wireless distributor Brightstar" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/softbank-eyeing-a-stake-wireless-distributor-brightstar> ;
    ns1:foundName "Supercell" ;
    ns1:industry "game developer" ;
    ns1:name "Supercell" ;
    ns1:sameAsHigh <https://1145.am/db/1186972/Supercell>,
        <https://1145.am/db/1738865/Supercell>,
        <https://1145.am/db/1747202/Supercell>,
        <https://1145.am/db/1795729/Supercell>,
        <https://1145.am/db/1812014/Glu_Mobile>,
        <https://1145.am/db/1827170/Supercell>,
        <https://1145.am/db/1830778/Supercell>,
        <https://1145.am/db/1837867/Gloops>,
        <https://1145.am/db/1853106/Supercell>,
        <https://1145.am/db/1907690/Supercell>,
        <https://1145.am/db/199367/Huuuge_Inc>,
        <https://1145.am/db/200203/Huuuge_Inc>,
        <https://1145.am/db/2047154/Supercell>,
        <https://1145.am/db/213600/Huuuge_Inc>,
        <https://1145.am/db/217400/Nexters_Global>,
        <https://1145.am/db/219332/Huuuge_Inc>,
        <https://1145.am/db/2655974/Supercell>,
        <https://1145.am/db/2656904/Supercell>,
        <https://1145.am/db/2656980/Supercell> ;
    ns1:sameAsMedium <https://1145.am/db/1766039/Supercell>,
        <https://1145.am/db/1810700/Supercell>,
        <https://1145.am/db/1819952/Supercell>,
        <https://1145.am/db/1821008/Supercell>,
        <https://1145.am/db/2655930/Supercell> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2175059/Kabel_Deutschland_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:description "cable operator" ;
    ns1:documentDate "2013-10-14T15:14:12+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Vodafone has completed its $ 10 billion take over of Germany's biggest cable operator, Kabel Deutschland." ;
    ns1:documentTitle "Aereo set to launch Android app; Vodafone closes Kabel Deutschland deal" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/aereo-set-to-launch-android-app-vodafone-closes-kabel-deutschland-deal> ;
    ns1:foundName "Kabel Deutschland",
        "take over",
        "withdraw" ;
    ns1:industry "cable operator" ;
    ns1:name "Kabel Deutschland",
        "take over",
        "withdraw" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2175059/Kabel_Deutschland_Acquisition> ;
    ns1:targetName "Kabel Deutschland" ;
    ns1:valueRaw "$ 10 billion" ;
    ns1:vendor <https://1145.am/db/2175059/Uk_Internet_Television_Service> ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2242437/Medical_Properties_Trust> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2242437/The_Medical_Center_Of_Southeast_Texas_Property_Acquisition> ;
    ns1:description "healthcare real estate investment trust" ;
    ns1:documentDate "2013-08-14T13:00:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "IASIS Healthcare Executes Real Estate Transaction as Part of Long-Term Strategic Growth Plan" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/iasis-healthcare-executes-real-estate-transaction-as-part-long-term-strategic-growth> ;
    ns1:foundName "Medical Properties Trust, Inc." ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2242437/The_Medical_Center_Of_Southeast_Texas_Property_Acquisition> ;
    ns1:name "Medical Properties Trust" ;
    ns1:sameAsHigh <https://1145.am/db/1070867/Sila_Realty_Trust>,
        <https://1145.am/db/1074214/Sila_Realty_Trust>,
        <https://1145.am/db/1094739/Sila_Realty_Trust>,
        <https://1145.am/db/112109/Global_Medical_Reit_Inc>,
        <https://1145.am/db/1179297/Healthcare_Realty_Trust_Inc>,
        <https://1145.am/db/1181370/Healthcare_Realty_Trust>,
        <https://1145.am/db/1186456/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/1191739/Caretrust_Reit_Inc>,
        <https://1145.am/db/1192274/Caretrust_Reit_Inc>,
        <https://1145.am/db/1192977/Sila_Realty_Trust_Inc>,
        <https://1145.am/db/1209501/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/1209503/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/1221931/Healthcare_Realty_Trust>,
        <https://1145.am/db/1258685/Flagship_Healthcare_Trust>,
        <https://1145.am/db/1322641/Medical_Properties_Trust>,
        <https://1145.am/db/1322910/Medical_Properties_Trust>,
        <https://1145.am/db/1336985/Physicians_Realty_Trust>,
        <https://1145.am/db/1341357/Physicians_Realty_Trust>,
        <https://1145.am/db/1397608/Medical_Properties_Trust>,
        <https://1145.am/db/1397811/Medical_Properties_Trust>,
        <https://1145.am/db/1952669/Medical_Properties_Trust>,
        <https://1145.am/db/2017080/One_Of_Diversified_Healthcare_Trusts>,
        <https://1145.am/db/2017286/Medical_Properties_Trust>,
        <https://1145.am/db/2034986/Diversified_Healthcare_Trust>,
        <https://1145.am/db/2089947/Medical_Properties_Trust>,
        <https://1145.am/db/2133695/Medical_Properties_Trust>,
        <https://1145.am/db/2195374/Medical_Properties_Trust>,
        <https://1145.am/db/2242439/Medical_Properties_Trust_Inc>,
        <https://1145.am/db/2244292/Medical_Properties_Trust_Inc>,
        <https://1145.am/db/2245294/Physicians_Realty_Trust>,
        <https://1145.am/db/2245304/Physicians_Realty_Trust>,
        <https://1145.am/db/2250673/American_Realty_Capital_Healthcare_Trust>,
        <https://1145.am/db/2257136/Medproperties_Holdings>,
        <https://1145.am/db/2257136/Physicians_Realty_Trust>,
        <https://1145.am/db/2785727/Physicians_Realty_Trust>,
        <https://1145.am/db/2785731/Physicians_Realty_Trust>,
        <https://1145.am/db/2791889/Physicians_Realty_Trust>,
        <https://1145.am/db/486121/Medical_Properties_Trust>,
        <https://1145.am/db/487775/Medical_Properties_Trust>,
        <https://1145.am/db/516825/Physicians_Realty_Lp>,
        <https://1145.am/db/516825/Physicians_Realty_Trust>,
        <https://1145.am/db/518094/Physicians_Realty_Lp>,
        <https://1145.am/db/518094/Physicians_Realty_Trust>,
        <https://1145.am/db/530993/Physicians_Realty_Lp>,
        <https://1145.am/db/530993/Physicians_Realty_Trust>,
        <https://1145.am/db/533106/Physicians_Realty_Lp>,
        <https://1145.am/db/533106/Physicians_Realty_Trust>,
        <https://1145.am/db/579888/Flagship_Healthcare_Trust>,
        <https://1145.am/db/702920/Physicians_Realty_Trust>,
        <https://1145.am/db/711308/Physicians_Realty_Trust>,
        <https://1145.am/db/866427/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/900554/Healthcare_Trust_Of_America_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1327320/Medical_Properties_Trust>,
        <https://1145.am/db/1329741/Medical_Properties_Trust>,
        <https://1145.am/db/1642288/Medical_Properties_Trust>,
        <https://1145.am/db/1643189/Medical_Properties_Trust>,
        <https://1145.am/db/2225233/Medical_Properties_Trust>,
        <https://1145.am/db/2237756/Medical_Properties_Trust>,
        <https://1145.am/db/2242401/Medical_Properties_Trust_Inc>,
        <https://1145.am/db/489597/Medical_Properties_Trust>,
        <https://1145.am/db/492025/Medical_Properties_Trust>,
        <https://1145.am/db/492975/Medical_Properties_Trust>,
        <https://1145.am/db/849416/Medical_Properties_Trust_Inc>,
        <https://1145.am/db/849877/Medical_Properties_Trust_Inc>,
        <https://1145.am/db/8983/Medical_Properties_Trust> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2242437/The_Medical_Center_Of_Southeast_Texas_Property_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-08-14T13:00:12+00:00"^^xsd:dateTime ;
    ns1:documentExtract "IASIS Healthcare LLC (\"IASIS\") , a leading provider of high quality, affordable healthcare services, today announced the execution of a sale-leaseback agreement with Medical Properties Trust, Inc., (\"MPT\") , the healthcare real estate investment trust (\"REIT\") that currently owns property associated with another IASIS facility." ;
    ns1:documentTitle "IASIS Healthcare Executes Real Estate Transaction as Part of Long-Term Strategic Growth Plan" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/iasis-healthcare-executes-real-estate-transaction-as-part-long-term-strategic-growth> ;
    ns1:foundName "leaseback",
        "owns",
        "sale" ;
    ns1:name "leaseback",
        "owns",
        "sale" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2242437/Iasis_Healthcare_Llc>,
        <https://1145.am/db/2242437/The_Medical_Center_Of_Southeast_Texas> ;
    ns1:targetDetails "property" ;
    ns1:targetName "The Medical Center of Southeast Texas" ;
    ns1:vendor <https://1145.am/db/2242437/Iasis_Healthcare_Llc> ;
    ns1:whereGeoName "Port Arthur" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4720039/about.rdf> ;
    ns1:whereRaw "Port Arthur, TX" .

<https://1145.am/db/2245294/Investment_Crescent_City_Surgical_Centre_Facility_Physicians_Realty_Trust_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-30T22:00:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Physicians Realty Trust Completes $ 37.5 Million Transaction with Crescent City Surgical Centre Facility." ;
    ns1:documentTitle "Physicians Realty Trust Completes $37.5 Million Transaction with Crescent City Surgical Centre Facility" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/physicians-realty-trust-completes-37-5-million-transaction-crescent-city-surgical-centre> ;
    ns1:foundName "Transaction" ;
    ns1:name "Transaction" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:valueRaw "$ 37.5 Million" ;
    ns1:whereRaw "Crescent City Surgical Centre Facility" .

<https://1145.am/db/2245294/Physicians_Realty_Trust> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "real estate" ;
    ns1:documentDate "2013-09-30T22:00:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Physicians Realty Trust Completes $37.5 Million Transaction with Crescent City Surgical Centre Facility" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/physicians-realty-trust-completes-37-5-million-transaction-crescent-city-surgical-centre> ;
    ns1:foundName "Physicians",
        "Physicians Realty Trust" ;
    ns1:industry "healthcare properties REIT" ;
    ns1:name "Physicians Realty Trust" ;
    ns1:participant <https://1145.am/db/2245294/Crescent_City_Surgical_Centre_Facility_Divestment> ;
    ns1:protagonist <https://1145.am/db/2245294/Investment_Crescent_City_Surgical_Centre_Facility_Physicians_Realty_Trust_Completed> ;
    ns1:sameAsHigh <https://1145.am/db/1070867/Sila_Realty_Trust>,
        <https://1145.am/db/1074214/Sila_Realty_Trust>,
        <https://1145.am/db/1094739/Sila_Realty_Trust>,
        <https://1145.am/db/112109/Global_Medical_Reit_Inc>,
        <https://1145.am/db/1179297/Healthcare_Realty_Trust_Inc>,
        <https://1145.am/db/1181370/Healthcare_Realty_Trust>,
        <https://1145.am/db/1186456/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/1191739/Caretrust_Reit_Inc>,
        <https://1145.am/db/1192274/Caretrust_Reit_Inc>,
        <https://1145.am/db/1192977/Sila_Realty_Trust_Inc>,
        <https://1145.am/db/1209501/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/1209503/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/1221931/Healthcare_Realty_Trust>,
        <https://1145.am/db/1258685/Flagship_Healthcare_Trust>,
        <https://1145.am/db/1322641/Medical_Properties_Trust>,
        <https://1145.am/db/1322910/Medical_Properties_Trust>,
        <https://1145.am/db/1336985/Physicians_Realty_Trust>,
        <https://1145.am/db/1341357/Physicians_Realty_Trust>,
        <https://1145.am/db/1397608/Medical_Properties_Trust>,
        <https://1145.am/db/1397811/Medical_Properties_Trust>,
        <https://1145.am/db/1952669/Medical_Properties_Trust>,
        <https://1145.am/db/2017080/One_Of_Diversified_Healthcare_Trusts>,
        <https://1145.am/db/2017286/Medical_Properties_Trust>,
        <https://1145.am/db/2034986/Diversified_Healthcare_Trust>,
        <https://1145.am/db/2089947/Medical_Properties_Trust>,
        <https://1145.am/db/2133695/Medical_Properties_Trust>,
        <https://1145.am/db/2195374/Medical_Properties_Trust>,
        <https://1145.am/db/2242437/Medical_Properties_Trust>,
        <https://1145.am/db/2242439/Medical_Properties_Trust_Inc>,
        <https://1145.am/db/2244292/Medical_Properties_Trust_Inc>,
        <https://1145.am/db/2245304/Physicians_Realty_Trust>,
        <https://1145.am/db/2250673/American_Realty_Capital_Healthcare_Trust>,
        <https://1145.am/db/2257136/Medproperties_Holdings>,
        <https://1145.am/db/2257136/Physicians_Realty_Trust>,
        <https://1145.am/db/2785727/Physicians_Realty_Trust>,
        <https://1145.am/db/2785731/Physicians_Realty_Trust>,
        <https://1145.am/db/2791889/Physicians_Realty_Trust>,
        <https://1145.am/db/486121/Medical_Properties_Trust>,
        <https://1145.am/db/487775/Medical_Properties_Trust>,
        <https://1145.am/db/516825/Physicians_Realty_Lp>,
        <https://1145.am/db/516825/Physicians_Realty_Trust>,
        <https://1145.am/db/518094/Physicians_Realty_Lp>,
        <https://1145.am/db/518094/Physicians_Realty_Trust>,
        <https://1145.am/db/530993/Physicians_Realty_Lp>,
        <https://1145.am/db/530993/Physicians_Realty_Trust>,
        <https://1145.am/db/533106/Physicians_Realty_Lp>,
        <https://1145.am/db/533106/Physicians_Realty_Trust>,
        <https://1145.am/db/579888/Flagship_Healthcare_Trust>,
        <https://1145.am/db/702920/Physicians_Realty_Trust>,
        <https://1145.am/db/711308/Physicians_Realty_Trust>,
        <https://1145.am/db/866427/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/900554/Healthcare_Trust_Of_America_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/848131/Physicians_Realty_Trust> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2245304/Foundation_Outpatient_Care_Building_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-10-01T13:00:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Physicians Realty Trust (NYSE: DOC) (\"the Company\") , a self-managed healthcare properties REIT, announced today the completion of the acquisition of the Foundation Outpatient Care Building located in Oklahoma City, OK.",
        "Physicians Realty Trust Completes $ 15.6 Million Acquisition of Foundation Outpatient Care Building." ;
    ns1:documentTitle "Physicians Realty Trust Completes $15.6 Million Acquisition of Foundation Outpatient Care Building" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/physicians-realty-trust-completes-15-6-million-acquisition-foundation-outpatient-care> ;
    ns1:foundName "Acquisition",
        "acquisition" ;
    ns1:name "Acquisition",
        "acquisition" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2245304/Foundation_Outpatient_Care_Building> ;
    ns1:targetName "Foundation Outpatient Care Building" ;
    ns1:valueRaw "$ 15.6 Million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2245304/Physicians_Realty_Trust> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2245304/Foundation_Outpatient_Care_Building_Acquisition> ;
    ns1:description "healthcare properties" ;
    ns1:documentDate "2013-10-01T13:00:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Physicians Realty Trust Completes $15.6 Million Acquisition of Foundation Outpatient Care Building" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/physicians-realty-trust-completes-15-6-million-acquisition-foundation-outpatient-care> ;
    ns1:foundName "Physicians Realty Trust" ;
    ns1:industry "healthcare properties" ;
    ns1:investor <https://1145.am/db/2245304/Foundation_Outpatient_Care_Building_Acquisition> ;
    ns1:name "Physicians Realty Trust" ;
    ns1:sameAsHigh <https://1145.am/db/1070867/Sila_Realty_Trust>,
        <https://1145.am/db/1074214/Sila_Realty_Trust>,
        <https://1145.am/db/1094739/Sila_Realty_Trust>,
        <https://1145.am/db/112109/Global_Medical_Reit_Inc>,
        <https://1145.am/db/1179297/Healthcare_Realty_Trust_Inc>,
        <https://1145.am/db/1181370/Healthcare_Realty_Trust>,
        <https://1145.am/db/1186456/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/1191739/Caretrust_Reit_Inc>,
        <https://1145.am/db/1192274/Caretrust_Reit_Inc>,
        <https://1145.am/db/1192977/Sila_Realty_Trust_Inc>,
        <https://1145.am/db/1209501/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/1209503/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/1221931/Healthcare_Realty_Trust>,
        <https://1145.am/db/1258685/Flagship_Healthcare_Trust>,
        <https://1145.am/db/1322641/Medical_Properties_Trust>,
        <https://1145.am/db/1322910/Medical_Properties_Trust>,
        <https://1145.am/db/1336985/Physicians_Realty_Trust>,
        <https://1145.am/db/1341357/Physicians_Realty_Trust>,
        <https://1145.am/db/1397608/Medical_Properties_Trust>,
        <https://1145.am/db/1397811/Medical_Properties_Trust>,
        <https://1145.am/db/1952669/Medical_Properties_Trust>,
        <https://1145.am/db/2017080/One_Of_Diversified_Healthcare_Trusts>,
        <https://1145.am/db/2017286/Medical_Properties_Trust>,
        <https://1145.am/db/2034986/Diversified_Healthcare_Trust>,
        <https://1145.am/db/2089947/Medical_Properties_Trust>,
        <https://1145.am/db/2133695/Medical_Properties_Trust>,
        <https://1145.am/db/2195374/Medical_Properties_Trust>,
        <https://1145.am/db/2242437/Medical_Properties_Trust>,
        <https://1145.am/db/2242439/Medical_Properties_Trust_Inc>,
        <https://1145.am/db/2244292/Medical_Properties_Trust_Inc>,
        <https://1145.am/db/2245294/Physicians_Realty_Trust>,
        <https://1145.am/db/2250673/American_Realty_Capital_Healthcare_Trust>,
        <https://1145.am/db/2257136/Medproperties_Holdings>,
        <https://1145.am/db/2257136/Physicians_Realty_Trust>,
        <https://1145.am/db/2785727/Physicians_Realty_Trust>,
        <https://1145.am/db/2785731/Physicians_Realty_Trust>,
        <https://1145.am/db/2791889/Physicians_Realty_Trust>,
        <https://1145.am/db/486121/Medical_Properties_Trust>,
        <https://1145.am/db/487775/Medical_Properties_Trust>,
        <https://1145.am/db/516825/Physicians_Realty_Lp>,
        <https://1145.am/db/516825/Physicians_Realty_Trust>,
        <https://1145.am/db/518094/Physicians_Realty_Lp>,
        <https://1145.am/db/518094/Physicians_Realty_Trust>,
        <https://1145.am/db/530993/Physicians_Realty_Lp>,
        <https://1145.am/db/530993/Physicians_Realty_Trust>,
        <https://1145.am/db/533106/Physicians_Realty_Lp>,
        <https://1145.am/db/533106/Physicians_Realty_Trust>,
        <https://1145.am/db/579888/Flagship_Healthcare_Trust>,
        <https://1145.am/db/702920/Physicians_Realty_Trust>,
        <https://1145.am/db/711308/Physicians_Realty_Trust>,
        <https://1145.am/db/866427/Healthcare_Realty_Trust_Incorporated>,
        <https://1145.am/db/900554/Healthcare_Trust_Of_America_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/848131/Physicians_Realty_Trust> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2288454/Shares_Investment_Biovest_Mdxhealth_Valiance_Asset_Management_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-06-28T15:11:04+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Belgian diagnostics outfit MDxHealth ($ MDXH) has scored $ 23.5 million through private placement, selling off about 8.7 million shares to expand its commercial abilities and spread the reach of its prostate cancer test." ;
    ns1:documentTitle "MDxHealth hauls in $23.5M for cancer test" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/mdxhealth-hauls-23-5m-for-cancer-test> ;
    ns1:foundName "private placement",
        "selling",
        "snatched" ;
    ns1:name "private placement",
        "selling",
        "snatched" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2288454/Mdxhealth> ;
    ns1:targetDetails "shares" ;
    ns1:valueRaw "$ 23.5 million" ;
    ns1:whereGeoName "Kingdom of Belgium" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:whereRaw "Belgium" .

<https://1145.am/db/2288800/Investment_Big-Namers_New_Enterprise_Associates_Cvrx_Cvrx_Johnson___Johnson_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-07-11T12:30:49+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CVRx has hauled in $ 29.6 million in its latest funding round, cash that will help the Minnesota devicemaker get its nerve-stimulating treatment for hypertension and heart failure through clinical trials.",
        "CVRx raised $ 29.6 million to develop its Barostim neo device.-Courtesy of CVRx." ;
    ns1:documentTitle "CVRx raises $29.6M for hypertension device" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cvrx-raises-29-6m-for-hypertension-device> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2288800/CVRX> ;
    ns1:valueRaw "$ 29.6 million" ;
    ns1:whereGeoName "Minnesota" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5037779/about.rdf> ;
    ns1:whereRaw "Minnesota" .

<https://1145.am/db/2290737/Gambro_Startup_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-09-10T15:43:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Days after closing its nearly $ 4 billion Gambro acquisition, Baxter ($ BAX) has snatched up a tiny Israeli startup for what amounts to pocket change in comparison." ;
    ns1:documentTitle "UPDATED: Baxter buys $9.5M startup on heels of $4B Gambro deal" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/updated-baxter-buys-9-5m-startup-heels-4b-gambro-deal> ;
    ns1:foundName "acquisition",
        "snatched up" ;
    ns1:name "acquisition",
        "snatched up" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2290737/Gambro> ;
    ns1:targetDetails "startup" ;
    ns1:targetName "Gambro" ;
    ns1:valueRaw "nearly $ 4 billion" ;
    ns1:whereGeoName "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Israel" .

<https://1145.am/db/2292103/Investment_Aisling_Capital_Florida_Opportunity_Funds_Lensar_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-03T12:42:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Florida's Lensar has picked up $ 87 million in a mix of equity and debt financing, cash the company will use to market its cataract surgery technology in a fast-growing space.",
        "Lensar scored $ 27 million in a private equity raise from Aisling Capital, Florida Growth and Florida Opportunity Funds, while the remaining $ 60 million comes from a credit agreement with PDL BioPharma." ;
    ns1:documentTitle "Lensar hauls in $87M for laser eye surgery tech" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/lensar-hauls-87m-for-laser-eye-surgery-tech> ;
    ns1:foundName "raise" ;
    ns1:name "raise" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2292103/Lensar> ;
    ns1:valueRaw "$ 27 million",
        "$ 87 million" ;
    ns1:whereGeoName "Florida" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4155751/about.rdf> ;
    ns1:whereRaw "Florida" .

<https://1145.am/db/2292103/Lensar> a org:Organization ;
    ns1:basedInHighGeoName "Florida" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4155751/about.rdf> ;
    ns1:basedInHighRaw "Florida" ;
    ns1:description "cataract surgery" ;
    ns1:documentDate "2013-10-03T12:42:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Lensar hauls in $87M for laser eye surgery tech" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/lensar-hauls-87m-for-laser-eye-surgery-tech> ;
    ns1:foundName "Lensar" ;
    ns1:name "Lensar" ;
    ns1:sameAsHigh <https://1145.am/db/2297120/Lensar>,
        <https://1145.am/db/2356283/Lensar_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2246648/Lensar> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2292563/Nanostim_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-10-14T13:32:37+00:00"^^xsd:dateTime ;
    ns1:documentExtract "St. Jude Medical ($ STJ) snatched up Nanostim for at least $ 123.5 million, giving it bragging rights as the owner of the only leadless cardiac pacemaker to hit the market so far.",
        "St. Jude will pay Nanostim's shareholders up to $ 65 million over time, assuming certain revenue - based milestones can be met." ;
    ns1:documentTitle "St. Jude Medical grabs Nanostim for $123.5M, gaining CE marked leadless pacer" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/st-jude-medical-grabs-nanostim-for-123-5m-gaining-ce-marked-leadless-pacer> ;
    ns1:foundName "snatched up" ;
    ns1:name "snatched up" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2292563/Nanostim> ;
    ns1:targetName "Nanostim" ;
    ns1:valueRaw "at least $ 123.5 million",
        "up to $ 65 million" ;
    ns1:whereGeoName "California" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:whereRaw "California" .

<https://1145.am/db/2294520/Politec_Sade_Share_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-11-26T14:10:52+00:00"^^xsd:dateTime ;
    ns1:documentExtract "U.K. orthopedics giant Smith & Nephew ($ SNN) has been riding its checkbook into emerging markets all year.",
        "Under the deal, S & N will buy one quarter of Politec Sade for an undisclosed sum, absorbing 30 employees and effectively cutting out the middleman for the Brazilian distribution of its growing wound-care offerings." ;
    ns1:documentTitle "Smith & Nephew's M&A blitz rolls on with Brazilian buy" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/smith-nephew-s-m-a-blitz-rolls-brazilian-buy> ;
    ns1:foundName "buy",
        "pick up" ;
    ns1:name "buy",
        "pick up" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2294520/Politec_Sade> ;
    ns1:targetDetails "share" ;
    ns1:targetName "Politec Sade" ;
    ns1:whereGeoName "Federative Republic of Brazil" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:whereRaw "Brazil" .

<https://1145.am/db/2294544/Crescendo_Bioscience_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment",
        "merger" ;
    ns1:documentDate "2013-11-27T19:36:56+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Myriad Genetics ($ MYGN) is inching closer to snatching up molecular diagnostic test maker Crescendo Bioscience." ;
    ns1:documentTitle "Myriad Genetics inches closer to acquiring Crescendo Bioscience" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/myriad-genetics-inches-closer-to-acquiring-crescendo-bioscience> ;
    ns1:foundName "invested",
        "snatching up" ;
    ns1:name "invested",
        "snatching up" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2294544/Crescendo_Bioscience> ;
    ns1:targetName "Crescendo",
        "Crescendo Bioscience" ;
    ns1:valueRaw "$ 25 million" ;
    ns1:whereGeoName "South San Francisco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:whereRaw "South San Francisco" .

<https://1145.am/db/2295945/Alverix_Share_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2014-01-07T15:25:26+00:00"^^xsd:dateTime ;
    ns1:documentExtract "After years of collaboration, Becton Dickinson ($ BDX) is buying out San Jose, CA's Alverix, deepening its holdings in point-of-care testing and expanding its palette of diagnostics technology.",
        "Life sciences financier Safeguard Scientifics had invested about $ 9.4 million in Alverix since 2007, good for a 49 % share, and the company will walk away with $ 17.4 million in cash thanks to BD's acquisition, it said in a release." ;
    ns1:documentTitle "BD trades $40M for diagnostics partner Alverix" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/bd-trades-40m-for-diagnostics-partner-alverix> ;
    ns1:foundName "buying out",
        "invested" ;
    ns1:name "buying out",
        "invested" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2295945/Alverix> ;
    ns1:targetDetails "share" ;
    ns1:targetName "Alverix" ;
    ns1:valueRaw "$ 17.4 million",
        "about $ 9.4 million" ;
    ns1:whenRaw "2007" ;
    ns1:whereGeoName "San Jos" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3621849/about.rdf> ;
    ns1:whereRaw "San Jose" .

<https://1145.am/db/2296920/Life_Technologies_Divisions_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2014-01-31T19:58:47+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Thermo Fisher ($ TMO) has finally grabbed what it needed to close its $ 13.6 billion buyout of Life Technologies-U.S. antitrust approval." ;
    ns1:documentTitle "U.S. regulators clear Thermo Fisher's $13.6B Life Tech deal, with conditions attached" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/u-s-regulators-clear-thermo-fisher-s-13-6b-life-tech-deal-conditions-attached> ;
    ns1:foundName "buyout",
        "sell" ;
    ns1:name "buyout",
        "sell" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2296920/Life_Technologies> ;
    ns1:targetDetails "divisions" ;
    ns1:targetName "Life Technologies" ;
    ns1:valueRaw "$ 13.6 billion" ;
    ns1:whereGeoName "Massachusetts" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6254926/about.rdf> ;
    ns1:whereRaw "Massachusetts" .

<https://1145.am/db/2305443/Safeguard_Scientifics> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2013-09-03T13:51:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Safeguard Scientifics Leads $10M Series B Financing for Quantia" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/safeguard-scientifics-leads-10m-series-b-financing-for-quantia> ;
    ns1:foundName "Safeguard Scientifics",
        "Safeguard Scientifics, Inc",
        "Safeguard Scientifics, Inc." ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2305443/Series_B_Investment_Fuse_Capital_Quantia_Inc_Safeguard_Scientifics_Completed> ;
    ns1:name "Safeguard Scientifics" ;
    ns1:sameAsHigh <https://1145.am/db/2316302/Safeguard_Scientifics> ;
    ns1:sameAsMedium <https://1145.am/db/1232627/Safeguard_Scientifics>,
        <https://1145.am/db/1383287/Safeguard_Scientifics>,
        <https://1145.am/db/1801934/Safeguard_Scientifics>,
        <https://1145.am/db/1843216/Safeguard_Scientifics>,
        <https://1145.am/db/1855887/Safeguard_Scientifics>,
        <https://1145.am/db/1873156/Safeguard_Scientifics>,
        <https://1145.am/db/1914893/Safeguard_Scientifics>,
        <https://1145.am/db/2147446/Safeguard_Scientifics>,
        <https://1145.am/db/2182583/Safeguard_Scientifics>,
        <https://1145.am/db/2290453/Safeguard_Scientifics>,
        <https://1145.am/db/2291872/Safeguard_Scientifics>,
        <https://1145.am/db/2292039/Safeguard_Scientifics>,
        <https://1145.am/db/2295945/Safeguard_Scientifics>,
        <https://1145.am/db/2297604/Safeguard_Scientifics>,
        <https://1145.am/db/2298535/Safeguard_Scientifics>,
        <https://1145.am/db/2304598/Safeguard_Scientifics>,
        <https://1145.am/db/2304605/Safeguard_Scientifics_Inc>,
        <https://1145.am/db/2305609/Safeguard_Scientifics>,
        <https://1145.am/db/2307837/Safeguard_Scientifics>,
        <https://1145.am/db/2317455/Safeguard_Scientifics_Inc>,
        <https://1145.am/db/2319506/Safeguard_Scientifics>,
        <https://1145.am/db/2322984/Safeguard_Scientifics>,
        <https://1145.am/db/2323003/Safeguard_Scientifics>,
        <https://1145.am/db/2323336/Safeguard_Scientifics>,
        <https://1145.am/db/2325237/Safeguard_Scientifics>,
        <https://1145.am/db/2354706/Safeguard_Scientifics>,
        <https://1145.am/db/2359125/Safeguard_Scientifics>,
        <https://1145.am/db/2436408/Safeguard_Scientifics_Inc>,
        <https://1145.am/db/2447203/Safeguard_Scientifics_Inc>,
        <https://1145.am/db/2576460/Safeguard_Scientifics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2305443/Series_B_Investment_Fuse_Capital_Quantia_Inc_Safeguard_Scientifics_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-03T13:51:44+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Safeguard Scientifics Leads $ 10M Series B Financing for Quantia.",
        "Safeguard Scientifics, Inc. (NYSE: SFE) deployed $ 7.5 million as part of a $ 10.0 million Series B financing for Quantia, Inc." ;
    ns1:documentTitle "Safeguard Scientifics Leads $10M Series B Financing for Quantia" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/safeguard-scientifics-leads-10m-series-b-financing-for-quantia> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2305443/Quantia_Inc>,
        <https://1145.am/db/2305443/Safeguard_Scientifics> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 10.0 million",
        "$ 10M",
        "$ 2.5 million",
        "$ 7.5 million" ;
    ns1:whereRaw "NYSE" .

<https://1145.am/db/2306519/Investment_Capital_Royalty_Partners_Lp_Raindance_Technologies_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-30T12:32:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "- RainDance Technologies, Inc., an innovative genomics tools company enabling ultra-sensitive detection of cancer and inherited diseases, today announced it has closed a structured debt financing with Capital Royalty Partners L.P.",
        "RainDance Technologies Secures $ 35 Million in Financing from Capital Royalty Partners." ;
    ns1:documentTitle "RainDance Technologies Secures $35 Million in Financing from Capital Royalty Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/raindance-technologies-secures-35-million-financing-from-capital-royalty-partners> ;
    ns1:foundName "debt",
        "financing" ;
    ns1:name "debt",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2306519/Raindance_Technologies> ;
    ns1:valueRaw "$ 35 Million",
        "up to $ 35 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2306529/Series_C_Investment_Arch_Venture_Partners_Boreal_Genomics_Kearny_Venture_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-07T12:15:07+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Boreal Genomics Secures $ 18 Million Series C Financing.",
        "LOS ALTOS, Calif., Oct. 4, 2013 /PRNewswire-iReach/ - Boreal Genomics, a privately held provider of technology for non-invasive genomic profiling of tumors from blood plasma of cancer patients, announced today the completion of an $ 18 million Series C financing round." ;
    ns1:documentTitle "Boreal Genomics Secures $18 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/boreal-genomics-secures-18-million-series-c-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2306529/Boreal_Genomics> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 18 Million",
        "$ 18 million" ;
    ns1:when "2013-10-04T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct. 4, 2013" ;
    ns1:whereGeoName "Los Altos" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5368335/about.rdf> ;
    ns1:whereRaw "LOS ALTOS, Calif" .

<https://1145.am/db/2312563/Investment_Framework_Programme_7_The_Epimirna_Consortium_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-18T12:45:09+00:00"^^xsd:dateTime ;
    ns1:documentExtract "EpimiRNA Consortium Receives 11.5 Million Funding by EU to Uncover the Effects of microRNA in Epilepsy.",
        "The EpimiRNA Consortium, involving 16 partners from 8 European countries, the USA and Brazil has received 11.5 million funding from the European Union's Framework Programme 7 to investigate molecular mechanisms, diagnostics and treatments for epilepsy." ;
    ns1:documentTitle "EpimiRNA Consortium Receives 11.5 Million Funding by EU to Uncover the Effects of microRNA in Epilepsy" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/epimirna-consortium-receives-%E2%82%AC11-5-million-funding-by-eu-to-uncover-effects-of-microrna> ;
    ns1:foundName "Funding",
        "funding" ;
    ns1:name "Funding",
        "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2312563/The_Epimirna_Consortium> ;
    ns1:valueRaw "11.5 Million",
        "11.5 million" ;
    ns1:whereGeoName "EU" ;
    ns1:whereRaw "EU" .

<https://1145.am/db/2312563/The_Epimirna_Consortium> a org:Organization ;
    ns1:basedInLowRaw "The EpimiRNA Consortium, involving 16 partners from 8 European countries, the USA and Brazil" ;
    ns1:description "research" ;
    ns1:documentDate "2013-09-18T12:45:09+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EpimiRNA Consortium Receives 11.5 Million Funding by EU to Uncover the Effects of microRNA in Epilepsy" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/epimirna-consortium-receives-%E2%82%AC11-5-million-funding-by-eu-to-uncover-effects-of-microrna> ;
    ns1:foundName "EpimiRNA Consortium",
        "The EpimiRNA Consortium" ;
    ns1:name "EpimiRNA Consortium",
        "The EpimiRNA Consortium" ;
    ns1:sameAsHigh <https://1145.am/db/2291636/The_Epimirna_Consortium> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2317344/KKR> a org:Organization ;
    ns1:basedInLowRaw "N.C" ;
    ns1:buyer <https://1145.am/db/2317344/Acquisition_Kkr_Completed>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services_Acquisition> ;
    ns1:documentDate "2013-09-25T17:50:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PRA and RPS Merger Completed" ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/pra-and-rps-merger-completed> ;
    ns1:foundName "KKR" ;
    ns1:investor <https://1145.am/db/2317344/Investment_Kkr_Completed>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services_Acquisition> ;
    ns1:name "KKR" ;
    ns1:sameAsMedium <https://1145.am/db/1011940/KKR>,
        <https://1145.am/db/1013124/KKR>,
        <https://1145.am/db/1015212/KKR>,
        <https://1145.am/db/1016588/KKR>,
        <https://1145.am/db/1026785/KKR>,
        <https://1145.am/db/1047409/KKR>,
        <https://1145.am/db/1048061/KKR>,
        <https://1145.am/db/1051390/KKR>,
        <https://1145.am/db/1055774/KKR>,
        <https://1145.am/db/1061971/KKR>,
        <https://1145.am/db/1063827/KKR>,
        <https://1145.am/db/1063843/KKR>,
        <https://1145.am/db/1064625/KKR>,
        <https://1145.am/db/1068387/KKR>,
        <https://1145.am/db/1081263/KKR>,
        <https://1145.am/db/1082650/KKR>,
        <https://1145.am/db/1083078/KKR>,
        <https://1145.am/db/1113018/KKR>,
        <https://1145.am/db/1118091/KKR>,
        <https://1145.am/db/112754/KKR>,
        <https://1145.am/db/1129736/KKR>,
        <https://1145.am/db/1131185/KKR>,
        <https://1145.am/db/1160033/KKR>,
        <https://1145.am/db/1160920/KKR>,
        <https://1145.am/db/1187769/KKR>,
        <https://1145.am/db/1190440/KKR>,
        <https://1145.am/db/1192098/KKR>,
        <https://1145.am/db/1192924/KKR>,
        <https://1145.am/db/1215547/KKR>,
        <https://1145.am/db/1215996/KKR>,
        <https://1145.am/db/1229887/KKR>,
        <https://1145.am/db/1230736/KKR>,
        <https://1145.am/db/1247887/KKR>,
        <https://1145.am/db/1248726/KKR>,
        <https://1145.am/db/1250422/KKR>,
        <https://1145.am/db/1260722/KKR>,
        <https://1145.am/db/1263937/KKR>,
        <https://1145.am/db/1264568/KKR>,
        <https://1145.am/db/1270094/KKR>,
        <https://1145.am/db/1281471/KKR>,
        <https://1145.am/db/1285688/KKR>,
        <https://1145.am/db/1294469/KKR>,
        <https://1145.am/db/1295782/KKR>,
        <https://1145.am/db/1296521/Kkr___Co>,
        <https://1145.am/db/1310687/KKR>,
        <https://1145.am/db/1364/Kkr___Co>,
        <https://1145.am/db/1381518/KKR>,
        <https://1145.am/db/1394821/KKR>,
        <https://1145.am/db/1397716/KKR>,
        <https://1145.am/db/1399415/KKR>,
        <https://1145.am/db/1416023/KKR>,
        <https://1145.am/db/1416277/Kkr___Co>,
        <https://1145.am/db/1420083/KKR>,
        <https://1145.am/db/1436822/KKR>,
        <https://1145.am/db/1438103/KKR>,
        <https://1145.am/db/1449022/KKR>,
        <https://1145.am/db/1449914/KKR>,
        <https://1145.am/db/1452259/KKR>,
        <https://1145.am/db/1452519/KKR>,
        <https://1145.am/db/1455940/KKR>,
        <https://1145.am/db/1460/KKR>,
        <https://1145.am/db/1473068/KKR>,
        <https://1145.am/db/1475136/KKR>,
        <https://1145.am/db/1476460/KKR>,
        <https://1145.am/db/149545/KKR>,
        <https://1145.am/db/1495463/KKR>,
        <https://1145.am/db/1496959/KKR>,
        <https://1145.am/db/1502843/Kkr_Inc>,
        <https://1145.am/db/1506577/KKR>,
        <https://1145.am/db/1509288/KKR>,
        <https://1145.am/db/1512558/KKR>,
        <https://1145.am/db/152934/KKR>,
        <https://1145.am/db/1546202/KKR>,
        <https://1145.am/db/1547814/KKR>,
        <https://1145.am/db/1554054/KKR>,
        <https://1145.am/db/1555857/KKR>,
        <https://1145.am/db/1590538/KKR>,
        <https://1145.am/db/1591345/KKR>,
        <https://1145.am/db/1591763/KKR>,
        <https://1145.am/db/1648448/KKR>,
        <https://1145.am/db/1649860/KKR>,
        <https://1145.am/db/1649938/KKR>,
        <https://1145.am/db/1651830/KKR>,
        <https://1145.am/db/1658979/KKR>,
        <https://1145.am/db/1660846/KKR>,
        <https://1145.am/db/1660963/KKR>,
        <https://1145.am/db/1661134/Kkr_Inc>,
        <https://1145.am/db/1661435/KKR>,
        <https://1145.am/db/1666847/KKR>,
        <https://1145.am/db/1668839/KKR>,
        <https://1145.am/db/1677859/KKR>,
        <https://1145.am/db/1680087/Kkr_Inc>,
        <https://1145.am/db/1680588/KKR>,
        <https://1145.am/db/1688398/KKR>,
        <https://1145.am/db/1693484/KKR>,
        <https://1145.am/db/171093/KKR>,
        <https://1145.am/db/1712/Kkr___Co>,
        <https://1145.am/db/172769/KKR>,
        <https://1145.am/db/173791/KKR>,
        <https://1145.am/db/1746839/KKR>,
        <https://1145.am/db/1749189/KKR>,
        <https://1145.am/db/1755085/KKR>,
        <https://1145.am/db/1757984/KKR>,
        <https://1145.am/db/1759036/KKR>,
        <https://1145.am/db/1760592/KKR>,
        <https://1145.am/db/1761520/KKR>,
        <https://1145.am/db/1765880/KKR>,
        <https://1145.am/db/1769962/KKR>,
        <https://1145.am/db/1789551/KKR>,
        <https://1145.am/db/1799106/KKR>,
        <https://1145.am/db/1803787/KKR>,
        <https://1145.am/db/1822745/KKR>,
        <https://1145.am/db/1845096/KKR>,
        <https://1145.am/db/1857803/KKR>,
        <https://1145.am/db/1943233/KKR>,
        <https://1145.am/db/1947119/KKR>,
        <https://1145.am/db/194974/KKR>,
        <https://1145.am/db/1950829/KKR>,
        <https://1145.am/db/195311/KKR>,
        <https://1145.am/db/195381/KKR>,
        <https://1145.am/db/195385/KKR>,
        <https://1145.am/db/1961469/KKR>,
        <https://1145.am/db/1968303/Kkr___Co>,
        <https://1145.am/db/1986543/KKR>,
        <https://1145.am/db/1996605/KKR>,
        <https://1145.am/db/2002801/KKR>,
        <https://1145.am/db/2008367/KKR>,
        <https://1145.am/db/2013193/KKR>,
        <https://1145.am/db/2023610/KKR>,
        <https://1145.am/db/2027104/KKR>,
        <https://1145.am/db/2028313/KKR>,
        <https://1145.am/db/2032776/KKR>,
        <https://1145.am/db/2038852/KKR>,
        <https://1145.am/db/2042348/KKR>,
        <https://1145.am/db/2043935/KKR>,
        <https://1145.am/db/2046870/KKR>,
        <https://1145.am/db/2050989/KKR>,
        <https://1145.am/db/2053511/KKR>,
        <https://1145.am/db/2056647/KKR>,
        <https://1145.am/db/2057136/KKR>,
        <https://1145.am/db/2058954/KKR>,
        <https://1145.am/db/2063964/KKR>,
        <https://1145.am/db/2066225/KKR>,
        <https://1145.am/db/2068310/KKR>,
        <https://1145.am/db/2069371/KKR>,
        <https://1145.am/db/2073937/KKR>,
        <https://1145.am/db/2075344/KKR>,
        <https://1145.am/db/2075473/KKR>,
        <https://1145.am/db/2076666/KKR>,
        <https://1145.am/db/2078541/KKR>,
        <https://1145.am/db/2078780/KKR>,
        <https://1145.am/db/2078827/Kkr___Co>,
        <https://1145.am/db/2079830/KKR>,
        <https://1145.am/db/2080075/KKR>,
        <https://1145.am/db/2080109/KKR>,
        <https://1145.am/db/2082516/KKR>,
        <https://1145.am/db/2085686/KKR>,
        <https://1145.am/db/2089349/KKR>,
        <https://1145.am/db/2089461/KKR>,
        <https://1145.am/db/2097007/KKR>,
        <https://1145.am/db/2101709/KKR>,
        <https://1145.am/db/2101746/KKR>,
        <https://1145.am/db/2109787/KKR>,
        <https://1145.am/db/2112887/KKR>,
        <https://1145.am/db/2113323/KKR>,
        <https://1145.am/db/2114093/KKR>,
        <https://1145.am/db/212359/KKR>,
        <https://1145.am/db/2124274/Kkr___Co>,
        <https://1145.am/db/2124401/KKR>,
        <https://1145.am/db/2124862/KKR>,
        <https://1145.am/db/212685/KKR>,
        <https://1145.am/db/2127688/KKR>,
        <https://1145.am/db/2131893/KKR>,
        <https://1145.am/db/2132583/KKR>,
        <https://1145.am/db/2132959/KKR>,
        <https://1145.am/db/2135051/KKR>,
        <https://1145.am/db/2136594/KKR>,
        <https://1145.am/db/2139470/KKR>,
        <https://1145.am/db/2145209/KKR>,
        <https://1145.am/db/2149115/KKR>,
        <https://1145.am/db/2149560/KKR>,
        <https://1145.am/db/2186299/KKR>,
        <https://1145.am/db/2194895/KKR>,
        <https://1145.am/db/2290211/KKR>,
        <https://1145.am/db/2290727/KKR>,
        <https://1145.am/db/2291651/KKR>,
        <https://1145.am/db/2291664/KKR>,
        <https://1145.am/db/2300371/KKR>,
        <https://1145.am/db/2314081/KKR>,
        <https://1145.am/db/2315158/KKR>,
        <https://1145.am/db/2317339/KKR>,
        <https://1145.am/db/2318461/KKR>,
        <https://1145.am/db/2328236/KKR>,
        <https://1145.am/db/2330390/KKR>,
        <https://1145.am/db/2336420/KKR>,
        <https://1145.am/db/2339666/KKR>,
        <https://1145.am/db/2345694/KKR>,
        <https://1145.am/db/2371655/KKR>,
        <https://1145.am/db/239551/KKR>,
        <https://1145.am/db/240235/Kkr___Co>,
        <https://1145.am/db/240501/Kkr___Co>,
        <https://1145.am/db/240691/KKR>,
        <https://1145.am/db/2429989/KKR>,
        <https://1145.am/db/2477137/KKR>,
        <https://1145.am/db/2477142/Kkr___Co>,
        <https://1145.am/db/2508331/KKR>,
        <https://1145.am/db/2544488/KKR>,
        <https://1145.am/db/2548051/KKR>,
        <https://1145.am/db/2558515/KKR>,
        <https://1145.am/db/255858/KKR>,
        <https://1145.am/db/2558602/KKR>,
        <https://1145.am/db/2560676/KKR>,
        <https://1145.am/db/2561249/KKR>,
        <https://1145.am/db/2573232/KKR>,
        <https://1145.am/db/2589365/KKR>,
        <https://1145.am/db/2590549/KKR>,
        <https://1145.am/db/2591281/KKR>,
        <https://1145.am/db/2591917/KKR>,
        <https://1145.am/db/2594570/KKR>,
        <https://1145.am/db/2594867/KKR>,
        <https://1145.am/db/2594877/KKR>,
        <https://1145.am/db/2637995/KKR>,
        <https://1145.am/db/2651063/KKR>,
        <https://1145.am/db/2686055/KKR>,
        <https://1145.am/db/2704480/KKR>,
        <https://1145.am/db/2704484/KKR>,
        <https://1145.am/db/2719490/KKR>,
        <https://1145.am/db/2719659/KKR>,
        <https://1145.am/db/2784659/KKR>,
        <https://1145.am/db/2785212/KKR>,
        <https://1145.am/db/2786374/KKR>,
        <https://1145.am/db/2794220/KKR>,
        <https://1145.am/db/2795258/KKR>,
        <https://1145.am/db/2795446/KKR>,
        <https://1145.am/db/2796657/KKR>,
        <https://1145.am/db/2796864/KKR>,
        <https://1145.am/db/2801896/KKR>,
        <https://1145.am/db/284837/KKR>,
        <https://1145.am/db/285425/KKR>,
        <https://1145.am/db/286585/KKR>,
        <https://1145.am/db/287966/KKR>,
        <https://1145.am/db/293364/Kkr___Co>,
        <https://1145.am/db/299964/KKR>,
        <https://1145.am/db/306695/KKR>,
        <https://1145.am/db/315335/KKR>,
        <https://1145.am/db/315346/KKR>,
        <https://1145.am/db/319737/KKR>,
        <https://1145.am/db/320746/KKR>,
        <https://1145.am/db/322468/KKR>,
        <https://1145.am/db/322674/KKR>,
        <https://1145.am/db/322933/KKR>,
        <https://1145.am/db/323184/KKR>,
        <https://1145.am/db/331041/KKR>,
        <https://1145.am/db/331072/KKR>,
        <https://1145.am/db/331120/KKR>,
        <https://1145.am/db/334317/KKR>,
        <https://1145.am/db/335627/KKR>,
        <https://1145.am/db/336437/KKR>,
        <https://1145.am/db/337257/KKR>,
        <https://1145.am/db/338225/KKR>,
        <https://1145.am/db/344076/KKR>,
        <https://1145.am/db/346092/Kkr___Co>,
        <https://1145.am/db/346265/KKR>,
        <https://1145.am/db/346358/Kkr___Co>,
        <https://1145.am/db/346368/Kkr___Co>,
        <https://1145.am/db/346523/KKR>,
        <https://1145.am/db/347280/KKR>,
        <https://1145.am/db/357173/KKR>,
        <https://1145.am/db/3573/KKR>,
        <https://1145.am/db/371665/KKR>,
        <https://1145.am/db/377907/KKR>,
        <https://1145.am/db/388746/KKR>,
        <https://1145.am/db/3947/KKR>,
        <https://1145.am/db/409008/KKR>,
        <https://1145.am/db/425087/KKR>,
        <https://1145.am/db/429762/KKR>,
        <https://1145.am/db/432705/KKR>,
        <https://1145.am/db/433673/KKR>,
        <https://1145.am/db/444316/KKR>,
        <https://1145.am/db/454758/KKR>,
        <https://1145.am/db/456088/KKR>,
        <https://1145.am/db/461148/KKR>,
        <https://1145.am/db/463978/KKR>,
        <https://1145.am/db/464569/KKR>,
        <https://1145.am/db/474753/KKR>,
        <https://1145.am/db/489290/KKR>,
        <https://1145.am/db/492468/KKR>,
        <https://1145.am/db/495917/KKR>,
        <https://1145.am/db/514250/KKR>,
        <https://1145.am/db/515346/KKR>,
        <https://1145.am/db/516118/KKR>,
        <https://1145.am/db/526965/KKR>,
        <https://1145.am/db/531779/KKR>,
        <https://1145.am/db/535518/KKR>,
        <https://1145.am/db/537800/KKR>,
        <https://1145.am/db/539290/KKR>,
        <https://1145.am/db/543668/KKR>,
        <https://1145.am/db/544684/KKR>,
        <https://1145.am/db/585991/KKR>,
        <https://1145.am/db/595003/KKR>,
        <https://1145.am/db/595062/KKR>,
        <https://1145.am/db/596244/KKR>,
        <https://1145.am/db/600948/KKR>,
        <https://1145.am/db/602304/KKR>,
        <https://1145.am/db/606208/KKR>,
        <https://1145.am/db/613807/KKR>,
        <https://1145.am/db/614524/KKR>,
        <https://1145.am/db/620441/KKR>,
        <https://1145.am/db/624398/KKR>,
        <https://1145.am/db/624410/KKR>,
        <https://1145.am/db/638312/KKR>,
        <https://1145.am/db/643839/KKR>,
        <https://1145.am/db/644358/KKR>,
        <https://1145.am/db/644418/KKR>,
        <https://1145.am/db/647441/KKR>,
        <https://1145.am/db/649646/KKR>,
        <https://1145.am/db/650038/KKR>,
        <https://1145.am/db/651358/KKR>,
        <https://1145.am/db/651798/KKR>,
        <https://1145.am/db/652863/KKR>,
        <https://1145.am/db/653953/KKR>,
        <https://1145.am/db/654033/KKR>,
        <https://1145.am/db/665056/KKR>,
        <https://1145.am/db/665505/KKR>,
        <https://1145.am/db/665815/KKR>,
        <https://1145.am/db/667263/KKR>,
        <https://1145.am/db/667997/KKR>,
        <https://1145.am/db/674055/KKR>,
        <https://1145.am/db/675103/KKR>,
        <https://1145.am/db/685346/KKR>,
        <https://1145.am/db/685746/KKR>,
        <https://1145.am/db/693816/KKR>,
        <https://1145.am/db/695839/KKR>,
        <https://1145.am/db/696425/KKR>,
        <https://1145.am/db/696885/KKR>,
        <https://1145.am/db/698056/KKR>,
        <https://1145.am/db/703846/KKR>,
        <https://1145.am/db/713772/KKR>,
        <https://1145.am/db/715525/KKR>,
        <https://1145.am/db/733298/KKR>,
        <https://1145.am/db/746000/KKR>,
        <https://1145.am/db/748180/KKR>,
        <https://1145.am/db/75900/KKR>,
        <https://1145.am/db/769166/KKR>,
        <https://1145.am/db/770078/KKR>,
        <https://1145.am/db/770929/KKR>,
        <https://1145.am/db/783138/KKR>,
        <https://1145.am/db/783577/KKR>,
        <https://1145.am/db/785008/KKR>,
        <https://1145.am/db/787319/KKR>,
        <https://1145.am/db/789202/KKR>,
        <https://1145.am/db/797358/KKR>,
        <https://1145.am/db/799510/KKR>,
        <https://1145.am/db/800916/KKR>,
        <https://1145.am/db/814184/KKR>,
        <https://1145.am/db/814340/Kkr___Co>,
        <https://1145.am/db/829559/KKR>,
        <https://1145.am/db/835332/KKR>,
        <https://1145.am/db/849227/KKR>,
        <https://1145.am/db/865540/KKR>,
        <https://1145.am/db/872702/KKR>,
        <https://1145.am/db/882663/KKR>,
        <https://1145.am/db/893768/KKR>,
        <https://1145.am/db/899462/KKR>,
        <https://1145.am/db/900594/KKR>,
        <https://1145.am/db/900629/KKR>,
        <https://1145.am/db/907556/KKR>,
        <https://1145.am/db/908834/KKR>,
        <https://1145.am/db/908839/KKR>,
        <https://1145.am/db/908843/KKR>,
        <https://1145.am/db/908907/KKR>,
        <https://1145.am/db/910191/KKR>,
        <https://1145.am/db/912132/Kkr___Co>,
        <https://1145.am/db/913484/KKR>,
        <https://1145.am/db/91884/KKR>,
        <https://1145.am/db/923834/KKR>,
        <https://1145.am/db/92448/KKR>,
        <https://1145.am/db/924993/KKR>,
        <https://1145.am/db/926313/KKR>,
        <https://1145.am/db/929269/KKR>,
        <https://1145.am/db/930281/KKR>,
        <https://1145.am/db/932790/KKR>,
        <https://1145.am/db/934927/KKR>,
        <https://1145.am/db/94535/KKR>,
        <https://1145.am/db/953014/KKR>,
        <https://1145.am/db/963947/KKR>,
        <https://1145.am/db/968064/KKR>,
        <https://1145.am/db/968112/KKR>,
        <https://1145.am/db/970108/KKR>,
        <https://1145.am/db/971684/KKR>,
        <https://1145.am/db/972089/KKR>,
        <https://1145.am/db/972213/KKR>,
        <https://1145.am/db/976442/KKR>,
        <https://1145.am/db/978086/KKR>,
        <https://1145.am/db/978783/KKR>,
        <https://1145.am/db/984390/KKR>,
        <https://1145.am/db/986270/KKR>,
        <https://1145.am/db/989353/KKR>,
        <https://1145.am/db/992099/KKR> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2317344/Research_Pharmaceutical_Services> a org:Organization ;
    ns1:basedInLowRaw "N.C" ;
    ns1:description "pharmaceutical services" ;
    ns1:documentDate "2013-09-25T17:50:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PRA and RPS Merger Completed" ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/pra-and-rps-merger-completed> ;
    ns1:foundName "ReSearch Pharmaceutical Services" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "ReSearch Pharmaceutical Services" ;
    ns1:sameAsHigh <https://1145.am/db/101025/Scpharmaceuticals_Inc>,
        <https://1145.am/db/101329/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1031042/Intomics>,
        <https://1145.am/db/1033561/Hs_Pharmaceuticals>,
        <https://1145.am/db/1054457/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/1054503/Hs_Pharmaceuticals>,
        <https://1145.am/db/1061901/Pharmaessentia_Corporation>,
        <https://1145.am/db/1070158/Biognosys>,
        <https://1145.am/db/1079560/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1080385/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1092000/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/11010/Progenics_Pharmaceuticals>,
        <https://1145.am/db/1104169/20045078>,
        <https://1145.am/db/1118439/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1141704/Inmed_Pharmaceuticals>,
        <https://1145.am/db/1174705/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1176480/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1185008/TDV>,
        <https://1145.am/db/1186876/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1216583/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1291286/Vital_Pharmaceuticals_Inc>,
        <https://1145.am/db/1294499/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1294506/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1295948/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1296487/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1307419/X4_Pharmaceuticals>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1329779/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1339033/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1343020/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/1370859/Bioivt>,
        <https://1145.am/db/1371279/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1387773/Aspire_Pharma>,
        <https://1145.am/db/1390741/Nexus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1409143/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417723/Altasciences>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443334/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443968/Pharmajet>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1487706/Phathom_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497210/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Indivior_Plc>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Indivior_Plc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1505968/Escient_Pharmaceuticals>,
        <https://1145.am/db/1508407/Escient_Pharmaceuticals>,
        <https://1145.am/db/1515279/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1520596/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1520597/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521624/Scpharmaceuticals>,
        <https://1145.am/db/1521695/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521941/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1523220/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1533327/Escient_Pharmaceuticals>,
        <https://1145.am/db/1533685/Escient_Pharmaceuticals>,
        <https://1145.am/db/1537336/Pharmajet>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1548955/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1557072/Essential_Pharma>,
        <https://1145.am/db/1559882/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1571078/Organon>,
        <https://1145.am/db/1585097/Scpharmaceuticals_Inc>,
        <https://1145.am/db/158742/Biogen_Inc>,
        <https://1145.am/db/1595580/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1613688/Pharmalex>,
        <https://1145.am/db/1624479/Indivior_Plc>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Indivior_Plc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/1632411/Scipher_Medicine>,
        <https://1145.am/db/1632862/Scipher_Medicine>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1680583/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/1687234/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/180589/Servier>,
        <https://1145.am/db/1955684/Eip_Pharma_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2038168/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039291/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039678/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2045820/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2049603/Inova_Pharmaceuticals>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2062156/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2066480/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2071248/Biogen>,
        <https://1145.am/db/2074741/Biogen_Inc>,
        <https://1145.am/db/2092442/Leo_Pharma>,
        <https://1145.am/db/2093802/Meitheal_Pharmaceuticals>,
        <https://1145.am/db/2100253/Biogen_Inc>,
        <https://1145.am/db/2101006/Leo_Pharma_A_S>,
        <https://1145.am/db/2138834/Altasciences>,
        <https://1145.am/db/2151781/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152434/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2153727/Amunix_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154118/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155006/Medicines_Company>,
        <https://1145.am/db/2155312/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155622/Isa_Pharmaceuticals>,
        <https://1145.am/db/2155792/Ucb_Pharma>,
        <https://1145.am/db/2155798/Ucb_Pharma>,
        <https://1145.am/db/2155994/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2198945/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2201094/Pharmadeals_Ltd>,
        <https://1145.am/db/2204969/Organon_Biosciences>,
        <https://1145.am/db/2207034/Cequent_Pharmaceuticals>,
        <https://1145.am/db/221697/Gw_Pharmaceuticals>,
        <https://1145.am/db/2217819/Pharmacopeia>,
        <https://1145.am/db/221787/Gw_Pharmaceuticals>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2224859/Biologics>,
        <https://1145.am/db/2229191/Biologics>,
        <https://1145.am/db/2279276/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2279648/Organon>,
        <https://1145.am/db/2280123/Casi_Pharmaceuticals>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2283570/Pherin_Pharmaceuticals>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285117/Immedica>,
        <https://1145.am/db/2285495/Bioivt>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2287505/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2287572/T3_Pharmaceuticals>,
        <https://1145.am/db/2288192/Servier>,
        <https://1145.am/db/2290842/X4_Pharmaceuticals>,
        <https://1145.am/db/2291791/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2294547/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2294570/Pharmatek>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2297534/Bio>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2299414/Biogen>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2301718/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2301735/Idera_Pharmaceuticals>,
        <https://1145.am/db/2301764/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302275/Map_Pharmaceuticals>,
        <https://1145.am/db/2302426/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302431/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2302574/Via_Pharmaceuticals>,
        <https://1145.am/db/2302579/Via_Pharmaceuticals>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2302658/Biotie>,
        <https://1145.am/db/2302707/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2302774/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302779/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302890/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2302897/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303121/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303131/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303182/Pharmexa>,
        <https://1145.am/db/2303208/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2303792/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2304044/Novamed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304097/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2304135/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2304610/Pharmos_Corp>,
        <https://1145.am/db/2304745/Critical_Pharmaceuticals>,
        <https://1145.am/db/2304831/Pharmion_Corporation>,
        <https://1145.am/db/2304934/Medicure>,
        <https://1145.am/db/2304985/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2305742/Mh_Pharma_Uk>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2305927/Entremed>,
        <https://1145.am/db/2305956/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2306299/Verily>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2307239/Pharmaxis_Ltd>,
        <https://1145.am/db/2307246/Pharmaxis>,
        <https://1145.am/db/2307254/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2307651/Organon>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307871/Access_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2308446/Pharmathene>,
        <https://1145.am/db/2308922/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308964/Slate_Pharmaceuticals>,
        <https://1145.am/db/2309001/Biocon>,
        <https://1145.am/db/2309301/Inc>,
        <https://1145.am/db/2309923/Diasome_Pharmaceuticals>,
        <https://1145.am/db/2310002/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2310002/Map_Pharmaceuticals>,
        <https://1145.am/db/2310045/Slate_Pharmaceuticals>,
        <https://1145.am/db/2310071/Encysive_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310200/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2310219/Docpharma>,
        <https://1145.am/db/2310232/Genaissance_Pharmaceuticals>,
        <https://1145.am/db/2310471/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/2310473/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310476/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2310480/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310790/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310993/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2311166/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2311202/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311217/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2311264/Medicure>,
        <https://1145.am/db/2311726/Inc>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312193/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2312344/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2312416/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2312476/Nps_Pharmaceuticals>,
        <https://1145.am/db/2312479/Nps_Pharmaceuticals>,
        <https://1145.am/db/2313305/Tetraphase_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313306/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313320/Ore_Pharmaceuticals>,
        <https://1145.am/db/2313323/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2313527/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2313528/Us_Pharmaceutical_Company>,
        <https://1145.am/db/2314217/Sciele_Pharma>,
        <https://1145.am/db/2314271/Biomarck_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2314277/Biomarck_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314375/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2314816/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314837/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2315159/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2315192/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315485/Polpharma>,
        <https://1145.am/db/2315571/Sciele_Pharma>,
        <https://1145.am/db/2315624/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315624/Pharmos>,
        <https://1145.am/db/2315925/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316239/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2316418/Pharmaventures_Ltd>,
        <https://1145.am/db/2316435/Pharmaventures_Ltd>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317337/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2317635/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2317762/Pharmathene>,
        <https://1145.am/db/2317826/Anormed>,
        <https://1145.am/db/2317826/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2317842/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317895/Esprit_Pharma>,
        <https://1145.am/db/2317929/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2318105/Pharma_Inc>,
        <https://1145.am/db/2318114/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318248/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318285/Pht_Corporation>,
        <https://1145.am/db/2318469/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2318554/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318574/Idera_Pharmaceuticals>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318743/Pharmos_Corporation>,
        <https://1145.am/db/2318808/Pharmathene>,
        <https://1145.am/db/2318986/Corgentech>,
        <https://1145.am/db/2318994/Cornerstone_Biopharma>,
        <https://1145.am/db/2319208/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319687/Advisys>,
        <https://1145.am/db/2319790/Pharmacyclics>,
        <https://1145.am/db/2319806/Satori_Pharmaceuticals>,
        <https://1145.am/db/2319809/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320009/Map_Pharmaceuticals>,
        <https://1145.am/db/2320025/Am-Pharma>,
        <https://1145.am/db/2320025/Esprit_Pharma>,
        <https://1145.am/db/2320461/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320767/Via_Pharmaceuticals>,
        <https://1145.am/db/2320903/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2320949/Medicines_Company>,
        <https://1145.am/db/2321148/Savient_Pharmaceuticals>,
        <https://1145.am/db/2321157/Access_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321565/2009-2010>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2321860/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2321871/Astion_Pharma>,
        <https://1145.am/db/2321899/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2322135/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322235/Pharmacopeia>,
        <https://1145.am/db/2322291/Polpharma>,
        <https://1145.am/db/2322481/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322632/Savient_Pharmaceuticals>,
        <https://1145.am/db/2322942/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2322953/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2323173/Pharmacopeia>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323225/Arqule>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323358/Organon_Biosciences>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2324024/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2324243/Arqule>,
        <https://1145.am/db/2324417/Biomimetic_Pharmaceuticals>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2324838/Biogen>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2325725/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326025/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2326148/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2326286/Idera_Pharmaceuticals>,
        <https://1145.am/db/2326403/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2326466/Macromed>,
        <https://1145.am/db/2326474/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327450/York_Pharma>,
        <https://1145.am/db/2327480/Transdel_Pharmaceuticals>,
        <https://1145.am/db/2327649/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2327849/Pharmacia_Corporation>,
        <https://1145.am/db/2328043/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/2328220/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2328222/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2328616/Map_Pharmaceuticals>,
        <https://1145.am/db/2328650/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2328729/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2328988/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2328990/Mdrna>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329309/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2329643/Pharmaceuticals_Inc>,
        <https://1145.am/db/2329756/Provid_Pharmaceuticals>,
        <https://1145.am/db/2329814/Map_Pharmaceuticals>,
        <https://1145.am/db/2329816/Map_Pharmaceuticals>,
        <https://1145.am/db/2330057/Pharmathene>,
        <https://1145.am/db/2330086/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330094/Idera_Pharmaceuticals>,
        <https://1145.am/db/2330207/Bioxell>,
        <https://1145.am/db/2330207/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2330534/Pharmion>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330667/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330880/Access_Pharmaceuticals>,
        <https://1145.am/db/2330880/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330989/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331745/Elan_Pharmaceuticals>,
        <https://1145.am/db/2331756/Pro-Pharmaceuticals>,
        <https://1145.am/db/2331875/Bioalliance_Pharma>,
        <https://1145.am/db/2332473/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2332596/Esprit_Pharma>,
        <https://1145.am/db/2332777/S_*_Bio>,
        <https://1145.am/db/2332974/Osi_Pharmaceuticals>,
        <https://1145.am/db/2332980/Pharmos_Corporation>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333569/Ception>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2334034/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2334119/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334121/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334183/Idera_Pharmaceuticals>,
        <https://1145.am/db/2335077/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336160/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2336293/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2336378/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336442/Bionor_Pharma_Asa>,
        <https://1145.am/db/2336452/Pharmaxis_Ltd>,
        <https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336506/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2336524/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336934/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337345/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337348/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2337547/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2338390/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338401/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2338430/Pharmacyclics>,
        <https://1145.am/db/2338551/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2338877/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339019/Isa_Pharmaceuticals_Bv>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2339570/Map_Pharmaceuticals>,
        <https://1145.am/db/2339718/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2339727/Pharmacyclics_Inc>,
        <https://1145.am/db/2339787/Pharmalink_Ab>,
        <https://1145.am/db/2339892/Pharmacyclics>,
        <https://1145.am/db/2339907/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2339910/Biomed_Pharmaceuticals>,
        <https://1145.am/db/2339922/Pharmaform>,
        <https://1145.am/db/2339979/Theravance>,
        <https://1145.am/db/2340000/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340224/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340291/Pharmasset>,
        <https://1145.am/db/2340373/Nps_Pharmaceuticals>,
        <https://1145.am/db/2340431/Savient_Pharmaceuticals>,
        <https://1145.am/db/2341523/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2341742/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2341752/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341998/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342469/Pharmadel>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342800/Pharmathene>,
        <https://1145.am/db/2342805/Pharmathene>,
        <https://1145.am/db/2342918/Pharmalink_Ab>,
        <https://1145.am/db/2343264/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2343277/Pharmasset>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2343837/Medicines_Co>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344011/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344076/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344079/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344131/Pharmascience_Inc>,
        <https://1145.am/db/2344207/Entremed>,
        <https://1145.am/db/2344624/Pharmagen_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344739/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344939/Theravance>,
        <https://1145.am/db/2344955/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2345106/Map_Pharmaceuticals>,
        <https://1145.am/db/2345474/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345902/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346542/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2346800/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346807/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2346951/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346964/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2347127/Pharmacyte_Biotech>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347227/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2347272/Pharmascience>,
        <https://1145.am/db/2347519/Pharmadeals_Ltd>,
        <https://1145.am/db/2347644/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347648/Pharminox_Limited>,
        <https://1145.am/db/2347659/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347982/Epicept>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348506/Am-Pharma_Bv>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348763/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2348864/Vital_Science_Corp>,
        <https://1145.am/db/2349103/Biota_Pharmaceuticals>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349348/R-Pharm>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349965/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350852/Isa_Pharmaceuticals>,
        <https://1145.am/db/2351091/Biomotiv>,
        <https://1145.am/db/2351471/Mymetics_Corporation>,
        <https://1145.am/db/2351818/Biocon>,
        <https://1145.am/db/2352046/Costim_Pharmaceuticals>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352177/Theravance_Inc>,
        <https://1145.am/db/2352180/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2352333/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2352538/Biota_Pharmaceuticals>,
        <https://1145.am/db/2352659/Nps_Pharmaceuticals>,
        <https://1145.am/db/2352784/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2352805/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2352808/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353006/Radient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353093/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353098/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353254/Pharma_Inc>,
        <https://1145.am/db/2353262/Sound_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2353364/Am-Pharma>,
        <https://1145.am/db/2353651/Pharmathene>,
        <https://1145.am/db/2353668/Biotie>,
        <https://1145.am/db/2354002/N30_Pharmaceuticals>,
        <https://1145.am/db/2354062/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354064/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354083/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354086/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354124/Uk>,
        <https://1145.am/db/2354146/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2354376/Aspireo_Pharmaceuticals>,
        <https://1145.am/db/2354380/Pharmaxis>,
        <https://1145.am/db/2354388/Pharmaxis>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354406/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354804/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2354836/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2355099/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355109/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355324/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355678/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2355721/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2355884/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355941/Theratechnologies>,
        <https://1145.am/db/2355974/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2356294/Company>,
        <https://1145.am/db/2356294/Inc>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2357329/Pharmalink_Ab>,
        <https://1145.am/db/2357333/Pharmalink>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357636/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2358047/Entremed>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358732/Osi_Pharmaceuticals>,
        <https://1145.am/db/2358877/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359266/D-Pharm>,
        <https://1145.am/db/2359401/Scpharmaceuticals_Inc>,
        <https://1145.am/db/2359438/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2359474/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359668/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2359882/Biotie>,
        <https://1145.am/db/2359926/Entremed>,
        <https://1145.am/db/2360155/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2360588/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360697/Medgenics>,
        <https://1145.am/db/2360739/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2360945/Entremed>,
        <https://1145.am/db/2361244/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2361516/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2362593/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363186/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363285/Phenex_Pharmaceuticals_Ag>,
        <https://1145.am/db/2363340/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2363452/Pharmasum_Therapeutics_As>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2363955/Savient_Pharmaceuticals>,
        <https://1145.am/db/2364093/Biotie>,
        <https://1145.am/db/2364252/Nps_Pharmaceuticals>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364276/S_*_Bio>,
        <https://1145.am/db/2364494/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2364495/Bioalliance_Pharma>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364541/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2364585/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364593/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364601/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364774/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364884/Entremed_Inc>,
        <https://1145.am/db/2365030/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2365098/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365224/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2365423/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2365724/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365763/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2366139/Prism_Pharmaceuticals>,
        <https://1145.am/db/2366388/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366521/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367021/Biotie>,
        <https://1145.am/db/2367070/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2367280/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2367483/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367496/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367951/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2367962/Catalyst_Pharmaceuticals>,
        <https://1145.am/db/2368070/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2368339/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2368420/Intec_Pharma>,
        <https://1145.am/db/2368593/Bioquiddity_Incorporated>,
        <https://1145.am/db/2368632/Pharmacyclics>,
        <https://1145.am/db/2368739/Novartis_Pharmaceuticals>,
        <https://1145.am/db/2368826/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369004/Biogen>,
        <https://1145.am/db/2369037/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369144/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369233/Biopharmx_Corporation>,
        <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2369812/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2369931/Biogen>,
        <https://1145.am/db/2370022/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2370078/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2370082/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2370089/Abide_Therapeutics>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370637/Medgenics_Inc>,
        <https://1145.am/db/2370797/Pharmanest>,
        <https://1145.am/db/2370798/Pharmalink_Ab>,
        <https://1145.am/db/2370946/Biogen>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2371279/Biomunex_Pharmaceuticals>,
        <https://1145.am/db/2371491/Biopharmx_Corporation>,
        <https://1145.am/db/2536754/Oramed_Pharma>,
        <https://1145.am/db/2536756/Zao>,
        <https://1145.am/db/2537468/Pharmascience_Inc>,
        <https://1145.am/db/2538171/Biomeda_Group>,
        <https://1145.am/db/2538567/Upm_Pharmaceuticals>,
        <https://1145.am/db/2538861/Par_Pharmaceuticals>,
        <https://1145.am/db/2538901/The_Harvard_Drug_Group>,
        <https://1145.am/db/2539516/Par_Pharmaceuticals>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2540193/Pharmanest>,
        <https://1145.am/db/2540449/Biocon>,
        <https://1145.am/db/2540951/Rytary>,
        <https://1145.am/db/2541039/Elan_Pharmaceuticals>,
        <https://1145.am/db/2541239/Pharmstar>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541717/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2541810/British_Pharma>,
        <https://1145.am/db/2542218/Pharmacyclics>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544111/Unique_Pharmaceuticals>,
        <https://1145.am/db/2544358/Mundipharma>,
        <https://1145.am/db/2544596/Polpharma>,
        <https://1145.am/db/2544679/Neopharma>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2545143/Mundipharma>,
        <https://1145.am/db/2545411/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2546441/Intas_Pharmaceuticals>,
        <https://1145.am/db/2546529/Pharma_Tech_Industries>,
        <https://1145.am/db/2546629/Par_Pharmaceutical>,
        <https://1145.am/db/2547189/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2548585/Par_Pharmaceuticals>,
        <https://1145.am/db/2548674/Sopharma>,
        <https://1145.am/db/2549477/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2549520/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2549919/Pharmathen>,
        <https://1145.am/db/2550212/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2550471/Pharmaform>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2550685/Upm_Pharmaceuticals>,
        <https://1145.am/db/2551427/Pharmablock_Sciences>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552169/Alembic_Pharmaceuticals>,
        <https://1145.am/db/2552465/Medis>,
        <https://1145.am/db/2552641/Plethico_Pharmaceuticals>,
        <https://1145.am/db/2552642/Mankind_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552794/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553276/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553512/Pharmax_Pharmaceuticals>,
        <https://1145.am/db/2553708/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2554237/Intas_Pharmaceuticals>,
        <https://1145.am/db/2554810/Continuus_Pharmaceuticals>,
        <https://1145.am/db/2554814/Globalpharma>,
        <https://1145.am/db/2554858/Medicure_Usa_Inc>,
        <https://1145.am/db/2555338/Pharmacore>,
        <https://1145.am/db/2555890/Pharmalucence>,
        <https://1145.am/db/2555896/Pharmalucence>,
        <https://1145.am/db/2556805/Medicis_Pharmaceuticals>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2557538/Neopharma>,
        <https://1145.am/db/2558025/Pharmaxis>,
        <https://1145.am/db/2558026/Pharmaxis>,
        <https://1145.am/db/2558970/Biostar_Pharmaceuticals>,
        <https://1145.am/db/2559783/Polpharma>,
        <https://1145.am/db/2560083/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561100/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561312/Oxford_Pharmaceuticals>,
        <https://1145.am/db/2561438/Pharmacia___Upjohn>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2562199/Novartis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562500/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2563255/Active_Pharmaceutical_Ingredients>,
        <https://1145.am/db/2563497/Creo_Pharmaceuticals>,
        <https://1145.am/db/2563497/Polpharma>,
        <https://1145.am/db/2564196/Pharmaron>,
        <https://1145.am/db/2564713/C2_Pharma>,
        <https://1145.am/db/2567007/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2567055/Sovereign_Pharmaceuticals>,
        <https://1145.am/db/2567283/The_Pharma_Giant>,
        <https://1145.am/db/2567438/Biogen>,
        <https://1145.am/db/2567651/Indivior>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2568205/Biogen>,
        <https://1145.am/db/2568375/Biogen>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569187/Pharmacyclics>,
        <https://1145.am/db/2569370/Co>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570068/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2570289/Pharmacyclics>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570449/Biocon>,
        <https://1145.am/db/2570741/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2572200/The_Medicines_Company>,
        <https://1145.am/db/2572870/Hi-Tech_Pharmaceuticals>,
        <https://1145.am/db/2573057/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2573058/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2573147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2573271/Physician_Therapeutics>,
        <https://1145.am/db/2573391/Url_Pharma>,
        <https://1145.am/db/2573392/Url_Pharma>,
        <https://1145.am/db/2573887/Biogen>,
        <https://1145.am/db/2574679/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2574891/Pharmacyclics>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2575242/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2575462/Paras_Pharmaceuticals>,
        <https://1145.am/db/2575623/Inova_Pharmaceuticals>,
        <https://1145.am/db/2576205/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577145/Medicis_Pharmaceutical>,
        <https://1145.am/db/2577259/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals>,
        <https://1145.am/db/2577675/Biogen>,
        <https://1145.am/db/2577684/Biogen>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2577934/Pharmascience>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578319/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2578473/Aa_Pharma>,
        <https://1145.am/db/2578481/Aa_Pharma_Inc>,
        <https://1145.am/db/2579147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2579211/Eusa_Pharma>,
        <https://1145.am/db/2579538/Pharmaforce>,
        <https://1145.am/db/2580123/Savient_Pharmaceuticals>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2581225/Inova_Pharmaceuticals>,
        <https://1145.am/db/2582110/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582153/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2582174/Pharmasset>,
        <https://1145.am/db/2582320/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2583013/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583022/Url_Pharma>,
        <https://1145.am/db/2583220/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2583270/Pharmaswiss>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583402/Osi_Pharmaceuticals>,
        <https://1145.am/db/2583414/Polpharma>,
        <https://1145.am/db/2583769/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2584209/Pharmaswiss_Sa>,
        <https://1145.am/db/2584226/Pharmaswiss_Sa>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2585281/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2585887/Pharma_Inc>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587155/Millennium_Pharma>,
        <https://1145.am/db/2587616/Pharmaq>,
        <https://1145.am/db/2587696/R-Pharm>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588718/Pharmacyclics>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2589884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590159/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2590409/Biogen>,
        <https://1145.am/db/2590910/Savient_Pharmaceuticals>,
        <https://1145.am/db/2591540/Polpharma>,
        <https://1145.am/db/2591690/Medicis_Pharmaceutical>,
        <https://1145.am/db/2591938/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2593142/Access_Pharmaceuticals>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594042/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594116/Pharmerica>,
        <https://1145.am/db/2594602/Osi_Pharma>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595190/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595210/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595413/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596307/Savient_Pharmaceuticals>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596369/Pharmadeals_Ltd>,
        <https://1145.am/db/2596818/Pharmasset>,
        <https://1145.am/db/2597158/Nps_Pharmaceuticals>,
        <https://1145.am/db/2597180/Prism_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2597935/Osi_Pharmaceuticals>,
        <https://1145.am/db/2598027/Nps_Pharmaceuticals>,
        <https://1145.am/db/2598099/Paras_Pharmaceuticals>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598195/Pharmatech>,
        <https://1145.am/db/2598605/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2765310/Biogen>,
        <https://1145.am/db/281576/Mymd_Pharmaceuticals>,
        <https://1145.am/db/307255/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/324642/Mundipharma>,
        <https://1145.am/db/367137/Biomat>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/380389/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/407888/Quoin_Pharmaceuticals>,
        <https://1145.am/db/410129/Catalyst_Pharmaceuticals_Inc>,
        <https://1145.am/db/427157/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/431169/Pharmablock>,
        <https://1145.am/db/4491/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/452957/Aerie_Pharmaceuticals>,
        <https://1145.am/db/468221/Aerie_Pharmaceuticals>,
        <https://1145.am/db/481129/Biocon_Ltd>,
        <https://1145.am/db/485351/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/486302/Phathom_Pharmaceuticals>,
        <https://1145.am/db/487010/Scipher_Medicine>,
        <https://1145.am/db/488564/Aerie_Pharmaceuticals>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538112/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/545583/Citius_Pharmaceuticals>,
        <https://1145.am/db/546391/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/567789/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/585607/Am-Pharma>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/662016/Prestige_Biopharma_Limited>,
        <https://1145.am/db/668495/Scipher_Medicine>,
        <https://1145.am/db/669775/Scipher_Medicine>,
        <https://1145.am/db/693128/Ascensus_Specialties>,
        <https://1145.am/db/700482/Novartis_Pharmaceuticals>,
        <https://1145.am/db/712037/Amunix_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/713105/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713736/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/714923/Betterlife_Pharma_Inc>,
        <https://1145.am/db/715385/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/718008/Pharnext_Sa>,
        <https://1145.am/db/723883/Mymd_Pharmaceuticals>,
        <https://1145.am/db/724999/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/734669/Escient_Pharmaceuticals>,
        <https://1145.am/db/742794/Hr_Pharmaceuticals_Inc>,
        <https://1145.am/db/771062/Gw_Pharmaceuticals>,
        <https://1145.am/db/793071/Biogen_Inc>,
        <https://1145.am/db/835485/Pharmaessentia_Corporation>,
        <https://1145.am/db/854026/Aerie_Pharmaceuticals>,
        <https://1145.am/db/883896/Biontech>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/887575/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/889331/Tha_Pharma>,
        <https://1145.am/db/912469/Aerie_Pharmaceuticals>,
        <https://1145.am/db/913730/Aerie_Pharmaceuticals>,
        <https://1145.am/db/922740/Grand_Pharma>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2315158/Research_Pharmaceutical_Services> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318461/Investment_Bend_Research_Capsugel_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-11-11T13:08:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Deal-happy CMO Capsugel has n't forgotten about its latest acquiree, planning to invest $ 20 million in Bend Research's spray-dried dispersion technology just a month after closing the buyout deal.",
        "Over the past year, Capsugel has used its wallet to get a bigger stake in the contract manufacturing world, first buying Scotland's Encap Drug Delivery to add liquid and semi-solid encapsulations to its offerings, and then picking up Bend this fall, bringing in technologies for modified release, inhalation delivery and biotherapeutic processing." ;
    ns1:documentTitle "Capsugel bets $20M on Bend's commercial manufacturing" ;
    ns1:documentURL <https://www.fiercebiotech.com/manufacturing/capsugel-bets-20m-on-bend-s-commercial-manufacturing> ;
    ns1:foundName "invest",
        "picking" ;
    ns1:name "invest",
        "picking" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2318461/Bend_Research> ;
    ns1:targetName "Bend" ;
    ns1:valueRaw "$ 20 million" ;
    ns1:whenRaw "this fall" ;
    ns1:whereGeoName "Oregon" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5744337/about.rdf> ;
    ns1:whereRaw "Oregon" .

<https://1145.am/db/2318461/KKR> a org:Organization ;
    ns1:description "healthcare dealmaking" ;
    ns1:documentDate "2013-11-11T13:08:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Capsugel bets $20M on Bend's commercial manufacturing" ;
    ns1:documentURL <https://www.fiercebiotech.com/manufacturing/capsugel-bets-20m-on-bend-s-commercial-manufacturing> ;
    ns1:foundName "KKR" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2318461/Cros_Pra_Stake_Investment> ;
    ns1:name "KKR" ;
    ns1:sameAsHigh <https://1145.am/db/1460/KKR>,
        <https://1145.am/db/2561249/KKR>,
        <https://1145.am/db/2746/Kkr___Co_Inc>,
        <https://1145.am/db/745381/Kkr_Health_Care_Strategic_Growth_Fund_Ii> ;
    ns1:sameAsMedium <https://1145.am/db/1011940/KKR>,
        <https://1145.am/db/1013124/KKR>,
        <https://1145.am/db/1015212/KKR>,
        <https://1145.am/db/1016588/KKR>,
        <https://1145.am/db/1026785/KKR>,
        <https://1145.am/db/1047409/KKR>,
        <https://1145.am/db/1048061/KKR>,
        <https://1145.am/db/1051390/KKR>,
        <https://1145.am/db/1055774/KKR>,
        <https://1145.am/db/1061971/KKR>,
        <https://1145.am/db/1063827/KKR>,
        <https://1145.am/db/1063843/KKR>,
        <https://1145.am/db/1064625/KKR>,
        <https://1145.am/db/1068387/KKR>,
        <https://1145.am/db/1081263/KKR>,
        <https://1145.am/db/1082650/KKR>,
        <https://1145.am/db/1083078/KKR>,
        <https://1145.am/db/1113018/KKR>,
        <https://1145.am/db/1118091/KKR>,
        <https://1145.am/db/112754/KKR>,
        <https://1145.am/db/1129736/KKR>,
        <https://1145.am/db/1131185/KKR>,
        <https://1145.am/db/1160033/KKR>,
        <https://1145.am/db/1160920/KKR>,
        <https://1145.am/db/1187769/KKR>,
        <https://1145.am/db/1190440/KKR>,
        <https://1145.am/db/1192098/KKR>,
        <https://1145.am/db/1192924/KKR>,
        <https://1145.am/db/1215547/KKR>,
        <https://1145.am/db/1215996/KKR>,
        <https://1145.am/db/1229887/KKR>,
        <https://1145.am/db/1230736/KKR>,
        <https://1145.am/db/1247887/KKR>,
        <https://1145.am/db/1248726/KKR>,
        <https://1145.am/db/1250422/KKR>,
        <https://1145.am/db/1260722/KKR>,
        <https://1145.am/db/1263937/KKR>,
        <https://1145.am/db/1264568/KKR>,
        <https://1145.am/db/1270094/KKR>,
        <https://1145.am/db/1281471/KKR>,
        <https://1145.am/db/1285688/KKR>,
        <https://1145.am/db/1294469/KKR>,
        <https://1145.am/db/1295782/KKR>,
        <https://1145.am/db/1296521/Kkr___Co>,
        <https://1145.am/db/1310687/KKR>,
        <https://1145.am/db/1364/Kkr___Co>,
        <https://1145.am/db/1381518/KKR>,
        <https://1145.am/db/1394821/KKR>,
        <https://1145.am/db/1397716/KKR>,
        <https://1145.am/db/1399415/KKR>,
        <https://1145.am/db/1416023/KKR>,
        <https://1145.am/db/1416277/Kkr___Co>,
        <https://1145.am/db/1420083/KKR>,
        <https://1145.am/db/1436822/KKR>,
        <https://1145.am/db/1438103/KKR>,
        <https://1145.am/db/1449022/KKR>,
        <https://1145.am/db/1449914/KKR>,
        <https://1145.am/db/1452259/KKR>,
        <https://1145.am/db/1452519/KKR>,
        <https://1145.am/db/1455940/KKR>,
        <https://1145.am/db/1473068/KKR>,
        <https://1145.am/db/1475136/KKR>,
        <https://1145.am/db/1476460/KKR>,
        <https://1145.am/db/149545/KKR>,
        <https://1145.am/db/1495463/KKR>,
        <https://1145.am/db/1496959/KKR>,
        <https://1145.am/db/1502843/Kkr_Inc>,
        <https://1145.am/db/1506577/KKR>,
        <https://1145.am/db/1509288/KKR>,
        <https://1145.am/db/1512558/KKR>,
        <https://1145.am/db/152934/KKR>,
        <https://1145.am/db/1546202/KKR>,
        <https://1145.am/db/1547814/KKR>,
        <https://1145.am/db/1554054/KKR>,
        <https://1145.am/db/1555857/KKR>,
        <https://1145.am/db/1590538/KKR>,
        <https://1145.am/db/1591345/KKR>,
        <https://1145.am/db/1591763/KKR>,
        <https://1145.am/db/1648448/KKR>,
        <https://1145.am/db/1649860/KKR>,
        <https://1145.am/db/1649938/KKR>,
        <https://1145.am/db/1651830/KKR>,
        <https://1145.am/db/1658979/KKR>,
        <https://1145.am/db/1660846/KKR>,
        <https://1145.am/db/1660963/KKR>,
        <https://1145.am/db/1661134/Kkr_Inc>,
        <https://1145.am/db/1661435/KKR>,
        <https://1145.am/db/1666847/KKR>,
        <https://1145.am/db/1668839/KKR>,
        <https://1145.am/db/1677859/KKR>,
        <https://1145.am/db/1680087/Kkr_Inc>,
        <https://1145.am/db/1680588/KKR>,
        <https://1145.am/db/1688398/KKR>,
        <https://1145.am/db/1693484/KKR>,
        <https://1145.am/db/171093/KKR>,
        <https://1145.am/db/1712/Kkr___Co>,
        <https://1145.am/db/172769/KKR>,
        <https://1145.am/db/173791/KKR>,
        <https://1145.am/db/1746839/KKR>,
        <https://1145.am/db/1749189/KKR>,
        <https://1145.am/db/1755085/KKR>,
        <https://1145.am/db/1757984/KKR>,
        <https://1145.am/db/1759036/KKR>,
        <https://1145.am/db/1760592/KKR>,
        <https://1145.am/db/1761520/KKR>,
        <https://1145.am/db/1765880/KKR>,
        <https://1145.am/db/1769962/KKR>,
        <https://1145.am/db/1789551/KKR>,
        <https://1145.am/db/1799106/KKR>,
        <https://1145.am/db/1803787/KKR>,
        <https://1145.am/db/1822745/KKR>,
        <https://1145.am/db/1845096/KKR>,
        <https://1145.am/db/1857803/KKR>,
        <https://1145.am/db/1943233/KKR>,
        <https://1145.am/db/1947119/KKR>,
        <https://1145.am/db/194974/KKR>,
        <https://1145.am/db/1950829/KKR>,
        <https://1145.am/db/195311/KKR>,
        <https://1145.am/db/195381/KKR>,
        <https://1145.am/db/195385/KKR>,
        <https://1145.am/db/1961469/KKR>,
        <https://1145.am/db/1968303/Kkr___Co>,
        <https://1145.am/db/1986543/KKR>,
        <https://1145.am/db/1996605/KKR>,
        <https://1145.am/db/2002801/KKR>,
        <https://1145.am/db/2008367/KKR>,
        <https://1145.am/db/2013193/KKR>,
        <https://1145.am/db/2023610/KKR>,
        <https://1145.am/db/2027104/KKR>,
        <https://1145.am/db/2028313/KKR>,
        <https://1145.am/db/2032776/KKR>,
        <https://1145.am/db/2038852/KKR>,
        <https://1145.am/db/2042348/KKR>,
        <https://1145.am/db/2043935/KKR>,
        <https://1145.am/db/2046870/KKR>,
        <https://1145.am/db/2050989/KKR>,
        <https://1145.am/db/2053511/KKR>,
        <https://1145.am/db/2056647/KKR>,
        <https://1145.am/db/2057136/KKR>,
        <https://1145.am/db/2058954/KKR>,
        <https://1145.am/db/2063964/KKR>,
        <https://1145.am/db/2066225/KKR>,
        <https://1145.am/db/2068310/KKR>,
        <https://1145.am/db/2069371/KKR>,
        <https://1145.am/db/2073937/KKR>,
        <https://1145.am/db/2075344/KKR>,
        <https://1145.am/db/2075473/KKR>,
        <https://1145.am/db/2076666/KKR>,
        <https://1145.am/db/2078541/KKR>,
        <https://1145.am/db/2078780/KKR>,
        <https://1145.am/db/2078827/Kkr___Co>,
        <https://1145.am/db/2079830/KKR>,
        <https://1145.am/db/2080075/KKR>,
        <https://1145.am/db/2080109/KKR>,
        <https://1145.am/db/2082516/KKR>,
        <https://1145.am/db/2085686/KKR>,
        <https://1145.am/db/2089349/KKR>,
        <https://1145.am/db/2089461/KKR>,
        <https://1145.am/db/2097007/KKR>,
        <https://1145.am/db/2101709/KKR>,
        <https://1145.am/db/2101746/KKR>,
        <https://1145.am/db/2109787/KKR>,
        <https://1145.am/db/2112887/KKR>,
        <https://1145.am/db/2113323/KKR>,
        <https://1145.am/db/2114093/KKR>,
        <https://1145.am/db/212359/KKR>,
        <https://1145.am/db/2124274/Kkr___Co>,
        <https://1145.am/db/2124401/KKR>,
        <https://1145.am/db/2124862/KKR>,
        <https://1145.am/db/212685/KKR>,
        <https://1145.am/db/2127688/KKR>,
        <https://1145.am/db/2131893/KKR>,
        <https://1145.am/db/2132583/KKR>,
        <https://1145.am/db/2132959/KKR>,
        <https://1145.am/db/2135051/KKR>,
        <https://1145.am/db/2136594/KKR>,
        <https://1145.am/db/2139470/KKR>,
        <https://1145.am/db/2145209/KKR>,
        <https://1145.am/db/2149115/KKR>,
        <https://1145.am/db/2149560/KKR>,
        <https://1145.am/db/2186299/KKR>,
        <https://1145.am/db/2194895/KKR>,
        <https://1145.am/db/2290211/KKR>,
        <https://1145.am/db/2290727/KKR>,
        <https://1145.am/db/2291651/KKR>,
        <https://1145.am/db/2291664/KKR>,
        <https://1145.am/db/2300371/KKR>,
        <https://1145.am/db/2314081/KKR>,
        <https://1145.am/db/2315158/KKR>,
        <https://1145.am/db/2317339/KKR>,
        <https://1145.am/db/2317344/KKR>,
        <https://1145.am/db/2328236/KKR>,
        <https://1145.am/db/2330390/KKR>,
        <https://1145.am/db/2336420/KKR>,
        <https://1145.am/db/2339666/KKR>,
        <https://1145.am/db/2345694/KKR>,
        <https://1145.am/db/2371655/KKR>,
        <https://1145.am/db/239551/KKR>,
        <https://1145.am/db/240235/Kkr___Co>,
        <https://1145.am/db/240501/Kkr___Co>,
        <https://1145.am/db/240691/KKR>,
        <https://1145.am/db/2429989/KKR>,
        <https://1145.am/db/2477137/KKR>,
        <https://1145.am/db/2477142/Kkr___Co>,
        <https://1145.am/db/2508331/KKR>,
        <https://1145.am/db/2544488/KKR>,
        <https://1145.am/db/2548051/KKR>,
        <https://1145.am/db/2558515/KKR>,
        <https://1145.am/db/255858/KKR>,
        <https://1145.am/db/2558602/KKR>,
        <https://1145.am/db/2560676/KKR>,
        <https://1145.am/db/2573232/KKR>,
        <https://1145.am/db/2589365/KKR>,
        <https://1145.am/db/2590549/KKR>,
        <https://1145.am/db/2591281/KKR>,
        <https://1145.am/db/2591917/KKR>,
        <https://1145.am/db/2594570/KKR>,
        <https://1145.am/db/2594867/KKR>,
        <https://1145.am/db/2594877/KKR>,
        <https://1145.am/db/2637995/KKR>,
        <https://1145.am/db/2651063/KKR>,
        <https://1145.am/db/2686055/KKR>,
        <https://1145.am/db/2704480/KKR>,
        <https://1145.am/db/2704484/KKR>,
        <https://1145.am/db/2719490/KKR>,
        <https://1145.am/db/2719659/KKR>,
        <https://1145.am/db/2784659/KKR>,
        <https://1145.am/db/2785212/KKR>,
        <https://1145.am/db/2786374/KKR>,
        <https://1145.am/db/2794220/KKR>,
        <https://1145.am/db/2795258/KKR>,
        <https://1145.am/db/2795446/KKR>,
        <https://1145.am/db/2796657/KKR>,
        <https://1145.am/db/2796864/KKR>,
        <https://1145.am/db/2801896/KKR>,
        <https://1145.am/db/284837/KKR>,
        <https://1145.am/db/285425/KKR>,
        <https://1145.am/db/286585/KKR>,
        <https://1145.am/db/287966/KKR>,
        <https://1145.am/db/293364/Kkr___Co>,
        <https://1145.am/db/299964/KKR>,
        <https://1145.am/db/306695/KKR>,
        <https://1145.am/db/315335/KKR>,
        <https://1145.am/db/315346/KKR>,
        <https://1145.am/db/319737/KKR>,
        <https://1145.am/db/320746/KKR>,
        <https://1145.am/db/322468/KKR>,
        <https://1145.am/db/322674/KKR>,
        <https://1145.am/db/322933/KKR>,
        <https://1145.am/db/323184/KKR>,
        <https://1145.am/db/331041/KKR>,
        <https://1145.am/db/331072/KKR>,
        <https://1145.am/db/331120/KKR>,
        <https://1145.am/db/334317/KKR>,
        <https://1145.am/db/335627/KKR>,
        <https://1145.am/db/336437/KKR>,
        <https://1145.am/db/337257/KKR>,
        <https://1145.am/db/338225/KKR>,
        <https://1145.am/db/344076/KKR>,
        <https://1145.am/db/346092/Kkr___Co>,
        <https://1145.am/db/346265/KKR>,
        <https://1145.am/db/346358/Kkr___Co>,
        <https://1145.am/db/346368/Kkr___Co>,
        <https://1145.am/db/346523/KKR>,
        <https://1145.am/db/347280/KKR>,
        <https://1145.am/db/357173/KKR>,
        <https://1145.am/db/3573/KKR>,
        <https://1145.am/db/371665/KKR>,
        <https://1145.am/db/377907/KKR>,
        <https://1145.am/db/388746/KKR>,
        <https://1145.am/db/3947/KKR>,
        <https://1145.am/db/409008/KKR>,
        <https://1145.am/db/425087/KKR>,
        <https://1145.am/db/429762/KKR>,
        <https://1145.am/db/432705/KKR>,
        <https://1145.am/db/433673/KKR>,
        <https://1145.am/db/444316/KKR>,
        <https://1145.am/db/454758/KKR>,
        <https://1145.am/db/456088/KKR>,
        <https://1145.am/db/461148/KKR>,
        <https://1145.am/db/463978/KKR>,
        <https://1145.am/db/464569/KKR>,
        <https://1145.am/db/474753/KKR>,
        <https://1145.am/db/489290/KKR>,
        <https://1145.am/db/492468/KKR>,
        <https://1145.am/db/495917/KKR>,
        <https://1145.am/db/514250/KKR>,
        <https://1145.am/db/515346/KKR>,
        <https://1145.am/db/516118/KKR>,
        <https://1145.am/db/526965/KKR>,
        <https://1145.am/db/531779/KKR>,
        <https://1145.am/db/535518/KKR>,
        <https://1145.am/db/537800/KKR>,
        <https://1145.am/db/539290/KKR>,
        <https://1145.am/db/543668/KKR>,
        <https://1145.am/db/544684/KKR>,
        <https://1145.am/db/585991/KKR>,
        <https://1145.am/db/595003/KKR>,
        <https://1145.am/db/595062/KKR>,
        <https://1145.am/db/596244/KKR>,
        <https://1145.am/db/600948/KKR>,
        <https://1145.am/db/602304/KKR>,
        <https://1145.am/db/606208/KKR>,
        <https://1145.am/db/613807/KKR>,
        <https://1145.am/db/614524/KKR>,
        <https://1145.am/db/620441/KKR>,
        <https://1145.am/db/624398/KKR>,
        <https://1145.am/db/624410/KKR>,
        <https://1145.am/db/638312/KKR>,
        <https://1145.am/db/643839/KKR>,
        <https://1145.am/db/644358/KKR>,
        <https://1145.am/db/644418/KKR>,
        <https://1145.am/db/647441/KKR>,
        <https://1145.am/db/649646/KKR>,
        <https://1145.am/db/650038/KKR>,
        <https://1145.am/db/651358/KKR>,
        <https://1145.am/db/651798/KKR>,
        <https://1145.am/db/652863/KKR>,
        <https://1145.am/db/653953/KKR>,
        <https://1145.am/db/654033/KKR>,
        <https://1145.am/db/665056/KKR>,
        <https://1145.am/db/665505/KKR>,
        <https://1145.am/db/665815/KKR>,
        <https://1145.am/db/667263/KKR>,
        <https://1145.am/db/667997/KKR>,
        <https://1145.am/db/674055/KKR>,
        <https://1145.am/db/675103/KKR>,
        <https://1145.am/db/685346/KKR>,
        <https://1145.am/db/685746/KKR>,
        <https://1145.am/db/693816/KKR>,
        <https://1145.am/db/695839/KKR>,
        <https://1145.am/db/696425/KKR>,
        <https://1145.am/db/696885/KKR>,
        <https://1145.am/db/698056/KKR>,
        <https://1145.am/db/703846/KKR>,
        <https://1145.am/db/713772/KKR>,
        <https://1145.am/db/715525/KKR>,
        <https://1145.am/db/733298/KKR>,
        <https://1145.am/db/746000/KKR>,
        <https://1145.am/db/748180/KKR>,
        <https://1145.am/db/75900/KKR>,
        <https://1145.am/db/769166/KKR>,
        <https://1145.am/db/770078/KKR>,
        <https://1145.am/db/770929/KKR>,
        <https://1145.am/db/783138/KKR>,
        <https://1145.am/db/783577/KKR>,
        <https://1145.am/db/785008/KKR>,
        <https://1145.am/db/787319/KKR>,
        <https://1145.am/db/789202/KKR>,
        <https://1145.am/db/797358/KKR>,
        <https://1145.am/db/799510/KKR>,
        <https://1145.am/db/800916/KKR>,
        <https://1145.am/db/814184/KKR>,
        <https://1145.am/db/814340/Kkr___Co>,
        <https://1145.am/db/829559/KKR>,
        <https://1145.am/db/835332/KKR>,
        <https://1145.am/db/849227/KKR>,
        <https://1145.am/db/865540/KKR>,
        <https://1145.am/db/872702/KKR>,
        <https://1145.am/db/882663/KKR>,
        <https://1145.am/db/893768/KKR>,
        <https://1145.am/db/899462/KKR>,
        <https://1145.am/db/900594/KKR>,
        <https://1145.am/db/900629/KKR>,
        <https://1145.am/db/907556/KKR>,
        <https://1145.am/db/908834/KKR>,
        <https://1145.am/db/908839/KKR>,
        <https://1145.am/db/908843/KKR>,
        <https://1145.am/db/908907/KKR>,
        <https://1145.am/db/910191/KKR>,
        <https://1145.am/db/912132/Kkr___Co>,
        <https://1145.am/db/913484/KKR>,
        <https://1145.am/db/91884/KKR>,
        <https://1145.am/db/923834/KKR>,
        <https://1145.am/db/92448/KKR>,
        <https://1145.am/db/924993/KKR>,
        <https://1145.am/db/926313/KKR>,
        <https://1145.am/db/929269/KKR>,
        <https://1145.am/db/930281/KKR>,
        <https://1145.am/db/932790/KKR>,
        <https://1145.am/db/934927/KKR>,
        <https://1145.am/db/94535/KKR>,
        <https://1145.am/db/953014/KKR>,
        <https://1145.am/db/963947/KKR>,
        <https://1145.am/db/968064/KKR>,
        <https://1145.am/db/968112/KKR>,
        <https://1145.am/db/970108/KKR>,
        <https://1145.am/db/971684/KKR>,
        <https://1145.am/db/972089/KKR>,
        <https://1145.am/db/972213/KKR>,
        <https://1145.am/db/976442/KKR>,
        <https://1145.am/db/978086/KKR>,
        <https://1145.am/db/978783/KKR>,
        <https://1145.am/db/984390/KKR>,
        <https://1145.am/db/986270/KKR>,
        <https://1145.am/db/989353/KKR>,
        <https://1145.am/db/992099/KKR> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318461/Panasonic> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:documentDate "2013-11-11T13:08:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Capsugel bets $20M on Bend's commercial manufacturing" ;
    ns1:documentURL <https://www.fiercebiotech.com/manufacturing/capsugel-bets-20m-on-bend-s-commercial-manufacturing> ;
    ns1:foundName "Panasonic" ;
    ns1:industry "healthcare" ;
    ns1:name "Panasonic" ;
    ns1:sameAsHigh <https://1145.am/db/2290211/Panasonic>,
        <https://1145.am/db/2290727/Panasonic>,
        <https://1145.am/db/2291134/Panasonic>,
        <https://1145.am/db/2291651/Panasonic>,
        <https://1145.am/db/2291664/Panasonic>,
        <https://1145.am/db/2297616/Panasonic_Healthcare_Company_Of_North_America>,
        <https://1145.am/db/2297727/Panasonic>,
        <https://1145.am/db/2312950/Panasonic_Healthcare>,
        <https://1145.am/db/2561249/Panasonic_Corp>,
        <https://1145.am/db/2561249/Panasonic_Healthcare>,
        <https://1145.am/db/2570097/Panasonic_Healthcare>,
        <https://1145.am/db/2570177/Panasonic_Healthcare>,
        <https://1145.am/db/2576841/Panasonic_Healthcare_Holdings_Co_Ltd>,
        <https://1145.am/db/2597465/Panasonics_Healthcare_Arm> ;
    ns1:sameAsMedium <https://1145.am/db/1506816/Panasonic_Corporation>,
        <https://1145.am/db/1510277/Panasonic_Corporation>,
        <https://1145.am/db/1709746/Panasonic>,
        <https://1145.am/db/1737297/Panasonic>,
        <https://1145.am/db/1784443/Panasonic>,
        <https://1145.am/db/1823230/Panasonic>,
        <https://1145.am/db/1860537/Panasonic>,
        <https://1145.am/db/1887449/Panasonic>,
        <https://1145.am/db/1919909/Panasonic>,
        <https://1145.am/db/2006785/Panasonic>,
        <https://1145.am/db/2276694/Panasonic>,
        <https://1145.am/db/2299135/Panasonic>,
        <https://1145.am/db/2300448/Panasonic>,
        <https://1145.am/db/2398007/Panasonic>,
        <https://1145.am/db/2420907/Panasonic>,
        <https://1145.am/db/262851/Panasonic_Corp>,
        <https://1145.am/db/2648461/Panasonic>,
        <https://1145.am/db/314214/Panasonic_Corp>,
        <https://1145.am/db/314217/Panasonic_Corp>,
        <https://1145.am/db/362830/Panasonic_Corp>,
        <https://1145.am/db/362839/Panasonic_Corp>,
        <https://1145.am/db/373672/Panasonic>,
        <https://1145.am/db/479517/Panasonic_Corporation>,
        <https://1145.am/db/481961/Panasonic_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340634/Domain_Associates> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2013-12-16T22:46:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen spinoff Atara banks $38.5M as it races ahead with CKD, cancer trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/amgen-spinoff-atara-banks-38-5m-as-it-races-ahead-ckd-cancer-trials> ;
    ns1:foundName "Domain",
        "Domain Associates" ;
    ns1:investor <https://1145.am/db/2340634/Series_B_Investment_Alexandria_Venture_Investments_Amgen_Atara_Biotherapeutics_Celgene_Dag_Ventures_Domain_Associates_Ecor1_Capital_Completed> ;
    ns1:name "Domain Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1859331/Domain_Associates>,
        <https://1145.am/db/2153759/Domain_Associates>,
        <https://1145.am/db/2155032/Domain_Associates>,
        <https://1145.am/db/2155189/Domain_Associates>,
        <https://1145.am/db/2289515/Domain_Associates>,
        <https://1145.am/db/2289819/Domain_Associates>,
        <https://1145.am/db/2290405/Domain_Associates>,
        <https://1145.am/db/2294753/Domain_Associates>,
        <https://1145.am/db/2296841/Domain_Associates>,
        <https://1145.am/db/2297408/Domain_Associates>,
        <https://1145.am/db/2299776/Domain_Associates>,
        <https://1145.am/db/2300270/Domain_Associates>,
        <https://1145.am/db/2300293/Domain_Associates>,
        <https://1145.am/db/2300337/Domain_Associates>,
        <https://1145.am/db/2300455/Domain_Associates>,
        <https://1145.am/db/2302292/Domain_Associates_Llc>,
        <https://1145.am/db/2302508/Domain_Associates>,
        <https://1145.am/db/2303641/Domain_Associates>,
        <https://1145.am/db/2303642/Domain_Associates>,
        <https://1145.am/db/2303793/Domain_Associates>,
        <https://1145.am/db/2304578/Domain_Associates>,
        <https://1145.am/db/2304587/Domain_Associates>,
        <https://1145.am/db/2305524/Domain_Associates>,
        <https://1145.am/db/2305530/Domain_Associates>,
        <https://1145.am/db/2305706/Domain_Associates>,
        <https://1145.am/db/2305713/Domain_Associates>,
        <https://1145.am/db/2305729/Domain_Associates>,
        <https://1145.am/db/2306290/Domain_Associates_Llc>,
        <https://1145.am/db/2306873/Domain_Associates>,
        <https://1145.am/db/2307237/Domain_Associates>,
        <https://1145.am/db/2307644/Domain_Associates>,
        <https://1145.am/db/2309809/Domain_Associates>,
        <https://1145.am/db/2310073/Domain_Associates>,
        <https://1145.am/db/2311099/Domain_Associates>,
        <https://1145.am/db/2311221/Domain_Associates>,
        <https://1145.am/db/2312051/Domain_Associates>,
        <https://1145.am/db/2312120/Domain_Associates>,
        <https://1145.am/db/2312297/Domain_Associates>,
        <https://1145.am/db/2313171/Domain_Associates>,
        <https://1145.am/db/2316210/Domain_Associates>,
        <https://1145.am/db/2316214/Domain_Associates>,
        <https://1145.am/db/2317145/Domain_Associates>,
        <https://1145.am/db/2317951/Domain_Associates>,
        <https://1145.am/db/2318934/Domain_Associates>,
        <https://1145.am/db/2320925/Domain_Associates>,
        <https://1145.am/db/2322231/Domain_Associates>,
        <https://1145.am/db/2326423/Domain_Associates>,
        <https://1145.am/db/2326430/Domain_Associates_Llc>,
        <https://1145.am/db/2328030/Domain_Associates_Llc>,
        <https://1145.am/db/2328034/Domain_Associates_Llc>,
        <https://1145.am/db/2330075/Domain_Associates>,
        <https://1145.am/db/2330539/Domain_Associates>,
        <https://1145.am/db/2330549/Domain_Associates>,
        <https://1145.am/db/2331026/Domain_Associates>,
        <https://1145.am/db/2331047/Domain_Associates>,
        <https://1145.am/db/2331784/Domain_Associates>,
        <https://1145.am/db/2336221/Domain_Associates>,
        <https://1145.am/db/2340284/Domain_Associates>,
        <https://1145.am/db/2341764/Domain_Associates>,
        <https://1145.am/db/2343206/Domain_Associates>,
        <https://1145.am/db/2344090/Domain_Associates>,
        <https://1145.am/db/2344092/Domain_Associates>,
        <https://1145.am/db/2344100/Domain_Associates>,
        <https://1145.am/db/2344782/Domain_Associates>,
        <https://1145.am/db/2347984/Domain_Associates>,
        <https://1145.am/db/2349143/Domain_Associates>,
        <https://1145.am/db/2349753/Domain_Associates>,
        <https://1145.am/db/2350044/Domain_Associates>,
        <https://1145.am/db/2352167/Domain_Associates>,
        <https://1145.am/db/2352170/Domain_Associates>,
        <https://1145.am/db/2352808/Domain_Associates>,
        <https://1145.am/db/2354899/Domain_Associates>,
        <https://1145.am/db/2354903/Domain_Associates>,
        <https://1145.am/db/2355936/Domain_Associates>,
        <https://1145.am/db/2355938/Domain_Associates>,
        <https://1145.am/db/2356301/Domain_Associates>,
        <https://1145.am/db/2357325/Domain_Associates>,
        <https://1145.am/db/2357981/Domain_Associates>,
        <https://1145.am/db/2358541/Domain_Associates>,
        <https://1145.am/db/2358883/Domain_Associates>,
        <https://1145.am/db/2361625/Domain_Associates>,
        <https://1145.am/db/2362278/Domain_Associates>,
        <https://1145.am/db/2365700/Domain_Associates>,
        <https://1145.am/db/2366128/Domain_Associates>,
        <https://1145.am/db/2366133/Domain_Associates>,
        <https://1145.am/db/2366187/Domain_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340683/License_Investment_Natrogen_Therapeutics_International_Osaka_Japan___Deerfield_Ill___New_Takeda_Pharmaceutical_Company_Limited_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-12-19T16:26:38+00:00"^^xsd:dateTime ;
    ns1:documentExtract "OSAKA, Japan & DEERFIELD, Ill. & NEW YORK-Takeda Pharmaceutical Company Limited (\"Takeda\") and Natrogen Therapeutics International, Inc. (\"Natrogen\") jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen." ;
    ns1:documentTitle "Takeda Announces Exclusive License and Option Agreement with Natrogen for Development of Natura-alpha for Inflammatory Bowel Disease" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/takeda-announces-exclusive-license-and-option-agreement-natrogen-for-development-of-natura> ;
    ns1:foundName "acquire" ;
    ns1:name "acquire" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2340683/Natrogen_Therapeutics_International> ;
    ns1:targetDetails "license" ;
    ns1:targetName "Natrogen Therapeutics International" ;
    ns1:whereGeoName "Japan" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1861060/about.rdf> ;
    ns1:whereRaw "Japan" .

<https://1145.am/db/2341764/Domain_Associates> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2013-07-29T05:31:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "aTyr Pharma Completes $49 Million Oversubscribed Financing to Advance Rare Autoimmune Disease Therapeutic Pipeline from a Newly Discovered Class of Proteins, Physiocrines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/atyr-pharma-completes-49-million-oversubscribed-financing-to-advance-rare-autoimmune> ;
    ns1:foundName "Domain Associates" ;
    ns1:investor <https://1145.am/db/2341764/Investment_Alta_Partners_Cardinal_Partners_Domain_Associates_Polaris_Partners_Atyr_Pharma_Completed> ;
    ns1:name "Domain Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1859331/Domain_Associates>,
        <https://1145.am/db/2153759/Domain_Associates>,
        <https://1145.am/db/2155032/Domain_Associates>,
        <https://1145.am/db/2155189/Domain_Associates>,
        <https://1145.am/db/2289515/Domain_Associates>,
        <https://1145.am/db/2289819/Domain_Associates>,
        <https://1145.am/db/2290405/Domain_Associates>,
        <https://1145.am/db/2294753/Domain_Associates>,
        <https://1145.am/db/2296841/Domain_Associates>,
        <https://1145.am/db/2297408/Domain_Associates>,
        <https://1145.am/db/2299776/Domain_Associates>,
        <https://1145.am/db/2300270/Domain_Associates>,
        <https://1145.am/db/2300293/Domain_Associates>,
        <https://1145.am/db/2300337/Domain_Associates>,
        <https://1145.am/db/2300455/Domain_Associates>,
        <https://1145.am/db/2302292/Domain_Associates_Llc>,
        <https://1145.am/db/2302508/Domain_Associates>,
        <https://1145.am/db/2303641/Domain_Associates>,
        <https://1145.am/db/2303642/Domain_Associates>,
        <https://1145.am/db/2303793/Domain_Associates>,
        <https://1145.am/db/2304578/Domain_Associates>,
        <https://1145.am/db/2304587/Domain_Associates>,
        <https://1145.am/db/2305524/Domain_Associates>,
        <https://1145.am/db/2305530/Domain_Associates>,
        <https://1145.am/db/2305706/Domain_Associates>,
        <https://1145.am/db/2305713/Domain_Associates>,
        <https://1145.am/db/2305729/Domain_Associates>,
        <https://1145.am/db/2306290/Domain_Associates_Llc>,
        <https://1145.am/db/2306873/Domain_Associates>,
        <https://1145.am/db/2307237/Domain_Associates>,
        <https://1145.am/db/2307644/Domain_Associates>,
        <https://1145.am/db/2309809/Domain_Associates>,
        <https://1145.am/db/2310073/Domain_Associates>,
        <https://1145.am/db/2311099/Domain_Associates>,
        <https://1145.am/db/2311221/Domain_Associates>,
        <https://1145.am/db/2312051/Domain_Associates>,
        <https://1145.am/db/2312120/Domain_Associates>,
        <https://1145.am/db/2312297/Domain_Associates>,
        <https://1145.am/db/2313171/Domain_Associates>,
        <https://1145.am/db/2316210/Domain_Associates>,
        <https://1145.am/db/2316214/Domain_Associates>,
        <https://1145.am/db/2317145/Domain_Associates>,
        <https://1145.am/db/2317951/Domain_Associates>,
        <https://1145.am/db/2318934/Domain_Associates>,
        <https://1145.am/db/2320925/Domain_Associates>,
        <https://1145.am/db/2322231/Domain_Associates>,
        <https://1145.am/db/2326423/Domain_Associates>,
        <https://1145.am/db/2326430/Domain_Associates_Llc>,
        <https://1145.am/db/2328030/Domain_Associates_Llc>,
        <https://1145.am/db/2328034/Domain_Associates_Llc>,
        <https://1145.am/db/2330075/Domain_Associates>,
        <https://1145.am/db/2330539/Domain_Associates>,
        <https://1145.am/db/2330549/Domain_Associates>,
        <https://1145.am/db/2331026/Domain_Associates>,
        <https://1145.am/db/2331047/Domain_Associates>,
        <https://1145.am/db/2331784/Domain_Associates>,
        <https://1145.am/db/2336221/Domain_Associates>,
        <https://1145.am/db/2340284/Domain_Associates>,
        <https://1145.am/db/2340634/Domain_Associates>,
        <https://1145.am/db/2343206/Domain_Associates>,
        <https://1145.am/db/2344090/Domain_Associates>,
        <https://1145.am/db/2344092/Domain_Associates>,
        <https://1145.am/db/2344100/Domain_Associates>,
        <https://1145.am/db/2344782/Domain_Associates>,
        <https://1145.am/db/2347984/Domain_Associates>,
        <https://1145.am/db/2349143/Domain_Associates>,
        <https://1145.am/db/2349753/Domain_Associates>,
        <https://1145.am/db/2350044/Domain_Associates>,
        <https://1145.am/db/2352167/Domain_Associates>,
        <https://1145.am/db/2352170/Domain_Associates>,
        <https://1145.am/db/2352808/Domain_Associates>,
        <https://1145.am/db/2354899/Domain_Associates>,
        <https://1145.am/db/2354903/Domain_Associates>,
        <https://1145.am/db/2355936/Domain_Associates>,
        <https://1145.am/db/2355938/Domain_Associates>,
        <https://1145.am/db/2356301/Domain_Associates>,
        <https://1145.am/db/2357325/Domain_Associates>,
        <https://1145.am/db/2357981/Domain_Associates>,
        <https://1145.am/db/2358541/Domain_Associates>,
        <https://1145.am/db/2358883/Domain_Associates>,
        <https://1145.am/db/2361625/Domain_Associates>,
        <https://1145.am/db/2362278/Domain_Associates>,
        <https://1145.am/db/2365700/Domain_Associates>,
        <https://1145.am/db/2366128/Domain_Associates>,
        <https://1145.am/db/2366133/Domain_Associates>,
        <https://1145.am/db/2366187/Domain_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344786/Rights_Investment_Bdc_Venture_Capital_Clementia_Pharmaceuticals_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-01-10T16:03:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MONTREAL, QC - (Marketwired - January 09, 2014) - Clementia Pharmaceuticals, Inc., a privately held clinical stage biotechnology company dedicated to the development and delivery of treatments for people living with rare diseases, announced today the closing of a $ 22.5 million Series A financing led by OrbiMed Advisors with participation by existing investor BDC Venture Capital.",
        "OrbiMed Advisors leads Series A round for Clementia Pharmaceuticals." ;
    ns1:documentTitle "OrbiMed Advisors leads Series A round for Clementia Pharmaceuticals" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/orbimed-advisors-leads-series-a-round-for-clementia-pharmaceuticals> ;
    ns1:foundName "acquire",
        "financing" ;
    ns1:name "acquire",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2344786/Clementia_Pharmaceuticals> ;
    ns1:targetDetails "Series A",
        "rights" ;
    ns1:valueRaw "$ 22.5 million" ;
    ns1:when "2014-01-09T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "January 09, 2014" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2347984/Domain_Associates> a org:Organization ;
    ns1:basedInLowRaw "WALTHAM" ;
    ns1:documentDate "2013-08-27T11:51:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/syndax-pharmaceuticals-secures-26-6-million-series-b-financing-for-advancement-of> ;
    ns1:foundName "Domain Associates" ;
    ns1:investor <https://1145.am/db/2347984/Series_B_Investment_Domain_Associates_Forward_Ventures_Mpm_Capital_Rusnanomedinvest_Syndax_Pharmaceuticals_Inc_Completed> ;
    ns1:name "Domain Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1859331/Domain_Associates>,
        <https://1145.am/db/2153759/Domain_Associates>,
        <https://1145.am/db/2155032/Domain_Associates>,
        <https://1145.am/db/2155189/Domain_Associates>,
        <https://1145.am/db/2289515/Domain_Associates>,
        <https://1145.am/db/2289819/Domain_Associates>,
        <https://1145.am/db/2290405/Domain_Associates>,
        <https://1145.am/db/2294753/Domain_Associates>,
        <https://1145.am/db/2296841/Domain_Associates>,
        <https://1145.am/db/2297408/Domain_Associates>,
        <https://1145.am/db/2299776/Domain_Associates>,
        <https://1145.am/db/2300270/Domain_Associates>,
        <https://1145.am/db/2300293/Domain_Associates>,
        <https://1145.am/db/2300337/Domain_Associates>,
        <https://1145.am/db/2300455/Domain_Associates>,
        <https://1145.am/db/2302292/Domain_Associates_Llc>,
        <https://1145.am/db/2302508/Domain_Associates>,
        <https://1145.am/db/2303641/Domain_Associates>,
        <https://1145.am/db/2303642/Domain_Associates>,
        <https://1145.am/db/2303793/Domain_Associates>,
        <https://1145.am/db/2304578/Domain_Associates>,
        <https://1145.am/db/2304587/Domain_Associates>,
        <https://1145.am/db/2305524/Domain_Associates>,
        <https://1145.am/db/2305530/Domain_Associates>,
        <https://1145.am/db/2305706/Domain_Associates>,
        <https://1145.am/db/2305713/Domain_Associates>,
        <https://1145.am/db/2305729/Domain_Associates>,
        <https://1145.am/db/2306290/Domain_Associates_Llc>,
        <https://1145.am/db/2306873/Domain_Associates>,
        <https://1145.am/db/2307237/Domain_Associates>,
        <https://1145.am/db/2307644/Domain_Associates>,
        <https://1145.am/db/2309809/Domain_Associates>,
        <https://1145.am/db/2310073/Domain_Associates>,
        <https://1145.am/db/2311099/Domain_Associates>,
        <https://1145.am/db/2311221/Domain_Associates>,
        <https://1145.am/db/2312051/Domain_Associates>,
        <https://1145.am/db/2312120/Domain_Associates>,
        <https://1145.am/db/2312297/Domain_Associates>,
        <https://1145.am/db/2313171/Domain_Associates>,
        <https://1145.am/db/2316210/Domain_Associates>,
        <https://1145.am/db/2316214/Domain_Associates>,
        <https://1145.am/db/2317145/Domain_Associates>,
        <https://1145.am/db/2317951/Domain_Associates>,
        <https://1145.am/db/2318934/Domain_Associates>,
        <https://1145.am/db/2320925/Domain_Associates>,
        <https://1145.am/db/2322231/Domain_Associates>,
        <https://1145.am/db/2326423/Domain_Associates>,
        <https://1145.am/db/2326430/Domain_Associates_Llc>,
        <https://1145.am/db/2328030/Domain_Associates_Llc>,
        <https://1145.am/db/2328034/Domain_Associates_Llc>,
        <https://1145.am/db/2330075/Domain_Associates>,
        <https://1145.am/db/2330539/Domain_Associates>,
        <https://1145.am/db/2330549/Domain_Associates>,
        <https://1145.am/db/2331026/Domain_Associates>,
        <https://1145.am/db/2331047/Domain_Associates>,
        <https://1145.am/db/2331784/Domain_Associates>,
        <https://1145.am/db/2336221/Domain_Associates>,
        <https://1145.am/db/2340284/Domain_Associates>,
        <https://1145.am/db/2340634/Domain_Associates>,
        <https://1145.am/db/2341764/Domain_Associates>,
        <https://1145.am/db/2343206/Domain_Associates>,
        <https://1145.am/db/2344090/Domain_Associates>,
        <https://1145.am/db/2344092/Domain_Associates>,
        <https://1145.am/db/2344100/Domain_Associates>,
        <https://1145.am/db/2344782/Domain_Associates>,
        <https://1145.am/db/2349143/Domain_Associates>,
        <https://1145.am/db/2349753/Domain_Associates>,
        <https://1145.am/db/2350044/Domain_Associates>,
        <https://1145.am/db/2352167/Domain_Associates>,
        <https://1145.am/db/2352170/Domain_Associates>,
        <https://1145.am/db/2352808/Domain_Associates>,
        <https://1145.am/db/2354899/Domain_Associates>,
        <https://1145.am/db/2354903/Domain_Associates>,
        <https://1145.am/db/2355936/Domain_Associates>,
        <https://1145.am/db/2355938/Domain_Associates>,
        <https://1145.am/db/2356301/Domain_Associates>,
        <https://1145.am/db/2357325/Domain_Associates>,
        <https://1145.am/db/2357981/Domain_Associates>,
        <https://1145.am/db/2358541/Domain_Associates>,
        <https://1145.am/db/2358883/Domain_Associates>,
        <https://1145.am/db/2361625/Domain_Associates>,
        <https://1145.am/db/2362278/Domain_Associates>,
        <https://1145.am/db/2365700/Domain_Associates>,
        <https://1145.am/db/2366128/Domain_Associates>,
        <https://1145.am/db/2366133/Domain_Associates>,
        <https://1145.am/db/2366187/Domain_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348968/Investment_Beacon_Angels_Desert_Angels_Sialix_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-02-05T13:44:27+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cambridge, Massachusetts, February 5, 2014 - Sialix, Inc., a biotechnology company developing products for the treatment and prevention of cancer, today announced the closing of an oversubscribed $ 1.2 million tranche of an angel - led financing.",
        "Sialix Closes Oversubscribed Second Tranche of Series B Financing." ;
    ns1:documentTitle "Sialix Closes Oversubscribed Second Tranche of Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sialix-closes-oversubscribed-second-tranche-of-series-b-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2348968/Sialix_Inc> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 1.2 million" ;
    ns1:when "2014-02-05T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "February 5, 2014" ;
    ns1:whereGeoName "New England" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/11919979/about.rdf> ;
    ns1:whereRaw "New England" .

<https://1145.am/db/2351129/Bay_City_Capital> a org:Organization ;
    ns1:documentDate "2013-09-11T12:33:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Bay City Capital" ;
    ns1:investor <https://1145.am/db/2351129/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "Bay City Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2292334/Bay_City_Capital>,
        <https://1145.am/db/2292353/Bay_City_Capital>,
        <https://1145.am/db/2296810/Bay_City_Capital>,
        <https://1145.am/db/2301824/Bay_City_Capital>,
        <https://1145.am/db/2302897/Bay_City_Capital>,
        <https://1145.am/db/2306568/Bay_City_Capital>,
        <https://1145.am/db/2308713/Bay_City_Capital>,
        <https://1145.am/db/2311570/Bay_City_Capital>,
        <https://1145.am/db/2312435/Bay_City_Capital>,
        <https://1145.am/db/2314492/Bay_City_Capital>,
        <https://1145.am/db/2319822/Bay_City_Capital_Llc>,
        <https://1145.am/db/2319965/Bay_City_Capital>,
        <https://1145.am/db/2320476/Bay_City_Capital>,
        <https://1145.am/db/2324289/Bay_City_Capital>,
        <https://1145.am/db/2326903/Bay_City_Capital>,
        <https://1145.am/db/2329010/Bay_City_Capital>,
        <https://1145.am/db/2329011/Bay_City_Capital>,
        <https://1145.am/db/2331700/Bay_City_Capital>,
        <https://1145.am/db/2331784/Bay_City_Capital>,
        <https://1145.am/db/2336510/Bay_City_Capital>,
        <https://1145.am/db/2336511/Bay_City_Capital>,
        <https://1145.am/db/2337599/Bay_City_Capital>,
        <https://1145.am/db/2342864/Bay_City_Capital>,
        <https://1145.am/db/2346534/Bay_City_Capital>,
        <https://1145.am/db/2350491/Bay_City_Capital>,
        <https://1145.am/db/2356290/Bay_City_Capital>,
        <https://1145.am/db/2357418/Bay_City_Capital>,
        <https://1145.am/db/2358409/Bay_City_Capital>,
        <https://1145.am/db/2359185/Bay_City_Capital>,
        <https://1145.am/db/2360266/Bay_City_Capital>,
        <https://1145.am/db/2367022/Bay_City_Capital>,
        <https://1145.am/db/2367023/Bay_City_Capital>,
        <https://1145.am/db/2367026/Bay_City_Capital>,
        <https://1145.am/db/2583466/Bay_City_Capital>,
        <https://1145.am/db/2588372/Bay_City_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351129/Civitas_Therapeutics> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2013-09-11T12:33:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Civitas Therapeutics",
        "Civitas Therapeutics, Inc." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Civitas Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2336224/Civitas_Therapeutics>,
        <https://1145.am/db/2336227/Civitas_Therapeutics>,
        <https://1145.am/db/2339763/Civitas_Therapeutics>,
        <https://1145.am/db/2348922/Civitas_Therapeutics>,
        <https://1145.am/db/2356842/Civitas_Therapeutics>,
        <https://1145.am/db/2356865/Civitas_Therapeutics>,
        <https://1145.am/db/2360266/Civitas_Therapeutics>,
        <https://1145.am/db/2360268/Civitas_Therapeutics>,
        <https://1145.am/db/2366753/Civitas_Therapeutics>,
        <https://1145.am/db/2366757/Civitas_Therapeutics>,
        <https://1145.am/db/2570154/Civitas>,
        <https://1145.am/db/2583466/Civitas_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2558109/Civitas_Therapeutics>,
        <https://1145.am/db/2593166/Civitas_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356283/Lensar_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Incline Village" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5505963/about.rdf> ;
    ns1:basedInHighRaw "INCLINE VILLAGE, Nev." ;
    ns1:description "Cataract surgery",
        "Pharmaceuticals" ;
    ns1:documentDate "2013-10-02T15:46:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PDL BioPharma Provides $60 Million in Financing to LENSAR" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pdl-biopharma-provides-60-million-financing-to-lensar> ;
    ns1:foundName "LENSAR",
        "LENSAR, Inc." ;
    ns1:name "LENSAR",
        "LENSAR, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2292103/Lensar>,
        <https://1145.am/db/2297120/Lensar> ;
    ns1:sameAsMedium <https://1145.am/db/2246648/Lensar> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356290/Bay_City_Capital> a org:Organization ;
    ns1:basedInLowRaw "The Netherlands" ;
    ns1:documentDate "2013-10-03T11:35:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merus Secures 31 Million in Series B Round Extension" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merus-secures-%E2%82%AC31-million-series-b-round-extension> ;
    ns1:foundName "Bay City Capital" ;
    ns1:investor <https://1145.am/db/2356290/Series_B_Investment_Aglaia_Oncology_Fund_Bay_City_Capital_Johnson___Johnson_Development_Corporation_Lsp_Merus_Bv_Novartis_Venture_Fund_Pfizer_Venture_Investments_Completed> ;
    ns1:name "Bay City Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2292334/Bay_City_Capital>,
        <https://1145.am/db/2292353/Bay_City_Capital>,
        <https://1145.am/db/2296810/Bay_City_Capital>,
        <https://1145.am/db/2301824/Bay_City_Capital>,
        <https://1145.am/db/2302897/Bay_City_Capital>,
        <https://1145.am/db/2306568/Bay_City_Capital>,
        <https://1145.am/db/2308713/Bay_City_Capital>,
        <https://1145.am/db/2311570/Bay_City_Capital>,
        <https://1145.am/db/2312435/Bay_City_Capital>,
        <https://1145.am/db/2314492/Bay_City_Capital>,
        <https://1145.am/db/2319822/Bay_City_Capital_Llc>,
        <https://1145.am/db/2319965/Bay_City_Capital>,
        <https://1145.am/db/2320476/Bay_City_Capital>,
        <https://1145.am/db/2324289/Bay_City_Capital>,
        <https://1145.am/db/2326903/Bay_City_Capital>,
        <https://1145.am/db/2329010/Bay_City_Capital>,
        <https://1145.am/db/2329011/Bay_City_Capital>,
        <https://1145.am/db/2331700/Bay_City_Capital>,
        <https://1145.am/db/2331784/Bay_City_Capital>,
        <https://1145.am/db/2336510/Bay_City_Capital>,
        <https://1145.am/db/2336511/Bay_City_Capital>,
        <https://1145.am/db/2337599/Bay_City_Capital>,
        <https://1145.am/db/2342864/Bay_City_Capital>,
        <https://1145.am/db/2346534/Bay_City_Capital>,
        <https://1145.am/db/2350491/Bay_City_Capital>,
        <https://1145.am/db/2351129/Bay_City_Capital>,
        <https://1145.am/db/2357418/Bay_City_Capital>,
        <https://1145.am/db/2358409/Bay_City_Capital>,
        <https://1145.am/db/2359185/Bay_City_Capital>,
        <https://1145.am/db/2360266/Bay_City_Capital>,
        <https://1145.am/db/2367022/Bay_City_Capital>,
        <https://1145.am/db/2367023/Bay_City_Capital>,
        <https://1145.am/db/2367026/Bay_City_Capital>,
        <https://1145.am/db/2583466/Bay_City_Capital>,
        <https://1145.am/db/2588372/Bay_City_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357333/Pharmalink> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Sweden" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:basedInHighRaw "Sweden" ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:description "orphan and niche products",
        "pharmaceutical research" ;
    ns1:documentDate "2013-10-04T13:02:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PHARMALINK RAISES SEK96 MILLION TO UNDERTAKE PIVOTAL STUDIES WITH LEAD PROGRAMS IN CANCER THERAPY AND RENAL DISEASE" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pharmalink-raises-sek96-million-to-undertake-pivotal-studies-lead-programs-cancer-therapy> ;
    ns1:foundName "PHARMALINK",
        "Pharmalink AB" ;
    ns1:industry "Pharmaceutical",
        "pharma" ;
    ns1:name "PHARMALINK",
        "Pharmalink" ;
    ns1:sameAsHigh <https://1145.am/db/101025/Scpharmaceuticals_Inc>,
        <https://1145.am/db/101329/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1031042/Intomics>,
        <https://1145.am/db/1033561/Hs_Pharmaceuticals>,
        <https://1145.am/db/1054457/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/1054503/Hs_Pharmaceuticals>,
        <https://1145.am/db/1061901/Pharmaessentia_Corporation>,
        <https://1145.am/db/1070158/Biognosys>,
        <https://1145.am/db/1079560/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1080385/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1092000/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/11010/Progenics_Pharmaceuticals>,
        <https://1145.am/db/1104169/20045078>,
        <https://1145.am/db/1118439/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1141704/Inmed_Pharmaceuticals>,
        <https://1145.am/db/1174705/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1176480/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1185008/TDV>,
        <https://1145.am/db/1186876/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1216583/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1291286/Vital_Pharmaceuticals_Inc>,
        <https://1145.am/db/1294499/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1294506/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1295948/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1296487/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1307419/X4_Pharmaceuticals>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1329779/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1339033/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1343020/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/1370859/Bioivt>,
        <https://1145.am/db/1371279/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1387773/Aspire_Pharma>,
        <https://1145.am/db/1390741/Nexus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1409143/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417723/Altasciences>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443334/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443968/Pharmajet>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1487706/Phathom_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497210/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Indivior_Plc>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Indivior_Plc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1505968/Escient_Pharmaceuticals>,
        <https://1145.am/db/1508407/Escient_Pharmaceuticals>,
        <https://1145.am/db/1515279/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1520596/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1520597/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521624/Scpharmaceuticals>,
        <https://1145.am/db/1521695/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521941/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1523220/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1533327/Escient_Pharmaceuticals>,
        <https://1145.am/db/1533685/Escient_Pharmaceuticals>,
        <https://1145.am/db/1537336/Pharmajet>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1548955/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1557072/Essential_Pharma>,
        <https://1145.am/db/1559882/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1571078/Organon>,
        <https://1145.am/db/1585097/Scpharmaceuticals_Inc>,
        <https://1145.am/db/158742/Biogen_Inc>,
        <https://1145.am/db/1595580/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1613688/Pharmalex>,
        <https://1145.am/db/1624479/Indivior_Plc>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Indivior_Plc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/1632411/Scipher_Medicine>,
        <https://1145.am/db/1632862/Scipher_Medicine>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1680583/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/1687234/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/180589/Servier>,
        <https://1145.am/db/1955684/Eip_Pharma_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2038168/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039291/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039678/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2045820/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2049603/Inova_Pharmaceuticals>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2062156/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2066480/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2071248/Biogen>,
        <https://1145.am/db/2074741/Biogen_Inc>,
        <https://1145.am/db/2092442/Leo_Pharma>,
        <https://1145.am/db/2093802/Meitheal_Pharmaceuticals>,
        <https://1145.am/db/2100253/Biogen_Inc>,
        <https://1145.am/db/2101006/Leo_Pharma_A_S>,
        <https://1145.am/db/2138834/Altasciences>,
        <https://1145.am/db/2151781/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152434/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2153727/Amunix_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154118/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155006/Medicines_Company>,
        <https://1145.am/db/2155312/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155622/Isa_Pharmaceuticals>,
        <https://1145.am/db/2155792/Ucb_Pharma>,
        <https://1145.am/db/2155798/Ucb_Pharma>,
        <https://1145.am/db/2155994/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2198945/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2201094/Pharmadeals_Ltd>,
        <https://1145.am/db/2204969/Organon_Biosciences>,
        <https://1145.am/db/2207034/Cequent_Pharmaceuticals>,
        <https://1145.am/db/221697/Gw_Pharmaceuticals>,
        <https://1145.am/db/2217819/Pharmacopeia>,
        <https://1145.am/db/221787/Gw_Pharmaceuticals>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2224859/Biologics>,
        <https://1145.am/db/2229191/Biologics>,
        <https://1145.am/db/2279276/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2279648/Organon>,
        <https://1145.am/db/2280123/Casi_Pharmaceuticals>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2283570/Pherin_Pharmaceuticals>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285117/Immedica>,
        <https://1145.am/db/2285495/Bioivt>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2287505/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2287572/T3_Pharmaceuticals>,
        <https://1145.am/db/2288192/Servier>,
        <https://1145.am/db/2290842/X4_Pharmaceuticals>,
        <https://1145.am/db/2291791/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2294547/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2294570/Pharmatek>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2297534/Bio>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2299414/Biogen>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2301718/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2301735/Idera_Pharmaceuticals>,
        <https://1145.am/db/2301764/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302275/Map_Pharmaceuticals>,
        <https://1145.am/db/2302426/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302431/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2302574/Via_Pharmaceuticals>,
        <https://1145.am/db/2302579/Via_Pharmaceuticals>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2302658/Biotie>,
        <https://1145.am/db/2302707/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2302774/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302779/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302890/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2302897/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303121/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303131/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303182/Pharmexa>,
        <https://1145.am/db/2303208/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2303792/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2304044/Novamed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304097/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2304135/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2304610/Pharmos_Corp>,
        <https://1145.am/db/2304745/Critical_Pharmaceuticals>,
        <https://1145.am/db/2304831/Pharmion_Corporation>,
        <https://1145.am/db/2304934/Medicure>,
        <https://1145.am/db/2304985/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2305742/Mh_Pharma_Uk>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2305927/Entremed>,
        <https://1145.am/db/2305956/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2306299/Verily>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2307239/Pharmaxis_Ltd>,
        <https://1145.am/db/2307246/Pharmaxis>,
        <https://1145.am/db/2307254/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2307651/Organon>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307871/Access_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2308446/Pharmathene>,
        <https://1145.am/db/2308922/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308964/Slate_Pharmaceuticals>,
        <https://1145.am/db/2309001/Biocon>,
        <https://1145.am/db/2309301/Inc>,
        <https://1145.am/db/2309923/Diasome_Pharmaceuticals>,
        <https://1145.am/db/2310002/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2310002/Map_Pharmaceuticals>,
        <https://1145.am/db/2310045/Slate_Pharmaceuticals>,
        <https://1145.am/db/2310071/Encysive_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310200/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2310219/Docpharma>,
        <https://1145.am/db/2310232/Genaissance_Pharmaceuticals>,
        <https://1145.am/db/2310471/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/2310473/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310476/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2310480/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310790/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310993/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2311166/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2311202/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311217/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2311264/Medicure>,
        <https://1145.am/db/2311726/Inc>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312193/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2312344/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2312416/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2312476/Nps_Pharmaceuticals>,
        <https://1145.am/db/2312479/Nps_Pharmaceuticals>,
        <https://1145.am/db/2313305/Tetraphase_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313306/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313320/Ore_Pharmaceuticals>,
        <https://1145.am/db/2313323/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2313527/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2313528/Us_Pharmaceutical_Company>,
        <https://1145.am/db/2314217/Sciele_Pharma>,
        <https://1145.am/db/2314271/Biomarck_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2314277/Biomarck_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314375/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2314816/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314837/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2315159/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2315192/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315485/Polpharma>,
        <https://1145.am/db/2315571/Sciele_Pharma>,
        <https://1145.am/db/2315624/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315624/Pharmos>,
        <https://1145.am/db/2315925/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316239/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2316418/Pharmaventures_Ltd>,
        <https://1145.am/db/2316435/Pharmaventures_Ltd>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317337/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2317635/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2317762/Pharmathene>,
        <https://1145.am/db/2317826/Anormed>,
        <https://1145.am/db/2317826/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2317842/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317895/Esprit_Pharma>,
        <https://1145.am/db/2317929/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2318105/Pharma_Inc>,
        <https://1145.am/db/2318114/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318248/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318285/Pht_Corporation>,
        <https://1145.am/db/2318469/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2318554/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318574/Idera_Pharmaceuticals>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318743/Pharmos_Corporation>,
        <https://1145.am/db/2318808/Pharmathene>,
        <https://1145.am/db/2318986/Corgentech>,
        <https://1145.am/db/2318994/Cornerstone_Biopharma>,
        <https://1145.am/db/2319208/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319687/Advisys>,
        <https://1145.am/db/2319790/Pharmacyclics>,
        <https://1145.am/db/2319806/Satori_Pharmaceuticals>,
        <https://1145.am/db/2319809/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320009/Map_Pharmaceuticals>,
        <https://1145.am/db/2320025/Am-Pharma>,
        <https://1145.am/db/2320025/Esprit_Pharma>,
        <https://1145.am/db/2320461/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320767/Via_Pharmaceuticals>,
        <https://1145.am/db/2320903/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2320949/Medicines_Company>,
        <https://1145.am/db/2321148/Savient_Pharmaceuticals>,
        <https://1145.am/db/2321157/Access_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321565/2009-2010>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2321860/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2321871/Astion_Pharma>,
        <https://1145.am/db/2321899/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2322135/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322235/Pharmacopeia>,
        <https://1145.am/db/2322291/Polpharma>,
        <https://1145.am/db/2322481/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322632/Savient_Pharmaceuticals>,
        <https://1145.am/db/2322942/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2322953/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2323173/Pharmacopeia>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323225/Arqule>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323358/Organon_Biosciences>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2324024/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2324243/Arqule>,
        <https://1145.am/db/2324417/Biomimetic_Pharmaceuticals>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2324838/Biogen>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2325725/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326025/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2326148/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2326286/Idera_Pharmaceuticals>,
        <https://1145.am/db/2326403/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2326466/Macromed>,
        <https://1145.am/db/2326474/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327450/York_Pharma>,
        <https://1145.am/db/2327480/Transdel_Pharmaceuticals>,
        <https://1145.am/db/2327649/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2327849/Pharmacia_Corporation>,
        <https://1145.am/db/2328043/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/2328220/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2328222/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2328616/Map_Pharmaceuticals>,
        <https://1145.am/db/2328650/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2328729/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2328988/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2328990/Mdrna>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329309/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2329643/Pharmaceuticals_Inc>,
        <https://1145.am/db/2329756/Provid_Pharmaceuticals>,
        <https://1145.am/db/2329814/Map_Pharmaceuticals>,
        <https://1145.am/db/2329816/Map_Pharmaceuticals>,
        <https://1145.am/db/2330057/Pharmathene>,
        <https://1145.am/db/2330086/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330094/Idera_Pharmaceuticals>,
        <https://1145.am/db/2330207/Bioxell>,
        <https://1145.am/db/2330207/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2330534/Pharmion>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330667/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330880/Access_Pharmaceuticals>,
        <https://1145.am/db/2330880/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330989/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331745/Elan_Pharmaceuticals>,
        <https://1145.am/db/2331756/Pro-Pharmaceuticals>,
        <https://1145.am/db/2331875/Bioalliance_Pharma>,
        <https://1145.am/db/2332473/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2332596/Esprit_Pharma>,
        <https://1145.am/db/2332777/S_*_Bio>,
        <https://1145.am/db/2332974/Osi_Pharmaceuticals>,
        <https://1145.am/db/2332980/Pharmos_Corporation>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333569/Ception>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2334034/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2334119/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334121/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334183/Idera_Pharmaceuticals>,
        <https://1145.am/db/2335077/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336160/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2336293/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2336378/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336442/Bionor_Pharma_Asa>,
        <https://1145.am/db/2336452/Pharmaxis_Ltd>,
        <https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336506/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2336524/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336934/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337345/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337348/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2337547/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2338390/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338401/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2338430/Pharmacyclics>,
        <https://1145.am/db/2338551/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2338877/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339019/Isa_Pharmaceuticals_Bv>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2339570/Map_Pharmaceuticals>,
        <https://1145.am/db/2339718/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2339727/Pharmacyclics_Inc>,
        <https://1145.am/db/2339787/Pharmalink_Ab>,
        <https://1145.am/db/2339892/Pharmacyclics>,
        <https://1145.am/db/2339907/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2339910/Biomed_Pharmaceuticals>,
        <https://1145.am/db/2339922/Pharmaform>,
        <https://1145.am/db/2339979/Theravance>,
        <https://1145.am/db/2340000/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340224/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340291/Pharmasset>,
        <https://1145.am/db/2340373/Nps_Pharmaceuticals>,
        <https://1145.am/db/2340431/Savient_Pharmaceuticals>,
        <https://1145.am/db/2341523/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2341742/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2341752/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341998/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342469/Pharmadel>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342800/Pharmathene>,
        <https://1145.am/db/2342805/Pharmathene>,
        <https://1145.am/db/2342918/Pharmalink_Ab>,
        <https://1145.am/db/2343264/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2343277/Pharmasset>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2343837/Medicines_Co>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344011/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344076/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344079/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344131/Pharmascience_Inc>,
        <https://1145.am/db/2344207/Entremed>,
        <https://1145.am/db/2344624/Pharmagen_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344739/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344939/Theravance>,
        <https://1145.am/db/2344955/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2345106/Map_Pharmaceuticals>,
        <https://1145.am/db/2345474/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345902/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346542/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2346800/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346807/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2346951/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346964/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2347127/Pharmacyte_Biotech>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347227/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2347272/Pharmascience>,
        <https://1145.am/db/2347519/Pharmadeals_Ltd>,
        <https://1145.am/db/2347644/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347648/Pharminox_Limited>,
        <https://1145.am/db/2347659/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347982/Epicept>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348506/Am-Pharma_Bv>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348763/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2348864/Vital_Science_Corp>,
        <https://1145.am/db/2349103/Biota_Pharmaceuticals>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349348/R-Pharm>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349965/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350852/Isa_Pharmaceuticals>,
        <https://1145.am/db/2351091/Biomotiv>,
        <https://1145.am/db/2351471/Mymetics_Corporation>,
        <https://1145.am/db/2351818/Biocon>,
        <https://1145.am/db/2352046/Costim_Pharmaceuticals>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352177/Theravance_Inc>,
        <https://1145.am/db/2352180/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2352333/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2352538/Biota_Pharmaceuticals>,
        <https://1145.am/db/2352659/Nps_Pharmaceuticals>,
        <https://1145.am/db/2352784/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2352805/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2352808/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353006/Radient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353093/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353098/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353254/Pharma_Inc>,
        <https://1145.am/db/2353262/Sound_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2353364/Am-Pharma>,
        <https://1145.am/db/2353651/Pharmathene>,
        <https://1145.am/db/2353668/Biotie>,
        <https://1145.am/db/2354002/N30_Pharmaceuticals>,
        <https://1145.am/db/2354062/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354064/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354083/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354086/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354124/Uk>,
        <https://1145.am/db/2354146/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2354376/Aspireo_Pharmaceuticals>,
        <https://1145.am/db/2354380/Pharmaxis>,
        <https://1145.am/db/2354388/Pharmaxis>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354406/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354804/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2354836/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2355099/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355109/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355324/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355678/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2355721/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2355884/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355941/Theratechnologies>,
        <https://1145.am/db/2355974/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2356294/Company>,
        <https://1145.am/db/2356294/Inc>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2357329/Pharmalink_Ab>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357636/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2358047/Entremed>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358732/Osi_Pharmaceuticals>,
        <https://1145.am/db/2358877/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359266/D-Pharm>,
        <https://1145.am/db/2359401/Scpharmaceuticals_Inc>,
        <https://1145.am/db/2359438/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2359474/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359668/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2359882/Biotie>,
        <https://1145.am/db/2359926/Entremed>,
        <https://1145.am/db/2360155/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2360588/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360697/Medgenics>,
        <https://1145.am/db/2360739/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2360945/Entremed>,
        <https://1145.am/db/2361244/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2361516/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2362593/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363186/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363285/Phenex_Pharmaceuticals_Ag>,
        <https://1145.am/db/2363340/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2363452/Pharmasum_Therapeutics_As>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2363955/Savient_Pharmaceuticals>,
        <https://1145.am/db/2364093/Biotie>,
        <https://1145.am/db/2364252/Nps_Pharmaceuticals>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364276/S_*_Bio>,
        <https://1145.am/db/2364494/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2364495/Bioalliance_Pharma>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364541/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2364585/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364593/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364601/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364774/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364884/Entremed_Inc>,
        <https://1145.am/db/2365030/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2365098/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365224/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2365423/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2365724/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365763/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2366139/Prism_Pharmaceuticals>,
        <https://1145.am/db/2366388/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366521/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367021/Biotie>,
        <https://1145.am/db/2367070/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2367280/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2367483/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367496/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367951/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2367962/Catalyst_Pharmaceuticals>,
        <https://1145.am/db/2368070/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2368339/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2368420/Intec_Pharma>,
        <https://1145.am/db/2368593/Bioquiddity_Incorporated>,
        <https://1145.am/db/2368632/Pharmacyclics>,
        <https://1145.am/db/2368739/Novartis_Pharmaceuticals>,
        <https://1145.am/db/2368826/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369004/Biogen>,
        <https://1145.am/db/2369037/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369144/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369233/Biopharmx_Corporation>,
        <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2369812/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2369931/Biogen>,
        <https://1145.am/db/2370022/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2370078/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2370082/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2370089/Abide_Therapeutics>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370637/Medgenics_Inc>,
        <https://1145.am/db/2370797/Pharmanest>,
        <https://1145.am/db/2370798/Pharmalink_Ab>,
        <https://1145.am/db/2370946/Biogen>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2371279/Biomunex_Pharmaceuticals>,
        <https://1145.am/db/2371491/Biopharmx_Corporation>,
        <https://1145.am/db/2536754/Oramed_Pharma>,
        <https://1145.am/db/2536756/Zao>,
        <https://1145.am/db/2537468/Pharmascience_Inc>,
        <https://1145.am/db/2538171/Biomeda_Group>,
        <https://1145.am/db/2538567/Upm_Pharmaceuticals>,
        <https://1145.am/db/2538861/Par_Pharmaceuticals>,
        <https://1145.am/db/2538901/The_Harvard_Drug_Group>,
        <https://1145.am/db/2539516/Par_Pharmaceuticals>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2540193/Pharmanest>,
        <https://1145.am/db/2540449/Biocon>,
        <https://1145.am/db/2540951/Rytary>,
        <https://1145.am/db/2541039/Elan_Pharmaceuticals>,
        <https://1145.am/db/2541239/Pharmstar>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541717/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2541810/British_Pharma>,
        <https://1145.am/db/2542218/Pharmacyclics>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544111/Unique_Pharmaceuticals>,
        <https://1145.am/db/2544358/Mundipharma>,
        <https://1145.am/db/2544596/Polpharma>,
        <https://1145.am/db/2544679/Neopharma>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2545143/Mundipharma>,
        <https://1145.am/db/2545411/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2546441/Intas_Pharmaceuticals>,
        <https://1145.am/db/2546529/Pharma_Tech_Industries>,
        <https://1145.am/db/2546629/Par_Pharmaceutical>,
        <https://1145.am/db/2547189/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2548585/Par_Pharmaceuticals>,
        <https://1145.am/db/2548674/Sopharma>,
        <https://1145.am/db/2549477/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2549520/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2549919/Pharmathen>,
        <https://1145.am/db/2550212/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2550471/Pharmaform>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2550685/Upm_Pharmaceuticals>,
        <https://1145.am/db/2551427/Pharmablock_Sciences>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552169/Alembic_Pharmaceuticals>,
        <https://1145.am/db/2552465/Medis>,
        <https://1145.am/db/2552641/Plethico_Pharmaceuticals>,
        <https://1145.am/db/2552642/Mankind_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552794/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553276/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553512/Pharmax_Pharmaceuticals>,
        <https://1145.am/db/2553708/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2554237/Intas_Pharmaceuticals>,
        <https://1145.am/db/2554810/Continuus_Pharmaceuticals>,
        <https://1145.am/db/2554814/Globalpharma>,
        <https://1145.am/db/2554858/Medicure_Usa_Inc>,
        <https://1145.am/db/2555338/Pharmacore>,
        <https://1145.am/db/2555890/Pharmalucence>,
        <https://1145.am/db/2555896/Pharmalucence>,
        <https://1145.am/db/2556805/Medicis_Pharmaceuticals>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2557538/Neopharma>,
        <https://1145.am/db/2558025/Pharmaxis>,
        <https://1145.am/db/2558026/Pharmaxis>,
        <https://1145.am/db/2558970/Biostar_Pharmaceuticals>,
        <https://1145.am/db/2559783/Polpharma>,
        <https://1145.am/db/2560083/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561100/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561312/Oxford_Pharmaceuticals>,
        <https://1145.am/db/2561438/Pharmacia___Upjohn>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2562199/Novartis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562500/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2563255/Active_Pharmaceutical_Ingredients>,
        <https://1145.am/db/2563497/Creo_Pharmaceuticals>,
        <https://1145.am/db/2563497/Polpharma>,
        <https://1145.am/db/2564196/Pharmaron>,
        <https://1145.am/db/2564713/C2_Pharma>,
        <https://1145.am/db/2567007/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2567055/Sovereign_Pharmaceuticals>,
        <https://1145.am/db/2567283/The_Pharma_Giant>,
        <https://1145.am/db/2567438/Biogen>,
        <https://1145.am/db/2567651/Indivior>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2568205/Biogen>,
        <https://1145.am/db/2568375/Biogen>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569187/Pharmacyclics>,
        <https://1145.am/db/2569370/Co>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570068/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2570289/Pharmacyclics>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570449/Biocon>,
        <https://1145.am/db/2570741/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2572200/The_Medicines_Company>,
        <https://1145.am/db/2572870/Hi-Tech_Pharmaceuticals>,
        <https://1145.am/db/2573057/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2573058/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2573147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2573271/Physician_Therapeutics>,
        <https://1145.am/db/2573391/Url_Pharma>,
        <https://1145.am/db/2573392/Url_Pharma>,
        <https://1145.am/db/2573887/Biogen>,
        <https://1145.am/db/2574679/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2574891/Pharmacyclics>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2575242/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2575462/Paras_Pharmaceuticals>,
        <https://1145.am/db/2575623/Inova_Pharmaceuticals>,
        <https://1145.am/db/2576205/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577145/Medicis_Pharmaceutical>,
        <https://1145.am/db/2577259/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals>,
        <https://1145.am/db/2577675/Biogen>,
        <https://1145.am/db/2577684/Biogen>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2577934/Pharmascience>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578319/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2578473/Aa_Pharma>,
        <https://1145.am/db/2578481/Aa_Pharma_Inc>,
        <https://1145.am/db/2579147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2579211/Eusa_Pharma>,
        <https://1145.am/db/2579538/Pharmaforce>,
        <https://1145.am/db/2580123/Savient_Pharmaceuticals>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2581225/Inova_Pharmaceuticals>,
        <https://1145.am/db/2582110/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582153/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2582174/Pharmasset>,
        <https://1145.am/db/2582320/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2583013/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583022/Url_Pharma>,
        <https://1145.am/db/2583220/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2583270/Pharmaswiss>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583402/Osi_Pharmaceuticals>,
        <https://1145.am/db/2583414/Polpharma>,
        <https://1145.am/db/2583769/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2584209/Pharmaswiss_Sa>,
        <https://1145.am/db/2584226/Pharmaswiss_Sa>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2585281/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2585887/Pharma_Inc>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587155/Millennium_Pharma>,
        <https://1145.am/db/2587616/Pharmaq>,
        <https://1145.am/db/2587696/R-Pharm>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588718/Pharmacyclics>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2589884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590159/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2590409/Biogen>,
        <https://1145.am/db/2590910/Savient_Pharmaceuticals>,
        <https://1145.am/db/2591540/Polpharma>,
        <https://1145.am/db/2591690/Medicis_Pharmaceutical>,
        <https://1145.am/db/2591938/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2593142/Access_Pharmaceuticals>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594042/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594116/Pharmerica>,
        <https://1145.am/db/2594602/Osi_Pharma>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595190/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595210/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595413/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596307/Savient_Pharmaceuticals>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596369/Pharmadeals_Ltd>,
        <https://1145.am/db/2596818/Pharmasset>,
        <https://1145.am/db/2597158/Nps_Pharmaceuticals>,
        <https://1145.am/db/2597180/Prism_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2597935/Osi_Pharmaceuticals>,
        <https://1145.am/db/2598027/Nps_Pharmaceuticals>,
        <https://1145.am/db/2598099/Paras_Pharmaceuticals>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598195/Pharmatech>,
        <https://1145.am/db/2598605/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2765310/Biogen>,
        <https://1145.am/db/281576/Mymd_Pharmaceuticals>,
        <https://1145.am/db/307255/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/324642/Mundipharma>,
        <https://1145.am/db/367137/Biomat>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/380389/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/407888/Quoin_Pharmaceuticals>,
        <https://1145.am/db/410129/Catalyst_Pharmaceuticals_Inc>,
        <https://1145.am/db/427157/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/431169/Pharmablock>,
        <https://1145.am/db/4491/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/452957/Aerie_Pharmaceuticals>,
        <https://1145.am/db/468221/Aerie_Pharmaceuticals>,
        <https://1145.am/db/481129/Biocon_Ltd>,
        <https://1145.am/db/485351/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/486302/Phathom_Pharmaceuticals>,
        <https://1145.am/db/487010/Scipher_Medicine>,
        <https://1145.am/db/488564/Aerie_Pharmaceuticals>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538112/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/545583/Citius_Pharmaceuticals>,
        <https://1145.am/db/546391/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/567789/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/585607/Am-Pharma>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/662016/Prestige_Biopharma_Limited>,
        <https://1145.am/db/668495/Scipher_Medicine>,
        <https://1145.am/db/669775/Scipher_Medicine>,
        <https://1145.am/db/693128/Ascensus_Specialties>,
        <https://1145.am/db/700482/Novartis_Pharmaceuticals>,
        <https://1145.am/db/712037/Amunix_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/713105/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713736/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/714923/Betterlife_Pharma_Inc>,
        <https://1145.am/db/715385/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/718008/Pharnext_Sa>,
        <https://1145.am/db/723883/Mymd_Pharmaceuticals>,
        <https://1145.am/db/724999/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/734669/Escient_Pharmaceuticals>,
        <https://1145.am/db/742794/Hr_Pharmaceuticals_Inc>,
        <https://1145.am/db/771062/Gw_Pharmaceuticals>,
        <https://1145.am/db/793071/Biogen_Inc>,
        <https://1145.am/db/835485/Pharmaessentia_Corporation>,
        <https://1145.am/db/854026/Aerie_Pharmaceuticals>,
        <https://1145.am/db/883896/Biontech>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/887575/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/889331/Tha_Pharma>,
        <https://1145.am/db/912469/Aerie_Pharmaceuticals>,
        <https://1145.am/db/913730/Aerie_Pharmaceuticals>,
        <https://1145.am/db/922740/Grand_Pharma>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357333/Series_C_Investment_Industrifonden_Investinor_Pharmalink_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-04T13:02:55+00:00"^^xsd:dateTime ;
    ns1:documentExtract "PHARMALINK RAISES SEK96 MILLION TO UNDERTAKE PIVOTAL STUDIES WITH LEAD PROGRAMS IN CANCER THERAPY AND RENAL DISEASE.",
        "Pharmalink AB, a specialty pharma company focused on orphan and niche products, today announces it has raised SEK96 million (11m / US $ 15m) in a Series C financing round." ;
    ns1:documentTitle "PHARMALINK RAISES SEK96 MILLION TO UNDERTAKE PIVOTAL STUDIES WITH LEAD PROGRAMS IN CANCER THERAPY AND RENAL DISEASE" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pharmalink-raises-sek96-million-to-undertake-pivotal-studies-lead-programs-cancer-therapy> ;
    ns1:foundName "RAISES",
        "financing",
        "raised" ;
    ns1:name "RAISES",
        "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2357333/Pharmalink> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "SEK96 MILLION",
        "SEK96 million",
        "US $ 15m",
        "11m" ;
    ns1:whereGeoName "Kingdom of Sweden" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:whereRaw "Sweden" .

<https://1145.am/db/2358297/Gamida_Cell_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2014-03-18T12:36:59+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Israel's Globes is reporting that Novartis is pursuing a deal to buy out Israel's Gamida Cell for \"hundreds of millions\" of dollars upfront and hundreds of millions more in milestones, adding up to a total of about $ 600 million." ;
    ns1:documentTitle "Report: Novartis circles a deal to buy Gamida Cell in $600M deal" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/report-novartis-circles-a-deal-to-buy-gamida-cell-600m-deal> ;
    ns1:foundName "acquisition",
        "buy out" ;
    ns1:name "acquisition",
        "buy out" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2358297/Gamida_Cell> ;
    ns1:targetName "Gamida Cell" ;
    ns1:valueRaw "\"hundreds of millions",
        "about $ 600 million",
        "hundreds of millions",
        "of dollars" ;
    ns1:whereGeoName "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Israel" .

<https://1145.am/db/2476855/Merger_Meyer-Franklin_Travel_Worldview_Travel_Worldview_Travel_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2013-09-05T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Worldview Travel, headquartered in Santa Ana, California, with branches across the U.S. and Canada, will merge Meyer-Franklin Travel with Worldview Travel Bermuda (formerly C Travel) ." ;
    ns1:documentTitle "Worldview Travel Acquires Bermuda-Based Meyer-Franklin Travel" ;
    ns1:documentURL <https://www.travelagentcentral.com/running-your-business/worldview-travel-acquires-bermuda-based-meyer-franklin-travel> ;
    ns1:foundName "merge" ;
    ns1:name "merge" ;
    ns1:sourceName "Travel Agent Central" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Bermuda" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3573345/about.rdf> ;
    ns1:whereRaw "Bermuda" .

<https://1145.am/db/2476855/Meyer-Franklin_Travel_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2013-09-05T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Worldview Travel has announced the acquisition of Meyer-Franklin Travel in Bermuda.",
        "Worldview Travel, headquartered in Santa Ana, California, with branches across the U.S. and Canada, will merge Meyer-Franklin Travel with Worldview Travel Bermuda (formerly C Travel) ." ;
    ns1:documentTitle "Worldview Travel Acquires Bermuda-Based Meyer-Franklin Travel" ;
    ns1:documentURL <https://www.travelagentcentral.com/running-your-business/worldview-travel-acquires-bermuda-based-meyer-franklin-travel> ;
    ns1:foundName "acquisition",
        "merge" ;
    ns1:name "acquisition",
        "merge" ;
    ns1:sourceName "Travel Agent Central" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2476855/Meyer-Franklin_Travel> ;
    ns1:targetName "Meyer-Franklin Travel" ;
    ns1:whereGeoName "Bermuda" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3573345/about.rdf> ;
    ns1:whereRaw "Bermuda" .

<https://1145.am/db/2544488/Gland_Pharma> a org:Organization ;
    ns1:basedInHighGeoName "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:basedInHighRaw "India" ;
    ns1:description "manufactures heparin and some other products" ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "Gland Pharma" ;
    ns1:industry "Pharma" ;
    ns1:name "Gland Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1539584/Gland_Pharma>,
        <https://1145.am/db/1540074/Gland_Pharma_Ltd>,
        <https://1145.am/db/1981788/Gland_Pharma_Ltd>,
        <https://1145.am/db/2540502/Gland_Pharma>,
        <https://1145.am/db/2540508/Gland_Pharma>,
        <https://1145.am/db/2541368/Gland_Pharma>,
        <https://1145.am/db/2545444/Gland_Pharma>,
        <https://1145.am/db/2552191/Gland_Pharma>,
        <https://1145.am/db/2555291/Gland_Pharma>,
        <https://1145.am/db/2555342/Gland_Pharma>,
        <https://1145.am/db/2563847/Gland_Pharma>,
        <https://1145.am/db/2563850/Gland_Pharma>,
        <https://1145.am/db/2565596/Gland_Pharma>,
        <https://1145.am/db/2573232/Gland_Pharma>,
        <https://1145.am/db/2594867/Gland_Pharma>,
        <https://1145.am/db/2594877/Gland_Pharma>,
        <https://1145.am/db/2597465/Gland_Pharma>,
        <https://1145.am/db/2748691/Gland_Pharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2544488/KKR> a org:Organization ;
    ns1:basedInLowRaw "India" ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "KKR" ;
    ns1:industry "investment firm" ;
    ns1:investor <https://1145.am/db/2544488/Gland_Pharma_Stake_Investment> ;
    ns1:name "KKR" ;
    ns1:sameAsHigh <https://1145.am/db/1015212/KKR>,
        <https://1145.am/db/1016588/KKR>,
        <https://1145.am/db/1051390/KKR>,
        <https://1145.am/db/1055774/KKR>,
        <https://1145.am/db/1061971/KKR>,
        <https://1145.am/db/1063827/KKR>,
        <https://1145.am/db/1064625/KKR>,
        <https://1145.am/db/1068387/KKR>,
        <https://1145.am/db/1083078/KKR>,
        <https://1145.am/db/1113018/KKR>,
        <https://1145.am/db/1118091/KKR>,
        <https://1145.am/db/1160033/KKR>,
        <https://1145.am/db/1160920/KKR>,
        <https://1145.am/db/1190440/KKR>,
        <https://1145.am/db/1192098/KKR>,
        <https://1145.am/db/1192924/KKR>,
        <https://1145.am/db/1215547/KKR>,
        <https://1145.am/db/1215996/KKR>,
        <https://1145.am/db/1229887/KKR>,
        <https://1145.am/db/1230736/KKR>,
        <https://1145.am/db/1247887/KKR>,
        <https://1145.am/db/1248726/KKR>,
        <https://1145.am/db/1250422/KKR>,
        <https://1145.am/db/1260722/KKR>,
        <https://1145.am/db/1263937/KKR>,
        <https://1145.am/db/1264568/KKR>,
        <https://1145.am/db/1270094/KKR>,
        <https://1145.am/db/1281471/KKR>,
        <https://1145.am/db/1285688/KKR>,
        <https://1145.am/db/1294469/KKR>,
        <https://1145.am/db/1295782/KKR>,
        <https://1145.am/db/1310687/KKR>,
        <https://1145.am/db/1354162/Kkr___Co_Inc>,
        <https://1145.am/db/1364/Kkr___Co>,
        <https://1145.am/db/1381518/KKR>,
        <https://1145.am/db/1397716/KKR>,
        <https://1145.am/db/1399415/KKR>,
        <https://1145.am/db/1436822/KKR>,
        <https://1145.am/db/1438103/KKR>,
        <https://1145.am/db/1438344/Kkr___Co_Inc>,
        <https://1145.am/db/1449022/KKR>,
        <https://1145.am/db/1449914/KKR>,
        <https://1145.am/db/1452259/KKR>,
        <https://1145.am/db/1452519/KKR>,
        <https://1145.am/db/1455940/KKR>,
        <https://1145.am/db/1473068/KKR>,
        <https://1145.am/db/1475136/KKR>,
        <https://1145.am/db/1476460/KKR>,
        <https://1145.am/db/1495463/KKR>,
        <https://1145.am/db/1496959/KKR>,
        <https://1145.am/db/1506577/KKR>,
        <https://1145.am/db/1509288/KKR>,
        <https://1145.am/db/1512558/KKR>,
        <https://1145.am/db/152934/KKR>,
        <https://1145.am/db/1546202/KKR>,
        <https://1145.am/db/1547814/KKR>,
        <https://1145.am/db/1554054/KKR>,
        <https://1145.am/db/1555857/KKR>,
        <https://1145.am/db/1590538/KKR>,
        <https://1145.am/db/1591345/KKR>,
        <https://1145.am/db/1591763/KKR>,
        <https://1145.am/db/1648448/KKR>,
        <https://1145.am/db/1649860/KKR>,
        <https://1145.am/db/1649938/KKR>,
        <https://1145.am/db/1651830/KKR>,
        <https://1145.am/db/1658552/Kkr___Co_Inc>,
        <https://1145.am/db/1658979/KKR>,
        <https://1145.am/db/1666847/KKR>,
        <https://1145.am/db/1668839/KKR>,
        <https://1145.am/db/1680087/Kkr_Inc>,
        <https://1145.am/db/1680588/KKR>,
        <https://1145.am/db/1688398/KKR>,
        <https://1145.am/db/1693484/KKR>,
        <https://1145.am/db/171093/KKR>,
        <https://1145.am/db/1712/Kkr___Co>,
        <https://1145.am/db/172769/KKR>,
        <https://1145.am/db/173791/KKR>,
        <https://1145.am/db/1749189/KKR>,
        <https://1145.am/db/1755085/KKR>,
        <https://1145.am/db/1757984/KKR>,
        <https://1145.am/db/1760592/KKR>,
        <https://1145.am/db/1789551/KKR>,
        <https://1145.am/db/1822745/KKR>,
        <https://1145.am/db/1845096/KKR>,
        <https://1145.am/db/1847465/Kohlberg_Kravis_Roberts>,
        <https://1145.am/db/1943233/KKR>,
        <https://1145.am/db/1947119/KKR>,
        <https://1145.am/db/194974/KKR>,
        <https://1145.am/db/1950829/KKR>,
        <https://1145.am/db/195311/KKR>,
        <https://1145.am/db/195381/KKR>,
        <https://1145.am/db/195385/KKR>,
        <https://1145.am/db/1961469/KKR>,
        <https://1145.am/db/1986543/KKR>,
        <https://1145.am/db/1990444/Kkr___Co_Inc>,
        <https://1145.am/db/1996605/KKR>,
        <https://1145.am/db/2000656/Kkr___Co_Inc>,
        <https://1145.am/db/2002801/KKR>,
        <https://1145.am/db/2008367/KKR>,
        <https://1145.am/db/2008433/Kkr___Co_Inc>,
        <https://1145.am/db/2023610/KKR>,
        <https://1145.am/db/2028313/KKR>,
        <https://1145.am/db/2043935/KKR>,
        <https://1145.am/db/2053511/KKR>,
        <https://1145.am/db/2057136/KKR>,
        <https://1145.am/db/2058954/KKR>,
        <https://1145.am/db/2066225/KKR>,
        <https://1145.am/db/2069371/KKR>,
        <https://1145.am/db/2073937/KKR>,
        <https://1145.am/db/2075344/KKR>,
        <https://1145.am/db/2078780/KKR>,
        <https://1145.am/db/2078827/Kkr___Co>,
        <https://1145.am/db/2079830/KKR>,
        <https://1145.am/db/2080109/KKR>,
        <https://1145.am/db/2085686/KKR>,
        <https://1145.am/db/2089461/KKR>,
        <https://1145.am/db/2097007/KKR>,
        <https://1145.am/db/2109787/KKR>,
        <https://1145.am/db/2113323/KKR>,
        <https://1145.am/db/2114093/KKR>,
        <https://1145.am/db/212359/KKR>,
        <https://1145.am/db/2124274/Kkr___Co>,
        <https://1145.am/db/212685/KKR>,
        <https://1145.am/db/2131893/KKR>,
        <https://1145.am/db/2132583/KKR>,
        <https://1145.am/db/2132959/KKR>,
        <https://1145.am/db/2135051/KKR>,
        <https://1145.am/db/2149115/KKR>,
        <https://1145.am/db/2186299/KKR>,
        <https://1145.am/db/2194895/KKR>,
        <https://1145.am/db/2290211/KKR>,
        <https://1145.am/db/2290727/KKR>,
        <https://1145.am/db/2300371/KKR>,
        <https://1145.am/db/2314081/KKR>,
        <https://1145.am/db/2315159/New_York-KKR>,
        <https://1145.am/db/2317339/KKR>,
        <https://1145.am/db/2330390/KKR>,
        <https://1145.am/db/2333983/Kohlberg_Kravis_Roberts>,
        <https://1145.am/db/2336420/KKR>,
        <https://1145.am/db/239551/KKR>,
        <https://1145.am/db/240235/Kkr___Co>,
        <https://1145.am/db/240501/Kkr___Co>,
        <https://1145.am/db/240691/KKR>,
        <https://1145.am/db/2429989/KKR>,
        <https://1145.am/db/2477137/KKR>,
        <https://1145.am/db/2477142/Kkr___Co>,
        <https://1145.am/db/2536699/Kohlberg_Kravis_Roberts>,
        <https://1145.am/db/2558515/KKR>,
        <https://1145.am/db/255858/KKR>,
        <https://1145.am/db/2560676/KKR>,
        <https://1145.am/db/2573232/KKR>,
        <https://1145.am/db/2591281/KKR>,
        <https://1145.am/db/2591917/KKR>,
        <https://1145.am/db/2594570/KKR>,
        <https://1145.am/db/2594867/KKR>,
        <https://1145.am/db/2637995/KKR>,
        <https://1145.am/db/2647818/Kohlberg_Kravis_Roberts___Co>,
        <https://1145.am/db/2651063/KKR>,
        <https://1145.am/db/2669352/Kohlberg_Kravis_Roberts___Co>,
        <https://1145.am/db/2686055/KKR>,
        <https://1145.am/db/2719490/KKR>,
        <https://1145.am/db/2721631/Kkr_And_Tiga_Investments>,
        <https://1145.am/db/2744046/Kohlberg_Kravis_Roberts>,
        <https://1145.am/db/2785212/KKR>,
        <https://1145.am/db/2786374/KKR>,
        <https://1145.am/db/2795258/KKR>,
        <https://1145.am/db/2795446/KKR>,
        <https://1145.am/db/2796864/KKR>,
        <https://1145.am/db/284837/KKR>,
        <https://1145.am/db/2891/Kkr_Deutsche_Bank>,
        <https://1145.am/db/299964/KKR>,
        <https://1145.am/db/306695/KKR>,
        <https://1145.am/db/315335/KKR>,
        <https://1145.am/db/315346/KKR>,
        <https://1145.am/db/319737/KKR>,
        <https://1145.am/db/322468/KKR>,
        <https://1145.am/db/322674/KKR>,
        <https://1145.am/db/322933/KKR>,
        <https://1145.am/db/334317/KKR>,
        <https://1145.am/db/336437/KKR>,
        <https://1145.am/db/337257/KKR>,
        <https://1145.am/db/338225/KKR>,
        <https://1145.am/db/344076/KKR>,
        <https://1145.am/db/346092/Kkr___Co>,
        <https://1145.am/db/346265/KKR>,
        <https://1145.am/db/346358/Kkr___Co>,
        <https://1145.am/db/346368/Kkr___Co>,
        <https://1145.am/db/346523/KKR>,
        <https://1145.am/db/347280/KKR>,
        <https://1145.am/db/357173/KKR>,
        <https://1145.am/db/3573/KKR>,
        <https://1145.am/db/371665/KKR>,
        <https://1145.am/db/377208/Kkr___Co_Inc>,
        <https://1145.am/db/388746/KKR>,
        <https://1145.am/db/409008/KKR>,
        <https://1145.am/db/429762/KKR>,
        <https://1145.am/db/432705/KKR>,
        <https://1145.am/db/433673/KKR>,
        <https://1145.am/db/444316/KKR>,
        <https://1145.am/db/456088/KKR>,
        <https://1145.am/db/461148/KKR>,
        <https://1145.am/db/463978/KKR>,
        <https://1145.am/db/464569/KKR>,
        <https://1145.am/db/474753/KKR>,
        <https://1145.am/db/514250/KKR>,
        <https://1145.am/db/515346/KKR>,
        <https://1145.am/db/523447/Kkr_And_Carlyle>,
        <https://1145.am/db/531779/KKR>,
        <https://1145.am/db/537800/KKR>,
        <https://1145.am/db/538125/Kkr___Co_Inc>,
        <https://1145.am/db/539290/KKR>,
        <https://1145.am/db/544684/KKR>,
        <https://1145.am/db/585991/KKR>,
        <https://1145.am/db/595003/KKR>,
        <https://1145.am/db/595062/KKR>,
        <https://1145.am/db/596244/KKR>,
        <https://1145.am/db/600948/KKR>,
        <https://1145.am/db/602304/KKR>,
        <https://1145.am/db/613807/KKR>,
        <https://1145.am/db/614524/KKR>,
        <https://1145.am/db/624410/KKR>,
        <https://1145.am/db/638312/KKR>,
        <https://1145.am/db/647441/KKR>,
        <https://1145.am/db/651358/KKR>,
        <https://1145.am/db/652863/KKR>,
        <https://1145.am/db/653953/KKR>,
        <https://1145.am/db/665505/KKR>,
        <https://1145.am/db/667263/KKR>,
        <https://1145.am/db/667997/KKR>,
        <https://1145.am/db/674055/KKR>,
        <https://1145.am/db/675103/KKR>,
        <https://1145.am/db/693816/KKR>,
        <https://1145.am/db/695839/KKR>,
        <https://1145.am/db/696425/KKR>,
        <https://1145.am/db/696885/KKR>,
        <https://1145.am/db/698056/KKR>,
        <https://1145.am/db/699689/Kkr___Co_Inc>,
        <https://1145.am/db/703846/KKR>,
        <https://1145.am/db/75900/KKR>,
        <https://1145.am/db/769166/KKR>,
        <https://1145.am/db/770078/KKR>,
        <https://1145.am/db/783138/KKR>,
        <https://1145.am/db/785008/KKR>,
        <https://1145.am/db/787319/KKR>,
        <https://1145.am/db/797358/KKR>,
        <https://1145.am/db/799510/KKR>,
        <https://1145.am/db/800916/KKR>,
        <https://1145.am/db/835332/KKR>,
        <https://1145.am/db/849227/KKR>,
        <https://1145.am/db/865540/KKR>,
        <https://1145.am/db/884300/Kkr___Co_Inc>,
        <https://1145.am/db/893768/KKR>,
        <https://1145.am/db/907556/KKR>,
        <https://1145.am/db/908907/KKR>,
        <https://1145.am/db/910191/KKR>,
        <https://1145.am/db/912132/Kkr___Co>,
        <https://1145.am/db/91884/KKR>,
        <https://1145.am/db/923834/KKR>,
        <https://1145.am/db/924993/KKR>,
        <https://1145.am/db/926313/KKR>,
        <https://1145.am/db/929269/KKR>,
        <https://1145.am/db/930281/KKR>,
        <https://1145.am/db/932790/KKR>,
        <https://1145.am/db/934927/KKR>,
        <https://1145.am/db/94535/KKR>,
        <https://1145.am/db/964816/Kkr___Co_Inc>,
        <https://1145.am/db/968064/KKR>,
        <https://1145.am/db/968112/KKR>,
        <https://1145.am/db/970108/KKR>,
        <https://1145.am/db/971684/KKR>,
        <https://1145.am/db/972089/KKR>,
        <https://1145.am/db/972213/KKR>,
        <https://1145.am/db/984390/KKR>,
        <https://1145.am/db/986270/KKR>,
        <https://1145.am/db/989353/KKR>,
        <https://1145.am/db/992099/KKR>,
        <https://1145.am/db/997068/Kohlberg_Kravis_Roberts> ;
    ns1:sameAsMedium <https://1145.am/db/1011940/KKR>,
        <https://1145.am/db/1013124/KKR>,
        <https://1145.am/db/1026785/KKR>,
        <https://1145.am/db/1047409/KKR>,
        <https://1145.am/db/1048061/KKR>,
        <https://1145.am/db/1063843/KKR>,
        <https://1145.am/db/1081263/KKR>,
        <https://1145.am/db/1082650/KKR>,
        <https://1145.am/db/112754/KKR>,
        <https://1145.am/db/1129736/KKR>,
        <https://1145.am/db/1131185/KKR>,
        <https://1145.am/db/1187769/KKR>,
        <https://1145.am/db/1296521/Kkr___Co>,
        <https://1145.am/db/1394821/KKR>,
        <https://1145.am/db/1416023/KKR>,
        <https://1145.am/db/1416277/Kkr___Co>,
        <https://1145.am/db/1420083/KKR>,
        <https://1145.am/db/1460/KKR>,
        <https://1145.am/db/149545/KKR>,
        <https://1145.am/db/1502843/Kkr_Inc>,
        <https://1145.am/db/1660846/KKR>,
        <https://1145.am/db/1660963/KKR>,
        <https://1145.am/db/1661134/Kkr_Inc>,
        <https://1145.am/db/1661435/KKR>,
        <https://1145.am/db/1677859/KKR>,
        <https://1145.am/db/1746839/KKR>,
        <https://1145.am/db/1759036/KKR>,
        <https://1145.am/db/1761520/KKR>,
        <https://1145.am/db/1765880/KKR>,
        <https://1145.am/db/1769962/KKR>,
        <https://1145.am/db/1799106/KKR>,
        <https://1145.am/db/1803787/KKR>,
        <https://1145.am/db/1857803/KKR>,
        <https://1145.am/db/1968303/Kkr___Co>,
        <https://1145.am/db/2013193/KKR>,
        <https://1145.am/db/2027104/KKR>,
        <https://1145.am/db/2032776/KKR>,
        <https://1145.am/db/2038852/KKR>,
        <https://1145.am/db/2042348/KKR>,
        <https://1145.am/db/2046870/KKR>,
        <https://1145.am/db/2050989/KKR>,
        <https://1145.am/db/2056647/KKR>,
        <https://1145.am/db/2063964/KKR>,
        <https://1145.am/db/2068310/KKR>,
        <https://1145.am/db/2075473/KKR>,
        <https://1145.am/db/2076666/KKR>,
        <https://1145.am/db/2078541/KKR>,
        <https://1145.am/db/2080075/KKR>,
        <https://1145.am/db/2082516/KKR>,
        <https://1145.am/db/2089349/KKR>,
        <https://1145.am/db/2101709/KKR>,
        <https://1145.am/db/2101746/KKR>,
        <https://1145.am/db/2112887/KKR>,
        <https://1145.am/db/2124401/KKR>,
        <https://1145.am/db/2124862/KKR>,
        <https://1145.am/db/2127688/KKR>,
        <https://1145.am/db/2136594/KKR>,
        <https://1145.am/db/2139470/KKR>,
        <https://1145.am/db/2145209/KKR>,
        <https://1145.am/db/2149560/KKR>,
        <https://1145.am/db/2291651/KKR>,
        <https://1145.am/db/2291664/KKR>,
        <https://1145.am/db/2315158/KKR>,
        <https://1145.am/db/2317344/KKR>,
        <https://1145.am/db/2318461/KKR>,
        <https://1145.am/db/2328236/KKR>,
        <https://1145.am/db/2339666/KKR>,
        <https://1145.am/db/2345694/KKR>,
        <https://1145.am/db/2371655/KKR>,
        <https://1145.am/db/2508331/KKR>,
        <https://1145.am/db/2548051/KKR>,
        <https://1145.am/db/2558602/KKR>,
        <https://1145.am/db/2561249/KKR>,
        <https://1145.am/db/2589365/KKR>,
        <https://1145.am/db/2590549/KKR>,
        <https://1145.am/db/2594877/KKR>,
        <https://1145.am/db/2704480/KKR>,
        <https://1145.am/db/2704484/KKR>,
        <https://1145.am/db/2719659/KKR>,
        <https://1145.am/db/2784659/KKR>,
        <https://1145.am/db/2794220/KKR>,
        <https://1145.am/db/2796657/KKR>,
        <https://1145.am/db/2801896/KKR>,
        <https://1145.am/db/285425/KKR>,
        <https://1145.am/db/286585/KKR>,
        <https://1145.am/db/287966/KKR>,
        <https://1145.am/db/293364/Kkr___Co>,
        <https://1145.am/db/320746/KKR>,
        <https://1145.am/db/323184/KKR>,
        <https://1145.am/db/331041/KKR>,
        <https://1145.am/db/331072/KKR>,
        <https://1145.am/db/331120/KKR>,
        <https://1145.am/db/335627/KKR>,
        <https://1145.am/db/377907/KKR>,
        <https://1145.am/db/3947/KKR>,
        <https://1145.am/db/425087/KKR>,
        <https://1145.am/db/454758/KKR>,
        <https://1145.am/db/489290/KKR>,
        <https://1145.am/db/492468/KKR>,
        <https://1145.am/db/495917/KKR>,
        <https://1145.am/db/516118/KKR>,
        <https://1145.am/db/526965/KKR>,
        <https://1145.am/db/535518/KKR>,
        <https://1145.am/db/543668/KKR>,
        <https://1145.am/db/606208/KKR>,
        <https://1145.am/db/620441/KKR>,
        <https://1145.am/db/624398/KKR>,
        <https://1145.am/db/643839/KKR>,
        <https://1145.am/db/644358/KKR>,
        <https://1145.am/db/644418/KKR>,
        <https://1145.am/db/649646/KKR>,
        <https://1145.am/db/650038/KKR>,
        <https://1145.am/db/651798/KKR>,
        <https://1145.am/db/654033/KKR>,
        <https://1145.am/db/665056/KKR>,
        <https://1145.am/db/665815/KKR>,
        <https://1145.am/db/685346/KKR>,
        <https://1145.am/db/685746/KKR>,
        <https://1145.am/db/713772/KKR>,
        <https://1145.am/db/715525/KKR>,
        <https://1145.am/db/733298/KKR>,
        <https://1145.am/db/746000/KKR>,
        <https://1145.am/db/748180/KKR>,
        <https://1145.am/db/770929/KKR>,
        <https://1145.am/db/783577/KKR>,
        <https://1145.am/db/789202/KKR>,
        <https://1145.am/db/814184/KKR>,
        <https://1145.am/db/814340/Kkr___Co>,
        <https://1145.am/db/829559/KKR>,
        <https://1145.am/db/872702/KKR>,
        <https://1145.am/db/882663/KKR>,
        <https://1145.am/db/899462/KKR>,
        <https://1145.am/db/900594/KKR>,
        <https://1145.am/db/900629/KKR>,
        <https://1145.am/db/908834/KKR>,
        <https://1145.am/db/908839/KKR>,
        <https://1145.am/db/908843/KKR>,
        <https://1145.am/db/913484/KKR>,
        <https://1145.am/db/92448/KKR>,
        <https://1145.am/db/953014/KKR>,
        <https://1145.am/db/963947/KKR>,
        <https://1145.am/db/976442/KKR>,
        <https://1145.am/db/978086/KKR>,
        <https://1145.am/db/978783/KKR> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2577114/Viropharma_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "ipo" ;
    ns1:documentDate "2014-01-10T13:06:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Dublin, Ireland - January 10, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has extended the expiration of its previously announced tender offer by a wholly owned subsidiary of Shire for all of the outstanding common shares of ViroPharma Incorporated (NASDAQ: VPHM) until midnight, New York City time, on Thursday, January 23, 2014 (one minute after 11:59 p.m., New York City time, on January 23, 2014) .",
        "Shire extends tender offer for ViroPharma." ;
    ns1:documentTitle "Shire extends tender offer for ViroPharma" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/shire-extends-tender-offer-for-viropharma> ;
    ns1:foundName "tender offer" ;
    ns1:name "tender offer" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2577114/Viropharma> ;
    ns1:targetName "ViroPharma" ;
    ns1:whereGeoName "New York City",
        "Sher wraja" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/328591/about.rdf>,
        <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:whereRaw "New York City",
        "Shire" .

<https://1145.am/db/2580038/Bristol-Myers_Squibb> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2014-02-03T13:06:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AstraZeneca Completes the Acquistion of Bristol-Myers Squibb Share of Global Diabetes Alliance" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/astrazeneca-completes-acquistion-of-bristol-myers-squibb-share-of-global-diabetes-alliance> ;
    ns1:foundName "Bristol-Myers Squibb" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Bristol-Myers Squibb" ;
    ns1:sameAsHigh <https://1145.am/db/1055530/Bristol_Myers_Squibb>,
        <https://1145.am/db/1057172/Bristol_Myers_Squibb>,
        <https://1145.am/db/1094472/Bristol_Myers_Squibb>,
        <https://1145.am/db/1105768/Bristol_Myers_Squibb>,
        <https://1145.am/db/1106082/Bristol_Myers_Squibb>,
        <https://1145.am/db/1108228/Bristol_Myers_Squibb>,
        <https://1145.am/db/1110114/Bristol_Myers_Squibb_Co>,
        <https://1145.am/db/1111460/Bristol_Myers_Squibb>,
        <https://1145.am/db/1111853/Bristol_Myers_Squibb>,
        <https://1145.am/db/1113358/Bristol-Myers_Squibb>,
        <https://1145.am/db/1113452/Bristol_Myers_Squibb>,
        <https://1145.am/db/1114073/Bristol_Myers_Squibb>,
        <https://1145.am/db/1137730/Bristol_Myers_Squibb>,
        <https://1145.am/db/1142305/Bristol_Myers_Squibb>,
        <https://1145.am/db/1183637/Bristol_Myers_Squibb>,
        <https://1145.am/db/1184320/Bristol_Myers_Squibb>,
        <https://1145.am/db/1219346/Bristol_Myers_Squibb>,
        <https://1145.am/db/1219817/Bristol_Myers_Squibb>,
        <https://1145.am/db/1281441/Bristol_Myers_Squibb>,
        <https://1145.am/db/1285047/Bristol_Myers_Squibb>,
        <https://1145.am/db/1288028/Bristol_Myers_Squibb>,
        <https://1145.am/db/1340338/Bristol_Myers_Squibb>,
        <https://1145.am/db/1536915/Bristol_Myers_Squibb>,
        <https://1145.am/db/1613666/Bristol_Myers_Squibb>,
        <https://1145.am/db/1983649/Bristol_Myers_Squibb>,
        <https://1145.am/db/1984876/Bristol_Myers_Squibb_Co>,
        <https://1145.am/db/2139444/Bristol_Myers_Squibb>,
        <https://1145.am/db/2139540/Bristol-Myers_Squibb>,
        <https://1145.am/db/2140511/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2153042/Bristol_Myers_Squibb>,
        <https://1145.am/db/2155237/Bristol-Myers_Squibb>,
        <https://1145.am/db/2228329/Bristol-Myers_Squibb>,
        <https://1145.am/db/2278861/Bristol_Myers_Squibb>,
        <https://1145.am/db/2279340/Bristol_Myers_Squibb>,
        <https://1145.am/db/2279903/Bristol_Myers_Squibb>,
        <https://1145.am/db/2280782/Bristol_Myers_Squibb>,
        <https://1145.am/db/2280925/Bristol_Myers_Squibb>,
        <https://1145.am/db/2283422/Bristol_Myers_Squibb>,
        <https://1145.am/db/2283468/Bristol_Myer_Squibb>,
        <https://1145.am/db/2284339/Bristol_Myers>,
        <https://1145.am/db/2284393/Bristol_Myers_Squibb>,
        <https://1145.am/db/2284903/Bristol_Myers_Squibb>,
        <https://1145.am/db/2287082/Bristol_Myers_Squibb>,
        <https://1145.am/db/2287351/Bristol_Myers>,
        <https://1145.am/db/2287369/Bristol_Myers>,
        <https://1145.am/db/2289865/Bristol-Myers_Squibb>,
        <https://1145.am/db/2291777/Bristol-Myers_Squibb>,
        <https://1145.am/db/2292287/Bristol>,
        <https://1145.am/db/2292710/Bristol-Myers_Squibb>,
        <https://1145.am/db/2292751/Bristol-Myers_Squibb>,
        <https://1145.am/db/2293175/Bristol-Myers_Squibb>,
        <https://1145.am/db/2295625/Bristol-Myers_Squibb>,
        <https://1145.am/db/2296531/Still_Bristol-Myers>,
        <https://1145.am/db/2299388/Bristol-Myers>,
        <https://1145.am/db/2299902/Bristol-Myers_Squibb>,
        <https://1145.am/db/2299941/Bristol-Myers_Squibb>,
        <https://1145.am/db/2300768/Bristol-Myers>,
        <https://1145.am/db/2301227/Bristol-Myers_Squibb>,
        <https://1145.am/db/2301536/Bristol-Myers_Squibb>,
        <https://1145.am/db/2301687/Bristol-Myers_Squibb>,
        <https://1145.am/db/2302975/Bristol-Myers_Squibb>,
        <https://1145.am/db/2303034/Bristol-Myers_Squibb>,
        <https://1145.am/db/2303037/Bristol-Myers_Squibb>,
        <https://1145.am/db/2303791/Bristol-Myers_Squibb>,
        <https://1145.am/db/2307060/Bristol-Myers>,
        <https://1145.am/db/2307066/Bristol-Myers_Squibb>,
        <https://1145.am/db/2307968/Bristol-Myers_Squibb>,
        <https://1145.am/db/2308778/Bristol-Myers_Squibb>,
        <https://1145.am/db/2309929/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2310002/Bristol-Myers_Squibb>,
        <https://1145.am/db/2312194/Bristol-Myers_Squibb>,
        <https://1145.am/db/2312220/Bristol-Myers_Squibb>,
        <https://1145.am/db/2312436/Bristol-Myers_Squibb>,
        <https://1145.am/db/2312783/Bristol-Myers>,
        <https://1145.am/db/2313397/Bristol-Myers_Squibb>,
        <https://1145.am/db/2314245/Bristol-Myers_Squibb>,
        <https://1145.am/db/2314447/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2314979/Bristol-Myers_Squibb>,
        <https://1145.am/db/2319442/Bristol-Myers_Squibb>,
        <https://1145.am/db/2319838/Bristol-Myers_Squibb>,
        <https://1145.am/db/2320315/Bristol-Myers_Squibb>,
        <https://1145.am/db/2320316/Bristol-Myers_Squibb>,
        <https://1145.am/db/2320973/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2321014/Bristol-Myers>,
        <https://1145.am/db/2321432/Bristol-Myers_Squibb>,
        <https://1145.am/db/2324209/Bristol-Myers_Squibb>,
        <https://1145.am/db/2325918/Bristol-Myers_Squibb>,
        <https://1145.am/db/2326610/Bristol-Myers_Squibb>,
        <https://1145.am/db/2328576/Bristol-Myers_Squibb>,
        <https://1145.am/db/2328577/Bristol-Myers_Squibb>,
        <https://1145.am/db/2329134/Bristol-Myers_Squibb>,
        <https://1145.am/db/2329655/Bristol-Myers_Squibb>,
        <https://1145.am/db/2331201/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2331819/Bristol-Myers_Squibb>,
        <https://1145.am/db/2331823/Bristol_Myers_Squibb>,
        <https://1145.am/db/2332660/Bristol_Myers_Squibb>,
        <https://1145.am/db/2332832/Bristol-Myers_Squibb>,
        <https://1145.am/db/2332836/Bristol-Myers_Squibb>,
        <https://1145.am/db/2333555/Bristol-Myers_Squibb>,
        <https://1145.am/db/2336201/Bristol-Myers_Squibb>,
        <https://1145.am/db/2336234/Bristol-Myers_Squibb>,
        <https://1145.am/db/2336237/Bristol-Myers_Squibb>,
        <https://1145.am/db/2336386/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2336564/Bristol-Myers>,
        <https://1145.am/db/2336567/Bristol-Myers_Squibb>,
        <https://1145.am/db/2336870/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2337743/Bristol-Myers_Squibb>,
        <https://1145.am/db/2337982/Bristol-Myers_Squibb>,
        <https://1145.am/db/2338000/Bristol-Myers_Squibbs>,
        <https://1145.am/db/2339534/Bristol-Myers_Squibb>,
        <https://1145.am/db/2339822/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2340675/Bristol-Myers_Squibb>,
        <https://1145.am/db/2341602/Bristol-Myers_Squibb>,
        <https://1145.am/db/2341628/Bristol-Myers_Squibb_Company_(bmy)>,
        <https://1145.am/db/2341871/Bristol-Myers_Squibb>,
        <https://1145.am/db/2341934/Bristol-Myers>,
        <https://1145.am/db/2343626/Bristol-Myers_Squibb>,
        <https://1145.am/db/2343628/Bristol-Myers_Squibb>,
        <https://1145.am/db/2344043/Bristol-Myers_Squibb>,
        <https://1145.am/db/2344635/Bristol-Myers_Squibb>,
        <https://1145.am/db/2345426/Bristol-Myers_Squibb>,
        <https://1145.am/db/2345436/Bristol-Myers_Squibb>,
        <https://1145.am/db/2345774/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2347040/Bristol-Myers_Squibb>,
        <https://1145.am/db/2347449/Bristol-Myers_Squibb>,
        <https://1145.am/db/2347466/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2347486/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2347488/Bristol-Myers_Squibb>,
        <https://1145.am/db/2348034/Bristol-Myers_Squibb>,
        <https://1145.am/db/2348079/Bristol-Myers_Squibb>,
        <https://1145.am/db/2348351/Bristol-Myers_Squibb>,
        <https://1145.am/db/2350453/Bristol-Myers_Squibb>,
        <https://1145.am/db/2351670/Bristol-Myers_Squibb>,
        <https://1145.am/db/2351689/Bristol-Myers_Squibb>,
        <https://1145.am/db/2351759/Bristol-Myers_Squibb>,
        <https://1145.am/db/2352534/Bristol-Myers_Squibb>,
        <https://1145.am/db/2354567/Bristol-Myers_Squibb>,
        <https://1145.am/db/2354577/Bristol-Myers_Squibb>,
        <https://1145.am/db/2355667/Bristol-Myers_Squibb>,
        <https://1145.am/db/2355669/Bristol-Myers_Squibb>,
        <https://1145.am/db/2356005/Bristol-Myers_Squibb>,
        <https://1145.am/db/2356340/Bristol-Myers_Squibb>,
        <https://1145.am/db/2356740/Bristol>,
        <https://1145.am/db/2357757/Bristol-Myers_Squibb>,
        <https://1145.am/db/2358038/Bristol-Myers_Squibb>,
        <https://1145.am/db/2358039/Bristol-Myers_Squibb>,
        <https://1145.am/db/2358044/Bristol-Myers_Squibb>,
        <https://1145.am/db/2358078/Bristol-Myers_Squibb>,
        <https://1145.am/db/2359117/Bristol-Myers_Squibb>,
        <https://1145.am/db/2362965/Bristol-Myers_Squibb>,
        <https://1145.am/db/2362966/Bristol-Myers>,
        <https://1145.am/db/2364049/Bristol-Myers_Squibb>,
        <https://1145.am/db/2364052/Bristol-Myers_Squibb>,
        <https://1145.am/db/2364740/Bristol-Myers_Squibb>,
        <https://1145.am/db/2364742/Bristol-Myers_Squibb>,
        <https://1145.am/db/2364743/Bristol-Myers_Squibb>,
        <https://1145.am/db/2364774/Bristol-Myers>,
        <https://1145.am/db/2365157/Bristol-Myers_Squibb>,
        <https://1145.am/db/2365605/Bristol-Myers_Squibb>,
        <https://1145.am/db/2366402/Bristol-Myers_Squibb>,
        <https://1145.am/db/2367078/Bristol-Myers_Squibb>,
        <https://1145.am/db/2367082/Bristol-Myers_Squibb>,
        <https://1145.am/db/2367085/Bristol-Myers_Squibb>,
        <https://1145.am/db/2367182/Bristol-Myers_Squibb>,
        <https://1145.am/db/2367306/Bristol-Myers_Squibb>,
        <https://1145.am/db/2367562/Bristol-Myers_Squibb>,
        <https://1145.am/db/2367569/Bristol-Myers_Squibb>,
        <https://1145.am/db/2367705/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2368765/Bristol-Myers_Squibb>,
        <https://1145.am/db/2368768/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2368770/Bristol-Myers_Squibb>,
        <https://1145.am/db/2369703/Bristol-Myers_Squibb>,
        <https://1145.am/db/2369708/Bristol-Myers_Squibb>,
        <https://1145.am/db/2369710/Bristol-Myers_Squibb>,
        <https://1145.am/db/2370861/Bristol-Myers_Squibb>,
        <https://1145.am/db/2370990/Bristol-Myers_Squibb>,
        <https://1145.am/db/2371186/Bristol-Myers_Squibb>,
        <https://1145.am/db/2371215/Bristol-Myers_Squibb>,
        <https://1145.am/db/2371285/Bristol-Myers_Squibb>,
        <https://1145.am/db/2509115/Bristol_Myers_Squibb>,
        <https://1145.am/db/2536422/Bristol-Myers_Squibb>,
        <https://1145.am/db/2536960/Bristol-Myers_Squibb>,
        <https://1145.am/db/2537396/Bristol-Myers_Squibb>,
        <https://1145.am/db/2537448/Bristol-Myers_Squibb>,
        <https://1145.am/db/2537537/Bristol-Myers_Squibb>,
        <https://1145.am/db/2539308/Bristol-Myers_Squibb>,
        <https://1145.am/db/2539341/Bristol-Myers_Squibb>,
        <https://1145.am/db/2542218/Bristol-Myers>,
        <https://1145.am/db/2543185/Bristol-Myers_Squibb>,
        <https://1145.am/db/2543220/Bristol-Myers_Squibb>,
        <https://1145.am/db/2543227/Bristol-Myers>,
        <https://1145.am/db/2543236/Bristol-Myers_Squibb>,
        <https://1145.am/db/2543655/Bristol-Myers_Squibb>,
        <https://1145.am/db/2544206/Bristol-Myers_Squibb>,
        <https://1145.am/db/2545023/Bristol-Myers_Squibb>,
        <https://1145.am/db/2545052/Bristol-Myers_Squibb>,
        <https://1145.am/db/2546563/Bristol>,
        <https://1145.am/db/2546564/Bristol-Myers_Squibb>,
        <https://1145.am/db/2550188/Bristol-Myers_Squibb>,
        <https://1145.am/db/2550394/Bristol-Myers_Squibb>,
        <https://1145.am/db/2551883/Bristol-Myers_Squibb>,
        <https://1145.am/db/2553958/Bristol-Myers_Squibb>,
        <https://1145.am/db/2554303/Bristol-Myers_Squibb>,
        <https://1145.am/db/2554631/Bristol-Myers_Squibb>,
        <https://1145.am/db/2554897/Bristol-Myers_Squibb>,
        <https://1145.am/db/2555760/Bristol-Myers_Squibb>,
        <https://1145.am/db/2556543/Bristol-Myers_Squibb>,
        <https://1145.am/db/2557238/Bristol-Myers_Squibb>,
        <https://1145.am/db/2558657/Bristol-Myers_Squibb>,
        <https://1145.am/db/2558664/Bristol-Myers_Squibb>,
        <https://1145.am/db/2558727/Bristol-Myers_Squibb>,
        <https://1145.am/db/2559407/Bristol-Myers_Squibb>,
        <https://1145.am/db/2560287/Bristol-Myers_Squibb>,
        <https://1145.am/db/2560564/Bristol_Myers_Squibb>,
        <https://1145.am/db/2561325/Bristol-Myers_Squibb>,
        <https://1145.am/db/2562459/Bristol-Myers_Squibb>,
        <https://1145.am/db/2562503/Bristol-Myers_Squibb>,
        <https://1145.am/db/2562693/Bristol_Myers>,
        <https://1145.am/db/2563390/Bristol-Myers_Squibb>,
        <https://1145.am/db/2563587/Bristol-Myers_Squibb>,
        <https://1145.am/db/2563889/Bristol-Myers_Squibb>,
        <https://1145.am/db/2564274/Bristol_Myers_Squibb>,
        <https://1145.am/db/2565218/Bristol-Myers_Squibb>,
        <https://1145.am/db/2565258/Bristol-Myers_Squibb>,
        <https://1145.am/db/2565297/Bristol_Myers_Squibb>,
        <https://1145.am/db/2565318/Bristol_Myers>,
        <https://1145.am/db/2566282/Bristol_Myers_Squibb>,
        <https://1145.am/db/2567006/Bristol-Myers_Squibb>,
        <https://1145.am/db/2567124/Bristol-Myers_Squibb>,
        <https://1145.am/db/2567466/Bristol_Myers_Squibb>,
        <https://1145.am/db/2569734/Bristol-Myers_Squibb>,
        <https://1145.am/db/2569735/Bristol-Myers_Squibb>,
        <https://1145.am/db/2572655/Bristol-Myers_Squibb_And_Otsuka>,
        <https://1145.am/db/2573375/Bristol-Myers_Squibb>,
        <https://1145.am/db/2573535/Bristol-Myers_Squibb>,
        <https://1145.am/db/2573593/Bristol-Myers_Squibb>,
        <https://1145.am/db/2575176/Bristol-Myers_Squibb>,
        <https://1145.am/db/2575289/Bristol-Myers_Squibb>,
        <https://1145.am/db/2576086/Bristol-Myers>,
        <https://1145.am/db/2578540/Bristol-Myers_Squibb>,
        <https://1145.am/db/2578567/Bristol-Myers_Squibb>,
        <https://1145.am/db/2580053/Bristol-Myers_Squibb>,
        <https://1145.am/db/2581155/Bristol-Myers_Squibb>,
        <https://1145.am/db/2581159/Bristol>,
        <https://1145.am/db/2582111/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2582116/Bristol-Myers_Squibb>,
        <https://1145.am/db/2582120/Bristol-Myers_Squibb>,
        <https://1145.am/db/2582228/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2583120/Bristol-Myers_Squibb>,
        <https://1145.am/db/2584317/Bristol-Myers_Squibb>,
        <https://1145.am/db/2584318/Bristol-Myers_Squibb>,
        <https://1145.am/db/2585238/Bristol-Myers_Squibb>,
        <https://1145.am/db/2585263/Bristol-Myers_Squibb>,
        <https://1145.am/db/2588614/Bristol-Myers_Squibb>,
        <https://1145.am/db/2588910/Bristol-Myers_Squibb>,
        <https://1145.am/db/2589029/Bristol-Myers_Squibb>,
        <https://1145.am/db/2589053/Bristol-Myers_Squibb>,
        <https://1145.am/db/2589142/Bristol-Myers_Squibb>,
        <https://1145.am/db/2589861/Bristol-Myers_Squibb>,
        <https://1145.am/db/2589921/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2592024/Bristol-Myers_Squibb>,
        <https://1145.am/db/2592993/Bristol-Myers_Squibb>,
        <https://1145.am/db/2594365/Bristol-Myers_Squibb>,
        <https://1145.am/db/2594370/Bristol-Myers_Squibb>,
        <https://1145.am/db/2595133/Bristol-Myers_Squibb>,
        <https://1145.am/db/2595615/Bristol-Myers_Squibb>,
        <https://1145.am/db/2595843/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2595876/Bristol-Myers_Squibb>,
        <https://1145.am/db/2596107/Bristol-Myers_Squibb>,
        <https://1145.am/db/2596128/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2596135/Bristol-Myers_Squibb>,
        <https://1145.am/db/2596137/Bristol-Myers_Squibb>,
        <https://1145.am/db/2596434/Bristol-Myers_Squibb>,
        <https://1145.am/db/2597274/Bristol-Myers_Squibb>,
        <https://1145.am/db/2597554/Bristol-Myers>,
        <https://1145.am/db/2597935/Bristol-Myers_Squibb>,
        <https://1145.am/db/2598099/Bristol-Myers_Squibb>,
        <https://1145.am/db/2598195/Bristol-Myers_Squibb>,
        <https://1145.am/db/2598626/Bristol-Myers_Squibb>,
        <https://1145.am/db/2598639/Bristol-Myers_Squibb>,
        <https://1145.am/db/2716207/Bristol_Myers_Squibb>,
        <https://1145.am/db/2786473/Bristol_Myers_Squibb>,
        <https://1145.am/db/2796875/Bristol_Myers_Squibb>,
        <https://1145.am/db/290500/Bristol-Myers_Squibb_Co_And_Bluebird_Bio_Inc>,
        <https://1145.am/db/426688/Bristol_Myers_Squibb>,
        <https://1145.am/db/569732/Bristol_Myers_Squibb_Co>,
        <https://1145.am/db/768063/Bristol_Myers_Squibb>,
        <https://1145.am/db/815499/Bristol_Myers_Squibb>,
        <https://1145.am/db/831553/Bristol-Myers_Squibb>,
        <https://1145.am/db/833098/Bristol-Myers_Squibb> ;
    ns1:sameAsMedium <https://1145.am/db/1213113/Bristol_Myers_Squibb>,
        <https://1145.am/db/1318775/Bristol-Myers_Squibb>,
        <https://1145.am/db/1319026/Bristol-Myers_Squibb>,
        <https://1145.am/db/1822601/Bristol-Myers_Squibb>,
        <https://1145.am/db/2279067/Bristol_Myers_Squibb>,
        <https://1145.am/db/2279854/Bristol_Myers_Squibb>,
        <https://1145.am/db/2301461/Bristol-Myers_Squibb>,
        <https://1145.am/db/2305254/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2311150/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2326568/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2347038/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2360289/Bristol-Myers_Squibb>,
        <https://1145.am/db/2360963/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2537500/Bristol-Myers_Squibb>,
        <https://1145.am/db/2543552/Bristol-Myers_Squibb>,
        <https://1145.am/db/2543648/Bristol-Myers_Squibb>,
        <https://1145.am/db/2592791/Bristol-Myers_Squibb_Company>,
        <https://1145.am/db/2788420/Bristol_Myers_Squibb>,
        <https://1145.am/db/870410/Bristol-Myers_Squibb>,
        <https://1145.am/db/979509/Bristol_Myers_Squibb> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2582969/Paladin_Labs_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2014-02-27T12:34:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Endo Announces Shareholder Approval of its Acquisition of Paladin Labs.",
        "MALVERN, Pa., Feb. 26, 2014 /PRNewswire/ - Endo Health Solutions Inc. (NASDAQ: ENDP) (\"Endo\") today announced that, at the shareholder meeting held today, proposals related to Endo's proposed acquisition of Paladin Labs Inc. (TSX: PLB) (\"Paladin\") were approved by Endo's shareholders." ;
    ns1:documentTitle "Endo Announces Shareholder Approval of its Acquisition of Paladin Labs" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/endo-announces-shareholder-approval-of-its-acquisition-of-paladin-labs> ;
    ns1:foundName "Acquisition",
        "acquisition" ;
    ns1:name "Acquisition",
        "acquisition" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2582969/Paladin_Labs> ;
    ns1:targetName "Paladin",
        "Paladin Labs" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2583466/Bay_City_Capital> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2013-09-11T14:12:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Bay City Capital" ;
    ns1:investor <https://1145.am/db/2583466/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> ;
    ns1:name "Bay City Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1830084/Bay_Partners>,
        <https://1145.am/db/1836989/Bay_Partners>,
        <https://1145.am/db/1879250/Baytech_Venture_Capital>,
        <https://1145.am/db/2306568/Bay_City_Capital>,
        <https://1145.am/db/2357418/Bay_City_Capital>,
        <https://1145.am/db/2367204/Mission_Bay_Capital>,
        <https://1145.am/db/2370208/Mission_Bay_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2292334/Bay_City_Capital>,
        <https://1145.am/db/2292353/Bay_City_Capital>,
        <https://1145.am/db/2296810/Bay_City_Capital>,
        <https://1145.am/db/2301824/Bay_City_Capital>,
        <https://1145.am/db/2302897/Bay_City_Capital>,
        <https://1145.am/db/2308713/Bay_City_Capital>,
        <https://1145.am/db/2311570/Bay_City_Capital>,
        <https://1145.am/db/2312435/Bay_City_Capital>,
        <https://1145.am/db/2314492/Bay_City_Capital>,
        <https://1145.am/db/2319822/Bay_City_Capital_Llc>,
        <https://1145.am/db/2319965/Bay_City_Capital>,
        <https://1145.am/db/2320476/Bay_City_Capital>,
        <https://1145.am/db/2324289/Bay_City_Capital>,
        <https://1145.am/db/2326903/Bay_City_Capital>,
        <https://1145.am/db/2329010/Bay_City_Capital>,
        <https://1145.am/db/2329011/Bay_City_Capital>,
        <https://1145.am/db/2331700/Bay_City_Capital>,
        <https://1145.am/db/2331784/Bay_City_Capital>,
        <https://1145.am/db/2336510/Bay_City_Capital>,
        <https://1145.am/db/2336511/Bay_City_Capital>,
        <https://1145.am/db/2337599/Bay_City_Capital>,
        <https://1145.am/db/2342864/Bay_City_Capital>,
        <https://1145.am/db/2346534/Bay_City_Capital>,
        <https://1145.am/db/2350491/Bay_City_Capital>,
        <https://1145.am/db/2351129/Bay_City_Capital>,
        <https://1145.am/db/2356290/Bay_City_Capital>,
        <https://1145.am/db/2358409/Bay_City_Capital>,
        <https://1145.am/db/2359185/Bay_City_Capital>,
        <https://1145.am/db/2360266/Bay_City_Capital>,
        <https://1145.am/db/2367022/Bay_City_Capital>,
        <https://1145.am/db/2367023/Bay_City_Capital>,
        <https://1145.am/db/2367026/Bay_City_Capital>,
        <https://1145.am/db/2588372/Bay_City_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2583466/Civitas_Therapeutics> a org:Organization ;
    ns1:basedInLowRaw "CHELSEA, MASS" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2013-09-11T14:12:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "Civitas Therapeutics",
        "Civitas Therapeutics, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Civitas Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2336224/Civitas_Therapeutics>,
        <https://1145.am/db/2336227/Civitas_Therapeutics>,
        <https://1145.am/db/2339763/Civitas_Therapeutics>,
        <https://1145.am/db/2348922/Civitas_Therapeutics>,
        <https://1145.am/db/2351129/Civitas_Therapeutics>,
        <https://1145.am/db/2356842/Civitas_Therapeutics>,
        <https://1145.am/db/2356865/Civitas_Therapeutics>,
        <https://1145.am/db/2360266/Civitas_Therapeutics>,
        <https://1145.am/db/2360268/Civitas_Therapeutics>,
        <https://1145.am/db/2366753/Civitas_Therapeutics>,
        <https://1145.am/db/2366757/Civitas_Therapeutics>,
        <https://1145.am/db/2558109/Civitas_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2593166/Civitas_Therapeutics> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586763/Adcock_Ingram_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:basedInHighGeoName "South Africa" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/953987/about.rdf> ;
    ns1:basedInHighRaw "South Africa" ;
    ns1:documentDate "2013-07-03T15:46:47+00:00"^^xsd:dateTime ;
    ns1:documentExtract "@ FiercePharma: Chile's CFR Pharma offers $ 1.3B for leading South African drug maker Adcock Ingram." ;
    ns1:documentTitle "Merck pulls Recombivax lot on cracked-vial risk; India's Elder Pharma to buy OTC drugmaker;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/merck-pulls-recombivax-lot-on-cracked-vial-risk-india-s-elder-pharma-to-buy-otc-drugmaker> ;
    ns1:foundName "Adcock Ingram",
        "offers",
        "settles" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Adcock Ingram",
        "offers",
        "settles" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2586763/Adcock_Ingram_Acquisition> ;
    ns1:targetName "Adcock Ingram" ;
    ns1:valueRaw "$ 1.3B",
        "$ 2.2M" ;
    ns1:vendor <https://1145.am/db/2586763/King_Pharmaceuticals> ;
    ns1:whereGeoName "Africa" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255146/about.rdf> ;
    ns1:whereRaw "South African" .

<https://1145.am/db/2586763/Max_Healthcare_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-07-03T15:46:47+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Elder Pharma's U.K. subsidiary snapped up Max Healthcare to re-enter the over-the-counter pharmaceuticals market." ;
    ns1:documentTitle "Merck pulls Recombivax lot on cracked-vial risk; India's Elder Pharma to buy OTC drugmaker;" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/merck-pulls-recombivax-lot-on-cracked-vial-risk-india-s-elder-pharma-to-buy-otc-drugmaker> ;
    ns1:foundName "snapped up" ;
    ns1:name "snapped up" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2586763/Max_Healthcare> ;
    ns1:targetName "Max Healthcare" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "U.K." .

<https://1145.am/db/2593433/Onyx_Pharmaceuticals_Inc_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2013-08-27T07:00:42+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SAN DIEGO and SAN FRANCISCO, Aug. 26, 2013 /PRNewswire/ - Shareholder rights attorneys at Robbins Arroyo LLP are investigating the acquisition of Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) (\"Onyx\") by Amgen Inc. (NASDAQ: AMGN) (\"Amgen\") ." ;
    ns1:documentTitle "Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acquisition-of-onyx-pharmaceuticals-inc-by-amgen-inc-may-not-be-best-interests-of-onyx> ;
    ns1:foundName "acquire",
        "acquisition" ;
    ns1:name "acquire",
        "acquisition" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2593433/Onyx_Pharmaceuticals_Inc> ;
    ns1:targetName "Onyx Pharmaceuticals",
        "Onyx Pharmaceuticals, Inc." ;
    ns1:whereGeoName "San Diego County",
        "San Francisco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf>,
        <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:whereRaw "SAN DIEGO and SAN FRANCISCO" .

<https://1145.am/db/2595564/Elan_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-09-19T15:58:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "If Amgen completes its deal for Onyx and Perrigo gets its $ 8.6 billion buyout of Elan ($ ELN) complete, then the second half has a chance of powering M & A to the best in three years." ;
    ns1:documentTitle "With $29B in deals so far, 2013 shaping up as big M&A year" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/29b-deals-so-far-2013-shaping-up-as-big-m-a-year> ;
    ns1:foundName "Elan",
        "buyout" ;
    ns1:name "Elan",
        "buyout" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "stopped" ;
    ns1:target <https://1145.am/db/2595564/Elan_Acquisition> ;
    ns1:targetName "Elan" ;
    ns1:valueRaw "$ 8.6 billion" .

<https://1145.am/db/2595564/Onyx_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-09-19T15:58:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "If Amgen completes its deal for Onyx and Perrigo gets its $ 8.6 billion buyout of Elan ($ ELN) complete, then the second half has a chance of powering M & A to the best in three years." ;
    ns1:documentTitle "With $29B in deals so far, 2013 shaping up as big M&A year" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/29b-deals-so-far-2013-shaping-up-as-big-m-a-year> ;
    ns1:foundName "deal" ;
    ns1:name "deal" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2595564/Onyx> ;
    ns1:targetName "Onyx" ;
    ns1:valueRaw "$ 8.6 billion" .

<https://1145.am/db/2597465/Gland_Pharma> a org:Organization ;
    ns1:basedInHighGeoName "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:basedInHighRaw "India" ;
    ns1:documentDate "2013-10-11T15:13:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "KKR on verge of buying stake in India's Gland, sources say" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/kkr-on-verge-of-buying-stake-india-s-gland-sources-say> ;
    ns1:foundName "Gland Pharma" ;
    ns1:industry "drugmaker" ;
    ns1:name "Gland Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1539584/Gland_Pharma>,
        <https://1145.am/db/1540074/Gland_Pharma_Ltd>,
        <https://1145.am/db/1981788/Gland_Pharma_Ltd>,
        <https://1145.am/db/2540502/Gland_Pharma>,
        <https://1145.am/db/2540508/Gland_Pharma>,
        <https://1145.am/db/2541368/Gland_Pharma>,
        <https://1145.am/db/2544488/Gland_Pharma>,
        <https://1145.am/db/2545444/Gland_Pharma>,
        <https://1145.am/db/2552191/Gland_Pharma>,
        <https://1145.am/db/2555291/Gland_Pharma>,
        <https://1145.am/db/2555342/Gland_Pharma>,
        <https://1145.am/db/2563847/Gland_Pharma>,
        <https://1145.am/db/2563850/Gland_Pharma>,
        <https://1145.am/db/2565596/Gland_Pharma>,
        <https://1145.am/db/2573232/Gland_Pharma>,
        <https://1145.am/db/2594867/Gland_Pharma>,
        <https://1145.am/db/2594877/Gland_Pharma>,
        <https://1145.am/db/2748691/Gland_Pharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2608080/Access_Communications_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2013-10-07T13:45:18+00:00"^^xsd:dateTime ;
    ns1:documentExtract "FiberLink is just one of many acquisitions that Zayo has made in recent months that align with its network infrastructure services strategy.",
        "Just last week it completed its purchase of Minnesota - based Access Communications, which came after a string of other regional fiber provider acquisitions including USCarrier, FiberGate, First Telecom Services and Litecast.",
        "Zayo wraps up Access Communications acquisition, adds 1,200 metro fiber miles." ;
    ns1:documentTitle "Zayo acquires FiberLink, expands dark fiber network to 26,000 miles" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/zayo-acquires-fiberlink-expands-dark-fiber-network-to-26-000-miles> ;
    ns1:foundName "acquisition",
        "purchase" ;
    ns1:name "acquisition",
        "purchase" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2608080/Access_Communications> ;
    ns1:targetName "Access Communications" ;
    ns1:when "2023-10-14T07:44:09.219652"^^xsd:dateTime,
        "2023-10-14T07:44:09.817783"^^xsd:dateTime,
        "2023-10-14T07:44:10.057045"^^xsd:dateTime,
        "2023-10-14T07:44:10.752702"^^xsd:dateTime,
        "2023-10-14T07:44:10.972325"^^xsd:dateTime,
        "2023-10-14T07:44:11.347812"^^xsd:dateTime ;
    ns1:whenRaw "last week" ;
    ns1:whereGeoName "Minnesota" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5037779/about.rdf> ;
    ns1:whereRaw "Minnesota" .

<https://1145.am/db/2608080/Acquisition_Fiberlink_Zayo_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-10-07T13:45:18+00:00"^^xsd:dateTime ;
    ns1:documentExtract "FiberLink is just one of many acquisitions that Zayo has made in recent months that align with its network infrastructure services strategy." ;
    ns1:documentTitle "Zayo acquires FiberLink, expands dark fiber network to 26,000 miles" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/zayo-acquires-fiberlink-expands-dark-fiber-network-to-26-000-miles> ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "has not happened" .

<https://1145.am/db/2651118/Maroc_Telecom> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Morocco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2542007/about.rdf> ;
    ns1:basedInHighRaw "Morocco" ;
    ns1:documentDate "2013-07-17T14:56:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Growth returns in Spain; Etisalat may have a partner for Maroc Telecom stake" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/growth-returns-spain-etisalat-may-have-a-partner-for-maroc-telecom-stake> ;
    ns1:foundName "Maroc Telecom" ;
    ns1:name "Maroc Telecom" ;
    ns1:sameAsMedium <https://1145.am/db/2604246/Maroc_Telecom>,
        <https://1145.am/db/2650898/Maroc_Telecom>,
        <https://1145.am/db/2651156/Maroc_Telecom>,
        <https://1145.am/db/2651496/Maroc_Telecom>,
        <https://1145.am/db/2651782/Maroc_Telecom>,
        <https://1145.am/db/2654132/Maroc_Telecom>,
        <https://1145.am/db/2655001/Maroc_Telecom>,
        <https://1145.am/db/2657814/Maroc_Telecom>,
        <https://1145.am/db/2658891/Maroc_Telecom>,
        <https://1145.am/db/2662038/Maroc_Telecom>,
        <https://1145.am/db/2663091/Maroc_Telecom>,
        <https://1145.am/db/2665333/Maroc_Telecom>,
        <https://1145.am/db/2667532/Maroc_Telecom>,
        <https://1145.am/db/2668512/Maroc_Telecom>,
        <https://1145.am/db/2668561/Maroc_Telecom>,
        <https://1145.am/db/2668596/Maroc_Telecom>,
        <https://1145.am/db/2669629/Maroc_Telecom>,
        <https://1145.am/db/2669641/Maroc_Telecom>,
        <https://1145.am/db/2670741/Maroc_Telecom>,
        <https://1145.am/db/2673046/Maroc_Telecom>,
        <https://1145.am/db/2673070/Maroc_Telecom>,
        <https://1145.am/db/2674199/Maroc_Telecom>,
        <https://1145.am/db/2677850/Maroc_Telecom>,
        <https://1145.am/db/2678974/Maroc_Telecom> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2651118/Maroc_Telecom_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-07-17T14:56:49+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Morocco's Caisse de Depot et de Gestion (CDG) may team up with Etisalat in the latter's planned purchase of a majority stake in Maroc Telecom." ;
    ns1:documentTitle "Growth returns in Spain; Etisalat may have a partner for Maroc Telecom stake" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/growth-returns-spain-etisalat-may-have-a-partner-for-maroc-telecom-stake> ;
    ns1:foundName "purchase" ;
    ns1:name "purchase" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2651118/Maroc_Telecom> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Maroc Telecom" ;
    ns1:whereGeoName "Kingdom of Morocco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2542007/about.rdf> ;
    ns1:whereRaw "Morocco" .

<https://1145.am/db/2651156/Maroc_Telecom> a org:Organization ;
    ns1:basedInLowRaw "Morocco" ;
    ns1:documentDate "2013-07-24T11:16:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vivendi pushes ahead with plan to offload Maroc Telecom" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/vivendi-pushes-ahead-plan-to-offload-maroc-telecom> ;
    ns1:foundName "Maroc Telecom" ;
    ns1:industry "telecoms" ;
    ns1:name "Maroc Telecom" ;
    ns1:sameAsHigh <https://1145.am/db/2650898/Maroc_Telecom>,
        <https://1145.am/db/2651782/Maroc_Telecom>,
        <https://1145.am/db/2654132/Maroc_Telecom>,
        <https://1145.am/db/2657814/Maroc_Telecom>,
        <https://1145.am/db/2658891/Maroc_Telecom>,
        <https://1145.am/db/2663091/Maroc_Telecom>,
        <https://1145.am/db/2668512/Maroc_Telecom>,
        <https://1145.am/db/2668561/Maroc_Telecom>,
        <https://1145.am/db/2669629/Maroc_Telecom>,
        <https://1145.am/db/2673070/Maroc_Telecom>,
        <https://1145.am/db/2674199/Maroc_Telecom> ;
    ns1:sameAsMedium <https://1145.am/db/2604246/Maroc_Telecom>,
        <https://1145.am/db/2651118/Maroc_Telecom>,
        <https://1145.am/db/2651496/Maroc_Telecom>,
        <https://1145.am/db/2655001/Maroc_Telecom>,
        <https://1145.am/db/2662038/Maroc_Telecom>,
        <https://1145.am/db/2665333/Maroc_Telecom>,
        <https://1145.am/db/2667532/Maroc_Telecom>,
        <https://1145.am/db/2668596/Maroc_Telecom>,
        <https://1145.am/db/2669641/Maroc_Telecom>,
        <https://1145.am/db/2670741/Maroc_Telecom>,
        <https://1145.am/db/2673046/Maroc_Telecom>,
        <https://1145.am/db/2677850/Maroc_Telecom>,
        <https://1145.am/db/2678974/Maroc_Telecom> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2662077/Divestment_Batelco_Cable___Wireless_Communications_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "divestment" ;
    ns1:documentDate "2014-01-03T17:01:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> After the unravelling of its Seychelles deal, Batelco has also agreed to unwind its Monaco deal with Cable & Wireless Communications." ;
    ns1:documentTitle "Turkcell refutes 180M tax demand; KPN takes control of FTTH operator" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/turkcell-refutes-eu180m-tax-demand-kpn-takes-control-ftth-operator> ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Republic of Seychelles" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/241170/about.rdf> ;
    ns1:whereRaw "Seychelles" .

<https://1145.am/db/2662077/Reggefiber_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2014-01-03T17:01:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> KPN said it has taken control of its FTTH operator Reggefiber after it increased its holding to 60 per cent at a cost of up to 161 million ($ 219 million) .",
        "> KPN said it has taken control of its FTTH operator Reggefiber after it increased its holding to 60 per cent at a cost of up to 161 million ($ 219 million)." ;
    ns1:documentTitle "Turkcell refutes 180M tax demand; KPN takes control of FTTH operator" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/turkcell-refutes-eu180m-tax-demand-kpn-takes-control-ftth-operator> ;
    ns1:foundName "control",
        "taken control" ;
    ns1:name "control",
        "taken control" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2662077/Reggefiber> ;
    ns1:targetName "Reggefiber" ;
    ns1:valueRaw "$ 219 million",
        "up to 161 million" .

<https://1145.am/db/2663183/E-Plus_Merger> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2014-01-28T21:03:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Indeed, reports this week also said the European Commission has raised \"concerns\" about Hutchison Whampoa's plan to buy Telefnica Ireland and merge it with 3 Ireland, while it's already clear that it will not be smooth sailing for Telefnica's planned acquisition of Germany's E-Plus from KPN to form Germany's largest mobile operator." ;
    ns1:documentTitle "As Vodafone closes its Verizon deal, the rumour mill goes into overdrive" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/as-vodafone-closes-its-verizon-deal-rumour-mill-goes-into-overdrive> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2663183/E-Plus> ;
    ns1:targetName "E-Plus" ;
    ns1:vendor <https://1145.am/db/2663183/KPN> ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2663183/Telefnica_Ireland_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2014-01-28T21:03:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Indeed, reports this week also said the European Commission has raised \"concerns\" about Hutchison Whampoa's plan to buy Telefnica Ireland and merge it with 3 Ireland, while it's already clear that it will not be smooth sailing for Telefnica's planned acquisition of Germany's E-Plus from KPN to form Germany's largest mobile operator." ;
    ns1:documentTitle "As Vodafone closes its Verizon deal, the rumour mill goes into overdrive" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/as-vodafone-closes-its-verizon-deal-rumour-mill-goes-into-overdrive> ;
    ns1:foundName "buy",
        "merge" ;
    ns1:name "buy",
        "merge" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2663183/Telefnica_Ireland> ;
    ns1:targetName "Telefnica Ireland" ;
    ns1:vendor <https://1145.am/db/2663183/KPN> ;
    ns1:whereGeoName "Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2963597/about.rdf> ;
    ns1:whereRaw "Ireland" .

<https://1145.am/db/2682450/Clearwire_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:basedInLowRaw "US" ;
    ns1:description "mergers and acquisitions" ;
    ns1:documentDate "2013-08-12T14:10:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "After years of talking about mergers and acquisitions, the nation's top wireless carriers got down to business during the second quarter of this year, with T-Mobile US (NYSE: TMUS) working to integrate its purchase of MetroPCS and Sprint (NYSE: S) closing on its purchase of Clearwire and netting an investment from Japan's SoftBank." ;
    ns1:documentTitle "M&A catches fire: 24M wireless subscribers moving from Tier 2 to Tier 1 carriers" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/m-a-catches-fire-24m-wireless-subscribers-moving-from-tier-2-to-tier-1-carriers> ;
    ns1:foundName "Clearwire",
        "purchase" ;
    ns1:industry "wireless carriers" ;
    ns1:name "Clearwire",
        "purchase" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2682450/Clearwire_Acquisition> ;
    ns1:targetName "Clearwire" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "US" .

<https://1145.am/db/2683079/Blackberry> a org:Organization ;
    ns1:description "smartphone maker" ;
    ns1:documentDate "2013-09-04T21:18:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: BlackBerry hopes to wrap up sales process by November" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-blackberry-hopes-to-wrap-up-sales-process-by-november> ;
    ns1:foundName "BlackBerry" ;
    ns1:industry "smartphone" ;
    ns1:name "BlackBerry" ;
    ns1:sameAsHigh <https://1145.am/db/1814383/Blackberry>,
        <https://1145.am/db/1838842/Blackberry>,
        <https://1145.am/db/1850698/Blackberry>,
        <https://1145.am/db/2098356/Blackberry_Ltd>,
        <https://1145.am/db/2663334/Blackberry>,
        <https://1145.am/db/2678056/Blackberry>,
        <https://1145.am/db/2683080/Blackberry>,
        <https://1145.am/db/2786734/Blackberry> ;
    ns1:sameAsMedium <https://1145.am/db/1779043/Blackberry>,
        <https://1145.am/db/1811042/Blackberry>,
        <https://1145.am/db/1816730/Blackberry>,
        <https://1145.am/db/1848217/Blackberry>,
        <https://1145.am/db/1990298/Blackberry>,
        <https://1145.am/db/2203750/Blackberry_Ltd>,
        <https://1145.am/db/2275341/Blackberry>,
        <https://1145.am/db/2608115/Blackberry>,
        <https://1145.am/db/2643859/Blackberry>,
        <https://1145.am/db/2651356/Blackberry>,
        <https://1145.am/db/2653474/Blackberry>,
        <https://1145.am/db/2654259/Blackberry>,
        <https://1145.am/db/2654828/Blackberry>,
        <https://1145.am/db/2655153/Blackberry>,
        <https://1145.am/db/2656027/Blackberry>,
        <https://1145.am/db/2656049/Blackberry>,
        <https://1145.am/db/2657055/Blackberry>,
        <https://1145.am/db/2659028/Blackberry>,
        <https://1145.am/db/2660881/Blackberry>,
        <https://1145.am/db/2664675/Blackberry>,
        <https://1145.am/db/2669013/Blackberry>,
        <https://1145.am/db/2673373/Blackberry>,
        <https://1145.am/db/2684131/Blackberry>,
        <https://1145.am/db/799471/Blackberry_Ltd>,
        <https://1145.am/db/799510/Blackberry_Ltd> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2683079/Microsoft> a org:Organization ;
    ns1:buyer <https://1145.am/db/2683079/Business_Acquisition_Microsoft_Nokia_Has_Not_Happened> ;
    ns1:description "Windows Phone" ;
    ns1:documentDate "2013-09-04T21:18:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: BlackBerry hopes to wrap up sales process by November" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-blackberry-hopes-to-wrap-up-sales-process-by-november> ;
    ns1:foundName "Microsoft" ;
    ns1:name "Microsoft" ;
    ns1:sameAsHigh <https://1145.am/db/1843539/Nokia>,
        <https://1145.am/db/2656076/Nokia>,
        <https://1145.am/db/2683074/Nokia>,
        <https://1145.am/db/2683079/Nokia> ;
    ns1:sameAsMedium <https://1145.am/db/1017437/Microsoft_Corp>,
        <https://1145.am/db/1025001/Microsoft_Corp>,
        <https://1145.am/db/1092654/Microsoft>,
        <https://1145.am/db/1190136/Microsoft>,
        <https://1145.am/db/1311662/Microsoft_Corp>,
        <https://1145.am/db/1314290/Microsoft>,
        <https://1145.am/db/1343611/Microsoft_Corp>,
        <https://1145.am/db/1346180/Microsoft>,
        <https://1145.am/db/1382052/Microsoft_Corp>,
        <https://1145.am/db/1398821/Microsoft>,
        <https://1145.am/db/1428802/Microsoft>,
        <https://1145.am/db/1487902/Microsoft>,
        <https://1145.am/db/1527244/Microsoft_Corp>,
        <https://1145.am/db/1558774/Microsoft>,
        <https://1145.am/db/1566732/Microsoft>,
        <https://1145.am/db/1571096/Microsoft>,
        <https://1145.am/db/1600830/Microsoft_Corp>,
        <https://1145.am/db/1617851/Microsoft>,
        <https://1145.am/db/1618044/Microsoft_Corp>,
        <https://1145.am/db/161893/Microsoft>,
        <https://1145.am/db/1631476/Microsoft_Corp>,
        <https://1145.am/db/1633549/Microsoft>,
        <https://1145.am/db/1654251/Microsoft>,
        <https://1145.am/db/1655883/Microsoft>,
        <https://1145.am/db/1678251/Microsoft>,
        <https://1145.am/db/1689071/Microsoft>,
        <https://1145.am/db/1691718/Microsoft_Corp>,
        <https://1145.am/db/1695812/Microsoft>,
        <https://1145.am/db/1697158/Microsoft>,
        <https://1145.am/db/1697321/Microsoft>,
        <https://1145.am/db/1697590/Microsoft>,
        <https://1145.am/db/1698342/Microsoft>,
        <https://1145.am/db/1699320/Microsoft>,
        <https://1145.am/db/1699790/Microsoft>,
        <https://1145.am/db/1701497/Microsoft>,
        <https://1145.am/db/1703728/Microsoft_Corporation>,
        <https://1145.am/db/1706033/Microsoft>,
        <https://1145.am/db/1708523/Microsoft>,
        <https://1145.am/db/1708611/Microsoft>,
        <https://1145.am/db/1709652/Microsoft>,
        <https://1145.am/db/1709976/Microsoft>,
        <https://1145.am/db/1710427/Microsoft>,
        <https://1145.am/db/1710962/Microsoft>,
        <https://1145.am/db/1711305/Microsoft>,
        <https://1145.am/db/1712686/Microsoft_Corp>,
        <https://1145.am/db/1712862/Microsoft>,
        <https://1145.am/db/1714418/Microsoft>,
        <https://1145.am/db/1716650/Microsoft>,
        <https://1145.am/db/1717533/Microsoft>,
        <https://1145.am/db/1718033/Microsoft>,
        <https://1145.am/db/1718245/Microsoft>,
        <https://1145.am/db/1719232/Microsoft>,
        <https://1145.am/db/1721134/Microsoft>,
        <https://1145.am/db/1723140/Microsoft_Corp>,
        <https://1145.am/db/1726210/Microsoft>,
        <https://1145.am/db/1727481/Microsoft>,
        <https://1145.am/db/1734650/Microsoft>,
        <https://1145.am/db/1734778/Microsoft>,
        <https://1145.am/db/1734931/Microsoft>,
        <https://1145.am/db/1735301/Microsoft>,
        <https://1145.am/db/1737935/Microsoft>,
        <https://1145.am/db/1741120/Microsoft>,
        <https://1145.am/db/1741140/Microsoft>,
        <https://1145.am/db/1742118/Microsoft>,
        <https://1145.am/db/1746848/Microsoft>,
        <https://1145.am/db/1746971/Microsoft>,
        <https://1145.am/db/1747044/Microsoft>,
        <https://1145.am/db/1747812/Microsoft>,
        <https://1145.am/db/1748887/Microsoft>,
        <https://1145.am/db/1749016/Microsoft>,
        <https://1145.am/db/1751726/Microsoft>,
        <https://1145.am/db/1752062/Microsoft>,
        <https://1145.am/db/1754464/Microsoft>,
        <https://1145.am/db/1755059/Microsoft>,
        <https://1145.am/db/1755209/Microsoft>,
        <https://1145.am/db/1758390/Microsoft>,
        <https://1145.am/db/1758900/Microsoft>,
        <https://1145.am/db/1758924/Microsoft>,
        <https://1145.am/db/1759192/Microsoft>,
        <https://1145.am/db/1759760/Microsoft>,
        <https://1145.am/db/1759766/Microsoft>,
        <https://1145.am/db/1760029/Microsoft>,
        <https://1145.am/db/1760205/Microsoft>,
        <https://1145.am/db/1760729/Microsoft>,
        <https://1145.am/db/1760981/Microsoft>,
        <https://1145.am/db/1762702/Microsoft>,
        <https://1145.am/db/1763332/Microsoft>,
        <https://1145.am/db/1764427/Microsoft>,
        <https://1145.am/db/1768188/Microsoft>,
        <https://1145.am/db/1768388/Microsoft>,
        <https://1145.am/db/1769233/Microsoft>,
        <https://1145.am/db/1770225/Microsoft>,
        <https://1145.am/db/1770401/Microsoft>,
        <https://1145.am/db/1771744/Microsoft>,
        <https://1145.am/db/1772579/Microsoft>,
        <https://1145.am/db/1772600/Microsoft>,
        <https://1145.am/db/1773454/Microsoft>,
        <https://1145.am/db/1777695/Microsoft>,
        <https://1145.am/db/1778043/Microsoft>,
        <https://1145.am/db/1778089/Microsoft>,
        <https://1145.am/db/1778879/Microsoft>,
        <https://1145.am/db/1780530/Microsoft>,
        <https://1145.am/db/1781499/Microsoft>,
        <https://1145.am/db/1782580/Microsoft>,
        <https://1145.am/db/1783135/Microsoft>,
        <https://1145.am/db/1786640/Microsoft>,
        <https://1145.am/db/1786753/Microsoft>,
        <https://1145.am/db/1786991/Microsoft>,
        <https://1145.am/db/1788358/Microsoft>,
        <https://1145.am/db/1790700/Microsoft>,
        <https://1145.am/db/1791808/Microsoft>,
        <https://1145.am/db/1792227/Microsoft>,
        <https://1145.am/db/1792368/Microsoft>,
        <https://1145.am/db/1792666/Microsoft>,
        <https://1145.am/db/1792965/Microsoft>,
        <https://1145.am/db/1793015/Microsoft>,
        <https://1145.am/db/1794612/Microsoft>,
        <https://1145.am/db/1795244/Microsoft>,
        <https://1145.am/db/1795255/Microsoft>,
        <https://1145.am/db/1795869/Microsoft>,
        <https://1145.am/db/1795925/Microsoft>,
        <https://1145.am/db/1796232/Microsoft>,
        <https://1145.am/db/1796259/Microsoft>,
        <https://1145.am/db/1796273/Microsoft>,
        <https://1145.am/db/1798246/Microsoft>,
        <https://1145.am/db/1798437/Microsoft>,
        <https://1145.am/db/1800013/Microsoft>,
        <https://1145.am/db/1801241/Microsoft>,
        <https://1145.am/db/1802129/Microsoft>,
        <https://1145.am/db/1803214/Microsoft>,
        <https://1145.am/db/1807226/Microsoft>,
        <https://1145.am/db/1808409/Microsoft>,
        <https://1145.am/db/1809462/Microsoft>,
        <https://1145.am/db/1810877/Microsoft>,
        <https://1145.am/db/1811070/Microsoft>,
        <https://1145.am/db/1811482/Microsoft>,
        <https://1145.am/db/1813957/Microsoft>,
        <https://1145.am/db/1814632/Microsoft>,
        <https://1145.am/db/1814865/Microsoft>,
        <https://1145.am/db/1816265/Microsoft>,
        <https://1145.am/db/1816532/Microsoft>,
        <https://1145.am/db/1817819/Microsoft>,
        <https://1145.am/db/1818394/Microsoft>,
        <https://1145.am/db/1818533/Microsoft>,
        <https://1145.am/db/1818534/Microsoft>,
        <https://1145.am/db/1819909/Microsoft>,
        <https://1145.am/db/1820048/Microsoft>,
        <https://1145.am/db/1822222/Microsoft>,
        <https://1145.am/db/1823778/Microsoft>,
        <https://1145.am/db/1824780/Microsoft>,
        <https://1145.am/db/1825996/Microsoft>,
        <https://1145.am/db/1826121/Microsoft>,
        <https://1145.am/db/1827341/Microsoft>,
        <https://1145.am/db/1828648/Microsoft>,
        <https://1145.am/db/1828902/Microsoft>,
        <https://1145.am/db/1830298/Microsoft>,
        <https://1145.am/db/1831301/Microsoft>,
        <https://1145.am/db/1832770/Microsoft>,
        <https://1145.am/db/1833510/Microsoft>,
        <https://1145.am/db/1834475/Microsoft>,
        <https://1145.am/db/1835226/Microsoft>,
        <https://1145.am/db/1835448/Microsoft>,
        <https://1145.am/db/1838210/Microsoft>,
        <https://1145.am/db/1838478/Microsoft>,
        <https://1145.am/db/1839207/Microsoft>,
        <https://1145.am/db/1841018/Microsoft_Corp>,
        <https://1145.am/db/1842562/Microsoft>,
        <https://1145.am/db/1842887/Microsoft>,
        <https://1145.am/db/1843454/Microsoft>,
        <https://1145.am/db/1843539/Microsoft>,
        <https://1145.am/db/1843972/Microsoft>,
        <https://1145.am/db/1852125/Microsoft>,
        <https://1145.am/db/1853227/Microsoft>,
        <https://1145.am/db/1854780/Microsoft>,
        <https://1145.am/db/1854945/Microsoft>,
        <https://1145.am/db/1855966/Microsoft>,
        <https://1145.am/db/1856684/Microsoft>,
        <https://1145.am/db/1858254/Microsoft>,
        <https://1145.am/db/1858451/Microsoft>,
        <https://1145.am/db/1858692/Microsoft>,
        <https://1145.am/db/1860773/Microsoft>,
        <https://1145.am/db/1861339/Microsoft>,
        <https://1145.am/db/1871130/Microsoft>,
        <https://1145.am/db/1871611/Microsoft>,
        <https://1145.am/db/1874678/Microsoft>,
        <https://1145.am/db/1875189/Microsoft>,
        <https://1145.am/db/1879673/Microsoft>,
        <https://1145.am/db/1879985/Microsoft>,
        <https://1145.am/db/1881214/Microsoft>,
        <https://1145.am/db/1882058/Microsoft>,
        <https://1145.am/db/1882161/Microsoft>,
        <https://1145.am/db/1884277/Microsoft>,
        <https://1145.am/db/1885560/Microsoft>,
        <https://1145.am/db/1888008/Microsoft>,
        <https://1145.am/db/1895009/Microsoft>,
        <https://1145.am/db/1897581/Microsoft>,
        <https://1145.am/db/1901098/Microsoft>,
        <https://1145.am/db/1902016/Microsoft>,
        <https://1145.am/db/1902079/Microsoft>,
        <https://1145.am/db/1902847/Microsoft>,
        <https://1145.am/db/1903669/Microsoft>,
        <https://1145.am/db/1903721/Microsoft>,
        <https://1145.am/db/1905425/Microsoft>,
        <https://1145.am/db/1909119/Microsoft_Corp>,
        <https://1145.am/db/1910290/Microsoft_Corp>,
        <https://1145.am/db/1914747/Microsoft>,
        <https://1145.am/db/1915432/Microsoft>,
        <https://1145.am/db/1915560/Microsoft>,
        <https://1145.am/db/1941048/Microsoft_Corp>,
        <https://1145.am/db/1942901/Microsoft_Corp>,
        <https://1145.am/db/1943925/Microsoft_Corp>,
        <https://1145.am/db/1947749/Microsoft>,
        <https://1145.am/db/1947898/Microsoft>,
        <https://1145.am/db/1948338/Microsoft>,
        <https://1145.am/db/1961649/Microsoft>,
        <https://1145.am/db/1974598/Microsoft>,
        <https://1145.am/db/1981521/Microsoft>,
        <https://1145.am/db/1982175/Microsoft>,
        <https://1145.am/db/1984927/Microsoft>,
        <https://1145.am/db/1986630/Microsoft>,
        <https://1145.am/db/1987503/Microsoft>,
        <https://1145.am/db/1993523/Microsoft>,
        <https://1145.am/db/199718/Microsoft>,
        <https://1145.am/db/199816/Microsoft>,
        <https://1145.am/db/2002065/Microsoft_Corp>,
        <https://1145.am/db/2004213/Microsoft_Corp>,
        <https://1145.am/db/2006775/Microsoft>,
        <https://1145.am/db/2007265/Microsoft>,
        <https://1145.am/db/2008078/Microsoft_Corp>,
        <https://1145.am/db/2011789/Microsoft>,
        <https://1145.am/db/2013724/Microsoft>,
        <https://1145.am/db/2015713/Microsoft_Corp>,
        <https://1145.am/db/2015981/Microsoft>,
        <https://1145.am/db/2029229/Microsoft>,
        <https://1145.am/db/2033848/Microsoft>,
        <https://1145.am/db/2034613/Microsoft>,
        <https://1145.am/db/2034974/Microsoft_Corp>,
        <https://1145.am/db/2036186/Microsoft>,
        <https://1145.am/db/2036982/Microsoft_Corp>,
        <https://1145.am/db/2037760/Microsoft>,
        <https://1145.am/db/2039253/Microsoft>,
        <https://1145.am/db/2040859/Microsoft>,
        <https://1145.am/db/2045433/Microsoft>,
        <https://1145.am/db/2047060/Microsoft>,
        <https://1145.am/db/2050229/Microsoft>,
        <https://1145.am/db/2053053/Microsoft>,
        <https://1145.am/db/2053123/Microsoft>,
        <https://1145.am/db/2053654/Microsoft>,
        <https://1145.am/db/2059318/Microsoft>,
        <https://1145.am/db/2059491/Microsoft>,
        <https://1145.am/db/2059502/Microsoft>,
        <https://1145.am/db/2059547/Microsoft>,
        <https://1145.am/db/2060416/Microsoft>,
        <https://1145.am/db/2060997/Microsoft>,
        <https://1145.am/db/2062372/Microsoft>,
        <https://1145.am/db/2063305/Microsoft>,
        <https://1145.am/db/2063335/Microsoft_Corp>,
        <https://1145.am/db/2063909/Microsoft>,
        <https://1145.am/db/2064352/Microsoft>,
        <https://1145.am/db/2065497/Microsoft>,
        <https://1145.am/db/2067787/Microsoft>,
        <https://1145.am/db/2072814/Microsoft>,
        <https://1145.am/db/2083718/Microsoft>,
        <https://1145.am/db/2093298/Microsoft>,
        <https://1145.am/db/2094024/Microsoft>,
        <https://1145.am/db/2109233/Microsoft>,
        <https://1145.am/db/2120040/Microsoft>,
        <https://1145.am/db/2122854/Microsoft>,
        <https://1145.am/db/2127651/Microsoft>,
        <https://1145.am/db/2144448/Microsoft>,
        <https://1145.am/db/2145163/Microsoft>,
        <https://1145.am/db/2148259/Microsoft>,
        <https://1145.am/db/2162386/Microsoft>,
        <https://1145.am/db/217185/Microsoft>,
        <https://1145.am/db/2172604/Microsoft>,
        <https://1145.am/db/2173138/Microsoft>,
        <https://1145.am/db/2174297/Microsoft>,
        <https://1145.am/db/2178519/Microsoft>,
        <https://1145.am/db/2180858/Microsoft>,
        <https://1145.am/db/2187630/Microsoft>,
        <https://1145.am/db/2197267/Microsoft>,
        <https://1145.am/db/2198071/Microsoft>,
        <https://1145.am/db/2198670/Microsoft>,
        <https://1145.am/db/2207923/Microsoft>,
        <https://1145.am/db/2225131/Microsoft>,
        <https://1145.am/db/2278997/Microsoft>,
        <https://1145.am/db/2279241/Microsoft>,
        <https://1145.am/db/228046/Microsoft>,
        <https://1145.am/db/2284483/Microsoft>,
        <https://1145.am/db/232308/Microsoft_Corp>,
        <https://1145.am/db/232337/Microsoft_Corp>,
        <https://1145.am/db/2326224/Microsoft_Corp>,
        <https://1145.am/db/2508969/Microsoft>,
        <https://1145.am/db/2601736/Microsoft>,
        <https://1145.am/db/2602130/Microsoft>,
        <https://1145.am/db/2602724/Microsoft>,
        <https://1145.am/db/2602863/Microsoft>,
        <https://1145.am/db/2602958/Microsoft>,
        <https://1145.am/db/2603484/Microsoft>,
        <https://1145.am/db/2604604/Microsoft>,
        <https://1145.am/db/2606540/Microsoft>,
        <https://1145.am/db/2611328/Microsoft>,
        <https://1145.am/db/2611331/Microsoft>,
        <https://1145.am/db/2611481/Microsoft>,
        <https://1145.am/db/2612223/Microsoft>,
        <https://1145.am/db/2612606/Microsoft>,
        <https://1145.am/db/2613829/Microsoft>,
        <https://1145.am/db/2617989/Microsoft>,
        <https://1145.am/db/2620025/Microsoft>,
        <https://1145.am/db/2620026/Microsoft>,
        <https://1145.am/db/2622354/Microsoft>,
        <https://1145.am/db/2623559/Microsoft>,
        <https://1145.am/db/2626449/Microsoft>,
        <https://1145.am/db/2627269/Microsoft>,
        <https://1145.am/db/2628760/Microsoft>,
        <https://1145.am/db/2634465/Microsoft>,
        <https://1145.am/db/2634487/Microsoft>,
        <https://1145.am/db/2636189/Microsoft>,
        <https://1145.am/db/2636234/Microsoft>,
        <https://1145.am/db/2639094/Microsoft>,
        <https://1145.am/db/2640110/Microsoft>,
        <https://1145.am/db/2640182/Microsoft>,
        <https://1145.am/db/2644494/Microsoft>,
        <https://1145.am/db/2648410/Microsoft>,
        <https://1145.am/db/2648535/Microsoft>,
        <https://1145.am/db/2648546/Microsoft>,
        <https://1145.am/db/2651427/Microsoft>,
        <https://1145.am/db/2651769/Microsoft>,
        <https://1145.am/db/2652890/Microsoft>,
        <https://1145.am/db/2653297/Microsoft>,
        <https://1145.am/db/2653310/Microsoft>,
        <https://1145.am/db/2653481/Microsoft>,
        <https://1145.am/db/2653908/Microsoft>,
        <https://1145.am/db/2654138/Microsoft>,
        <https://1145.am/db/2654146/Microsoft>,
        <https://1145.am/db/2654238/Microsoft>,
        <https://1145.am/db/2654294/Microsoft>,
        <https://1145.am/db/2654510/Microsoft>,
        <https://1145.am/db/2654524/Microsoft>,
        <https://1145.am/db/2655064/Microsoft>,
        <https://1145.am/db/2655146/Microsoft>,
        <https://1145.am/db/2655423/Microsoft>,
        <https://1145.am/db/2655439/Microsoft>,
        <https://1145.am/db/2655461/Microsoft>,
        <https://1145.am/db/2656101/Microsoft>,
        <https://1145.am/db/2656359/Microsoft>,
        <https://1145.am/db/2656986/Microsoft>,
        <https://1145.am/db/2657038/Microsoft>,
        <https://1145.am/db/2658038/Microsoft>,
        <https://1145.am/db/2658913/Microsoft>,
        <https://1145.am/db/2659072/Microsoft>,
        <https://1145.am/db/2659897/Microsoft>,
        <https://1145.am/db/2659924/Microsoft>,
        <https://1145.am/db/2659958/Microsoft>,
        <https://1145.am/db/2661009/Microsoft>,
        <https://1145.am/db/2661125/Microsoft>,
        <https://1145.am/db/2661187/Microsoft>,
        <https://1145.am/db/2662106/Microsoft>,
        <https://1145.am/db/2662211/Microsoft>,
        <https://1145.am/db/2662486/Microsoft>,
        <https://1145.am/db/2663295/Microsoft>,
        <https://1145.am/db/2663557/Microsoft>,
        <https://1145.am/db/2664293/Microsoft>,
        <https://1145.am/db/2664464/Microsoft>,
        <https://1145.am/db/2666156/Microsoft>,
        <https://1145.am/db/2667065/Microsoft>,
        <https://1145.am/db/2667078/Microsoft>,
        <https://1145.am/db/2667474/Microsoft>,
        <https://1145.am/db/2667526/Microsoft>,
        <https://1145.am/db/2667660/Microsoft>,
        <https://1145.am/db/2669494/Microsoft>,
        <https://1145.am/db/2670705/Microsoft>,
        <https://1145.am/db/2671587/Microsoft>,
        <https://1145.am/db/2671878/Microsoft>,
        <https://1145.am/db/2672066/Microsoft>,
        <https://1145.am/db/2672194/Microsoft>,
        <https://1145.am/db/2672819/Microsoft>,
        <https://1145.am/db/2673373/Microsoft>,
        <https://1145.am/db/2673385/Microsoft>,
        <https://1145.am/db/2673437/Microsoft>,
        <https://1145.am/db/2673898/Microsoft>,
        <https://1145.am/db/2675617/Microsoft>,
        <https://1145.am/db/2679159/Microsoft>,
        <https://1145.am/db/2679256/Microsoft>,
        <https://1145.am/db/2679342/Microsoft>,
        <https://1145.am/db/2681897/Microsoft>,
        <https://1145.am/db/2682508/Microsoft>,
        <https://1145.am/db/2683061/Microsoft>,
        <https://1145.am/db/2683066/Microsoft>,
        <https://1145.am/db/2683067/Microsoft>,
        <https://1145.am/db/2683069/Microsoft>,
        <https://1145.am/db/2683074/Microsoft>,
        <https://1145.am/db/2683077/Microsoft>,
        <https://1145.am/db/2683451/Microsoft>,
        <https://1145.am/db/2683465/Microsoft>,
        <https://1145.am/db/2683818/Microsoft>,
        <https://1145.am/db/2686285/Microsoft>,
        <https://1145.am/db/2686301/Microsoft>,
        <https://1145.am/db/2686449/Microsoft>,
        <https://1145.am/db/2700623/Microsoft>,
        <https://1145.am/db/2738271/Microsoft>,
        <https://1145.am/db/2754611/Microsoft>,
        <https://1145.am/db/2760139/Microsoft_Corp>,
        <https://1145.am/db/2761530/Microsoft_Corp>,
        <https://1145.am/db/2762134/Microsoft>,
        <https://1145.am/db/2762347/Microsoft_Corp>,
        <https://1145.am/db/2762562/Microsoft>,
        <https://1145.am/db/2776232/Microsoft>,
        <https://1145.am/db/2782429/Microsoft>,
        <https://1145.am/db/2801091/Microsoft_Corporation>,
        <https://1145.am/db/282538/Microsoft_Corp>,
        <https://1145.am/db/305288/Microsoft_Corp>,
        <https://1145.am/db/305594/Microsoft_Corp>,
        <https://1145.am/db/347978/Microsoft_Corp>,
        <https://1145.am/db/348031/Microsoft_Corp>,
        <https://1145.am/db/355324/Microsoft_Corp>,
        <https://1145.am/db/355332/Microsoft_Corp>,
        <https://1145.am/db/361491/Microsoft>,
        <https://1145.am/db/365521/Microsoft_Corp>,
        <https://1145.am/db/387846/Microsoft_Corp>,
        <https://1145.am/db/505767/Microsoft_Corp>,
        <https://1145.am/db/544757/Microsoft>,
        <https://1145.am/db/549213/Microsoft_Corp>,
        <https://1145.am/db/644370/Microsoft_Corp>,
        <https://1145.am/db/692886/Microsoft_Corp>,
        <https://1145.am/db/698837/Microsoft>,
        <https://1145.am/db/710355/Microsoft>,
        <https://1145.am/db/710798/Microsoft>,
        <https://1145.am/db/765281/Microsoft_Corp>,
        <https://1145.am/db/766576/Microsoft_Corp>,
        <https://1145.am/db/767841/Microsoft>,
        <https://1145.am/db/767857/Microsoft_Corp>,
        <https://1145.am/db/771073/Microsoft>,
        <https://1145.am/db/771474/Microsoft>,
        <https://1145.am/db/771701/Microsoft_Corp>,
        <https://1145.am/db/771800/Microsoft_Corp>,
        <https://1145.am/db/772395/Microsoft>,
        <https://1145.am/db/774623/Microsoft_Corp>,
        <https://1145.am/db/784797/Microsoft>,
        <https://1145.am/db/798667/Microsoft_Corp>,
        <https://1145.am/db/798704/Microsoft>,
        <https://1145.am/db/798950/Microsoft_Corp>,
        <https://1145.am/db/816467/Microsoft_Corp>,
        <https://1145.am/db/817822/Microsoft_Corp>,
        <https://1145.am/db/829840/Microsoft_Corp>,
        <https://1145.am/db/85685/Microsoft_Corp>,
        <https://1145.am/db/867602/Microsoft_Corporation>,
        <https://1145.am/db/871474/Microsoft_Corporation>,
        <https://1145.am/db/877583/Microsoft_Corp>,
        <https://1145.am/db/879601/Microsoft>,
        <https://1145.am/db/880066/Microsoft_Corp>,
        <https://1145.am/db/907229/Microsoft>,
        <https://1145.am/db/920712/Microsoft>,
        <https://1145.am/db/969129/Microsoft>,
        <https://1145.am/db/973870/Microsoft> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2683079/Nokia> a org:Organization ;
    ns1:basedInLowRaw "Finland" ;
    ns1:description "Microsoft" ;
    ns1:documentDate "2013-09-04T21:18:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: BlackBerry hopes to wrap up sales process by November" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-blackberry-hopes-to-wrap-up-sales-process-by-november> ;
    ns1:foundName "Nokia" ;
    ns1:name "Nokia" ;
    ns1:sameAsHigh <https://1145.am/db/1843539/Nokia>,
        <https://1145.am/db/2656076/Nokia>,
        <https://1145.am/db/2683074/Nokia>,
        <https://1145.am/db/2683079/Microsoft> ;
    ns1:sameAsMedium <https://1145.am/db/1037186/Nokia>,
        <https://1145.am/db/1359660/Nokia>,
        <https://1145.am/db/1376231/Nokia>,
        <https://1145.am/db/1396756/Nokia>,
        <https://1145.am/db/1619378/Nokia>,
        <https://1145.am/db/165554/Nokia>,
        <https://1145.am/db/1695286/Nokia>,
        <https://1145.am/db/1696015/Nokia>,
        <https://1145.am/db/1696105/Nokia>,
        <https://1145.am/db/1698635/Nokia>,
        <https://1145.am/db/1703449/Nokia>,
        <https://1145.am/db/1712040/Nokia>,
        <https://1145.am/db/1712862/Nokia>,
        <https://1145.am/db/1714727/Nokia_Corp>,
        <https://1145.am/db/1717500/Nokia>,
        <https://1145.am/db/1738836/Nokia>,
        <https://1145.am/db/176372/Nokia>,
        <https://1145.am/db/1783319/Nokia>,
        <https://1145.am/db/1784898/Nokia>,
        <https://1145.am/db/1790667/Nokia>,
        <https://1145.am/db/1790669/Nokia>,
        <https://1145.am/db/1790693/Nokia>,
        <https://1145.am/db/1793899/Nokia>,
        <https://1145.am/db/1795878/Nokia>,
        <https://1145.am/db/1801551/Nokia>,
        <https://1145.am/db/1807573/Nokia>,
        <https://1145.am/db/1814938/Nokia>,
        <https://1145.am/db/1825996/Nokia>,
        <https://1145.am/db/1827015/Nokia>,
        <https://1145.am/db/1828575/Nokia>,
        <https://1145.am/db/1830298/Nokia>,
        <https://1145.am/db/1831301/Nokia>,
        <https://1145.am/db/1833187/Nokia>,
        <https://1145.am/db/1835448/Nokia>,
        <https://1145.am/db/1835609/Nokia>,
        <https://1145.am/db/1838210/Nokia>,
        <https://1145.am/db/1839894/Nokia>,
        <https://1145.am/db/1845326/Nokia>,
        <https://1145.am/db/1846111/Nokia>,
        <https://1145.am/db/1846882/Nokia>,
        <https://1145.am/db/1853227/Nokia>,
        <https://1145.am/db/1858692/Nokia>,
        <https://1145.am/db/1865499/Nokia>,
        <https://1145.am/db/1865872/Nokia>,
        <https://1145.am/db/1870230/Nokia>,
        <https://1145.am/db/1871174/Nokia>,
        <https://1145.am/db/1875661/Nokia_Inc>,
        <https://1145.am/db/1879750/Nokia>,
        <https://1145.am/db/1882299/Nokia>,
        <https://1145.am/db/1890614/Nokia>,
        <https://1145.am/db/1890976/Nokia>,
        <https://1145.am/db/1895447/Nokia>,
        <https://1145.am/db/1896374/Nokia>,
        <https://1145.am/db/1904425/Nokia>,
        <https://1145.am/db/1906036/Nokia>,
        <https://1145.am/db/1916486/Nokia>,
        <https://1145.am/db/1917471/Nokia>,
        <https://1145.am/db/1924700/Nokia>,
        <https://1145.am/db/1927944/Nokia>,
        <https://1145.am/db/2170316/Nokia>,
        <https://1145.am/db/2174288/Nokia>,
        <https://1145.am/db/2174456/Nokia>,
        <https://1145.am/db/2599088/Nokia>,
        <https://1145.am/db/2599918/Nokia>,
        <https://1145.am/db/2600870/Nokia>,
        <https://1145.am/db/2601537/Nokia>,
        <https://1145.am/db/2603904/Nokia>,
        <https://1145.am/db/2607614/Nokia>,
        <https://1145.am/db/2609511/Nokia>,
        <https://1145.am/db/2609716/Nokia>,
        <https://1145.am/db/2614782/Nokia>,
        <https://1145.am/db/2614789/Nokia>,
        <https://1145.am/db/2614792/Nokia>,
        <https://1145.am/db/2615500/Nokia>,
        <https://1145.am/db/2617770/Nokia>,
        <https://1145.am/db/2618495/Nokia>,
        <https://1145.am/db/2621187/Nokia>,
        <https://1145.am/db/2621962/Nokia>,
        <https://1145.am/db/2623767/Nokia>,
        <https://1145.am/db/2624147/Nokia>,
        <https://1145.am/db/2624535/Nokia>,
        <https://1145.am/db/2624696/Nokia>,
        <https://1145.am/db/2624733/Nokia>,
        <https://1145.am/db/2626031/Nokia>,
        <https://1145.am/db/2627160/Nokia>,
        <https://1145.am/db/2627372/Nokia>,
        <https://1145.am/db/2627414/Nokia>,
        <https://1145.am/db/2628699/Nokia>,
        <https://1145.am/db/2629266/Nokia>,
        <https://1145.am/db/2629267/Nokia>,
        <https://1145.am/db/2630737/Nokia>,
        <https://1145.am/db/2631028/Nokia>,
        <https://1145.am/db/2631707/Nokia>,
        <https://1145.am/db/2631993/Nokia>,
        <https://1145.am/db/2633794/Nokia>,
        <https://1145.am/db/2634501/Nokia>,
        <https://1145.am/db/2634920/Nokia>,
        <https://1145.am/db/2635003/Nokia>,
        <https://1145.am/db/2635759/Nokia>,
        <https://1145.am/db/2636183/Nokia>,
        <https://1145.am/db/2636760/Nokia>,
        <https://1145.am/db/2636765/Nokia>,
        <https://1145.am/db/2636778/Nokia>,
        <https://1145.am/db/2637157/Nokia>,
        <https://1145.am/db/2640215/Nokia>,
        <https://1145.am/db/2640228/Nokia>,
        <https://1145.am/db/2640373/Nokia>,
        <https://1145.am/db/2640910/Nokia>,
        <https://1145.am/db/2641276/Nokia>,
        <https://1145.am/db/2641414/Nokia>,
        <https://1145.am/db/2642217/Nokia>,
        <https://1145.am/db/2642235/Nokia>,
        <https://1145.am/db/2642646/Nokia>,
        <https://1145.am/db/2643193/Nokia>,
        <https://1145.am/db/2643195/Nokia>,
        <https://1145.am/db/2645829/Nokia>,
        <https://1145.am/db/2648546/Nokia>,
        <https://1145.am/db/2648701/Nokia>,
        <https://1145.am/db/2648885/Nokia>,
        <https://1145.am/db/2648954/Nokia>,
        <https://1145.am/db/2649144/Nokia>,
        <https://1145.am/db/2649563/Nokia>,
        <https://1145.am/db/2651127/Nokia>,
        <https://1145.am/db/2651231/Nokia>,
        <https://1145.am/db/2652286/Nokia>,
        <https://1145.am/db/2652949/Nokia>,
        <https://1145.am/db/2653255/Nokia>,
        <https://1145.am/db/2653265/Nokia>,
        <https://1145.am/db/2653297/Nokia>,
        <https://1145.am/db/2653300/Nokia>,
        <https://1145.am/db/2653310/Nokia>,
        <https://1145.am/db/2654000/Nokia>,
        <https://1145.am/db/2654017/Nokia>,
        <https://1145.am/db/2654138/Nokia>,
        <https://1145.am/db/2654146/Nokia>,
        <https://1145.am/db/2654241/Nokia>,
        <https://1145.am/db/2654294/Nokia>,
        <https://1145.am/db/2654800/Nokia>,
        <https://1145.am/db/2654830/Nokia>,
        <https://1145.am/db/2654869/Nokia>,
        <https://1145.am/db/2654873/Nokia>,
        <https://1145.am/db/2655001/Nokia>,
        <https://1145.am/db/2655146/Nokia>,
        <https://1145.am/db/2655779/Nokia>,
        <https://1145.am/db/2656279/Nokia>,
        <https://1145.am/db/2656749/Nokia>,
        <https://1145.am/db/2656794/Nokia>,
        <https://1145.am/db/2656808/Nokia>,
        <https://1145.am/db/2656858/Nokia>,
        <https://1145.am/db/2656866/Nokia>,
        <https://1145.am/db/2656920/Nokia>,
        <https://1145.am/db/2657048/Nokia>,
        <https://1145.am/db/2657106/Nokia>,
        <https://1145.am/db/2657253/Nokia>,
        <https://1145.am/db/2657268/Nokia>,
        <https://1145.am/db/2658174/Nokia>,
        <https://1145.am/db/2658419/Nokia>,
        <https://1145.am/db/2658434/Nokia>,
        <https://1145.am/db/2658583/Nokia>,
        <https://1145.am/db/2658760/Nokia>,
        <https://1145.am/db/2658770/Nokia>,
        <https://1145.am/db/2658774/Nokia>,
        <https://1145.am/db/2658799/Nokia>,
        <https://1145.am/db/2658913/Nokia>,
        <https://1145.am/db/2659333/Nokia>,
        <https://1145.am/db/2659924/Nokia>,
        <https://1145.am/db/2660647/Nokia>,
        <https://1145.am/db/2661009/Nokia>,
        <https://1145.am/db/2661124/Nokia>,
        <https://1145.am/db/2661125/Nokia>,
        <https://1145.am/db/2661307/Nokia>,
        <https://1145.am/db/2661570/Nokia>,
        <https://1145.am/db/2662029/Nokia>,
        <https://1145.am/db/2662211/Nokia>,
        <https://1145.am/db/2662505/Nokia>,
        <https://1145.am/db/2662711/Nokia>,
        <https://1145.am/db/2663033/Nokia>,
        <https://1145.am/db/2663052/Nokia>,
        <https://1145.am/db/2663295/Nokia>,
        <https://1145.am/db/2664139/Nokia>,
        <https://1145.am/db/2664167/Nokia>,
        <https://1145.am/db/2665201/Nokia>,
        <https://1145.am/db/2665211/Nokia>,
        <https://1145.am/db/2665218/Nokia>,
        <https://1145.am/db/2665697/Nokia>,
        <https://1145.am/db/2666307/Nokia>,
        <https://1145.am/db/2666818/Nokia>,
        <https://1145.am/db/2667146/Nokia>,
        <https://1145.am/db/2667474/Nokia>,
        <https://1145.am/db/2667526/Nokia>,
        <https://1145.am/db/2667660/Nokia>,
        <https://1145.am/db/2667808/Nokia>,
        <https://1145.am/db/2668422/Nokia>,
        <https://1145.am/db/2668600/Nokia>,
        <https://1145.am/db/2668973/Nokia>,
        <https://1145.am/db/2669356/Nokia>,
        <https://1145.am/db/2669831/Nokia>,
        <https://1145.am/db/2670472/Nokia>,
        <https://1145.am/db/2670745/Nokia>,
        <https://1145.am/db/2670934/Nokia>,
        <https://1145.am/db/2670935/Nokia>,
        <https://1145.am/db/2671116/Nokia>,
        <https://1145.am/db/2671140/Nokia>,
        <https://1145.am/db/2671171/Nokia>,
        <https://1145.am/db/2671363/Nokia>,
        <https://1145.am/db/2671571/Nokia>,
        <https://1145.am/db/2671749/Nokia>,
        <https://1145.am/db/2671764/Nokia>,
        <https://1145.am/db/2671825/Nokia>,
        <https://1145.am/db/2671931/Nokia>,
        <https://1145.am/db/2672194/Nokia>,
        <https://1145.am/db/2672328/Nokia>,
        <https://1145.am/db/2672515/Nokia>,
        <https://1145.am/db/2673284/Nokia>,
        <https://1145.am/db/2673373/Nokia>,
        <https://1145.am/db/2673385/Nokia>,
        <https://1145.am/db/2673516/Nokia>,
        <https://1145.am/db/2673525/Nokia>,
        <https://1145.am/db/2673653/Nokia>,
        <https://1145.am/db/2674160/Nokia>,
        <https://1145.am/db/2674307/Nokia>,
        <https://1145.am/db/2674340/Nokia>,
        <https://1145.am/db/2674487/Nokia>,
        <https://1145.am/db/2674670/Nokia>,
        <https://1145.am/db/2675030/Nokia>,
        <https://1145.am/db/2675387/Nokia>,
        <https://1145.am/db/2675874/Nokia>,
        <https://1145.am/db/2676121/Nokia>,
        <https://1145.am/db/2676774/Nokia>,
        <https://1145.am/db/2676911/Nokia>,
        <https://1145.am/db/2677134/Nokia>,
        <https://1145.am/db/2677206/Nokia>,
        <https://1145.am/db/2677229/Nokia>,
        <https://1145.am/db/2677310/Nokia>,
        <https://1145.am/db/2679410/Nokia>,
        <https://1145.am/db/2679418/Nokia>,
        <https://1145.am/db/2679533/Nokia_Corporation>,
        <https://1145.am/db/2679971/Nokia>,
        <https://1145.am/db/2680041/Nokia>,
        <https://1145.am/db/2680066/Nokia>,
        <https://1145.am/db/2680459/Nokia>,
        <https://1145.am/db/2680747/Nokia>,
        <https://1145.am/db/2680827/Nokia>,
        <https://1145.am/db/2681000/Nokia>,
        <https://1145.am/db/2681206/Nokia>,
        <https://1145.am/db/2682053/Nokia>,
        <https://1145.am/db/2682100/Nokia>,
        <https://1145.am/db/2682469/Nokia>,
        <https://1145.am/db/2683061/Nokia>,
        <https://1145.am/db/2683066/Nokia>,
        <https://1145.am/db/2683067/Nokia>,
        <https://1145.am/db/2683077/Nokia>,
        <https://1145.am/db/2683232/Nokia>,
        <https://1145.am/db/2683444/Nokia>,
        <https://1145.am/db/2683445/Nokia>,
        <https://1145.am/db/2683465/Nokia>,
        <https://1145.am/db/2683670/Nokia>,
        <https://1145.am/db/2685818/Nokia>,
        <https://1145.am/db/2685958/Nokia> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2683818/Nokia_Solutions_And_Networks> a org:Organization ;
    ns1:basedInLowRaw "Finland" ;
    ns1:buyer <https://1145.am/db/2683818/Nokia_Solutions_And_Networks_Unit_Acquisition> ;
    ns1:description "Nokia Solutions and Networks (NSN) unit" ;
    ns1:documentDate "2013-09-26T13:47:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Reports: Nokia's board considering NSN deal with Alcatel-Lucent" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/reports-nokia-s-board-considering-nsn-deal-alcatel-lucent> ;
    ns1:foundName "Nokia",
        "Nokia Solutions and Networks" ;
    ns1:name "Nokia",
        "Nokia Solutions and Networks" ;
    ns1:sameAsHigh <https://1145.am/db/2654238/Nokia_Solutions_And_Networks> ;
    ns1:sameAsMedium <https://1145.am/db/2651897/Nokia_Solutions_And_Networks>,
        <https://1145.am/db/2653481/Nokia_Solutions_And_Networks>,
        <https://1145.am/db/2659072/Nokia_Solutions_And_Networks>,
        <https://1145.am/db/2662061/Nokia_Solutions_And_Networks>,
        <https://1145.am/db/2667512/Nokia_Solutions_And_Networks>,
        <https://1145.am/db/2681746/Nokia_Solutions_And_Networks>,
        <https://1145.am/db/2683451/Nokia_Solutions_And_Networks>,
        <https://1145.am/db/2761285/Nokia_Solutions_And_Networks> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2684131/Blackberry> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2013-10-07T14:25:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Report: BlackBerry in talks with Google, Cisco, SAP" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-blackberry-talks-google-cisco-sap> ;
    ns1:foundName "BlackBerry" ;
    ns1:name "BlackBerry" ;
    ns1:sameAsMedium <https://1145.am/db/1779043/Blackberry>,
        <https://1145.am/db/1811042/Blackberry>,
        <https://1145.am/db/1814383/Blackberry>,
        <https://1145.am/db/1816730/Blackberry>,
        <https://1145.am/db/1838842/Blackberry>,
        <https://1145.am/db/1848217/Blackberry>,
        <https://1145.am/db/1850698/Blackberry>,
        <https://1145.am/db/1990298/Blackberry>,
        <https://1145.am/db/2098356/Blackberry_Ltd>,
        <https://1145.am/db/2203750/Blackberry_Ltd>,
        <https://1145.am/db/2275341/Blackberry>,
        <https://1145.am/db/2608115/Blackberry>,
        <https://1145.am/db/2643859/Blackberry>,
        <https://1145.am/db/2651356/Blackberry>,
        <https://1145.am/db/2653474/Blackberry>,
        <https://1145.am/db/2654259/Blackberry>,
        <https://1145.am/db/2654828/Blackberry>,
        <https://1145.am/db/2655153/Blackberry>,
        <https://1145.am/db/2656027/Blackberry>,
        <https://1145.am/db/2656049/Blackberry>,
        <https://1145.am/db/2657055/Blackberry>,
        <https://1145.am/db/2659028/Blackberry>,
        <https://1145.am/db/2660881/Blackberry>,
        <https://1145.am/db/2663334/Blackberry>,
        <https://1145.am/db/2664675/Blackberry>,
        <https://1145.am/db/2669013/Blackberry>,
        <https://1145.am/db/2673373/Blackberry>,
        <https://1145.am/db/2678056/Blackberry>,
        <https://1145.am/db/2683079/Blackberry>,
        <https://1145.am/db/2683080/Blackberry>,
        <https://1145.am/db/2786734/Blackberry>,
        <https://1145.am/db/799471/Blackberry_Ltd>,
        <https://1145.am/db/799510/Blackberry_Ltd> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2684131/Blackberry_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-10-07T14:25:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "A consortium led by Fairfax Financial Holdings, BlackBerry's largest investor at around 10 percent, has signed a letter of intent to take BlackBerry private in a $ 9 per share deal that values BlackBerry at $ 4.7 billion." ;
    ns1:documentTitle "Report: BlackBerry in talks with Google, Cisco, SAP" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/report-blackberry-talks-google-cisco-sap> ;
    ns1:foundName "private",
        "take" ;
    ns1:name "private",
        "take" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2684131/Blackberry> ;
    ns1:targetName "BlackBerry" .

<https://1145.am/db/2684180/Brightstar_Corp_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-10-16T14:58:38+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Sprint (NYSE: S) parent SoftBank is continuing its buying streak, and it indicated Wednesday that it is in talks to take a stake in U.S. wireless device distributor Brightstar Corp.",
        "The Japanese Nikkei newspaper earlier reported SoftBank is in talks to buy a majority stake in Brightstar in a deal that could be worth more than $ 1 billion, though it did n't identify the source of the information, according to Bloomberg." ;
    ns1:documentTitle "SoftBank eyeing a stake in wireless distributor Brightstar" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/softbank-eyeing-a-stake-wireless-distributor-brightstar> ;
    ns1:foundName "buy",
        "take" ;
    ns1:name "buy",
        "take" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened",
        "unknown" ;
    ns1:target <https://1145.am/db/2684180/Brightstar_Corp> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Brightstar",
        "Brightstar Corp" ;
    ns1:valueRaw "more than $ 1 billion" ;
    ns1:whereGeoName "Japan",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1861060/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "Japanese",
        "U.S" .

<https://1145.am/db/2684180/Supercell_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-10-16T14:58:38+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The new move comes a day after SoftBank's mobile game subsidiary, GungHo Online Entertainment, agreed to pay $ 1.53 billion for a majority stake in Supercell, the Finnish game developer of the popular tablet game \"Clash of Clans .\"" ;
    ns1:documentTitle "SoftBank eyeing a stake in wireless distributor Brightstar" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/softbank-eyeing-a-stake-wireless-distributor-brightstar> ;
    ns1:foundName "pay" ;
    ns1:name "pay" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2684180/Supercell> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Supercell" ;
    ns1:valueRaw "$ 1.53 billion" ;
    ns1:whereGeoName "Republic of Finland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/660013/about.rdf> ;
    ns1:whereRaw "Finland" .

<https://1145.am/db/2288758/Warburg_Pincus> a org:Organization ;
    ns1:description "private equity" ;
    ns1:documentDate "2013-07-02T19:19:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biomet could be next on the billion-dollar block" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/biomet-could-be-next-billion-dollar-block> ;
    ns1:foundName "Warburg Pincus" ;
    ns1:industry "private equity" ;
    ns1:name "Warburg Pincus" ;
    ns1:sameAsHigh <https://1145.am/db/1009073/Ta_Associates>,
        <https://1145.am/db/1041706/Ta_Associates>,
        <https://1145.am/db/1043624/Ta_Associates>,
        <https://1145.am/db/107233/Warburg_Pincus>,
        <https://1145.am/db/1077261/Warburg_Pincus>,
        <https://1145.am/db/108315/Warburg_Pincus>,
        <https://1145.am/db/1152296/Triwest_Capital_Partners>,
        <https://1145.am/db/1186101/Ta_Associates>,
        <https://1145.am/db/1202687/Ta_Associates>,
        <https://1145.am/db/1215231/Ta_Associates>,
        <https://1145.am/db/129974/Warburg_Pincus>,
        <https://1145.am/db/1317266/Warburg_Pincus>,
        <https://1145.am/db/1349968/Warburg_Pincus_Llc>,
        <https://1145.am/db/1356470/Ta_Associates>,
        <https://1145.am/db/1357688/Ta_Associates>,
        <https://1145.am/db/1370039/Ta_Associates>,
        <https://1145.am/db/1370311/Ta_Associates>,
        <https://1145.am/db/1378133/Apax_Partners>,
        <https://1145.am/db/1405696/Warburg_Pincus>,
        <https://1145.am/db/1410242/Ta_Associates>,
        <https://1145.am/db/1433001/Warburg_Pincus_Lcc>,
        <https://1145.am/db/156114/Warburg_Pincus_International>,
        <https://1145.am/db/156121/Warburg_Pincus_International>,
        <https://1145.am/db/157827/Warburg_Pincus_International>,
        <https://1145.am/db/157887/Warburg_Pincus_International>,
        <https://1145.am/db/1622232/Ta_Associates>,
        <https://1145.am/db/1622721/Ta_Associates>,
        <https://1145.am/db/1655979/Warburg_Pincus>,
        <https://1145.am/db/1656176/Warburg_Pincus>,
        <https://1145.am/db/1674046/Warbug_Pincus>,
        <https://1145.am/db/1676487/Warburg_Pincus>,
        <https://1145.am/db/1716813/Warburg_Pincus>,
        <https://1145.am/db/1726154/Apax_Partners>,
        <https://1145.am/db/1727676/Ta_Associates>,
        <https://1145.am/db/1754707/Ta_Associates>,
        <https://1145.am/db/1763980/Apax_Funds>,
        <https://1145.am/db/1790731/Warburg_Pincus>,
        <https://1145.am/db/1831318/Warburg_Pincus>,
        <https://1145.am/db/1862907/Warburg_Pincus>,
        <https://1145.am/db/1870054/Warburg_Pincus>,
        <https://1145.am/db/1874806/Warburg_Pincus>,
        <https://1145.am/db/1887816/Warburg_Pincus>,
        <https://1145.am/db/1896967/Ta_Associates>,
        <https://1145.am/db/1904886/Ta_Associates>,
        <https://1145.am/db/196955/Warburg_Pincus>,
        <https://1145.am/db/1995465/Apax>,
        <https://1145.am/db/1997451/Warburg_Pincus>,
        <https://1145.am/db/1997970/Warburg_Pincus>,
        <https://1145.am/db/1998744/Warburg_Pincus>,
        <https://1145.am/db/2001027/Warburg_Pincus>,
        <https://1145.am/db/2065567/Warburg_Pincus>,
        <https://1145.am/db/2072166/Apax>,
        <https://1145.am/db/2072812/Apax>,
        <https://1145.am/db/2076122/Warburg_Pincus>,
        <https://1145.am/db/2080624/Ta_Associates_And_Warburg_Pincus_Llc>,
        <https://1145.am/db/2081192/Warburg_Pincus>,
        <https://1145.am/db/2098398/Apax>,
        <https://1145.am/db/2132018/Warburg_Pincus>,
        <https://1145.am/db/2207195/Warburg_Pincus>,
        <https://1145.am/db/2214443/Apax_Partners_Llp>,
        <https://1145.am/db/2300214/Warburg_Pincus>,
        <https://1145.am/db/2308601/Warburg_Pincus>,
        <https://1145.am/db/2316851/Warburg_Pincus_Ventures>,
        <https://1145.am/db/2319237/Warburg_Pincus>,
        <https://1145.am/db/2324915/Apax_Partners>,
        <https://1145.am/db/2327248/Warburg_Pincus>,
        <https://1145.am/db/2327264/Warburg_Pincus>,
        <https://1145.am/db/2348272/Warburg_Pincus_Llc>,
        <https://1145.am/db/235654/Warburg_Pincus_Llc>,
        <https://1145.am/db/2360639/Warburg_Pincus>,
        <https://1145.am/db/2367969/Warburg_Pincus>,
        <https://1145.am/db/2367976/Warburg_Pincus>,
        <https://1145.am/db/238604/Warburg_Pincus>,
        <https://1145.am/db/239134/Warburg_Pincus_Capital_Corporation_I-A>,
        <https://1145.am/db/2562224/Warburg_Pincus>,
        <https://1145.am/db/2578179/Warburg_Pincus_Montagu_Private_Equity>,
        <https://1145.am/db/2647818/Apax>,
        <https://1145.am/db/2650891/Apax>,
        <https://1145.am/db/2651063/Apax>,
        <https://1145.am/db/2660508/Apax_Partners>,
        <https://1145.am/db/2664134/Warburg_Pincus_Apax>,
        <https://1145.am/db/2668430/Warburg_Pincus>,
        <https://1145.am/db/2669352/Apax_Partners>,
        <https://1145.am/db/2677923/Apax>,
        <https://1145.am/db/2679079/Apax_Partners>,
        <https://1145.am/db/2695363/Warburg_Pincus>,
        <https://1145.am/db/271314/Warburg_Pincus>,
        <https://1145.am/db/2722001/Warburg_Pincus>,
        <https://1145.am/db/272400/Warburg_Pincus>,
        <https://1145.am/db/2732060/Warburg_Pincus>,
        <https://1145.am/db/2747164/Warburg_Pincus>,
        <https://1145.am/db/2793449/Ta_Associates>,
        <https://1145.am/db/2800144/Warburg_Pincus>,
        <https://1145.am/db/343545/Ta_Associates>,
        <https://1145.am/db/359185/Warburg_Pincus>,
        <https://1145.am/db/455601/Apax_Partners>,
        <https://1145.am/db/455601/Warburg_Pincus_Llc>,
        <https://1145.am/db/463733/Warburg_Pincus>,
        <https://1145.am/db/478732/Warburg_Pincus>,
        <https://1145.am/db/503743/Ta_Associates>,
        <https://1145.am/db/504569/Ta_Associates>,
        <https://1145.am/db/582835/Warburg_Pincus>,
        <https://1145.am/db/606291/Warburg_Pincus>,
        <https://1145.am/db/626765/Ta_Associates>,
        <https://1145.am/db/645602/Ta_Associates>,
        <https://1145.am/db/646657/Ta_Associates>,
        <https://1145.am/db/686490/Ta_Associates>,
        <https://1145.am/db/689219/Ta_Associates>,
        <https://1145.am/db/746878/Ta_Associates>,
        <https://1145.am/db/821887/Apax_Partners>,
        <https://1145.am/db/824983/Apax_Partners>,
        <https://1145.am/db/825385/Apax_Partners_Llp>,
        <https://1145.am/db/904219/Ta_Associates>,
        <https://1145.am/db/905376/Ta_Associates>,
        <https://1145.am/db/938662/Ta_Associates>,
        <https://1145.am/db/944277/Warburg_Pincus> ;
    ns1:sameAsMedium <https://1145.am/db/1106851/Warburg_Pincus>,
        <https://1145.am/db/1121839/Warburg_Pincus>,
        <https://1145.am/db/1138823/Warburg_Pincus>,
        <https://1145.am/db/1141070/Warburg_Pincus>,
        <https://1145.am/db/1149542/Warburg_Pincus>,
        <https://1145.am/db/1153239/Warburg_Pincus>,
        <https://1145.am/db/1153356/Warburg_Pincus>,
        <https://1145.am/db/1216854/Warburg_Pincus>,
        <https://1145.am/db/1244609/Warburg_Pincus>,
        <https://1145.am/db/1245131/Warburg_Pincus>,
        <https://1145.am/db/1361475/Warburg_Pincus>,
        <https://1145.am/db/1721480/Warburg_Pincus>,
        <https://1145.am/db/1722916/Warburg_Pincus>,
        <https://1145.am/db/1742050/Warburg_Pincus>,
        <https://1145.am/db/1742981/Warburg_Pincus>,
        <https://1145.am/db/1748765/Warburg_Pincus>,
        <https://1145.am/db/1754511/Warburg_Pincus>,
        <https://1145.am/db/1758165/Warburg_Pincus>,
        <https://1145.am/db/1762611/Warburg_Pincus>,
        <https://1145.am/db/1766425/Warburg_Pincus>,
        <https://1145.am/db/1777495/Warburg_Pincus>,
        <https://1145.am/db/1783572/Warburg_Pincus>,
        <https://1145.am/db/1788883/Warburg_Pincus>,
        <https://1145.am/db/1789335/Warburg_Pincus>,
        <https://1145.am/db/1802244/Warburg_Pincus>,
        <https://1145.am/db/1807465/Warburg_Pincus>,
        <https://1145.am/db/1812233/Warburg_Pincus>,
        <https://1145.am/db/1854800/Warburg_Pincus>,
        <https://1145.am/db/1969536/Warburg_Pincus>,
        <https://1145.am/db/1993235/Warburg_Pincus>,
        <https://1145.am/db/2069862/Warburg_Pincus>,
        <https://1145.am/db/2097376/Warburg_Pincus>,
        <https://1145.am/db/2134779/Warburg_Pincus>,
        <https://1145.am/db/2183196/Warburg_Pincus>,
        <https://1145.am/db/2183330/Warburg_Pincus>,
        <https://1145.am/db/2238793/Warburg_Pincus>,
        <https://1145.am/db/2270672/Warburg_Pincus>,
        <https://1145.am/db/2291095/Warburg_Pincus>,
        <https://1145.am/db/2296562/Warburg_Pincus>,
        <https://1145.am/db/2300064/Warburg_Pincus>,
        <https://1145.am/db/2309051/Warburg_Pincus>,
        <https://1145.am/db/2315159/Warburg_Pincus>,
        <https://1145.am/db/2318581/Warburg_Pincus>,
        <https://1145.am/db/2319236/Warburg_Pincus>,
        <https://1145.am/db/2324159/Warburg_Pincus>,
        <https://1145.am/db/2326119/Warburg_Pincus>,
        <https://1145.am/db/2352277/Warburg_Pincus>,
        <https://1145.am/db/2353256/Warburg_Pincus>,
        <https://1145.am/db/2353260/Warburg_Pincus>,
        <https://1145.am/db/2362453/Warburg_Pincus>,
        <https://1145.am/db/2543471/Warburg_Pincus>,
        <https://1145.am/db/2544488/Warburg_Pincus>,
        <https://1145.am/db/2547596/Warburg_Pincus>,
        <https://1145.am/db/254889/Warburg_Pincus>,
        <https://1145.am/db/2560285/Warburg_Pincus>,
        <https://1145.am/db/2579025/Warburg_Pincus>,
        <https://1145.am/db/2596296/Warburg_Pincus>,
        <https://1145.am/db/2638371/Warburg_Pincus>,
        <https://1145.am/db/268598/Warburg_Pincus>,
        <https://1145.am/db/2688027/Warburg_Pincus>,
        <https://1145.am/db/2735857/Warburg_Pincus>,
        <https://1145.am/db/299488/Warburg_Pincus>,
        <https://1145.am/db/405249/Warburg_Pincus>,
        <https://1145.am/db/460556/Warburg_Pincus>,
        <https://1145.am/db/489663/Warburg_Pincus>,
        <https://1145.am/db/505222/Warburg_Pincus>,
        <https://1145.am/db/539514/Warburg_Pincus>,
        <https://1145.am/db/542434/Warburg_Pincus>,
        <https://1145.am/db/547444/Warburg_Pincus>,
        <https://1145.am/db/556611/Warburg_Pincus>,
        <https://1145.am/db/601860/Warburg_Pincus>,
        <https://1145.am/db/627360/Warburg_Pincus>,
        <https://1145.am/db/721581/Warburg_Pincus>,
        <https://1145.am/db/745350/Warburg_Pincus_Llc>,
        <https://1145.am/db/768222/Warburg_Pincus>,
        <https://1145.am/db/817588/Warburg_Pincus>,
        <https://1145.am/db/823283/Warburg_Pincus>,
        <https://1145.am/db/829348/Warburg_Pincus>,
        <https://1145.am/db/85758/Warburg_Pincus>,
        <https://1145.am/db/867907/Warburg_Pincus>,
        <https://1145.am/db/934889/Warburg_Pincus>,
        <https://1145.am/db/962121/Warburg_Pincus>,
        <https://1145.am/db/963964/Warburg_Pincus> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2304545/Series_B_Investment_Ame_Cloud_Ventures_Bina_Technologies_Columbus_Nova_Technology_Partners_Mohsen_Moazami_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-07-31T11:52:55+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Bina Accelerates Growth with Fully Subscribed $ 8M Series B Round, Adds to Executive Team.",
        "Bina Technologies, the genomic big data science platform accelerating personalized medicine, today announced that they have added to their Series B financing round with $ 1.75M in additional funding, bringing their total Series B round to $ 8M." ;
    ns1:documentTitle "Bina Accelerates Growth with Fully Subscribed $8M Series B Round, Adds to Executive Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/bina-accelerates-growth-fully-subscribed-8m-series-b-round-adds-to-executive-team> ;
    ns1:foundName "financing",
        "funding" ;
    ns1:name "financing",
        "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2304545/Bina_Technologies> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 1.75M",
        "$ 8M" ;
    ns1:whereGeoName "Columbus" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4509177/about.rdf> ;
    ns1:whereRaw "Columbus" .

<https://1145.am/db/2305445/Investment_Eagle_Genomics_Jonathan_Milner_Midven_Rainbow_Seed_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-03T13:24:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Eagle Genomics secures 590,000 to expand its current bioinformatics offerings.",
        "Eagle Genomics, an expert provider of bioinformatics software and services across a wide range of the life science and other sectors, has today announced the first closing of 590,000, as part of a planned 1million investment round in line with plans to expand its offerings." ;
    ns1:documentTitle "Eagle Genomics secures 590,000 to expand its current bioinformatics offerings" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/eagle-genomics-secures-%C2%A3590-000-to-expand-its-current-bioinformatics-offerings> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2305445/Eagle_Genomics>,
        <https://1145.am/db/2305445/Midven> ;
    ns1:valueRaw "1million",
        "590,000" ;
    ns1:whereGeoName "Eagle County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5420332/about.rdf> ;
    ns1:whereRaw "Eagle Genomics" .

<https://1145.am/db/2317344/Research_Pharmaceutical_Services_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-09-25T17:50:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "RALEIGH, N.C. - PRA International (\"PRA\") , a leading clinical research organization, today announced the completion of its merger with ReSearch Pharmaceutical Services (\"RPS\") and the closing of the acquisition by KKR." ;
    ns1:documentTitle "PRA and RPS Merger Completed" ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/pra-and-rps-merger-completed> ;
    ns1:foundName "acquisition",
        "merger" ;
    ns1:name "acquisition",
        "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2317344/Research_Pharmaceutical_Services> ;
    ns1:targetName "ReSearch Pharmaceutical Services" ;
    ns1:whereGeoName "Raleigh" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4487042/about.rdf> ;
    ns1:whereRaw "RALEIGH" .

<https://1145.am/db/2339894/Series_C_Preferred_Stock_Equity_Investment_Andrea_Holdings_International_Ltd_Lithera_Mirae_Asset_Venture_Investment_Rusnanomedinvest_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-07-18T15:55:45+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Lithera Announces Second Closing of $ 27.3 Million Series C Financing.",
        "SAN DIEGO, July 18, Jul 18, 2013 (GLOBE NEWSWIRE via COMTEX) - Lithera, Inc. (\"Lithera\" or \"the Company\") , a clinical stage pharmaceutical company focused on aesthetic and medical indications, today announced that it has completed a second closing of its Series C preferred stock equity financing, securing an additional $ 6.7 million in equity capital and bringing the total capital raised in this round to $ 27.3 million." ;
    ns1:documentTitle "Lithera Announces Second Closing of $27.3 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lithera-announces-second-closing-of-27-3-million-series-c-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2339894/Lithera> ;
    ns1:targetDetails "Series C",
        "preferred stock equity" ;
    ns1:valueRaw "$ 27.3 Million",
        "$ 27.3 million",
        "$ 6.7 million" ;
    ns1:when "2013-07-18T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "July 18, 2013" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "SAN DIEGO" .

<https://1145.am/db/2339925/Series_B_Investment_Alcresta_Bessemer_Venture_Partners_Frazier_Healthcare_Third_Rock_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-07-22T09:44:01+00:00"^^xsd:dateTime ;
    ns1:documentExtract "- July 22, 2013 - Alcresta, a leading medical nutrition company developing innovative enzyme - based products for adults, infants, and individuals battling acute conditions or chronic diseases, today announced that it has secured $ 10 million in Series B financing.",
        "Alcresta Secures $ 10 Million Series B Financing," ;
    ns1:documentTitle "Alcresta Secures $10 Million Series B Financing, Prepares for 2014 Commercial Launch of Novel Point-of-Care Nutritional Products" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/alcresta-secures-10-million-series-b-financing-prepares-for-2014-commercial-launch> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2339925/Alcresta> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 10 Million",
        "$ 10 million" ;
    ns1:when "2013-07-22T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "July 22, 2013" .

<https://1145.am/db/2340634/Amgen> a org:Organization ;
    ns1:basedInHighGeoName "Thousand Oaks" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5402405/about.rdf> ;
    ns1:basedInHighRaw "Thousand Oaks, CA" ;
    ns1:description "Biotech" ;
    ns1:documentDate "2013-12-16T22:46:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amgen spinoff Atara banks $38.5M as it races ahead with CKD, cancer trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/amgen-spinoff-atara-banks-38-5m-as-it-races-ahead-ckd-cancer-trials> ;
    ns1:foundName "Amgen" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2340634/Series_B_Investment_Alexandria_Venture_Investments_Amgen_Atara_Biotherapeutics_Celgene_Dag_Ventures_Domain_Associates_Ecor1_Capital_Completed> ;
    ns1:name "Amgen" ;
    ns1:sameAsHigh <https://1145.am/db/1044120/Maat_Pharma>,
        <https://1145.am/db/1216593/Small_Pharma_Inc>,
        <https://1145.am/db/1254815/Amgen>,
        <https://1145.am/db/1258904/Amgen_Inc>,
        <https://1145.am/db/1387633/Maat_Pharma>,
        <https://1145.am/db/1388835/Maat_Pharma>,
        <https://1145.am/db/1434130/Amgen>,
        <https://1145.am/db/1464274/Ambrx_Biopharma_Inc>,
        <https://1145.am/db/1465418/Ambrx_Biopharma_Inc>,
        <https://1145.am/db/1568872/Amgen_Inc>,
        <https://1145.am/db/1573831/Amgen>,
        <https://1145.am/db/1614229/Nmd_Pharma>,
        <https://1145.am/db/1673901/Amgen>,
        <https://1145.am/db/198163/Amgen>,
        <https://1145.am/db/2043001/Amgen>,
        <https://1145.am/db/2100118/Small_Pharma_Inc>,
        <https://1145.am/db/2106270/Amgen>,
        <https://1145.am/db/2150271/Small_Pharma_Inc>,
        <https://1145.am/db/2153258/Amgen>,
        <https://1145.am/db/2153734/Biogen>,
        <https://1145.am/db/2154415/Amgen>,
        <https://1145.am/db/2155409/Amgen>,
        <https://1145.am/db/2155659/Amgen>,
        <https://1145.am/db/2282934/Amgen>,
        <https://1145.am/db/2283321/Amgen>,
        <https://1145.am/db/2285195/Amgen>,
        <https://1145.am/db/2285614/Amgen>,
        <https://1145.am/db/2285991/Amgen>,
        <https://1145.am/db/2286174/Amgen>,
        <https://1145.am/db/2286730/Biogen>,
        <https://1145.am/db/2295041/Moderna>,
        <https://1145.am/db/2296078/Biogen>,
        <https://1145.am/db/2313429/Amgen>,
        <https://1145.am/db/2318877/Amgen>,
        <https://1145.am/db/2320754/Amgen>,
        <https://1145.am/db/2322040/Amgen>,
        <https://1145.am/db/2327526/Amgen>,
        <https://1145.am/db/2329762/Amgen>,
        <https://1145.am/db/2338329/Amgen>,
        <https://1145.am/db/2338346/Amgen>,
        <https://1145.am/db/2344369/Amgen>,
        <https://1145.am/db/2349030/Amgen>,
        <https://1145.am/db/2350471/Amgen>,
        <https://1145.am/db/2353195/Moderna>,
        <https://1145.am/db/2354835/Amgen>,
        <https://1145.am/db/2355383/Amgen>,
        <https://1145.am/db/2357336/Amgen>,
        <https://1145.am/db/2359165/Amgen>,
        <https://1145.am/db/2360080/Amgen>,
        <https://1145.am/db/2362552/Amgen>,
        <https://1145.am/db/2364216/Amgen>,
        <https://1145.am/db/2366930/Biogen>,
        <https://1145.am/db/2538019/Amgen>,
        <https://1145.am/db/2539787/Amgen>,
        <https://1145.am/db/2540225/Amgen>,
        <https://1145.am/db/2548575/Amgen>,
        <https://1145.am/db/2553162/Amgen>,
        <https://1145.am/db/2554152/Amgen>,
        <https://1145.am/db/2556729/Amgen>,
        <https://1145.am/db/2557428/Moderna>,
        <https://1145.am/db/2561317/Amgen>,
        <https://1145.am/db/2567468/Amgen>,
        <https://1145.am/db/2567517/Amgen>,
        <https://1145.am/db/2567981/Amgen>,
        <https://1145.am/db/2575263/Amgen>,
        <https://1145.am/db/2583990/Amgen>,
        <https://1145.am/db/2587770/Amgen>,
        <https://1145.am/db/258901/Amgen_Inc>,
        <https://1145.am/db/2592924/Amgen>,
        <https://1145.am/db/2594292/Amgen>,
        <https://1145.am/db/2595930/Amgen>,
        <https://1145.am/db/2789236/Amgen>,
        <https://1145.am/db/531806/Amgen_Inc>,
        <https://1145.am/db/829447/Nmd_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/1252426/Amgen_Inc>,
        <https://1145.am/db/1253935/Amgen>,
        <https://1145.am/db/1262006/Amgen>,
        <https://1145.am/db/1406211/Amgen>,
        <https://1145.am/db/1488570/Amgen>,
        <https://1145.am/db/1541946/Amgen>,
        <https://1145.am/db/1570839/Amgen_Inc>,
        <https://1145.am/db/1574155/Amgen>,
        <https://1145.am/db/1575688/Amgen_Inc>,
        <https://1145.am/db/1576668/Amgen_Inc>,
        <https://1145.am/db/1929668/Amgen>,
        <https://1145.am/db/1981398/Amgen>,
        <https://1145.am/db/2008430/Amgen_Inc>,
        <https://1145.am/db/2008790/Amgen>,
        <https://1145.am/db/2009117/Amgen_Inc>,
        <https://1145.am/db/2011679/Amgen>,
        <https://1145.am/db/2012933/Amgen_Inc>,
        <https://1145.am/db/2013008/Amgen_Inc>,
        <https://1145.am/db/2016970/Amgen>,
        <https://1145.am/db/2046726/Amgen>,
        <https://1145.am/db/2098829/Amgen>,
        <https://1145.am/db/2105082/Amgen>,
        <https://1145.am/db/2107919/Amgen>,
        <https://1145.am/db/2117067/Amgen>,
        <https://1145.am/db/2117986/Amgen>,
        <https://1145.am/db/2138386/Amgen>,
        <https://1145.am/db/2152715/Amgen>,
        <https://1145.am/db/2249776/Amgen_Inc>,
        <https://1145.am/db/2282387/Amgen>,
        <https://1145.am/db/2291231/Amgen>,
        <https://1145.am/db/2292224/Amgen>,
        <https://1145.am/db/2292876/Amgen>,
        <https://1145.am/db/2299349/Amgen>,
        <https://1145.am/db/2302052/Amgen>,
        <https://1145.am/db/2303414/Amgen>,
        <https://1145.am/db/2312121/Amgen>,
        <https://1145.am/db/2317845/Amgen>,
        <https://1145.am/db/2320759/Amgen>,
        <https://1145.am/db/2320765/Amgen>,
        <https://1145.am/db/2320771/Amgen>,
        <https://1145.am/db/2320775/Amgen>,
        <https://1145.am/db/2321459/Amgen>,
        <https://1145.am/db/2321989/Amgen>,
        <https://1145.am/db/2322632/Amgen>,
        <https://1145.am/db/2326533/Amgen>,
        <https://1145.am/db/2326559/Amgen>,
        <https://1145.am/db/2327547/Amgen>,
        <https://1145.am/db/2328748/Amgen>,
        <https://1145.am/db/2333460/Amgen>,
        <https://1145.am/db/2334046/Amgen>,
        <https://1145.am/db/2337433/Amgen>,
        <https://1145.am/db/2337435/Amgen_Inc>,
        <https://1145.am/db/2337848/Amgen>,
        <https://1145.am/db/2338027/Amgen>,
        <https://1145.am/db/2338828/Amgen>,
        <https://1145.am/db/2340408/Amgen>,
        <https://1145.am/db/2340669/Amgen>,
        <https://1145.am/db/2343511/Amgen>,
        <https://1145.am/db/2343601/Amgen>,
        <https://1145.am/db/2343780/Amgen>,
        <https://1145.am/db/2343862/Amgen>,
        <https://1145.am/db/2344631/Amgen>,
        <https://1145.am/db/2344864/Amgen>,
        <https://1145.am/db/2345191/Amgen>,
        <https://1145.am/db/2345783/Amgen>,
        <https://1145.am/db/2345886/Amgen>,
        <https://1145.am/db/2346293/Amgen>,
        <https://1145.am/db/2347966/Amgen>,
        <https://1145.am/db/2347970/Amgen>,
        <https://1145.am/db/2347976/Amgen>,
        <https://1145.am/db/2349444/Amgen>,
        <https://1145.am/db/2350029/Amgen>,
        <https://1145.am/db/2350465/Amgen>,
        <https://1145.am/db/2352800/Amgen>,
        <https://1145.am/db/2353167/Amgen>,
        <https://1145.am/db/2355378/Amgen>,
        <https://1145.am/db/2355392/Amgen>,
        <https://1145.am/db/2355427/Amgen>,
        <https://1145.am/db/2357269/Amgen>,
        <https://1145.am/db/2357271/Amgen>,
        <https://1145.am/db/2357303/Amgen>,
        <https://1145.am/db/2357451/Amgen>,
        <https://1145.am/db/2357454/Amgen>,
        <https://1145.am/db/2357920/Amgen>,
        <https://1145.am/db/2358934/Amgen>,
        <https://1145.am/db/2359462/Amgen>,
        <https://1145.am/db/2359481/Amgen>,
        <https://1145.am/db/2359498/Amgen>,
        <https://1145.am/db/2360086/Amgen>,
        <https://1145.am/db/2361037/Amgen>,
        <https://1145.am/db/2361971/Amgen>,
        <https://1145.am/db/2361972/Amgen>,
        <https://1145.am/db/2361973/Amgen>,
        <https://1145.am/db/2363673/Amgen>,
        <https://1145.am/db/2367430/Amgen_Inc>,
        <https://1145.am/db/2368788/Amgen_Inc>,
        <https://1145.am/db/2370120/Amgen>,
        <https://1145.am/db/2370174/Amgen>,
        <https://1145.am/db/2370215/Amgen>,
        <https://1145.am/db/2370217/Amgen>,
        <https://1145.am/db/2371301/Amgen>,
        <https://1145.am/db/2543232/Amgen>,
        <https://1145.am/db/2543655/Amgen>,
        <https://1145.am/db/2544701/Amgen>,
        <https://1145.am/db/2545663/Amgen>,
        <https://1145.am/db/2545765/Amgen>,
        <https://1145.am/db/2550685/Amgen>,
        <https://1145.am/db/2550884/Amgen>,
        <https://1145.am/db/2551883/Amgen>,
        <https://1145.am/db/2551884/Amgen>,
        <https://1145.am/db/2553564/Amgen>,
        <https://1145.am/db/2555175/Amgen>,
        <https://1145.am/db/2557364/Amgen>,
        <https://1145.am/db/2558012/Amgen>,
        <https://1145.am/db/2558039/Amgen>,
        <https://1145.am/db/2558051/Amgen>,
        <https://1145.am/db/2558418/Amgen>,
        <https://1145.am/db/2559077/Amgen>,
        <https://1145.am/db/2561305/Amgen>,
        <https://1145.am/db/2561325/Amgen>,
        <https://1145.am/db/2561650/Amgen>,
        <https://1145.am/db/2566335/Amgen>,
        <https://1145.am/db/2566348/Amgen>,
        <https://1145.am/db/2567960/Amgen>,
        <https://1145.am/db/2568005/Amgen>,
        <https://1145.am/db/2568075/Amgen>,
        <https://1145.am/db/2568519/Amgen>,
        <https://1145.am/db/2572535/Amgen>,
        <https://1145.am/db/2572655/Amgen>,
        <https://1145.am/db/2573455/Amgen>,
        <https://1145.am/db/2573903/Amgen>,
        <https://1145.am/db/2573924/Amgen>,
        <https://1145.am/db/2573976/Amgen>,
        <https://1145.am/db/2574586/Amgen>,
        <https://1145.am/db/2575289/Amgen>,
        <https://1145.am/db/2576018/Amgen>,
        <https://1145.am/db/2576242/Amgen>,
        <https://1145.am/db/2576498/Amgen>,
        <https://1145.am/db/2577110/Amgen>,
        <https://1145.am/db/2577115/Amgen>,
        <https://1145.am/db/2577120/Amgen>,
        <https://1145.am/db/2578110/Amgen>,
        <https://1145.am/db/2578164/Amgen>,
        <https://1145.am/db/2578286/Amgen>,
        <https://1145.am/db/2579211/Amgen>,
        <https://1145.am/db/2579278/Amgen>,
        <https://1145.am/db/2580209/Amgen>,
        <https://1145.am/db/2580211/Amgen>,
        <https://1145.am/db/2580383/Amgen_Inc>,
        <https://1145.am/db/2581309/Amgen>,
        <https://1145.am/db/2581359/Amgen>,
        <https://1145.am/db/2581917/Amgen>,
        <https://1145.am/db/2584352/Amgen>,
        <https://1145.am/db/2585068/Amgen>,
        <https://1145.am/db/2586068/Amgen>,
        <https://1145.am/db/2586750/Amgen>,
        <https://1145.am/db/2587009/Amgen>,
        <https://1145.am/db/2589106/Amgen>,
        <https://1145.am/db/2590194/Amgen>,
        <https://1145.am/db/2590988/Amgen_Inc>,
        <https://1145.am/db/2590989/Amgen>,
        <https://1145.am/db/2591587/Amgen>,
        <https://1145.am/db/2591594/Amgen>,
        <https://1145.am/db/2592573/Amgen>,
        <https://1145.am/db/2592618/Amgen>,
        <https://1145.am/db/2593423/Amgen>,
        <https://1145.am/db/2593426/Amgen>,
        <https://1145.am/db/2593433/Amgen_Inc>,
        <https://1145.am/db/2593434/Amgen>,
        <https://1145.am/db/2593465/Amgen>,
        <https://1145.am/db/2593681/Amgen>,
        <https://1145.am/db/2593973/Amgen>,
        <https://1145.am/db/2594099/Amgen>,
        <https://1145.am/db/2594285/Amgen>,
        <https://1145.am/db/2594298/Amgen>,
        <https://1145.am/db/2594347/Amgen>,
        <https://1145.am/db/2594990/Amgen>,
        <https://1145.am/db/2594993/Amgen>,
        <https://1145.am/db/2595020/Amgen>,
        <https://1145.am/db/2595549/Amgen>,
        <https://1145.am/db/2595564/Amgen>,
        <https://1145.am/db/2595587/Amgen>,
        <https://1145.am/db/2595605/Amgen>,
        <https://1145.am/db/2595608/Amgen>,
        <https://1145.am/db/2596467/Amgen>,
        <https://1145.am/db/2596819/Amgen>,
        <https://1145.am/db/2597499/Amgen>,
        <https://1145.am/db/2598066/Amgen>,
        <https://1145.am/db/2716207/Amgen>,
        <https://1145.am/db/2802001/Amgen>,
        <https://1145.am/db/559746/Amgen> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348967/Series_A_Investment_Lumos_Pharma_New_Enterprise_Associates_Sante_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-02-04T16:40:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "\" We are extremely pleased to announce the closing of our Series A financing round from Sante Ventures and NEA ,\" says Lumos Pharma's Founder, President, and CEO Rick Hawkins.",
        "AUSTIN, Texas, Feb 4, 2014 /PRNewswire/ - Lumos Pharma, an early stage biopharmaceutical development company, announced today that it has raised $ 14 million in Series A financing." ;
    ns1:documentTitle "Lumos Pharma Announces Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/lumos-pharma-announces-series-a-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2348967/Lumos_Pharma> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 14 million" ;
    ns1:when "2014-02-04T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2014-02-04" ;
    ns1:whereGeoName "Texas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:whereRaw "Texas" .

<https://1145.am/db/2350030/Series_A_Investment_Sr_One_Ipierian_Ipierian_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-04T11:47:21+00:00"^^xsd:dateTime ;
    ns1:documentExtract "iPierian, Inc., announced today that a new financing of $ 30 million has been secured to continue to advance iPierian's drug development in neurodegenerative disease as well as to provide a Series A round to launch a spin-out company, True North Therapeutics." ;
    ns1:documentTitle "$30 Million Secured in iPierian Financing and Series A Financing for Launch of Spin-out, True North Therapeutics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/30-million-secured-ipierian-financing-and-series-a-financing-for-launch-of-spin-out-true> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2350030/Ipierian>,
        <https://1145.am/db/2350030/True_North_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:targetName "True North Therapeutics" ;
    ns1:valueRaw "$ 30 million" .

<https://1145.am/db/2360521/Series_A_Investment_Hatteras_Venture_Partners_Osage_University_Partners_Sideris_Pharmaceuticals_Sunstates_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-22T14:46:58+00:00"^^xsd:dateTime ;
    ns1:documentExtract "BOSTON & GAINESVILLE, Fla., Oct 22, 2013 (BUSINESS WIRE) - Sideris Pharmaceuticals, Inc., announced today that it has successfully completed a $ 32 million Series A equity financing.",
        "Sideris Pharmaceuticals Completes $ 32 Million Equity Financing and Signs Agreement With Global Pharmaceutical Company." ;
    ns1:documentTitle "Sideris Pharmaceuticals Completes $32 Million Equity Financing and Signs Agreement With Global Pharmaceutical Company" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/sideris-pharmaceuticals-completes-32-million-equity-financing-and-signs-agreement-global> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2360521/Sideris_Pharmaceuticals> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 32 Million",
        "$ 32 million" ;
    ns1:when "2013-10-22T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct 22, 2013" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2362552/Amgen> a org:Organization ;
    ns1:basedInHighGeoName "South San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:basedInHighRaw "South San Francisco" ;
    ns1:documentDate "2013-10-29T13:45:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UPDATED: Calithera grabs $35M round to fund first slate of cancer drug studies" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/updated-calithera-grabs-35m-round-to-fund-first-slate-of-cancer-drug-studies> ;
    ns1:foundName "Amgen" ;
    ns1:industry "Biotech" ;
    ns1:investor <https://1145.am/db/2362552/Investment_Amgen_Calithera_Biosciences_Has_Not_Happened> ;
    ns1:name "Amgen" ;
    ns1:sameAsHigh <https://1145.am/db/1044120/Maat_Pharma>,
        <https://1145.am/db/1216593/Small_Pharma_Inc>,
        <https://1145.am/db/1254815/Amgen>,
        <https://1145.am/db/1258904/Amgen_Inc>,
        <https://1145.am/db/1387633/Maat_Pharma>,
        <https://1145.am/db/1388835/Maat_Pharma>,
        <https://1145.am/db/1434130/Amgen>,
        <https://1145.am/db/1464274/Ambrx_Biopharma_Inc>,
        <https://1145.am/db/1465418/Ambrx_Biopharma_Inc>,
        <https://1145.am/db/1568872/Amgen_Inc>,
        <https://1145.am/db/1573831/Amgen>,
        <https://1145.am/db/1614229/Nmd_Pharma>,
        <https://1145.am/db/1673901/Amgen>,
        <https://1145.am/db/198163/Amgen>,
        <https://1145.am/db/2043001/Amgen>,
        <https://1145.am/db/2100118/Small_Pharma_Inc>,
        <https://1145.am/db/2106270/Amgen>,
        <https://1145.am/db/2150271/Small_Pharma_Inc>,
        <https://1145.am/db/2153258/Amgen>,
        <https://1145.am/db/2154415/Amgen>,
        <https://1145.am/db/2155409/Amgen>,
        <https://1145.am/db/2155659/Amgen>,
        <https://1145.am/db/2282934/Amgen>,
        <https://1145.am/db/2283321/Amgen>,
        <https://1145.am/db/2285195/Amgen>,
        <https://1145.am/db/2285614/Amgen>,
        <https://1145.am/db/2285991/Amgen>,
        <https://1145.am/db/2286174/Amgen>,
        <https://1145.am/db/2313429/Amgen>,
        <https://1145.am/db/2318877/Amgen>,
        <https://1145.am/db/2320754/Amgen>,
        <https://1145.am/db/2322040/Amgen>,
        <https://1145.am/db/2327526/Amgen>,
        <https://1145.am/db/2329762/Amgen>,
        <https://1145.am/db/2338329/Amgen>,
        <https://1145.am/db/2338346/Amgen>,
        <https://1145.am/db/2340634/Amgen>,
        <https://1145.am/db/2344369/Amgen>,
        <https://1145.am/db/2349030/Amgen>,
        <https://1145.am/db/2350471/Amgen>,
        <https://1145.am/db/2354835/Amgen>,
        <https://1145.am/db/2355383/Amgen>,
        <https://1145.am/db/2357336/Amgen>,
        <https://1145.am/db/2359165/Amgen>,
        <https://1145.am/db/2360080/Amgen>,
        <https://1145.am/db/2364216/Amgen>,
        <https://1145.am/db/2538019/Amgen>,
        <https://1145.am/db/2539787/Amgen>,
        <https://1145.am/db/2540225/Amgen>,
        <https://1145.am/db/2548575/Amgen>,
        <https://1145.am/db/2553162/Amgen>,
        <https://1145.am/db/2554152/Amgen>,
        <https://1145.am/db/2556729/Amgen>,
        <https://1145.am/db/2561317/Amgen>,
        <https://1145.am/db/2567468/Amgen>,
        <https://1145.am/db/2567517/Amgen>,
        <https://1145.am/db/2567981/Amgen>,
        <https://1145.am/db/2575263/Amgen>,
        <https://1145.am/db/2583990/Amgen>,
        <https://1145.am/db/2587770/Amgen>,
        <https://1145.am/db/258901/Amgen_Inc>,
        <https://1145.am/db/2592924/Amgen>,
        <https://1145.am/db/2594292/Amgen>,
        <https://1145.am/db/2595930/Amgen>,
        <https://1145.am/db/2789236/Amgen>,
        <https://1145.am/db/531806/Amgen_Inc>,
        <https://1145.am/db/829447/Nmd_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/1252426/Amgen_Inc>,
        <https://1145.am/db/1253935/Amgen>,
        <https://1145.am/db/1262006/Amgen>,
        <https://1145.am/db/1406211/Amgen>,
        <https://1145.am/db/1488570/Amgen>,
        <https://1145.am/db/1541946/Amgen>,
        <https://1145.am/db/1570839/Amgen_Inc>,
        <https://1145.am/db/1574155/Amgen>,
        <https://1145.am/db/1575688/Amgen_Inc>,
        <https://1145.am/db/1576668/Amgen_Inc>,
        <https://1145.am/db/1929668/Amgen>,
        <https://1145.am/db/1981398/Amgen>,
        <https://1145.am/db/2008430/Amgen_Inc>,
        <https://1145.am/db/2008790/Amgen>,
        <https://1145.am/db/2009117/Amgen_Inc>,
        <https://1145.am/db/2011679/Amgen>,
        <https://1145.am/db/2012933/Amgen_Inc>,
        <https://1145.am/db/2013008/Amgen_Inc>,
        <https://1145.am/db/2016970/Amgen>,
        <https://1145.am/db/2046726/Amgen>,
        <https://1145.am/db/2098829/Amgen>,
        <https://1145.am/db/2105082/Amgen>,
        <https://1145.am/db/2107919/Amgen>,
        <https://1145.am/db/2117067/Amgen>,
        <https://1145.am/db/2117986/Amgen>,
        <https://1145.am/db/2138386/Amgen>,
        <https://1145.am/db/2152715/Amgen>,
        <https://1145.am/db/2249776/Amgen_Inc>,
        <https://1145.am/db/2282387/Amgen>,
        <https://1145.am/db/2291231/Amgen>,
        <https://1145.am/db/2292224/Amgen>,
        <https://1145.am/db/2292876/Amgen>,
        <https://1145.am/db/2299349/Amgen>,
        <https://1145.am/db/2302052/Amgen>,
        <https://1145.am/db/2303414/Amgen>,
        <https://1145.am/db/2312121/Amgen>,
        <https://1145.am/db/2317845/Amgen>,
        <https://1145.am/db/2320759/Amgen>,
        <https://1145.am/db/2320765/Amgen>,
        <https://1145.am/db/2320771/Amgen>,
        <https://1145.am/db/2320775/Amgen>,
        <https://1145.am/db/2321459/Amgen>,
        <https://1145.am/db/2321989/Amgen>,
        <https://1145.am/db/2322632/Amgen>,
        <https://1145.am/db/2326533/Amgen>,
        <https://1145.am/db/2326559/Amgen>,
        <https://1145.am/db/2327547/Amgen>,
        <https://1145.am/db/2328748/Amgen>,
        <https://1145.am/db/2333460/Amgen>,
        <https://1145.am/db/2334046/Amgen>,
        <https://1145.am/db/2337433/Amgen>,
        <https://1145.am/db/2337435/Amgen_Inc>,
        <https://1145.am/db/2337848/Amgen>,
        <https://1145.am/db/2338027/Amgen>,
        <https://1145.am/db/2338828/Amgen>,
        <https://1145.am/db/2340408/Amgen>,
        <https://1145.am/db/2340669/Amgen>,
        <https://1145.am/db/2343511/Amgen>,
        <https://1145.am/db/2343601/Amgen>,
        <https://1145.am/db/2343780/Amgen>,
        <https://1145.am/db/2343862/Amgen>,
        <https://1145.am/db/2344631/Amgen>,
        <https://1145.am/db/2344864/Amgen>,
        <https://1145.am/db/2345191/Amgen>,
        <https://1145.am/db/2345783/Amgen>,
        <https://1145.am/db/2345886/Amgen>,
        <https://1145.am/db/2346293/Amgen>,
        <https://1145.am/db/2347966/Amgen>,
        <https://1145.am/db/2347970/Amgen>,
        <https://1145.am/db/2347976/Amgen>,
        <https://1145.am/db/2349444/Amgen>,
        <https://1145.am/db/2350029/Amgen>,
        <https://1145.am/db/2350465/Amgen>,
        <https://1145.am/db/2352800/Amgen>,
        <https://1145.am/db/2353167/Amgen>,
        <https://1145.am/db/2355378/Amgen>,
        <https://1145.am/db/2355392/Amgen>,
        <https://1145.am/db/2355427/Amgen>,
        <https://1145.am/db/2357269/Amgen>,
        <https://1145.am/db/2357271/Amgen>,
        <https://1145.am/db/2357303/Amgen>,
        <https://1145.am/db/2357451/Amgen>,
        <https://1145.am/db/2357454/Amgen>,
        <https://1145.am/db/2357920/Amgen>,
        <https://1145.am/db/2358934/Amgen>,
        <https://1145.am/db/2359462/Amgen>,
        <https://1145.am/db/2359481/Amgen>,
        <https://1145.am/db/2359498/Amgen>,
        <https://1145.am/db/2360086/Amgen>,
        <https://1145.am/db/2361037/Amgen>,
        <https://1145.am/db/2361971/Amgen>,
        <https://1145.am/db/2361972/Amgen>,
        <https://1145.am/db/2361973/Amgen>,
        <https://1145.am/db/2363673/Amgen>,
        <https://1145.am/db/2367430/Amgen_Inc>,
        <https://1145.am/db/2368788/Amgen_Inc>,
        <https://1145.am/db/2370120/Amgen>,
        <https://1145.am/db/2370174/Amgen>,
        <https://1145.am/db/2370215/Amgen>,
        <https://1145.am/db/2370217/Amgen>,
        <https://1145.am/db/2371301/Amgen>,
        <https://1145.am/db/2543232/Amgen>,
        <https://1145.am/db/2543655/Amgen>,
        <https://1145.am/db/2544701/Amgen>,
        <https://1145.am/db/2545663/Amgen>,
        <https://1145.am/db/2545765/Amgen>,
        <https://1145.am/db/2550685/Amgen>,
        <https://1145.am/db/2550884/Amgen>,
        <https://1145.am/db/2551883/Amgen>,
        <https://1145.am/db/2551884/Amgen>,
        <https://1145.am/db/2553564/Amgen>,
        <https://1145.am/db/2555175/Amgen>,
        <https://1145.am/db/2557364/Amgen>,
        <https://1145.am/db/2558012/Amgen>,
        <https://1145.am/db/2558039/Amgen>,
        <https://1145.am/db/2558051/Amgen>,
        <https://1145.am/db/2558418/Amgen>,
        <https://1145.am/db/2559077/Amgen>,
        <https://1145.am/db/2561305/Amgen>,
        <https://1145.am/db/2561325/Amgen>,
        <https://1145.am/db/2561650/Amgen>,
        <https://1145.am/db/2566335/Amgen>,
        <https://1145.am/db/2566348/Amgen>,
        <https://1145.am/db/2567960/Amgen>,
        <https://1145.am/db/2568005/Amgen>,
        <https://1145.am/db/2568075/Amgen>,
        <https://1145.am/db/2568519/Amgen>,
        <https://1145.am/db/2572535/Amgen>,
        <https://1145.am/db/2572655/Amgen>,
        <https://1145.am/db/2573455/Amgen>,
        <https://1145.am/db/2573903/Amgen>,
        <https://1145.am/db/2573924/Amgen>,
        <https://1145.am/db/2573976/Amgen>,
        <https://1145.am/db/2574586/Amgen>,
        <https://1145.am/db/2575289/Amgen>,
        <https://1145.am/db/2576018/Amgen>,
        <https://1145.am/db/2576242/Amgen>,
        <https://1145.am/db/2576498/Amgen>,
        <https://1145.am/db/2577110/Amgen>,
        <https://1145.am/db/2577115/Amgen>,
        <https://1145.am/db/2577120/Amgen>,
        <https://1145.am/db/2578110/Amgen>,
        <https://1145.am/db/2578164/Amgen>,
        <https://1145.am/db/2578286/Amgen>,
        <https://1145.am/db/2579211/Amgen>,
        <https://1145.am/db/2579278/Amgen>,
        <https://1145.am/db/2580209/Amgen>,
        <https://1145.am/db/2580211/Amgen>,
        <https://1145.am/db/2580383/Amgen_Inc>,
        <https://1145.am/db/2581309/Amgen>,
        <https://1145.am/db/2581359/Amgen>,
        <https://1145.am/db/2581917/Amgen>,
        <https://1145.am/db/2584352/Amgen>,
        <https://1145.am/db/2585068/Amgen>,
        <https://1145.am/db/2586068/Amgen>,
        <https://1145.am/db/2586750/Amgen>,
        <https://1145.am/db/2587009/Amgen>,
        <https://1145.am/db/2589106/Amgen>,
        <https://1145.am/db/2590194/Amgen>,
        <https://1145.am/db/2590988/Amgen_Inc>,
        <https://1145.am/db/2590989/Amgen>,
        <https://1145.am/db/2591587/Amgen>,
        <https://1145.am/db/2591594/Amgen>,
        <https://1145.am/db/2592573/Amgen>,
        <https://1145.am/db/2592618/Amgen>,
        <https://1145.am/db/2593423/Amgen>,
        <https://1145.am/db/2593426/Amgen>,
        <https://1145.am/db/2593433/Amgen_Inc>,
        <https://1145.am/db/2593434/Amgen>,
        <https://1145.am/db/2593465/Amgen>,
        <https://1145.am/db/2593681/Amgen>,
        <https://1145.am/db/2593973/Amgen>,
        <https://1145.am/db/2594099/Amgen>,
        <https://1145.am/db/2594285/Amgen>,
        <https://1145.am/db/2594298/Amgen>,
        <https://1145.am/db/2594347/Amgen>,
        <https://1145.am/db/2594990/Amgen>,
        <https://1145.am/db/2594993/Amgen>,
        <https://1145.am/db/2595020/Amgen>,
        <https://1145.am/db/2595549/Amgen>,
        <https://1145.am/db/2595564/Amgen>,
        <https://1145.am/db/2595587/Amgen>,
        <https://1145.am/db/2595605/Amgen>,
        <https://1145.am/db/2595608/Amgen>,
        <https://1145.am/db/2596467/Amgen>,
        <https://1145.am/db/2596819/Amgen>,
        <https://1145.am/db/2597499/Amgen>,
        <https://1145.am/db/2598066/Amgen>,
        <https://1145.am/db/2716207/Amgen>,
        <https://1145.am/db/2802001/Amgen>,
        <https://1145.am/db/559746/Amgen> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2541466/Peptides_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2013-08-29T11:25:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CordenPharma to Acquire Peptisyntha from Solvay, Expanding Peptides Custom Synthesis Business.",
        "PLANKSTADT, Germany-International Chemical Investors Group (ICIG) and the Solvay Group have entered into an agreement under which ICIG will acquire Peptisyntha SA, the Brussels, Belgium, based custom manufacturer of peptides for pharmaceutical use." ;
    ns1:documentTitle "CordenPharma to Acquire Peptisyntha from Solvay, Expanding Peptides Custom Synthesis Business" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/cordenpharma-to-acquire-peptisyntha-from-solvay-expanding-peptides-custom-synthesis> ;
    ns1:foundName "Acquire",
        "acquire" ;
    ns1:name "Acquire",
        "acquire" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2541466/Peptides> ;
    ns1:targetName "Peptides",
        "Peptisyntha" ;
    ns1:vendor <https://1145.am/db/2541466/Solvay_Group> ;
    ns1:whereGeoName "Kingdom of Belgium" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:whereRaw "Belgium" .

<https://1145.am/db/2544488/Cambridge_Major_Laboratories_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2013-10-23T15:30:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "American Capital ($ ACAS) , which already controls heparin maker Scientific Protein Laboratories, last year agreed to pay $ 212 million to buy Germantown, WI - based API maker Cambridge Major Laboratories." ;
    ns1:documentTitle "Actis invests $48M in API maker Symbiotec" ;
    ns1:documentURL <https://www.fiercepharma.com/partnering/actis-invests-48m-api-maker-symbiotec> ;
    ns1:foundName "buy",
        "pay" ;
    ns1:name "buy",
        "pay" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2544488/Cambridge_Major_Laboratories> ;
    ns1:targetName "Cambridge Major Laboratories" ;
    ns1:valueRaw "$ 212 million" ;
    ns1:whereGeoName "Germantown" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4356050/about.rdf> ;
    ns1:whereRaw "Germantown" .

<https://1145.am/db/2550639/Profarma_Distribuidora_De_Produtos_Farmacuticos_Sa_Interest_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2014-03-25T11:11:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "24, 2014- AmerisourceBergen Corporation (NYSE: ABC) today announced that it has reached a definitive agreement to acquire a minority stake in Profarma Distribuidora de Produtos Farmacuticos S.A. (Profarma) , a leading pharmaceutical wholesaler in Brazil.",
        "AmerisourceBergen Acquires Minority Interest in Profarma Distribuidora de Produtos Farmacuticos S.A." ;
    ns1:documentTitle "AmerisourceBergen Acquires Minority Interest in Profarma Distribuidora de Produtos Farmacuticos S.A." ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/amerisourcebergen-acquires-minority-interest-profarma-distribuidora-de-produtos> ;
    ns1:foundName "Acquires",
        "acquire",
        "establish" ;
    ns1:name "Acquires",
        "acquire",
        "establish" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2550639/Profarma_Distribuidora_De_Produtos_Farmacuticos_Sa> ;
    ns1:targetDetails "Interest",
        "stake" ;
    ns1:targetName "Profarma Distribuidora de Produtos Farmacutico",
        "Profarma Distribuidora de Produtos Farmacuticos S.A." ;
    ns1:valueRaw "approximately $ 100 million" ;
    ns1:whereGeoName "Federative Republic of Brazil" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:whereRaw "Brazil" .

<https://1145.am/db/2556669/Series_A_Investment_Madison_Vaccines_Incorporated_State_Of_Wisconsin_Investment_Board_Venture_Investors_Llc_Wisconsin_Alumni_Research_Foundation_(warf)_Venture_Management_Llc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-01-14T19:27:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Madison Vaccines Closes $ 8 Million Series A Financing.",
        "Madison Vaccines Incorporated (MVI) a clinical stage biopharmaceutical company focused on advancing innovative therapies for prostate cancer today announced an initial close of an $ 8 million Series A financing." ;
    ns1:documentTitle "Madison Vaccines Closes $8 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/madison-vaccines-closes-8-million-series-a-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2556669/Madison_Vaccines_Incorporated> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 8 Million",
        "$ 8 million" ;
    ns1:whereGeoName "Wisconsin" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5279468/about.rdf> ;
    ns1:whereRaw "Wisconsin" .

<https://1145.am/db/2593433/Amgen_Inc> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO and SAN FRANCISCO" ;
    ns1:buyer <https://1145.am/db/2593433/Onyx_Pharmaceuticals_Inc_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2013-08-27T07:00:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/acquisition-of-onyx-pharmaceuticals-inc-by-amgen-inc-may-not-be-best-interests-of-onyx> ;
    ns1:foundName "Amgen",
        "Amgen Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Amgen",
        "Amgen Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1003058/Microbiologics>,
        <https://1145.am/db/1003231/Microbiologics>,
        <https://1145.am/db/1252426/Amgen_Inc>,
        <https://1145.am/db/1262006/Amgen>,
        <https://1145.am/db/1271008/Biohaven>,
        <https://1145.am/db/1322590/Biora_Therapeutics_Inc>,
        <https://1145.am/db/1488570/Amgen>,
        <https://1145.am/db/1541946/Amgen>,
        <https://1145.am/db/1574155/Amgen>,
        <https://1145.am/db/1620251/Pheast_Therapeutics>,
        <https://1145.am/db/1629415/Anivive_Lifesciences>,
        <https://1145.am/db/1684691/Theravance_Biopharma_Inc>,
        <https://1145.am/db/1956623/Concept_Life_Sciences>,
        <https://1145.am/db/1965949/Glenmark_Life_Sciences_Ltd>,
        <https://1145.am/db/2051134/Vernal_Biosciences>,
        <https://1145.am/db/2117986/Generate:_Biomedicines>,
        <https://1145.am/db/2153653/Myoscience>,
        <https://1145.am/db/2154415/Amgen>,
        <https://1145.am/db/2249221/Biomimetic_Therapeutics>,
        <https://1145.am/db/2283107/Concentra_Biosciences>,
        <https://1145.am/db/2286154/Q32_Bio>,
        <https://1145.am/db/2293310/Biogen>,
        <https://1145.am/db/2295270/Biomodex>,
        <https://1145.am/db/2296062/Arix_Bioscience>,
        <https://1145.am/db/2301414/Clinicalrm>,
        <https://1145.am/db/2304044/Fidelity_Biosciences>,
        <https://1145.am/db/2310302/Charter_Life_Sciences>,
        <https://1145.am/db/2311353/Charter_Life_Sciences>,
        <https://1145.am/db/2312121/Amgen>,
        <https://1145.am/db/2313305/Fidelity_Biosciences>,
        <https://1145.am/db/2314836/Ricerca_Biosciences>,
        <https://1145.am/db/2316380/Aeon_Bioscience>,
        <https://1145.am/db/2317581/Progen_Pharmaceuticals_Limited>,
        <https://1145.am/db/2317737/Fidelity_Biosciences>,
        <https://1145.am/db/2318795/Axial_Biotech>,
        <https://1145.am/db/2318905/Fidelity_Biosciences>,
        <https://1145.am/db/2320771/Amgen>,
        <https://1145.am/db/2320775/Amgen>,
        <https://1145.am/db/2322531/Forbion>,
        <https://1145.am/db/2322632/Amgen>,
        <https://1145.am/db/2324422/Intermune>,
        <https://1145.am/db/2326361/Charter_Life_Sciences>,
        <https://1145.am/db/2326373/Charter_Life_Sciences>,
        <https://1145.am/db/2326576/Fidelity_Biosciences>,
        <https://1145.am/db/2327649/Connetics>,
        <https://1145.am/db/2328012/Intermune>,
        <https://1145.am/db/2328729/Connetics>,
        <https://1145.am/db/2331983/Drugabuse_Sciences>,
        <https://1145.am/db/2333460/Amgen>,
        <https://1145.am/db/2337433/Amgen>,
        <https://1145.am/db/2337435/Amgen_Inc>,
        <https://1145.am/db/2337455/Clal_Biotechnology_Industries>,
        <https://1145.am/db/2338346/Amgen>,
        <https://1145.am/db/2339175/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2340040/Coherus_Biosciences>,
        <https://1145.am/db/2340882/Coherus_Biosciences>,
        <https://1145.am/db/2341621/Clal_Biotechnology_Industries>,
        <https://1145.am/db/2343862/Amgen>,
        <https://1145.am/db/2344864/Amgen>,
        <https://1145.am/db/2345886/Amgen>,
        <https://1145.am/db/2347976/Amgen>,
        <https://1145.am/db/2349030/Amgen>,
        <https://1145.am/db/2349444/Amgen>,
        <https://1145.am/db/2350029/Amgen>,
        <https://1145.am/db/2350465/Amgen>,
        <https://1145.am/db/2353167/Amgen>,
        <https://1145.am/db/2355392/Amgen>,
        <https://1145.am/db/2357070/Orgenesis_Inc>,
        <https://1145.am/db/2357303/Amgen>,
        <https://1145.am/db/2357336/Amgen>,
        <https://1145.am/db/2357451/Amgen>,
        <https://1145.am/db/2357905/The_Medicines_Company>,
        <https://1145.am/db/2359498/Amgen>,
        <https://1145.am/db/2361037/Amgen>,
        <https://1145.am/db/2362425/Osi_Pharmaceuticals>,
        <https://1145.am/db/2362756/Anavex_Life_Sciences_Corp>,
        <https://1145.am/db/2364216/Amgen>,
        <https://1145.am/db/2367430/Amgen_Inc>,
        <https://1145.am/db/2368189/Index_Pharmaceuticals>,
        <https://1145.am/db/2368788/Amgen_Inc>,
        <https://1145.am/db/2370120/Amgen>,
        <https://1145.am/db/2370174/Amgen>,
        <https://1145.am/db/2370215/Amgen>,
        <https://1145.am/db/2370217/Amgen>,
        <https://1145.am/db/2550523/Quotient_Bioresearch>,
        <https://1145.am/db/2550884/Amgen>,
        <https://1145.am/db/2551315/Fidelity_Biosciences>,
        <https://1145.am/db/2553162/Amgen>,
        <https://1145.am/db/2553564/Amgen>,
        <https://1145.am/db/2557364/Amgen>,
        <https://1145.am/db/2559940/Plumbline_Life_Sciences>,
        <https://1145.am/db/2561325/Amgen>,
        <https://1145.am/db/2566335/Amgen>,
        <https://1145.am/db/2567752/Biogen>,
        <https://1145.am/db/2572655/Amgen>,
        <https://1145.am/db/2573455/Amgen>,
        <https://1145.am/db/2575289/Amgen>,
        <https://1145.am/db/2576242/Amgen>,
        <https://1145.am/db/2577120/Amgen>,
        <https://1145.am/db/2578164/Amgen>,
        <https://1145.am/db/2579211/Amgen>,
        <https://1145.am/db/2580383/Amgen_Inc>,
        <https://1145.am/db/2581917/Amgen>,
        <https://1145.am/db/2584951/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2585500/Univercells>,
        <https://1145.am/db/2586750/Amgen>,
        <https://1145.am/db/2587009/Amgen>,
        <https://1145.am/db/2588372/Fidelity_Biosciences>,
        <https://1145.am/db/2590988/Amgen_Inc>,
        <https://1145.am/db/2591587/Amgen>,
        <https://1145.am/db/2591594/Amgen>,
        <https://1145.am/db/2591596/Agila_Specialties>,
        <https://1145.am/db/2592126/Intermune>,
        <https://1145.am/db/2592618/Amgen>,
        <https://1145.am/db/2593423/Amgen>,
        <https://1145.am/db/2593426/Amgen>,
        <https://1145.am/db/2593434/Amgen>,
        <https://1145.am/db/2593973/Amgen>,
        <https://1145.am/db/2594298/Amgen>,
        <https://1145.am/db/2594347/Amgen>,
        <https://1145.am/db/2594858/Afexa_Life_Sciences_Inc>,
        <https://1145.am/db/2595020/Amgen>,
        <https://1145.am/db/2595549/Amgen>,
        <https://1145.am/db/2595587/Amgen>,
        <https://1145.am/db/2595608/Amgen>,
        <https://1145.am/db/2596467/Amgen>,
        <https://1145.am/db/2596819/Amgen>,
        <https://1145.am/db/2598012/Afexa_Life_Sciences>,
        <https://1145.am/db/2598032/Afexa_Life_Sciences_Inc>,
        <https://1145.am/db/2598066/Amgen>,
        <https://1145.am/db/559746/Amgen>,
        <https://1145.am/db/696633/Aragen_Life_Sciences>,
        <https://1145.am/db/701847/Specific_Biologics_Inc>,
        <https://1145.am/db/714395/Arix_Bioscience_Plc>,
        <https://1145.am/db/763450/Boundless_Bio>,
        <https://1145.am/db/812449/Boundless_Bio>,
        <https://1145.am/db/979879/Advanced_Clinical>,
        <https://1145.am/db/980904/Advanced_Clinical> ;
    ns1:sameAsMedium <https://1145.am/db/1253935/Amgen>,
        <https://1145.am/db/1254815/Amgen>,
        <https://1145.am/db/1258904/Amgen_Inc>,
        <https://1145.am/db/1406211/Amgen>,
        <https://1145.am/db/1434130/Amgen>,
        <https://1145.am/db/1568872/Amgen_Inc>,
        <https://1145.am/db/1570839/Amgen_Inc>,
        <https://1145.am/db/1573831/Amgen>,
        <https://1145.am/db/1575688/Amgen_Inc>,
        <https://1145.am/db/1576668/Amgen_Inc>,
        <https://1145.am/db/1673901/Amgen>,
        <https://1145.am/db/1929668/Amgen>,
        <https://1145.am/db/1981398/Amgen>,
        <https://1145.am/db/198163/Amgen>,
        <https://1145.am/db/2008430/Amgen_Inc>,
        <https://1145.am/db/2008790/Amgen>,
        <https://1145.am/db/2009117/Amgen_Inc>,
        <https://1145.am/db/2011679/Amgen>,
        <https://1145.am/db/2012933/Amgen_Inc>,
        <https://1145.am/db/2013008/Amgen_Inc>,
        <https://1145.am/db/2016970/Amgen>,
        <https://1145.am/db/2043001/Amgen>,
        <https://1145.am/db/2046726/Amgen>,
        <https://1145.am/db/2098829/Amgen>,
        <https://1145.am/db/2105082/Amgen>,
        <https://1145.am/db/2106270/Amgen>,
        <https://1145.am/db/2107919/Amgen>,
        <https://1145.am/db/2117067/Amgen>,
        <https://1145.am/db/2117986/Amgen>,
        <https://1145.am/db/2138386/Amgen>,
        <https://1145.am/db/2152715/Amgen>,
        <https://1145.am/db/2153258/Amgen>,
        <https://1145.am/db/2155409/Amgen>,
        <https://1145.am/db/2155659/Amgen>,
        <https://1145.am/db/2249776/Amgen_Inc>,
        <https://1145.am/db/2282387/Amgen>,
        <https://1145.am/db/2282934/Amgen>,
        <https://1145.am/db/2283321/Amgen>,
        <https://1145.am/db/2285195/Amgen>,
        <https://1145.am/db/2285614/Amgen>,
        <https://1145.am/db/2285991/Amgen>,
        <https://1145.am/db/2286174/Amgen>,
        <https://1145.am/db/2291231/Amgen>,
        <https://1145.am/db/2292224/Amgen>,
        <https://1145.am/db/2292876/Amgen>,
        <https://1145.am/db/2299349/Amgen>,
        <https://1145.am/db/2302052/Amgen>,
        <https://1145.am/db/2303414/Amgen>,
        <https://1145.am/db/2313429/Amgen>,
        <https://1145.am/db/2317845/Amgen>,
        <https://1145.am/db/2318877/Amgen>,
        <https://1145.am/db/2320754/Amgen>,
        <https://1145.am/db/2320759/Amgen>,
        <https://1145.am/db/2320765/Amgen>,
        <https://1145.am/db/2321459/Amgen>,
        <https://1145.am/db/2321989/Amgen>,
        <https://1145.am/db/2322040/Amgen>,
        <https://1145.am/db/2326533/Amgen>,
        <https://1145.am/db/2326559/Amgen>,
        <https://1145.am/db/2327526/Amgen>,
        <https://1145.am/db/2327547/Amgen>,
        <https://1145.am/db/2328748/Amgen>,
        <https://1145.am/db/2329762/Amgen>,
        <https://1145.am/db/2334046/Amgen>,
        <https://1145.am/db/2337848/Amgen>,
        <https://1145.am/db/2338027/Amgen>,
        <https://1145.am/db/2338329/Amgen>,
        <https://1145.am/db/2338828/Amgen>,
        <https://1145.am/db/2340408/Amgen>,
        <https://1145.am/db/2340634/Amgen>,
        <https://1145.am/db/2340669/Amgen>,
        <https://1145.am/db/2343511/Amgen>,
        <https://1145.am/db/2343601/Amgen>,
        <https://1145.am/db/2343780/Amgen>,
        <https://1145.am/db/2344369/Amgen>,
        <https://1145.am/db/2344631/Amgen>,
        <https://1145.am/db/2345191/Amgen>,
        <https://1145.am/db/2345783/Amgen>,
        <https://1145.am/db/2346293/Amgen>,
        <https://1145.am/db/2347966/Amgen>,
        <https://1145.am/db/2347970/Amgen>,
        <https://1145.am/db/2350471/Amgen>,
        <https://1145.am/db/2352800/Amgen>,
        <https://1145.am/db/2354835/Amgen>,
        <https://1145.am/db/2355378/Amgen>,
        <https://1145.am/db/2355383/Amgen>,
        <https://1145.am/db/2355427/Amgen>,
        <https://1145.am/db/2357269/Amgen>,
        <https://1145.am/db/2357271/Amgen>,
        <https://1145.am/db/2357454/Amgen>,
        <https://1145.am/db/2357920/Amgen>,
        <https://1145.am/db/2358934/Amgen>,
        <https://1145.am/db/2359165/Amgen>,
        <https://1145.am/db/2359462/Amgen>,
        <https://1145.am/db/2359481/Amgen>,
        <https://1145.am/db/2360080/Amgen>,
        <https://1145.am/db/2360086/Amgen>,
        <https://1145.am/db/2361971/Amgen>,
        <https://1145.am/db/2361972/Amgen>,
        <https://1145.am/db/2361973/Amgen>,
        <https://1145.am/db/2362552/Amgen>,
        <https://1145.am/db/2363673/Amgen>,
        <https://1145.am/db/2371301/Amgen>,
        <https://1145.am/db/2538019/Amgen>,
        <https://1145.am/db/2539787/Amgen>,
        <https://1145.am/db/2540225/Amgen>,
        <https://1145.am/db/2543232/Amgen>,
        <https://1145.am/db/2543655/Amgen>,
        <https://1145.am/db/2544701/Amgen>,
        <https://1145.am/db/2545663/Amgen>,
        <https://1145.am/db/2545765/Amgen>,
        <https://1145.am/db/2548575/Amgen>,
        <https://1145.am/db/2550685/Amgen>,
        <https://1145.am/db/2551883/Amgen>,
        <https://1145.am/db/2551884/Amgen>,
        <https://1145.am/db/2554152/Amgen>,
        <https://1145.am/db/2555175/Amgen>,
        <https://1145.am/db/2556729/Amgen>,
        <https://1145.am/db/2558012/Amgen>,
        <https://1145.am/db/2558039/Amgen>,
        <https://1145.am/db/2558051/Amgen>,
        <https://1145.am/db/2558418/Amgen>,
        <https://1145.am/db/2559077/Amgen>,
        <https://1145.am/db/2561305/Amgen>,
        <https://1145.am/db/2561317/Amgen>,
        <https://1145.am/db/2561650/Amgen>,
        <https://1145.am/db/2566348/Amgen>,
        <https://1145.am/db/2567468/Amgen>,
        <https://1145.am/db/2567517/Amgen>,
        <https://1145.am/db/2567960/Amgen>,
        <https://1145.am/db/2567981/Amgen>,
        <https://1145.am/db/2568005/Amgen>,
        <https://1145.am/db/2568075/Amgen>,
        <https://1145.am/db/2568519/Amgen>,
        <https://1145.am/db/2572535/Amgen>,
        <https://1145.am/db/2573903/Amgen>,
        <https://1145.am/db/2573924/Amgen>,
        <https://1145.am/db/2573976/Amgen>,
        <https://1145.am/db/2574586/Amgen>,
        <https://1145.am/db/2575263/Amgen>,
        <https://1145.am/db/2576018/Amgen>,
        <https://1145.am/db/2576498/Amgen>,
        <https://1145.am/db/2577110/Amgen>,
        <https://1145.am/db/2577115/Amgen>,
        <https://1145.am/db/2578110/Amgen>,
        <https://1145.am/db/2578286/Amgen>,
        <https://1145.am/db/2579278/Amgen>,
        <https://1145.am/db/2580209/Amgen>,
        <https://1145.am/db/2580211/Amgen>,
        <https://1145.am/db/2581309/Amgen>,
        <https://1145.am/db/2581359/Amgen>,
        <https://1145.am/db/2583990/Amgen>,
        <https://1145.am/db/2584352/Amgen>,
        <https://1145.am/db/2585068/Amgen>,
        <https://1145.am/db/2586068/Amgen>,
        <https://1145.am/db/2587770/Amgen>,
        <https://1145.am/db/258901/Amgen_Inc>,
        <https://1145.am/db/2589106/Amgen>,
        <https://1145.am/db/2590194/Amgen>,
        <https://1145.am/db/2590989/Amgen>,
        <https://1145.am/db/2592573/Amgen>,
        <https://1145.am/db/2592924/Amgen>,
        <https://1145.am/db/2593465/Amgen>,
        <https://1145.am/db/2593681/Amgen>,
        <https://1145.am/db/2594099/Amgen>,
        <https://1145.am/db/2594285/Amgen>,
        <https://1145.am/db/2594292/Amgen>,
        <https://1145.am/db/2594990/Amgen>,
        <https://1145.am/db/2594993/Amgen>,
        <https://1145.am/db/2595564/Amgen>,
        <https://1145.am/db/2595605/Amgen>,
        <https://1145.am/db/2595930/Amgen>,
        <https://1145.am/db/2597499/Amgen>,
        <https://1145.am/db/2716207/Amgen>,
        <https://1145.am/db/2789236/Amgen>,
        <https://1145.am/db/2802001/Amgen>,
        <https://1145.am/db/531806/Amgen_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2595564/Amgen> a org:Organization ;
    ns1:buyer <https://1145.am/db/2595564/Elan_Acquisition>,
        <https://1145.am/db/2595564/Onyx_Acquisition> ;
    ns1:documentDate "2013-09-19T15:58:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "With $29B in deals so far, 2013 shaping up as big M&A year" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/29b-deals-so-far-2013-shaping-up-as-big-m-a-year> ;
    ns1:foundName "Amgen" ;
    ns1:industry "drug approvals" ;
    ns1:name "Amgen" ;
    ns1:sameAsMedium <https://1145.am/db/1252426/Amgen_Inc>,
        <https://1145.am/db/1253935/Amgen>,
        <https://1145.am/db/1254815/Amgen>,
        <https://1145.am/db/1258904/Amgen_Inc>,
        <https://1145.am/db/1262006/Amgen>,
        <https://1145.am/db/1406211/Amgen>,
        <https://1145.am/db/1434130/Amgen>,
        <https://1145.am/db/1488570/Amgen>,
        <https://1145.am/db/1541946/Amgen>,
        <https://1145.am/db/1568872/Amgen_Inc>,
        <https://1145.am/db/1570839/Amgen_Inc>,
        <https://1145.am/db/1573831/Amgen>,
        <https://1145.am/db/1574155/Amgen>,
        <https://1145.am/db/1575688/Amgen_Inc>,
        <https://1145.am/db/1576668/Amgen_Inc>,
        <https://1145.am/db/1673901/Amgen>,
        <https://1145.am/db/1929668/Amgen>,
        <https://1145.am/db/1981398/Amgen>,
        <https://1145.am/db/198163/Amgen>,
        <https://1145.am/db/2008430/Amgen_Inc>,
        <https://1145.am/db/2008790/Amgen>,
        <https://1145.am/db/2009117/Amgen_Inc>,
        <https://1145.am/db/2011679/Amgen>,
        <https://1145.am/db/2012933/Amgen_Inc>,
        <https://1145.am/db/2013008/Amgen_Inc>,
        <https://1145.am/db/2016970/Amgen>,
        <https://1145.am/db/2043001/Amgen>,
        <https://1145.am/db/2046726/Amgen>,
        <https://1145.am/db/2098829/Amgen>,
        <https://1145.am/db/2105082/Amgen>,
        <https://1145.am/db/2106270/Amgen>,
        <https://1145.am/db/2107919/Amgen>,
        <https://1145.am/db/2117067/Amgen>,
        <https://1145.am/db/2117986/Amgen>,
        <https://1145.am/db/2138386/Amgen>,
        <https://1145.am/db/2152715/Amgen>,
        <https://1145.am/db/2153258/Amgen>,
        <https://1145.am/db/2154415/Amgen>,
        <https://1145.am/db/2155409/Amgen>,
        <https://1145.am/db/2155659/Amgen>,
        <https://1145.am/db/2249776/Amgen_Inc>,
        <https://1145.am/db/2282387/Amgen>,
        <https://1145.am/db/2282934/Amgen>,
        <https://1145.am/db/2283321/Amgen>,
        <https://1145.am/db/2285195/Amgen>,
        <https://1145.am/db/2285614/Amgen>,
        <https://1145.am/db/2285991/Amgen>,
        <https://1145.am/db/2286174/Amgen>,
        <https://1145.am/db/2291231/Amgen>,
        <https://1145.am/db/2292224/Amgen>,
        <https://1145.am/db/2292876/Amgen>,
        <https://1145.am/db/2299349/Amgen>,
        <https://1145.am/db/2302052/Amgen>,
        <https://1145.am/db/2303414/Amgen>,
        <https://1145.am/db/2312121/Amgen>,
        <https://1145.am/db/2313429/Amgen>,
        <https://1145.am/db/2317845/Amgen>,
        <https://1145.am/db/2318877/Amgen>,
        <https://1145.am/db/2320754/Amgen>,
        <https://1145.am/db/2320759/Amgen>,
        <https://1145.am/db/2320765/Amgen>,
        <https://1145.am/db/2320771/Amgen>,
        <https://1145.am/db/2320775/Amgen>,
        <https://1145.am/db/2321459/Amgen>,
        <https://1145.am/db/2321989/Amgen>,
        <https://1145.am/db/2322040/Amgen>,
        <https://1145.am/db/2322632/Amgen>,
        <https://1145.am/db/2326533/Amgen>,
        <https://1145.am/db/2326559/Amgen>,
        <https://1145.am/db/2327526/Amgen>,
        <https://1145.am/db/2327547/Amgen>,
        <https://1145.am/db/2328748/Amgen>,
        <https://1145.am/db/2329762/Amgen>,
        <https://1145.am/db/2333460/Amgen>,
        <https://1145.am/db/2334046/Amgen>,
        <https://1145.am/db/2337433/Amgen>,
        <https://1145.am/db/2337435/Amgen_Inc>,
        <https://1145.am/db/2337848/Amgen>,
        <https://1145.am/db/2338027/Amgen>,
        <https://1145.am/db/2338329/Amgen>,
        <https://1145.am/db/2338346/Amgen>,
        <https://1145.am/db/2338828/Amgen>,
        <https://1145.am/db/2340408/Amgen>,
        <https://1145.am/db/2340634/Amgen>,
        <https://1145.am/db/2340669/Amgen>,
        <https://1145.am/db/2343511/Amgen>,
        <https://1145.am/db/2343601/Amgen>,
        <https://1145.am/db/2343780/Amgen>,
        <https://1145.am/db/2343862/Amgen>,
        <https://1145.am/db/2344369/Amgen>,
        <https://1145.am/db/2344631/Amgen>,
        <https://1145.am/db/2344864/Amgen>,
        <https://1145.am/db/2345191/Amgen>,
        <https://1145.am/db/2345783/Amgen>,
        <https://1145.am/db/2345886/Amgen>,
        <https://1145.am/db/2346293/Amgen>,
        <https://1145.am/db/2347966/Amgen>,
        <https://1145.am/db/2347970/Amgen>,
        <https://1145.am/db/2347976/Amgen>,
        <https://1145.am/db/2349030/Amgen>,
        <https://1145.am/db/2349444/Amgen>,
        <https://1145.am/db/2350029/Amgen>,
        <https://1145.am/db/2350465/Amgen>,
        <https://1145.am/db/2350471/Amgen>,
        <https://1145.am/db/2352800/Amgen>,
        <https://1145.am/db/2353167/Amgen>,
        <https://1145.am/db/2354835/Amgen>,
        <https://1145.am/db/2355378/Amgen>,
        <https://1145.am/db/2355383/Amgen>,
        <https://1145.am/db/2355392/Amgen>,
        <https://1145.am/db/2355427/Amgen>,
        <https://1145.am/db/2357269/Amgen>,
        <https://1145.am/db/2357271/Amgen>,
        <https://1145.am/db/2357303/Amgen>,
        <https://1145.am/db/2357336/Amgen>,
        <https://1145.am/db/2357451/Amgen>,
        <https://1145.am/db/2357454/Amgen>,
        <https://1145.am/db/2357920/Amgen>,
        <https://1145.am/db/2358934/Amgen>,
        <https://1145.am/db/2359165/Amgen>,
        <https://1145.am/db/2359462/Amgen>,
        <https://1145.am/db/2359481/Amgen>,
        <https://1145.am/db/2359498/Amgen>,
        <https://1145.am/db/2360080/Amgen>,
        <https://1145.am/db/2360086/Amgen>,
        <https://1145.am/db/2361037/Amgen>,
        <https://1145.am/db/2361971/Amgen>,
        <https://1145.am/db/2361972/Amgen>,
        <https://1145.am/db/2361973/Amgen>,
        <https://1145.am/db/2362552/Amgen>,
        <https://1145.am/db/2363673/Amgen>,
        <https://1145.am/db/2364216/Amgen>,
        <https://1145.am/db/2367430/Amgen_Inc>,
        <https://1145.am/db/2368788/Amgen_Inc>,
        <https://1145.am/db/2370120/Amgen>,
        <https://1145.am/db/2370174/Amgen>,
        <https://1145.am/db/2370215/Amgen>,
        <https://1145.am/db/2370217/Amgen>,
        <https://1145.am/db/2371301/Amgen>,
        <https://1145.am/db/2538019/Amgen>,
        <https://1145.am/db/2539787/Amgen>,
        <https://1145.am/db/2540225/Amgen>,
        <https://1145.am/db/2543232/Amgen>,
        <https://1145.am/db/2543655/Amgen>,
        <https://1145.am/db/2544701/Amgen>,
        <https://1145.am/db/2545663/Amgen>,
        <https://1145.am/db/2545765/Amgen>,
        <https://1145.am/db/2548575/Amgen>,
        <https://1145.am/db/2550685/Amgen>,
        <https://1145.am/db/2550884/Amgen>,
        <https://1145.am/db/2551883/Amgen>,
        <https://1145.am/db/2551884/Amgen>,
        <https://1145.am/db/2553162/Amgen>,
        <https://1145.am/db/2553564/Amgen>,
        <https://1145.am/db/2554152/Amgen>,
        <https://1145.am/db/2555175/Amgen>,
        <https://1145.am/db/2556729/Amgen>,
        <https://1145.am/db/2557364/Amgen>,
        <https://1145.am/db/2558012/Amgen>,
        <https://1145.am/db/2558039/Amgen>,
        <https://1145.am/db/2558051/Amgen>,
        <https://1145.am/db/2558418/Amgen>,
        <https://1145.am/db/2559077/Amgen>,
        <https://1145.am/db/2561305/Amgen>,
        <https://1145.am/db/2561317/Amgen>,
        <https://1145.am/db/2561325/Amgen>,
        <https://1145.am/db/2561650/Amgen>,
        <https://1145.am/db/2566335/Amgen>,
        <https://1145.am/db/2566348/Amgen>,
        <https://1145.am/db/2567468/Amgen>,
        <https://1145.am/db/2567517/Amgen>,
        <https://1145.am/db/2567960/Amgen>,
        <https://1145.am/db/2567981/Amgen>,
        <https://1145.am/db/2568005/Amgen>,
        <https://1145.am/db/2568075/Amgen>,
        <https://1145.am/db/2568519/Amgen>,
        <https://1145.am/db/2572535/Amgen>,
        <https://1145.am/db/2572655/Amgen>,
        <https://1145.am/db/2573455/Amgen>,
        <https://1145.am/db/2573903/Amgen>,
        <https://1145.am/db/2573924/Amgen>,
        <https://1145.am/db/2573976/Amgen>,
        <https://1145.am/db/2574586/Amgen>,
        <https://1145.am/db/2575263/Amgen>,
        <https://1145.am/db/2575289/Amgen>,
        <https://1145.am/db/2576018/Amgen>,
        <https://1145.am/db/2576242/Amgen>,
        <https://1145.am/db/2576498/Amgen>,
        <https://1145.am/db/2577110/Amgen>,
        <https://1145.am/db/2577115/Amgen>,
        <https://1145.am/db/2577120/Amgen>,
        <https://1145.am/db/2578110/Amgen>,
        <https://1145.am/db/2578164/Amgen>,
        <https://1145.am/db/2578286/Amgen>,
        <https://1145.am/db/2579211/Amgen>,
        <https://1145.am/db/2579278/Amgen>,
        <https://1145.am/db/2580209/Amgen>,
        <https://1145.am/db/2580211/Amgen>,
        <https://1145.am/db/2580383/Amgen_Inc>,
        <https://1145.am/db/2581309/Amgen>,
        <https://1145.am/db/2581359/Amgen>,
        <https://1145.am/db/2581917/Amgen>,
        <https://1145.am/db/2583990/Amgen>,
        <https://1145.am/db/2584352/Amgen>,
        <https://1145.am/db/2585068/Amgen>,
        <https://1145.am/db/2586068/Amgen>,
        <https://1145.am/db/2586750/Amgen>,
        <https://1145.am/db/2587009/Amgen>,
        <https://1145.am/db/2587770/Amgen>,
        <https://1145.am/db/258901/Amgen_Inc>,
        <https://1145.am/db/2589106/Amgen>,
        <https://1145.am/db/2590194/Amgen>,
        <https://1145.am/db/2590988/Amgen_Inc>,
        <https://1145.am/db/2590989/Amgen>,
        <https://1145.am/db/2591587/Amgen>,
        <https://1145.am/db/2591594/Amgen>,
        <https://1145.am/db/2592573/Amgen>,
        <https://1145.am/db/2592618/Amgen>,
        <https://1145.am/db/2592924/Amgen>,
        <https://1145.am/db/2593423/Amgen>,
        <https://1145.am/db/2593426/Amgen>,
        <https://1145.am/db/2593433/Amgen_Inc>,
        <https://1145.am/db/2593434/Amgen>,
        <https://1145.am/db/2593465/Amgen>,
        <https://1145.am/db/2593681/Amgen>,
        <https://1145.am/db/2593973/Amgen>,
        <https://1145.am/db/2594099/Amgen>,
        <https://1145.am/db/2594285/Amgen>,
        <https://1145.am/db/2594292/Amgen>,
        <https://1145.am/db/2594298/Amgen>,
        <https://1145.am/db/2594347/Amgen>,
        <https://1145.am/db/2594990/Amgen>,
        <https://1145.am/db/2594993/Amgen>,
        <https://1145.am/db/2595020/Amgen>,
        <https://1145.am/db/2595549/Amgen>,
        <https://1145.am/db/2595587/Amgen>,
        <https://1145.am/db/2595605/Amgen>,
        <https://1145.am/db/2595608/Amgen>,
        <https://1145.am/db/2595930/Amgen>,
        <https://1145.am/db/2596467/Amgen>,
        <https://1145.am/db/2596819/Amgen>,
        <https://1145.am/db/2597499/Amgen>,
        <https://1145.am/db/2598066/Amgen>,
        <https://1145.am/db/2716207/Amgen>,
        <https://1145.am/db/2789236/Amgen>,
        <https://1145.am/db/2802001/Amgen>,
        <https://1145.am/db/531806/Amgen_Inc>,
        <https://1145.am/db/559746/Amgen> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2597465/Panasonics_Healthcare_Arm> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:documentDate "2013-10-11T15:13:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "KKR on verge of buying stake in India's Gland, sources say" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/kkr-on-verge-of-buying-stake-india-s-gland-sources-say> ;
    ns1:foundName "PRA",
        "Panasonic" ;
    ns1:industry "healthcare" ;
    ns1:name "Panasonic",
        "Panasonic's healthcare arm" ;
    ns1:sameAsHigh <https://1145.am/db/2290211/Panasonic>,
        <https://1145.am/db/2290727/Panasonic>,
        <https://1145.am/db/2291134/Panasonic>,
        <https://1145.am/db/2291651/Panasonic>,
        <https://1145.am/db/2291664/Panasonic>,
        <https://1145.am/db/2297616/Panasonic_Healthcare_Company_Of_North_America>,
        <https://1145.am/db/2297727/Panasonic>,
        <https://1145.am/db/2312950/Panasonic_Healthcare>,
        <https://1145.am/db/2318461/Panasonic>,
        <https://1145.am/db/2561249/Panasonic_Corp>,
        <https://1145.am/db/2561249/Panasonic_Healthcare>,
        <https://1145.am/db/2570097/Panasonic_Healthcare>,
        <https://1145.am/db/2570177/Panasonic_Healthcare>,
        <https://1145.am/db/2576841/Panasonic_Healthcare_Holdings_Co_Ltd> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2651156/Maroc_Telecom_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "divestment" ;
    ns1:documentDate "2013-07-24T11:16:14+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Morocco's state investment vehicle Caisse de Depot et de Gestion (CDG) may team up with Etisalat in the latter's planned purchase of a majority stake in Maroc Telecom, CDG's CEO said earlier in July, according to Reuters.",
        "Vivendi took further step towards becoming a media-only group by entering into exclusive talks with Etisalat on the sale of its 53 per cent stake in Maroc Telecom for 4.2 billion ($ 5.54 billion) in cash." ;
    ns1:documentTitle "Vivendi pushes ahead with plan to offload Maroc Telecom" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/vivendi-pushes-ahead-plan-to-offload-maroc-telecom> ;
    ns1:foundName "purchase",
        "sale" ;
    ns1:name "purchase",
        "sale" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2651156/Maroc_Telecom> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Maroc Telecom" ;
    ns1:valueRaw "$ 5.54 billion" ;
    ns1:vendor <https://1145.am/db/2651156/Vivendi> ;
    ns1:whereGeoName "Kingdom of Morocco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2542007/about.rdf> ;
    ns1:whereRaw "Morocco" .

<https://1145.am/db/2663183/KPN> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:description "M & A" ;
    ns1:documentDate "2014-01-28T21:03:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "As Vodafone closes its Verizon deal, the rumour mill goes into overdrive" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/as-vodafone-closes-its-verizon-deal-rumour-mill-goes-into-overdrive> ;
    ns1:foundName "KPN" ;
    ns1:name "KPN" ;
    ns1:sameAsHigh <https://1145.am/db/2667481/KPN> ;
    ns1:sameAsMedium <https://1145.am/db/1916132/KPN>,
        <https://1145.am/db/2600194/KPN>,
        <https://1145.am/db/2604431/KPN>,
        <https://1145.am/db/2605931/KPN>,
        <https://1145.am/db/2610488/KPN>,
        <https://1145.am/db/2610810/KPN>,
        <https://1145.am/db/2611767/KPN>,
        <https://1145.am/db/2611935/KPN>,
        <https://1145.am/db/2615841/KPN>,
        <https://1145.am/db/2616385/KPN>,
        <https://1145.am/db/2632668/KPN>,
        <https://1145.am/db/2643393/KPN>,
        <https://1145.am/db/2651025/KPN>,
        <https://1145.am/db/2651143/KPN>,
        <https://1145.am/db/2651152/KPN>,
        <https://1145.am/db/2651365/KPN>,
        <https://1145.am/db/2651498/KPN>,
        <https://1145.am/db/2651511/KPN>,
        <https://1145.am/db/2651887/KPN>,
        <https://1145.am/db/2651900/KPN>,
        <https://1145.am/db/2651912/KPN>,
        <https://1145.am/db/2652053/KPN>,
        <https://1145.am/db/2652442/KPN>,
        <https://1145.am/db/2652516/KPN>,
        <https://1145.am/db/2652548/KPN>,
        <https://1145.am/db/2652570/KPN>,
        <https://1145.am/db/2652729/KPN>,
        <https://1145.am/db/2653256/KPN>,
        <https://1145.am/db/2653270/KPN>,
        <https://1145.am/db/2653291/KPN>,
        <https://1145.am/db/2654021/KPN>,
        <https://1145.am/db/2655000/KPN>,
        <https://1145.am/db/2655513/KPN>,
        <https://1145.am/db/2655934/KPN>,
        <https://1145.am/db/2656778/KPN>,
        <https://1145.am/db/2656878/KPN>,
        <https://1145.am/db/2658223/KPN>,
        <https://1145.am/db/2658756/KPN>,
        <https://1145.am/db/2658872/KPN>,
        <https://1145.am/db/2658917/KPN>,
        <https://1145.am/db/2659872/KPN>,
        <https://1145.am/db/2659938/KPN>,
        <https://1145.am/db/2660513/KPN>,
        <https://1145.am/db/2660832/KPN>,
        <https://1145.am/db/2660906/KPN>,
        <https://1145.am/db/2660929/KPN>,
        <https://1145.am/db/2661011/KPN>,
        <https://1145.am/db/2661991/KPN>,
        <https://1145.am/db/2662050/KPN>,
        <https://1145.am/db/2662065/KPN>,
        <https://1145.am/db/2662077/KPN>,
        <https://1145.am/db/2663189/KPN>,
        <https://1145.am/db/2664165/KPN>,
        <https://1145.am/db/2664273/KPN>,
        <https://1145.am/db/2665177/KPN>,
        <https://1145.am/db/2665887/KPN>,
        <https://1145.am/db/2666440/KPN>,
        <https://1145.am/db/2667525/KPN>,
        <https://1145.am/db/2668553/KPN>,
        <https://1145.am/db/2668563/KPN>,
        <https://1145.am/db/2668591/KPN>,
        <https://1145.am/db/2670667/KPN>,
        <https://1145.am/db/2670751/KPN>,
        <https://1145.am/db/2670756/KPN>,
        <https://1145.am/db/2670785/KPN>,
        <https://1145.am/db/2671812/KPN>,
        <https://1145.am/db/2671930/KPN>,
        <https://1145.am/db/2671934/KPN>,
        <https://1145.am/db/2671957/KPN>,
        <https://1145.am/db/2672644/KPN>,
        <https://1145.am/db/2672655/KPN>,
        <https://1145.am/db/2673088/KPN>,
        <https://1145.am/db/2673855/KPN>,
        <https://1145.am/db/2674207/KPN>,
        <https://1145.am/db/2674299/KPN>,
        <https://1145.am/db/2675473/KPN>,
        <https://1145.am/db/2675499/KPN>,
        <https://1145.am/db/2676204/KPN>,
        <https://1145.am/db/2676705/KPN>,
        <https://1145.am/db/2678643/KPN>,
        <https://1145.am/db/2678648/KPN>,
        <https://1145.am/db/2679767/KPN>,
        <https://1145.am/db/2679770/KPN>,
        <https://1145.am/db/2680106/KPN>,
        <https://1145.am/db/2680795/KPN>,
        <https://1145.am/db/2680826/KPN>,
        <https://1145.am/db/302501/KPN>,
        <https://1145.am/db/322674/KPN> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2683818/Nokia_Solutions_And_Networks_Unit_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2013-09-26T13:47:07+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Nokia's (NYSE: NOK) board is considering a deal between the company's Nokia Solutions and Networks (NSN) unit and rival Alcatel-Lucent (NYSE: ALU) , according to multiple reports." ;
    ns1:documentTitle "Reports: Nokia's board considering NSN deal with Alcatel-Lucent" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/reports-nokia-s-board-considering-nsn-deal-alcatel-lucent> ;
    ns1:foundName "acquire",
        "buy",
        "deal" ;
    ns1:name "acquire",
        "buy",
        "deal" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "stopped",
        "unknown" ;
    ns1:target <https://1145.am/db/2683818/Nokia_Solutions_And_Networks> ;
    ns1:targetDetails "unit" ;
    ns1:targetName "Nokia Solutions and Networks" ;
    ns1:valueRaw "$ 7.2 billion" ;
    ns1:vendor <https://1145.am/db/2683818/Alcatel-Lucent>,
        <https://1145.am/db/2683818/Nokia_Solutions_And_Networks> .

<https://1145.am/db/2242437/Iasis_Healthcare_Llc> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "healthcare services" ;
    ns1:documentDate "2013-08-14T13:00:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "IASIS Healthcare Executes Real Estate Transaction as Part of Long-Term Strategic Growth Plan" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/iasis-healthcare-executes-real-estate-transaction-as-part-long-term-strategic-growth> ;
    ns1:foundName "IASIS Healthcare LLC" ;
    ns1:industry "healthcare services" ;
    ns1:name "IASIS Healthcare LLC" ;
    ns1:sameAsHigh <https://1145.am/db/2245306/Iasis_Healthcare>,
        <https://1145.am/db/2252334/Iasis_Healthcare> ;
    ns1:sameAsMedium <https://1145.am/db/2232624/Iasis_Healthcare_Corporation>,
        <https://1145.am/db/2235312/Iasis_Healthcare>,
        <https://1145.am/db/2235982/Iasis_Healthcare>,
        <https://1145.am/db/2237582/Iasis_Healthcare_Llc>,
        <https://1145.am/db/2240328/Iasis_Healthcare>,
        <https://1145.am/db/2242439/Iasis_Healthcare_Llc>,
        <https://1145.am/db/2242987/Iasis_Healthcare>,
        <https://1145.am/db/2243215/Iasis_Healthcare>,
        <https://1145.am/db/2244260/Iasis_Healthcare>,
        <https://1145.am/db/2245999/Iasis_Healthcare>,
        <https://1145.am/db/2251901/Iasis_Healthcare_Llc>,
        <https://1145.am/db/2251918/Iasis_Healthcare> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2341764/Investment_Alta_Partners_Cardinal_Partners_Domain_Associates_Polaris_Partners_Atyr_Pharma_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-07-29T05:31:14+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SAN DIEGO - July 29, 2013 - aTyr Pharma, an innovative protein therapeutics enterprise focused on rare diseases, announced today the successful completion of a $ 49 million financing.",
        "aTyr Pharma Completes $ 49 Million Oversubscribed Financing to Advance Rare Autoimmune Disease Therapeutic Pipeline from a Newly Discovered Class of Proteins, Physiocrines." ;
    ns1:documentTitle "aTyr Pharma Completes $49 Million Oversubscribed Financing to Advance Rare Autoimmune Disease Therapeutic Pipeline from a Newly Discovered Class of Proteins, Physiocrines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/atyr-pharma-completes-49-million-oversubscribed-financing-to-advance-rare-autoimmune> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2341764/Atyr_Pharma> ;
    ns1:valueRaw "$ 49 Million",
        "$ 49 million" ;
    ns1:when "2013-07-29T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "July 29, 2013" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2341792/Series_B_Investment_Edimer_Pharmaceuticals_New_Enterprise_Associates_Sanofi-Genzyme_Bioventures_Third_Rock_Ventures_Vi_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-07-30T12:24:45+00:00"^^xsd:dateTime ;
    ns1:documentExtract "- July 30, 2013 - Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) , today announced it has secured $ 18 million in Series B financing.",
        "Edimer Secures $ 18M Series B Financing Led by New Enterprise Associates." ;
    ns1:documentTitle "Edimer Secures $18M Series B Financing Led by New Enterprise Associates" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/edimer-secures-18m-series-b-financing-led-by-new-enterprise-associates> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2341792/Edimer_Pharmaceuticals> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 18 million",
        "$ 18M" ;
    ns1:when "2013-07-30T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "July 30, 2013" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "Cambridge, Mass" .

<https://1145.am/db/2347984/Series_B_Investment_Domain_Associates_Forward_Ventures_Mpm_Capital_Rusnanomedinvest_Syndax_Pharmaceuticals_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-08-27T11:51:58+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Syndax Pharmaceuticals Secures $ 26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers.",
        "WALTHAM, Mass., Aug. 27, 2013 - Syndax Pharmaceuticals Inc., which is developing epigenetic therapies for treatment-resistant cancers, today announced it has secured a $ 26.6 million Series B financing." ;
    ns1:documentTitle "Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/syndax-pharmaceuticals-secures-26-6-million-series-b-financing-for-advancement-of> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2347984/Syndax_Pharmaceuticals_Inc> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 26.6 Million",
        "$ 26.6 million" ;
    ns1:when "2013-08-27T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2013-Aug-27" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2360415/Venture_Cash_Investment_5am_Ventures_Apposite_Capital_Aravis_Sa_Ruiyi_Versant_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-03-27T12:00:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "As more and more drugmakers set sights on China through partnerships and acquisitions, Sino-American biotech RuiYi is taking a more direct approach, raising $ 15 million in venture cash to develop novel drugs in the country, for the country." ;
    ns1:documentTitle "RuiYi banks $15M from A-list backers to amp up Chinese R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/ruiyi-banks-15m-from-a-list-backers-to-amp-up-chinese-r-d> ;
    ns1:foundName "raising" ;
    ns1:name "raising" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2360415/Ruiyi> ;
    ns1:targetDetails "venture",
        "venture cash" ;
    ns1:valueRaw "$ 15 million" ;
    ns1:whereGeoName "Peoples Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2558803/Seed_Investment_Cap-Cmv_Gmbh_Creathor_Venture_Nrwbank_Peppermint_Venture_Partners_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-03-27T11:44:16+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAP-CMV GmbH Raises New Funds to Further Develop Its Novel hCMV Vaccine and Appoints New CEO.",
        "Cologne, Germany, March 24, 2014 / B3C newswire / - CAP-CMV GmbH, a company focusing exclusively on the development of a novel vaccine protecting against human Cytomegalovirus (hCMV) infection, announced today that it raised in total  1.7 m from its investors Peppermint Venture Partners (PVP) , NRW.Bank, Creathor Venture, KfW and private investors in a combined seed/start-up investment." ;
    ns1:documentTitle "CAP-CMV GmbH Raises New Funds to Further Develop Its Novel hCMV Vaccine and Appoints New CEO" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/cap-cmv-gmbh-raises-new-funds-to-further-develop-its-novel-hcmv-vaccine-and-appoints-new> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2558803/Cap-Cmv_Gmbh> ;
    ns1:targetDetails "seed" ;
    ns1:valueRaw " 1.7 m" ;
    ns1:when "2014-03-24T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "March 24, 2014" ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2593445/Simcere_Pharmaceutical_Group_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2013-08-28T11:55:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NANJING, China, Aug. 28, 2013 /PRNewswire/ - Simcere Pharmaceutical Group (\"Simcere\" or the \"Company\") (NYSE: SCR) , a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, announced today that it has entered into a definitive Agreement and Plan of Merger (the \"Merger Agreement\") with Simcere Holding Limited (\"Parent\") and Simcere Acquisition Limited (\"Merger Sub\") , pursuant to which Parent will acquire Simcere (the \"Transaction\") for US $ 4.83 per ordinary share of the Company (a \"Share\") or US $ 9.66 per American depositary share, each representing two Shares (an \"ADS\") ." ;
    ns1:documentTitle "Simcere Pharmaceutical Group Enters Into Definitive Merger Agreement for Going Private Transaction" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/simcere-pharmaceutical-group-enters-into-definitive-merger-agreement-for-going-private> ;
    ns1:foundName "Merger",
        "acquire" ;
    ns1:name "Merger",
        "acquire" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2593445/Simcere_Pharmaceutical_Group> ;
    ns1:targetName "Simcere" ;
    ns1:whereGeoName "Peoples Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2305441/Equity_Investment_Abcam_Plc_Boundary_Capital_Ltd_Desktop_Genetics_Ltd_Execute_Technologies_Inc_Horizon_Discovery_Ltd_Michael_Martin_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-01T21:30:18+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Desktop Genetics Ltd (DeskGen) , a UK bioinformatics company aiming to revolutionize the way genetic engineers work together, announced today that it has secured an equity investment of 275,000.",
        "Desktop Genetics Ltd Receives 375,000 Funding to Commercialize Genetic Engineering Platform AutoClone." ;
    ns1:documentTitle "Desktop Genetics Ltd Receives 375,000 Funding to Commercialize Genetic Engineering Platform AutoClone" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/desktop-genetics-ltd-receives-%C2%A3375-000-funding-to-commercialize-genetic-engineering-platform> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2305441/Desktop_Genetics_Ltd> ;
    ns1:targetDetails "equity" ;
    ns1:valueRaw "275,000",
        "375,000" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2359468/Series_A_Investment_Aisling_Capital_Orbimed_Advisors_Seragon_Pharmaceuticals_Inc_The_Column_Group_Topspin_Fund_Venbio_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-17T14:32:27+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Seragon Pharmaceuticals Inc. today announced it has raised a total of $ 30 million in a Series A financing to advance the company's pipeline of therapies targeting hormone-driven cancers, including ARN-810 for the treatment of metastatic breast cancer.",
        "Seragon Pharmaceuticals Raises $ 30M in Series A Financing." ;
    ns1:documentTitle "Seragon Pharmaceuticals Raises $30M in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/seragon-pharmaceuticals-raises-30m-series-a-financing> ;
    ns1:foundName "financing",
        "raised" ;
    ns1:name "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2359468/Seragon_Pharmaceuticals_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 30 million",
        "$ 30M" ;
    ns1:when "2013-10-16T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "October 16, 2013" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "San Diego, CA" .

<https://1145.am/db/2229117/Investment_Chv_Capital_Health_Catalyst_Kaiser_Permanente_Ventures_Norwest_Venture_Partners_Partners_Healthcare_Sequoia_Capital_Sorenson_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2014-01-29T18:46:52+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Salt Lake City - based data warehousing and analytics company Health Catalyst announced this week that it has raised $ 41 million to enable $ 50 million product development investment from existing investors Sequoia Capital, Norwest Venture Partners, Kaiser Permanente Ventures, Sorenson Capital, CHV Capital (an Indiana University Health Company) and Partners HealthCare." ;
    ns1:documentTitle "Health Catalyst raises $41 million for product development; Austin City Council raises concerns over athenahealth deal;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/health-catalyst-raises-41-million-for-product-development-austin-city-council-raises-concerns> ;
    ns1:foundName "investment",
        "raised" ;
    ns1:name "investment",
        "raised" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2229117/Health_Catalyst> ;
    ns1:valueRaw "$ 41 million",
        "$ 50 million" ;
    ns1:whereGeoName "Salt Lake City" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5780993/about.rdf> ;
    ns1:whereRaw "Salt Lake City" .

<https://1145.am/db/2340634/Series_B_Investment_Alexandria_Venture_Investments_Amgen_Atara_Biotherapeutics_Celgene_Dag_Ventures_Domain_Associates_Ecor1_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-12-16T22:46:04+00:00"^^xsd:dateTime ;
    ns1:documentExtract "A little more than a year after launching with a portfolio of 6 early-stage assets from Amgen ($ AMGN) , Atara Biotherapeutics has rounded up $ 38.5 million in the first close of its Series B round, fueling its drive into Phase II with a lead asset while teeing up another program for its entry into the clinic." ;
    ns1:documentTitle "Amgen spinoff Atara banks $38.5M as it races ahead with CKD, cancer trials" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/amgen-spinoff-atara-banks-38-5m-as-it-races-ahead-ckd-cancer-trials> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2340634/Atara_Biotherapeutics> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 38.5 million" ;
    ns1:whereGeoName "Thousand Oaks" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5402405/about.rdf> ;
    ns1:whereRaw "Thousand Oaks, CA" .

<https://1145.am/db/2351129/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-11T12:33:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Civitas Therapeutics Secures $ 38 Million in Financing.",
        "September 11, 2013 - Civitas Therapeutics, Inc., a biopharmaceutical company with a lead program in Parkinson's disease that leverages the ARCUS respiratory delivery platform, today announced the successful completion of a $ 38 million Series B financing." ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2351129/Civitas_Therapeutics> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 38 Million",
        "$ 38 million" ;
    ns1:when "2013-09-11T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "September 11, 2013" ;
    ns1:whereGeoName "Chelsea" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4932879/about.rdf> ;
    ns1:whereRaw "CHELSEA, Mass" .

<https://1145.am/db/2356290/Series_B_Investment_Aglaia_Oncology_Fund_Bay_City_Capital_Johnson___Johnson_Development_Corporation_Lsp_Merus_Bv_Novartis_Venture_Fund_Pfizer_Venture_Investments_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-03T11:35:59+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Merus Secures 31 Million in Series B Round Extension.",
        "Utrecht, The Netherlands, October 3, 2013 - Merus B.V., a biopharmaceutical company focusing on innovative human antibody therapeutics, today announced a 31 million (US $ 42 million) extension to its Series B financing round, bringing the total round to 47.6 million (US $ 65 million) ." ;
    ns1:documentTitle "Merus Secures 31 Million in Series B Round Extension" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merus-secures-%E2%82%AC31-million-series-b-round-extension> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2356290/Merus_Bv> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "US $ 42 million",
        "US $ 65 million",
        "31 Million",
        "31 million",
        "47.6 million" ;
    ns1:whereGeoName "Kingdom of Spain" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:whereRaw "Spain" .

<https://1145.am/db/2583466/Series_B_Investment_Alkermes_Plc_Bay_City_Capital_Canaan_Partners_Civitas_Therapeutics_Fountain_Healthcare_Partners_Longitude_Capital_Ra_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-09-11T14:12:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "- Civitas Therapeutics, Inc., a biopharmaceutical company with a lead program in Parkinson's disease that leverages the ARCUS respiratory delivery platform, today announced the successful completion of a $ 38 million Series B financing.",
        "Civitas Therapeutics Secures $ 38 Million in Financing." ;
    ns1:documentTitle "Civitas Therapeutics Secures $38 Million in Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/civitas-therapeutics-secures-38-million-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2583466/Civitas_Therapeutics> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 38 Million",
        "$ 38 million" ;
    ns1:whereGeoName "Chelsea" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4932879/about.rdf> ;
    ns1:whereRaw "CHELSEA, MASS" .

<https://1145.am/db/2347977/Series_E_Investment_Argos_Therapeutics_Inc_Aurora_Funds_Forbion_Capital_Green_Cross_Corporation_Of_Seoul_Korea_Intersouth_Partners_Caisse_De_Depot_Et_Placement_De_Quebec_Lumira_Capital_Morningside_Group_Tvm_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-08-26T12:02:17+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Argos Therapeutics Secures $ 42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy.",
        "DURHAM, N.C. - August 26, 2013 - Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis technology platform, today announced that it has secured $ 42.5 million in a Series E financing." ;
    ns1:documentTitle "Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/argos-therapeutics-secures-42-5-million-financing-funds-pivotal-phase-3-adapt-trial-for> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2347977/Argos_Therapeutics_Inc> ;
    ns1:targetDetails "Series E" ;
    ns1:valueRaw "$ 30 Million",
        "$ 42.5 Million",
        "$ 42.5 million" ;
    ns1:when "2013-08-26T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "August 26, 2013" ;
    ns1:whereGeoName "Russian Federation" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:whereRaw "Russia" .

<https://1145.am/db/2362566/Series_C_Investment_Alta_Partners_Immune_Design_Osage_Partners_Proquest_Investments_Sanofi-Genzyme_Bioventures_The_Column_Group_Topspin_Partners_Versant_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2013-10-30T12:51:13+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Immune Design Raises Up to $ 49 Million Series C Financing.",
        "SEATTLE and SAN FRANCISCO, Oct. 30, 2013 /PRNewswire/ - Immune Design, a biotechnology company focused on the development of novel immune - based therapies for cancer and other chronic conditions, today announced it has closed a Series C financing totalling up to $ 49 million." ;
    ns1:documentTitle "Immune Design Raises Up to $49 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immune-design-raises-up-to-49-million-series-c-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2362566/Immune_Design> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 32.5 million",
        "16.5 million",
        "Up to $ 49 Million",
        "up to $ 49 million" ;
    ns1:when "2013-10-30T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct. 30, 2013" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

